{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## CORD-19-Research-Data-Set\n",
    "\n",
    "This workbook covers the process of querying data from a local MongoDB.\n",
    "\n",
    "For this code to run on your local system, you'll need to download the CORD-19 data set and built a local MongoDB from a subset of the JSON files. \n",
    "\n",
    "### Download data\n",
    "\n",
    "You can download the data from:\n",
    "\n",
    "https://pages.semanticscholar.org/coronavirus-research\n",
    "\n",
    "I'm using the non-commercial use subset (76mb download). To keep the example size manageable, I moved the first twenty records into the data directory of this repository. \n",
    "\n",
    "### Install Mongo\n",
    "\n",
    "Instructions for installation are available on the MongoDB Manual at:\n",
    "\n",
    "https://docs.mongodb.com/manual/installation/\n",
    "\n",
    "### Mongo Client\n",
    "\n",
    "You may want to get familiar with the MongoDB client and CRUD operations before working with python. \n",
    "\n",
    "### Build a MongoDB from the CORD-19 Subset\n",
    "\n",
    "start mongo\n",
    "```\n",
    "mongo\n",
    "```\n",
    "\n",
    "create a MongoDB named \"covid-noncomm-use-dataset\"\n",
    "```\n",
    "use covid-noncomm-use-dataset\n",
    "```\n",
    "\n",
    "to import the CORD-19 JSON files into a new collection named \"pmc_content\", run the script (in the data directory with the JSON files)\n",
    "```\n",
    "for f in *.json\n",
    "do\n",
    "\tmongoimport --db=covid-noncomm-use-subset --collection=pmc_content --file=$f\n",
    "done\n",
    "```\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "from pymongo import MongoClient"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "client = MongoClient()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "db = client['covid-noncomm-use-subset']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5ea71355b3c4f60e9b93e8f9'), 'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Editorial'}, {'text': \"The Middle East Respiratory Syndrome (MERS) crisis in Korea is coming to an end, but that's not the end of the story. The World Health Organization (WHO) has warned that the MERS crisis was a 'wakeup call. ' Like Severe Acute Respiratory Syndrome (SARS) in 2003 and swine flu in 2009, epidemic outbreaks will continue to happen anywhere. Korea was simply unlucky. In retrospect, it is regrettable to say that we could have done much better. Scholars and colleagues in the medical informatics field should take a moment and think hard about how we can work to fight against another epidemic invasion in the future.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'The Ebola epidemic of 2013 is the largest such outbreak on record, influencing many nations in Africa as well as other countries [1] . The WHO expert panel has pointed out the inadequate emergency care response and has recommended more effective mechanisms for research and development. Others have strongly recommended WHO to innovate because recent Ebola outbreaks have been radically different from previous events, and they have tended to be simultaneous and parallel: \"Highly mobile populations, the spread of Ebola into densely populated cities ... made this epidemic of many outbreaks difficult to control [2] . \"', 'cite_spans': [{'start': 129, 'end': 132, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 613, 'end': 616, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': \"Other criticisms also include outdated therapeutic protocols, irrelevant information, untimely communication, delays in decision-making due to uncoordinated leadership, unreasonable social behavior, and so on. The recom- tems. The NEDSS can be called a medical informatics leader, which provides a standardized information infrastructure with HL7, LOINC, and SNOMED-CT. Highly useful information is well organized and ready to be used in the US-CDC [6] , so we don't have to reinvent the wheel. All we need is to find a conduit for connection. For example, the task of disease surveillance for MERS is relatively small compared to NEDSS. Using the cell phone data network, we can instantly establish a real-time patient tracking system to monitor 3-tuple data (time, location, temperature) in the country. Cell phone rental can help track down suspicious foreign visitors from arrival to departure. With the support of ISO standards, global healthcare networking is not a hard nut to crack.\", 'cite_spans': [{'start': 449, 'end': 452, 'text': '[6]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'When the MERS epidemic outbreak was on the headline news, many attempts were made to compare MERS with tuberculosis. That is, the mortality rate of MERS is far below that of tuberculosis, so it was argued that there was no need to worry about it. The point was clear, but the timing was not right. Have you ever got a thorn stuck under your fingernail? Saying that \"It\\'s OK you\\'re not bleeding\" or \"You won\\'t die from it\" would not comfort anybody at all. I would venture to say that it is surely mistaken to compare the pain at present with a probable outcome yet to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': 'When hospital visitors became MERS patients, a typical example of nosocomial infection was demonstrated. It was a surprise attack, and the whole country was shaken and panicked. The WHO experts reminded us that hospital shopping greatly contributed to the rapid spread of MERS in Korea. We have to understand why patients pursue hospital shopping. The death of professionalism may be an unexpected result of the fashionable social network services (SNS). Patients use SNSs to data-mine their own diagnosis and prescription and then seek medical advice to compare with their own ideas about their personal health. However, such patients suggesting their own diagnoses and treatments can be described as \"Jack of all trades, master of none\". Medical informatics leadership was nowhere to be found. When the MERS epidemic turned fatal, SNS was the only rescue. MERS was unknown to the general public, and the cure was uncertain, so chaos was bound to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In Korea medical informatics is on trial. We are standing in front of a river that runs medicine. IT has been trying to cross the river but has never been successful, especially in medical expert systems. The other side of the river is not the land of promise. Because the river of medicine eventu-ally runs into the ocean of the human race, why don't we go with the river instead? There is no doubt that doctors and nurses were the final frontiers in the MERS battle. Despite all the wonderful scientific accomplishments, the MERS crisis reminds us that clinical expertise is the most important value as clearly as ever. Technology can help medicine, not the other way around; that is the way medical informatics should go in between.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"Taoism states that dynamic balance can be obtained from two opposite powers competing with each other, unifying as a complete energy. Similarly, medical informatics should be able to balance between analog medicine and digital technology to create a new value. Medicine is composed of oldfashioned values, such as rapport, which is fading out slowly. Digital technology should help clinicians restore the humanistic flavor of medicine by eliminating managerial overload in healthcare settings. Technology can start from there. Neither Cyclops (the single-eyed monster in Homer's Odyssey) nor Argus (the 100-eyed giant in Greek mythology) is ideal to find the right path. Two-eyed medical informaticians must walk through the path on the mountain ridge, carefully looking at both sides of IT and medicine for balance.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In 1347, the first biological warfare took place in the siege of Caffa (now Feodosia in Ukraine) on the Black Sea coast. The Mongol army with bubonic plague catapulted corpse of those who had died from the Black Death over the city walls. Fleeing from central trading ports along the coast, infected inhabitants and rats may have carried the disease throughout Europe [7] (The plague might have killed more than 25 million people). A few regions survived. They simply closed their ports of entry and isolated patients in remote places. The same principle still applies. When in doubt, isolate an infection until it's clear. Time goes by, technology advances, but the basic principle never changes. Medicine should stay analog with a little hint of digital. That's all it takes to fight against any epidemic or pandemic attack in the future.\", 'cite_spans': [{'start': 368, 'end': 371, 'text': '[7]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Report of the Ebola Interim Assessment Panel', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"What we've learned about fighting Ebola\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Dhillon', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Srikrishna', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Harvard Business Review; c2015', 'authors': [{'first': '(', 'middle': [], 'last': 'Boston', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ma)', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The next epidemic: lessons from Ebola', 'authors': [{'first': 'B', 'middle': [], 'last': 'Gates', 'suffix': ''}], 'year': 2015, 'venue': 'N Engl J Med', 'volume': '372', 'issn': '15', 'pages': '1381--1385', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'US Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Centers for Disease Control and Prevention; c2015', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Digital disease detection: harnessing the Web for public health surveillance', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Brownstein', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Freifeld', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Madoff', 'suffix': ''}], 'year': 2009, 'venue': 'N Engl J Med', 'volume': '360', 'issn': '21', 'pages': '2153--2160', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'History of biological warfare and bioterrorism', 'authors': [{'first': 'V', 'middle': [], 'last': 'Barras', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Microbiol Infect', 'volume': '20', 'issn': '6', 'pages': '497--502', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': 'Hune Cho http://dx.doi.org/10.4258/hir.2015.21.3.141', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea713694867d6c5a9bc5a31'), 'paper_id': '0a003aa69f43cee4357f1e943df79a8b87c0a88e', 'metadata': {'title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen', 'authors': [{'first': 'Paula', 'middle': [], 'last': 'Tucci', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Verónica', 'middle': [], 'last': 'Estevez', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Lorena', 'middle': [], 'last': 'Becco', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Florencia', 'middle': [], 'last': 'Cabrera-Cabrera', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Germán', 'middle': [], 'last': 'Grotiuz', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Eduardo', 'middle': [], 'last': 'Reolon', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Mónica', 'middle': [], 'last': 'Marín', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': 'marin@fcien.edu.uym.marín.'}]}, 'abstract': [{'text': 'Bovine Respiratory Disease is the most costly disease that affects beef and dairy cattle industry. Its etiology is multifactorial, arising from predisposing environmental stress conditions as well as the action of several different respiratory pathogens. This situation has hindered the development of effective control strategies. Although different type of vaccines are available, many currently marketed vaccines are based on inactivated cultures of the main viral and bacterial agents involved in this pathology. The molecular composition of commercial veterinary vaccines is a critical issue. The present work aims to define at the proteomic level the most relevant valence of a line of commercial respiratory vaccines widely used in Central and South America. Since Mannheimia haemolytica is responsible for most of the disease associated morbid-mortality, we focused on the main proteins secreted by this pathogen, in particular Leukotoxin A, its main virulence factor. By Western blot analysis and mass spectrometry, Leukotoxin A was identified as a major component of (http://creativecommons.org/licenses/by-nc-nd/4.0/). M. haemolytica culture supernatants. We also identified other ten M. haemolytica proteins, including outer membrane proteins, periplasmic transmembrane solute transporters and iron binding proteins, which are relevant to achieve protective immunity against the pathogen. This work allowed a detailed molecular characterization of this vaccine component, providing evidence of its quality and efficacy. Furthermore, our results contributed to the identification of several proteins of interest as subunit vaccine candidates.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Bovine Respiratory Disease (BRD) is one of the leading causes of death and economic loss for the beef and dairy cattle industry. It has an estimated annual cost to the worldwide cattle industry of over $3 billion (Potter, 2015) . This multifactorial syndrome can be caused either by viral or bacterial pathogens. Viral agents include bovine respiratory syncytial virus (BRSV) (Gershwin et al., 2000) , parainfluenza III virus (PI-3) (Fulton et al., 2000) , bovine viral diarrhea virus (BVDV) (Ridpath, 2010) and bovine corona virus (BCV) (Autio et al., 2007) . These respiratory viruses along with some mycoplasmal agents are generally the primary infectious agents involved in BRD (Potter, 2015) . This initial infection establishes a respiratory environment predisposing to the colonization and replication of pathogenic bacteria, including Mannheimia haemolytica (Al-Ghamdi et al., 2000) , Pasteurella multocida (Dabo et al., 2007) and Histophilus somni (Corbeil, 2007) , the former being responsible for up to 50% of the disease associated mortality (Narayanan et al., 2002; Potter, 2015) . M. haemolytica is a Gram negative opportunistic bacterium. Although it is a common bacterium of the upper respiratory tract and nasopharynx of healthy ruminants, it can also act as an opportunistic pathogen infecting the lower respiratory tract under stressful situations such as shipping, adverse environmental conditions or previous respiratory viral infection (Youssef et al., 2004; Orouji et al., 2012) .', 'cite_spans': [{'start': 213, 'end': 227, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 376, 'end': 399, 'text': '(Gershwin et al., 2000)', 'ref_id': 'BIBREF22'}, {'start': 433, 'end': 454, 'text': '(Fulton et al., 2000)', 'ref_id': 'BIBREF19'}, {'start': 492, 'end': 507, 'text': '(Ridpath, 2010)', 'ref_id': 'BIBREF43'}, {'start': 538, 'end': 558, 'text': '(Autio et al., 2007)', 'ref_id': 'BIBREF4'}, {'start': 682, 'end': 696, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 866, 'end': 890, 'text': '(Al-Ghamdi et al., 2000)', 'ref_id': 'BIBREF1'}, {'start': 915, 'end': 934, 'text': '(Dabo et al., 2007)', 'ref_id': 'BIBREF14'}, {'start': 957, 'end': 972, 'text': '(Corbeil, 2007)', 'ref_id': 'BIBREF12'}, {'start': 1054, 'end': 1078, 'text': '(Narayanan et al., 2002;', 'ref_id': 'BIBREF37'}, {'start': 1079, 'end': 1092, 'text': 'Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 1458, 'end': 1480, 'text': '(Youssef et al., 2004;', 'ref_id': 'BIBREF52'}, {'start': 1481, 'end': 1501, 'text': 'Orouji et al., 2012)', 'ref_id': None}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Being BRD a multifactorial disease, the development of effective control strategies has been difficult to accomplish. Vaccination against viral and bacterial pathogens involved in BRD is a useful tool to reduce the risk of this disease. Many commercial respiratory vaccines are composed by inactivated cultures of the most relevant pathogens (Edwards, 2010; Rodrigues et al., 2015) . These multivalent formulations are designed to reduce the impact of viral infections and to neutralize the severe associated bacterial infections. Therefore, to guarantee the efficacy of BRD vaccines, it is important to achieve a complete characterization of the antigens included in the vaccine and to verify the presence of those molecules critical for establishing an efficient immunological protection.', 'cite_spans': [{'start': 342, 'end': 357, 'text': '(Edwards, 2010;', 'ref_id': 'BIBREF16'}, {'start': 358, 'end': 381, 'text': 'Rodrigues et al., 2015)', 'ref_id': 'BIBREF44'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In this work we attempt to characterize the main proteins of M. haemolytica in a polyvalent inactivated BRD line of vaccines currently commercialized in Central and South America (Neumosan, Virbac Uruguay S.A. (former Santa Elena), http:// www.santaelena.com.uy). Among them we emphasize the study of Leukotoxin A (LKT), its main virulence factor, which has been shown to play an important role in the development of a protective immunity against the pathogen (Confer et al., 2009 ).', 'cite_spans': [{'start': 460, 'end': 480, 'text': '(Confer et al., 2009', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'LKT is a potent cytolytic toxin, with an apparent molecular weight (MW) of 105 kDa, actively secreted by all serotypes of the bacterium during the logarithmic phase of in vitro growth (Shewen and Wilkie, 1985; Chang et al., 1987) . It belongs to the family of the RTX (repeat in toxin) pore-forming cytolysins, which have been linked with the virulence of other bacterial species (Lo et al., 1987; Lainson et al., 1996) . It specifically targets ruminant leukocytes and plays a major role in pathogenesis of BRD by impairing the primary lung defense mechanism and by inducing inflammation as a consequence of leukocyte lysis (Conlon et al., 1991) . This phenomenon has been correlated with its ability to bind and interact with the ruminant beta2-integrin Lymphocyte Function-associated Antigen 1 (LFA-1) (CD11a/CD18) (Zecchinon et al., 2005; Singh et al., 2011) . Neutralizing antibodies generation against the cytolytic toxin is relevant for achieving a high level of protection (Mosier et al., 1989) . Immunity against M. haemolytica also requires antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988) and iron-regulated outer membrane proteins (Potter et al., 1999) .', 'cite_spans': [{'start': 184, 'end': 209, 'text': '(Shewen and Wilkie, 1985;', 'ref_id': 'BIBREF47'}, {'start': 210, 'end': 229, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 380, 'end': 397, 'text': '(Lo et al., 1987;', 'ref_id': 'BIBREF34'}, {'start': 398, 'end': 419, 'text': 'Lainson et al., 1996)', 'ref_id': 'BIBREF28'}, {'start': 625, 'end': 646, 'text': '(Conlon et al., 1991)', 'ref_id': 'BIBREF11'}, {'start': 818, 'end': 842, 'text': '(Zecchinon et al., 2005;', 'ref_id': 'BIBREF53'}, {'start': 843, 'end': 862, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}, {'start': 981, 'end': 1002, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 1102, 'end': 1127, 'text': '(Shewen and Wilkie, 1988)', 'ref_id': 'BIBREF48'}, {'start': 1171, 'end': 1192, 'text': '(Potter et al., 1999)', 'ref_id': 'BIBREF40'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Our aim is to bring more insight into the molecular composition of a M. haemolytica inactivated antigen used in bovine commercial vaccines, focusing on the identification of relevant secreted or surface-exposed proteins. This knowledge will support the development of specific quality control techniques to assist the optimization and standardization of the industrial vaccine production process.', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': '2.1. Laboratory scale M. haemolytica culture A seed culture was prepared by inoculation of an aliquot of master seed bank (MSB) of M. haemolytica serotype A1 (production strain code B059) in TSB-BHI (Tryptic Soy Broth, Brain Heart Infusion, Porcine) and incubation at 37.0 ± 1.0°C, for 12 h with orbital agitation (220 rpm). Inoculum was prepared by a 1:100 dilution of the seed culture in TSB-BHI and further incubation at 37.0 ± 1.0°C with orbital agitation until an optical density at 600 nm (OD 600nm ) of 0.2 to 0.3 units was reached. A benchtop fermentor (Biostat A, New Brunswick) with 2 L of fermentation media (TSB-BHI supplemented with 0.4% glucose) was inoculated with 20 mL of the inoculum culture (1:100 dilution). The fermentation culture was grown at 37.0 ± 1.0°C with dissolved oxygen set above 40% and variable Article No~e00158 agitation. During fermentation, samples were taken every one hour to measure OD 600nm , dissolved oxygen (%), glucose concentration (mg/dL) and pH. The culture was harvested when it reached stationary growth phase. Samples and the final culture were centrifuged at 8000×g for 30 min at 4°C and culture supernatants were stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Materials and methods'}, {'text': 'M. haemolytica culture for vaccine antigen preparation was performed following the industrial standardized protocol. Culture media used was developed by Virbac Uruguay S.A. and is based on protein hydrolysates, yeast extract, dextrose, and sodium and potassium salts. The inoculum was prepared as previously described using 1 vial of production seed of M. haemolytica serotype A1 (production strain code B059). The production fermentor was inoculated with a 1:100 dilution of the inoculum and the culture was performed at 37°C with automatic agitation and aeration until the end of the logarithmic growth phase. After harvesting, culture was inactivated by incubation at 37°C with formaldehyde 0.5% (v/v) during 24 h. To obtain culture supernatant the inactivated culture was centrifuged at 8000×g for 30 min at 4°C. Inactivated culture supernatant was stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Industrial M. haemolytica antigen preparation'}, {'text': 'Specific primers were designed to amplify a portion of LKT which contains the Cterminal domain of the protein. An in silico prediction of the location of linear Bcell epitopes was performed using Bepipred algorithm (Larsen et al., 2006) . As previously reported (Lee et al., 2001) , the portion of LktA with more immunogenic epitopes was the C-terminal domain. Therefore, a sequence including the main predicted epítopes (amino acid 713 to 873) was selected. M. haemolytica (production strain code B059) was cultured as the seed culture described above.', 'cite_spans': [{'start': 215, 'end': 236, 'text': '(Larsen et al., 2006)', 'ref_id': 'BIBREF29'}, {'start': 262, 'end': 280, 'text': '(Lee et al., 2001)', 'ref_id': None}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Culture was centrifuged at 10000×g and the cell pellet was stored at −70°C. M. haemolytica genomic DNA was extracted using a standard protocol (Ausubel et al., 1999) and partial LKT sequence was amplified by PCR. For LKT expression, restriction sites were included in primers for a directional cloning of LKT sequence in pET28a(+) vector (Novagen). E. coli BL21 DE3 (Novagen) competent cells were transformed with the construct and stored at −70°C in 15% glycerol. Plasmid DNA was isolated from E. coli using a commercial kit (QiaPrep Spin Miniprep, Qiagen). Plasmid sequence was confirmed by DNA sequencing at Institut Pasteur Montevideo (Uruguay). For LKT expression, a culture was performed in ZYM-5052 auto induction medium (Studier, 2005) for 18-20 h at 37.0 ± 1.0°C. As expected, by SDS-PAGE a band of approximately 40 kDa corresponding to the recombinant protein was observed. The protein was purified by IMAC chromatography (HisTrap HP, GE Healthcare) in an ÄKTA Purifier 100 (GE Healthcare). The Article No~e00158 purified protein was dialyzed against PBS 1X pH 7.4 and quantified by BCA (Pierce BCA Protein Assay Kit, Thermo Scientific).', 'cite_spans': [{'start': 143, 'end': 165, 'text': '(Ausubel et al., 1999)', 'ref_id': None}, {'start': 728, 'end': 743, 'text': '(Studier, 2005)', 'ref_id': 'BIBREF50'}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Two New Zealand white rabbits (2.5 Kg body weight) were maintained in the experimental animal facility (Instituto de Higiene, Universidad de la República, Uruguay) in accordance with animal procedures approved by the Honorary Commission of Animal Experimentation (CHEA protocol No 071140-000771-11).', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Both rabbits were immunized subcutaneously with 50 ug of recombinant LKT, on days 0 and 21 of the immunization protocol. Blood samples were taken on days 21, 45 and 115, and sera were prepared and stored at −20°C. Serum titers were determined by ELISA using 0.1 μg/well of recombinant LKT for coating, serum dilutions of 1:100 to 1:100.000, and conjugate dilution of 1:10.000 (Goat antirabbit IgG (whole molecule)-Peroxidase, Sigma). High titer sera were pooled and purified by protein A chromatography (HiTraprProtein A, GE Healthcare). Purified IgG reactivity against native and recombinant LKT was evaluated by Western blot as described below.', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Culture supernatants were analyzed by 12% SDS-PAGE and coomassie blue staining (Ausubel et al., 1999) . Molecular weight markers used were PageRuler Prestained Protein Ladder (Thermo Scientific) and Prestained Protein Ladder Broad Range (NEB).', 'cite_spans': [{'start': 79, 'end': 101, 'text': '(Ausubel et al., 1999)', 'ref_id': None}], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For Western blot analysis, proteins were transferred onto a nitrocellulose membrane (Hybond-C Extra, Amersham Biosciences) for one hour at 400 mA.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Rabbit antibodies against recombinant LKT, produced and purified by our work group, were used to identify LKT in culture supernatants. Briefly, membranes were incubated for 1 h at room temperature with anti-LKT antibodies at final concentration of 17.5 μg/mL in PBS 1X pH 7.4, 5% low fat milk, with gentle agitation. For antigen-antibody detection membranes were incubated for 1 h at room temperature with a 1:5000 dilution of anti-rabbit IgG (whole molecule)alkaline phosphatase antibody produced in goat (Sigma) in PBS 1X pH 7.4, 5% low fat milk. The intensity of resulting bands was quantified using a Molecular Imaging Software (Carestream Health Inc).', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For immune response evaluation bovine sera obtained from a calf infected with M. haemolytica and from a healthy calf were gently provided by Virbac Uruguay.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Inactivated and non inactivated culture supernatant samples analyzed by SDS-PAGE were transferred onto membranes, as previously described. Membranes were incubated for 1 h at room temperature with a 1:500 dilution of each serum and afterwards for 1 h at room temperature with a 1:5000 dilution of anti-bovine', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'IgG-HRP (Novex), all in PBS 1X pH 7.4, 5% low fat milk. Detection was performed using TMB liquid substrate system for membranes (Sigma).', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Inactivated culture supernatant obtained from the industrial process was concentrated 20X by ultrafiltration (Vivaspin 500, 5 kDa, GE Healthcare) and analyzed by SDS-PAGE and coomassie blue staining. The most defined and intense bands were identified by peptide mass fingerprinting at Institut Pasteur Montevideo (Uruguay) using a 4800 MALDI TOF/TOF Analyzer (Applied Biosystems). Peptides from each sample were obtained by trypsin treatment (Sequencing Grade, Promega) overnight at 37°C. Peptide mass spectra were acquired as previously described (Lima et al., 2011) and MS/MS collision induced dissociation experiments of selected peptides were performed. Proteins were identified by NCBInr database searching with peptide m/z values using MASCOT search engine (Matrix Science) (Perkins et al., 1999) with the following searching parameters: monoisotopic mass tolerance, 0.08 Da; fragment mass tolerance, 0.45 Da and one missing tryptic cleavage allowed. Significant scores (p < 0.05) were used as criteria for positive protein identification.', 'cite_spans': [{'start': 548, 'end': 567, 'text': '(Lima et al., 2011)', 'ref_id': 'BIBREF32'}, {'start': 780, 'end': 802, 'text': '(Perkins et al., 1999)', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'Mass spectrometry (MS)'}, {'text': 'During M. haemolytica laboratory scale fermentation, parameters such as glucose concentration, dissolved oxygen, optical density (OD 600nm ) and pH were determined in samples taken every one hour of culture. This fermentation showed a kinetic profile compatible with typical bacterial growth in a batch system (Fig. 1B) . Culture was harvested ten hours after fermentation start, at the beginning of the stationary growth phase.', 'cite_spans': [], 'ref_spans': [{'start': 310, 'end': 319, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'Supernatant samples of a M. haemolytica laboratory scale culture were analyzed in order to evaluate the LKT accumulation in the supernatant. To identify LKT specific anti-LKT antibodies were produced. In preliminary evaluation experiments, we confirmed that these antibodies showed the expected reactivity against native and recombinant LKT and a good specific antibody titer. By means of these antibodies we identified LKT as a single defined band of approximately 110 kDa in culture supernatant samples of M. haemolytica (Fig. 1A) . In parallel, the presence of LKT in this protein band was confirmed by MS analysis (MS/MS protein score 408, protein sequence coverage 36%).', 'cite_spans': [], 'ref_spans': [{'start': 523, 'end': 532, 'text': '(Fig. 1A)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'The intensity of the specific LKT band detected by Western blot was determined by molecular imaging software. This analysis showed that LKT expression Article No~e00158 correlates with growth kinetics, being associated with exponential growth phase of M. haemolytica (Fig. 1B) , as previously reported (Chang et al., 1987) . Therefore, the presence of LKT was verified in the culture supernatant of the M. haemolytica production strain, during the exponential growth phase of the culture.', 'cite_spans': [{'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 267, 'end': 276, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'For proteomic analysis, industrial antigen was prepared according to vaccine production protocol. Culture supernatant was obtained and concentrated by ultrafiltration. After SDS-PAGE electrophoresis and coomassie blue staining, selected bands were recovered for MS identification ( Fig. 2A) . This approach allowed the statistically significant identification of 11 proteins of M. haemolytica in the industrial antigen (Table 1) . LKT was identified, in accordance with previous results of laboratory scale fermentation, among other relevant proteins.', 'cite_spans': [], 'ref_spans': [{'start': 282, 'end': 290, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF1'}, {'start': 419, 'end': 428, 'text': '(Table 1)', 'ref_id': None}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Some of these are outer membrane proteins (OMPs), which along with LKT are critical to achieve a protective immunity to the pathogen Singh et al., 2011) . Subcellular in silico localization, predicted using free access PSORTb software (available at http://psort.hgc.jp/), indicated that most of the identified proteins are periplasmic (7/11), with others being extracellular (1/11) or located in the outer cell membrane (2/11).', 'cite_spans': [{'start': 133, 'end': 152, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}], 'ref_spans': [], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Although most proteins coincided with their theoretical MW (Table 1) Article No~e00158 (Fig. 2B ). This behavior of LKT in electrophoresis could be explained by crosslinking caused by formaldehyde treatment leading to high molecular weight structures.', 'cite_spans': [], 'ref_spans': [{'start': 59, 'end': 68, 'text': '(Table 1)', 'ref_id': None}, {'start': 87, 'end': 95, 'text': '(Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Immune reactivity of a serum obtained from a M. haemolytica infected calf against culture supernatant was addressed by Western blot. As shown in Fig. 2B several bands of both inactivated and non inactivated culture supernatant were specifically recognized by infected bovine serum and not by healthy bovine serum. Among them, LKT was the more reactive band. Ayalew et al., 2011) . (Rabus et al., 1999; Eidam et al., 2013) .', 'cite_spans': [{'start': 358, 'end': 378, 'text': 'Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}, {'start': 381, 'end': 401, 'text': '(Rabus et al., 1999;', 'ref_id': 'BIBREF42'}, {'start': 402, 'end': 421, 'text': 'Eidam et al., 2013)', 'ref_id': None}], 'ref_spans': [{'start': 145, 'end': 152, 'text': 'Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': '10 HisJ-like histidine ABC transport system-periplasmic binding protein MHH_RS14805 328 M9WWE6 28.0 kDa Periplasmic ABC transporter system component involved in molecule export through bacterial membrane (Eidam et al., 2013) . Belongs to ompA family (Eidam et al., 2013) . Ortholog Omp P6 reported as immunogen in other species (Roier et al., 2013; Alvarez et al., 2015) . * For this search protein scores greater than 87 are significant (p < 0.05).', 'cite_spans': [{'start': 204, 'end': 224, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 250, 'end': 270, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 328, 'end': 348, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 349, 'end': 370, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'disease associated morbid-mortality (Potter, 2015) , this kind of information is of utmost importance.', 'cite_spans': [{'start': 36, 'end': 50, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Available data demonstrate that the protective immunity against M. haemolytica can be acquired by neutralizing antibodies against Leukotoxin A (Mosier et al., 1989) , as well as antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988; Confer et al., 1995; Confer et al., 2009) . In order to promote an effective immune response, the presence of these pivotal elements in a BRD vaccine formulation is crucial.', 'cite_spans': [{'start': 143, 'end': 164, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 229, 'end': 254, 'text': '(Shewen and Wilkie, 1988;', 'ref_id': 'BIBREF48'}, {'start': 255, 'end': 275, 'text': 'Confer et al., 1995;', 'ref_id': 'BIBREF10'}, {'start': 276, 'end': 296, 'text': 'Confer et al., 2009)', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Based on previous reports that detected Leukotoxin A activity in bacterium-free culture supernatant from logarithmic-phase cultures (Chang et al., 1987) , Neumosan line of vaccines includes inactivated culture supernatants of an industrial optimized M. haemolytica culture. In this work we confirmed that LKT secretion is linked to the exponential growth phase during the antigen production culture, representing one of the primary secreted components. In culture supernatant, LKT was detected as a single band with the expected MW (approx. 110 kDa) (Lo et al., 1985; Chang et al., 1987) . Interestingly, after formaldehyde treatment, LKT was detected as a higher MW band (>230 kDa),', 'cite_spans': [{'start': 132, 'end': 152, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 550, 'end': 567, 'text': '(Lo et al., 1985;', 'ref_id': 'BIBREF33'}, {'start': 568, 'end': 587, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'suggesting that the toxin could be arranged as a high order structure, which could be fixed by this cross-linking agent (Klockenbusch and Kast, 2010) . This finding is in agreement with previous reports that showed that the molecular weight of native LKT in culture supernatant was higher than 400 kDa (Chang et al., 1987) .', 'cite_spans': [{'start': 120, 'end': 149, 'text': '(Klockenbusch and Kast, 2010)', 'ref_id': 'BIBREF27'}, {'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Besides LKT identification, we delved further into the characterization of the culture supernatant protein profile. By MS we identified other 10 proteins of M. haemolytica. Most of them are periplasmic and outer membrane proteins, which due to their extracellular location and exposure to the host immune system could represent interesting candidates to play a key role in the protection against this pathogen. It is worth mentioning that we also identified a cytoplasmic protein involved in carbohydrate metabolism (Formate C-acetyltransferase). This finding could be explained by some cellular lysis that could occur during bacterial growth and inactivation (Derzelle et al., 2005) , hence we cannot rule out that the culture supernatant may contain some cytoplasmic proteins.', 'cite_spans': [{'start': 660, 'end': 683, 'text': '(Derzelle et al., 2005)', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Some of the outer membrane proteins identified in this work have been reported as important immunogens and have been evaluated as recombinant subunit antigens due to their protective vaccine potential (Ayalew et al., 2011; Guzman-Brambila et al., 2012) . In particular, vaccination of mice and cattle with recombinant serotype specific antigen 1 (rSsa1) stimulated high antibody responses (Ayalew et al., 2011) . Besides, a \"Best-Reciprocal-Blast-Hit\" approach was performed in order to determine that M. haemolytica outer membrane protein P6 identified in this work, is ortholog to Omp P6 of H. somni and P. multocida, both reported as Article No~e00158', 'cite_spans': [{'start': 201, 'end': 222, 'text': '(Ayalew et al., 2011;', 'ref_id': 'BIBREF8'}, {'start': 223, 'end': 252, 'text': 'Guzman-Brambila et al., 2012)', 'ref_id': None}, {'start': 389, 'end': 410, 'text': '(Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'immunogenic in recent reports (Roier et al., 2013; Alvarez et al., 2015) . In that sense, the natural occurrence of these proteins in the inactivated vaccine antigen indicates that the vaccine contains the main components required for protection against M. haemolytica.', 'cite_spans': [{'start': 30, 'end': 50, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 51, 'end': 72, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Different proteins belonging to the ATP-binding cassette (ABC) transporter superfamily were identified in the commercial antigen. ABC transport systems are essential for many processes of the cell, such as uptake of amino acids, peptides, carbohydrates and metal ions in an ATP coupled process. There is increasing evidence that these transport systems play either direct or indirect roles in the virulence and pathogenicity of bacteria (Garmory and Titball, 2004) . In a recent work, other ABC transporters were identified as immunodominant proteins from M. haemolytica and H. somni in cattle immunized with a commercial cellular vaccine, confirming that the surface exposed transporters of these species are immunogenic (Alvarez et al., 2015) . Interestingly, our results evidence that ABC transporters are relevant components in the vaccine antigen, and therefore could be potential targets for the development of antibacterial subunit vaccines (Garmory and Titball, 2004) .', 'cite_spans': [{'start': 437, 'end': 464, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}, {'start': 722, 'end': 744, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 948, 'end': 975, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Finally, we also identified an iron-regulated periplasmic protein YfeA, previously described as immunodominant in animals immunized with a cellular M. haemolytica vaccine (Alvarez et al., 2015) , as well as with an OMP-enriched fraction of M. haemolytica (Ayalew et al., 2010) .', 'cite_spans': [{'start': 171, 'end': 193, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 255, 'end': 276, 'text': '(Ayalew et al., 2010)', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Taken together, these observations support the protective potential of several of the proteins indentified in the M. haemolytica antigen. As an additional outcome anti-LKT antibodies developed for LKT identification can be used in routine quantitative assays in order to establish acceptance criteria of antigen commercial batches.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Author contribution statement Contributed reagents, materials, analysis tools or data.', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}, {'text': 'Article No~e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}], 'bib_entries': {'BIBREF1': {'ref_id': 'b1', 'title': 'Serotyping of Mannheimia (Pasteurella) haemolytica isolates from the upper Midwest United States', 'authors': [{'first': 'G', 'middle': ['M'], 'last': 'Al-Ghamdi', 'suffix': ''}, {'first': 'T', 'middle': ['R'], 'last': 'Ames', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Baker', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Walker', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Chase', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Frank', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}], 'year': 2000, 'venue': 'J. Vet. Diagn. Invest', 'volume': '12', 'issn': '6', 'pages': '576--578', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach', 'authors': [{'first': 'A', 'middle': ['H'], 'last': 'Alvarez', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Gutierrez-Ortega', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hernandez-Gutierrez', 'suffix': ''}], 'year': 2015, 'venue': 'Can. J. Vet. Res', 'volume': '79', 'issn': '4', 'pages': '339--342', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds', 'authors': [{'first': 'T', 'middle': [], 'last': 'Autio', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pohjanvirta', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Holopainen', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Rikula', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Pentikainen', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Huovilainen', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Rusanen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Soveri', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Sihvonen', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pelkonen', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': ['D'], 'last': 'Hartson', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}], 'year': 2010, 'venue': 'Proteomics', 'volume': '10', 'issn': '11', 'pages': '2151--2164', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'A', 'middle': ['E'], 'last': 'Wilson', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Clin. Vaccine Immunol', 'volume': '18', 'issn': '12', 'pages': '2067--2074', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Step', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Wray', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Hansen', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 2009, 'venue': 'Vaccine', 'volume': '27', 'issn': '11', 'pages': '1771--1776', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Mccraw', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Durham', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Morton', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 1995, 'venue': 'Vet. Immunol. Immunopathol', 'volume': '47', 'issn': '1-2', 'pages': '101--110', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Conlon', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '2', 'pages': '587--591', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Histophilus somni host-parasite relationships', 'authors': [{'first': 'L', 'middle': ['B'], 'last': 'Corbeil', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '151--160', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Identification and characterization of the Pasteurella haemolytica leukotoxin', 'authors': [{'first': 'Y', 'middle': ['F'], 'last': 'Chang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Young', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Post', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Struck', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '10', 'pages': '2348--2354', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Pasteurella multocida and bovine respiratory disease', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Dabo', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Taylor', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '129--150', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein', 'authors': [{'first': 'S', 'middle': [], 'last': 'Derzelle', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bolotin', 'suffix': ''}, {'first': 'M', 'middle': ['Y'], 'last': 'Mistou', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Rul', 'suffix': ''}], 'year': 2005, 'venue': 'Appl. Environ. Microbiol', 'volume': '71', 'issn': '12', 'pages': '8597--8605', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Control methods for bovine respiratory disease for feedlot cattle', 'authors': [{'first': 'T', 'middle': ['A'], 'last': 'Edwards', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '273--284', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Complete genome sequence of Mannheimia haemolytica strain 42548 from a case of bovine respiratory disease', 'authors': [{'first': 'S', 'middle': [], 'last': 'Schwarz', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Fulton', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Purdy', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'J', 'middle': ['T'], 'last': 'Saliki', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Loan', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Burge', 'suffix': ''}], 'year': 2000, 'venue': 'Can. J. Vet. Res', 'volume': '64', 'issn': '3', 'pages': '151--159', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies', 'authors': [{'first': 'H', 'middle': ['S'], 'last': 'Garmory', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Titball', 'suffix': ''}], 'year': 2004, 'venue': 'Infect. Immun', 'volume': '72', 'issn': '12', 'pages': '6757--6763', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves', 'authors': [{'first': 'L', 'middle': ['J'], 'last': 'Gershwin', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Gunther', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Anderson', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Woolums', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Mcarthur-Vaughan', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Randel', 'suffix': ''}, {'first': 'G', 'middle': ['A'], 'last': 'Boyle', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Friebertshauser', 'suffix': ''}, {'first': 'P', 'middle': ['S'], 'last': 'Mcinturff', 'suffix': ''}], 'year': 2000, 'venue': 'Am. J. Vet. Res', 'volume': '61', 'issn': '3', 'pages': '291--298', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge', 'authors': [{'first': 'A', 'middle': ['E'], 'last': 'Ortuno-Sahagun', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Res. Vet. Sci', 'volume': '93', 'issn': '3', 'pages': '1293--1300', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Complete closed genome sequences of Mannheimia haemolytica serotypes A1 and A6, isolated from cattle', 'authors': [{'first': 'G', 'middle': ['P'], 'last': 'Harhay', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Koren', 'suffix': ''}, {'first': 'A', 'middle': ['M'], 'last': 'Phillippy', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Mcvey', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kuszak', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Clawson', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Harhay', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Heaton', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Chitko-Mckown', 'suffix': ''}, {'first': 'T', 'middle': ['P'], 'last': 'Smith', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2 Isolates D171 and D35 recovered from bovine pneumonia', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Hauglund', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Tatum', 'suffix': ''}, {'first': 'D', 'middle': ['O'], 'last': 'Bayles', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}], 'year': 2015, 'venue': 'Genome Announc', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1', 'authors': [{'first': 'C', 'middle': [], 'last': 'Klockenbusch', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kast', 'suffix': ''}], 'year': 2010, 'venue': 'J. Biomed. Biotechnol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin', 'authors': [{'first': 'F', 'middle': ['A'], 'last': 'Lainson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Murray', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Davies', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Donachie', 'suffix': ''}], 'year': 1996, 'venue': 'Microbiology', 'volume': '142', 'issn': '', 'pages': '2499--2507', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Improved method for predicting linear B-cell epitopes', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Larsen', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Lund', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nielsen', 'suffix': ''}], 'year': 2006, 'venue': 'Immunome Res', 'volume': '2', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2: ovine and bovine isolates', 'authors': [{'first': 'P', 'middle': ['K'], 'last': 'Lawrence', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Kittichotirat', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Bumgarner', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Mcdermott', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Herndon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Knowles', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Srikumaran', 'suffix': ''}], 'year': 2010, 'venue': 'J. Bacteriol', 'volume': '192', 'issn': '4', 'pages': '1167--1168', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches', 'authors': [{'first': 'A', 'middle': [], 'last': 'Lima', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Duran', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Schujman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Marchissio', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Portela', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Obal', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Pritsch', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'De Mendoza', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Cervenansky', 'suffix': ''}], 'year': 2011, 'venue': 'J. Proteomics', 'volume': '74', 'issn': '9', 'pages': '1720--1734', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'C', 'middle': ['N'], 'last': 'Greer', 'suffix': ''}], 'year': 1985, 'venue': 'Infect. Immun', 'volume': '50', 'issn': '3', 'pages': '667--671', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '9', 'pages': '1987--1996', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Cooney', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '10', 'pages': '3398--3406', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Mosier', 'suffix': ''}, {'first': 'K', 'middle': ['R'], 'last': 'Simons', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}, {'first': 'K', 'middle': ['D'], 'last': 'Clinkenbeard', 'suffix': ''}], 'year': 1989, 'venue': 'Infect. Immun', 'volume': '57', 'issn': '3', 'pages': '711--716', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Leukotoxins of gram-negative bacteria', 'authors': [{'first': 'S', 'middle': ['K'], 'last': 'Narayanan', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Nagaraja', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Chengappa', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Stewart', 'suffix': ''}], 'year': 2002, 'venue': 'Vet. Microbiol', 'volume': '84', 'issn': '4', 'pages': '337--356', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Probability-based protein identification by searching sequence databases using mass spectrometry data', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Perkins', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Pappin', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Creasy', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Cottrell', 'suffix': ''}], 'year': 1999, 'venue': 'Electrophoresis', 'volume': '20', 'issn': '18', 'pages': '3551--3567', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb', 'authors': [{'first': 'A', 'middle': ['A'], 'last': 'Potter', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Schryvers', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Ogunnariwo', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Hutchins', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Watts', 'suffix': ''}], 'year': 1999, 'venue': 'Pathogenesis', 'volume': '27', 'issn': '4', 'pages': '197--206', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Bovine respiratory disease', 'authors': [{'first': 'T', 'middle': [], 'last': 'Potter', 'suffix': ''}], 'year': 2015, 'venue': 'Livestock (Electronic)', 'volume': '20', 'issn': '1', 'pages': '14--18', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'TRAP transporters: an ancient family of extracytoplasmic solute-receptor-dependent secondary active transporters', 'authors': [{'first': 'R', 'middle': [], 'last': 'Rabus', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Jack', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Kelly', 'suffix': ''}, {'first': 'M', 'middle': ['H'], 'last': 'Saier', 'suffix': ''}], 'year': 1999, 'venue': 'Microbiology', 'volume': '145', 'issn': '', 'pages': '3431--3445', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The contribution of infections with bovine viral diarrhea viruses to bovine respiratory disease', 'authors': [{'first': 'J', 'middle': [], 'last': 'Ridpath', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '335--348', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Effects of vaccination against respiratory Article No~e00158 pathogens on feed intake, metabolic, and inflammatory responses in beef heifers', 'authors': [{'first': 'M', 'middle': ['C'], 'last': 'Rodrigues', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Cooke', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Marques', 'suffix': ''}, {'first': 'B', 'middle': ['I'], 'last': 'Cappellozza', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Arispe', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Keisler', 'suffix': ''}, {'first': 'D', 'middle': ['W'], 'last': 'Bohnert', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': 'Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles', 'authors': [{'first': 'S', 'middle': [], 'last': 'Roier', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Fenninger', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Leitner', 'suffix': ''}, {'first': 'G', 'middle': ['N'], 'last': 'Rechberger', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Reidl', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schild', 'suffix': ''}], 'year': 2013, 'venue': 'Int. J. Med. Microbiol', 'volume': '303', 'issn': '5', 'pages': '247--256', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1985, 'venue': 'Am. J. Vet. Res', 'volume': '46', 'issn': '5', 'pages': '1212--1214', 'other_ids': {}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1988, 'venue': 'Can. J. Vet. Res', 'volume': '52', 'issn': '1', 'pages': '30--36', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'Mannheimia haemolytica: bacterial-host interactions in bovine pneumonia', 'authors': [{'first': 'K', 'middle': [], 'last': 'Singh', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Ritchey', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Vet. Pathol', 'volume': '48', 'issn': '2', 'pages': '338--348', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'Protein production by auto-induction in high density shaking cultures', 'authors': [{'first': 'F', 'middle': ['W'], 'last': 'Studier', 'suffix': ''}], 'year': 2005, 'venue': 'Protein Expr. Purif', 'volume': '41', 'issn': '1', 'pages': '207--234', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Sequence diversity of the leukotoxin (lktA) gene in caprine and ovine strains of Mannheimia haemolytica', 'authors': [{'first': 'C', 'middle': [], 'last': 'Vougidou', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Sandalakis', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Psaroulaki', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Petridou', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ekateriniadou', 'suffix': ''}], 'year': 2013, 'venue': 'Vet. Rec', 'volume': '172', 'issn': '16', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Effect of bovine granulocyte colony-stimulating factor on the development of pneumonia caused by Mannheimia haemolytica', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Youssef', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Clark', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Caswell', 'suffix': ''}], 'year': 2004, 'venue': 'Vet. Pathol', 'volume': '41', 'issn': '6', 'pages': '649--657', 'other_ids': {}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'How Mannheimia haemolytica defeats host defence through a kiss of death mechanism', 'authors': [{'first': 'L', 'middle': [], 'last': 'Zecchinon', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fett', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Desmecht', 'suffix': ''}], 'year': 2005, 'venue': 'Vet. Res', 'volume': '36', 'issn': '2', 'pages': '133--156', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': ', LKT was identified by MS in a higher than expected MW band (>230 kDa). This result was confirmed by Western blot of inactivated supernatant using anti-LKT antibodies M. haemolytica culture growth and LKT secretion profile. A. Anti-LKT Western blot of M. haemolytica culture supernatant samples from different fermentation time points. M: fermentation media, T1-T10: samples from culture kinetics (1-10 h). MW: Molecular weight marker. B. M. haemolytica culture growth curve and kinetics of Leukotoxin secretion. Optical density (OD) at 600 nm, glucose concentration (mg/dL) and band intensity of LKT expressed in arbitrary units (AU) are plotted versus culture growth time measured in hours.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'This work provides an exhaustive molecular characterization of an inactivated culture supernatant of M. haemolytica included in a line of polyvalent commercial bovine vaccines (Neumosan, Virbac Uruguay). Since M. haemolytica is the main etiological agent of BRD and is also responsible for a high proportion of the Identification of M. haemolytica culture supernatant proteins. A. M. haemolytica proteins of inactivated culture supernatant (iCSN) resolved in SDS-PAGE and stained with coomassie blue. Bands corresponding to the proteins analyzed by MS (MALDI TOF/TOF) are numbered and referred to on Table 1. For complete image see Fig. S1 (Supplementary material). B. Analysis of culture supernatant proteins by Western blot. Left: M. haemolytica inactivated (iCSN) and non inactivated culture supernatant (CSN) proteins probed with anti-rLKT rabbit serum. Middle: Reactivity of bovine M. haemolytica infected serum against M. haemolytica iCSN and CSN. Right: Reactivity of bovine healthy serum against M. haemolytica iCSN and CSN. MW: Molecular weight marker.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Proteins identified in culture supernatant of M. haemolytica.', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': 'Paula Tucci: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Verónica Estevez, Lorena Becco: Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Florencia Cabrera-Cabrera: Performed the experiments; Analyzed and interpreted the data. Germán Grotiuz: Performed the experiments; Analyzed and interpreted the data;', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We thank Viviana Sánchez for critical reading of the manuscript, Danilo Segovia for assistance in cloning techniques and Florencia Arezzo for technical assistance during M. haemolytica laboratory scale fermentation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}, {'text': 'This work was partially financed by Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing interest statement'}, {'text': 'This work was partially supported by Agencia Nacional de Investigación e Innovación (ANII, Uruguay), Alianzas para la Innovación (ALI_2_2013_1_4783) and Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding statement'}, {'text': 'Supplementary content related to this article has been published online at http://dx. doi.org/10.1016/j.heliyon.2016.e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Additional information'}]}\n",
      "{'_id': ObjectId('5ea715dc30a90fa7fd8cb4e5'), 'paper_id': '0afa3ea846396533c7ca515968abcfea3f895082', 'metadata': {'title': 'Bone Marrow Dendritic Cells from Mice with an Altered Microbiota Provide Interleukin 17A-Dependent Protection against Entamoeba histolytica Colitis', 'authors': [{'first': 'Stacey', 'middle': ['L'], 'last': 'Burgess', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Erica', 'middle': [], 'last': 'Buonomo', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Maureen', 'middle': [], 'last': 'Carey', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Carrie', 'middle': [], 'last': 'Cowardin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Caitlin', 'middle': [], 'last': 'Naylor', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Zannatun', 'middle': [], 'last': 'Noor', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Marsha', 'middle': [], 'last': 'Wills-Karp', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'William', 'middle': ['A'], 'last': 'Petri', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Burgess', 'middle': [], 'last': 'Sl', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Buonomo', 'middle': ['E'], 'last': '', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Carey', 'middle': ['M'], 'last': 'Cowardin', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'C', 'middle': [], 'last': '', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Naylor', 'middle': ['C'], 'last': '', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Noor', 'middle': ['Z'], 'last': 'Wills-Karp M', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': '', 'middle': [], 'last': 'Petri', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [{'text': 'There is an emerging paradigm that the human microbiome is central to many aspects of health and may have a role in preventing enteric infection. Entamoeba histolytica is a major cause of amebic diarrhea in developing countries. It colonizes the colon lumen in close proximity to the gut microbiota. Interestingly, not all individuals are equally susceptible to E. histolytica infection. Therefore, as the microbiota is highly variable within individuals, we sought to determine if a component of the microbiota could regulate susceptibility to infection. In studies utilizing a murine model, we demonstrated that colonization of the gut with the commensal Clostridia-related bacteria known as segmented filamentous bacteria (SFB) is protective during E. histolytica infection. SFB colonization in this model was associated with elevated cecal levels of interleukin 17A (IL-17A), dendritic cells, and neutrophils. Bone marrow-derived dendritic cells (BMDCs) from SFB-colonized mice had higher levels of IL-23 production in response to stimulation with trophozoites. Adoptive transfer of BMDCs from an SFB ؉ to an SFB ؊ mouse was sufficient to provide protection against E. histolytica. IL-17A induction during BMDC transfer was necessary for this protection.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'IMPORTANCE Entamoeba histolytica is the causative agent of amebiasis, an infectious disease that contributes significantly to morbidity and mortality due to diarrhea in the developing world. We showed in a murine model that colonization with the commensal members of the Clostridia known as SFB provides protection against E. histolytica and that dendritic cells from SFBcolonized mice alone can recapitulate protection. Understanding interactions between enteropathogens, commensal intestinal bacteria, and the mucosal immune response, including dendritic cells, will help in the development of effective treatments for this disease and other infectious and inflammatory diseases. The demonstration of immune-mediated protection due to communication from the microbiome to the bone marrow represents an emerging field of study that will yield unique approaches to the development of these treatments. ., WA. 2014. Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis. mBio 5(6):e01817-14.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'port neutrophil infiltration in inflammatory-disease models (10) (11) (12) (13) . Neutrophils play a central role in cell-mediated clearance of parasites and may be important in clearance of E. histolytica (14) . IgA was also implicated in protection against E. histolytica infection in a childhood cohort and thus may be involved in immunity against the parasite (15) . Given that IL-17A and downstream mediators are important in immunity to E. histolytica, components of the intestinal microbiota that elicit exogenous IL-17A in the absence of intestinal pathology might prove to be protective during amebiasis.', 'cite_spans': [{'start': 60, 'end': 64, 'text': '(10)', 'ref_id': 'BIBREF9'}, {'start': 65, 'end': 69, 'text': '(11)', 'ref_id': 'BIBREF10'}, {'start': 70, 'end': 74, 'text': '(12)', 'ref_id': 'BIBREF11'}, {'start': 75, 'end': 79, 'text': '(13)', 'ref_id': 'BIBREF12'}, {'start': 206, 'end': 210, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 364, 'end': 368, 'text': '(15)', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': ''}, {'text': 'Segmented filamentous bacteria (SFB), or \"Candidatus Savagella,\" are genetically and morphologically unique members of the Clostridia. They represent an uncultivable component of the mammalian intestinal microbiota, reported to colonize both humans and mice (16) (17) (18) . It has been demonstrated that SFB colonization induces a potent Th17 helper response in the intestine that is dependent on intestinal dendritic cells (19, 20) . SFB colonization is associated with higher intestinal levels of both IL-17A and the damage-associated molecular pattern molecule and antimicrobial peptide serum amyloid A (SAA) (20) . SFB infection influences many models of intestinal and extraintestinal inflammatory disease, suggesting that it may have a systemic influence on the immune response (21) (22) (23) . Indeed, a growing body of literature suggests that intestinal colonization with commensal microorganisms can have extraintestinal effects on dendritic-cell precursors that influence susceptibility to pathogens (24) (25) (26) . It is also quite possible that mediators induced by the intestinal microbiota in the serum might influence the bone marrow in such a way as to prime DCs to provide protection against, or exacerbate, enteropathogen infections (27, 28) .', 'cite_spans': [{'start': 258, 'end': 262, 'text': '(16)', 'ref_id': 'BIBREF15'}, {'start': 263, 'end': 267, 'text': '(17)', 'ref_id': 'BIBREF16'}, {'start': 268, 'end': 272, 'text': '(18)', 'ref_id': 'BIBREF17'}, {'start': 425, 'end': 429, 'text': '(19,', 'ref_id': 'BIBREF18'}, {'start': 430, 'end': 433, 'text': '20)', 'ref_id': 'BIBREF19'}, {'start': 613, 'end': 617, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 785, 'end': 789, 'text': '(21)', 'ref_id': 'BIBREF20'}, {'start': 790, 'end': 794, 'text': '(22)', 'ref_id': 'BIBREF21'}, {'start': 795, 'end': 799, 'text': '(23)', 'ref_id': 'BIBREF22'}, {'start': 1012, 'end': 1016, 'text': '(24)', 'ref_id': 'BIBREF23'}, {'start': 1017, 'end': 1021, 'text': '(25)', 'ref_id': 'BIBREF24'}, {'start': 1022, 'end': 1026, 'text': '(26)', 'ref_id': 'BIBREF25'}, {'start': 1254, 'end': 1258, 'text': '(27,', 'ref_id': 'BIBREF26'}, {'start': 1259, 'end': 1262, 'text': '28)', 'ref_id': 'BIBREF27'}], 'ref_spans': [], 'section': ''}, {'text': 'Bone marrow dendritic cells (BMDCs) are known to be able to recapitulate effector functions of some in vivo antigen-presentingcell populations, and lipopolysaccharide (LPS)-matured BMDCs have been effectively utilized in adoptive transfer experiments to examine the influence of dendritic cells in infection models (28) (29) (30) . Thus, to begin to examine the influence of changes in the microbiota on resistance to amebic infection, we utilized a murine model and BMDCs to explore what influence colonization with SFB had on intestinal infection with E. histolytica. Here we dem-onstrate that colonization with SFB provided protection against E. histolytica colitis and that bone marrow dendritic cells (BM-DCs) derived from SFB-colonized mice were able to recapitulate protection in mice that had not been colonized with the bacteria. Protection mediated by BMDCs from SFB ϩ mice was IL-17A dependent. These data suggest that intestinal colonization with a commensal bacterium can alter bone marrow in such a way as to provide protection against parasite infection.', 'cite_spans': [{'start': 315, 'end': 319, 'text': '(28)', 'ref_id': 'BIBREF27'}, {'start': 320, 'end': 324, 'text': '(29)', 'ref_id': 'BIBREF28'}, {'start': 325, 'end': 329, 'text': '(30)', 'ref_id': 'BIBREF29'}], 'ref_spans': [], 'section': ''}, {'text': 'Cohousing Charles River (SFB ؉ ) and Jackson mice (SFB ؊ ) protected Jackson CBA mice from E. histolytica infection. To test if alteration if the intestinal microbiota could alter susceptibility to E. histolytica infection, mice from two different animal vendors, Charles River and Jackson Laboratories, were cohoused (31, 32) . The SFB status of mice after 3 weeks of cohousing was measured via qPCR and Gram stains. The cohoused mice were then challenged with E. histolytica trophozoites (2 ϫ 10 6 ) via intracecal injection. Seven days later, E. histolytica and SFB burden were measured by qPCR. Cohousing mice transferred SFB (Fig. 1A) , and potentially many other bacteria, and provided protection against E. histolytica infection (Fig. 1B) .', 'cite_spans': [{'start': 318, 'end': 322, 'text': '(31,', 'ref_id': 'BIBREF30'}, {'start': 323, 'end': 326, 'text': '32)', 'ref_id': 'BIBREF31'}], 'ref_spans': [{'start': 630, 'end': 639, 'text': '(Fig. 1A)', 'ref_id': 'FIGREF0'}, {'start': 736, 'end': 745, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'RESULTS'}, {'text': 'Segmented filamentous bacteria specifically protect against E. histolytica and induce increased IL-17A, IL-23, neutrophils, and dendritic cells in the intestine and SAA in the blood. As cohousing of mice both transferred SFB and was protective against E. histolytica infection, we sought to determine if SFB specifically provided protection against the ameba. We directly colonized CBA/J mice from Jackson Laboratories with SFB by orogastric gavage with SFB-monoassociated feces resuspended in phosphate-buffered saline (PBS), provided by the Yakult Central Institute for Microbiological Studies, 1 week prior to E. histolytica infection. Mice became colonized with SFB following gavage ( Fig. 2A) and were protected from infection with the ameba (Fig. 2B) . Additionally, there was increased IL-17A and IL-23 expression before ( onized mice after E. histolytica infection. We also observed increased SAA in serum in SFB-colonized mice after ameba infection (Fig. 2G ). BMDCs derived from SFB-colonized mice have an increased capacity to produce IL-23 that is partially recapitulated with SAA treatment. IL-23 is a key cytokine in the generation and maintenance of IL-17A-producing cells (33) . SAA can directly induce IL-23 from both DCs and macrophages (20, 34) and is known to upregulate an epigenetic mediator, JMJD3 (33) , that specifically increases IL-23 production in a macrophage cell line. Thus, as SFB increased frequency of intestinal DCs, IL-23, IL-17A expression, and circulating serum SAA, we examined the capacity of bone marrow DCs from SFB-infected mice to produce IL-23 in response to trophozoites. BMDCs were generated from SFB-free and SFB-infected mice and treated with trophozoites for 24 h. BMDCs and trophozoites were cocultured in RPMI with 10% fetal bovine serum (FBS) under aerobic conditions rather than in ameba culture medium under anaerobic conditions, as both DCs and trophozoites were viable after 24 h in these media; however, some cell death had occurred, as observed via trypan blue. Cytokines in the supernatants were then determined by enzyme-linked immunosorbent assay (ELISA) (IL-23; R&D Systems). BMDCs derived from mice that were colonized with SFB produced significantly more IL-23 in response to trophozoites (Fig. 3A) . These data suggested that SFB altered bone marrow cells in such a way as to favor increased IL-23 production. We hypothesized that SAA induced in the serum by intestinal SFB colonization could influence BMDCs to produce increased IL-23. Therefore, we wanted to test if the presence of SAA during the differentiation of SFB-free BMDCs might alter them in such a way that they also would produce more IL-23. Thus, SAA (10 g/l) was added for the first 4 days of bone marrow DC culture. Addition of SAA to BMDC culture from SFB-free mice partially recapitulated the increased IL-23 seen in BMDCs derived from SFB ϩ mice (Fig. 3B ). This suggested that SAA might be at least partially responsible for alteration of bone marrow DCs in this model. BMDCs from SFB ؉ but not SFB ؊ mice migrated to the intestine. To test if the increase in DCs in the gut of SFB ϩ mice was due to a direct effect on the bone marrow, BMDCs from SFBcolonized and SFB-free mice were adoptively transferred to SFB Ϫ mice. For in vivo transfers, day 6 BMDC from SFB Ϫ and SFB ϩ mice were matured with LPS (1 g/ml), and 16 h later, cells were stained with carboxyfluorescein succinimidyl ester (CFSE; 10 nM), and 5 ϫ 10 5 cells were administered via intraperitoneal injection. CFSE ϩ BMDC were detected in the lamina propria but only from SFB ϩ mice (Fig. 4) . The ability of SFB ϩ BMDCs to home to the gut may help explain the increased numbers of DCs seen in the lamina propria of SFB-colonized mice during E. histolytica infection (Fig. 2E) . These results were consistent with other studies that have shown that adoptive transfer of LPS-matured BMDCs results in DC trafficking to the intestine (28, 29, 35) .', 'cite_spans': [{'start': 1188, 'end': 1192, 'text': '(33)', 'ref_id': 'BIBREF32'}, {'start': 1255, 'end': 1259, 'text': '(20,', 'ref_id': 'BIBREF19'}, {'start': 1260, 'end': 1263, 'text': '34)', 'ref_id': 'BIBREF33'}, {'start': 1321, 'end': 1325, 'text': '(33)', 'ref_id': 'BIBREF32'}, {'start': 3932, 'end': 3936, 'text': '(28,', 'ref_id': 'BIBREF27'}, {'start': 3937, 'end': 3940, 'text': '29,', 'ref_id': 'BIBREF28'}, {'start': 3941, 'end': 3944, 'text': '35)', 'ref_id': 'BIBREF34'}], 'ref_spans': [{'start': 689, 'end': 697, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF1'}, {'start': 747, 'end': 756, 'text': '(Fig. 2B)', 'ref_id': 'FIGREF1'}, {'start': 958, 'end': 966, 'text': '(Fig. 2G', 'ref_id': 'FIGREF1'}, {'start': 2254, 'end': 2263, 'text': '(Fig. 3A)', 'ref_id': None}, {'start': 2882, 'end': 2890, 'text': '(Fig. 3B', 'ref_id': None}, {'start': 3584, 'end': 3592, 'text': '(Fig. 4)', 'ref_id': None}, {'start': 3768, 'end': 3777, 'text': '(Fig. 2E)', 'ref_id': 'FIGREF1'}], 'section': 'RESULTS'}, {'text': 'Adoptive transfer of BMDCs from SFB colonized mice was sufficient to provide protection against infection in an IL-17Adependent manner. We hypothesized that BMDCs from SFBcolonized mice may provide protection against amebiasis and that the mechanism of this protection might be via downstream induction of IL-17A. To explore this idea, we adoptively transferred BMDCs (5 ϫ 10 5 cells) from SFB Ϫ or SFB ϩ mice to SFB Ϫ mice prior to E. histolytica infection. Indeed, we found that BMDCs from SFB ϩ mice were sufficient both to confer protection (Fig. 5A) and to recapitulate the increase in neutrophils (Fig. 5B ) observed with SFB colonization alone. Blockade of IL-17A during transfer abrogated protection (Fig. 5C ) and neutrophil influx (Fig. 5D ) and led to a decrease in IgA induction (Fig. 5E ). We concluded that IL-17A and downstream innate and perhaps adaptive immune responses underlie the protection observed during adoptive transfer of BMDCs from SFB ϩ mice.', 'cite_spans': [], 'ref_spans': [{'start': 545, 'end': 554, 'text': '(Fig. 5A)', 'ref_id': 'FIGREF3'}, {'start': 603, 'end': 611, 'text': '(Fig. 5B', 'ref_id': 'FIGREF3'}, {'start': 708, 'end': 716, 'text': '(Fig. 5C', 'ref_id': 'FIGREF3'}, {'start': 741, 'end': 749, 'text': '(Fig. 5D', 'ref_id': 'FIGREF3'}, {'start': 791, 'end': 799, 'text': '(Fig. 5E', 'ref_id': 'FIGREF3'}], 'section': 'RESULTS'}, {'text': 'We have demonstrated that alteration of the microbiota via introduction of the commensal bacteria SFB impacts susceptibility to amebic infection in a murine model, likely via its impact on the mucosal immune system (36) . There was an increase in IL-17A and IL-23 expression in the intestines of SFB-colonized mice prior to and following amebic infection and a relative increase in neu- trophils after amebic infection. Our laboratory and others have shown that these effectors may provide protection against E. histolytica (14) . We also observed increased CD11c ϩ MHCII ϩ cells in the intestines of mice, suggesting that dendritic cells induced by SFB may also help mediate protection against infection. This is not surprising given that Goto et al. recently demonstrated that major histocompatibility complex class II (MHC-II)-dependent presentation of SFB antigens by intestinal DCs is crucial for Th17 cell induction (37) . Interestingly, protection in our model appeared to involve not only the mucosal immune response in the gut but also the bone marrow. Resistance to amebic colitis was adoptively transferred to SFB-free mice with bone marrow-derived dendritic cells (BM-DCs) from SFB-colonized mice. This suggested that SFB alteration of bone marrow cells might underlie protection against amebic colitis. BMDCs derived from SFB colonized mice produced more IL-23 in response to E. histolytica trophozoites than BMDCs from mice that were not colonized with the bacteria. However, this response was not specific to E. histolytica, as increased IL-23 production from SFB ϩ BMDCs was also seen with LPS and SAA treatment (data not shown). This suggests that SFB colonization of the intestine has conditioned bone marrow cells to be more responsive to stimulation with pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs), such as SAA, or, alternatively, that there were shifts in the populations of dendritic-cell precursors present in the bone marrow prior to BMDC culture in SFB-colonized mice.', 'cite_spans': [{'start': 215, 'end': 219, 'text': '(36)', 'ref_id': 'BIBREF35'}, {'start': 524, 'end': 528, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 922, 'end': 926, 'text': '(37)', 'ref_id': 'BIBREF36'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Therefore, in this model of SFB-induced alteration of the microbiome, it is not yet clear how SFB altered bone marrow cells. Future studies will be required to examine the possibility of shifts in dendritic-cell precursors or changes in responsiveness to DAMPS and PAMPS. In this context, intestinal inflammation or colonization with commensal organisms has been shown to alter populations of bone marrow progenitor cells (25, 26, 38) . However, exactly how cross talk occurs between the intestine and bone marrow is not well understood. Recent work has shown that gut microbiota metabolism of dietary fiber can increase the concentration of circulating short-chain fatty acids (SCFAs) and that treatment of mice with the SCFA propionate led to alterations in bone marrow hematopoiesis (39) . A similar mechanism might underlie protection in our model of E. histolytica/SFB coinfection. However, SFB-mediated alteration of the metabolome has not been explored. SFB do, however, have an intimate association with the gut intestinal mucosa, likely due to their limited metabolic capability (40, 41) . These bacteria are thus known to alter host gene expression in the intestine (41) . SAA has been shown to be upregulated in the intestines of mice colonized with SFB (20) , and we have demonstrated that SAA is also increased in the serum of E. histolytica/SFB-infected mice. SAA is known to be produced by many cell types, including epithelial cells (3), and SFB tightly associate with the intestinal mucosa (4). SAA-dependent induction of Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression has also been described (33) , including IL-23, in SAA-stimulated macrophages. It is thus not hard to imagine that circulating SAA might act on bone marrow cells to alter IL-23 induction via epigenetic mechanisms (33) . Indeed, we cultured BMDCs from SFB Ϫ mice in the presence of SAA for the first 4 days of culture and then removed the mediator, and the resulting differentiated BMDCs produced significantly more IL-23 than BMDCs from SFB Ϫ mice alone. However, this did not fully recapitulate the increase in IL-23 production seen in BMDCs from SFB-colonized mice. This study is not conclusive, however, and multiple mechanisms, perhaps including alteration of metabolic by-products, may underlie the increased IL-23 production seen in BMDCs from SFBcolonized mice. We propose a model in which intestinal colonization with SFB leads to induction of systemically circulating me-diators, perhaps including SAA, that alter bone marrow dendriticcell precursors so that they provide protection against E. histolytica via induction of downstream effectors, which may include IL-17A, neutrophils, and IgA (Fig. 6) .', 'cite_spans': [{'start': 422, 'end': 426, 'text': '(25,', 'ref_id': 'BIBREF24'}, {'start': 427, 'end': 430, 'text': '26,', 'ref_id': 'BIBREF25'}, {'start': 431, 'end': 434, 'text': '38)', 'ref_id': 'BIBREF37'}, {'start': 786, 'end': 790, 'text': '(39)', 'ref_id': 'BIBREF38'}, {'start': 1088, 'end': 1092, 'text': '(40,', 'ref_id': 'BIBREF39'}, {'start': 1093, 'end': 1096, 'text': '41)', 'ref_id': 'BIBREF40'}, {'start': 1176, 'end': 1180, 'text': '(41)', 'ref_id': 'BIBREF40'}, {'start': 1265, 'end': 1269, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 1641, 'end': 1645, 'text': '(33)', 'ref_id': 'BIBREF32'}, {'start': 1830, 'end': 1834, 'text': '(33)', 'ref_id': 'BIBREF32'}], 'ref_spans': [{'start': 2718, 'end': 2726, 'text': '(Fig. 6)', 'ref_id': 'FIGREF4'}], 'section': 'DISCUSSION'}, {'text': 'In conclusion, we have demonstrated that colonization with a specific component of the intestinal microbiota, SFB, provided protection against infection with the protozoan pathogen E. histolytica and that BMDCs and downstream IL-17A induction recapitulated this protection. This work therefore suggests that alteration of the microbiome can mediate resistance to intestinal infection via extraintestinal effects on bone marrow cells. Future studies will be required to describe and understand the underlying mechanisms of these microbiome-induced changes in bone marrow dendritic-cell precursors.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Male 5-week-old CBA/J mice (Jackson Laboratories, Charles River) were housed in a specific-pathogen-free facility in micro-isolator cages and provided autoclaved food (Lab Diet 5010) and water ad libitum. All procedures were approved by the Institutional Animal Care and Use Committee of the University of Virginia.', 'cite_spans': [], 'ref_spans': [], 'section': 'Mice.'}, {'text': 'E. histolytica culture and intracecal injection. Animal-passaged HM1:IMSS E. histolytica trophozoites were cultured from cecal contents of infected mice in complete trypsin-yeast-iron (TYI-33) medium supplemented with Diamond vitamin mix (JRH Biosciences), 100 U/ml of penicillin and streptomycin, and bovine serum (Sigma-Aldrich). Prior to injection, trophozoites were grown to log phase, and 2 ϫ 10 6 parasites were suspended in 150 l culture medium and injected intracecally (42) .', 'cite_spans': [{'start': 478, 'end': 482, 'text': '(42)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Mice.'}, {'text': 'SFB colonization. Mice were colonized with SFB by cohousing for 3 weeks with SFB ϩ age-matched mice or directly colonized with SFB by orogastric gavage with SFB-monoassociated feces (a kind gift from the Yakult Central Institute for Microbiological Studies) 1 week prior to E. histolytica infection. SFB-monoassociated feces were independently confirmed to be associated with SFB only, with no presence of other bacteria or fungal contamination, by both Y. Umesaki and us via qPCR, Sanger sequencing, and culture (43) . Quantitative real-time RT-PCR. SFB and E. histolytica colonization were measured by real-time PCR. For SFB colonization, qPCR with Sybr green was performed, and data were normalized to expression of a conserved Eubacteria 16S RNA gene (EUB). Primer sequences are as follows: EUB forward, 5=-ACTCCTACGGGAGGCAGCAGT-3=; EUB reverse, 5=-ATTACCGCGGCTGCTGGC-3=; SFB forward, 5=-GACGCTGAGGCAT GAGAGCAT-3=; SFB reverse, 5=-GACGGCACGGATTGTTATTCA-3=. A 6-carboxyfluorescein (FAM)-labeled probe (44), a standard curve prepared from trophozoites, and quantitative PCR (qPCR) were utilized for E. histolytica quantification; the primer and probe sequences are as follows: Eh-f, AAC AGT AAT AGT TTC TTT GGT TAG TAA AA; Eh-r, CTT AGA ATG TCA TTT CTC AAT TCA T; Eh-YYT, ATT AGT ACA AAA TGG CCA ATT CAT TCA-dark quencher; IL-17A F, 5=-ACTACCTCAA CCGTTCCACG-3=; IL-17A R, 5=-AGAATTCATGTGGTGGTCCAG-3=. Cytokines were measured via qPCR with Sybr green, and data were normalized to expression of S14: IL-23p19F, 5=-GACCCACAAGGACTCAA GGA-3=; IL-23p19 R, 5=-CATGGGGCTATCAGGGAGTA-3=; S14 F, 5=-T GGTGTCTGCCACATCTTTGCATC-3=; S14 R, 5=-AGTCACTCGGCAG ATGGTTTCCTT-3=. Melting temperatures were 60°C for EUB, SFB, IL-17A, and IL-23 and for E. histolytica (44) . Primers and probes were purchased from Integrated DNA Technologies, Coralville, IA, USA.', 'cite_spans': [{'start': 513, 'end': 517, 'text': '(43)', 'ref_id': 'BIBREF42'}, {'start': 1746, 'end': 1750, 'text': '(44)', 'ref_id': 'BIBREF43'}], 'ref_spans': [], 'section': 'Mice.'}, {'text': 'Serum SAA was measured by ELISA (ab157723; Abcam, Cambridge, England).', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'Bone marrow-derived-dendritic-cell (BMDC) culture. Bone marrow cells were harvested from 4 weeks old male CBA/J mice from Jackson Laboratories that had been treated by gavage with PBS or SFB the week prior. Cells were cultured in RPMI with 10% FBS supplemented on days 0 and 3 with granulocyte-macrophage colony-stimulating factor (GM-CSF) (10 ng/ml; Peprotech) and harvested on day 6. For in vitro experiments, 2.5 ϫ 10 5 cells were plated per well of a flat-bottom 96-well dish and treated with trophozoites for 24 h. Cytokines in the supernatants were determined by ELISA (IL-23; R&D Systems).', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'DC transfer. For in vivo transfers, day 6 BMDCs were stimulated with LPS (1 g/ml); 16 h later, cells were washed in PBS, and 5 ϫ 10 5 cells were administered intraperitoneally. For CFSE experiments, cells were stained with CFSE in PBS for 10 min (10 nM) and then washed twice in PBS prior to adoptive transfer.', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'IL-17A blockade. Four-week-old CBA/J mice were treated with 200 g rat anti-mouse IL-17A monoclonal antibody (MAb) (clone M210; Amgen) or rat IgG2a isotype control (clone 2A3; BioXcell) at 3 days before and on the day of BMDC transfer (500,000 intraperitoneally from mice receiving SFB gavage or those not receiving SFB gavage). Mice were challenged intracecally with 2 ϫ 10 6 trophozoites 7 days after BMDC transfer.', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'In vitro culture and flow cytometry of intestinal cells. For intracellular staining, intestinal tissue was digested in Liberase TL (0.17 mg/ml Roche) and DNase (0.5 mg/ml; Sigma) for 45 min at 37°C and processed into a single-cell suspension. A total of 1 ϫ 10 6 cells were incubated with CD16/CD32 MAb (BD Biosciences) to block Fc binding, followed by staining with CD11V-BV421, MHCII-FITC, TCR-beta-APC, B220-APC, CD45.2-APC, Ly6G-PE, Ly6C-Percp Cy 5.5, or CD11b-Pacific Blue and run on an LSR Fortessa cell analyzer (BD Biosciences). The data were analyzed with FlowJo (Tree Star Inc.).', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': \"Statistical analysis. An analysis of variance (ANOVA) followed by the Tukey-Kramer test was used for analysis of differences among multiple groups. Student's t test was used for comparisons between two groups. P values of less than 0.05 were considered significant. Results of representative experiments are shown; all experiments were replicated 2 to 4 times, with 4 to 12 individuals per group.\", 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'Supplemental material for this article may be found at http://mbio.asm.org /lookup/suppl/doi:10.1128/mBio.01817-14/-/DCSupplemental. Figure S1 , EPS file, 1.8 MB.', 'cite_spans': [], 'ref_spans': [{'start': 133, 'end': 142, 'text': 'Figure S1', 'ref_id': 'FIGREF0'}], 'section': 'SUPPLEMENTAL MATERIAL'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'WHO/PAHO informal consultation on intestinal protozoal infections. World Health Organization', 'authors': [{'first': 'O', 'middle': ['M'], 'last': 'De La Sante', 'suffix': ''}], 'year': 2004, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Update on human infections caused by intestinal protozoa', 'authors': [{'first': 'K', 'middle': ['K'], 'last': 'Pierce', 'suffix': ''}, {'first': 'B', 'middle': ['D'], 'last': 'Kirkpatrick', 'suffix': ''}], 'year': 2009, 'venue': 'Curr. Opin. Gastroenterol', 'volume': '25', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh', 'authors': [{'first': 'D', 'middle': [], 'last': 'Mondal', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Minak', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Alam', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Dai', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Korpe', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Haque', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}], 'year': 2012, 'venue': 'Clin. Infect. Dis', 'volume': '54', 'issn': '', 'pages': '185--192', 'other_ids': {'DOI': ['10.1093/cid/cir807']}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study', 'authors': [{'first': 'K', 'middle': ['L'], 'last': 'Kotloff', 'suffix': ''}, {'first': 'J', 'middle': ['P'], 'last': 'Nataro', 'suffix': ''}, {'first': 'W', 'middle': ['C'], 'last': 'Blackwelder', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Nasrin', 'suffix': ''}, {'first': 'T', 'middle': ['H'], 'last': 'Farag', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Panchalingam', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wu', 'suffix': ''}, {'first': 'S', 'middle': ['O'], 'last': 'Sow', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Sur', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Breiman', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Faruque', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Zaidi', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Saha', 'suffix': ''}, {'first': 'P', 'middle': ['L'], 'last': 'Alonso', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Tamboura', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Sanogo', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Onwuchekwa', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Manna', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ramamurthy', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Kanungo', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Ochieng', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Omore', 'suffix': ''}, {'first': 'J', 'middle': ['O'], 'last': 'Oundo', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Hossain', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Das', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ahmed', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Qureshi', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Quadri', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Adegbola', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Antonio', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Hossain', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Akinsola', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Mandomando', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Nhampossa', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Acácio', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Biswas', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'O&apos;reilly', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Mintz', 'suffix': ''}, {'first': 'L', 'middle': ['Y'], 'last': 'Berkeley', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Muhsen', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Sommerfelt', 'suffix': ''}, {'first': 'R', 'middle': ['M'], 'last': 'Robins-Browne', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Levine', 'suffix': ''}], 'year': 2013, 'venue': 'Lancet', 'volume': '382', 'issn': '13', 'pages': '60844--60846', 'other_ids': {'DOI': ['10.1016/S0140-6736(13)60844-2']}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'The dynamic interdependence of amebiasis, innate immunity, and undernutrition. Semin. Immunopathol', 'authors': [{'first': 'H', 'middle': ['P'], 'last': 'Verkerke', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Marie', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '34', 'issn': '', 'pages': '771--785', 'other_ids': {'DOI': ['10.1007/s00281-012-0349-1']}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study', 'authors': [{'first': 'D', 'middle': [], 'last': 'Mondal', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Sack', 'suffix': ''}, {'first': 'B', 'middle': ['D'], 'last': 'Kirkpatrick', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Haque', 'suffix': ''}], 'year': 2006, 'venue': 'Trans. R. Soc. Trop. Med. Hyg', 'volume': '100', 'issn': '', 'pages': '1032--1038', 'other_ids': {'DOI': ['10.1016/j.trstmh.2005.12.012']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Interactions between parasites and microbial communities in the human gut', 'authors': [{'first': 'F', 'middle': [], 'last': 'Berrilli', 'suffix': ''}, {'first': 'Di', 'middle': [], 'last': 'Cave', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Cavallero', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'D&apos;amelio', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Front. Cell. Infect. Microbiol', 'volume': '2', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.3389/fcimb.2012.00141']}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'CD4 ϩ and CD8 ϩ T cell-and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine', 'authors': [{'first': 'X', 'middle': [], 'last': 'Guo', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Barroso', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Lyerly', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}, {'first': 'E', 'middle': ['R'], 'last': 'Houpt', 'suffix': ''}], 'year': 2011, 'venue': 'Vaccine', 'volume': '29', 'issn': '', 'pages': '772--777', 'other_ids': {'DOI': ['10.1016/j.vaccine.2010.11.013']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis', 'authors': [{'first': 'A', 'middle': ['T'], 'last': 'Cao', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Yao', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Gong', 'suffix': ''}, {'first': 'C', 'middle': ['O'], 'last': 'Elson', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Cong', 'suffix': ''}], 'year': 2012, 'venue': 'J. Immunol', 'volume': '189', 'issn': '', 'pages': '4666--4673', 'other_ids': {'DOI': ['10.4049/jimmunol.1200955']}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Th17 cytokines and the gut mucosal barrier', 'authors': [{'first': 'C', 'middle': [], 'last': 'Blaschitz', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Raffatellu', 'suffix': ''}], 'year': 2010, 'venue': 'J. Clin. Immunol', 'volume': '30', 'issn': '', 'pages': '196--203', 'other_ids': {'DOI': ['10.1007/s10875-010-9368-7']}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm', 'authors': [{'first': 'T', 'middle': [], 'last': 'Fujisawa', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Velichko', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Thai', 'suffix': ''}, {'first': 'L', 'middle': ['Y'], 'last': 'Hung', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Wu', 'suffix': ''}], 'year': 2009, 'venue': 'J. Immunol', 'volume': '183', 'issn': '', 'pages': '6236--6243', 'other_ids': {'DOI': ['10.4049/jimmunol.0900614']}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice', 'authors': [{'first': 'J', 'middle': [], 'last': 'Mei', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Dai', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hoffmann', 'suffix': ''}, {'first': 'K', 'middle': ['M'], 'last': 'Hudock', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'S', 'middle': ['H'], 'last': 'Guttentag', 'suffix': ''}, {'first': 'J', 'middle': ['K'], 'last': 'Kolls', 'suffix': ''}, {'first': 'P', 'middle': ['M'], 'last': 'Oliver', 'suffix': ''}, {'first': 'F', 'middle': ['D'], 'last': 'Bushman', 'suffix': ''}, {'first': 'G', 'middle': ['S'], 'last': 'Worthen', 'suffix': ''}], 'year': 2012, 'venue': 'J. Clin. Invest', 'volume': '122', 'issn': '', 'pages': '974--986', 'other_ids': {'DOI': ['10.1172/JCI60588']}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies', 'authors': [{'first': 'M', 'middle': ['S'], 'last': 'Maddur', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Miossec', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Kaveri', 'suffix': ''}, {'first': 'J', 'middle': ['T'], 'last': 'Bayry', 'suffix': ''}], 'year': 2012, 'venue': 'Am. J. Pathol', 'volume': '181', 'issn': '', 'pages': '8--18', 'other_ids': {'DOI': ['10.1016/j.ajpath.2012.03.044']}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1ϩ cells', 'authors': [{'first': 'A', 'middle': [], 'last': 'Asgharpour', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Gilchrist', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Baba', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Hamano', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Houpt', 'suffix': ''}], 'year': 2005, 'venue': 'Infect. Immun', 'volume': '73', 'issn': '', 'pages': '4522--4529', 'other_ids': {'DOI': ['10.1128/IAI.73.8.4522-4529.2005']}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children', 'authors': [{'first': 'R', 'middle': [], 'last': 'Haque', 'suffix': ''}, {'first': 'I', 'middle': ['M'], 'last': 'Ali', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Sack', 'suffix': ''}, {'first': 'B', 'middle': ['M'], 'last': 'Farr', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Ramakrishnan', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}], 'year': 2001, 'venue': 'J. Infect. Dis', 'volume': '183', 'issn': '', 'pages': '1787--1793', 'other_ids': {'DOI': ['10.1086/320740']}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Singlecell sequencing provides clues about the host interactions of segmented filamentous bacteria (SFB)', 'authors': [{'first': 'S', 'middle': ['J'], 'last': 'Pamp', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Harrington', 'suffix': ''}, {'first': 'S', 'middle': ['R'], 'last': 'Quake', 'suffix': ''}, {'first': 'D', 'middle': ['A'], 'last': 'Relman', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Blainey', 'suffix': ''}], 'year': None, 'venue': 'Genome Res', 'volume': '22', 'issn': '', 'pages': '1107--1119', 'other_ids': {'DOI': ['10.1101/gr.131482.111']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Comparative analysis of the distribution of segmented filamentous bacteria in humans, mice and chickens', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Yin', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Liao', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Jiang', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'H', 'middle': ['D'], 'last': 'Yu', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Xiang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Wang', 'suffix': ''}], 'year': 2012, 'venue': 'ISME J', 'volume': '7', 'issn': '', 'pages': '615--621', 'other_ids': {'DOI': ['10.1038/ismej.2012.128']}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Habitat, succession, attachment, and morphology of segmented, filamentous microbes indigenous to the murine gastrointestinal tract', 'authors': [{'first': 'C', 'middle': ['P'], 'last': 'Davis', 'suffix': ''}, {'first': 'D', 'middle': ['C'], 'last': 'Savage', 'suffix': ''}], 'year': 1974, 'venue': 'Infect Immun', 'volume': '10', 'issn': '', 'pages': '948--956', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Goto', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Panea', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Nakato', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Cebula', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'M', 'middle': ['G'], 'last': 'Diez', 'suffix': ''}, {'first': 'T', 'middle': ['M'], 'last': 'Laufer', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ignatowicz', 'suffix': ''}, {'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}], 'year': 2014, 'venue': 'Immunity', 'volume': '40', 'issn': '', 'pages': '594--607', 'other_ids': {'DOI': ['10.1016/j.immuni.2014.03.005']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Induction of intestinal Th17 cells by segmented filamentous bacteria', 'authors': [{'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Atarashi', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Manel', 'suffix': ''}, {'first': 'E', 'middle': ['L'], 'last': 'Brodie', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Shima', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Karaoz', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Wei', 'suffix': ''}, {'first': 'K', 'middle': ['C'], 'last': 'Goldfarb', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Santee', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Lynch', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Tanoue', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Imaoka', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Itoh', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Takeda', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Umesaki', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Honda', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Littman', 'suffix': ''}], 'year': 2009, 'venue': 'Cell', 'volume': '139', 'issn': '', 'pages': '485--498', 'other_ids': {'DOI': ['10.1016/j.cell.2009.09.033']}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Kriegel', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Sefik', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Hill', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Wu', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Benoist', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Mathis', 'suffix': ''}], 'year': 2011, 'venue': 'Proc. Natl. Acad. Sci. U. S. A', 'volume': '108', 'issn': '', 'pages': '11548--11553', 'other_ids': {'DOI': ['10.1073/pnas.1108924108']}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells', 'authors': [{'first': 'H', 'middle': ['J'], 'last': 'Wu', 'suffix': ''}, {'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Darce', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Hattori', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Shima', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Umesaki', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Littman', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Benoist', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Mathis', 'suffix': ''}], 'year': 2010, 'venue': 'Immunity', 'volume': '32', 'issn': '', 'pages': '815--827', 'other_ids': {'DOI': ['10.1016/j.immuni.2010.06.001']}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis', 'authors': [{'first': 'Y', 'middle': ['K'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Menezes', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Umesaki', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Mazmanian', 'suffix': ''}], 'year': 2011, 'venue': 'Proc. Natl. Acad. Sci. U. S. A', 'volume': '108', 'issn': '', 'pages': '4615--4622', 'other_ids': {'DOI': ['10.1073/pnas.1000082107']}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Gut microbiota promote hematopoiesis to control bacterial infection', 'authors': [{'first': 'A', 'middle': [], 'last': 'Khosravi', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yáñez', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Price', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Chow', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Merad', 'suffix': ''}, {'first': 'H', 'middle': ['S'], 'last': 'Goodridge', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Mazmanian', 'suffix': ''}], 'year': 2014, 'venue': 'Cell Host Microbe', 'volume': '15', 'issn': '', 'pages': '374--381', 'other_ids': {'DOI': ['10.1016/j.chom.2014.02.006']}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Hill', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Siracusa', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Abt', 'suffix': ''}, {'first': 'B', 'middle': ['S'], 'last': 'Kim', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Kobuley', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Kubo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Kambayashi', 'suffix': ''}, {'first': 'D', 'middle': ['F'], 'last': 'Larosa', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Renner', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Orange', 'suffix': ''}, {'first': 'F', 'middle': ['D'], 'last': 'Bushman', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Artis', 'suffix': ''}], 'year': 2012, 'venue': 'Nat. Med', 'volume': '18', 'issn': '', 'pages': '538--546', 'other_ids': {'DOI': ['10.1038/nm.2657']}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation', 'authors': [{'first': 'T', 'middle': [], 'last': 'Griseri', 'suffix': ''}, {'first': 'B', 'middle': ['S'], 'last': 'Mckenzie', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Schiering', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Powrie', 'suffix': ''}], 'year': 2012, 'venue': 'Immunity', 'volume': '37', 'issn': '', 'pages': '1116--1129', 'other_ids': {'DOI': ['10.1016/j.immuni.2012.08.025']}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'The intestinal metabolome: an intersection between microbiota and host', 'authors': [{'first': 'L', 'middle': ['K'], 'last': 'Ursell', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Haiser', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Van Treuren', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Garg', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Reddivari', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Vanamala', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Dorrestein', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Turnbaugh', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Knight', 'suffix': ''}], 'year': 2014, 'venue': 'Gastroenterology', 'volume': '146', 'issn': '', 'pages': '1470--1476', 'other_ids': {'DOI': ['10.1053/j.gastro.2014.03.001']}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis', 'authors': [{'first': 'E', 'middle': [], 'last': 'Pastille', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Didovic', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Brauckmann', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Rani', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Agrawal', 'suffix': ''}, {'first': 'F', 'middle': ['U'], 'last': 'Schade', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'S', 'middle': ['B'], 'last': 'Flohé', 'suffix': ''}], 'year': 2011, 'venue': 'J. Immunol', 'volume': '186', 'issn': '', 'pages': '977--986', 'other_ids': {'DOI': ['10.4049/jimmunol.1001147']}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10 ϩ CD4 ϩ T cells', 'authors': [{'first': 'S', 'middle': [], 'last': 'Stäger', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Maroof', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Zubairi', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Sanos', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Kopf', 'suffix': ''}, {'first': 'P', 'middle': ['M'], 'last': 'Kaye', 'suffix': ''}], 'year': 2006, 'venue': 'Eur. J. Immunol', 'volume': '36', 'issn': '', 'pages': '1764--1771', 'other_ids': {'DOI': ['10.1002/eji.200635937']}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice', 'authors': [{'first': 'J', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Van Rooijen', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Perlman', 'suffix': ''}], 'year': 2009, 'venue': 'PLoS Pathog', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.ppat.1000636']}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors', 'authors': [{'first': 'M', 'middle': ['R'], 'last': 'Hufeldt', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Nielsen', 'suffix': ''}, {'first': 'F', 'middle': ['K'], 'last': 'Vogensen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Midtvedt', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Hansen', 'suffix': ''}], 'year': 2010, 'venue': 'Comp. Med', 'volume': '60', 'issn': '', 'pages': '336--347', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Temporal stability of the mouse gut microbiota in relation to innate and adaptive immunity', 'authors': [{'first': 'P', 'middle': ['A'], 'last': 'Dimitriu', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Boyce', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Samarakoon', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Hartmann', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Johnson', 'suffix': ''}, {'first': 'W', 'middle': ['W'], 'last': 'Mohn', 'suffix': ''}], 'year': 2013, 'venue': 'Environ. Microbiol. Rep', 'volume': '5', 'issn': '', 'pages': '200--210', 'other_ids': {'DOI': ['10.1111/j.1758-2229.2012.00393.x']}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages', 'authors': [{'first': 'Q', 'middle': [], 'last': 'Yan', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Sun', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Ye', 'suffix': ''}], 'year': 2014, 'venue': 'Cell. Signal', 'volume': '26', 'issn': '', 'pages': '1783--1791', 'other_ids': {'DOI': ['10.1016/j.cellsig.2014.03.025']}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice', 'authors': [{'first': 'J', 'middle': ['L'], 'last': 'Ather', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Ckless', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martin', 'suffix': ''}, {'first': 'K', 'middle': ['L'], 'last': 'Foley', 'suffix': ''}, {'first': 'B', 'middle': ['T'], 'last': 'Suratt', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Boyson', 'suffix': ''}, {'first': 'K', 'middle': ['A'], 'last': 'Fitzgerald', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Flavell', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Eisenbarth', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Poynter', 'suffix': ''}], 'year': 2011, 'venue': 'J. Immunol', 'volume': '187', 'issn': '', 'pages': '64--73', 'other_ids': {'DOI': ['10.4049/jimmunol.1100500']}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells', 'authors': [{'first': '-O&apos;', 'middle': [], 'last': 'Sheasley', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Neill', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Brinkman', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Ferguson', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Dispenza', 'suffix': ''}], 'year': 2007, 'venue': 'J. Immunol', 'volume': '178', 'issn': '', 'pages': '1512--1522', 'other_ids': {'DOI': ['10.4049/jimmunol.178.3.1512']}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Human nutrition, the gut microbiome and the immune system', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Kau', 'suffix': ''}, {'first': 'P', 'middle': ['P'], 'last': 'Ahern', 'suffix': ''}, {'first': 'N', 'middle': ['W'], 'last': 'Griffin', 'suffix': ''}, {'first': 'A', 'middle': ['L'], 'last': 'Goodman', 'suffix': ''}, {'first': 'J', 'middle': ['I'], 'last': 'Gordon', 'suffix': ''}], 'year': 2011, 'venue': 'Nature', 'volume': '474', 'issn': '', 'pages': '327--336', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Goto', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Panea', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Nakato', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Cebula', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'M', 'middle': ['G'], 'last': 'Diez', 'suffix': ''}, {'first': 'T', 'middle': ['M'], 'last': 'Laufer', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ignatowicz', 'suffix': ''}, {'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}], 'year': 2014, 'venue': 'Immunity', 'volume': '40', 'issn': '', 'pages': '594--607', 'other_ids': {'DOI': ['10.1016/j.immuni.2014.03.005']}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Gut microbiota promote hematopoiesis to control bacterial Infection', 'authors': [{'first': 'A', 'middle': [], 'last': 'Khosravi', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yáñez', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Price', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Chow', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Merad', 'suffix': ''}, {'first': 'H', 'middle': ['S'], 'last': 'Goodridge', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Mazmanian', 'suffix': ''}], 'year': 2014, 'venue': 'Cell Host Microbe', 'volume': '15', 'issn': '', 'pages': '374--381', 'other_ids': {'DOI': ['10.1016/j.chom.2014.02.006']}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis', 'authors': [{'first': 'A', 'middle': [], 'last': 'Trompette', 'suffix': ''}, {'first': 'E', 'middle': ['S'], 'last': 'Gollwitzer', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Yadava', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Sichelstiel', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Sprenger', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Ngom-Bru', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Blanchard', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Junt', 'suffix': ''}, {'first': 'L', 'middle': ['P'], 'last': 'Nicod', 'suffix': ''}, {'first': 'N', 'middle': ['L'], 'last': 'Harris', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Marsland', 'suffix': ''}], 'year': 2014, 'venue': 'Nat. Med', 'volume': '20', 'issn': '', 'pages': '159--166', 'other_ids': {'DOI': ['10.1038/nm.3444']}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'The genome of Th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment', 'authors': [{'first': 'A', 'middle': [], 'last': 'Sczesnak', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Segata', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Qin', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Gevers', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Petrosino', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Huttenhower', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Littman', 'suffix': ''}, {'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}], 'year': 2011, 'venue': 'Cell Host Microbe', 'volume': '10', 'issn': '', 'pages': '260--272', 'other_ids': {'DOI': ['10.1016/j.chom.2011.08.005']}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing', 'authors': [{'first': 'T', 'middle': [], 'last': 'Kuwahara', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Ogura', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Oshima', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kurokawa', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ooka', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Hirakawa', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Itoh', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Nakayama-Imaohji', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ichimura', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Itoh', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Ishifune', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Maekawa', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Yasutomo', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Hattori', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Hayashi', 'suffix': ''}], 'year': 2011, 'venue': 'DNA Res', 'volume': '18', 'issn': '', 'pages': '291--303', 'other_ids': {'DOI': ['10.1093/dnares/dsr022']}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4 ϩ T cells', 'authors': [{'first': 'E', 'middle': ['R'], 'last': 'Houpt', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Glembocki', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Obrig', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Moskaluk', 'suffix': ''}, {'first': 'L', 'middle': ['A'], 'last': 'Lockhart', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Wright', 'suffix': ''}, {'first': 'R', 'middle': ['M'], 'last': 'Seaner', 'suffix': ''}, {'first': 'T', 'middle': ['R'], 'last': 'Keepers', 'suffix': ''}, {'first': 'T', 'middle': ['D'], 'last': 'Wilkins', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}], 'year': 2002, 'venue': 'J. Immunol', 'volume': '169', 'issn': '', 'pages': '4496--4503', 'other_ids': {'DOI': ['10.4049/jimmunol.169.8.4496']}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Umesaki', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Okada', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Matsumoto', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Imaoka', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Setoyama', 'suffix': ''}], 'year': 1995, 'venue': 'Microbiol Immunol', 'volume': '39', 'issn': '', 'pages': '555--562', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'Realtime-PCR assay for diagnosis of Entamoeba histolytica infection', 'authors': [{'first': 'S', 'middle': [], 'last': 'Roy', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Kabir', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Mondal', 'suffix': ''}, {'first': 'I', 'middle': ['K'], 'last': 'Ali', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Haque', 'suffix': ''}], 'year': 2005, 'venue': 'J. Clin. Microbiol', 'volume': '43', 'issn': '', 'pages': '2168--2172', 'other_ids': {'DOI': ['10.1128/JCM.43.5.2168-2172.2005']}}}, 'ref_entries': {'FIGREF0': {'text': 'Fig. S1) and after (Fig. 2Cand D) E. histolytica infection. Neutrophils (Fig. 2E; also, seeFig. S1cin the supplemental material) and DCs (Fig. 2F; also, seeFig. S1din the supplemental material) were also elevated in the intestine of SFB col-Cohousing mice from different vendors transfers SFB and confers protection against Entamoeba histolytica infection. qPCR was used to quantify relative expression compared to total bacteria and trophozoites of SFB (A) and Entamoeba histolytica (B), respectively, in cecal lysate from SFB Ϫ CBA/J mice that were cohoused with SFB ϩ C3H mice and noncohoused mice; mice were infected with 2 million E. histolytica trophozoites via cecal laparotomy. *, P Ͻ 0.05.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'SFB-colonized mice are protected from E. histolytica infection, have increased IL-17A, IL-23, neutrophils, and DCs in their intestines, and have more serum amyloid A (SAA) in their serum. Quantification via qPCR of SFB relative expression compared to total bacteria (A) and enumeration of trophozoites (B) was performed in cecal lysate from mice given gavages with PBS or SFB-monoassociated feces (Yakult) 7 days prior to intracecal infection with E. histolytica. IL-17A (C) and IL-23 (D) induction in ceca (lamina propria) was measured via qPCR, and neutrophil and DC infiltration was measured by flow cytometry and indicated markers (E and F). (G) Serum SAA was measured by ELISA. *, P Ͻ 0.05.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': \"Bone marrow-derived DCs from mice colonized with SFB produce more IL-23 in response to E. histolytica trophozoites, and increased IL-23 production can be partially recapitulated in non-SFB-colonized mice with addition of SAA. Bone marrow cells were harvested from 4-week-old male CBA/J mice infected with or free of SFB, and cells were cultured in RPMI with 10% FBS, supplemented on days 0 and 3 with GM-CSF (10 ng/ml; Peprotech), and harvested on day 6. (A) A total of 2.5 ϫ 10 5 cells were plated per well of a flat-bottom 96-well dish and treated with medium or trophozoites (Trophs) for 24 h. IL-23 in the supernatants was measured by ELISA. (B) BMDCs were cultured as described above with the addition of a third group with BMDCs from SFB-naive mice in which SAA was added to GM-CSF-containing medium for the first 4 days of culture only. Cells were washed and then plated with 2,500 trophozoites, and IL-23 was measured after 24 hours as described above. *, P Ͻ 0.05. BMDCS from SFB-colonized mice migrated to the lamina propria of SFB-free mice upon adoptive transfer via the intraperitoneal route. Bone marrow cells (500,000) from SFB ϩ or SFB Ϫ mice were CFSE stained and adoptively transferred to 5-week-old CBA/J mice free of SFB. Flow cytometry for CFSE staining was performed on single cells isolated from spleens, Peyer's patches (PP), mesenteric lymph nodes (MLN), and lamina propria (LP). *, P Ͻ 0.05.\", 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'BMDCs from mice colonized with SFB are sufficient to confer protection against E. histolytica colonization and recapitulate protective immune response, and blockade of IL-17A during adoptive transfer abrogates this protection. A total of 500,000 bone marrow cells from SFB ϩ or SFB Ϫ mice prepared as described in Materials and Methods were adoptively transferred to 5-week-old CBA/J mice free of SFB 1 week prior to infection with 2 million E. histolytica trophozoites via cecal laparotomy. E. histolytica (A) organisms in cecal lysate were quantified via qPCR. (B) Neutrophil infiltration in cecum by indicated markers. Fourweek-old CBA/J mice were treated with 200 g rat anti-mouse IL-17A MAb (clone M210; Amgen) or rat IgG2a isotype control (clone 2A3; BioXcell) 3 days before BMDC transfer (500,000 intraperitoneally from mice that received SFB gavage and mice that did not) and 7 days after and then infected with 2 million trophozoites that day. (C) E. histolytica in cecal lysate from mice was quantified via qPCR. (D) Neutrophil infiltration was measured via flow cytometry by indicated markers. (E) Total serum IgA was measured by ELISA. *, P Ͻ 0.05.', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'Model for SFB-mediated protection against E. histolytica colonization. SFB colonization of the intestine may induce soluble mediators, including SAA, which can have local effects as well as trigger systemic changes in bone marrow that support increased IL-23 production from dendritic-cell subsets and downstream IL-17A-mediated innate and adaptive immune responses. These effectors may then protect against intestinal E. histolytica infection.', 'latex': None, 'type': 'figure'}}, 'back_matter': [{'text': 'This work was supported by NIH grant 5R01 AI026649-25 to W.P. We thank Yoshinori Umesaki, from the Yakult Central Institute for Microbial Research (Tokyo, Japan) for supplying the SFB-monocolonized feces. We also gratefully acknowledge the gift of anti-IL-17A monoclonal antibodies from Alison Budelsky at Amgen Incorporated (Seattle, WA) and Florent Ginhoux, Brian Kelsall, and Tom Braciale for helpful discussions.S.B., W.P., and M.W.-K. contributed to the design, analysis and interpretation of the data. S.B., E.B., M.C., C.C., C.N., and Z.N. conducted experiments and critiqued the work. S.B. and W.P. wrote the manuscript.', 'cite_spans': [], 'ref_spans': [], 'section': 'ACKNOWLEDGMENTS'}]}\n",
      "{'_id': ObjectId('5ea715ef46e78c4e9dc70804'), 'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Editorial'}, {'text': \"The Middle East Respiratory Syndrome (MERS) crisis in Korea is coming to an end, but that's not the end of the story. The World Health Organization (WHO) has warned that the MERS crisis was a 'wakeup call. ' Like Severe Acute Respiratory Syndrome (SARS) in 2003 and swine flu in 2009, epidemic outbreaks will continue to happen anywhere. Korea was simply unlucky. In retrospect, it is regrettable to say that we could have done much better. Scholars and colleagues in the medical informatics field should take a moment and think hard about how we can work to fight against another epidemic invasion in the future.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'The Ebola epidemic of 2013 is the largest such outbreak on record, influencing many nations in Africa as well as other countries [1] . The WHO expert panel has pointed out the inadequate emergency care response and has recommended more effective mechanisms for research and development. Others have strongly recommended WHO to innovate because recent Ebola outbreaks have been radically different from previous events, and they have tended to be simultaneous and parallel: \"Highly mobile populations, the spread of Ebola into densely populated cities ... made this epidemic of many outbreaks difficult to control [2] . \"', 'cite_spans': [{'start': 129, 'end': 132, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 613, 'end': 616, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': \"Other criticisms also include outdated therapeutic protocols, irrelevant information, untimely communication, delays in decision-making due to uncoordinated leadership, unreasonable social behavior, and so on. The recom- tems. The NEDSS can be called a medical informatics leader, which provides a standardized information infrastructure with HL7, LOINC, and SNOMED-CT. Highly useful information is well organized and ready to be used in the US-CDC [6] , so we don't have to reinvent the wheel. All we need is to find a conduit for connection. For example, the task of disease surveillance for MERS is relatively small compared to NEDSS. Using the cell phone data network, we can instantly establish a real-time patient tracking system to monitor 3-tuple data (time, location, temperature) in the country. Cell phone rental can help track down suspicious foreign visitors from arrival to departure. With the support of ISO standards, global healthcare networking is not a hard nut to crack.\", 'cite_spans': [{'start': 449, 'end': 452, 'text': '[6]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'When the MERS epidemic outbreak was on the headline news, many attempts were made to compare MERS with tuberculosis. That is, the mortality rate of MERS is far below that of tuberculosis, so it was argued that there was no need to worry about it. The point was clear, but the timing was not right. Have you ever got a thorn stuck under your fingernail? Saying that \"It\\'s OK you\\'re not bleeding\" or \"You won\\'t die from it\" would not comfort anybody at all. I would venture to say that it is surely mistaken to compare the pain at present with a probable outcome yet to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': 'When hospital visitors became MERS patients, a typical example of nosocomial infection was demonstrated. It was a surprise attack, and the whole country was shaken and panicked. The WHO experts reminded us that hospital shopping greatly contributed to the rapid spread of MERS in Korea. We have to understand why patients pursue hospital shopping. The death of professionalism may be an unexpected result of the fashionable social network services (SNS). Patients use SNSs to data-mine their own diagnosis and prescription and then seek medical advice to compare with their own ideas about their personal health. However, such patients suggesting their own diagnoses and treatments can be described as \"Jack of all trades, master of none\". Medical informatics leadership was nowhere to be found. When the MERS epidemic turned fatal, SNS was the only rescue. MERS was unknown to the general public, and the cure was uncertain, so chaos was bound to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In Korea medical informatics is on trial. We are standing in front of a river that runs medicine. IT has been trying to cross the river but has never been successful, especially in medical expert systems. The other side of the river is not the land of promise. Because the river of medicine eventu-ally runs into the ocean of the human race, why don't we go with the river instead? There is no doubt that doctors and nurses were the final frontiers in the MERS battle. Despite all the wonderful scientific accomplishments, the MERS crisis reminds us that clinical expertise is the most important value as clearly as ever. Technology can help medicine, not the other way around; that is the way medical informatics should go in between.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"Taoism states that dynamic balance can be obtained from two opposite powers competing with each other, unifying as a complete energy. Similarly, medical informatics should be able to balance between analog medicine and digital technology to create a new value. Medicine is composed of oldfashioned values, such as rapport, which is fading out slowly. Digital technology should help clinicians restore the humanistic flavor of medicine by eliminating managerial overload in healthcare settings. Technology can start from there. Neither Cyclops (the single-eyed monster in Homer's Odyssey) nor Argus (the 100-eyed giant in Greek mythology) is ideal to find the right path. Two-eyed medical informaticians must walk through the path on the mountain ridge, carefully looking at both sides of IT and medicine for balance.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In 1347, the first biological warfare took place in the siege of Caffa (now Feodosia in Ukraine) on the Black Sea coast. The Mongol army with bubonic plague catapulted corpse of those who had died from the Black Death over the city walls. Fleeing from central trading ports along the coast, infected inhabitants and rats may have carried the disease throughout Europe [7] (The plague might have killed more than 25 million people). A few regions survived. They simply closed their ports of entry and isolated patients in remote places. The same principle still applies. When in doubt, isolate an infection until it's clear. Time goes by, technology advances, but the basic principle never changes. Medicine should stay analog with a little hint of digital. That's all it takes to fight against any epidemic or pandemic attack in the future.\", 'cite_spans': [{'start': 368, 'end': 371, 'text': '[7]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Report of the Ebola Interim Assessment Panel', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"What we've learned about fighting Ebola\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Dhillon', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Srikrishna', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Harvard Business Review; c2015', 'authors': [{'first': '(', 'middle': [], 'last': 'Boston', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ma)', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The next epidemic: lessons from Ebola', 'authors': [{'first': 'B', 'middle': [], 'last': 'Gates', 'suffix': ''}], 'year': 2015, 'venue': 'N Engl J Med', 'volume': '372', 'issn': '15', 'pages': '1381--1385', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'US Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Centers for Disease Control and Prevention; c2015', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Digital disease detection: harnessing the Web for public health surveillance', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Brownstein', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Freifeld', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Madoff', 'suffix': ''}], 'year': 2009, 'venue': 'N Engl J Med', 'volume': '360', 'issn': '21', 'pages': '2153--2160', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'History of biological warfare and bioterrorism', 'authors': [{'first': 'V', 'middle': [], 'last': 'Barras', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Microbiol Infect', 'volume': '20', 'issn': '6', 'pages': '497--502', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': 'Hune Cho http://dx.doi.org/10.4258/hir.2015.21.3.141', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715efc7f7cfde7827d5af'), 'paper_id': '0a003aa69f43cee4357f1e943df79a8b87c0a88e', 'metadata': {'title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen', 'authors': [{'first': 'Paula', 'middle': [], 'last': 'Tucci', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Verónica', 'middle': [], 'last': 'Estevez', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Lorena', 'middle': [], 'last': 'Becco', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Florencia', 'middle': [], 'last': 'Cabrera-Cabrera', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Germán', 'middle': [], 'last': 'Grotiuz', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Eduardo', 'middle': [], 'last': 'Reolon', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Mónica', 'middle': [], 'last': 'Marín', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': 'marin@fcien.edu.uym.marín.'}]}, 'abstract': [{'text': 'Bovine Respiratory Disease is the most costly disease that affects beef and dairy cattle industry. Its etiology is multifactorial, arising from predisposing environmental stress conditions as well as the action of several different respiratory pathogens. This situation has hindered the development of effective control strategies. Although different type of vaccines are available, many currently marketed vaccines are based on inactivated cultures of the main viral and bacterial agents involved in this pathology. The molecular composition of commercial veterinary vaccines is a critical issue. The present work aims to define at the proteomic level the most relevant valence of a line of commercial respiratory vaccines widely used in Central and South America. Since Mannheimia haemolytica is responsible for most of the disease associated morbid-mortality, we focused on the main proteins secreted by this pathogen, in particular Leukotoxin A, its main virulence factor. By Western blot analysis and mass spectrometry, Leukotoxin A was identified as a major component of (http://creativecommons.org/licenses/by-nc-nd/4.0/). M. haemolytica culture supernatants. We also identified other ten M. haemolytica proteins, including outer membrane proteins, periplasmic transmembrane solute transporters and iron binding proteins, which are relevant to achieve protective immunity against the pathogen. This work allowed a detailed molecular characterization of this vaccine component, providing evidence of its quality and efficacy. Furthermore, our results contributed to the identification of several proteins of interest as subunit vaccine candidates.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Bovine Respiratory Disease (BRD) is one of the leading causes of death and economic loss for the beef and dairy cattle industry. It has an estimated annual cost to the worldwide cattle industry of over $3 billion (Potter, 2015) . This multifactorial syndrome can be caused either by viral or bacterial pathogens. Viral agents include bovine respiratory syncytial virus (BRSV) (Gershwin et al., 2000) , parainfluenza III virus (PI-3) (Fulton et al., 2000) , bovine viral diarrhea virus (BVDV) (Ridpath, 2010) and bovine corona virus (BCV) (Autio et al., 2007) . These respiratory viruses along with some mycoplasmal agents are generally the primary infectious agents involved in BRD (Potter, 2015) . This initial infection establishes a respiratory environment predisposing to the colonization and replication of pathogenic bacteria, including Mannheimia haemolytica (Al-Ghamdi et al., 2000) , Pasteurella multocida (Dabo et al., 2007) and Histophilus somni (Corbeil, 2007) , the former being responsible for up to 50% of the disease associated mortality (Narayanan et al., 2002; Potter, 2015) . M. haemolytica is a Gram negative opportunistic bacterium. Although it is a common bacterium of the upper respiratory tract and nasopharynx of healthy ruminants, it can also act as an opportunistic pathogen infecting the lower respiratory tract under stressful situations such as shipping, adverse environmental conditions or previous respiratory viral infection (Youssef et al., 2004; Orouji et al., 2012) .', 'cite_spans': [{'start': 213, 'end': 227, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 376, 'end': 399, 'text': '(Gershwin et al., 2000)', 'ref_id': 'BIBREF22'}, {'start': 433, 'end': 454, 'text': '(Fulton et al., 2000)', 'ref_id': 'BIBREF19'}, {'start': 492, 'end': 507, 'text': '(Ridpath, 2010)', 'ref_id': 'BIBREF43'}, {'start': 538, 'end': 558, 'text': '(Autio et al., 2007)', 'ref_id': 'BIBREF4'}, {'start': 682, 'end': 696, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 866, 'end': 890, 'text': '(Al-Ghamdi et al., 2000)', 'ref_id': 'BIBREF1'}, {'start': 915, 'end': 934, 'text': '(Dabo et al., 2007)', 'ref_id': 'BIBREF14'}, {'start': 957, 'end': 972, 'text': '(Corbeil, 2007)', 'ref_id': 'BIBREF12'}, {'start': 1054, 'end': 1078, 'text': '(Narayanan et al., 2002;', 'ref_id': 'BIBREF37'}, {'start': 1079, 'end': 1092, 'text': 'Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 1458, 'end': 1480, 'text': '(Youssef et al., 2004;', 'ref_id': 'BIBREF52'}, {'start': 1481, 'end': 1501, 'text': 'Orouji et al., 2012)', 'ref_id': None}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Being BRD a multifactorial disease, the development of effective control strategies has been difficult to accomplish. Vaccination against viral and bacterial pathogens involved in BRD is a useful tool to reduce the risk of this disease. Many commercial respiratory vaccines are composed by inactivated cultures of the most relevant pathogens (Edwards, 2010; Rodrigues et al., 2015) . These multivalent formulations are designed to reduce the impact of viral infections and to neutralize the severe associated bacterial infections. Therefore, to guarantee the efficacy of BRD vaccines, it is important to achieve a complete characterization of the antigens included in the vaccine and to verify the presence of those molecules critical for establishing an efficient immunological protection.', 'cite_spans': [{'start': 342, 'end': 357, 'text': '(Edwards, 2010;', 'ref_id': 'BIBREF16'}, {'start': 358, 'end': 381, 'text': 'Rodrigues et al., 2015)', 'ref_id': 'BIBREF44'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In this work we attempt to characterize the main proteins of M. haemolytica in a polyvalent inactivated BRD line of vaccines currently commercialized in Central and South America (Neumosan, Virbac Uruguay S.A. (former Santa Elena), http:// www.santaelena.com.uy). Among them we emphasize the study of Leukotoxin A (LKT), its main virulence factor, which has been shown to play an important role in the development of a protective immunity against the pathogen (Confer et al., 2009 ).', 'cite_spans': [{'start': 460, 'end': 480, 'text': '(Confer et al., 2009', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'LKT is a potent cytolytic toxin, with an apparent molecular weight (MW) of 105 kDa, actively secreted by all serotypes of the bacterium during the logarithmic phase of in vitro growth (Shewen and Wilkie, 1985; Chang et al., 1987) . It belongs to the family of the RTX (repeat in toxin) pore-forming cytolysins, which have been linked with the virulence of other bacterial species (Lo et al., 1987; Lainson et al., 1996) . It specifically targets ruminant leukocytes and plays a major role in pathogenesis of BRD by impairing the primary lung defense mechanism and by inducing inflammation as a consequence of leukocyte lysis (Conlon et al., 1991) . This phenomenon has been correlated with its ability to bind and interact with the ruminant beta2-integrin Lymphocyte Function-associated Antigen 1 (LFA-1) (CD11a/CD18) (Zecchinon et al., 2005; Singh et al., 2011) . Neutralizing antibodies generation against the cytolytic toxin is relevant for achieving a high level of protection (Mosier et al., 1989) . Immunity against M. haemolytica also requires antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988) and iron-regulated outer membrane proteins (Potter et al., 1999) .', 'cite_spans': [{'start': 184, 'end': 209, 'text': '(Shewen and Wilkie, 1985;', 'ref_id': 'BIBREF47'}, {'start': 210, 'end': 229, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 380, 'end': 397, 'text': '(Lo et al., 1987;', 'ref_id': 'BIBREF34'}, {'start': 398, 'end': 419, 'text': 'Lainson et al., 1996)', 'ref_id': 'BIBREF28'}, {'start': 625, 'end': 646, 'text': '(Conlon et al., 1991)', 'ref_id': 'BIBREF11'}, {'start': 818, 'end': 842, 'text': '(Zecchinon et al., 2005;', 'ref_id': 'BIBREF53'}, {'start': 843, 'end': 862, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}, {'start': 981, 'end': 1002, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 1102, 'end': 1127, 'text': '(Shewen and Wilkie, 1988)', 'ref_id': 'BIBREF48'}, {'start': 1171, 'end': 1192, 'text': '(Potter et al., 1999)', 'ref_id': 'BIBREF40'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Our aim is to bring more insight into the molecular composition of a M. haemolytica inactivated antigen used in bovine commercial vaccines, focusing on the identification of relevant secreted or surface-exposed proteins. This knowledge will support the development of specific quality control techniques to assist the optimization and standardization of the industrial vaccine production process.', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': '2.1. Laboratory scale M. haemolytica culture A seed culture was prepared by inoculation of an aliquot of master seed bank (MSB) of M. haemolytica serotype A1 (production strain code B059) in TSB-BHI (Tryptic Soy Broth, Brain Heart Infusion, Porcine) and incubation at 37.0 ± 1.0°C, for 12 h with orbital agitation (220 rpm). Inoculum was prepared by a 1:100 dilution of the seed culture in TSB-BHI and further incubation at 37.0 ± 1.0°C with orbital agitation until an optical density at 600 nm (OD 600nm ) of 0.2 to 0.3 units was reached. A benchtop fermentor (Biostat A, New Brunswick) with 2 L of fermentation media (TSB-BHI supplemented with 0.4% glucose) was inoculated with 20 mL of the inoculum culture (1:100 dilution). The fermentation culture was grown at 37.0 ± 1.0°C with dissolved oxygen set above 40% and variable Article No~e00158 agitation. During fermentation, samples were taken every one hour to measure OD 600nm , dissolved oxygen (%), glucose concentration (mg/dL) and pH. The culture was harvested when it reached stationary growth phase. Samples and the final culture were centrifuged at 8000×g for 30 min at 4°C and culture supernatants were stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Materials and methods'}, {'text': 'M. haemolytica culture for vaccine antigen preparation was performed following the industrial standardized protocol. Culture media used was developed by Virbac Uruguay S.A. and is based on protein hydrolysates, yeast extract, dextrose, and sodium and potassium salts. The inoculum was prepared as previously described using 1 vial of production seed of M. haemolytica serotype A1 (production strain code B059). The production fermentor was inoculated with a 1:100 dilution of the inoculum and the culture was performed at 37°C with automatic agitation and aeration until the end of the logarithmic growth phase. After harvesting, culture was inactivated by incubation at 37°C with formaldehyde 0.5% (v/v) during 24 h. To obtain culture supernatant the inactivated culture was centrifuged at 8000×g for 30 min at 4°C. Inactivated culture supernatant was stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Industrial M. haemolytica antigen preparation'}, {'text': 'Specific primers were designed to amplify a portion of LKT which contains the Cterminal domain of the protein. An in silico prediction of the location of linear Bcell epitopes was performed using Bepipred algorithm (Larsen et al., 2006) . As previously reported (Lee et al., 2001) , the portion of LktA with more immunogenic epitopes was the C-terminal domain. Therefore, a sequence including the main predicted epítopes (amino acid 713 to 873) was selected. M. haemolytica (production strain code B059) was cultured as the seed culture described above.', 'cite_spans': [{'start': 215, 'end': 236, 'text': '(Larsen et al., 2006)', 'ref_id': 'BIBREF29'}, {'start': 262, 'end': 280, 'text': '(Lee et al., 2001)', 'ref_id': None}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Culture was centrifuged at 10000×g and the cell pellet was stored at −70°C. M. haemolytica genomic DNA was extracted using a standard protocol (Ausubel et al., 1999) and partial LKT sequence was amplified by PCR. For LKT expression, restriction sites were included in primers for a directional cloning of LKT sequence in pET28a(+) vector (Novagen). E. coli BL21 DE3 (Novagen) competent cells were transformed with the construct and stored at −70°C in 15% glycerol. Plasmid DNA was isolated from E. coli using a commercial kit (QiaPrep Spin Miniprep, Qiagen). Plasmid sequence was confirmed by DNA sequencing at Institut Pasteur Montevideo (Uruguay). For LKT expression, a culture was performed in ZYM-5052 auto induction medium (Studier, 2005) for 18-20 h at 37.0 ± 1.0°C. As expected, by SDS-PAGE a band of approximately 40 kDa corresponding to the recombinant protein was observed. The protein was purified by IMAC chromatography (HisTrap HP, GE Healthcare) in an ÄKTA Purifier 100 (GE Healthcare). The Article No~e00158 purified protein was dialyzed against PBS 1X pH 7.4 and quantified by BCA (Pierce BCA Protein Assay Kit, Thermo Scientific).', 'cite_spans': [{'start': 143, 'end': 165, 'text': '(Ausubel et al., 1999)', 'ref_id': None}, {'start': 728, 'end': 743, 'text': '(Studier, 2005)', 'ref_id': 'BIBREF50'}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Two New Zealand white rabbits (2.5 Kg body weight) were maintained in the experimental animal facility (Instituto de Higiene, Universidad de la República, Uruguay) in accordance with animal procedures approved by the Honorary Commission of Animal Experimentation (CHEA protocol No 071140-000771-11).', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Both rabbits were immunized subcutaneously with 50 ug of recombinant LKT, on days 0 and 21 of the immunization protocol. Blood samples were taken on days 21, 45 and 115, and sera were prepared and stored at −20°C. Serum titers were determined by ELISA using 0.1 μg/well of recombinant LKT for coating, serum dilutions of 1:100 to 1:100.000, and conjugate dilution of 1:10.000 (Goat antirabbit IgG (whole molecule)-Peroxidase, Sigma). High titer sera were pooled and purified by protein A chromatography (HiTraprProtein A, GE Healthcare). Purified IgG reactivity against native and recombinant LKT was evaluated by Western blot as described below.', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Culture supernatants were analyzed by 12% SDS-PAGE and coomassie blue staining (Ausubel et al., 1999) . Molecular weight markers used were PageRuler Prestained Protein Ladder (Thermo Scientific) and Prestained Protein Ladder Broad Range (NEB).', 'cite_spans': [{'start': 79, 'end': 101, 'text': '(Ausubel et al., 1999)', 'ref_id': None}], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For Western blot analysis, proteins were transferred onto a nitrocellulose membrane (Hybond-C Extra, Amersham Biosciences) for one hour at 400 mA.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Rabbit antibodies against recombinant LKT, produced and purified by our work group, were used to identify LKT in culture supernatants. Briefly, membranes were incubated for 1 h at room temperature with anti-LKT antibodies at final concentration of 17.5 μg/mL in PBS 1X pH 7.4, 5% low fat milk, with gentle agitation. For antigen-antibody detection membranes were incubated for 1 h at room temperature with a 1:5000 dilution of anti-rabbit IgG (whole molecule)alkaline phosphatase antibody produced in goat (Sigma) in PBS 1X pH 7.4, 5% low fat milk. The intensity of resulting bands was quantified using a Molecular Imaging Software (Carestream Health Inc).', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For immune response evaluation bovine sera obtained from a calf infected with M. haemolytica and from a healthy calf were gently provided by Virbac Uruguay.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Inactivated and non inactivated culture supernatant samples analyzed by SDS-PAGE were transferred onto membranes, as previously described. Membranes were incubated for 1 h at room temperature with a 1:500 dilution of each serum and afterwards for 1 h at room temperature with a 1:5000 dilution of anti-bovine', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'IgG-HRP (Novex), all in PBS 1X pH 7.4, 5% low fat milk. Detection was performed using TMB liquid substrate system for membranes (Sigma).', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Inactivated culture supernatant obtained from the industrial process was concentrated 20X by ultrafiltration (Vivaspin 500, 5 kDa, GE Healthcare) and analyzed by SDS-PAGE and coomassie blue staining. The most defined and intense bands were identified by peptide mass fingerprinting at Institut Pasteur Montevideo (Uruguay) using a 4800 MALDI TOF/TOF Analyzer (Applied Biosystems). Peptides from each sample were obtained by trypsin treatment (Sequencing Grade, Promega) overnight at 37°C. Peptide mass spectra were acquired as previously described (Lima et al., 2011) and MS/MS collision induced dissociation experiments of selected peptides were performed. Proteins were identified by NCBInr database searching with peptide m/z values using MASCOT search engine (Matrix Science) (Perkins et al., 1999) with the following searching parameters: monoisotopic mass tolerance, 0.08 Da; fragment mass tolerance, 0.45 Da and one missing tryptic cleavage allowed. Significant scores (p < 0.05) were used as criteria for positive protein identification.', 'cite_spans': [{'start': 548, 'end': 567, 'text': '(Lima et al., 2011)', 'ref_id': 'BIBREF32'}, {'start': 780, 'end': 802, 'text': '(Perkins et al., 1999)', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'Mass spectrometry (MS)'}, {'text': 'During M. haemolytica laboratory scale fermentation, parameters such as glucose concentration, dissolved oxygen, optical density (OD 600nm ) and pH were determined in samples taken every one hour of culture. This fermentation showed a kinetic profile compatible with typical bacterial growth in a batch system (Fig. 1B) . Culture was harvested ten hours after fermentation start, at the beginning of the stationary growth phase.', 'cite_spans': [], 'ref_spans': [{'start': 310, 'end': 319, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'Supernatant samples of a M. haemolytica laboratory scale culture were analyzed in order to evaluate the LKT accumulation in the supernatant. To identify LKT specific anti-LKT antibodies were produced. In preliminary evaluation experiments, we confirmed that these antibodies showed the expected reactivity against native and recombinant LKT and a good specific antibody titer. By means of these antibodies we identified LKT as a single defined band of approximately 110 kDa in culture supernatant samples of M. haemolytica (Fig. 1A) . In parallel, the presence of LKT in this protein band was confirmed by MS analysis (MS/MS protein score 408, protein sequence coverage 36%).', 'cite_spans': [], 'ref_spans': [{'start': 523, 'end': 532, 'text': '(Fig. 1A)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'The intensity of the specific LKT band detected by Western blot was determined by molecular imaging software. This analysis showed that LKT expression Article No~e00158 correlates with growth kinetics, being associated with exponential growth phase of M. haemolytica (Fig. 1B) , as previously reported (Chang et al., 1987) . Therefore, the presence of LKT was verified in the culture supernatant of the M. haemolytica production strain, during the exponential growth phase of the culture.', 'cite_spans': [{'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 267, 'end': 276, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'For proteomic analysis, industrial antigen was prepared according to vaccine production protocol. Culture supernatant was obtained and concentrated by ultrafiltration. After SDS-PAGE electrophoresis and coomassie blue staining, selected bands were recovered for MS identification ( Fig. 2A) . This approach allowed the statistically significant identification of 11 proteins of M. haemolytica in the industrial antigen (Table 1) . LKT was identified, in accordance with previous results of laboratory scale fermentation, among other relevant proteins.', 'cite_spans': [], 'ref_spans': [{'start': 282, 'end': 290, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF1'}, {'start': 419, 'end': 428, 'text': '(Table 1)', 'ref_id': None}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Some of these are outer membrane proteins (OMPs), which along with LKT are critical to achieve a protective immunity to the pathogen Singh et al., 2011) . Subcellular in silico localization, predicted using free access PSORTb software (available at http://psort.hgc.jp/), indicated that most of the identified proteins are periplasmic (7/11), with others being extracellular (1/11) or located in the outer cell membrane (2/11).', 'cite_spans': [{'start': 133, 'end': 152, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}], 'ref_spans': [], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Although most proteins coincided with their theoretical MW (Table 1) Article No~e00158 (Fig. 2B ). This behavior of LKT in electrophoresis could be explained by crosslinking caused by formaldehyde treatment leading to high molecular weight structures.', 'cite_spans': [], 'ref_spans': [{'start': 59, 'end': 68, 'text': '(Table 1)', 'ref_id': None}, {'start': 87, 'end': 95, 'text': '(Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Immune reactivity of a serum obtained from a M. haemolytica infected calf against culture supernatant was addressed by Western blot. As shown in Fig. 2B several bands of both inactivated and non inactivated culture supernatant were specifically recognized by infected bovine serum and not by healthy bovine serum. Among them, LKT was the more reactive band. Ayalew et al., 2011) . (Rabus et al., 1999; Eidam et al., 2013) .', 'cite_spans': [{'start': 358, 'end': 378, 'text': 'Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}, {'start': 381, 'end': 401, 'text': '(Rabus et al., 1999;', 'ref_id': 'BIBREF42'}, {'start': 402, 'end': 421, 'text': 'Eidam et al., 2013)', 'ref_id': None}], 'ref_spans': [{'start': 145, 'end': 152, 'text': 'Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': '10 HisJ-like histidine ABC transport system-periplasmic binding protein MHH_RS14805 328 M9WWE6 28.0 kDa Periplasmic ABC transporter system component involved in molecule export through bacterial membrane (Eidam et al., 2013) . Belongs to ompA family (Eidam et al., 2013) . Ortholog Omp P6 reported as immunogen in other species (Roier et al., 2013; Alvarez et al., 2015) . * For this search protein scores greater than 87 are significant (p < 0.05).', 'cite_spans': [{'start': 204, 'end': 224, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 250, 'end': 270, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 328, 'end': 348, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 349, 'end': 370, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'disease associated morbid-mortality (Potter, 2015) , this kind of information is of utmost importance.', 'cite_spans': [{'start': 36, 'end': 50, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Available data demonstrate that the protective immunity against M. haemolytica can be acquired by neutralizing antibodies against Leukotoxin A (Mosier et al., 1989) , as well as antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988; Confer et al., 1995; Confer et al., 2009) . In order to promote an effective immune response, the presence of these pivotal elements in a BRD vaccine formulation is crucial.', 'cite_spans': [{'start': 143, 'end': 164, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 229, 'end': 254, 'text': '(Shewen and Wilkie, 1988;', 'ref_id': 'BIBREF48'}, {'start': 255, 'end': 275, 'text': 'Confer et al., 1995;', 'ref_id': 'BIBREF10'}, {'start': 276, 'end': 296, 'text': 'Confer et al., 2009)', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Based on previous reports that detected Leukotoxin A activity in bacterium-free culture supernatant from logarithmic-phase cultures (Chang et al., 1987) , Neumosan line of vaccines includes inactivated culture supernatants of an industrial optimized M. haemolytica culture. In this work we confirmed that LKT secretion is linked to the exponential growth phase during the antigen production culture, representing one of the primary secreted components. In culture supernatant, LKT was detected as a single band with the expected MW (approx. 110 kDa) (Lo et al., 1985; Chang et al., 1987) . Interestingly, after formaldehyde treatment, LKT was detected as a higher MW band (>230 kDa),', 'cite_spans': [{'start': 132, 'end': 152, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 550, 'end': 567, 'text': '(Lo et al., 1985;', 'ref_id': 'BIBREF33'}, {'start': 568, 'end': 587, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'suggesting that the toxin could be arranged as a high order structure, which could be fixed by this cross-linking agent (Klockenbusch and Kast, 2010) . This finding is in agreement with previous reports that showed that the molecular weight of native LKT in culture supernatant was higher than 400 kDa (Chang et al., 1987) .', 'cite_spans': [{'start': 120, 'end': 149, 'text': '(Klockenbusch and Kast, 2010)', 'ref_id': 'BIBREF27'}, {'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Besides LKT identification, we delved further into the characterization of the culture supernatant protein profile. By MS we identified other 10 proteins of M. haemolytica. Most of them are periplasmic and outer membrane proteins, which due to their extracellular location and exposure to the host immune system could represent interesting candidates to play a key role in the protection against this pathogen. It is worth mentioning that we also identified a cytoplasmic protein involved in carbohydrate metabolism (Formate C-acetyltransferase). This finding could be explained by some cellular lysis that could occur during bacterial growth and inactivation (Derzelle et al., 2005) , hence we cannot rule out that the culture supernatant may contain some cytoplasmic proteins.', 'cite_spans': [{'start': 660, 'end': 683, 'text': '(Derzelle et al., 2005)', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Some of the outer membrane proteins identified in this work have been reported as important immunogens and have been evaluated as recombinant subunit antigens due to their protective vaccine potential (Ayalew et al., 2011; Guzman-Brambila et al., 2012) . In particular, vaccination of mice and cattle with recombinant serotype specific antigen 1 (rSsa1) stimulated high antibody responses (Ayalew et al., 2011) . Besides, a \"Best-Reciprocal-Blast-Hit\" approach was performed in order to determine that M. haemolytica outer membrane protein P6 identified in this work, is ortholog to Omp P6 of H. somni and P. multocida, both reported as Article No~e00158', 'cite_spans': [{'start': 201, 'end': 222, 'text': '(Ayalew et al., 2011;', 'ref_id': 'BIBREF8'}, {'start': 223, 'end': 252, 'text': 'Guzman-Brambila et al., 2012)', 'ref_id': None}, {'start': 389, 'end': 410, 'text': '(Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'immunogenic in recent reports (Roier et al., 2013; Alvarez et al., 2015) . In that sense, the natural occurrence of these proteins in the inactivated vaccine antigen indicates that the vaccine contains the main components required for protection against M. haemolytica.', 'cite_spans': [{'start': 30, 'end': 50, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 51, 'end': 72, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Different proteins belonging to the ATP-binding cassette (ABC) transporter superfamily were identified in the commercial antigen. ABC transport systems are essential for many processes of the cell, such as uptake of amino acids, peptides, carbohydrates and metal ions in an ATP coupled process. There is increasing evidence that these transport systems play either direct or indirect roles in the virulence and pathogenicity of bacteria (Garmory and Titball, 2004) . In a recent work, other ABC transporters were identified as immunodominant proteins from M. haemolytica and H. somni in cattle immunized with a commercial cellular vaccine, confirming that the surface exposed transporters of these species are immunogenic (Alvarez et al., 2015) . Interestingly, our results evidence that ABC transporters are relevant components in the vaccine antigen, and therefore could be potential targets for the development of antibacterial subunit vaccines (Garmory and Titball, 2004) .', 'cite_spans': [{'start': 437, 'end': 464, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}, {'start': 722, 'end': 744, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 948, 'end': 975, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Finally, we also identified an iron-regulated periplasmic protein YfeA, previously described as immunodominant in animals immunized with a cellular M. haemolytica vaccine (Alvarez et al., 2015) , as well as with an OMP-enriched fraction of M. haemolytica (Ayalew et al., 2010) .', 'cite_spans': [{'start': 171, 'end': 193, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 255, 'end': 276, 'text': '(Ayalew et al., 2010)', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Taken together, these observations support the protective potential of several of the proteins indentified in the M. haemolytica antigen. As an additional outcome anti-LKT antibodies developed for LKT identification can be used in routine quantitative assays in order to establish acceptance criteria of antigen commercial batches.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Author contribution statement Contributed reagents, materials, analysis tools or data.', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}, {'text': 'Article No~e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}], 'bib_entries': {'BIBREF1': {'ref_id': 'b1', 'title': 'Serotyping of Mannheimia (Pasteurella) haemolytica isolates from the upper Midwest United States', 'authors': [{'first': 'G', 'middle': ['M'], 'last': 'Al-Ghamdi', 'suffix': ''}, {'first': 'T', 'middle': ['R'], 'last': 'Ames', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Baker', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Walker', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Chase', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Frank', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}], 'year': 2000, 'venue': 'J. Vet. Diagn. Invest', 'volume': '12', 'issn': '6', 'pages': '576--578', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach', 'authors': [{'first': 'A', 'middle': ['H'], 'last': 'Alvarez', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Gutierrez-Ortega', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hernandez-Gutierrez', 'suffix': ''}], 'year': 2015, 'venue': 'Can. J. Vet. Res', 'volume': '79', 'issn': '4', 'pages': '339--342', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds', 'authors': [{'first': 'T', 'middle': [], 'last': 'Autio', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pohjanvirta', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Holopainen', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Rikula', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Pentikainen', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Huovilainen', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Rusanen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Soveri', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Sihvonen', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pelkonen', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': ['D'], 'last': 'Hartson', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}], 'year': 2010, 'venue': 'Proteomics', 'volume': '10', 'issn': '11', 'pages': '2151--2164', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'A', 'middle': ['E'], 'last': 'Wilson', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Clin. Vaccine Immunol', 'volume': '18', 'issn': '12', 'pages': '2067--2074', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Step', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Wray', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Hansen', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 2009, 'venue': 'Vaccine', 'volume': '27', 'issn': '11', 'pages': '1771--1776', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Mccraw', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Durham', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Morton', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 1995, 'venue': 'Vet. Immunol. Immunopathol', 'volume': '47', 'issn': '1-2', 'pages': '101--110', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Conlon', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '2', 'pages': '587--591', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Histophilus somni host-parasite relationships', 'authors': [{'first': 'L', 'middle': ['B'], 'last': 'Corbeil', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '151--160', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Identification and characterization of the Pasteurella haemolytica leukotoxin', 'authors': [{'first': 'Y', 'middle': ['F'], 'last': 'Chang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Young', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Post', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Struck', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '10', 'pages': '2348--2354', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Pasteurella multocida and bovine respiratory disease', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Dabo', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Taylor', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '129--150', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein', 'authors': [{'first': 'S', 'middle': [], 'last': 'Derzelle', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bolotin', 'suffix': ''}, {'first': 'M', 'middle': ['Y'], 'last': 'Mistou', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Rul', 'suffix': ''}], 'year': 2005, 'venue': 'Appl. Environ. Microbiol', 'volume': '71', 'issn': '12', 'pages': '8597--8605', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Control methods for bovine respiratory disease for feedlot cattle', 'authors': [{'first': 'T', 'middle': ['A'], 'last': 'Edwards', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '273--284', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Complete genome sequence of Mannheimia haemolytica strain 42548 from a case of bovine respiratory disease', 'authors': [{'first': 'S', 'middle': [], 'last': 'Schwarz', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Fulton', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Purdy', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'J', 'middle': ['T'], 'last': 'Saliki', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Loan', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Burge', 'suffix': ''}], 'year': 2000, 'venue': 'Can. J. Vet. Res', 'volume': '64', 'issn': '3', 'pages': '151--159', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies', 'authors': [{'first': 'H', 'middle': ['S'], 'last': 'Garmory', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Titball', 'suffix': ''}], 'year': 2004, 'venue': 'Infect. Immun', 'volume': '72', 'issn': '12', 'pages': '6757--6763', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves', 'authors': [{'first': 'L', 'middle': ['J'], 'last': 'Gershwin', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Gunther', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Anderson', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Woolums', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Mcarthur-Vaughan', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Randel', 'suffix': ''}, {'first': 'G', 'middle': ['A'], 'last': 'Boyle', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Friebertshauser', 'suffix': ''}, {'first': 'P', 'middle': ['S'], 'last': 'Mcinturff', 'suffix': ''}], 'year': 2000, 'venue': 'Am. J. Vet. Res', 'volume': '61', 'issn': '3', 'pages': '291--298', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge', 'authors': [{'first': 'A', 'middle': ['E'], 'last': 'Ortuno-Sahagun', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Res. Vet. Sci', 'volume': '93', 'issn': '3', 'pages': '1293--1300', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Complete closed genome sequences of Mannheimia haemolytica serotypes A1 and A6, isolated from cattle', 'authors': [{'first': 'G', 'middle': ['P'], 'last': 'Harhay', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Koren', 'suffix': ''}, {'first': 'A', 'middle': ['M'], 'last': 'Phillippy', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Mcvey', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kuszak', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Clawson', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Harhay', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Heaton', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Chitko-Mckown', 'suffix': ''}, {'first': 'T', 'middle': ['P'], 'last': 'Smith', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2 Isolates D171 and D35 recovered from bovine pneumonia', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Hauglund', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Tatum', 'suffix': ''}, {'first': 'D', 'middle': ['O'], 'last': 'Bayles', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}], 'year': 2015, 'venue': 'Genome Announc', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1', 'authors': [{'first': 'C', 'middle': [], 'last': 'Klockenbusch', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kast', 'suffix': ''}], 'year': 2010, 'venue': 'J. Biomed. Biotechnol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin', 'authors': [{'first': 'F', 'middle': ['A'], 'last': 'Lainson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Murray', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Davies', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Donachie', 'suffix': ''}], 'year': 1996, 'venue': 'Microbiology', 'volume': '142', 'issn': '', 'pages': '2499--2507', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Improved method for predicting linear B-cell epitopes', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Larsen', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Lund', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nielsen', 'suffix': ''}], 'year': 2006, 'venue': 'Immunome Res', 'volume': '2', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2: ovine and bovine isolates', 'authors': [{'first': 'P', 'middle': ['K'], 'last': 'Lawrence', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Kittichotirat', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Bumgarner', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Mcdermott', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Herndon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Knowles', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Srikumaran', 'suffix': ''}], 'year': 2010, 'venue': 'J. Bacteriol', 'volume': '192', 'issn': '4', 'pages': '1167--1168', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches', 'authors': [{'first': 'A', 'middle': [], 'last': 'Lima', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Duran', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Schujman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Marchissio', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Portela', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Obal', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Pritsch', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'De Mendoza', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Cervenansky', 'suffix': ''}], 'year': 2011, 'venue': 'J. Proteomics', 'volume': '74', 'issn': '9', 'pages': '1720--1734', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'C', 'middle': ['N'], 'last': 'Greer', 'suffix': ''}], 'year': 1985, 'venue': 'Infect. Immun', 'volume': '50', 'issn': '3', 'pages': '667--671', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '9', 'pages': '1987--1996', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Cooney', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '10', 'pages': '3398--3406', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Mosier', 'suffix': ''}, {'first': 'K', 'middle': ['R'], 'last': 'Simons', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}, {'first': 'K', 'middle': ['D'], 'last': 'Clinkenbeard', 'suffix': ''}], 'year': 1989, 'venue': 'Infect. Immun', 'volume': '57', 'issn': '3', 'pages': '711--716', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Leukotoxins of gram-negative bacteria', 'authors': [{'first': 'S', 'middle': ['K'], 'last': 'Narayanan', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Nagaraja', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Chengappa', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Stewart', 'suffix': ''}], 'year': 2002, 'venue': 'Vet. Microbiol', 'volume': '84', 'issn': '4', 'pages': '337--356', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Probability-based protein identification by searching sequence databases using mass spectrometry data', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Perkins', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Pappin', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Creasy', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Cottrell', 'suffix': ''}], 'year': 1999, 'venue': 'Electrophoresis', 'volume': '20', 'issn': '18', 'pages': '3551--3567', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb', 'authors': [{'first': 'A', 'middle': ['A'], 'last': 'Potter', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Schryvers', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Ogunnariwo', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Hutchins', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Watts', 'suffix': ''}], 'year': 1999, 'venue': 'Pathogenesis', 'volume': '27', 'issn': '4', 'pages': '197--206', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Bovine respiratory disease', 'authors': [{'first': 'T', 'middle': [], 'last': 'Potter', 'suffix': ''}], 'year': 2015, 'venue': 'Livestock (Electronic)', 'volume': '20', 'issn': '1', 'pages': '14--18', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'TRAP transporters: an ancient family of extracytoplasmic solute-receptor-dependent secondary active transporters', 'authors': [{'first': 'R', 'middle': [], 'last': 'Rabus', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Jack', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Kelly', 'suffix': ''}, {'first': 'M', 'middle': ['H'], 'last': 'Saier', 'suffix': ''}], 'year': 1999, 'venue': 'Microbiology', 'volume': '145', 'issn': '', 'pages': '3431--3445', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The contribution of infections with bovine viral diarrhea viruses to bovine respiratory disease', 'authors': [{'first': 'J', 'middle': [], 'last': 'Ridpath', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '335--348', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Effects of vaccination against respiratory Article No~e00158 pathogens on feed intake, metabolic, and inflammatory responses in beef heifers', 'authors': [{'first': 'M', 'middle': ['C'], 'last': 'Rodrigues', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Cooke', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Marques', 'suffix': ''}, {'first': 'B', 'middle': ['I'], 'last': 'Cappellozza', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Arispe', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Keisler', 'suffix': ''}, {'first': 'D', 'middle': ['W'], 'last': 'Bohnert', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': 'Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles', 'authors': [{'first': 'S', 'middle': [], 'last': 'Roier', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Fenninger', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Leitner', 'suffix': ''}, {'first': 'G', 'middle': ['N'], 'last': 'Rechberger', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Reidl', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schild', 'suffix': ''}], 'year': 2013, 'venue': 'Int. J. Med. Microbiol', 'volume': '303', 'issn': '5', 'pages': '247--256', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1985, 'venue': 'Am. J. Vet. Res', 'volume': '46', 'issn': '5', 'pages': '1212--1214', 'other_ids': {}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1988, 'venue': 'Can. J. Vet. Res', 'volume': '52', 'issn': '1', 'pages': '30--36', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'Mannheimia haemolytica: bacterial-host interactions in bovine pneumonia', 'authors': [{'first': 'K', 'middle': [], 'last': 'Singh', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Ritchey', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Vet. Pathol', 'volume': '48', 'issn': '2', 'pages': '338--348', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'Protein production by auto-induction in high density shaking cultures', 'authors': [{'first': 'F', 'middle': ['W'], 'last': 'Studier', 'suffix': ''}], 'year': 2005, 'venue': 'Protein Expr. Purif', 'volume': '41', 'issn': '1', 'pages': '207--234', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Sequence diversity of the leukotoxin (lktA) gene in caprine and ovine strains of Mannheimia haemolytica', 'authors': [{'first': 'C', 'middle': [], 'last': 'Vougidou', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Sandalakis', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Psaroulaki', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Petridou', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ekateriniadou', 'suffix': ''}], 'year': 2013, 'venue': 'Vet. Rec', 'volume': '172', 'issn': '16', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Effect of bovine granulocyte colony-stimulating factor on the development of pneumonia caused by Mannheimia haemolytica', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Youssef', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Clark', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Caswell', 'suffix': ''}], 'year': 2004, 'venue': 'Vet. Pathol', 'volume': '41', 'issn': '6', 'pages': '649--657', 'other_ids': {}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'How Mannheimia haemolytica defeats host defence through a kiss of death mechanism', 'authors': [{'first': 'L', 'middle': [], 'last': 'Zecchinon', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fett', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Desmecht', 'suffix': ''}], 'year': 2005, 'venue': 'Vet. Res', 'volume': '36', 'issn': '2', 'pages': '133--156', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': ', LKT was identified by MS in a higher than expected MW band (>230 kDa). This result was confirmed by Western blot of inactivated supernatant using anti-LKT antibodies M. haemolytica culture growth and LKT secretion profile. A. Anti-LKT Western blot of M. haemolytica culture supernatant samples from different fermentation time points. M: fermentation media, T1-T10: samples from culture kinetics (1-10 h). MW: Molecular weight marker. B. M. haemolytica culture growth curve and kinetics of Leukotoxin secretion. Optical density (OD) at 600 nm, glucose concentration (mg/dL) and band intensity of LKT expressed in arbitrary units (AU) are plotted versus culture growth time measured in hours.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'This work provides an exhaustive molecular characterization of an inactivated culture supernatant of M. haemolytica included in a line of polyvalent commercial bovine vaccines (Neumosan, Virbac Uruguay). Since M. haemolytica is the main etiological agent of BRD and is also responsible for a high proportion of the Identification of M. haemolytica culture supernatant proteins. A. M. haemolytica proteins of inactivated culture supernatant (iCSN) resolved in SDS-PAGE and stained with coomassie blue. Bands corresponding to the proteins analyzed by MS (MALDI TOF/TOF) are numbered and referred to on Table 1. For complete image see Fig. S1 (Supplementary material). B. Analysis of culture supernatant proteins by Western blot. Left: M. haemolytica inactivated (iCSN) and non inactivated culture supernatant (CSN) proteins probed with anti-rLKT rabbit serum. Middle: Reactivity of bovine M. haemolytica infected serum against M. haemolytica iCSN and CSN. Right: Reactivity of bovine healthy serum against M. haemolytica iCSN and CSN. MW: Molecular weight marker.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Proteins identified in culture supernatant of M. haemolytica.', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': 'Paula Tucci: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Verónica Estevez, Lorena Becco: Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Florencia Cabrera-Cabrera: Performed the experiments; Analyzed and interpreted the data. Germán Grotiuz: Performed the experiments; Analyzed and interpreted the data;', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We thank Viviana Sánchez for critical reading of the manuscript, Danilo Segovia for assistance in cloning techniques and Florencia Arezzo for technical assistance during M. haemolytica laboratory scale fermentation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}, {'text': 'This work was partially financed by Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing interest statement'}, {'text': 'This work was partially supported by Agencia Nacional de Investigación e Innovación (ANII, Uruguay), Alianzas para la Innovación (ALI_2_2013_1_4783) and Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding statement'}, {'text': 'Supplementary content related to this article has been published online at http://dx. doi.org/10.1016/j.heliyon.2016.e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Additional information'}]}\n",
      "{'_id': ObjectId('5ea715ef6864341d366a56f2'), 'paper_id': '0a098b3876e799d9b21608e26e80d05aa9ec6475', 'metadata': {'title': '', 'authors': [{'first': 'J', 'middle': ['B'], 'last': 'Bump', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': \"This paper addresses the need for conceptual and analytic clarity on nutrition governance, an essential underpinning of more effective approaches for undernutrition, the 'single greatest constraint to global development' and obesity, which already accounts for 4% of the world's disease burden and is growing rapidly. The governance of nutrition, which is essential to designing and implementing policies to realise the right to food, is among the most important and most defining duties of society. But research and action on nutrition governance are hampered by the absence of conceptual rigour, even as the continuing very high burden of undernutrition and the rapid rise in obesity highlight the need for such structures. The breadth of nutrition itself suggests that governance is both needed and sure to be complicated. This analysis explores the reasons attention has come to governance in development policy making, and why it has focused on nutrition governance in particular. It then assesses how the concept of nutrition governance has been used, finding that it has become increasingly prominent in scholarship on poor nutritional outcomes, but remains weakly specified and is invoked by different authors to mean different things. Undernutrition analysts have stressed coordination problems and structural issues related to the general functioning of government. Those studying obesity have emphasised international trade policies, regulatory issues and corporate behaviour. This paper argues that the lack of a clear, operational definition of governance is a serious obstacle to conceptualising and solving major problems in nutrition. To address this need, it develops a unified definition of nutrition governance consisting of three principles: accountability, participation and responsiveness. These are justified with reference to the social contract that defines modern nations and identifies citizens as the ultimate source of national power and legitimacy. A unified framework is then employed to explore solutions to nutrition governance problems.\", 'cite_spans': [], 'ref_spans': [], 'section': 'AbsTrACT'}, {'text': 'Nutrition is a requirement of all life and one of the most basic underpinnings of health, and as such is of great interest to all people. The right to food is therefore one of the most fundamental human entitlements and a central responsibility for all states. 1 2 The governance of nutrition, which is essential to designing and implementing policies to realise this right, 3 4 is thus among the most important and most defining duties of society. Better governance, broadly defined, has potential to improve many aspects of nutrition, for instance by coordinating actions between sectors and agencies, promoting accountability of corporate actors, improving the food supply, increasing community ownership in intervention programmes, improving the responsiveness of government to citizen demand and helping to uphold the right to food.', 'cite_spans': [{'start': 261, 'end': 264, 'text': '1 2', 'ref_id': None}, {'start': 375, 'end': 378, 'text': '3 4', 'ref_id': None}], 'ref_spans': [], 'section': 'InTroduCTIon'}, {'text': 'What is already known? ► The governance of nutrition is essential to addressing both undernutrition and obesity, but international and domestic actors have struggled in this area.', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': 'What are the new findings?', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': '► Governance has risen on donor agendas since the fall of the Berlin Wall in 1989, and has become more important with the proliferation of international actors, increasing cross-border actions and greater globalisation of commerce and disease. ► Increased prominence of nutrition governance reflects greater donor engagement, the multisectoral nature of food, increasing obesity the need for health-related regulation of trade and food crises caused by climate change and food crop diversion. ► Existing governance frameworks do not clarify their principles; this paper develops a unified conceptualisation of nutrition governance from basic philosophy to show the relationships between undernutrition and obesity, clarify the challenges and illuminate opportunities for intervention.', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': '► Nutrition governance and the right to food can be advanced by using the three elements of accountability, participation and responsiveness to assess all governance interventions and the performance of international actors.', 'cite_spans': [], 'ref_spans': [], 'section': 'What do the new findings imply?'}, {'text': \"But both research and action on nutrition governance are hampered by the absence of clarity or consensus on the meaning of this concept, even as many problems highlight the need for such structures. Undernutrition alone has been called 'the single greatest constraint facing global development' 5 and obesity accounts for nearly 4% of the entire global disease burden already and is increasing rapidly. 6 Globalisation of the food industry has been linked to rising obesity, diet-related chronic disease and the nutritional transition. 7 The breadth of nutrition itself suggests that governance is both needed and sure to be complicated. The production, distribution, sale and consumption of food engages agriculture, trade, transportation, education, health and other areas of both the public and private sectors.\", 'cite_spans': [{'start': 295, 'end': 296, 'text': '5', 'ref_id': 'BIBREF4'}, {'start': 403, 'end': 404, 'text': '6', 'ref_id': 'BIBREF5'}, {'start': 536, 'end': 537, 'text': '7', 'ref_id': 'BIBREF6'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Nonetheless, despite this need, basic questions about nutrition governance lack ready answers. For instance, what are the most important elements of governance? When planning a governance improvement intervention, where would one begin? For all the things that governance seems to be, what is it not? Is it the same as politics, or something different?', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Conceptual rigour around nutrition governance would help navigate the seemingly impenetrable tangle of issues that now characterise this topic. The range of actors includes everything from individuals to the multinational food industry. The spectrum of influences is just as wide, including everything from personal preferences to national policies and global trade regimes, each of which has different sources of authority and legitimacy. In many scenarios, the lines of accountability are not obvious and even the relevant constituencies can be challenging to identify. Despite the profound influence of governance on nutrition, Sunguya et al have found that only 40% of low-income and middle-income country (LMIC) governments even have policies in this area. And although logic suggests that having a policy would be helpful, their analysis found no association with better nutrition outcomes. 8 In many places, rapid urbanisation is exacerbating weak governance problems, 9 and unregistered informal settlements expose the dysfunction of traditional welfare state approaches when citizens become invisible to the bureaucracy. 10 11 Where citizens do participate in the policy process, they may be ambivalent about issues experts view as urgent, 12 or their opinions may be influenced by food industry marketing or sponsored research. 13 14 How would one analyse or manage these complex issues?', 'cite_spans': [{'start': 897, 'end': 898, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 976, 'end': 977, 'text': '9', 'ref_id': 'BIBREF8'}, {'start': 1130, 'end': 1135, 'text': '10 11', 'ref_id': None}, {'start': 1249, 'end': 1251, 'text': '12', 'ref_id': 'BIBREF11'}, {'start': 1338, 'end': 1343, 'text': '13 14', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The purpose of this article is to rigorously analyse nutrition governance, which is essential to more effective intervention by national and international actors striving to uphold the right to food. First, I explain the literature review methods used to gather materials for analysis. Second, I examine why governance has become prominent on the health and development agendas. Third, I investigate the meaning of nutrition governance empirically, by assessing how the concept has been used. Fourth, I develop a clear definition of nutrition governance. Fifth, I present a framework for analysing nutrition governance and characterising its major features. In the conclusion, I use the framework to illuminate governance problems and corresponding opportunities for global-level actors.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"This inquiry began with a search of literature to gather information for the analysis and to gain insights into activities related to nutrition governance. To identify publications on nutrition governance, a keyword search for 'nutrition governance' was conducted in the PubMed database. i PubMed was chosen as the starting point because it is the world's largest database of health and medical literature. To capture additional literature from the social sciences, humanities, newspapers and books, the JSTOR database was searched, as well. Searches with Google Scholar and a review of citations in the most directly relevant papers were used to complete the initial sample. ii All results were reviewed and papers were retained if they used the term nutrition governance, or focused on nutrition and included aspects of governance as defined broadly by Lee et al to include accountability, transparency, participation, responsiveness, a consensus orientation, the rule of law, effectiveness and efficiency and equity and inclusiveness. 15 Papers were excluded if they mentioned nutrition governance insubstantially or were irrelevant, for instance, as part of author affiliations, but not in the article itself. [16] [17] [18] [19] A more extensive discussion of methods is available as online supplementary annex 1.\", 'cite_spans': [{'start': 676, 'end': 678, 'text': 'ii', 'ref_id': None}, {'start': 1038, 'end': 1040, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 1214, 'end': 1218, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 1219, 'end': 1223, 'text': '[17]', 'ref_id': 'BIBREF16'}, {'start': 1224, 'end': 1228, 'text': '[18]', 'ref_id': 'BIBREF17'}, {'start': 1229, 'end': 1233, 'text': '[19]', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'MeTHods'}, {'text': 'The final sample for analysis comprised 177 papers. Table 1 presents the search strategy for each database along with the number of papers obtained:', 'cite_spans': [], 'ref_spans': [{'start': 52, 'end': 59, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'MeTHods'}, {'text': \"The limitations of this exercise include at least the following: these databases are biased towards English-language publications and western journals, and may not accurately capture governance work, even in these areas. Scholarship on governance may not have been indexed consistently or with the same keywords over the period of interest. The journals indexed by PubMed are not constant and the aggregate number has increased over this period. The searches used the keyword 'governance', which is a current term but may not have been the most commonly used term for describing its subject over the past 40 years. These limitations notwithstanding, the review is likely to have generated a reasonable sample of literature for analysing the aspects of nutrition governance of interest in this paper. \", 'cite_spans': [], 'ref_spans': [], 'section': 'MeTHods'}, {'text': 'FIndIngs And dIsCussIon Governance is such an obvious requirement for development that it is not intuitive why attention should have come to this area only in the past two or three decades, and especially in the last 10 years. I decided to investigate the reasons, hypothesising that they would help demonstrate the importance of nutrition governance and reveal the specific problems it is expected to solve.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"governance and the development policy agenda Before the fall of the Berlin Wall in 1989, most aid was conditional on geopolitical alignment rather than on how states treated their own citizens. But after the Cold War, economic and political rights issues were no longer enmeshed in the larger US-Soviet ideological struggle. Freed from this constraint, western donors began to project their own political convictions via democratisation and governance projects. The growth of the rights movement and several international agreements on rights in the early 1990s testifies further to the power of this shift. 20 When the concern for state alignment evaporated, it helped bring attention to the role of governance in translating development aid into poverty reduction. This was an important factor in the introduction and subsequent popularity of the Sector Wide Approaches (SWAps) and other general budget support mechanisms that blossomed in the 1990s. 21 After mixed results from the 1980s' Washington Consensus aid approach, it was also clear that the market alone would not solve all problems; the rise of governance was a partial retreat from that position, 22 as was the embrace of public-private partnerships. 23 Weaknesses in governance at various levels from the national to the global drew attention as constraints to health systems. 24 The proliferation of actors in global health also spurred calls for better governance because of the need for coordination and accountability. 25 Targeted aid and democratisation projects became even more closely linked after the 9/11 attacks brought emphasis in US policymaking to the problems of failed states and poor populations. After 9/11, US assistance was directed to poor people in failed states in hopes of preventing scarcity-induced radicalizsation. The emphasis on safety nets and social protection could be read as a move by donors to enhance democratic participation by the poor. 26 However, these actions also fit neatly in the long legacy of aid programmes targeting health issues primarily because of their impact on trade and markets. 27 In the last 10 years, governance has become a well-established subfield in global health, in part because many problems related to governance have become more obvious. Governance was a natural follow-on focus after the decentralisation policies widely promoted in the 1990s, particularly because many of the formal policies and institutions designed to promote local engagement had not actually democratised decision making. 28 But the growing attention to governance also reflects rapid globalisation. The rising threat of disease and the growth of interstate commerce both increase the need for shared decision making between diverse groups and entities. 29 30 Globalisation has also highlighted the need for governance over both health and trade, which since World War II have been institutionalised distinctly. 31 Large-scale disease outbreaks, such as severe acute respiratory syndrome in 2003 and Ebola in West Africa in 2014 have made visible the importance of functioning governance mechanisms in health. [32] [33] [34] Trade-related non-communicable diseases linked to tobacco, processed foods and other goods have exposed shortcomings in existing structures. 35 International actors have recognised governance in many of their projects and analyses. Beginning in 1996, the World Bank began collecting governance indicators every other year; since 2002, it has collected these data annually from 212 countries and territories. 36 World Bank projects classified as 'Public Sector Governance' have become far more numerous over the years. In the 1980s, there were 304 such projects. In the 1990s, there 20 The multiplication of new NGOs, UN entities, corporations and others engaged in nutrition has continued and represents a growing challenge for coordination. 25 39 Additionally, the complexity of nutrition and its engagement with a great many sectors-agriculture, education, trade, health and others-present many coordination challenges. Second, food and nutrition interventions could be targeted at the community level and could give voice to poor citizens by promoting their participation. Hence, they were seen as natural vehicles to advance donors' general priorities in economic and political rights, and in attempting to prevent scarcity-induced radicalisation in failed states. More broadly, donors attempted to enhance democratic participation by the poor, but questions of how donor-driven governance models were supposed to interact with existing governance structures largely went unaddressed. 26 Third, the advance of globalisation highlighted the need for supranational regulation and strengthened governance at all levels. In 1999, Lang argued that globalisation was undermining traditional governance of food because national authority was not capable to regulating multinational businesses or countering their marketing. 40 The global growth of fast food and advertising largely bypassed health authorities because it was regulated internationally only as a trade issue with little reference to health consequences. 41 Others have advanced similar points on the importance of 'food governance', 42 for food and nutrition, perhaps similar to the Framework Convention on Tobacco Control, and coordinated action by the World Bank, WHO and the UN. 35 43 44 Fourth, real food prices rose quickly in the 2000s, peaking in 2008 and 2011, driven by depreciation in the dollar, diversion of some crops to biofuel use, oil price appreciation, export restrictions, demand surges, droughts and other factors. 45 46 Between 2000 and 2011, food prices increased 183% in real terms. 47 The disastrous humanitarian consequences of this increase, including conflict and instability, 48 generated political motivation for discussing food security, agriculture and trade policy and other aspects of global nutrition, particularly with respect to undernutrition. [49] [50] [51] Fifth, multilateral organisations and academics have been active. Governance was identified as one of the principal weaknesses in global nutrition by WHO's Commission on Social Determinants of Health in 2008 52 ; a Lancet commission cited governance problems as a central obstacle to effective international intervention against undernutrition. 53 Also in 2008 (formalised 2011), the Food and Agriculture Organization, Unicef and World Food Programme (WFP) agreed to launch Renewed Efforts Against Child Hunger and undernutrition (REACH) to strengthen UN actions to fight hunger and malnutrition by coordinating actions within recipient countries. In 2009-2010, WHO and many partners launched the Scaling Up Nutrition (SUN) movement to spur progress against undernutrition. 54 In 2010, WHO's Nutrition Landscape Information System launched with a series of governance indicators, 55 which has made it easier to quantify and demonstrate the large impact of governance on nutrition. 8 Since 2011, REACH has focused on strengthening nutrition management and governance, and supporting multisectoral nutrition actions, such as nutrition-sensitive programming. 39 56 These multilateral efforts have all brought attention to governance, although some have attracted criticism for expanding the influence of the private sector in public health policy. 57 58 This historical analysis reveals why nutrition governance is so crucial. First, it is essential to realise the right to food. Second, it is a tractable place to advance development through encouraging participation and democratisation, and as such is a powerful lever to realise many rights. Third, it is needed to coordinate between the many sectors important to nutrition, and among the many agencies and entities operating domestically and internationally. Fourth, it is required to address the affects of trade on health, particularly in the globalised food industry.\", 'cite_spans': [{'start': 608, 'end': 610, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 953, 'end': 955, 'text': '21', 'ref_id': 'BIBREF20'}, {'start': 1162, 'end': 1164, 'text': '22', 'ref_id': 'BIBREF21'}, {'start': 1216, 'end': 1218, 'text': '23', 'ref_id': 'BIBREF22'}, {'start': 1343, 'end': 1345, 'text': '24', 'ref_id': 'BIBREF23'}, {'start': 1489, 'end': 1491, 'text': '25', 'ref_id': 'BIBREF24'}, {'start': 1941, 'end': 1943, 'text': '26', 'ref_id': 'BIBREF25'}, {'start': 2100, 'end': 2102, 'text': '27', 'ref_id': 'BIBREF26'}, {'start': 2528, 'end': 2530, 'text': '28', 'ref_id': 'BIBREF27'}, {'start': 2760, 'end': 2765, 'text': '29 30', 'ref_id': None}, {'start': 2918, 'end': 2920, 'text': '31', 'ref_id': 'BIBREF30'}, {'start': 3116, 'end': 3120, 'text': '[32]', 'ref_id': 'BIBREF31'}, {'start': 3121, 'end': 3125, 'text': '[33]', 'ref_id': 'BIBREF32'}, {'start': 3126, 'end': 3130, 'text': '[34]', 'ref_id': 'BIBREF33'}, {'start': 3272, 'end': 3274, 'text': '35', 'ref_id': 'BIBREF34'}, {'start': 3539, 'end': 3541, 'text': '36', 'ref_id': 'BIBREF35'}, {'start': 3713, 'end': 3715, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 3873, 'end': 3878, 'text': '25 39', 'ref_id': None}, {'start': 4620, 'end': 4622, 'text': '26', 'ref_id': 'BIBREF25'}, {'start': 4952, 'end': 4954, 'text': '40', 'ref_id': 'BIBREF39'}, {'start': 5147, 'end': 5149, 'text': '41', 'ref_id': 'BIBREF40'}, {'start': 5226, 'end': 5228, 'text': '42', 'ref_id': 'BIBREF41'}, {'start': 5375, 'end': 5377, 'text': '35', 'ref_id': 'BIBREF34'}, {'start': 5378, 'end': 5383, 'text': '43 44', 'ref_id': None}, {'start': 5628, 'end': 5633, 'text': '45 46', 'ref_id': None}, {'start': 5699, 'end': 5701, 'text': '47', 'ref_id': None}, {'start': 5974, 'end': 5978, 'text': '[49]', 'ref_id': 'BIBREF48'}, {'start': 5979, 'end': 5983, 'text': '[50]', 'ref_id': 'BIBREF49'}, {'start': 5984, 'end': 5988, 'text': '[51]', 'ref_id': 'BIBREF50'}, {'start': 6334, 'end': 6336, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 6763, 'end': 6765, 'text': '54', 'ref_id': 'BIBREF53'}, {'start': 6869, 'end': 6871, 'text': '55', 'ref_id': 'BIBREF54'}, {'start': 6970, 'end': 6971, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 7145, 'end': 7150, 'text': '39 56', 'ref_id': None}, {'start': 7334, 'end': 7339, 'text': '57 58', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The need for governance A review of the literature identified in this search finds that most authors use \\'governance\\' in explanation of their primary findings, but usually do not focus on governance itself. In this usage, one theme could be called \\'the need for governance\\', which investigates problems and BMJ Global Health explains them with reference to weak or missing governance. At the global level, this literature includes calls for better governance as global and national policy environments become more complex 59 and the globalisation of the food industry overwhelms existing governance structures. 60 Governance problems are central to the maldistribution underlying local or regional food insecurity even though global production is adequate. 61 Quality of governance was identified as an important determinant of progress towards the Millennium Development Goals and successful primary healthcare implementation, 62 and as a fundamental component of high performing states: \\'…the most effective, relevant national policies will emerge from a system of governance that firmly connects the needs of the poor to a politically responsive local government that has the technical and institutional capacity to act\\'. 3 A high-profile Lancet article focusing mainly on the global level identified accountability and participation as leading problems: \\'The international community needs to identify and establish a new global governance structure that can provide greater accountability and participation for civil society and the private sector\\'. 53 The WHO Code of Marketing of Breast Milk Substitutes has provisions for punishing violators, but governance problems have rendered the code largely unenforced and ineffective. [63] [64] [65] Donors have attempted to promote accountability and participation mechanisms, but many interventions do not translate into benefits for those not already enfranchised, such as women, 66 and many efforts have been assailed by activists for advancing private sector influence in public health processes. 58 67 68 The importance of nutrition governance is demonstrated by experiences and analyses in many national and local contexts, as well. Some of the largest are collective action problems. 69 In India, which has among the highest burdens related to suboptimal nutrition, governance problems have been deemed more significant than scientific or technical obstacles, 70 and is needed to translate economic growth into progress against undernutrition. 71 Looking at urban areas of the same country, Bhojani et al characterised the main governance problems as weak regulation of quality in the private sector; poor coordination across care providers in the public and private sectors and between clinics, health centres and hospitals; rampant bribery and the absence of systems to respond to formal grievances or provide accountability to citizens. 72 In a policy analysis of maternal and child health in Pakistan, Siddiqi et al argued that good governance is needed to translate policies into results. 73 In a discussion of food security and fisheries, weaknesses in governance were revealed in overfishing, depletion of stocks, minimal enforcement, low oversight and inadequate coordination of policies and actions between national and global authorities. 74 Understanding governance structures is also extremely important for designing strategies to advance food policy on political agendas. 75 The politics of food policy hinges both on government leadership and activism by civil society organisations. 76 Others used \\'governance\\' as an organising category to identify coordination problems, which arise from nutrition\\'s intersectoral nature, as reported in India and Brazil, to name two examples. 77 78 Coordination problems can arise at the intersection of public and private sectors-the Bangladesh Government attempted to advance governance in its policies, but the exercise\\'s impact was attributed to NGO partners. 79 Some analysts have assessed the effect of governance through comparative and synthetic investigations. In a comparison of fragile states, those with higher quality of governance were more likely to join SUN, while the \\'prevalence of malnutrition, health system functioning and level of citizen empowerment had little or no impact\\' on the decision to join. 80 A synthetic review of 58 controlled evaluations argued that \\'nutrition is now recognised to be a governance issue\\', and that better governance was associated with lower prevalence of child undernutrition. 81 A comparison of water quality in Brazil, Ecuador and Malawi found \\'…that access to safe water could be improved if certain water governance challenges were addressed: coordination and data sharing between minis-tries…; monitoring and enforcement of water quality laws; and sufficient technical capacity to improve administrative and technical management of water services…\\'\" 82 \\'Governance\\' has also been used as a general category for describing specific interventions, many of them successful. Extensive community engagement helped address governance problems in Vietnam. 83 Collaboration and coordination problems were resolved with shared governance structures in Colombia. 84 In both Australia and the UK, the clarity and transparency of governance arrangements was important to facilitating cooperation and coordination in obesity reduction efforts. 85 86 In the Philippines, long-term capacity building in both the public and private sectors has facilitated governance by collecting and analysing data to generate evidence for improving policymaking. 87 Systematic data analysis in Haiti has helped to elucidate many factors that promoted good nutrition governance, including \\'effective evidence-based advocacy, partnerships and design, implementation and scale-up of nutrition-specific and sensitive interventions\\'. 88 Another area of scholarship using governance has focused on citizen attitudes and perceptions to explore why technically sound policies are challenging to adopt and implement. Reasons include popular ambivalence towards experts\\' opinion, 12 or the shaping of debate by food industry marketing or sponsored research. 13 14 Contested views of the role of the state versus the private sector were central to the growing obesity epidemic in Australia, where many people did not want the state to counter fast food advertising. 89 Also, politicians were the least trusted group for information on food, according to a telephone survey by the same researchers (farmers were the most trusted). 90 This contest for influence is very difficult for public health advocates. Denmark introduced a saturated fat tax in 2011, supported with BMJ Global Health public health arguments, but it was opposed by the food industry and related actors. Although the tax began to change the national diet as public health advocates had hoped, the tax had no organised supporters and the food industry successfully lobbied for its abolishment the following year. 91 Calls for improved governance were not always matched by clarity about exactly what is needed, suggesting that governance can be challenging to specify and is not always discussed in meaningful detail. Given the complexity and vagueness of both \\'nutrition\\' and \\'governance\\', this finding is hardly surprising. Others have reached this same conclusion. A systematic review of health system barriers to antiretroviral therapy provision found that many authors cited governance problems, but the collective evidence was weak because individual cases included too little context to convey what this meant in detail. 92 In a systematic review of the impact of health systems and policies on behaviour change to promote child survival in LMICs, Velez et al concluded, \\'The evidence directly addressing how to improve the financing and governance of health systems was weak or not available\\'. 93 Another broad review focused on agriculture research, finding that despite vast influence of governance on the agriculture-nutrition impact, only six studies, just 4% of the sample, actually focused on governance. 94 Addressing nutrition governance directly A far smaller portion of the literature reviewed in this study focused directly on nutrition governance, typically regarding undernutrition. In historical perspective, undernutrition, hunger and food insecurity are all wellknown problems that surely predate the written record, whereas obesity has become a public health concern only very recently. In this light, it may not be surprising that a majority of the papers on nutrition governance concerned undernutrition and concentrated on the governance issues related to that problem. The major institutional actors mentioned in the literature review focus the preponderance of activities on undernutrition, including Unicef, SCN, WFP and WHO, and major initiatives such as SUN and REACH, although both Unicef and WHO have smaller portfolios targeting obesity.', 'cite_spans': [{'start': 522, 'end': 524, 'text': '59', 'ref_id': 'BIBREF57'}, {'start': 611, 'end': 613, 'text': '60', 'ref_id': 'BIBREF58'}, {'start': 757, 'end': 759, 'text': '61', 'ref_id': 'BIBREF59'}, {'start': 928, 'end': 930, 'text': '62', 'ref_id': 'BIBREF60'}, {'start': 1225, 'end': 1226, 'text': '3', 'ref_id': 'BIBREF2'}, {'start': 1554, 'end': 1556, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 1733, 'end': 1737, 'text': '[63]', 'ref_id': 'BIBREF61'}, {'start': 1738, 'end': 1742, 'text': '[64]', 'ref_id': 'BIBREF62'}, {'start': 1743, 'end': 1747, 'text': '[65]', 'ref_id': 'BIBREF63'}, {'start': 1931, 'end': 1933, 'text': '66', 'ref_id': 'BIBREF64'}, {'start': 2050, 'end': 2052, 'text': '58', 'ref_id': 'BIBREF56'}, {'start': 2053, 'end': 2058, 'text': '67 68', 'ref_id': None}, {'start': 2240, 'end': 2242, 'text': '69', 'ref_id': 'BIBREF67'}, {'start': 2416, 'end': 2418, 'text': '70', 'ref_id': 'BIBREF68'}, {'start': 2500, 'end': 2502, 'text': '71', 'ref_id': 'BIBREF69'}, {'start': 2896, 'end': 2898, 'text': '72', 'ref_id': 'BIBREF70'}, {'start': 3050, 'end': 3052, 'text': '73', 'ref_id': 'BIBREF71'}, {'start': 3305, 'end': 3307, 'text': '74', 'ref_id': 'BIBREF72'}, {'start': 3442, 'end': 3444, 'text': '75', 'ref_id': 'BIBREF73'}, {'start': 3555, 'end': 3557, 'text': '76', 'ref_id': 'BIBREF74'}, {'start': 3750, 'end': 3755, 'text': '77 78', 'ref_id': None}, {'start': 3971, 'end': 3973, 'text': '79', 'ref_id': 'BIBREF77'}, {'start': 4330, 'end': 4332, 'text': '80', 'ref_id': 'BIBREF78'}, {'start': 4538, 'end': 4540, 'text': '81', 'ref_id': 'BIBREF79'}, {'start': 4916, 'end': 4918, 'text': '82', 'ref_id': 'BIBREF80'}, {'start': 5115, 'end': 5117, 'text': '83', 'ref_id': 'BIBREF81'}, {'start': 5219, 'end': 5221, 'text': '84', 'ref_id': 'BIBREF82'}, {'start': 5397, 'end': 5402, 'text': '85 86', 'ref_id': None}, {'start': 5599, 'end': 5601, 'text': '87', 'ref_id': 'BIBREF85'}, {'start': 5865, 'end': 5867, 'text': '88', 'ref_id': 'BIBREF86'}, {'start': 6106, 'end': 6108, 'text': '12', 'ref_id': 'BIBREF11'}, {'start': 6184, 'end': 6189, 'text': '13 14', 'ref_id': None}, {'start': 6391, 'end': 6393, 'text': '89', 'ref_id': 'BIBREF88'}, {'start': 6555, 'end': 6557, 'text': '90', 'ref_id': 'BIBREF89'}, {'start': 7006, 'end': 7008, 'text': '91', 'ref_id': 'BIBREF90'}, {'start': 7621, 'end': 7623, 'text': '92', 'ref_id': 'BIBREF91'}, {'start': 7895, 'end': 7897, 'text': '93', 'ref_id': 'BIBREF92'}, {'start': 8112, 'end': 8114, 'text': '94', 'ref_id': 'BIBREF93'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Some authors defined nutrition governance using broad definitions. As illustrated by Solon's articulation, 'governance' may be simply stated: 'Governance is the process of decision-making and implementation'. 87 Pinstrup-Andersen and Watson take a similarly broad approach in writing that 'governance deals with how… conflicting interests are resolved', and may be defined as '…the exercise of authority or management of resources through institutions, policies, traditions, cultures and societal norms'. 95 In these and similar cases, the inclusiveness makes it difficult to understand what would be excluded from 'governance', and it is hard to imagine what specific interventions would follow naturally from the definitions.\", 'cite_spans': [{'start': 209, 'end': 211, 'text': '87', 'ref_id': 'BIBREF85'}, {'start': 505, 'end': 507, 'text': '95', 'ref_id': 'BIBREF94'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Other authors invoked governance to discuss or analyse a limited subset of concepts. For instance, the highly influential Lancet paper by Morris et al focused on governance barriers to international action against undernutrition that could be categorised as coordination, accountability and distributional. 53 These categories are intuitive because they are at the root of food insecurity, and have long been important in undernutrition scholarship and programming. Coordination problems are common because undernutrition often relates to complicated circumstances in which many actors operate without clear lines of authority, responsibility or accountability. Conflict, natural disaster and multiple failures of markets and/or states are all common settings for undernutrition. The UN System Standing Committee on Nutrition (SCN) was founded in 1977 (as SubCommittee on Nutrition) with the express purpose of coordinating UN actions against nutrition problems. 96 A major stated reason for launching SUN in 2010 was to harmonise views, policies and actions across a broader set of stakeholders including countries and donors. 97 98 The proliferation of global health actors has exacerbated this problem further. 99 Accountability problems are commonly referenced because many analysts view governments as guarantors of food security, and insecurity thus represents a government failure, which might be rectified or reduced if governments were more accountable to their citizens. The intersectoral nature of food security also means that many parts of a government may be responsible, but hard to hold accountable. 70 100 Increasing the participation and voice of at-risk groups is a common recommendation. 81 One important pathway is that greater participation and better governance are associated with improved access to safe water, although there are likely many more, as well. 100 101 Adequacy of global food production and its persistent scarcity in particular settings points to distribution, or allocation issues. 100 The same dynamic plays out within countries, where poor distribution systems leave some areas vulnerable even as food is sufficient when measured at the national level. 102 Distributional issues are not strictly limited to food-the distribution of rights and entitlements are also core governance issues with large implications for nutrition. 73 103 104 Among the most prominent nutrition governance frameworks identified in this review was developed at the Institute for Development Studies by Mejía Acosta and Fanzo, and Haddad et al. 105 106 The framework highlights cooperation and coordination-both prominent themes in undernutrition as explained above-and also adds sustainable funding and monitoring and advocacy. The explicit inclusion of funding recognises the central requirement of adequate resources, which the authors characterise as the 'cement' that holds cooperation and coordination together. 105 The monitoring and advocacy category acknowledges the need for governments to collect relevant information and produce analyses to BMJ Global Health understand where there are problems, design and implement solutions and track progress. Advocacy represents the critical role of civil society in detecting problems, raising awareness and facilitating solutions, whether by direct delivery or influencing the government.\", 'cite_spans': [{'start': 307, 'end': 309, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 1128, 'end': 1130, 'text': '97', 'ref_id': 'BIBREF96'}, {'start': 1131, 'end': 1133, 'text': '98', 'ref_id': 'BIBREF97'}, {'start': 1214, 'end': 1216, 'text': '99', 'ref_id': 'BIBREF98'}, {'start': 1616, 'end': 1618, 'text': '70', 'ref_id': 'BIBREF68'}, {'start': 1619, 'end': 1622, 'text': '100', 'ref_id': 'BIBREF99'}, {'start': 1708, 'end': 1710, 'text': '81', 'ref_id': 'BIBREF79'}, {'start': 1882, 'end': 1889, 'text': '100 101', 'ref_id': None}, {'start': 2022, 'end': 2025, 'text': '100', 'ref_id': 'BIBREF99'}, {'start': 2195, 'end': 2198, 'text': '102', 'ref_id': 'BIBREF101'}, {'start': 2369, 'end': 2371, 'text': '73', 'ref_id': 'BIBREF71'}, {'start': 2372, 'end': 2379, 'text': '103 104', 'ref_id': None}, {'start': 2563, 'end': 2570, 'text': '105 106', 'ref_id': None}, {'start': 2936, 'end': 2939, 'text': '105', 'ref_id': 'BIBREF104'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Very different views on governance came from studies focusing on obesity, where primary themes include the globalisation of food, the products and marketing of multinational corporations (MNCs) and individual lifestyle choices. 40-42 63 107 Globalisation has changed the landscape of food and nutrition by concentrating power in large firms, changing consumer taste through marketing, and limiting the effectiveness of traditional governance mechanisms. Representation, participation, voice, accountability and regulation all are rooted in national structures and are easy to circumvent for MNCs. Where accountability is discussed, it emphasises corporate accountability 108 and tends to focus on global level regulatory issues concerning trade and health. 42 Addressing the Australian context, Sacks et al developed a matrix of sectors and governance levels for thinking about some of these issues, which they used to identify policy options. 109 The sectors ranged from primary production and food processing to distributions, marketing, retail and catering/food service. Governance levels include local, state, national and international. Although the authors do not use the term, this can be considered a nutrition governance framework. Sacks et al identify policy issues and the level of government where they may be addressed. For example, in food processing, safety standards are usually a state government responsibility and product composition standards are usually decided at the national level.', 'cite_spans': [{'start': 228, 'end': 240, 'text': '40-42 63 107', 'ref_id': None}, {'start': 671, 'end': 674, 'text': '108', 'ref_id': 'BIBREF107'}, {'start': 757, 'end': 759, 'text': '42', 'ref_id': 'BIBREF41'}, {'start': 944, 'end': 947, 'text': '109', 'ref_id': 'BIBREF108'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Analysing nutrition governance frameworks These nutrition governance frameworks include elements that are well supported by intuition and research, and draw attention to some critical areas of nutrition governance in both undernutrition and obesity. Their many strengths are evident in the above review: individually, they identify some of the most pressing issues in nutrition governance, and collectively, they provide a place to begin understanding the very difficult landscape of one of humanity's greatest problems.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"However, a synthetic view of scholarship on nutrition governance finds an incomplete picture. There is no shared language or methods common to all the frameworks, and none articulate the philosophical principles on which they are based. Furthermore, they emphasise global-level, technical perspectives, and tend not to consider political issues or variation in state capacity, which can run from strong to absent, as in humanitarian settings. This is limiting, and sometimes becomes problematic. A main limitation is that the frameworks explain only the part of nutrition governance on which they are focused, but do not illuminate the larger landscape. Additionally, the lack of a philosophical basis means that they have difficulty explaining their priorities or defending their boundaries, should the need arise. For instance, the frameworks by Morris et al and Mejía Acosta and Fanzo do not include participation or transparency among their central elements. This choice may reflect that the dominant historical problem in undernutrition is inadequate food, and in this perspective the most basic citizen view can be presumed-the demand for more food. It may also reflect a strong focus on the multilateral architecture of aid, which tends to neglect crucial factors such as domestic political commitment. A full-text search of the Sacks et al framework article does not find a single mention of either 'cooperation' or 'coordination'. It is unlikely that any analyst of governance-including the authors of these fine papers-would say that participation is unimportant, or that transparency is seldom needed, or that coordination is trivial.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Observing the different elements in nutrition governance frameworks raises a dilemma that can be resolved by weighing breadth and depth in either of two directions. In the more inclusive direction, additional elements are added to the framework to increase its explanatory coverage, as with some of the other frameworks covered earlier. In the direction of specificity, the framework must be qualified to particular settings in which the included elements did matter or might matter most. Neither direction is completely satisfying because they trade off universality and specificity without establishing the relationship between the two.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"An obvious division in uses of nutrition governance lies between those concerned with undernutrition and those focused on obesity. The papers reviewed here focused on one or the other, but not both. This division appears to be highly influential on the governance problems that were reported. The authors focusing on undernutrition typically highlighted administrative issues, such as coordination for service delivery, distributional problems and responsiveness or accountability to citizen demand. The authors focusing on obesity typically emphasised political or political economic issues, including the globalisation of the food industry, multinational corporate accountability problems, coordination for regulatory and policy making purposes and the political economy of production and consumption, which includes the contest for public opinion and allows for conflict over food choices. This division suggests that either analysts employ different definitions of governance or refer to 'governance' with reference to specific manifestations rather than underlying principles.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The absence of discussion on these underlying principles creates additional problems, as well. First, these definitions do not prioritise the importance of their elements, meaning it is difficult to know if anything is more important than anything else. Second, the lack of prioritisation disguises the interaction or possible causality between the elements. Third, it is hard to determine what would not qualify as a governance problem, which disguises the difference between issues best approached from this perspective and those that could be addressed BMJ Global Health more easily with another lens. These limitations pose challenges for conceptualising nutrition governance more broadly or attempting to implement solutions.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Although it is not the focus of this paper, I speculate that historical differences between the communities studying undernutrition and obesity account for some of the differences in perspective. The authors writing on undernutrition were more likely to have technical backgrounds in medicine, nutrition sciences, agriculture and related areas. Those focusing on obesity were more likely to have experience with law and the social sciences, and many had previous experience with tobacco control or other areas of globalised trade and health, and tended to draw on scholarship by leading authors in those areas. 15 30 31 110 111 There was little or no overlap in these groups.', 'cite_spans': [{'start': 611, 'end': 613, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 614, 'end': 627, 'text': '30 31 110 111', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'A unified framework for nutrition governance As the basis for equitably realising the right to food and upholding the right to health, nutrition governance is grounded in universal principles. But as I have discussed above, current articulations of nutrition governance are divided by problem type-undernutrition or obesityand grounded in specific contexts where those problems are found. At one time, undernutrition was the only nutrition problem, and when obesity first emerged as a public health problem it was confined to relatively distinct geographies. This is no longer the case. The nutrition transition 112 and the double burden of undernutrition and obesity mean that single countries are required to deal with both problems. Accordingly, it is for both philosophical and practical considerations that a unified framework for nutrition governance is desirable.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"The starting point for a unified nutrition governance framework is a definition of governance itself. A simple and classic definition of politics was offered by Lasswell in the 1930s as who gets what, when and how, which refers to the underlying definition of politics as a distributive process. 113 I argue that governance can be considered as the structures through which such distributive decisions are made and enforced. This conceptualisation emphasises the structural or formalised elements of the process, which is reflected in common usage of 'governance' in connection with a normative judgement, as in good or strong governance, or bad or weak governance. The conception of something that can be judged this way means there is a standard for doing so, which in this case I define as any of the three dimensions of governance I will propose.\", 'cite_spans': [{'start': 296, 'end': 299, 'text': '113', 'ref_id': 'BIBREF112'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The basis for my conceptualisation of governance is the social contract that underlies modern nations, as first articulated by Rousseau 114 and Locke 115 in the Enlightenment. This idea holds that citizens cede some powers to the state in exchange for the protection of their remaining rights, and is based on the principle that citizens are the ultimate source of power and the ultimate conveyors of legitimacy. 114 115 I apply the concept of citizens as the source of power and authority to governance and propose that it can be distilled around the primary principles of accountability, participation and responsiveness. Accountability recognises citizens as the source of state power. Participation comes from the recognition that state legitimacy is conditioned on the consent of those governed. Responsiveness refers to the timeliness of the link between what people want, as expressed by participation, and the accountability that may be exercised when needed services are not forthcoming. With particular reference to nutrition, timeliness can be of vital importance, and thus responsiveness is elevated to primary status along with accountability and participation, even though it could be argued that these latter two principles should already reflect responsiveness. Evaluating governance means that each principle should be measured with reference to the authority and legitimacy granted by citizens and their judgements of performance. Stated concisely:', 'cite_spans': [{'start': 127, 'end': 139, 'text': 'Rousseau 114', 'ref_id': None}, {'start': 150, 'end': 153, 'text': '115', 'ref_id': 'BIBREF114'}, {'start': 413, 'end': 420, 'text': '114 115', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Nutrition governance is the ability of institutions and other structures to uphold the principles of participation, responsiveness, and accountability in the realization of the right to food and the achievement of optimal nutrition for all citizens.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'These three primary principles are central to human rights law, appearing prominently in the International Covenant on Economic, Social and Cultural Rights, 116 and beneath them lie many others. As reviewed by Lee et al., for the WHO Commission on Social Determinants of Health, broad conceptions of governance include the three mentioned above and also transparency, a consensus orientation, the rule of law, effectiveness and efficiency and equity and inclusiveness. 15 No doubt there are many more, to be sure. However, I argue that these others are secondary. For instance, I would argue that accountability, participation and responsiveness all require transparency, which for that reason is not a leading independent category. Similarly, I argue that the leading three also depend on equity and the rule of law. A consensus orientation, effectiveness and efficiency and equity and inclusiveness are all factors that citizens would reflect in their participation and their preferences for accountability.', 'cite_spans': [{'start': 157, 'end': 160, 'text': '116', 'ref_id': 'BIBREF115'}, {'start': 469, 'end': 471, 'text': '15', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'With this definition established, it can be used to clarify governance challenges and how they relate to each other. In my view, existing scholarship can be categorised in four areas, as shown below in table 2 as a map of sample nutrition governance problems in undernutrition and obesity at the national and global levels. This exercise reveals how existing frameworks tend to focus on only one square, for example, undernutrition at the global level, as by Morris et al. 53 table 3 further develops this idea by applying the three main pillars of accountability, participation and responsiveness to undernutrition and obesity. Note that this is a characterisation of existing scholarship, and is not inclusive of many important issues that are covered lightly or not at all. Inadequate attention BMJ Global Health has been paid to the interaction of global, national and local levels, or to the differences in capacity and context in strong states, weak stakes, humanitarian disasters or elsewhere, for instance.', 'cite_spans': [{'start': 473, 'end': 475, 'text': '53', 'ref_id': 'BIBREF52'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Employing the three categories of accountability, participation and responsiveness facilitates a comparison of undernutrition and obesity problems from a governance perspective. This exercise highlights undernutrition as a problem of dysfunctional structures-mainly people do not get what they want and cannot enforce accountability, although there can be information and education aspects, as well. Aligning services with wants thus addresses the problem, meaning that people who need food then get food. Obesity problems are different-people get too much of what they want, or want unhealthful things (these are also causes of undernutrition-overweight). Because of this, obesity can-and does-occur where governance structures function well. In such cases, a principal challenge lies in the contest for perception and opinion on food and related policies. The formal structural governance problems are subtle because they concern broad political economy issues that are hard to analyse and remain unknown to many people. These include tax policy, agricultural policies, inadequate government authority and regulatory capture and ineffectiveness. Although the beneficiaries of the food industry are engaged, those harmed are not necessarily inclined to think of themselves as harmed or to identify any particular agent as the cause of their problems.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Governance has emerged as an important focus in development programming over the last three decades, and nutrition governance in particular has great potential to improve health. But this analysis finds that although the concept of 'nutrition governance' has become increasingly prominent in scholarship on poor nutritional outcomes, it remains weakly specified and is invoked by different authors to mean different things. An important division of approaches and general meanings exists between those who have focused on undernutrition and those who have concentrated on obesity. Those in the former group have stressed coordination problems and structural issues related to the general functioning of government and the low accountability of international actors. Those in the later group have emphasised international trade policies, regulatory issues and corporate behaviour.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': 'By developing a definition of governance based on the social contract and applying it to nutrition, this paper presents a framework for considering all nutrition problems at the same time. Using the framework to assess undernutrition and obesity finds that its principles apply well in either case, but they indicate different weaknesses. In general, undernutrition problems relate to structural flaws, such as poor or absent accountability, weak or missing participation or inadequate responsiveness. Under the assumption that people do not want to be undernourished, then the problem can be crudely characterised as unmet demand-citizens are not getting a service entitlement they need and want. Some of these issues may also underlie obesity problems, but those scenarios are additionally characterised by more insidious dynamics. Accountability and participation can be strong, but may be corrupted by marketing and other influences on citizen perception. The demands expressed by citizens may be accurately-and harmfully-expressed in unhealthy foods, habits and environments. This shifts the intervention area from governance structures per se to the inputs-the things that citizens want-and can be characterised as a contest for perceptions about good choices in food, food policy and related issues of regulation, tax and trade.', 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': \"The vast prevalence of obesity and undernutrition shows that governments, international agencies and other actors have failed to uphold the right to food and optimal nutrition for most of the world's citizens. This is among the leading embarrassments to all humanity, and is of such widespread consequence that delay in remedial action cannot be justified. The clarification of the three basic governance principles of accountability, participation and responsiveness provides categories for assessing government performance and aid programmes alike. Advancing the state-citizen contract is central to all areas of development, and hence the imperative to assess how aid affects governance applies to every donor-supported project. Projects that bypass or weaken the social contract have been common in the past, but should never be accepted. These ideas may be particularly useful to civil society groups and academic organisations that monitor development assistance efforts and seek to compel governments to uphold the right to food. \", 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': 'For global level institutions, the implications of this analysis lie in two areas. For undernutrition problems, interventions to strengthen the connection between states and their citizens and mechanisms to allow states to hold international actors accountable would help address many major weaknesses. In turn, this would help states and international actors better promote participation and become more responsive. This task is urgent. Undernutrition tends to affect the most vulnerable and is prioritised in the Sustainable Development Goals for that reason. With particular reference to obesity, many of the governance problems identified by this paper have international dimensions that constrain national policy solutions. Globalisation is increasing the importance of this dynamic and points to an urgent need for supranational regulation of the food industry and concerted efforts to contest the perceptions it advances through marketing. No country has yet succeeded in turning the still-rising tide of obesity, regardless of the strength of its governance or the size of its income, further indicating the need for coordinated global action.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Acknowledgements I gratefully acknowledge helpful comments from Prerna Banati, Yarlini Balarajan, Carmen Jacqueline Ho, and the anonymous reviewers. All errors remain my own.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Contributors I am the sole author of this work and am responsible for its content.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Funding UNICEF Office of Research-Innocenti.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Competing interests None declared.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Patient consent Not required.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Provenance and peer review Not commissioned; externally peer reviewed. open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is Table 3 Comparison of governance areas for undernutrition and obesity at global and national levels', 'cite_spans': [], 'ref_spans': [{'start': 391, 'end': 398, 'text': 'Table 3', 'ref_id': None}], 'section': 'Twitter @jessebump'}, {'text': 'Accountability Global: multilaterals, bilaterals, NGOs and others that have a legal or adopted nutrition mandate are not punished or rewarded for their individual or collective performance. Persistent coordination problems result. Also, accountability for food production or crop diversion hard to establish.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'Global: accountability is very weak for transnational corporate activities and foreign government policies related to food, such as in subsidy, tax and trade. Largely, accountability mechanisms are absent.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'National: engagement of many sectors creates coordination problems and clouds accountabilities. Government tends to be least accountable to the marginalised people most vulnerable to undernutrition, indicating the need for improved state performance overall.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': \"National: accountabilities for unhealthy foods and deceptive marketing are difficult to establish precisely, and citizens' demand for accountability is often influenced in favour of private interests and against health professionals.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'Global: in theory, national representation in the UN system assures the channel of participation by citizens, but this is highly problematic in many cases, including weak or failed states, or for marginalised or excluded groups, such as migrants, refugees or the vulnerable. Areas of low participation are at greatest risk of undernutrition.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'Global: national representation in global affairs is predominantly in non-health areas and is often linked to corporate interests. This calls for supranational regulatory mechanisms to allow more participation, or the channels for other states and citizens to influence national government positions.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'National: participation by citizens is weak in many cases. People who need nutrition interventions may not be aware, and even if they are, cannot always express their demand effectively. Typically, this need is not visible or meaningful to the state, not reflected in programmes of services, and weak participation means it does not connect to democratic or judicial accountability mechanisms.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'National: participation is often strong-because citizens exercise electoral and economic power in support of corporate interests, and food products and consumption patterns that are unhealthful. The participation problem is not the ability to influence, but the contest for perception about foods, food companies and regulation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'Global: multilaterals, bilaterals, NGOs and others operating in nutrition do not respond to the demands and needs of those they ostensibly serve. This is underpinned by low participation and missing or absent accountability mechanisms.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'Global: extremely limited accountability mechanisms mean that there is no easily identified authority to respond specifically to obesity-related issues.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'National: those most likely to suffer undernutrition are typically not able to organise or participate, making it difficult for even well-intentioned states to identify and respond.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'National: government responses may be more immediate to well-organised corporate demands; responsiveness to citizens often concentrated around infrequent elections. Citizens may favour unhealthy policies, as well.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http:// creativecommons. org/ licenses/ by-nc/ 4. 0/.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'UN Special Rapporteur on the right to food', 'authors': [{'first': 'De', 'middle': [], 'last': 'Schutter', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Report on agroecology and the right to food', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'General Comment No. 12: The right to adequate food', 'authors': [{'first': '', 'middle': [], 'last': 'Un Cescr', 'suffix': ''}], 'year': 1999, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Population, development and food security: an unresolved challenge for the twenty-first century', 'authors': [{'first': 'M', 'middle': [], 'last': 'Villarreal', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Stloukal', 'suffix': ''}], 'year': 2005, 'venue': 'Genus', 'volume': '61', 'issn': '', 'pages': '215--261', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The right to food: Holding global actors accountable under international law', 'authors': [{'first': 'S', 'middle': [], 'last': 'Narula', 'suffix': ''}], 'year': 2005, 'venue': \"Colum J Transnat'l L\", 'volume': '44', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': \"Assessing countries' commitment to accelerate nutrition action demonstrated in PRSPs, UNDAFs and through nutrition governance. SCN news / United Nations\", 'authors': [{'first': 'K', 'middle': [], 'last': 'Engesveen', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Nishida', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Prudhon', 'suffix': ''}], 'year': 2009, 'venue': 'Administrative Committee on Coordination, Subcommittee on Nutrition', 'volume': '37', 'issn': '', 'pages': '10--16', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study', 'authors': [{'first': 'M', 'middle': [], 'last': 'Ng', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fleming', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Robinson', 'suffix': ''}], 'year': 2013, 'venue': 'The Lancet', 'volume': '384', 'issn': '', 'pages': '766--81', 'other_ids': {'DOI': ['10.1016/S0140-6736(14)60460-8']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases', 'authors': [{'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}], 'year': 2006, 'venue': 'Global Health', 'volume': '2', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-2-4']}}, 'BIBREF7': {'ref_id': 'b7', 'title': \"Strong nutrition governance is a key to addressing nutrition transition in low and middle-income countries: review of countries' nutrition policies\", 'authors': [{'first': 'B', 'middle': ['F'], 'last': 'Sunguya', 'suffix': ''}, {'first': 'Kic', 'middle': [], 'last': 'Ong', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Dhakal', 'suffix': ''}], 'year': 2014, 'venue': 'Nutr J', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1475-2891-13-65']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Displacement in urban areas: new challenges, new partnerships', 'authors': [{'first': 'J', 'middle': [], 'last': 'Crisp', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Morris', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Refstie', 'suffix': ''}], 'year': 2012, 'venue': 'Disasters', 'volume': '36', 'issn': '', 'pages': '23--42', 'other_ids': {'DOI': ['10.1111/j.1467-7717.2012.01284.x']}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Off the map: the health and social implications of being a non-notified slum in India', 'authors': [{'first': 'R', 'middle': [], 'last': 'Subbaraman', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'O&apos;brien', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Shitole', 'suffix': ''}], 'year': 2012, 'venue': 'Environ Urban', 'volume': '24', 'issn': '', 'pages': '643--63', 'other_ids': {'DOI': ['10.1177/0956247812456356']}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Invisibility and the Welfare State in the Developing World. Hasmath R, ed. Inclusive Growth, Development and Welfare Policy: A Critical Assessment', 'authors': [{'first': 'W', 'middle': ['J'], 'last': 'Poverty', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '211--239', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Public opinion and the politics of obesity in America', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Oliver', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2005, 'venue': 'J Health Polit Policy Law', 'volume': '30', 'issn': '', 'pages': '923--54', 'other_ids': {'DOI': ['10.1215/03616878-30-5-923']}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'The Perils of Ignoring History: Big Tobacco Played Dirty and Millions Died. How Similar Is Big Food?', 'authors': [{'first': 'K', 'middle': ['D'], 'last': 'Brownell', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Warner', 'suffix': ''}], 'year': 2009, 'venue': 'Milbank Quarterly', 'volume': '87', 'issn': '', 'pages': '259--94', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Coca-Cola Funds Scientists Who Shift Blame for Obesity Away From Bad Diets', 'authors': [{'first': 'A', 'middle': [], 'last': 'O&apos;connor', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Globalization, Global Governance and the Social Determinants of Health: A review of the linkages and agenda for action. Ottowa: Globalization and Health Knowledge Network', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koivusalo', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Ollila', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Food security and nutrition interventions in response to the AIDS epidemic: assessing global action and evidence', 'authors': [{'first': 'N', 'middle': ['L'], 'last': 'Aberman', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Rawat', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Drimie', 'suffix': ''}], 'year': 2014, 'venue': 'AIDS Behav', 'volume': '18', 'issn': '5', 'pages': '554--65', 'other_ids': {'DOI': ['10.1007/s10461-014-0822-z']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Nutritional contribution of street foods to the diet of people in developing countries: a systematic review', 'authors': [{'first': 'N', 'middle': ['P'], 'last': 'Steyn', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Mchiza', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Hill', 'suffix': ''}], 'year': 2014, 'venue': 'Public Health Nutr', 'volume': '17', 'issn': '', 'pages': '1363--74', 'other_ids': {'DOI': ['10.1017/S1368980013001158']}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Health and welfare effects of integrating AIDS treatment with food assistance in resource constrained settings: A systematic review of theory and evidence', 'authors': [{'first': 'N', 'middle': [], 'last': 'Tirivayi', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Groot', 'suffix': ''}], 'year': 2011, 'venue': 'Soc Sci Med', 'volume': '73', 'issn': '', 'pages': '685--92', 'other_ids': {'DOI': ['10.1016/j.socscimed.2011.06.056']}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Clinic-Based Food Assistance is Associated with Increased Medication Adherence among HIV-Infected Adults on Long-Term Antiretroviral Therapy in Zambia', 'authors': [{'first': 'N', 'middle': [], 'last': 'Tirivayi', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Koethe', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Groot', 'suffix': ''}], 'year': 2012, 'venue': 'J AIDS Clin Res', 'volume': '03', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.4172/2155-6113.1000171']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'The right to food in the post-Cold War era', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Marchione', 'suffix': ''}], 'year': 1996, 'venue': 'Food Policy', 'volume': '21', 'issn': '', 'pages': '83--102', 'other_ids': {'DOI': ['10.1016/0306-9192(95)00070-4']}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Bilateral health aid: lessons from Europe', 'authors': [{'first': 'P', 'middle': ['S'], 'last': 'Hill', 'suffix': ''}], 'year': 2000, 'venue': 'Aust N Z J Public Health', 'volume': '24', 'issn': '', 'pages': '432--438', 'other_ids': {'DOI': ['10.1111/j.1467-842X.2000.tb01607.x']}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Development and governance: an uneasy relationship', 'authors': [{'first': 'W', 'middle': [], 'last': 'Hout', 'suffix': ''}], 'year': 2009, 'venue': 'Governance and the Depoliticisation of Development. London: Routledge', 'volume': '', 'issn': '', 'pages': '29--43', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Public-Private Partnerships for Combating Micronutrient Malnutrition', 'authors': [{'first': 'M', 'middle': [], 'last': 'Chopra', 'suffix': ''}], 'year': 2001, 'venue': 'Food Nutr Bull', 'volume': '22', 'issn': '', 'pages': '431--436', 'other_ids': {'DOI': ['10.1177/156482650102200416']}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Governing Health Systems', 'authors': [{'first': 'M', 'middle': [], 'last': 'Reich', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Takemi', 'suffix': ''}], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Governance for global and national health: a role for framework conventions?', 'authors': [{'first': 'T', 'middle': ['G'], 'last': 'Evans', 'suffix': ''}], 'year': 2013, 'venue': 'Health Hum Rights', 'volume': '15', 'issn': '', 'pages': '5--7', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Interactions with the recipient community in targeted food and nutrition programs', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Marchione', 'suffix': ''}], 'year': 2005, 'venue': 'J Nutr', 'volume': '135', 'issn': '', 'pages': '886--895', 'other_ids': {'DOI': ['10.1093/jn/135.4.886']}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Proceedings of the fourth international congress on tropical medicine and malaria', 'authors': [{'first': 'O', 'middle': [], 'last': 'Address', 'suffix': ''}], 'year': 1948, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Spaces for change?: the politics of citizen participation in new democratic arenas: Zed Books', 'authors': [{'first': 'A', 'middle': [], 'last': 'Cornwall', 'suffix': ''}, {'first': 'V', 'middle': ['S'], 'last': 'Coelho', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Grand challenges in global health governance', 'authors': [{'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}, {'first': 'E', 'middle': ['A'], 'last': 'Mok', 'suffix': ''}], 'year': 2009, 'venue': 'Br Med Bull', 'volume': '90', 'issn': '', 'pages': '7--18', 'other_ids': {'DOI': ['10.1093/bmb/ldp014']}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'The Pit and the Pendulum: Can globalization take health governance forward?', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2004, 'venue': 'Development', 'volume': '47', 'issn': '', 'pages': '11--17', 'other_ids': {'DOI': ['10.1057/palgrave.development.1100025']}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Bridging the divide: global governance of trade and health', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Sridhar', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Patel', 'suffix': ''}], 'year': 2009, 'venue': 'Lancet', 'volume': '373', 'issn': '', 'pages': '416--438', 'other_ids': {'DOI': ['10.1016/S0140-6736(08)61776-6']}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'The new International Health Regulations: an historic development for international law and public health', 'authors': [{'first': 'D', 'middle': ['P'], 'last': 'Fidler', 'suffix': ''}, {'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}], 'year': 2006, 'venue': 'J Law Med Ethics', 'volume': '34', 'issn': '', 'pages': '85--94', 'other_ids': {'DOI': ['10.1111/j.1748-720X.2006.00011.x']}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'The race for Ebola drugs: pharmaceuticals, security and global health governance', 'authors': [{'first': 'A', 'middle': [], 'last': 'Roemer-Mahler', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Elbe', 'suffix': ''}], 'year': 2016, 'venue': 'Third World Q', 'volume': '37', 'issn': '', 'pages': '487--506', 'other_ids': {'DOI': ['10.1080/01436597.2015.1111136']}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Ebola: a crisis in global health leadership', 'authors': [{'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Friedman', 'suffix': ''}], 'year': 2014, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Non-communicable diseases and global health governance: enhancing global processes to improve health development', 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Magnusson', 'suffix': ''}], 'year': 2007, 'venue': 'Global Health', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-3-2']}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Governance matters VIII: aggregate and individual governance indicators', 'authors': [{'first': 'D', 'middle': [], 'last': 'Kaufmann', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kraay', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Mastruzzi', 'suffix': ''}], 'year': 1996, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': \"Portfolio Review Summary: Summary Review of DFID's Governance Portfolio\", 'authors': [{'first': '', 'middle': [], 'last': 'Dfid', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Governance', 'suffix': ''}], 'year': 2004, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'The world health report 2007: A safer future: global public health security in the 21st century', 'authors': [], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Joint Evaluation of the REACH Initiative (Renewed Effort Against Child Hunger and Undernutrition', 'authors': [], 'year': 2011, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Diet, health and globalization: five key questions', 'authors': [{'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}], 'year': 1999, 'venue': 'Proc Nutr Soc', 'volume': '58', 'issn': '', 'pages': '335--378', 'other_ids': {'DOI': ['10.1017/S0029665199000452']}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'A global response to a global problem: the epidemic of overnutrition', 'authors': [{'first': 'M', 'middle': [], 'last': 'Chopra', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Galbraith', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Darnton-Hill', 'suffix': ''}], 'year': 2002, 'venue': 'Bull World Health Organ', 'volume': '80', 'issn': '', 'pages': '952--960', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Trade liberalization and the diet transition: a public health response', 'authors': [{'first': 'G', 'middle': [], 'last': 'Rayner', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}], 'year': 2006, 'venue': 'Health Promot Int', 'volume': '21', 'issn': 'suppl_1', 'pages': '67--74', 'other_ids': {'DOI': ['10.1093/heapro/dal053']}}, 'BIBREF42': {'ref_id': 'b42', 'title': \"Rethinking global health challenges: towards a 'global compact' for reducing the burden of chronic disease\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Magnusson', 'suffix': ''}], 'year': 2009, 'venue': 'Public Health', 'volume': '123', 'issn': '', 'pages': '265--74', 'other_ids': {'DOI': ['10.1016/j.puhe.2008.12.023']}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The role of business in addressing the long-term implications of the current food crisis', 'authors': [{'first': 'D', 'middle': [], 'last': 'Yach', 'suffix': ''}], 'year': 2008, 'venue': 'Global Health', 'volume': '4', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-4-12']}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Anatomy of a crisis: the causes and consequences of surging food prices', 'authors': [{'first': 'D', 'middle': [], 'last': 'Headey', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Fan', 'suffix': ''}], 'year': 2008, 'venue': 'Agricultural Economics', 'volume': '39', 'issn': '', 'pages': '375--91', 'other_ids': {'DOI': ['10.1111/j.1574-0862.2008.00345.x']}}, 'BIBREF45': {'ref_id': 'b45', 'title': 'Rethinking the global food crisis: The role of trade shocks', 'authors': [{'first': 'D', 'middle': [], 'last': 'Headey', 'suffix': ''}], 'year': 2011, 'venue': 'Food Policy', 'volume': '36', 'issn': '', 'pages': '136--182', 'other_ids': {'DOI': ['10.1016/j.foodpol.2010.10.003']}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Understanding and responding to the links between conflict and hunger', 'authors': [{'first': 'E', 'middle': [], 'last': 'Messer', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Cohen', 'suffix': ''}], 'year': 2011, 'venue': 'Dev Pract', 'volume': '21', 'issn': '', 'pages': '481--488', 'other_ids': {'DOI': ['10.1080/09614524.2011.562281']}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Price Volatility in Food and Agricultural Markets: Policy Responses', 'authors': [{'first': 'I', 'middle': [], 'last': 'Fao', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Unctad', 'suffix': ''}], 'year': 2011, 'venue': 'Food and Agricultural Organization', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'The 2008 food price crisis: rethinking food security policies: UN', 'authors': [{'first': 'A', 'middle': [], 'last': 'Mittal', 'suffix': ''}], 'year': 2009, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'High food prices: the what, who, and how of proposed policy actions', 'authors': [{'first': 'Von', 'middle': [], 'last': 'Braun', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Ahmed', 'middle': ['A'], 'last': 'Asenso-Okyere', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Closing the gap in a generation: Health equity through action on the social determinants of health', 'authors': [], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Maternal and Child Undernutrition Study Group. Effective international action against undernutrition: why has it proven so difficult and what can be done to accelerate progress?', 'authors': [{'first': 'S', 'middle': ['S'], 'last': 'Morris', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Cogill', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Uauy', 'suffix': ''}], 'year': 2008, 'venue': 'Lancet', 'volume': '371', 'issn': '', 'pages': '608--629', 'other_ids': {'DOI': ['10.1016/S0140-6736(07)61695-X']}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'The history of the SUN Movement: Scaling Up Nutrition', 'authors': [], 'year': 2018, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF54': {'ref_id': 'b54', 'title': 'Nutrition Landscape Information System (NLIS) country profile indicators: interpretation guide. Geneva: WHO, 2012. 56. REACH. REACH Country Facilitator Manual', 'authors': [], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF55': {'ref_id': 'b55', 'title': 'Conflicts of interest and global health and nutrition governance: The illusion of robust principles', 'authors': [{'first': 'J', 'middle': [], 'last': 'Richter', 'suffix': ''}], 'year': 2015, 'venue': 'BMJ', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF56': {'ref_id': 'b56', 'title': \"Activists: Don't join SUN, a nutrition drive\", 'authors': [{'first': 'India', 'middle': [], 'last': 'Times Of', 'suffix': ''}], 'year': 2017, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF57': {'ref_id': 'b57', 'title': 'Nutrition and sustainability: an emerging food policy discourse', 'authors': [{'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Barling', 'suffix': ''}], 'year': 2013, 'venue': 'Proc Nutr Soc', 'volume': '72', 'issn': '', 'pages': '1--12', 'other_ids': {'DOI': ['10.1017/S002966511200290X']}}, 'BIBREF58': {'ref_id': 'b58', 'title': 'Nutrition: the new world disorder', 'authors': [{'first': 'G', 'middle': [], 'last': 'Cannon', 'suffix': ''}], 'year': 2002, 'venue': 'Asia Pac J Clin Nutr', 'volume': '11', 'issn': 's3', 'pages': '498--509', 'other_ids': {'DOI': ['10.1046/j.1440-6047.11.supp3.5.x']}}, 'BIBREF59': {'ref_id': 'b59', 'title': 'Feeding the world in the coming decades requires improvements in investment, technology and institutions', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martorell', 'suffix': ''}], 'year': 2002, 'venue': 'J Nutr', 'volume': '132', 'issn': '', 'pages': '3435--3441', 'other_ids': {'DOI': ['10.1093/jn/132.11.3435S']}}, 'BIBREF60': {'ref_id': 'b60', 'title': 'Primary health care: making Alma-Ata a reality', 'authors': [{'first': 'J', 'middle': [], 'last': 'Walley', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Lawn', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Tinker', 'suffix': ''}], 'year': 2008, 'venue': 'Lancet', 'volume': '372', 'issn': '', 'pages': '1001--1008', 'other_ids': {'DOI': ['10.1016/S0140-6736(08)61409-9']}}, 'BIBREF61': {'ref_id': 'b61', 'title': 'Ethical consequences for professionals from the globalization of food, nutrition and health', 'authors': [{'first': 'N', 'middle': ['W'], 'last': 'Solomons', 'suffix': ''}], 'year': 2002, 'venue': 'Asia Pac J Clin Nutr', 'volume': '11', 'issn': 's3', 'pages': '653--65', 'other_ids': {'DOI': ['10.1046/j.1440-6047.11.supp3.14.x']}}, 'BIBREF62': {'ref_id': 'b62', 'title': 'Three decades of the WHO code and marketing of infant formulas', 'authors': [{'first': 'S', 'middle': [], 'last': 'Forsyth', 'suffix': ''}], 'year': 2012, 'venue': 'Curr Opin Clin Nutr Metab Care', 'volume': '15', 'issn': '', 'pages': '273--280', 'other_ids': {'DOI': ['10.1097/MCO.0b013e32835204ad']}}, 'BIBREF63': {'ref_id': 'b63', 'title': 'Non-compliance with the International Code of Marketing of Breast Milk Substitutes is not confined to the infant formula industry', 'authors': [{'first': 'S', 'middle': [], 'last': 'Forsyth', 'suffix': ''}], 'year': 2013, 'venue': 'J Public Health', 'volume': '35', 'issn': '', 'pages': '185--90', 'other_ids': {'DOI': ['10.1093/pubmed/fds084']}}, 'BIBREF64': {'ref_id': 'b64', 'title': 'We are forgotten on earth\": international development targets, poverty, and gender in Ethiopia', 'authors': [{'first': 'Von', 'middle': [], 'last': 'Massow', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2000, 'venue': 'Gend Dev', 'volume': '8', 'issn': '', 'pages': '45--54', 'other_ids': {'DOI': ['10.1080/741923410']}}, 'BIBREF65': {'ref_id': 'b65', 'title': 'Nutrition getting the attention it deserves?', 'authors': [{'first': '', 'middle': [], 'last': 'Irin', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF66': {'ref_id': 'b66', 'title': 'GAIN gains NGO status from WHO after it severs big business ties (or does it?): NutraIngredients', 'authors': [{'first': 'S', 'middle': [], 'last': 'Starling', 'suffix': ''}], 'year': 2014, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF67': {'ref_id': 'b67', 'title': 'Role of government in public health: Current scenario in India and future scope', 'authors': [{'first': 'S', 'middle': [], 'last': 'Lakshminarayanan', 'suffix': ''}], 'year': 2011, 'venue': 'J Family Community Med', 'volume': '18', 'issn': '', 'pages': '26--30', 'other_ids': {'DOI': ['10.4103/1319-1683.78635']}}, 'BIBREF68': {'ref_id': 'b68', 'title': 'Flaws in Child Nutrition and Health Governance', 'authors': [{'first': 'A', 'middle': [], 'last': 'Gupta', 'suffix': ''}, {'first': 'N', 'middle': ['S'], 'last': 'Khaira', 'suffix': ''}], 'year': 2008, 'venue': 'Economic and Political Weekly', 'volume': '43', 'issn': '', 'pages': '17--21', 'other_ids': {}}, 'BIBREF69': {'ref_id': 'b69', 'title': 'Why India needs a national nutrition strategy', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}], 'year': 2011, 'venue': 'BMJ', 'volume': '343', 'issn': '', 'pages': '6687--6731', 'other_ids': {'DOI': ['10.1136/bmj.d6687']}}, 'BIBREF70': {'ref_id': 'b70', 'title': 'Health system challenges in organizing quality diabetes care for urban poor in South India', 'authors': [{'first': 'U', 'middle': [], 'last': 'Bhojani', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Devedasan', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Mishra', 'suffix': ''}], 'year': 2014, 'venue': 'PLoS One', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pone.0106522']}}, 'BIBREF71': {'ref_id': 'b71', 'title': \"Pakistan's maternal and child health policy: analysis, lessons and the way forward\", 'authors': [{'first': 'S', 'middle': [], 'last': 'Siddiqi', 'suffix': ''}, {'first': 'I', 'middle': ['U'], 'last': 'Haq', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Ghaffar', 'suffix': ''}], 'year': 2004, 'venue': 'Health Policy', 'volume': '69', 'issn': '', 'pages': '117--147', 'other_ids': {'DOI': ['10.1016/j.healthpol.2003.12.007']}}, 'BIBREF72': {'ref_id': 'b72', 'title': 'Food security and marine capture fisheries: characteristics, trends, drivers and future perspectives', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Garcia', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Rosenberg', 'suffix': ''}], 'year': 2010, 'venue': 'Philos Trans R Soc Lond B Biol Sci', 'volume': '365', 'issn': '', 'pages': '2869--80', 'other_ids': {'DOI': ['10.1098/rstb.2010.0171']}}, 'BIBREF73': {'ref_id': 'b73', 'title': 'Getting food policy on the Mayoral table: a comparison of two election cycles in New York and London', 'authors': [{'first': 'N', 'middle': [], 'last': 'Freudenberg', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Atkinson', 'suffix': ''}], 'year': 2015, 'venue': 'Public Health', 'volume': '129', 'issn': '', 'pages': '295--302', 'other_ids': {'DOI': ['10.1016/j.puhe.2015.02.018']}}, 'BIBREF74': {'ref_id': 'b74', 'title': 'The politics of success in the fight against malnutrition in Peru', 'authors': [{'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Food Policy', 'volume': '44', 'issn': '', 'pages': '26--35', 'other_ids': {'DOI': ['10.1016/j.foodpol.2013.10.009']}}, 'BIBREF75': {'ref_id': 'b75', 'title': 'Brazilian obesity prevention and control initiatives', 'authors': [{'first': 'P', 'middle': ['C'], 'last': 'Jaime', 'suffix': ''}, {'first': 'Acf', 'middle': [], 'last': 'Da Silva', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Gentil', 'suffix': ''}], 'year': 2013, 'venue': 'Obesity Reviews', 'volume': '14', 'issn': '2', 'pages': '88--95', 'other_ids': {'DOI': ['10.1111/obr.12101']}}, 'BIBREF76': {'ref_id': 'b76', 'title': 'Role of innovative institutional structures in integrated governance. A case study of integrating health and nutrition programs in Chhattisgarh', 'authors': [{'first': 'A', 'middle': [], 'last': 'Kalita', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mondal', 'suffix': ''}], 'year': 2012, 'venue': 'India. J Health Organ Manag', 'volume': '26', 'issn': '', 'pages': '758--77', 'other_ids': {'DOI': ['10.1108/14777261211277005']}}, 'BIBREF77': {'ref_id': 'b77', 'title': 'Perspectives for integration into the local health system of community-based management of acute malnutrition in children under 5 years: a qualitative study in Bangladesh', 'authors': [{'first': 'C', 'middle': ['E'], 'last': 'Kouam', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Delisle', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Ebbing', 'suffix': ''}], 'year': 2014, 'venue': 'Nutr J', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1475-2891-13-22']}}, 'BIBREF78': {'ref_id': 'b78', 'title': 'Scaling up nutrition in fragile and conflict-affected states: The pivotal role of governance', 'authors': [{'first': 'Saj', 'middle': [], 'last': 'Taylor', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Perez-Ferrer', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Griffiths', 'suffix': ''}], 'year': 2015, 'venue': 'Soc Sci Med', 'volume': '126', 'issn': '', 'pages': '119--146', 'other_ids': {'DOI': ['10.1016/j.socscimed.2014.12.016']}}, 'BIBREF79': {'ref_id': 'b79', 'title': 'Tackling the drivers of child undernutrition in developing countries: what works and how should interventions be designed?', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pridmore', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Carr-Hill', 'suffix': ''}], 'year': 2011, 'venue': 'Public Health Nutr', 'volume': '14', 'issn': '', 'pages': '688--93', 'other_ids': {'DOI': ['10.1017/S1368980010001795']}}, 'BIBREF80': {'ref_id': 'b80', 'title': 'Drinking water quality governance: A comparative case study of Brazil, Ecuador, and Malawi', 'authors': [{'first': 'G', 'middle': ['L'], 'last': 'Kayser', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Amjad', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Dalcanale', 'suffix': ''}], 'year': 2015, 'venue': 'Environ Sci Policy', 'volume': '48', 'issn': '', 'pages': '186--95', 'other_ids': {'DOI': ['10.1016/j.envsci.2014.12.019']}}, 'BIBREF81': {'ref_id': 'b81', 'title': 'Utilisation of wartime nutrition survival experiences', 'authors': [{'first': 'T', 'middle': [], 'last': 'Giay', 'suffix': ''}], 'year': 1998, 'venue': 'Asia Pacific journal of clinical nutrition', 'volume': '7', 'issn': '', 'pages': '311--314', 'other_ids': {}}, 'BIBREF82': {'ref_id': 'b82', 'title': 'Lessons from collaborative governance and sociobiology theories for reinforcing sustained cooperation: a government food security case study', 'authors': [{'first': 'L', 'middle': ['A'], 'last': 'Montoya', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Montoya', 'suffix': ''}, {'first': 'Sánchez', 'middle': [], 'last': 'González', 'suffix': ''}, {'first': 'O', 'middle': ['D'], 'last': '', 'suffix': ''}], 'year': 2015, 'venue': 'Public Health', 'volume': '129', 'issn': '', 'pages': '916--947', 'other_ids': {'DOI': ['10.1016/j.puhe.2015.01.030']}}, 'BIBREF83': {'ref_id': 'b83', 'title': \"A stakeholder analysis of the perceived outcomes of developing and implementing England's obesity strategy\", 'authors': [{'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'A', 'middle': ['L'], 'last': 'Ahern', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Jebb', 'suffix': ''}], 'year': 2008, 'venue': 'BMC Public Health', 'volume': '14', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1471-2458-14-441']}}, 'BIBREF84': {'ref_id': 'b84', 'title': 'Community-based interventions for obesity prevention: lessons learned by Australian policy-makers', 'authors': [{'first': 'M', 'middle': ['M'], 'last': 'Haby', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Doherty', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Welch', 'suffix': ''}], 'year': 2012, 'venue': 'BMC Res Notes', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1756-0500-5-20']}}, 'BIBREF85': {'ref_id': 'b85', 'title': 'Good governance for nutrition in the Philippines: elements, experiences, and lessons learned', 'authors': [{'first': 'F', 'middle': ['S'], 'last': 'Solon', 'suffix': ''}], 'year': 2006, 'venue': 'Food Nutr Bull', 'volume': '27', 'issn': '', 'pages': '343--52', 'other_ids': {'DOI': ['10.1177/156482650602700409']}}, 'BIBREF86': {'ref_id': 'b86', 'title': 'Précis of nutrition of children and women in Haiti: analyses of data from', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Ayoya', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Heidkamp', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Ngnie-Teta', 'suffix': ''}], 'year': 1995, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF88': {'ref_id': 'b88', 'title': 'Governing childhood obesity: framing regulation of fast food advertising in the Australian print media', 'authors': [{'first': 'J', 'middle': [], 'last': 'Henderson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Coveney', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Ward', 'suffix': ''}], 'year': 2009, 'venue': 'Soc Sci Med', 'volume': '69', 'issn': '', 'pages': '1402--1410', 'other_ids': {'DOI': ['10.1016/j.socscimed.2009.08.025']}}, 'BIBREF89': {'ref_id': 'b89', 'title': 'Farmers are the most trusted part of the Australian food chain: results from a national survey of consumers', 'authors': [{'first': 'J', 'middle': [], 'last': 'Henderson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Coveney', 'suffix': ''}, {'first': 'P', 'middle': ['R'], 'last': 'Ward', 'suffix': ''}], 'year': 2011, 'venue': 'Aust N Z J Public Health', 'volume': '35', 'issn': '', 'pages': '319--343', 'other_ids': {'DOI': ['10.1111/j.1753-6405.2011.00725.x']}}, 'BIBREF90': {'ref_id': 'b90', 'title': 'The Danish tax on saturated fat: why it did not survive', 'authors': [{'first': 'S', 'middle': [], 'last': 'Vallgårda', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Holm', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Jensen', 'suffix': ''}], 'year': 2015, 'venue': 'Eur J Clin Nutr', 'volume': '69', 'issn': '', 'pages': '223--229', 'other_ids': {'DOI': ['10.1038/ejcn.2014.224']}}, 'BIBREF91': {'ref_id': 'b91', 'title': 'A systematic review of health system barriers and enablers for antiretroviral therapy (ART) for HIV-infected pregnant and postpartum women', 'authors': [{'first': 'C', 'middle': ['J'], 'last': 'Colvin', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Konopka', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Chalker', 'suffix': ''}], 'year': 2014, 'venue': 'PLoS One', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pone.0108150']}}, 'BIBREF92': {'ref_id': 'b92', 'title': 'The role of health systems and policy in producing behavior and social change to enhance child survival and development in low-and middle-income countries: an examination of the evidence', 'authors': [{'first': 'L', 'middle': ['F'], 'last': 'Vélez', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sanitato', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Barry', 'suffix': ''}], 'year': 2014, 'venue': 'J Health Commun', 'volume': '19', 'issn': '', 'pages': '89--121', 'other_ids': {'DOI': ['10.1080/10810730.2014.939313']}}, 'BIBREF93': {'ref_id': 'b93', 'title': 'Agriculture for improved nutrition: the current research landscape', 'authors': [{'first': 'R', 'middle': [], 'last': 'Turner', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Jeff', 'suffix': ''}], 'year': 2013, 'venue': 'Food Nutr Bull', 'volume': '34', 'issn': '', 'pages': '369--77', 'other_ids': {'DOI': ['10.1177/156482651303400401']}}, 'BIBREF94': {'ref_id': 'b94', 'title': 'Food Policy for Developing Countries: The Role of Government in Global, National, and Local Food Systems. 1 den', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pinstrup-Andersen', 'suffix': ''}, {'first': 'D', 'middle': ['D'], 'last': 'Watson', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ii', 'suffix': ''}], 'year': 2011, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF95': {'ref_id': 'b95', 'title': 'Standing Committee on Nutrition Mandate', 'authors': [{'first': '', 'middle': [], 'last': 'Unscn', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Un', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF96': {'ref_id': 'b96', 'title': 'Maternal and Child Nutrition Study Group. The politics of reducing malnutrition: building commitment and accelerating progress', 'authors': [{'first': 'S', 'middle': [], 'last': 'Gillespie', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Mannar', 'suffix': ''}], 'year': 2013, 'venue': 'Lancet', 'volume': '382', 'issn': '', 'pages': '552--69', 'other_ids': {'DOI': ['10.1016/S0140-6736(13)60842-9']}}, 'BIBREF97': {'ref_id': 'b97', 'title': 'Global nutrition: What should change?', 'authors': [{'first': 'A', 'middle': [], 'last': 'Müller', 'suffix': ''}, {'first': 'D', 'middle': ['C'], 'last': 'Coitinho', 'suffix': ''}], 'year': 2011, 'venue': 'Food Nutr Bull', 'volume': '32', 'issn': '2', 'pages': '56--64', 'other_ids': {'DOI': ['10.1177/15648265110322S202']}}, 'BIBREF98': {'ref_id': 'b98', 'title': 'Recent Shifts in Global Governance: Implications for the Response to Non-communicable Diseases', 'authors': [{'first': 'D', 'middle': [], 'last': 'Sridhar', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Brolan', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Durrani', 'suffix': ''}], 'year': 2013, 'venue': 'PLoS Med', 'volume': '10', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pmed.1001487']}}, 'BIBREF99': {'ref_id': 'b99', 'title': 'Reducing Child Undernutrition: Past Drivers and Priorities for the Post-MDG Era', 'authors': [{'first': 'L', 'middle': ['C'], 'last': 'Smith', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}], 'year': 2015, 'venue': 'World Dev', 'volume': '68', 'issn': '', 'pages': '180--204', 'other_ids': {'DOI': ['10.1016/j.worlddev.2014.11.014']}}, 'BIBREF100': {'ref_id': 'b100', 'title': 'Responseoriented measuring inequalities in Tehran: second round of UrbanHealth Equity Assessment and Response Tool (Urban HEART-2), concepts and framework', 'authors': [{'first': 'M', 'middle': [], 'last': 'Asadi-Lari', 'suffix': ''}, {'first': 'M', 'middle': ['R'], 'last': 'Vaez-Mahdavi', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Faghihzadeh', 'suffix': ''}], 'year': 2013, 'venue': 'Med J Islam Repub Iran', 'volume': '27', 'issn': '', 'pages': '236--284', 'other_ids': {}}, 'BIBREF101': {'ref_id': 'b101', 'title': 'Agriculture, health, and wealth convergence: bridging traditional food systems and modern agribusiness solutions', 'authors': [{'first': 'L', 'middle': [], 'last': 'Dube', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Webb', 'suffix': ''}, {'first': 'N', 'middle': ['K'], 'last': 'Arora', 'suffix': ''}], 'year': 2014, 'venue': 'Ann N Y Acad Sci', 'volume': '1331', 'issn': '', 'pages': '1--14', 'other_ids': {'DOI': ['10.1111/nyas.12602']}}, 'BIBREF102': {'ref_id': 'b102', 'title': 'Food security in the Asia-Pacific: Malthus, limits and environmental challenges', 'authors': [{'first': 'C', 'middle': ['D'], 'last': 'Butler', 'suffix': ''}], 'year': 2009, 'venue': 'Asia Pac J Clin Nutr', 'volume': '18', 'issn': '', 'pages': '577--84', 'other_ids': {}}, 'BIBREF103': {'ref_id': 'b103', 'title': 'Can experience-based household food security scales help improve food security governance?', 'authors': [{'first': 'R', 'middle': [], 'last': 'Pérez-Escamilla', 'suffix': ''}], 'year': 2012, 'venue': 'Glob Food Sec', 'volume': '1', 'issn': '', 'pages': '120--125', 'other_ids': {'DOI': ['10.1016/j.gfs.2012.10.006']}}, 'BIBREF104': {'ref_id': 'b104', 'title': 'Fighting maternal and child malnutrition: analysing the political and institutional determinants of delivering a national multisectoral response in six countries', 'authors': [{'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Fanzo', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF105': {'ref_id': 'b105', 'title': 'Accelerating reductions in undernutrition: what can nutrition governance tell us', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Fanzo', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF106': {'ref_id': 'b106', 'title': 'Food and Globalization', 'authors': [{'first': 'L', 'middle': [], 'last': 'Phillips', 'suffix': ''}], 'year': 2006, 'venue': 'Annual Review of Anthropology', 'volume': '35', 'issn': '', 'pages': '37--57', 'other_ids': {'DOI': ['10.1146/annurev.anthro.35.081705.123214']}}, 'BIBREF107': {'ref_id': 'b107', 'title': 'An accountability framework to promote healthy food environments', 'authors': [{'first': 'V', 'middle': ['I'], 'last': 'Kraak', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Swinburn', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Lawrence', 'suffix': ''}], 'year': 2014, 'venue': 'Public Health Nutr', 'volume': '17', 'issn': '', 'pages': '2467--83', 'other_ids': {'DOI': ['10.1017/S1368980014000093']}}, 'BIBREF108': {'ref_id': 'b108', 'title': 'A systematic policy approach to changing the food system and physical activity environments to prevent obesity', 'authors': [{'first': 'G', 'middle': [], 'last': 'Sacks', 'suffix': ''}, {'first': 'B', 'middle': ['A'], 'last': 'Swinburn', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Lawrence', 'suffix': ''}], 'year': 2008, 'venue': 'Aust New Zealand Health Policy', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1743-8462-5-13']}}, 'BIBREF109': {'ref_id': 'b109', 'title': 'Global health promotion: how can we strengthen governance and build effective strategies?', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2006, 'venue': 'Health Promot Int', 'volume': '21', 'issn': 'suppl_1', 'pages': '42--50', 'other_ids': {'DOI': ['10.1093/heapro/dal050']}}, 'BIBREF110': {'ref_id': 'b110', 'title': 'The multiple meanings of global health governance: a call for conceptual clarity', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kamradt-Scott', 'suffix': ''}], 'year': 2014, 'venue': 'Global Health', 'volume': '10', 'issn': '', 'pages': '28--38', 'other_ids': {'DOI': ['10.1186/1744-8603-10-28']}}, 'BIBREF111': {'ref_id': 'b111', 'title': 'The nutrition transition in high-and low-income countries: what are the policy lessons?', 'authors': [{'first': 'B', 'middle': [], 'last': 'Popkin', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Ng', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Sw', 'suffix': ''}], 'year': 2007, 'venue': 'Agricultural Economics', 'volume': '37', 'issn': '', 'pages': '199--211', 'other_ids': {'DOI': ['10.1111/j.1574-0862.2007.00245.x']}}, 'BIBREF112': {'ref_id': 'b112', 'title': 'Politics: Who Gets What, When, How', 'authors': [{'first': 'H', 'middle': ['D'], 'last': 'Lasswell', 'suffix': ''}], 'year': 1936, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF114': {'ref_id': 'b114', 'title': 'Two Treatises of Government. London: Awnsham Churchill, 1690', 'authors': [{'first': 'J', 'middle': [], 'last': 'Locke', 'suffix': ''}], 'year': None, 'venue': 'BMJ Global Health', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF115': {'ref_id': 'b115', 'title': 'International Covenant on Economic, Social and Cultural Rights', 'authors': [], 'year': 1966, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': \"Search conducted 3 May 2015. Search detail: ('nutritional status' (MeSH Terms) OR ('nutritional' (All Fields) AND 'status'(All Fields)) OR 'nutritional status' (All Fields) OR 'nutrition' (All Fields) OR 'nutritional sciences' (MeSH Terms) OR ('nutritional' (All Fields) AND 'sciences' (All Fields)) OR 'nutritional sciences' (All Fields)) AND ('Governance (Oxf)' (Journal) OR 'governance' (All Fields)). ii These included: Mejía Acosta et al 105 ; Gillespie et al 97 ; Haddad et al 106 ;. Sunguya et al.8\", 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'data sharing statement No additional data are available.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Nutrition governance literature search strategy and results by source', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': \"the need for international legal standards iii Data obtained 18 March 2016 from World Bank's 'Projects and Operations' website: http://www.worldbank.org/projects/ search?lang=en&searchTerm=&mjthemecode_exact=2\", 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'Sample nutrition governance problems at national and global levels', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715ef19a2fa9193482bdf'), 'paper_id': '0a17c029515e527bfad8a67810ab82f4a3d6a299', 'metadata': {'title': 'The outbreak of COVID-19: An overview', 'authors': [{'first': 'Yi-Chi', 'middle': [], 'last': 'Wu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Taipei Veterans General Hospital', 'location': {'settlement': 'Taipei', 'country': 'Taiwan, ROC'}}, 'email': ''}, {'first': 'Ching-Sung', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Taipei Veterans General Hospital', 'location': {'settlement': 'Taipei', 'country': 'Taiwan, ROC'}}, 'email': ''}, {'first': 'Yu-Jiun', 'middle': [], 'last': 'Chan', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Taipei Veterans General Hospital', 'location': {'settlement': 'Taipei', 'country': 'Taiwan, ROC'}}, 'email': 'yjchan@vghtpe.gov.twy.-j.chan.'}]}, 'abstract': [], 'body_text': [{'text': 'In late December 2019, an outbreak of a mysterious pneumonia characterized by fever, dry cough, and fatigue, and occasional gastrointestinal symptoms happened in a seafood wholesale wet market, the Huanan Seafood Wholesale Market, in Wuhan, Hubei, China. 1 The initial outbreak was reported in the market in December 2019 and involved about 66% of the staff there. The market was shut down on January 1, 2020, after the announcement of an epidemiologic alert by the local health authority on December 31, 2019. However, in the following month (January) thousands of people in China, including many provinces (such as Hubei, Zhejiang, Guangdong, Henan, Hunan, etc.) and cities (Beijing and Shanghai) were attacked by the rampant spreading of the disease. 2 Furthermore, the disease traveled to other countries, such as Thailand, Japan, Republic of Korea, Viet Nam, Germany, United States, and Singapore. The first case reported in our country was on January 21, 2019. As of February 6, 2020, a total of 28,276 confirmed cases with 565 deaths globally were documented by WHO, involving at least 25 countries. 3 The pathogen of the outbreak was later identified as a novel beta-coronavirus, named 2019 novel coronavirus (2019-nCoV) and recalled to our mind the terrible memory of the severe acute respiratory syndrome (SARS-2003, caused by another beta-coronavirus) that occurred 17 years ago.', 'cite_spans': [{'start': 255, 'end': 256, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 754, 'end': 755, 'text': '2', 'ref_id': 'BIBREF1'}, {'start': 1107, 'end': 1108, 'text': '3', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"In 2003, a new coronavirus, the etiology of a mysterious pneumonia, also originated from southeast China, especially Guangdong province, and was named SARS coronavirus that fulfilled the Koch's postulate. 4 The mortality rate caused by the virus was around 10%-15%. 5, 6 Through the years, the medical facilities have been improved; nevertheless, no proper treatment or vaccine is available for the SARS. 6 The emergence of another outbreak in 2012 of novel coronavirus in Middle East shared similar features with the outbreak in 2003. 7 Both were caused by coronavirus but the intermediate host for MERS is thought to be the dromedary camel and the mortality can be up to 37%. 5 The initial clinical manifestations for both SARS and MERS are usually nonspecific except that the majority of patients presented with fever and respiratory symptoms. Unprotected hospital staff who were exposed to patients' droplets or through contact prone to be infected and nosocomial infections ensue. 1,6 Furthermore, cases associated with travel had been identified for SARS, MERS, and COVID-19. 5, [8] [9] [10] [11] Because of global transportation and the popularity of tourism, COVID-19 is a genuine threat to Taiwan.\", 'cite_spans': [{'start': 205, 'end': 206, 'text': '4', 'ref_id': 'BIBREF4'}, {'start': 266, 'end': 268, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 269, 'end': 270, 'text': '6', 'ref_id': 'BIBREF6'}, {'start': 405, 'end': 406, 'text': '6', 'ref_id': 'BIBREF6'}, {'start': 678, 'end': 679, 'text': '5', 'ref_id': 'BIBREF5'}, {'start': 1082, 'end': 1084, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 1085, 'end': 1088, 'text': '[8]', 'ref_id': 'BIBREF8'}, {'start': 1089, 'end': 1092, 'text': '[9]', 'ref_id': 'BIBREF9'}, {'start': 1093, 'end': 1097, 'text': '[10]', 'ref_id': 'BIBREF10'}, {'start': 1098, 'end': 1102, 'text': '[11]', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Coronavirus is an enveloped, positive single-strand RNA virus. It belongs to the Orthocoronavirinae subfamily, as the name, with the characteristic \"crown-like\" spikes on their surfaces. 5 Together with SARS-CoV, bat SARS-like CoV and others also fall into the genus beta-coronavirus. COVID-19 (caused by 2019-nCoV infection) is classified as a fifth-category notifiable communicable disease in Taiwan on January 15, 2019. 12 The genus beta-coronavirus can be divided into several subgroups. The 2019-nCoV, SARS-CoV, and bat SARS-like CoV belong to Abstract: In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus # , emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020) . It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%-5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms. Sarbecovirus, while the MERS-CoV to Merbecovirus. 13 SARS-CoV, MERS-CoV, and 2019-nCoV all cause diseases in humans but each subgroup may have mild different biologic characteristic and virulence. [5] [6] [7] The exact origin, location, and natural reservoir of the 2019-nCoV remain unclear, although it is believed that the virus is zoonotic and bats may be the culprits because of sequence identity to the bat-CoV. 5, 13 According to previous studies on the SARS-and MERS-CoV, epidemiologic investigations, their natural reservoir is bat, while palm civet or raccoon dog may be the intermediate (or susceptible) host for SARS-CoV and the dromedary camel for MERS-CoV. 5, 13 A field study for the SARS-CoV on palm civet ruled out the possibility as the natural reservoir (low positive rate); instead, the prevalence of bat coronavirus among wild life is high and it shares a certain sequence identity with the human SARS-CoV. 14 Therefore, bats are considered the natural host reservoir of SARS-like coronavirus. 13 However, the origin or natural host for the 2019-nCoV is not clear, although it might come from a kind of wild life in the wet market. 1 Theoretically, if people contact or eat the reservoir or infected animal, they could be infected. However, to result in large scaled person-to-person transmission as in the past SARS outbreak, the virus must spread efficiently. Initially, the 2019-CoV outbreak was reported as limited person-to-person transmission and a contaminated source from infected or sick wild animals in the wet market may have been the common origin. 1,2 But more and more evidences came out with clusters of outbreaks among family confirmed the possibility of personto-person transmission. 8, 10, 11, 15, 16 In addition, the involvement of human angiotensin-converting enzyme 2 (hACE2) as the cellular receptor (like SARS) made droplet transmission to the lower respiratory tract possible. 5, 17 Furthermore, contact transmission like SARS is also likely although the survival time in the environment for the 2019-nCoV is not clear at present. Currently, there was no evidence of air-borne transmission. Viral RNAs could be found in nasal discharge, sputum, and sometimes blood or feces. 1, 9, 10, 13, 15 But whether oral-fecal transmission can happen has not yet been confirmed. Once people are infected by the 2019-nCoV, it is believed that, like SARS, there is no infectivity until the onset of symptoms. 15 However, one report describes infection from an asymptomatic contact but the investigation was not solid. 10 The infectious doses for 2019-nCoV is not clear, but a high viral load of up to 10 8 copies/mL in patient\\'s sputum has been reported. 10 The viral load increases initially and still can be detected 12 days after onset of symptoms. 9 Therefore, the infectivity of patients with 2019-nCoV may last for about 2 weeks. However, whether infectious viral particles from patients do exist at the later stage requires validation.', 'cite_spans': [{'start': 187, 'end': 188, 'text': '5', 'ref_id': 'BIBREF5'}, {'start': 423, 'end': 425, 'text': '12', 'ref_id': None}, {'start': 1002, 'end': 1020, 'text': 'February 11, 2020)', 'ref_id': None}, {'start': 1859, 'end': 1861, 'text': '13', 'ref_id': 'BIBREF13'}, {'start': 2006, 'end': 2009, 'text': '[5]', 'ref_id': 'BIBREF5'}, {'start': 2010, 'end': 2013, 'text': '[6]', 'ref_id': 'BIBREF6'}, {'start': 2014, 'end': 2017, 'text': '[7]', 'ref_id': 'BIBREF7'}, {'start': 2226, 'end': 2228, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 2229, 'end': 2231, 'text': '13', 'ref_id': 'BIBREF13'}, {'start': 2479, 'end': 2481, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 2482, 'end': 2484, 'text': '13', 'ref_id': 'BIBREF13'}, {'start': 2823, 'end': 2825, 'text': '13', 'ref_id': 'BIBREF13'}, {'start': 2961, 'end': 2962, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 3530, 'end': 3532, 'text': '8,', 'ref_id': 'BIBREF8'}, {'start': 3533, 'end': 3536, 'text': '10,', 'ref_id': 'BIBREF10'}, {'start': 3537, 'end': 3540, 'text': '11,', 'ref_id': 'BIBREF11'}, {'start': 3541, 'end': 3544, 'text': '15,', 'ref_id': 'BIBREF15'}, {'start': 3545, 'end': 3547, 'text': '16', 'ref_id': 'BIBREF16'}, {'start': 3730, 'end': 3732, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 3733, 'end': 3735, 'text': '17', 'ref_id': 'BIBREF17'}, {'start': 4028, 'end': 4030, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 4031, 'end': 4033, 'text': '9,', 'ref_id': 'BIBREF9'}, {'start': 4034, 'end': 4037, 'text': '10,', 'ref_id': 'BIBREF10'}, {'start': 4038, 'end': 4041, 'text': '13,', 'ref_id': 'BIBREF13'}, {'start': 4042, 'end': 4044, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 4248, 'end': 4250, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 4357, 'end': 4359, 'text': '10', 'ref_id': 'BIBREF10'}, {'start': 4494, 'end': 4496, 'text': '10', 'ref_id': 'BIBREF10'}, {'start': 4591, 'end': 4592, 'text': '9', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'VIROLOGY'}, {'text': 'The illness onset of the first laboratory-confirmed case of 2019-nCoV infection was on December 1, 2019 in Wuhan, China (Table 1) . 1 Initially, an outbreak involving a local market, the Huanan Seafood Market, with at least 41 people was reported. 1 The local health authority issued an \"epidemiologic alert\" on December 31, 2019, and the market was shut down on January 1, 2020. A total of 59 suspected cases with fever and dry cough were referred to a designated hospital (the Jin Yin-tan Hospital). Of the 59 suspected cases, 41 patients were confirmed by nextgeneration sequencing or real-time reverse transcription-polymerase chain reaction (RT-PCR). Twenty-seven (66%, 27/41) patients had history of Huanan Seafood Market exposure. 1 However, there is a caveat that the first case on December 1 did not show history of Huanan Seafood Market exposure and the subsequent cases started on December 10, nine days later. In the following days, a burst of cases was spreading from Wuhan to the whole Hubei province. Subsequently, many cities and provinces were attacked by this virus. One of the reasons may be due to the heavy transportation load during the Chinese Lunar New Year (on January 25) period. The first exported case was into Thailand on January 13, 2020. However, the disease spread rapidly and globally. Not only familial clusters but also outbreaks in ocean liners were reported. As of February 6, 2020, a total of 28,276 confirmed cases with 565 deaths globally were documented by WHO, involving at least 25 countries. 3 The WHO issued an public health emergencies of international concern (PHEIC) alarm on January 30, 2020. Many stringent quarantine procedures and fever surveillance were underway. The initial mortality rates for patients in the hospital were estimated to be 11%-15%, 1,15 but more recent data were 2%-3%. It is very likely that person-to-person transmissions occur via droplets and contact. Nosocomial infections in the healthcare facilities did happen and stress the importance of good infection control.', 'cite_spans': [{'start': 132, 'end': 133, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 248, 'end': 249, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 738, 'end': 739, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 1536, 'end': 1537, 'text': '3', 'ref_id': 'BIBREF3'}], 'ref_spans': [{'start': 120, 'end': 129, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'EPIDEMIOLOGY'}, {'text': 'COVID-19 has a mean incubation period of 5.2 days (95% confidence interval, 4.1-7.0). 16 The infection is acute without any carrier status. Symptoms usually begin with nonspecific syndromes, including fever, dry cough, and fatigue. Multiple systems may be involved, including respiratory (cough, short of breath, sore throat, rhinorrhea, hemoptysis, and chest pain), gastrointestinal (diarrhea, nausea, and vomiting), musculoskeletal (muscle ache), and neurologic (headache or confusion). More common signs and symptoms are fever (83%-98%), cough (76%-82%), and short of breath (31%-55%). There were about 15% with fever, cough, and short of breath. 1,15 Conjunctival injection was not reported in the early series and cases with age under 18 were few. After onset of illness, the symptoms are somehow mild and the median time to first hospital admission is 7.0 days (4.0-8.0). But the disease progresses to short of breath (~8 days), acute respiratory distress syndrome (ARDS) (~9 days), and to mechanical ventilation (~10.5 days) in about 39% patients. 1 Patients with fatal disease develop ARDS and worsened in a short period of time and died of multiple organ failure. 1, 15 The mortality rate in the early series of hospitalized patients was 11%-15%, but the later statistics was 2%-3%. 1, [15] [16] [17] The 2019-nCoV virus may enter the host through respiratory tract or mucosal surfaces (such as conjunctiva). Oral-fecal transmission has not been confirmed. The virus has a preferential tropism to human airway epithelial cells and the cellular receptor, The first confirmed nCoV case in Wuhan (no Huanan seafood market exposure) December 10', 'cite_spans': [{'start': 86, 'end': 88, 'text': '16', 'ref_id': 'BIBREF16'}, {'start': 1055, 'end': 1056, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 1173, 'end': 1175, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 1176, 'end': 1178, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 1292, 'end': 1294, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 1295, 'end': 1299, 'text': '[15]', 'ref_id': 'BIBREF15'}, {'start': 1300, 'end': 1304, 'text': '[16]', 'ref_id': 'BIBREF16'}, {'start': 1305, 'end': 1309, 'text': '[17]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'The first confirmed nCoV case with Huanan seafood market exposure December 31', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'An epidemiological alert by local agency 2020 January 1 Huanan seafood market shut down January 13', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'The first nCoV case in Thailand (Wuhan history) January 15', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'A notifiable communicable disease (by Taiwan CDC) January 21', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'The first nCoV case in Taiwan (Wuhan history) January 30', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'Public health emergencies of international concern (PHEIC) alarm by WHO Review Article. (2020) 83:3 J Chin Med Assoc like SARS, is ACE2. 18 However, the pathological changes of the disease and its pathogenesis in human is not clearly elucidated. Theoretically lungs are the major involved organ. Will the virus replicate in other part of the body is not clear.', 'cite_spans': [{'start': 137, 'end': 139, 'text': '18', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': \"The COVID-19 usually presents as an acute viral respiratory tract infection and many differential diagnoses related to common viral pneumonia should be considered, such as influenza, parainfluenza, adenovirus infection, respiratory syncytial virus infection, metapneumovirus infection, and atypical pathogens, such as Mycoplasma pneumoniae and Clamydophila pneumoniae infections etc. 1, 8 Therefore, it is crucial to trace the travel and exposure history when approaching a suspected patient back from an epidemic area. In addition, commercial respiratory syndromic diagnostic kits that detect multiple etiological agents (such as Filmarray Respiratory Panel) may help timely differential diagnosis. Laboratory diagnosis for COVID-19 should be performed in a well-equipped laboratory with up to biosafety level 3 facilities for the viral culture. In Taiwan, COVID-19 is a fifth-category notifiable communicable disease and should be reported to Taiwan Confirmatory laboratory diagnosis usually rely on a real-time RT-PCR assay to detect viral RNA by targeting a consensus E region of pan beta-CoV or other more specific regions (such as RdRp or N region) 1,13,15 Chest x-ray and computer tomography (CT) usually revealed bilateral pneumonia (75-98%) with multiple mottling and ground-grass opacity. 1, 15 Routine laboratory data in the early stage of COVID-19 epidemic are similar to common viral infection: lymphopenia, prolonged prothrombin time, elevated D-dimer, liver enzymes (alanine aminotransferase), total bilirubin, and lactate dehydrogenase, with worsening data in ICU cases. 1 Leukocytosis may occur if complicated with secondary bacterial infection. Considering patients' and laboratory safety, physicians should carefully evaluate the necessity of frequent blood sampling and conduct aspiration to prevent the risk of unexpected exposure.\", 'cite_spans': [{'start': 384, 'end': 386, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 387, 'end': 388, 'text': '8', 'ref_id': 'BIBREF8'}, {'start': 1299, 'end': 1301, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 1302, 'end': 1304, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 1587, 'end': 1588, 'text': '1', 'ref_id': 'BIBREF0'}], 'ref_spans': [{'start': 945, 'end': 951, 'text': 'Taiwan', 'ref_id': None}], 'section': 'DIAGNOSIS'}, {'text': 'Currently, there is no validated treatment for COVID-19. The main strategies are symptomatic and supportive care, such as keeping vital signs, maintaining oxygen saturation and blood pressure, and treating complications, such as secondary infections or organs failure.', 'cite_spans': [], 'ref_spans': [], 'section': 'TREATMENT'}, {'text': 'Because of the potential mortality of COVID-19, many investigational treatments are underway:', 'cite_spans': [], 'ref_spans': [], 'section': 'TREATMENT'}, {'text': \"1. Remdesivir: The experimental drug is a novel nucleotide analogue prodrug in development by Gilead Sciences, Inc. It is an unapproved antiviral drug being developed for Ebola and SARS. In a case report on the first case of 2019-nCoV in the United States administering remdesivir for compassionate use on day 11 after illness resulted in decreasing viral loads in nasopharyngeal and oropharyngeal samples and the patient's clinical condition improved. 9 However, randomized controlled trials are needed to determine the safety and efficacy of this drug for treatment of patients with 2019-nCoV infection. 2. Convalescent therapies (plasma from recovered COVID-19 patients): This strategy had been used to support passive immunization. Based on the studies from MERS, the therapeutic agents with potential benefits include convalescent plasma, interferon-beta/ribavirin combination therapy, and lopinavir. 19 However, there are no experience on COVID-19 and no randomized controlled clinical trials for this management at present. 3. Antiviral drugs: lopinavir/ritonavir and ribavirin had been tried to treat SARS disease with apparent favorable clinical response. 20 In vitro antiviral activity against SARS-associated coronavirus at 48 hours for lopinavir and ribavirin was demonstrated at concentrations of 4 and 50 µg/mL, respectively. A recent report found uncanny similarity of unique insertions in the 2019-nCoV spike protein to HIV-1 gp120 and Gag. 21 Will anti-HIV drugs affect the 2019-nCoV treatment outcome? Further randomized controlled trials in patients with COVID-19 are mandatory. 4. Vaccine: There is currently no vaccine available for preventing 2019-nCoV infection. The spike protein may serve as a vaccine candidate, but the effect to human requires further evaluation.\", 'cite_spans': [{'start': 453, 'end': 454, 'text': '9', 'ref_id': 'BIBREF9'}, {'start': 906, 'end': 908, 'text': '19', 'ref_id': 'BIBREF19'}, {'start': 1165, 'end': 1167, 'text': '20', 'ref_id': 'BIBREF20'}, {'start': 1457, 'end': 1459, 'text': '21', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'TREATMENT'}, {'text': 'Since there are no standard treatments for COVID-19, it is important to avoid infection or further spreading. For general population, travel to epidemic area of COVID-19 (mainly in China, especially Wuhan, and Hong Kong and Macaw), contact, or eating wild animal is dissuaded. For those who had history of travel from epidemic area in recent 14 days, body temperature monitor and self-surveillance for 14 days should be performed. If compatible symptoms developed, designated transportation is recommended to prevent unprotected exposure. For healthcare workers, personal protective equipment should be put on and taken off properly while caring a probable or confirmed patients. Stringent protection procedures should be conducted for high-risk procedures (such as endoscopy, Ambu bagging, and endotracheal tube intubation). Once exposed to blood or body fluids of the patient unprotected, the healthcare workers should flush thoroughly the exposure site by water or soap. Afterward, body temperature should be monitored for 14 days. The confirmed case should be isolated (prefer a negative pressure isolation room or, alternatively, a single room with good ventilation). Under the circumstances of resolved symptoms for 24 hours and consecutive two negative results, isolation could be released. Corpses should be burned or buried deep.', 'cite_spans': [], 'ref_spans': [], 'section': 'PREVENTION'}, {'text': 'Treatments effective against coronavirus include steam and heat. The virus is susceptible to many active ingredients (AI), such as sodium hypochlorite (0.1%-0.5%), 70% ethyl alcohol, povidone-iodine (1% iodine), chloroxylenol (0.24%), 50% isopropanol, 0.05% benzalkonium chloride, 1% cresol soap, or hydrogen peroxide (0.5%-7.0%), etc. 22 Just like the WHO recommendations for Ebola virus (RG4) disinfection, the environment with spills of blood or body fluids could be cleaned up with 1:10 dilution of 5.25% household bleach for 10 minutes. 23 In conclusion, 2019-nCoV infection is a zoonotic disease with low to moderate mortality rate. Currently, there is no standard treatment for the disease and supportive treatment was the only strategy. Although many experimental trials are on the way, the best we can do to prevent a rampant outbreak is stringent infection control operation. Clinicians should consider the possibility of 2019-nCoV virus infection in persons with travel or exposure history with compatible incubation period and presenting symptoms. First-line healthcare providers should be highly aware of appropriate infection prevention measures for suspected patients.', 'cite_spans': [{'start': 336, 'end': 338, 'text': '22', 'ref_id': 'BIBREF22'}, {'start': 542, 'end': 544, 'text': '23', 'ref_id': 'BIBREF23'}], 'ref_spans': [], 'section': 'PREVENTION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Clinical features of patients infected with 2019 novel coronavirus in Wuhan', 'authors': [{'first': 'C', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ren', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Hu Y', 'suffix': ''}], 'year': 2020, 'venue': 'China. Lancet', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['Doi:10.1016/S0140-6736(20)30183-5']}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Novel Coronavirus (2019-nCoV)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'World Health Organization. 2019-nCoV Situation Report', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': \"Koch's postulates fulfilled for SARS virus\", 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Ron', 'suffix': ''}, {'first': 'Thijs', 'middle': [], 'last': 'Fouchier', 'suffix': ''}, {'first': 'Martin', 'middle': [], 'last': 'Kuiken', 'suffix': ''}, {'first': ';', 'middle': [], 'last': 'Schutten', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Gerard', 'suffix': ''}], 'year': 2003, 'venue': 'Nature', 'volume': '423', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Another decade, another coronavirus', 'authors': [{'first': 'S', 'middle': [], 'last': 'Perlman', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMe2001126']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Peiris', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Chu', 'suffix': ''}, {'first': 'V', 'middle': ['C'], 'last': 'Cheng', 'suffix': ''}, {'first': 'K', 'middle': ['S'], 'last': 'Chan', 'suffix': ''}, {'first': 'I', 'middle': ['F'], 'last': 'Hung', 'suffix': ''}, {'first': 'L', 'middle': ['L'], 'last': 'Poon', 'suffix': ''}], 'year': 2003, 'venue': 'Lancet', 'volume': '361', 'issn': '', 'pages': '1767--72', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia', 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Zaki', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Van Boheemen', 'suffix': ''}, {'first': 'T', 'middle': ['M'], 'last': 'Bestebroer', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Osterhaus', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Fouchier', 'suffix': ''}], 'year': 2012, 'venue': 'N Engl J Med', 'volume': '367', 'issn': '', 'pages': '1814--1834', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster', 'authors': [{'first': 'Chan', 'middle': [], 'last': 'Jasper', 'suffix': ''}, {'first': 'F', 'middle': ['W'], 'last': 'Yuan', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Kok', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': '', 'suffix': ''}, {'first': 'To', 'middle': [], 'last': 'Kelvin', 'suffix': ''}, {'first': 'K', 'middle': ['W'], 'last': 'Chu', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2020, 'venue': 'Lancet', 'volume': '', 'issn': '', 'pages': '30154--30163', 'other_ids': {'DOI': ['10.1016/S0140-6736(20']}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'First case of 2019 novel coronavirus in the United States', 'authors': [{'first': 'M', 'middle': ['L'], 'last': 'Holshue', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Debolt', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Lindquist', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Lofy', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Wiesman', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Bruce', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMoa2001191']}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Transmission of 2019-nCoV infection from an asymptomatic contact in Germany', 'authors': [{'first': 'C', 'middle': [], 'last': 'Rothe', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Schunk', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Sothmann', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Bretzel', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Froeschl', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wallrauch', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMc2001468']}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Importation and human-to-human transmission of a novel coronavirus in Vietnam', 'authors': [{'first': 'L', 'middle': ['T'], 'last': 'Pgab', 'suffix': ''}, {'first': 'T', 'middle': ['V'], 'last': 'Nguyen', 'suffix': ''}, {'first': 'Q', 'middle': ['C'], 'last': 'Luong', 'suffix': ''}, {'first': 'T', 'middle': ['V'], 'last': 'Nguyen', 'suffix': ''}, {'first': 'H', 'middle': ['Y'], 'last': 'Nguyen', 'suffix': ''}, {'first': 'H', 'middle': ['Q'], 'last': 'Le', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMc2001272']}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'A novel coronavirus from patients with pneumonia in China', 'authors': [{'first': 'N', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Song', 'suffix': ''}], 'year': 2019, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMoa2001017']}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding', 'authors': [{'first': 'R', 'middle': [], 'last': 'Lu', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Niu', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wu', 'suffix': ''}], 'year': 2020, 'venue': 'Lancet', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study', 'authors': [{'first': 'N', 'middle': [], 'last': 'Chen', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Zhou', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Dong', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Qu', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Gong', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Han', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '30211--30218', 'other_ids': {'DOI': ['10.1016/S0140-6736(20']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia', 'authors': [{'first': 'Q', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Guan', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Wu', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Zhou', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Tong', 'suffix': ''}], 'year': None, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMoa200131']}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan', 'authors': [{'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Tang', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Wei', 'suffix': ''}], 'year': 2020, 'venue': 'China. J Med Virol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1002/jmv.25689']}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'A novel coronavirus emerging in China -Key Questions for Impact Assessment', 'authors': [{'first': 'V', 'middle': ['J'], 'last': 'Munster', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koopmans', 'suffix': ''}, {'first': 'N', 'middle': ['V'], 'last': 'Doremalen', 'suffix': ''}, {'first': 'D', 'middle': ['V'], 'last': 'Riel', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Wit', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMp2000929']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'A review of treatment modalities for middle east respiratory syndrome', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Mo', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Fisher', 'suffix': ''}], 'year': 2016, 'venue': 'J Antimicrob Chemother', 'volume': '71', 'issn': '', 'pages': '3340--50', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Chu', 'suffix': ''}, {'first': 'V', 'middle': ['C'], 'last': 'Cheng', 'suffix': ''}, {'first': 'I', 'middle': ['F'], 'last': 'Hung', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Wong', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Chan', 'suffix': ''}, {'first': 'K', 'middle': ['S'], 'last': 'Chan', 'suffix': ''}], 'year': 2004, 'venue': 'Thorax', 'volume': '59', 'issn': '', 'pages': '252--258', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pradhan', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Pandey', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Mishra', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Gupta', 'suffix': ''}, {'first': 'P', 'middle': ['K'], 'last': 'Tripathi', 'suffix': ''}, {'first': 'M', 'middle': ['B'], 'last': 'Menon', 'suffix': ''}], 'year': 2020, 'venue': '', 'volume': '2020', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['https:/www.biorxiv.org/content/10.1101/2020.01.30.927871v2']}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Interim Guidelines for Environmental Cleaning and Disinfection of Areas Exposed to Confirmed Case(s) of 2019 Novel Coronavirus (2019-nCoV) in Non-Healthcare Commercial Premises', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Hand Hygiene for Health Workers Caring for Ebola Patients', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': '11, 2020: designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by ICTV. (ICTV=The International Committee on Taxonomy of Viruses).', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'novel coronavirus; CDC = center of disease control; WHO = the World Health Organization.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': \"Centers of Disease Control (CDC) within 24 hours. The definitions of reported COVID-19 include (as of February 7, 2020): (1) Clinical conditions, met any following one (1.1) febrile illness (≥38°C) or acute respiratory infection (1.2) clinical, radiological, or pathological evidence of pneumonia. (2) Laboratory conditions, with any of the following: (2.1) clinical specimen (nasopharyngeal swab, sputum, or lower respiratory tract aspirates, etc.) that were isolated and identified as 2019-nCoV (2.2) Clinical specimen that show positive by RT-PCR. (3) Epidemiologic conditions, with any of the following 14 days before onset of symptoms (3.1) History of travel history from or evidence of contacting patients with fever or respiratory symptoms in the first class epidemic area of COVID-19 (currently Hubei, including Wuhan and Guangdong) (3.2) history of travel from or living in other part of mainland China (including Hong Kong and Macaw) (3.3) history of contact with probable or confirmed COVID-19 cases, including health provider, under the same roof, direct contact of the mucus or body fluid. Once the case fulfills (1) any clinical and epidemiologic condition 3.1 or 3.3 or (2) clinical condition 1.2 and epidemiologic condition 3.2 or (3) any laboratory condition, the patient should be reported to Taiwan CDC within 24 hours. If the first laboratory report is negative but patients' symptoms persist without explainable etiology, a second sample should be examined 24 hours later in case of first negative to rule out initial false-negative result. (Taiwan CDC guideline)\", 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Chronological list of 2019-nCoV global outbreak', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715efb948695dcc1072ae'), 'paper_id': '0a19aacc124c9c42d66d481a9d0c837a76a252e6', 'metadata': {'title': 'VIRUS ON T H E CEREBRAL ACTIVITY OF P L E U R O P N E U M O N I A -L I K E ORGANISMS I N M I C E', 'authors': [{'first': 'John', 'middle': ['B'], 'last': 'Nelson', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': 'Shortly after the isolation of MHV(C) from Balb C mice, in 1955, it was found that Swiss weanlings were equally susceptible and because of their availability they were subsequently used in activity tests (1) . Princeton mice were consistently resistant. Intraperitoneal injection in Swiss mice was generally followed by focal or diffuse necrosis of the liver but was not attended by nervous manifestations. On intracerebral injection the virus produced significant changes in the brain, with some destruction of nerve cells. Lymphocytic infiltration was commonly observed in brain sections but polymorphonuclear leukocytes were absent. Lesions produced in the liver, following carriage of the virus from the brain, were generally focal in character. The death rate was variable. In one series of passages, 12 of 25 mice died between the 3rd and the 5th day after injection. Survival after the 3rd day was irregularly attended by paralysis of the hind legs. The most common sign was a rigid backward extension of one or both limbs. The affected leg was functionless and was dragged by the mouse in moving. This type of paralysis was observed in 9 of the 25 mice. At autopsy on the 5th or 6th day, 5 of them were erect and active while 4 were prone and unable to move. A tendency to roll sideways, if lightly prodded, was observed in one of the latter mice. All of the cranially injected animals showed weight losses of 1 to 3 gin.', 'cite_spans': [{'start': 204, 'end': 207, 'text': '(1)', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': ''}, {'text': 'Unusually acute signs of illness appeared in Swiss mice during the first cranial passage series. By the 3rd transfer, leukocytes were demonstrable in direct films 179 and later in sections from the brain. A cerebral suspension prepared from the mice of the 5th transfer yielded a pure growth of PPLO. The passage series was continued with a Coors filtrate of the contaminated suspension and subsequently maintained in the absence of PPLO. In 1938, Sabin (2) described a nervous disorder of mice that appeared during the cerebral passage of toxoplasma. The characteristic sign was a rolling motion on the long axis of the body. It was also observed after intraabdominal and intrathoracic injection. The incidence was 20 to 40 per cent. Two kinds of brain lesions were found in sections. The first one was indicated by destruction of the periventricular tissue and extensive leukocytic infiltration. It was present in all mice. The second lesion, consisting of almost complete necrosis and lysis of the posterior pole of the cerebellum, occurred only in mice with rolling signs.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Sabin (3) subsequently found that a pleuropneumonia-like organism, later termed type A (5) , was the etiologic factor. The disease was fully reproduced by intracerebral injection of the agent in pure culture. If grown in glucose-serum broth the organism produced a true exotoxin which resulted in the same nervous signs and cerebellar lesion on intravenous injection. Findlay et al. (4) , also in 1938, noted that mice injected intracerebrally, in series, with a neurotropic strain of yellow fever virus developed nervous signs within 2 days, instead of 4 to 5 days. Rolling with a sideways motion was observed in some of the mice. An agent that was not cultivable in ordinary media was separated from the brain but was subsequently lost on passage.', 'cite_spans': [{'start': 6, 'end': 9, 'text': '(3)', 'ref_id': 'BIBREF2'}, {'start': 87, 'end': 90, 'text': '(5)', 'ref_id': 'BIBREF4'}, {'start': 383, 'end': 386, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': ''}, {'text': 'A similar condition was later observed during brain passage of the S strain of lymphocytic choriomeningitis virus. Rolling occurred in about 10 per cent of the injected mice. Seventy-five per cent died in 2 to 7 days. Some of the survivors developed hydrocephalus between the 8th and the 21st day.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Brain sections showed neurolysis and an intense infiltration of leukocytes. The lateral ventricles, meninges, and choroid plexus were invaded. In hydrocephalus the leukocytes were largely replaced by lymphocytes and mononuclears.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'PPLO designated L5 were invariably isolated from the brains of mice with rolling signs. This organism by itself was incapable of reproducing the disease but mixed with a neurotropic virus or agar, or after rapid intracerebral passage, its virulence was raised and the rolling signs resulted. Several other types of PPLO (L,, Ls, and L4) were inactive in the presence of virus.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': \"Cross-protection tests indicated that Sabin's type A organism was closely related to Ls but his was considerably more virulent.\", 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'The first experiments on the behavior of PPLO in the brain were made in normal mice with 2 strains of the catarrhal type, designated S and J. Swiss and Princeton weanlings were injected intracerebrally with pure cultures of the organisms in the absence of any other microbial agent. Subsequent passages were made with brain suspensions.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'The mice used in all of the following experiments were Swiss and Princeton weanlings, 10 to 12 gin. in weight, from colonies maintained at The Rockefeller Institute. They were injected in groups of 4 or 6, using mice of either sex but the same sex in any one group. The intracerebrai injections were made with approximately 0.02 ml. of inoculum, in mice lightly anesthetized with ether. The brain suspensions were prepared in saline from minced tissue, using a TenBroeck grinder, and were about 10 per cent in concentration. Freshly prepared suspensions were generally held for a short period, until sedimentation had occurred, and the supernatant used. In some instances penicillin was added in the amount of 1000 units per ml.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'The PPLO strain designated S was the one originally isolated from the brains of Swiss mice during the cranial passage of MHV(C). The results of nasal and intraperitoneal injection in Princeton weanlings had indicated that it was a catarrhal type. The intracerebral passage in Swiss mice was begun with the 2nd transfer of the organism grown for 48 hours in 20 per cent horse serum--heart infusion bouillon (pH 8).', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': \"Most of the injected mice were killed on the 7th day and their brains removed aseptically. At least one brain from each passage group was placed in Zenker's solution, for histologic study, and sections cut from 3 levels including the cerebellum. They were stained with eosinmethylene blue. A small amount of tissue was aspirated with a capillary pipette from 2 or more of the remaining brains, the pipette being inserted between the hemispheres. Gramstained films of the tissue were prepared for microscopic examination. Cultures were also made on 20 per cent horse serum-nutrient agar plates containing 2500 units of penicillin. Finally, a suspension was prepared from the pooled brains for passaging. In some of the later tests cultures were also made from the suspensions. Several of the mice in this experiment were held under observation for 14 days and killed without a complete examination. Five subsequent passages were made, in each case with a brain suspension from the preceding transfer. Essentially the same methods were used in all of the following tests.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'The PPLO strain designated J was originally isolated during an outbreak of infectious catarrh in a small colony of Japanese mice. It has been maintained for many years in this laboratory by nasal passage or contact in Princeton mice. Intracerebral passage was begun in Princeton weanlings with a freshly isolated 72 hour old culture, the 3rd transfer on isolation from middle ear exudate. Four subsequent cerebral passages were made in Princeton mice and one in Swiss mice.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'Twenty-eight of the 32 Swiss mice used in the 6 cerebral passages of the S strain of PPLO were killed on the 7th day after injection, and 4 on the 14th day. All of the animals gained weight during the observation period and were normal in appearance. At autopsy they showed no consistent pathologic findings. Leukocytes were not observed in either direct films or sections and there was no indication of encephalitis or meningitis. Thirteen of 16 brain cultures gave a pure growth of PPLO and 3 were negative. The amount of growth was regularly scanty, 8 of the plates having 10 colonies or less.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'Similar results were obtained with the cerebral passage of the J strain in Princeton mice. The 25 animals used in the 5 transfers were normal in appearance during the observation period of 7 days. At autopsy, leukocytes were not observed in either brain films or sections. Cultures from the suspensions yielded only a scanty growth of PPLO colonies. In the single experiment with Swiss mice the injected animals were held for 4 weeks. They were likewise normal during life and at autopsy. The terminal culture from the brain suspension yielded 8 PPLO colonies.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'The Reaction with Catarrhal Strains of PPLO.--This series was begun with the S strain of PPLO. Eight successive cranial transfers were made in Swiss weanlings, starting with a brain suspension which contained both the organisms and the virus. Prior to use this suspension had been maintained in a frozen state at --20°C. for 21 weeks.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Five mice were used in each of the 8 brain passages. Mter injection they were held under observation until one or more deaths had occurred. At this time, usually the 3rd or 4th day, the survivors were killed with ether and autopsied. Direct brain films and cultures were made from at least one mouse in each passage. Six brains were sectioned for later study.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Twenty of the 40 mice in this series of passages died, 14 on the 3rd day and 6 on the 4th. The 20 survivors were acutely ill when killed for autopsy. They regularly showed a marked loss in weight, up to 4 grn. per mouse. Roughening of the hair was a variable finding. Many of the mice were inactive and some were prone. Convulsive movements were irregularly observed and a tendency to roll was seen in 3. At autopsy the livers commonly showed a normal red color but were regularly spotted with small white loci. These areas were often few in number, 10 or less, and in some instances were visible only on low power magnification. The Gram-stained films regularly showed leukocytes in considerable numbers. In some films extra-and intracellular groupings of PPLO were clearly demonstrable. Areas of inflammation with innumerable leukocytes were observed in the brain sections. A pure growth of PPLO colonies, varying from several thousand to innumerable, was obtained on the plate cultures from 7 of the passages. The growth from the brains of the first passage, which had been made with a previously frozen suspension, was relatively meagre. A culture made from the pooled livers of the 2 survivors in the second passage was bacteriologically sterile.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Supplementary experiments in this group were carried out with 3 additional PPLO strains of the catarrhal type. One strain (J) was recovered from the middle ear exudate of experimentally infected mice and 2 strains (RZ and RH) from naturally infected albino rats. All 3 strains were of recent isolation. Two cerebral passages were made in Swiss weanlings with each of the strains. In preparing the inoculum for the first passage a brain suspension containing only MHV(C) was mixed with an equal volume of a fluid culture of PPLO. The second passage was made with a brain suspension which contained both agents.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'With the RZ strain of PPLO the outward signs of illness were delayed until the 5th day. In other respects the outcome of these tests essentially duplicated the results with the S strain. Signs of acute illness were regularly observed in the injected mice. Thirteen of the 30 animals used in the combined tests died. A tendency to roll was observed in only 2 of the 17 survivors. At autopsy a sparse distribution of small surface foci was observed in all of the livers. Leukocytes were regularly present in brain films and numerous colonies of PPLO were obtained on plate cultures. Brain sections from 2 mice in each group showed extensive leukocytic infiltration.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': \"In the experiment with the J strain of PPLO, cultures were also made from the heart's blood, liver, and spleen. All of these suspensions were bacteriologically sterile. Aside from the liver, the abdominal and thoracic organs of these mice, and indeed of all the mice in the entire series of experiments, were normal in the gross.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'The effect of long continued cultivation on the cerebral activity of PPLO was determined with a culture of the J strain that had been transferred 100 times in serum-bouillon at intervals of 2 to 3 days. In the presence of MHV(C) its pathogenicity was fully as great as that of the recently isolated strains.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'One titration experiment was carried out with brains removed on the 3rd day from Swiss mice injected intracerebrally with MHV(C) and the J strain of PPLO. The highest dilution of the suspension that gave a leukocytic response with positive cultures was 10 -4 . The brains from mice which received the 10 -5 dilution showed no lesions and were bacteriologically sterile.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'The Reaction with Conjunctival Strains of PPLO.--The observations on the activity of MHV(C) and PPLO in the brain were continued with 2 strains of the conjunctival type, designated P and B. These organisms are much less pathogenic for mice than those of the catarrhal type and are commonly inactive on nasal or intraperitoneal injection in susceptible weanlings. Under natural conditions they are associated with a low grade inflammation of the conjunctivae (6).', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'The P strain was obtained from Princeton mice infected by direct contact. A passage series with this strain was begun in 1950 and has been maintained to date. A culture of recent isolation from conjunctival washings (the 3rd subculture) and one that had been recultured after 79 transfers and then stored for 8 months at -20°C. were used. The B strain was obtained from a naturally infected mouse, one of a group sent to us for examination from the Brookhaven National Laboratory. The 2nd culture transfer was employed.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'In the presence of active MHV(C) 2 cerebral passages were made in Swiss weanlings with each of the 2 P strain cultures and 10 passages with the B strain. A single passage was also made with the latter culture in the absence of virus.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'On combination with MHV(C) the activity of the P strain in the brain was essentially the same as that of the catarrhal types. The subculture of the transplant that had been transferred 79 times and then stored in a frozen state was fully as active as the recently isolated one. The first experiments with the B strain showed evidence of an accelerated lethal outcome which was substantiated by subsequent passages. Outward signs of illness were also more con-spicuous with this strain. In other respects its behavior resembled that of the P strain. In the absence of virus the organisms survived in the brain for 2 weeks but produced no demonstrable reaction.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Twelve of the 20 mice used in the 2 experiments with the P strain died on the 3rd to the 5th day after injection. Prior to death they showed external signs of illness. One animal tended to roll. Eight mice were killed and autopsied on the 3rd or 4th day. Their livers were spotted with surface areas of focal necrosis. Leukocytes were regularly present in the brains and numerous colonies of PPLO were obtained on culture.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Deaths in the passage series with the B strain began a day earlier, 15 of the 50 mice dying on the 2nd day after injection. Signs of acute illness were observed in many of the survivors at this time. Fourteen additional deaths occurred between the 3rd and the 5th day. Leukocytes were invariably seen in films or sections from the 21 mice that were killed for autopsy. All of the brain cultures yielded many colonies of PPLO. Two of these mice were hydrocephalic, one showed circling movements, and 5 displayed a tendency to roll.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Earlier observations on the behavior of MHV(C) in different strains of mice had indicated that the virus alone was commonly inactive on intraperitoneal or intracerebral injection in Princeton weanlings (1) . As an extension of the present findings on the behavior of MHV(C) and PPLO in the brains of Swiss mice a group of experiments was carried out in Princeton mice to determine whether or not either agent was influenced by the presence of the other.', 'cite_spans': [{'start': 202, 'end': 205, 'text': '(1)', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'In a preliminary experiment 5 Princeton weanlings were injected intracerebrally with a brain suspension containing only the virus. These mice showed no outward signs of illness and when killed on the 7th day were strictly normal. Leukocytes were not demonstrable in brain films or sections and cultures were bacteriologically sterile.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Ten mice were then injected intracerebrally with a mixture of the virus and the S strain of catarrhal PPLO. A similar number received the virus and the J strain of the organisms. The 20 mice, in the 2 groups, were unaffected by the inoculum. When killed on the 7th day the livers were free from focal lesions and the brains showed no indication of leukocytic infiltration. On culture, brain suspensions prepared from each of the 2 groups yielded a sparse growth of PPLO colonies.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'The highly virulent Princeton type of mouse hepatitis virus, MHV(Pr), is pathogenic for Princeton weanlings on intracerebral injection (1). Cerebral multiplication of the virus is not attended, however, by outward signs of nervous disorder and at autopsy there is little evidence of cellular injury in the brain. Carriage of the virus from the brain to the liver commonly occurs and is followed by the customary necrosis. The hepatic reaction is generally fatal.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'Swiss weanlings are naturally resistant to MHV(Pr). The virus fails to multiply in the brain and is usually not recoverable by passage to susceptible Princeton mice. At autopsy the brains and livers are regularly lesion-free.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'Two additional groups of experiments were carried out to determine the cerebral response of Princeton and Swiss weanlings to MHV(Pr) in combination with PPLO.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'Five cerebral passages were made in a total of 25 Princeton mice with a mixture of MHV(Pr) and the J strain of PPLO. Fifteen deaths were recorded as follows: 1 on the 2nd day, 10 on the 3rd, 3 on the 4th, and 1 on the 5th. Ten mice were killed and autopsied, most of them on the 3rd day. Prior to death they appeared acutely ill but were free from outward signs of nervous disorder. The livers of these mice showed focal or semidiffuse necrosis. Leukocytes were observed in brain films and massive areas of leukocytic infiltration in sections. Innumerable colonies of PPLO were obtained on culture.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'Twenty Swiss weanlings were injected intracerebrally with a mixture of MHV(Pr) and PPLO, 10 receiving the J strain and 10 the S strain. There were no deaths. All of the mice gained weight normally and showed no outward signs of illness when killed on the 7th or the 10th day. At autopsy the livers were normal. Leukocytes were not observed in either films or sections from the brains. Eight of 10 brain cultures yielded a few discrete colonies of PPLO and 2 were without growth.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'A group of experiments was carried out in Princeton and Swiss weaniings to determine the effect of agar on the growth and activity of PPLO in the brain. Findlay et al. (4) had reported that cultures of PPLO which failed to produce rolling signs on intracerebral injection did so in some mice on the addition of agar.', 'cite_spans': [{'start': 168, 'end': 171, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'The J strain of PPLO was used in all of these tests. Heart infusion agar (pH 8) was liquefied, cooled to 40°C., and diluted 1 to 5 with saline, The undiluted medium contained 1.5 per cent agar and was used as routine in the isolation of PPLO. The diluted semisolid agar was mixed with an equal volume of young PPLO cultures in 20 per cent horse serum-bouillon. Twenty-four weanlings of each mouse strain were injected intracerebrally with this inoculum. One series of 3 cerebral passages was made in Princeton mice, starting with a brain suspension from 2 animals injected with the PPLO-agar mixture. Finally, as a control on the activity of the medium, mice of both strains were injected with a sterile mixture of agar and horse serum-bouillon.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'Six of the 48 mice used in the first group of experiments died on the 7th to the 19th day after injection. The survivors were killed and autopsied at in-tervals of 1 and 3 weeks. All of the mice, including those that died, gained weight normally and were free from any outward signs of nervous disorder. Thirteen of the 21 Princeton mice that were killed and 6 of the Swiss showed leukocytes in either films or sections of the brain and a good growth of PPLO on culture. In the absence of an inflammatory reaction the growth was meagre.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'As Findlay et al. (4) had previously noted in their experiments, a significant number of the mice were frankly hydrocephalic. Twelve Princeton weanlings and 10 Swiss showed free fluid in the cranial cavity, accompanied in some instances by a marked elevation of the skull and circumscribed sunken areas in the anterior portion of one or both hemispheres. The brain usually appeared paler than normal.', 'cite_spans': [{'start': 18, 'end': 21, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'All of the 18 mice in the passage series survived and were normal in appearance through the 14th day when they were killed. At autopsy leukocytes were not observed in brain films or sections and only a meagre growth of PPLO was obtained on culture. In the first passage, however, 3 of the mice were hydrocephalic. Their skulls were not elevated but the cranial cavities contained free fluid and areas of collapse were present in one or both hemispheres.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'Two of the 6 Princeton mice injected with the sterile mixture of agar and horse serum-bouillon died. The 10 survivors in both groups showed no outward signs of nervous disorder and were killed on the 21st day. The skulls of 2 Princeton mice were elevated and free fluid was present in the cranial cavities. Four of the Swiss mice were also hydrocephalic, though their skulls were not elevated. Films and sections from the brains of these mice showed no leukocytes and cultures were bacteriologically sterile.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'Brain sections from the mice injected with the fluid cultures of PPLO alone were essentially normal. A few lymphocytes were occasionally observed but leukocytes were regularly absent. In some sections the ventricles were somewhat dilated.', 'cite_spans': [], 'ref_spans': [], 'section': 'Histological Examination of the Brains'}, {'text': 'Sections of the cerebrum from the mice injected with a mixture of virus with neurotropic activity and PPLO invariably showed an inflammatory reaction with a preponderance of leukocytes. The most common lesion was a roughly semicircular band composed largely of leukocytes, a few lymphocytes, much necrotic debris, red blood cells, and fibrin (Figs. 1 and 2). It partially enclosed the ventricular spaces and the intermeshing horns of the bilateral ganglia. Large mononuclear cells packed with fat vacuoles (gitter cells) and droplets of free fat were generally observed at its margin. The nerve cells of the adjacent ganglia often showed necrosis with deep blue pyknotic nuclei and pink staining debris. In a few sections the reaction was limited to one or more sharply demarcated abscesses. Dilation of the ventricles sometimes occurred but was not a characteristic finding. Leukocytie involvement of the meninges was observed but was rarely conspicuous. Leukocytes also invaded the cerebellum but much less frequently. A few sections showed degeneration of nerve cells particularly those in the granular layer (Fig. 5) . It was not consistent, however~ in respect to the appearance of rolling signs prior to autopsy.', 'cite_spans': [], 'ref_spans': [{'start': 1112, 'end': 1120, 'text': '(Fig. 5)', 'ref_id': None}], 'section': 'Histological Examination of the Brains'}, {'text': 'Brain sections from the mice injected with the agar-PPLO mixture showed 2 types of cellular response. In the presence of actively growing PPLO there was a marked inflammatory reaction which was commonly circumscribed (Fig. 4) . Leukocytes predominated but lymphocytes and large mononuclear cells, with and without fat droplets, were also present. There was much necrotic debris. In some mice there was definite evidence of encapsulation by connective tissue. Necrosis of nerve cells in the nearby ganglia was generally not observed. Portions of the meninges, particularly in the cerebellum, were distended by an infiltration of leukocytes and lymphocytes. Some of the sections also showed widely dilated ventricles.', 'cite_spans': [], 'ref_spans': [{'start': 217, 'end': 225, 'text': '(Fig. 4)', 'ref_id': None}], 'section': 'Histological Examination of the Brains'}, {'text': 'In the absence of actively growing PPLO there was commonly a lymphocytic infiltration together with hydrocephalus. With no or low magnification the ground substance of the brain was separated symmetrically by unstained open spaces (Fig. 3) . Microscopically the central and lateral ventricles were greatly dilated and often extended beyond the limits of the ependymal cell layer. In some instances this layer had broken away from the margin of the cavity. Rupture of the distended ventricles, possibly at autopsy, with release of the fluid may account for the areas of collapse observed in the intact brain. Lymphocytes and large mononuclear cells were usually present within and around the margin of the ventricles and also in the meninges. Leukocytes were absent. The nerve ceils of the ganglia were intact and appeared normal. Sections from some of the mice injected with the sterile mixture of agar and horse serum-bouillon showed a similar distension of the ventricles but little or no cellular reaction.', 'cite_spans': [], 'ref_spans': [{'start': 231, 'end': 239, 'text': '(Fig. 3)', 'ref_id': None}], 'section': 'Histological Examination of the Brains'}, {'text': 'In naturally infected mice the sites most often frequented by PPLO are the nasal passages and the middle ears. Localization in the lungs, conjunctivae, and joints also occurs but is more sporadic. The present findings together with the earlier ones of Sabin (2, 3) and of Findlay et al. (4) indicate that PPLO may occasionally invade the central nervous system.', 'cite_spans': [{'start': 287, 'end': 290, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'It is not surprising that PPLO have been recovered in a few instances from the brains of supposedly normal mice. The first isolate that we obtained was an organism of the catarrhal type which is widely distributed in nature. This type is enzootic in the Swiss colony, from which our mice were obtained, but is not present in the Princeton colony. In diseased mice the organisms occasionally migrate inwardly from the tympanic cavity to the labyrinth. A small local abscess that impinges on the brain may be produced and provide access to the meninges. Carriage via the circulating blood is also a possibility and would account for the transport of the conjunctival type which ordinarily does not invade the middle ear.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"The normal mouse brain evidently fails to provide optimal conditions for the growth of most PPLO. Sabin's type A organism (5) which produces an extotoxin is an outstanding exception. On cranial injection the organisms that we studied survived in the brain for a period of weeks. The level of growth was barely sufficient, however, to maintain them by serial passage and too low to provoke a counter-reaction. Growth was markedly increased by the simultaneous injection of mouse hepatitis virus and was attended by a vigorous leukocytic response. There was no indication of specificity in relation to the type of PPLO, as earlier reported by Findlay et al. (4) . Multiplication of the virus in the brain was a prerequisite but encephalitis was not essential. AI-though direct proof is lacking, it is tempting to attribute the growth enhancement to fatty substances liberated in the brain by the virus. Edward (7) and Smith, Lecce, and Lynn (8) have presented evidence that lipoids, probably lipoproteins, are generally needed for the growth of PPLO in vitro.\", 'cite_spans': [{'start': 656, 'end': 659, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Rolling occurred so infrequently in mice injected with the mixture of MHV and PPLO that it could hardly be called a characteristic sign. It was also observed in an occasional mouse injected with MHV(C) alone. This virus was productive of considerable injury to the brain but rarely affected the nerve cells of the cerebral ganglia. In the absence of the virus or agar PPLO showed little or no evidence of neurotropism. The intracerebral injection of both microbic agents commonly resulted, however, in extensive destruction of the nerve cells in the anterior horns of the cerebrum. This outcome was indicative of an interaction between the 2 agents and suggestive of synergism.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Our findings in regard to the effect of agar on the cerebral behavior of PPLO in mice agreed with the earlier observations of Findlay et al. (4) as to its enhancing properties but differed from theirs in detail. In our experiments none of the mice injected with the agar-PPLO mixture showed any outward signs of nervous disorder. In Swiss mice there was a marked difference between agar and MHV(C) in respect to the number of individuals with an increased growth of PPLO and a leukocytic response at autopsy. The actual rates were about 30 per cent with agar and practically 100 per cent with the virus. Princeton mice were more responsive, the rate with agar being 60 per cent. The present observations suggest that hydrocephalus which frequently appeared in the injected mice was in part a response to the agar as the same condition also followed the injection of a sterile agar inoculum. SUMMARY Pleuropneumonia-like organisms (PPLO) of the catarrhal type were isolated from the brain of a Swiss mouse during the cranial passage of mouse hepatitis virus-MHV(C). Cranial injection of the PPLO alone in Swiss and Princeton weanlings was attended by a meagre growth of the organisms in the brain, with no pathologic change.', 'cite_spans': [{'start': 141, 'end': 144, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The growth of both catarrhal and conjunctival strains of PPLO in the brains of Swiss mice was greatly enhanced by the simultaneous injection of MHV(C). Rolling was not a characteristic sign prior to autopsy. Brain sections regularly showed a vigorous leukocytic response, commonly accompanied by the destruction of nerve cells in the anterior horns of the cerebrum. Injected in Princeton mice together with the virus, the organisms barely survived and were inactive. MHV(Pr) enhanced the growth and pathogenicity of PPLO in the brains of Princeton mice but failed to do so in Swiss.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The behavior of PPLO in the brain was likewise affected by the presence of agar, as earlier observed by Findlay et al. In comparison with the effect of MHV, the enhancement was reduced in rate in both strains of mice and was not accompanied by outward signs of nervous disorder. Hydrocephalus which often followed injection of the PPLO-agar mixture was also produced by agarbouillon alone.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'All of the following cross-sections of the brain were stained with eosin-rnethyl ene blue. They were photographed by Mr. J. A. Carlile. ', 'cite_spans': [], 'ref_spans': [], 'section': 'BIBLIOGRAPHY EXPLANATION OF PLATE 13'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Acute hepatitis associated with mouse leukemia. V. The neurotropic properties of the causal virus', 'authors': [{'first': 'J', 'middle': ['B'], 'last': 'Nelson', 'suffix': ''}], 'year': 1955, 'venue': 'J. Exp. Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Isolation of a filtrable, transmissible agent with \"neurolytic\" properties from toxoplasma-infected tissues', 'authors': [{'first': 'A', 'middle': ['B'], 'last': 'Sabin', 'suffix': ''}], 'year': 1938, 'venue': 'Science', 'volume': '88', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Identification of the filtrable, transmissible neurolytic agent isolated from toxoplasma-infected tissue as a new pleuropneumonia-like microbe', 'authors': [{'first': 'A', 'middle': ['B'], 'last': 'Sabin', 'suffix': ''}], 'year': 1938, 'venue': 'Science', 'volume': '88', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Rolling disease', 'authors': [{'first': 'G', 'middle': ['M'], 'last': 'Findlay', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Klieneberger', 'suffix': ''}, {'first': 'F', 'middle': ['O'], 'last': 'Maccallum', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Mackenzie', 'suffix': ''}], 'year': None, 'venue': 'Lancet', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'The filtrable micro~rganisms of the pleuropneumonia group', 'authors': [{'first': 'A', 'middle': ['B'], 'last': 'Sabin', 'suffix': ''}], 'year': 1941, 'venue': 'Baa. Rev', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Association of a special strain of pleuropneumonia-like organisms with conjunctivitis in a mouse colony', 'authors': [{'first': 'J', 'middle': ['B'], 'last': 'Nelson', 'suffix': ''}], 'year': 1950, 'venue': 'J. Exp. Meal', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Cholesterol in the growth of organisms of the pleuropneumonia group', 'authors': [{'first': 'D', 'middle': ['F'], 'last': 'Edward', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Fitzgerald', 'suffix': ''}], 'year': 1951, 'venue': 'J. Gen. Microbiol', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'A lipoprotein as a growth factor for certain pleuropneumonialike organisms', 'authors': [{'first': 'P', 'middle': ['F'], 'last': 'Smith', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Lecce', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Lynn', 'suffix': ''}], 'year': 1954, 'venue': 'J. Bact', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'FIG. |. The cerebral reaction in a mouse injected with MHV(C) and PPLO. The intermeshed horns of the ganglia are partially enclosed by massive areas of leukocytic infiltration, showing as double bands. X 6.3. FIG. 2. A higher magnification of the same section. The outer horn of the ganglion showed marked nerve cell destruction which is not well brought out by the black and white print. There was no ventricular distension. X 20.5. FIG. 3. Hydrocephalic reaction in cerebrum of a mouse injected with PPLO and agar. The ground substance was compressed and displaced by the greatly distended ventricles. Lymphocytes were scattered throughout these spaces but leukocytes were absent. X 6.3. FIG. 4. Inflammatory reaction in cerebrum of a mouse injected with PPLO and agar. The circumscribed area between the bilateral horns contained both lymphocytes and mononuclear cells, as well as leukocytes. There was no destruction of nerve cells in the ganglia. X 20.5. FIG. 5. Cerebellar reaction in a mouse injected with MHV(C) and the B strain of PPLO. This mouse was a \"roller.\" In the central portion there was practically complete destruction of nerve cells. Along the outer margin of this area was a band of migratory cells, chiefly leukocytes. )< 20.5.', 'latex': None, 'type': 'figure'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715ef1dcdfc57ca7805b4'), 'paper_id': '0a1f43c04e0e22fb6efbd94611920bc9680d7ae3', 'metadata': {'title': 'TNF-α − 308 G N A and IFN-γ + 874 A N T gene polymorphisms in Egyptian patients with lupus erythematosus', 'authors': [{'first': 'Wfaa', 'middle': [], 'last': 'Al-Kholy', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mansoura University', 'location': {'country': 'Egypt'}}, 'email': ''}, {'first': 'Afaf', 'middle': [], 'last': 'Elsaid', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mansoura University', 'location': {'country': 'Egypt'}}, 'email': ''}, {'first': 'Aml', 'middle': [], 'last': 'Sleem', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mansoura University', 'location': {'country': 'Egypt'}}, 'email': ''}, {'first': 'Hend', 'middle': [], 'last': 'Fathy', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mansoura University', 'location': {'country': 'Egypt'}}, 'email': ''}, {'first': 'Rami', 'middle': [], 'last': 'Elshazli', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Tanta University', 'location': {'country': 'Egypt'}}, 'email': ''}, {'first': 'Ahmad', 'middle': [], 'last': 'Settin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mansoura University', 'location': {'country': 'Egypt'}}, 'email': ''}]}, 'abstract': [{'text': 'Background: Systemic lupus erythematosus (SLE) is associated with immunogenetic factors. This study was planned to test for the association of TNF-α − 308 and IFN-γ +874 gene polymorphisms with susceptibility and severity of SLE in Egyptian cases. Subjects and methods: This is a case controlled study including 125 Egyptian cases with SLE in addition to 112 healthy unrelated individuals from the same locality. For all participants, TNF-α − 308 G NA and IFN-γ + 874 ANT genetic polymorphisms were characterized using the PCR technique. Results: Cases with SLE showed a significantly higher TNF-α −308 A allele carriage rate (AA + GA genotypes) compared to controls (26.4% vs. 12.5%, p = 0.009, OR = 2.51, 95% CI = 1.26-4.99). These cases showed also a significantly higher carriage rate for the IFN-γ +874 T allele (AT + TT genotypes) compared to controls (47.2% vs. 32.1%, p = 0.02, OR = 1.89, 95% CI = 1.11-3.21). Comparing age, gender, and disease severity presented by nephritis class, activity and chronicity indices in cases carrying the TNF-α −308 A allele and in cases carrying IFN-γ +874 T allele versus others showed no significant difference (p N 0.05). Conclusions: TNF-α −308 A and IFN-γ +874 T allele carriage are associated with susceptibility but not severity of SLE in Egyptian subjects.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Systemic lupus erythematosus (SLE) is the prototypic autoimmune complex disease which is characterized by excessive production of autoantibodies against a broad range of self-antigens (Gurevitz et al., 2013) . Vital organs and tissues are often implicated, including kidney, brain, cardiovascular, joint and skin (Sánchez et al., 2006) . One of its most severe manifestations is lupus nephritis (LN), which remains a cause of substantial morbidity and mortality, either secondary to kidney disease, or as a result of intense immunosuppressive drug toxicity (Sestak et al., 2007; Hiraki et al., 2012; Pons-Estel et al., 2011) . Genes most likely contribute to the development of lupus have been identified particularly of the major histocompatibility complex (MHC) types HLA-A1, B8, and DR3 (Wakeland et al., 2001; Walport et al., 1982) . In addition, there is a strong evidence supporting the role of cytokine genes in the pathogenesis of SLE (Lin et al., 2009 ). One of the major cytokines that has been intensely investigated is the tumor necrosis factor alpha (TNF-α), an important pro-inflammatory cytokine that plays an important role in the inflammatory and immune responses (Aggarwal et al., 2012) . High serum levels of TNF-α have been reported in SLE that correlated well with the renal inflammatory activity (Studnicka-Benke et al., 1996; Aringer et al., 2002; Maury and Teppo, 1989; Postal and Appenzeller, 2011) . Effects of TNF-α were found to be related to activation of a cascade of inflammatory events, enhancing expression of adhesion molecules, activation of neutrophils in addition to acting as a costimulator for T cell activation and antibody production (Serrano et al., 2006) . The single-nucleotide polymorphism (SNP) TNFα −308 GN A (rs1800629) is located on chromosome 6p21.3, within the class III region of MHC. The TNF-α −308 A allele has been reported to be a stronger transcriptional activator in vitro than the common G allele. Therefore, the A allele frequency has been associated with the risk of autoimmune disorders (Zou et al., 2011; Santos et al., 2012) .', 'cite_spans': [{'start': 184, 'end': 207, 'text': '(Gurevitz et al., 2013)', 'ref_id': 'BIBREF13'}, {'start': 313, 'end': 335, 'text': '(Sánchez et al., 2006)', 'ref_id': 'BIBREF29'}, {'start': 557, 'end': 578, 'text': '(Sestak et al., 2007;', 'ref_id': 'BIBREF32'}, {'start': 579, 'end': 599, 'text': 'Hiraki et al., 2012;', 'ref_id': 'BIBREF14'}, {'start': 600, 'end': 624, 'text': 'Pons-Estel et al., 2011)', 'ref_id': 'BIBREF26'}, {'start': 790, 'end': 813, 'text': '(Wakeland et al., 2001;', 'ref_id': 'BIBREF43'}, {'start': 814, 'end': 835, 'text': 'Walport et al., 1982)', 'ref_id': 'BIBREF44'}, {'start': 943, 'end': 960, 'text': '(Lin et al., 2009', 'ref_id': 'BIBREF19'}, {'start': 1181, 'end': 1204, 'text': '(Aggarwal et al., 2012)', 'ref_id': 'BIBREF0'}, {'start': 1318, 'end': 1348, 'text': '(Studnicka-Benke et al., 1996;', 'ref_id': 'BIBREF34'}, {'start': 1349, 'end': 1370, 'text': 'Aringer et al., 2002;', 'ref_id': 'BIBREF3'}, {'start': 1371, 'end': 1393, 'text': 'Maury and Teppo, 1989;', 'ref_id': 'BIBREF21'}, {'start': 1394, 'end': 1423, 'text': 'Postal and Appenzeller, 2011)', 'ref_id': 'BIBREF27'}, {'start': 1675, 'end': 1697, 'text': '(Serrano et al., 2006)', 'ref_id': 'BIBREF31'}, {'start': 2049, 'end': 2067, 'text': '(Zou et al., 2011;', 'ref_id': 'BIBREF46'}, {'start': 2068, 'end': 2088, 'text': 'Santos et al., 2012)', 'ref_id': 'BIBREF30'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Interferon-gamma (IFN-γ) is one of the main cytokines secreted by activated T lymphocytes and has antiproliferative, antiviral and immunomodulatory activities as it controls the development of T helper 1 (Th1) cells (Silva et al., 1992; Torrico et al., 1991) . Several studies have indicated that expression of the IFN-γ level has significant effects into the susceptibility of various autoimmune diseases. There is a report showing significant increasing IFN-γ messenger ribonucleic acid expression in peripheral blood mononuclear cells of patients with SLE that might trigger inflammatory responses (Baccala et al., 2005; Meta Gene 9 (2016) ', 'cite_spans': [{'start': 216, 'end': 236, 'text': '(Silva et al., 1992;', 'ref_id': 'BIBREF33'}, {'start': 237, 'end': 258, 'text': 'Torrico et al., 1991)', 'ref_id': 'BIBREF41'}, {'start': 601, 'end': 623, 'text': '(Baccala et al., 2005;', 'ref_id': 'BIBREF4'}, {'start': 624, 'end': 642, 'text': 'Meta Gene 9 (2016)', 'ref_id': None}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Meta Gene j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / m g e n e Csiszár et al., 2000) . The human IFN-γ gene located on chromosome 12q24.1 has a SNP in the first intron at its 5′ end, adjacent to a CA repeat region (+ 874 A NT, rs2430561) which was known to influence the secretion of IFN-γ and had been implicated in numerous autoimmune and chronic inflammatory conditions (Chong et al., 2006; Pravica et al., 2000) . Analysis of the biological role of this SNP suggested that + 874 T allele carriers showed higher production of IFN-γ (Pravica et al., 2000; López-Maderuelo et al., 2003) . The aim of this study is to investigate the association between TNF-α − 308 G N A and IFN-γ + 874 A NT gene polymorphisms with the SLE susceptibility and severity among Egyptian subjects.', 'cite_spans': [{'start': 100, 'end': 121, 'text': 'Csiszár et al., 2000)', 'ref_id': 'BIBREF8'}, {'start': 410, 'end': 430, 'text': '(Chong et al., 2006;', 'ref_id': 'BIBREF7'}, {'start': 431, 'end': 452, 'text': 'Pravica et al., 2000)', 'ref_id': 'BIBREF28'}, {'start': 572, 'end': 594, 'text': '(Pravica et al., 2000;', 'ref_id': 'BIBREF28'}, {'start': 595, 'end': 624, 'text': 'López-Maderuelo et al., 2003)', 'ref_id': 'BIBREF20'}], 'ref_spans': [], 'section': 'Contents lists available at ScienceDirect'}, {'text': 'This is a case controlled study involving 125 adult patients with SLE all suffering from LN (72 females and 53 males, age mean ± SD = 23.4 ± 4.4 years) and 112 healthy unrelated subjects (46 males and 66 females, age mean ± SD = 28.3 ± 6.2 years). Patients were recruited from the Urology and Nephrology Center, Mansoura University, Egypt. The diagnosis of SLE in patients was according to the American College of Rheumatology (1982) revised criteria for SLE (Tan et al., 1982) . Assessment of the severity of SLE was based upon the classification of LN (Weening et al., 2004) where class I: normal glomeruli (0 cases), class II: purely mesangial disease (8 cases), class III: focal proliferative glomerulonephritis (25 cases), class IV: diffuse proliferative glomerulonephritis (88 cases), and class V: membranous glomerulonephritis (4 cases). The study was approved by the ethical and scientific committees of Mansoura University. An informed consent was also obtained from all participants before the start of the study.', 'cite_spans': [{'start': 459, 'end': 477, 'text': '(Tan et al., 1982)', 'ref_id': 'BIBREF37'}, {'start': 554, 'end': 576, 'text': '(Weening et al., 2004)', 'ref_id': 'BIBREF45'}], 'ref_spans': [], 'section': 'Subjects and methods'}, {'text': 'For all participants, genomic DNA from a peripheral blood was extracted and purified using the kit provided by Gentra Systems, USA. Typing of the TNF-α − 308 G NA (rs1800629) SNP and IFN-γ + 874 ANT (rs2430561) were performed using the polymerase chain reaction with amplification refractory mutation system (PCR-ARMS) as described by Perrey et al. (Perrey et al., 1999) and Pravica et al. (Pravica et al., 2000) respectively. The PCR amplification was carried out using Veriti® thermal cycler (Applied Biosystems, USA) in a 20 μl total volume containing about 100 ng of genomic DNA template, 2 pM of each primer, 2 mM of each dNTP, 1.5 mM of MgCl 2 , 1 × PCR buffer and 0.6 U of Taq DNA polymerase. TNF-α Primer sequences were as follows: TNF-α G forward primer: 5′-ATA GGT TTT GAG GGG CAT GG-3′; TNF-α A forward primer: 5′-AATA GGT TTT GAG GGG CAT GA-3′; and reverse primer, 5′-TCT CGG TTT CTT CTC CAT CG-3′. Reaction conditions were carried out in a thermocycler at 95°C for 1 min followed by 10 cycles of 95°C for 15 s, 65°C for 50 s, and 72°C for 40 s and then 20 cycles of 95°C for 20 s, 56°C for 50 s, and 72°C for 50 s. On the other hand, primer sequences for INF-γ were as follows: reverse primer: 5′-TCA ACA AAG CTG ATA CTC CA-3′, INF-γ A forward primer: 5′-TTC TTA CAA CAC AAA ATC AAA TCA-3′, INF-γ T forward primer: 5′-TTC TTA CAA CAC AAA ATC AAA TCT-3′. The PCR conditions consisted of an initial denaturation step at 95°C for 2 min, 10 cycles of incubation at 95°C for 15 s, 62°C for 50 s and 72°C for 40 s, followed by 20 cycles of incubation at 95°C for 20 s, 56°C for 50 s and 72°C for 50 s, with a final extension at 72°C for 5 min. The amplified PCR products were analyzed by 2% agarose gel and ethidium bromide staining followed by ultraviolet visualization. The PCR product for TNF-α − 308 was detected at 184 bp ( Fig. 1) while that of IFN-γ + 874 was detected at 263 bp (Fig. 2) .', 'cite_spans': [{'start': 349, 'end': 370, 'text': '(Perrey et al., 1999)', 'ref_id': 'BIBREF25'}, {'start': 390, 'end': 412, 'text': '(Pravica et al., 2000)', 'ref_id': 'BIBREF28'}], 'ref_spans': [{'start': 1836, 'end': 1843, 'text': 'Fig. 1)', 'ref_id': 'FIGREF0'}, {'start': 1893, 'end': 1901, 'text': '(Fig. 2)', 'ref_id': 'FIGREF1'}], 'section': 'DNA extraction, purification and amplification'}, {'text': \"Data were analyzed using the statistical package of social science (SPSS, version 17.0) software program. The frequencies of studied genotypic and allelic polymorphisms among cases were compared to those of controls using Fisher's exact test and odds ratio (OR) with the 95% confidence interval (95% CI). For statistical analysis, the significance of clinical parameters related to age, gender, SLE classes, severity index and chronicity index was determined by Fisher's exact test. Conformity with the Hardy Weinberg law of genetic equilibrium was tested by Chi square test comparing the observed versus expected genotype frequencies in both groups of cases and controls. A minimum level of statistical significance was considered at a p level of b0.05.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Statistical analysis'}, {'text': 'Cases with SLE showed a significantly higher TNF-α −308 (GA + AA genotypes) compared to controls (26.4% vs. 12.5%, p = 0.009, OR = 2.51, 95% CI = 1.26-4.99) (Table 1) . Similarly, cases showed a significantly higher carriage rate for the IFNG-γ + 874 (AT + TT genotypes) compared to controls (47.2% vs. 32.1%, p = 0.02, OR = 1.89, 95% CI = 1.11-3.21) ( Table 2) . This was mainly due to the higher frequency of the heterozygous TNF-α GA and INF-γ AT genotypes, consistent with the dominant mode of inheritance. On other hand, comparing the homozygous genotype frequency between cases and control (recessive model) did not yield any significant difference. The frequencies of TNF-α and IFN-γ genotypes were in agreement with Hardy-Weinberg equilibrium in both groups of SLE cases and controls (p N 0.05) (Tables 1 and 2). Cases of TNF-α GA + AA genotypes vs. those with the GG genotype (1 and 2) represent genotype GA, lanes (3 and 4) represent genotype GA, lanes (5 and 6) represent genotype GA, lanes (7 and 8) represent genotype GA, lanes (9 and 10) represent genotype GA, TNF-α −308 GNA was detected at 184 bp. and those having the INF-γ AT + TT genotypes vs. those with the AA genotype revealed no significant difference regarding their age, gender and nephritis class, activity and chronicity indices (p N 0.05) ( Table 3) .', 'cite_spans': [], 'ref_spans': [{'start': 157, 'end': 166, 'text': '(Table 1)', 'ref_id': 'TABREF1'}, {'start': 353, 'end': 361, 'text': 'Table 2)', 'ref_id': 'TABREF2'}, {'start': 885, 'end': 894, 'text': '(1 and 2)', 'ref_id': 'FIGREF0'}, {'start': 1319, 'end': 1327, 'text': 'Table 3)', 'ref_id': None}], 'section': 'Results'}, {'text': 'This study tested the association of two important gene polymorphisms with SLE presenting mainly with nephritis. It showed clearly IFN-γ + 874 T and TNF-α − 308 A alleles are risk alleles for SLE in Egyptian subjects although apparently not affecting the clinical severity of the disease. In another study done among Egyptian SLE patients recruited from Upper Egypt, Ahmed et al. have found a high frequency of the TNF-α −308 A allele in the SLE patients but not in patients with nephritis (Ahmed et al., 2014) .', 'cite_spans': [{'start': 490, 'end': 510, 'text': '(Ahmed et al., 2014)', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Recent meta-analysis has shown also that individuals carrying TNF-α −308 A risk allele were significantly associated with SLE in European, South American and Mexican subjects but was not associated with SLE in Asian and African subjects (Pan et al., 2012) . Similar conclusion regarding the association of TNF-α − 308 A allele was also found among Brazilian (Angelo et al., 2012) , Colombian (Guarnizo-Zuccardi et al., 2007) , Mexican (Jiménez-Morales et al., 2009) , North American (Parks et al., 2004) , Spanish (Suárez et al., 2005) , Asian (Lin et al., 2009) and Caucasian (van der Linden et al., 2001) patients. This might be explained by the fact that TNF-α is a pro-inflammatory cytokine involved in different immune-regulated diseases including autoimmune, infectious, and malignant ones (Lee et al., 2006) .', 'cite_spans': [{'start': 237, 'end': 255, 'text': '(Pan et al., 2012)', 'ref_id': 'BIBREF23'}, {'start': 358, 'end': 379, 'text': '(Angelo et al., 2012)', 'ref_id': 'BIBREF2'}, {'start': 392, 'end': 424, 'text': '(Guarnizo-Zuccardi et al., 2007)', 'ref_id': 'BIBREF12'}, {'start': 435, 'end': 465, 'text': '(Jiménez-Morales et al., 2009)', 'ref_id': 'BIBREF16'}, {'start': 483, 'end': 503, 'text': '(Parks et al., 2004)', 'ref_id': 'BIBREF24'}, {'start': 514, 'end': 535, 'text': '(Suárez et al., 2005)', 'ref_id': 'BIBREF35'}, {'start': 544, 'end': 566, 'text': '(Lin et al., 2009) and', 'ref_id': 'BIBREF19'}, {'start': 567, 'end': 606, 'text': 'Caucasian (van der Linden et al., 2001)', 'ref_id': None}, {'start': 796, 'end': 814, 'text': '(Lee et al., 2006)', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': \"Regarding the other polymorphism, we could find that a few number of articles were done to analyze the relationship between the IFN-γ +874 ANT SNP and susceptibility to SLE. For instance, Kim et al. found an association between the + 874 A N T IFN-γ polymorphism and SLE patients in Korean patients (Kim et al., 2010) . This might be also explained by the fact that IFN-γ is an important cytokine produced in response to inflammatory stimuli to regulate the human immune response. It was believed that the pathogenesis of SLE involves the over-production of IFN-γ (Bennett et al., 2003) . It has been postulated that genetic polymorphisms affecting cytokine transcription exist in the regulatory regions of pro-inflammatory cytokine genes, and that such polymorphisms may control the level of inflammation (Baechler et al., 2003) . In addition, the positive association was found between the amino acid polymorphism (Val14Met) within the IFN-γ receptor 1 gene and SLE. Several studies have indicated that alterable expression of the IFN-γ level has significant effects to the susceptibility of various autoimmune diseases, particularly in SLE (Csiszár et al., 2000; Tanaka et al., 1999) . Nonetheless, other studies found contradictory results of no association of TNF-α − 308 G NA polymorphism with SLE among Argentinean (Muñoz et al., 2014) , Mexican (Zúñiga et al., 2001) , Japanese (Takeuchi et al., 2005) , Colombian (Tobón et al., 2005) , African Americans (Parks et al., 2004 ), Italian (D'Alfonso et al., 1996 , Chinese (Fong et al., 1996) , Thai and Portuguese (Santos et al., 2012) patients. In spite of the above evidence, we have encountered two studies stating a non-association of IFN-γ +874 T allele and SLE among Thai and Brazilian subjects (Tangwattanachuleeporn et al., 2007; da Silva et al., 2014) . (1 and 2) represent genotype AT, lanes (3 and 4) represent genotype TT, lanes (5 and 6) represent genotype AT, lanes (7 and 8) represent genotype AT, lanes (9 and 10) represent genotype TT, lanes (11 and 12) represent genotype AT, IFN-γ +874 ANT was detected at 263 bp. ⁎ p b 0.05 = significant. ** p b 0.01 highly significant. ⁎ p b 0.05 = significant. ** p b 0.01 highly significant.\", 'cite_spans': [{'start': 188, 'end': 198, 'text': 'Kim et al.', 'ref_id': None}, {'start': 299, 'end': 317, 'text': '(Kim et al., 2010)', 'ref_id': 'BIBREF17'}, {'start': 564, 'end': 586, 'text': '(Bennett et al., 2003)', 'ref_id': 'BIBREF6'}, {'start': 806, 'end': 829, 'text': '(Baechler et al., 2003)', 'ref_id': 'BIBREF5'}, {'start': 1143, 'end': 1165, 'text': '(Csiszár et al., 2000;', 'ref_id': 'BIBREF8'}, {'start': 1166, 'end': 1186, 'text': 'Tanaka et al., 1999)', 'ref_id': 'BIBREF38'}, {'start': 1322, 'end': 1342, 'text': '(Muñoz et al., 2014)', 'ref_id': 'BIBREF22'}, {'start': 1353, 'end': 1374, 'text': '(Zúñiga et al., 2001)', 'ref_id': 'BIBREF47'}, {'start': 1386, 'end': 1409, 'text': '(Takeuchi et al., 2005)', 'ref_id': 'BIBREF36'}, {'start': 1422, 'end': 1442, 'text': '(Tobón et al., 2005)', 'ref_id': 'BIBREF40'}, {'start': 1463, 'end': 1482, 'text': '(Parks et al., 2004', 'ref_id': 'BIBREF24'}, {'start': 1483, 'end': 1517, 'text': \"), Italian (D'Alfonso et al., 1996\", 'ref_id': None}, {'start': 1528, 'end': 1547, 'text': '(Fong et al., 1996)', 'ref_id': 'BIBREF11'}, {'start': 1570, 'end': 1591, 'text': '(Santos et al., 2012)', 'ref_id': 'BIBREF30'}, {'start': 1757, 'end': 1793, 'text': '(Tangwattanachuleeporn et al., 2007;', 'ref_id': 'BIBREF39'}, {'start': 1794, 'end': 1816, 'text': 'da Silva et al., 2014)', 'ref_id': 'BIBREF9'}], 'ref_spans': [{'start': 1819, 'end': 1828, 'text': '(1 and 2)', 'ref_id': 'FIGREF0'}], 'section': 'Discussion'}, {'text': 'These contradictory results might be attributed to different ethnic origins in addition to diverse genetic and epigenetic interactions with different environmental effects. The relatively small sample size might also present other limiting factor. Lastly, we can conclude that TNF-α − 308 G N A and IFN-γ +874 ANT gene polymorphisms might play a role in the susceptibility but not the severity and activity of lupus in Egyptian cases. However, taking into consideration the limiting factors, we recommend undertaking a wide-scale multicenter study into the entire genome sequence studying all cytokine gene polymorphisms and their expression status in cases of SLE.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey', 'authors': [{'first': 'B', 'middle': ['B'], 'last': 'Aggarwal', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Gupta', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Kim', 'suffix': ''}], 'year': 2012, 'venue': 'Blood', 'volume': '119', 'issn': '3', 'pages': '651--665', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Association between TNF promoter −308 GNA and LTA 252 ANG polymorphisms and systemic lupus erythematosus', 'authors': [{'first': 'H', 'middle': ['H'], 'last': 'Ahmed', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Taha', 'suffix': ''}, {'first': 'H.-S', 'middle': [], 'last': 'Darweesh', 'suffix': ''}, {'first': 'H', 'middle': ['M'], 'last': 'Morsi', 'suffix': ''}], 'year': 2014, 'venue': 'Mol. Biol. Rep', 'volume': '41', 'issn': '4', 'pages': '2029--2036', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Tumor necrosis factor alpha promoter polymorphism −308 G/A in Brazilian patients with systemic lupus erythematosus', 'authors': [{'first': 'H', 'middle': ['D'], 'last': 'Angelo', 'suffix': ''}, {'first': 'H', 'middle': ['A'], 'last': 'Da Silva', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Asano', 'suffix': ''}, {'first': 'M', 'middle': ['T'], 'last': 'Muniz', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'De Mascena Diniz', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Maia', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Pr', 'suffix': ''}], 'year': 2012, 'venue': 'Hum. Immunol', 'volume': '73', 'issn': '11', 'pages': '1166--1170', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death', 'authors': [{'first': 'M', 'middle': [], 'last': 'Aringer', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Feierl', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Steiner', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Stummvoll', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Höfler', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Steiner', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Radda', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Smole', 'suffix': ''}, {'first': 'W', 'middle': ['B'], 'last': 'Graninger', 'suffix': ''}], 'year': 2002, 'venue': 'Lupus', 'volume': '11', 'issn': '2', 'pages': '102--108', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Interferons as pathogenic effectors in autoimmunity', 'authors': [{'first': 'R', 'middle': [], 'last': 'Baccala', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Kono', 'suffix': ''}, {'first': 'A', 'middle': ['N'], 'last': 'Theofilopoulos', 'suffix': ''}], 'year': 2005, 'venue': 'Immunol. Rev', 'volume': '204', 'issn': '', 'pages': '9--26', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus', 'authors': [{'first': 'E', 'middle': ['C'], 'last': 'Baechler', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Batliwalla', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Karypis', 'suffix': ''}, {'first': 'P', 'middle': ['M'], 'last': 'Gaffney', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Ortmann', 'suffix': ''}, {'first': 'K', 'middle': ['J'], 'last': 'Espe', 'suffix': ''}, {'first': 'K', 'middle': ['B'], 'last': 'Shark', 'suffix': ''}, {'first': 'W', 'middle': ['J'], 'last': 'Grande', 'suffix': ''}, {'first': 'K', 'middle': ['M'], 'last': 'Hughes', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Kapur', 'suffix': ''}, {'first': 'P', 'middle': ['K'], 'last': 'Gregersen', 'suffix': ''}, {'first': 'T', 'middle': ['W'], 'last': 'Behrens', 'suffix': ''}], 'year': 2003, 'venue': 'Proc. Natl. Acad. Sci. U. S. A', 'volume': '100', 'issn': '5', 'pages': '2610--2615', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Interferon and granulopoiesis signatures in systemic lupus erythematosus blood', 'authors': [{'first': 'L', 'middle': [], 'last': 'Bennett', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Palucka', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Arce', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Cantrell', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Borvak', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Banchereau', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Pascual', 'suffix': ''}], 'year': 2003, 'venue': 'J. Exp. Med', 'volume': '197', 'issn': '6', 'pages': '711--723', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'The interferon gamma gene polymorphism + 874 A/T is associated with severe acute respiratory syndrome', 'authors': [{'first': 'W', 'middle': ['P'], 'last': 'Chong', 'suffix': ''}, {'first': 'W', 'middle': ['K'], 'last': 'Ip', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Tso', 'suffix': ''}, {'first': 'M', 'middle': ['W'], 'last': 'Ng', 'suffix': ''}, {'first': 'W', 'middle': ['H'], 'last': 'Wong', 'suffix': ''}, {'first': 'H', 'middle': ['K'], 'last': 'Law', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Yung', 'suffix': ''}, {'first': 'E', 'middle': ['Y'], 'last': 'Chow', 'suffix': ''}, {'first': 'K', 'middle': ['L'], 'last': 'Au', 'suffix': ''}, {'first': 'E', 'middle': ['Y'], 'last': 'Chan', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Lim', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Peiris', 'suffix': ''}, {'first': 'Y', 'middle': ['L'], 'last': 'Lau', 'suffix': ''}], 'year': 2006, 'venue': 'BMC Infect. Dis', 'volume': '6', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)', 'authors': [{'first': 'A', 'middle': [], 'last': 'Csiszár', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Nagy', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Gergely', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pozsonyi', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Pócsik', 'suffix': ''}], 'year': 2000, 'venue': 'Clin. Exp. Immunol', 'volume': '122', 'issn': '3', 'pages': '464--470', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus', 'authors': [{'first': 'H', 'middle': ['D'], 'last': 'Da Silva', 'suffix': ''}, {'first': 'A', 'middle': ['P'], 'last': 'Da Silva', 'suffix': ''}, {'first': 'H', 'middle': ['A'], 'last': 'Da Silva', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Asano', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Maia Mde', 'suffix': ''}, {'first': 'P', 'middle': ['R'], 'last': 'De Souza', 'suffix': ''}], 'year': 2014, 'venue': 'Mol. Biol. Rep', 'volume': '41', 'issn': '4', 'pages': '2493--2500', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population', 'authors': [{'first': 'S', 'middle': [], 'last': 'D&apos;alfonso', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Colombo', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Della Bella', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Scorza', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Momigliano-Richiardi', 'suffix': ''}], 'year': 1996, 'venue': 'Tissue Antigens', 'volume': '47', 'issn': '6', 'pages': '551--555', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus', 'authors': [{'first': 'K', 'middle': ['Y'], 'last': 'Fong', 'suffix': ''}, {'first': 'H', 'middle': ['S'], 'last': 'Howe', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Tin', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Boey', 'suffix': ''}, {'first': 'P', 'middle': ['H'], 'last': 'Feng', 'suffix': ''}], 'year': 1996, 'venue': 'Ann. Acad. Med. Singap', 'volume': '25', 'issn': '1', 'pages': '90--93', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus', 'authors': [{'first': 'P', 'middle': [], 'last': 'Guarnizo-Zuccardi', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Lopez', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Giraldo', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Garcia', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Rodriguez', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ramirez', 'suffix': ''}], 'year': 2007, 'venue': 'Tissue Antigens', 'volume': '70', 'issn': '', 'pages': '376--382', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Systemic lupus erythematosus: a review of the disease and treatment options', 'authors': [{'first': 'S', 'middle': ['L'], 'last': 'Gurevitz', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Snyder', 'suffix': ''}, {'first': 'E', 'middle': ['K'], 'last': 'Wessel', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Frey', 'suffix': ''}, {'first': 'B', 'middle': ['A'], 'last': 'Williamson', 'suffix': ''}], 'year': 2013, 'venue': 'Consult. Pharm', 'volume': '28', 'issn': '2', 'pages': '110--121', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population', 'authors': [{'first': 'L', 'middle': ['T'], 'last': 'Hiraki', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Feldman', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'G', 'middle': ['S'], 'last': 'Alarcón', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Fischer', 'suffix': ''}, {'first': 'W', 'middle': ['C'], 'last': 'Winkelmayer', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Costenbader', 'suffix': ''}], 'year': 2012, 'venue': 'Arthritis Rheum', 'volume': '64', 'issn': '8', 'pages': '2669--2676', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism −863, but not −308 and −238, in Thai population', 'authors': [{'first': 'N', 'middle': [], 'last': 'Hirankarn', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Avihingsanon', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Wongpiyabovorn', 'suffix': ''}], 'year': 2007, 'venue': 'Int. J. Immunogenet', 'volume': '34', 'issn': '', 'pages': '425--430', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population', 'authors': [{'first': 'S', 'middle': [], 'last': 'Jiménez-Morales', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Velázquez-Cruz', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Ramírez-Bello', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Bonilla-González', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Romero-Hidalgo', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Escamilla-Guerrero', 'suffix': ''}], 'year': 2009, 'venue': 'Hum. Immunol', 'volume': '70', 'issn': '', 'pages': '251--256', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kim', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Cho', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Sestak', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Namjou', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Kang', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Bae', 'suffix': ''}], 'year': 2010, 'venue': 'Ann. Rheum. Dis', 'volume': '69', 'issn': '6', 'pages': '1247--1250', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Meta-analysis of TNF-alpha promoter −308 A/G polymorphism and SLE susceptibility', 'authors': [{'first': 'Y', 'middle': ['H'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Harley', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Nath', 'suffix': ''}], 'year': 2006, 'venue': 'Eur. J. Hum. Genet', 'volume': '14', 'issn': '', 'pages': '364--371', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients', 'authors': [{'first': 'Y', 'middle': ['J'], 'last': 'Lin', 'suffix': ''}, {'first': 'R', 'middle': ['H'], 'last': 'Chen', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Wan', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Sheu', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Huang', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Lin', 'suffix': ''}, {'first': 'S', 'middle': ['Y'], 'last': 'Chen', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Lai', 'suffix': ''}, {'first': 'Y', 'middle': ['C'], 'last': 'Lan', 'suffix': ''}, {'first': 'K', 'middle': ['C'], 'last': 'Hsueh', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Tsai', 'suffix': ''}, {'first': 'T', 'middle': ['H'], 'last': 'Lin', 'suffix': ''}, {'first': 'Y', 'middle': ['M'], 'last': 'Huang', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Chao', 'suffix': ''}, {'first': 'D', 'middle': ['Y'], 'last': 'Chen', 'suffix': ''}, {'first': 'F', 'middle': ['J'], 'last': 'Tsai', 'suffix': ''}], 'year': 2009, 'venue': 'Lupus', 'volume': '18', 'issn': '11', 'pages': '974--979', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis', 'authors': [{'first': 'D', 'middle': [], 'last': 'López-Maderuelo', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Arnalich', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Serantes', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'González', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Codoceo', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Madero', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Vázquez', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Montiel', 'suffix': ''}], 'year': 2003, 'venue': 'Am. J. Respir. Crit. Care Med', 'volume': '167', 'issn': '7', 'pages': '970--975', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Tumor necrosis factor in the serum of patients with systemic lupus erythematosus', 'authors': [{'first': 'C', 'middle': ['P'], 'last': 'Maury', 'suffix': ''}, {'first': 'A', 'middle': ['M'], 'last': 'Teppo', 'suffix': ''}], 'year': 1989, 'venue': 'Arthritis Rheum', 'volume': '32', 'issn': '2', 'pages': '146--150', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': '4G/5G plasminogen activator inhibitor-1 and −308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Muñoz', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Aranda', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Allievi', 'suffix': ''}, {'first': 'A', 'middle': ['O'], 'last': 'Orden', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Perés Wingeyer', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Trobo', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Alvarez', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Eimon', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Barreira', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Schneeberger', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Dal Pra', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Sarano', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Hofman', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Chamorro', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'De Larrañaga', 'suffix': ''}], 'year': 2014, 'venue': 'Clin. Exp. Med', 'volume': '14', 'issn': '1', 'pages': '83--89', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis', 'authors': [{'first': 'H', 'middle': ['F'], 'last': 'Pan', 'suffix': ''}, {'first': 'R', 'middle': ['X'], 'last': 'Leng', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'W', 'middle': ['Z'], 'last': 'Qin', 'suffix': ''}, {'first': 'L', 'middle': ['L'], 'last': 'Chen', 'suffix': ''}, {'first': 'Z', 'middle': ['Q'], 'last': 'Zha', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Tao', 'suffix': ''}, {'first': 'D', 'middle': ['Q'], 'last': 'Ye', 'suffix': ''}], 'year': 2012, 'venue': 'Rheumatol. Int', 'volume': '32', 'issn': '7', 'pages': '2083--2092', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism', 'authors': [{'first': 'C', 'middle': ['G'], 'last': 'Parks', 'suffix': ''}, {'first': 'J', 'middle': ['P'], 'last': 'Pandey', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Dooley', 'suffix': ''}, {'first': 'E', 'middle': ['L'], 'last': 'Treadwell', 'suffix': ''}, {'first': 'E', 'middle': ['W'], 'last': 'St Clair', 'suffix': ''}, {'first': 'G', 'middle': ['S'], 'last': 'Gilkeson', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Feghali-Bostwick', 'suffix': ''}, {'first': 'G', 'middle': ['S'], 'last': 'Cooper', 'suffix': ''}], 'year': 2004, 'venue': 'Hum. Immunol', 'volume': '65', 'issn': '6', 'pages': '622--631', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms', 'authors': [{'first': 'C', 'middle': [], 'last': 'Perrey', 'suffix': ''}, {'first': 'S', 'middle': ['J'], 'last': 'Turner', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Pravica', 'suffix': ''}, {'first': 'W', 'middle': ['M'], 'last': 'Howell', 'suffix': ''}, {'first': 'I', 'middle': ['V'], 'last': 'Hutchinson', 'suffix': ''}], 'year': 1999, 'venue': 'Transpl. Immunol', 'volume': '7', 'issn': '2', 'pages': '127--128', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Epidemiology and management of refractory lupus nephritis', 'authors': [{'first': 'G', 'middle': ['J'], 'last': 'Pons-Estel', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Serrano', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Plasín', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Espinosa', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Cervera', 'suffix': ''}], 'year': 2011, 'venue': 'Autoimmun. Rev', 'volume': '10', 'issn': '11', 'pages': '655--663', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'The role of tumor necrosis factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus', 'authors': [{'first': 'M', 'middle': [], 'last': 'Postal', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Appenzeller', 'suffix': ''}], 'year': 2011, 'venue': 'Cytokine', 'volume': '56', 'issn': '3', 'pages': '537--543', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production', 'authors': [{'first': 'V', 'middle': [], 'last': 'Pravica', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Perrey', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Stevens', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Lee', 'suffix': ''}, {'first': 'I', 'middle': ['V'], 'last': 'Hutchinson', 'suffix': ''}], 'year': 2000, 'venue': 'Hum. Immunol', 'volume': '61', 'issn': '9', 'pages': '863--866', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus', 'authors': [{'first': 'E', 'middle': [], 'last': 'Sánchez', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Sabio', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Callejas', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'De Ramón', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Garcia-Portales', 'suffix': ''}, {'first': 'F', 'middle': ['J'], 'last': 'García-Hernández', 'suffix': ''}], 'year': 2006, 'venue': 'BMC Med. Genet', 'volume': '7', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'TNF promoter −308 GNA and LTA 252 ANG polymorphisms in Portuguese patients with systemic lupus erythematosus', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Santos', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Carmona-Fernandes', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Caetano-Lopes', 'suffix': ''}, {'first': 'I', 'middle': ['P'], 'last': 'Perpétuo', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Vidal', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Capela', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Da Silva', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Je', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Rheumatol. Int', 'volume': '32', 'issn': '8', 'pages': '2239--2244', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Non-HLA associations with autoimmune diseases', 'authors': [{'first': 'N', 'middle': ['C'], 'last': 'Serrano', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Millan', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Páez', 'suffix': ''}], 'year': 2006, 'venue': 'Autoimmun. Rev', 'volume': '5', 'issn': '3', 'pages': '209--214', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Current status of lupus genetics', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Sestak', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Nath', 'suffix': ''}, {'first': 'A', 'middle': ['H'], 'last': 'Sawalha', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Harley', 'suffix': ''}], 'year': 2007, 'venue': 'Arthritis Res. Ther', 'volume': '9', 'issn': '', 'pages': '210--219', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Silva', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Morrissey', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Grabstein', 'suffix': ''}, {'first': 'K', 'middle': ['M'], 'last': 'Mohler', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Anderson', 'suffix': ''}, {'first': 'S', 'middle': ['G'], 'last': 'Reed', 'suffix': ''}], 'year': 1992, 'venue': 'J. Exp. Med', 'volume': '175', 'issn': '1', 'pages': '169--174', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus', 'authors': [{'first': 'A', 'middle': [], 'last': 'Studnicka-Benke', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Steiner', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Petera', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Smolen', 'suffix': ''}], 'year': 1996, 'venue': 'Br. J. Rheumatol', 'volume': '35', 'issn': '11', 'pages': '1067--1074', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus', 'authors': [{'first': 'A', 'middle': [], 'last': 'Suárez', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'López', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Mozo', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Gutiérrez', 'suffix': ''}], 'year': 2005, 'venue': 'Ann. Rheum. Dis', 'volume': '64', 'issn': '11', 'pages': '1605--1610', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Genetic contribution of the tumour necrosis factor (TNF) B + 252*2/2 genotype, but not the TNFa,b microsatellite alleles, to systemic lupus erythematosus in Japanese patients', 'authors': [{'first': 'F', 'middle': [], 'last': 'Takeuchi', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Nakano', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Nabeta', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Hong', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kawasugi', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Mori', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Okudaira', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Kuwata', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Tanimoto', 'suffix': ''}], 'year': 2005, 'venue': 'Int. J. Immunogenet', 'volume': '32', 'issn': '3', 'pages': '173--178', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'The 1982 revised criteria for the classification of systemic lupus erythematosus', 'authors': [{'first': 'E', 'middle': ['M'], 'last': 'Tan', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Cohen', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Fries', 'suffix': ''}, {'first': 'A', 'middle': ['T'], 'last': 'Masi', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Mcshane', 'suffix': ''}, {'first': 'N', 'middle': ['F'], 'last': 'Rothfield', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Schaller', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Talal', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Winchester', 'suffix': ''}], 'year': 1982, 'venue': 'Arthritis Rheum', 'volume': '25', 'issn': '11', 'pages': '1271--1277', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Tanaka', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Nakashima', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hisano', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Kohsaka', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Nemoto', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Niiro', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Otsuka', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Otsuka', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Imamura', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Niho', 'suffix': ''}], 'year': 1999, 'venue': 'Immunogenetics', 'volume': '49', 'issn': '4', 'pages': '266--271', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Association of interferon-gamma gene polymorphism (+ 874A) with arthritis manifestation in SLE', 'authors': [{'first': 'M', 'middle': [], 'last': 'Tangwattanachuleeporn', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Sodsai', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Avihingsanon', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Wongpiyabovorn', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Wongchinsri', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Hirankarn', 'suffix': ''}], 'year': 2007, 'venue': 'Clin. Rheumatol', 'volume': '26', 'issn': '11', 'pages': '1921--1924', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': \"Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjögren's syndrome\", 'authors': [{'first': 'G', 'middle': ['J'], 'last': 'Tobón', 'suffix': ''}, {'first': 'P', 'middle': ['A'], 'last': 'Correa', 'suffix': ''}, {'first': 'L', 'middle': ['M'], 'last': 'Gomez', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Anaya', 'suffix': ''}], 'year': 2005, 'venue': 'Clin. Exp. Rheumatol', 'volume': '23', 'issn': '3', 'pages': '339--344', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice', 'authors': [{'first': 'F', 'middle': [], 'last': 'Torrico', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Heremans', 'suffix': ''}, {'first': 'M', 'middle': ['T'], 'last': 'Rivera', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Van Marck', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Billiau', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Carlier', 'suffix': ''}], 'year': 1991, 'venue': 'J. Immunol', 'volume': '146', 'issn': '10', 'pages': '3626--3632', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus', 'authors': [{'first': 'M', 'middle': ['W'], 'last': 'Van Der Linden', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Van Der Slik', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Zanelli', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Giphart', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Pieterman', 'suffix': ''}, {'first': 'G', 'middle': ['M'], 'last': 'Schreuder', 'suffix': ''}], 'year': 2001, 'venue': 'Genes Immun', 'volume': '2', 'issn': '', 'pages': '373--380', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'Delineating the genetic basis of systemic lupus erythematosus', 'authors': [{'first': 'E', 'middle': ['K'], 'last': 'Wakeland', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'R', 'middle': ['R'], 'last': 'Graham', 'suffix': ''}, {'first': 'T', 'middle': ['W'], 'last': 'Behrens', 'suffix': ''}], 'year': 2001, 'venue': 'Immunity', 'volume': '15', 'issn': '3', 'pages': '397--408', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'The immunogenetics of SLE', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Walport', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Black', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Batchelor', 'suffix': ''}], 'year': 1982, 'venue': 'Clin. Rheum. Dis', 'volume': '8', 'issn': '1', 'pages': '3--21', 'other_ids': {}}, 'BIBREF45': {'ref_id': 'b45', 'title': 'The classification of glomerulonephritis in systemic lupus erythematosus revisited', 'authors': [{'first': 'J', 'middle': ['J'], 'last': 'Weening', 'suffix': ''}, {'first': 'V', 'middle': ['D'], 'last': 'D&apos;agati', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Schwartz', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Seshan', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Alpers', 'suffix': ''}, {'first': 'G', 'middle': ['B'], 'last': 'Appel', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Balow', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Bruijn', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Cook', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Ferrario', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Fogo', 'suffix': ''}, {'first': 'E', 'middle': ['M'], 'last': 'Ginzler', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Hebert', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Hill', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Hill', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Jennette', 'suffix': ''}, {'first': 'N', 'middle': ['C'], 'last': 'Kong', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Lesavre', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Lockshin', 'suffix': ''}, {'first': 'L', 'middle': ['M'], 'last': 'Looi', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Makino', 'suffix': ''}, {'first': 'L', 'middle': ['A'], 'last': 'Moura', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nagata', 'suffix': ''}], 'year': 2004, 'venue': 'J. Am. Soc. Nephrol', 'volume': '15', 'issn': '2', 'pages': '241--250', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': 'Metaanalysis of TNF-α promoter − 308A/G polymorphism and SLE susceptibility in Asian populations', 'authors': [{'first': 'Y', 'middle': ['F'], 'last': 'Zou', 'suffix': ''}, {'first': 'X', 'middle': ['L'], 'last': 'Feng', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Tao', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Su', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Pan', 'suffix': ''}, {'first': 'F', 'middle': ['F'], 'last': 'Liao', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Fan', 'suffix': ''}, {'first': 'D', 'middle': ['Q'], 'last': 'Ye', 'suffix': ''}], 'year': 2011, 'venue': 'Rheumatol. Int', 'volume': '31', 'issn': '8', 'pages': '1055--1064', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE)', 'authors': [{'first': 'J', 'middle': [], 'last': 'Zúñiga', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Vargas-Alarcón', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Hernández-Pacheco', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Portal-Celhay', 'suffix': ''}, {'first': 'J', 'middle': ['K'], 'last': 'Yamamoto-Furusho', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Granados', 'suffix': ''}], 'year': 2001, 'venue': 'Genes Immun', 'volume': '2', 'issn': '', 'pages': '363--366', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'The genotypes of TNF-α −308 GNA; lane M indicate DNA Ladder 100 bp, lanes', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'The genotypes of IFN-γ +874 ANT; lane M indicate DNA Ladder 100 bp, lanes', 'latex': None, 'type': 'figure'}, 'TABREF1': {'text': 'Genotype frequencies of TNF −308 in SLE cases compared to controls.', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'Genotype frequencies of IFNG +874 in SLE cases compared to controls. TT + AT vs. AA (dominant) 0.02 ⁎ 1.89 (1.11-3.21) AT vs. AA + TT (overdominant) 0.01 ⁎⁎ 2.04 (1.17-3.54) TT vs. AA + AT (recessive)', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'Authors are grateful for the Staff members of Rheumatology Department, Mansoura University Hospital, Egypt for their help in selecting cases under the study.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgement'}, {'text': 'The authors declare that they have no conflict of interest. 3.7 ± 0.6 3.5 ± 0.4 0.48 3.7 ± 0.5 3.9 ± 0.7 0.72 Activity index (M ± SD) 10.7 ± 4.6 11.4 ± 10.8 0.73 11.1 ± 4.2 17.2 ± 25.9 0.12 Chronicity index (M ± SD)1.2 ± 0.9 2.8 ± 13.6 0.47 1.6 ± 1.2 1.1 ± 0.9 0.23', 'cite_spans': [], 'ref_spans': [], 'section': 'Conflict of interest'}]}\n",
      "{'_id': ObjectId('5ea715f06410cd97f622beac'), 'paper_id': '0a296d80d8a8c0408c1ea9559c0f0589fb35cb03', 'metadata': {'title': 'Molecular epidemiology and phylogenetic analysis of diverse bovine astroviruses associated with diarrhea in cattle and water buffalo calves in China', 'authors': [{'first': 'Niyokwishimira', 'middle': [], 'last': 'Alfred', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Huan', 'middle': [], 'last': 'Liu', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Lan', 'middle': [], 'last': 'Li', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Shao', 'middle': ['Feng'], 'last': 'Hong', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Hai', 'middle': ['Bo'], 'last': 'Tang', 'suffix': '', 'affiliation': {'laboratory': 'State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Zhang', 'middle': [], 'last': 'Wei', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Ying', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Kai', 'middle': [], 'last': 'Fa', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': '', 'middle': [], 'last': 'Li', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Yi', 'middle': ['Zhi'], 'last': 'Zhong', 'suffix': '', 'affiliation': {'laboratory': 'State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Wei', 'middle': ['Jian'], 'last': 'Huang', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}]}, 'abstract': [{'text': 'Astroviruses are the principal causative agents of gastroenteritis in humans and have been associated with diarrhea in other mammals as well as birds. However, astroviral infection of animals had been poorly studied. In the present study, 211 rectal swabs collected from cattle and water buffalo calves with mild to severe diarrhea were tested for bovine astrovirus (BAstV) by RT-PCR. Results: 92/211 (43.6%) samples were positive for BAstV, at a rate of 46.10% (71/154) in cattle and 36.84% (21/57) in water buffalo. Phylogenetic analysis based on the partial and full-length of 25 ORF2 amino acid sequences obtained in this study classified the Guangxi BAstVs isolates into five subgroups under the genus of Mamastrovirus, genotype MAstV33, which suggested that the water buffalo was a new host of this genogroup that previously included only cattle and roe deer. Despite the origin of the host, the Guangxi BAstV isolates were closely related to the BAstV Hong Kong isolates (B18/HK and B76-2/HK), but highly divergent from the BAstV NeuroS1 isolate previously associated with neurologic disease in cattle in the U.S.A. Nucleotide sequence-based characterization of the ORF1b/ORF2 junction and corresponding overlapping regions showed distinctive properties, which may be common to BAstVs. Our results suggested that cattle and water buffalo are prone to infection of closely related astroviruses, which probably evolved from the same ancestor. The current study described astroviruses in water buffalo for the first time and is thus far among the largest epidemiological investigations of BAstV infection in cattle conducted in China.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': \"Astroviruses are small and non-enveloped with a single-stranded, positive-sense RNA genome of 6.4 to 7.3 kb in length consisting of three open reading frames (ORFs): ORF1a, which encodes the non-structural polyprotein 1a; ORF1b, which encodes the polyprotein 1ab, including the RNA-dependent RNA polymerase (RdRp) that is expressed by a ribosomal frameshift at the ORF1a/1b junction [1, 15] ; and ORF2, which encodes a viral capsid structural polyprotein. The current International Committee on Taxonomy of Viruses (ICTV) system divides the Astroviridae family into two genera, Mamastrovirus and Avastrovirus, which infect mammals and birds, respectively [5, 21] . Astrovirus was first identified in 1975 as the causative agent of infantile diarrhea in a maternity ward in England [1] . In 2011, astrovirus infection has expanded to 22 animal species or families, including various terrestrial domestic animals, wild animals and aquatic animals, (turkey, chicken, pig, cattle, dogs, cats, deer, ducks, mink, rabbit, sea lion, bats, etc.) [3, 5, 18, 21, 24, 28] . Bovine astrovirus (BAstV) was first described in England in 1978 from acute enteritis of calves [24] and initially considered to be avirulent, as experimental infection of two gnotobiotic calves with astrovirus-like virus did not cause diarrhea [24] . However, in 1984, two bovine astrovirus isolates from the U.S.A., US1 and US2, which were found to be antigenically related to an isolate in England (U.K.), were shown to cause infection and cytopathology of M cells of the dome epithelium covering the Payer's patches of the calf ileum [25] . In addition, astroviruses in co-infection with other enteric pathogens, such as bovine rotavirus (BRV) and bovine torovirus (BToV; Breda virus), were shown to increase the severity of astrovirus infection [26] . In 1985, a serologically based investigation classified bovine astroviruses into two serotypes: BoAstV-1 and BoAstV-2. Meanwhile, a study on the earliest three isolates of bovine astroviruses (UK, US1 and US2) implied that these isolates were different serotypes, suggesting that multiple serotypes of bovine astroviruses may exist in nature [25] . Astroviruses, as well as noroviruses, hepatitis A and E, and rotaviruses, are commonly reported as major causes of foodborne illnesses [2] . Astroviruses are commonly detected alongside other enteric viruses, especially noroviruses in alimentary specimens. A previous study suggested that BAstV may be excreted by up to 60-100% of calves on farms [4] , but a later study showed that only 5 (2.4%) of 209 rectal swabs collected from asymptomatic adult cattle tested positive for BAstV [21] . Unlike other enteric viruses, bovine astrovirus is characterized by asymptomatic viral shedding in stool samples without heavy diarrheal disease [4, 24] .\", 'cite_spans': [{'start': 383, 'end': 386, 'text': '[1,', 'ref_id': None}, {'start': 387, 'end': 390, 'text': '15]', 'ref_id': 'BIBREF16'}, {'start': 655, 'end': 658, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 659, 'end': 662, 'text': '21]', 'ref_id': 'BIBREF22'}, {'start': 781, 'end': 784, 'text': '[1]', 'ref_id': None}, {'start': 1038, 'end': 1041, 'text': '[3,', 'ref_id': 'BIBREF2'}, {'start': 1042, 'end': 1044, 'text': '5,', 'ref_id': 'BIBREF4'}, {'start': 1045, 'end': 1048, 'text': '18,', 'ref_id': 'BIBREF19'}, {'start': 1049, 'end': 1052, 'text': '21,', 'ref_id': 'BIBREF22'}, {'start': 1053, 'end': 1056, 'text': '24,', 'ref_id': 'BIBREF25'}, {'start': 1057, 'end': 1060, 'text': '28]', 'ref_id': 'BIBREF29'}, {'start': 1159, 'end': 1163, 'text': '[24]', 'ref_id': 'BIBREF25'}, {'start': 1308, 'end': 1312, 'text': '[24]', 'ref_id': 'BIBREF25'}, {'start': 1601, 'end': 1605, 'text': '[25]', 'ref_id': 'BIBREF26'}, {'start': 1813, 'end': 1817, 'text': '[26]', 'ref_id': 'BIBREF27'}, {'start': 2162, 'end': 2166, 'text': '[25]', 'ref_id': 'BIBREF26'}, {'start': 2304, 'end': 2307, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 2516, 'end': 2519, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 2653, 'end': 2657, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 2805, 'end': 2808, 'text': '[4,', 'ref_id': 'BIBREF3'}, {'start': 2809, 'end': 2812, 'text': '24]', 'ref_id': 'BIBREF25'}], 'ref_spans': [], 'section': ''}, {'text': 'Even though bovine astrovirus was one of the earliest mammalian astroviruses to be discovered and studied in detail, no further research has been performed on this important enteric pathogen over the past three decades, and its genomic sequence remained uncharacterized until its rediscovery and genomic characterization in 2011 in Hong Kong [21] . The lack of large-scale epidemiological surveillance of bovine astrovirus has continued the divergence of opinions on the morbidity of bovine astrovirus in cattle, especially considering that there is no report of astrovirus infection of water buffalo in the current literature. Furthermore, little molecular information about bovine astrovirus is available, and only limited information is available regarding animal astroviruses in general [9] . Therefore, the diversity, epidemiology and molecular characterization of animal astroviruses remain unclear due to the lack of studies, likely because of the difficulty to grow these viruses in cells and tissue cultures.', 'cite_spans': [{'start': 342, 'end': 346, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 791, 'end': 794, 'text': '[9]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': ''}, {'text': 'Here, we report our results of a relatively extensive epidemiological survey to elucidate the diversity of bovine astroviruses circulating among cattle and water buffalo in Guangxi province, China, by characterization of subgenomic sequences of the ORF1b/ORF2 overlap region and the 3′-end of ORF2.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Samples: A total of 211 rectal swabs were collected from calves, aged 0-6 months, with mild to severe diarrhea from five industrial farms (3 dairy and 2 water buffalo) in Guangxi province, China. All samples were collected in sterile tubes containing 10 ml of 1/100 antibiotic 10 mM phosphatebuffered saline and transported on ice to our laboratory within 24 hr. Samples were homogenized by vortexing for 5 min at room temperature and centrifuged at 3,000 × g for 15 min at 4°C, and then, the supernatant was aliquoted and stored at −80°C until assayed.', 'cite_spans': [], 'ref_spans': [], 'section': 'MATERIALS AND METHODS'}, {'text': \"Nucleic acid extraction and cDNA bank synthesis: RNA was extracted from 300 µl of the supernatant obtained from each rectal swab using the RNAiso PLUS kit (Takara Bio, Inc., Dalian, China) following the manufacturer's instructions. Extracted RNA was eluted in 35 µl of RNase-free H 2 O (Takara Bio, Inc.) and used for first strand cDNA bank synthesis with the PrimeScript II 1st strand cDNA Synthesis kit (Takara Bio, Inc.) in accordance with the manufacturer's instructions.\", 'cite_spans': [], 'ref_spans': [], 'section': 'MATERIALS AND METHODS'}, {'text': 'Detection of bovine astrovirus and genome cloning and sequencing: Bovine astrovirus was detected by reverse transcriptase polymerase chain reaction (RT-PCR) analysis using the degenerate primer pair (forward) DPF 5′-GAYTG-GACBCGHTWTGATGG-3′ and (reverse) DPR 5′-KYT-TRACCCACATNCCAA-3′ to target a 418-bp fragment of the RdRp region common to astroviruses, as described previously [21] with some modifications. Some of the RT-PCR-positive samples were sequenced and primarily analyzed by comparison of nucleotide sequences using the online Basic Local Alignment Search Tool (http://blast.ncbi. nlm.nih.gov/Blast.cgi) to confirm the detection of astrovi-ruses. Subsequently, we amplified the 3′-end of ORF2 and the ORF1b/ORF2 regions, which have been confirmed by subgenomic RNA analysis for characterization of astroviruses. Since the direct amplification with gene specific primers (GSPs) failed, the Rapid Amplification of cDNA Ends (RACE) method was implemented to amplify the 3′-end of the ORF1b/ORF2 region. The 3′-end RACE amplification was performed as described previously [16] with the following modifications to the primer pair: QT 5′-CCAGTGAGC AGAGTGACGAGGACTCGAGCTCAAGCT (T) 16 -3′ and QO 5′-CCAGTGAGCAGAGTGACG-3′. The RACE products were reused as templates in a nested PCR performed to amplify desired sequences using GSPs designed in this study based on the B76-2/HK sequence available in the GenBank database (http://www.ncbi.nlm.nih.gov/genbank/) under the accession number HQ916317.1.The GSPs were designed using OLIGO 7 software (Molecular Biology Insights, Inc., Colorado Springs, CO, U.S.A.). The nucleotide sequences of the primer pairs used to amplify the partial 3′-end of ORF2 were as follows: (forward, B1205F and B1350F) 5′-CAG-GTCACCCCAGGCAACAC-3′ and 5′-ATCATACAGGC-GGGCACGAGT-3′, respectively, and (reverse, B1205R) 5′-CCCTTCACCTATGCTAATCAAATC-3′ (expected products length, 1,200 and 1,426 bp, respectively). The two primer pairs used to amplify the ORF1b/ORF2 region were as follows: (1) The PCR cycling conditions consisted of 95°C for 5 min followed by 35 cycles of 94°C for 1 min, 52°C for 1 min, 72°C for 1 min and a final extension step at 72°C for 10 min in an automated thermal cycler (Bio-Rad Laboratories, Inc., Hercules, CA, U.S.A.). 3′-RACE PCR and amplification of the ORF1b/ORF2 region were performed under the same conditions as for the PCR analysis described above with cycling set at 58°C as the annealing temperature for 3′RACE and 56°C as the annealing temperature for amplification of the ORF1b/ORF2 region and an elongation step at 72°C for 1 min for each 1 kb.', 'cite_spans': [{'start': 380, 'end': 384, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 1080, 'end': 1084, 'text': '[16]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'MATERIALS AND METHODS'}, {'text': 'The PCR products of expected sizes were purified and then cloned into pMD18-T plasmid vectors (Takara Bio, Inc.), which were then used to transform competent Escherichia coli Top 10 cells. The recombinant plasmids were submitted in duplicate for DNA sequencing to Invitrogen Biotech (Beijing, China). Editing and assembly of nucleotide sequences were performed using the SeqMan program included in the Lasergene 7 Genomics Suite (DNAstar, Inc., Madison, WI, U.S.A.).', 'cite_spans': [], 'ref_spans': [], 'section': 'MATERIALS AND METHODS'}, {'text': 'The status of a combination of astrovirus with other gastrointestinal viruses was assessed by RT-PCR.', 'cite_spans': [], 'ref_spans': [], 'section': 'Assessment of the co-infection status of BAstV with other bovine gastrointestinal viruses:'}, {'text': 'Phylogenetic and genome analysis: Phylogenetic trees were constructed based on the nucleotide sequences of both partial and full-length ORF2 sequences using the Bootstrap Test Phylogeny algorithm with the neighbor-joining method included in the MEGA 4.1 software package (http://www. megasoftware.net/). Sequences were compared with those of other mammalian astroviruses. Pair distances of nucleotide sequences between bovine and water buffalo astroviruses, as well as the ORF1b/ORF2 junction, were analyzed using DNAstar software (Lasergene 7; MegAlign Program with the ClustalW sequence alignment algorithm).', 'cite_spans': [], 'ref_spans': [], 'section': 'Assessment of the co-infection status of BAstV with other bovine gastrointestinal viruses:'}, {'text': 'Of the 211 rectal swabs tested, 92 (43.6%) were positive for bovine astrovirus (cattle: 46.10%, 71/154; water buffalo: 36.84%, 21/57) ( Table 1 ). These results indicate that astroviruses are widely distributed among cattle and water buffalo populations in Guangxi province, China.', 'cite_spans': [], 'ref_spans': [{'start': 136, 'end': 143, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'Screening and detection of BAstV in cattle and water buffalo:'}, {'text': 'The status of co-infection of BAstV with other bovine gastrointestinal viruses: To assess the status of co-infection with BAstV and other bovine gastrointestinal viruses, 32 samples randomly selected from our study stock were subjected to RT-PCR analysis. Six viruses: bovine astrovirus (BAstV), bovine enterovirus (BEV), bovine viral diarrhea virus (BVDV), bovine coronavirus (BCoV), bovine rotavirus (BRV) and bovine torovirus (BToV) were analyzed in accordance with the results of previous studies [7, 8, 11, 20, 27] . The primer sequences used for detection of gastrointestinal viruses other than astrovirus are shown in Table 2 . As shown in Table 3 , our results clearly demonstrated BAstV co-infections with one or more gastrointestinal viruses in 87.5% (28/32) of cases. Interestingly, 4 (12.5%) of 32 samples were only positive for BAstV and negative for the all other gastrointestinal viruses tested in this study. Thus, the co-infection status was as follows: BEV, 53.1% (17/32); BAstV, 46.9% (15/32); BVDV, 18.7% (6/32); BCoV, 15.6% (5/32); BRV, 6.25% (2/32); and BToV, 0% (0/32).', 'cite_spans': [{'start': 501, 'end': 504, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 505, 'end': 507, 'text': '8,', 'ref_id': None}, {'start': 508, 'end': 511, 'text': '11,', 'ref_id': 'BIBREF12'}, {'start': 512, 'end': 515, 'text': '20,', 'ref_id': 'BIBREF21'}, {'start': 516, 'end': 519, 'text': '27]', 'ref_id': 'BIBREF28'}], 'ref_spans': [{'start': 625, 'end': 632, 'text': 'Table 2', 'ref_id': 'TABREF1'}, {'start': 647, 'end': 654, 'text': 'Table 3', 'ref_id': 'TABREF2'}], 'section': 'Screening and detection of BAstV in cattle and water buffalo:'}, {'text': 'Gene cloning and sequencing: We attempted to amplify the genomes of the 92 BAstV-positive samples. However, sequencing proved difficult due to the limited volume of the clinical samples and to the fact that virus cultivation was unsuccessful. We only successfully amplified and cloned 18 partial nucleotide sequences of approximately 1,200-1,426 bp in length in most 3′-ends of ORF2 (of the18 sequences, 12 were derived from cattle and six from water buffalo). Besides, seven fragments of approximately 3,000 bp in length (five derived from cattle and two from water buffalo) partially covering ORF1b and the full length of ORF2 were successfully amplified. In all, 25 sequences were obtained and submitted to the NCBI GenBank under the accession ', 'cite_spans': [], 'ref_spans': [], 'section': 'Screening and detection of BAstV in cattle and water buffalo:'}, {'text': 'numbers KJ476832-KJ476856. Phylogenetic and genomic analysis: To identify strains of astroviruses circulating among cattle and water buffalo populations in Guangxi province, phylogenetic tree analysis was performed based on both partial and full-length ORF2 sequences (1). Phylogenetic analysis of partial ORF2 sequences showed that three isolates (BAstGX S7-7, BAstGX S12-7 and BAstGX S17-7) from Dairy Farm A clustered together with one isolate (BAstGX J25) from Dairy Farm B forming a subgroup, which had a high similarity with BAstV-B76-2/HK and BAstV-B18/ HK isolated from cattle in Hong Kong. Five of six isolates from water buffalo (Bu-fAstGX M52, BufAstGX M53, BufAstGX M54, BufAstGX M541 and BufAstGX M552) clustered together appeared to form a new independent subgroup. However, one water buffalo isolate (BufAstGX 141) formed a new subgroup and appeared to be very closely related to the CcAstV-1/ DNK/2010 isolate from a roe deer in Europe [17] , suggesting that the Guangxi isolates from water buffalo could be classified into two subgroups. Seven of eight isolates (BAstGX J7, BAstGX J8, BAstGX J22, BAstGX J23, BAstGX J27, BAstGX J251 and BAstGX 252) from Dairy Farm B formed a new subgroup, while one isolate (BAstGX G1) from Dairy Farm C formed a new subgroup on its own from other cattle isolates. Regardless of origin, the isolates from cattle were divided into three subgroups, while those from water buffalo were divided into two subgroups. However, five subgroups of the Guangxi cattle and water buffalo astrovirus isolates belonged to one genogroup previously composed of bovine and roe deer astroviruses (BAstv-B76-2/HK, BAstV-B18/ HK, CcAstV-1/DNK/2010 and CcAstV-2/DNK/2010) in the genus Mamastrovirus, genotype MAstV33 (Fig. 1a) . To confirm this classification, we next constructed another phylogenetic tree based on the seven predicted full-length ORF2 sequences deduced from amino acid sequences (five from cattle and two from water buffalo) obtained in this study together with other full-length ORF2 sequences of other mammalian astroviruses retrieved from the GenBank database. The phylogenetic relationships within the complete ORF2 sequences of different mammalian astroviruses were addressed in reference to the taxonomic proposals for astrovirus classification criteria as described by the Astroviridae Study Group in 2010, and each genotype was represented at least by one prototype strain. The obtained results confirmed the classification under the genus Mamastrovirus, genotype MAstV33, which, thus far, includes only cattle and roe deer astroviruses (Fig. 1b) . Both the partial and full length ORF2 sequences of water buffalo isolates constituted new subgroups in the clade of the genotype MAstV33. The above results classified water buffalo as new host species of the genus Mamastrovirus, genotype MAstV33 ( Fig. 1a and 1b) . Analysis of the ORF1b/ORF2 junction identified a highly conserved 17-nt sequence motif (5′-cgctccttgcctaaaat-3′) upstream of ORF2 within the ORF1b/ORF2 region (Fig.  2a) . The ORF1b/ORF2 overlapping region contained 56 nt that overlapped between the ORF2 start codon and the ORF1b stop codon, with the exception of BAstV NeuroS1 (a divergent bovine astrovirus). The most 3′-end of ORF2 of the bovine-related astroviruses was highly conserved by 42 nt (Fig. 2b) , while this region has been reported as conserved by only 19 nt in human astroviruses [12] .', 'cite_spans': [{'start': 952, 'end': 956, 'text': '[17]', 'ref_id': 'BIBREF18'}, {'start': 3418, 'end': 3422, 'text': '[12]', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 1746, 'end': 1755, 'text': '(Fig. 1a)', 'ref_id': None}, {'start': 2592, 'end': 2601, 'text': '(Fig. 1b)', 'ref_id': None}, {'start': 2852, 'end': 2867, 'text': 'Fig. 1a and 1b)', 'ref_id': None}, {'start': 3029, 'end': 3039, 'text': '(Fig.  2a)', 'ref_id': None}, {'start': 3321, 'end': 3330, 'text': '(Fig. 2b)', 'ref_id': None}], 'section': 'Screening and detection of BAstV in cattle and water buffalo:'}, {'text': 'Here, we detected a high prevalence of bovine astrovirus by RT-PCR from rectal swabs collected from young calves of cattle and water buffalo with diarrhea. However, more studies are needed to determine whether the persistent diarrhea observed in these calves was mainly associated with the high prevalence of astroviruses, as previous studies reported that bovine astroviruses were not directly associated with severe diarrhea in calves under natural conditions [4, 24] . However, other reports [14, 26] indicated that bovine astrovirus may evolve to severe diarrhea in co-infections with other gastrointestinal viruses, as in the case of BAstV co-infection with BRV or BToV (Breda virus) [26] . Nonetheless, the epidemiology of bovine astrovirus remains unclear, especially considering the limited number of studies of cattle and water buffalo. While excretion of BAstV may occur in up to 60-100% of calves on farms [4] , only 5 (2.4%) of 209 rectal swabs collected from asymptomatic adult cattle were positive for BAstV [21] . In the present study, sampling at different time points demonstrated a high prevalence of up to 56.52% among calves with diarrhea. Moreover, in our complementary study, astrovirus was detected alongside other gastrointestinal viruses, including BEV, BCoV, BRV and BVDV, in 87.5% of cases. Surprisingly, 12.5% of these cases were positive for bovine astrovirus, but yet negative for other tested gastrointestinal viruses. In contrast, titers of BRV and BToV, which have been previously reported as principal gastrointestinal co-infecting viruses with bovine astrovirus, were minimal or undetectable in this study. From these results, it is clear that astrovirus may be directly associated with diarrhea or possibly linked to other factors, such as poor hygienic conditions or associated with other non-viral pathogens, such as bacteria or parasites, which are known causative agents of diarrhea in calves. Similar results were reported in Korea, where co-infection of bovine astrovirus with gastrointestinal viruses, other than BRV and BToV, was associated with clinical symptoms of diarrhea in 20-and 14-day-old calves [14] .', 'cite_spans': [{'start': 462, 'end': 465, 'text': '[4,', 'ref_id': 'BIBREF3'}, {'start': 466, 'end': 469, 'text': '24]', 'ref_id': 'BIBREF25'}, {'start': 495, 'end': 499, 'text': '[14,', 'ref_id': 'BIBREF15'}, {'start': 500, 'end': 503, 'text': '26]', 'ref_id': 'BIBREF27'}, {'start': 689, 'end': 693, 'text': '[26]', 'ref_id': 'BIBREF27'}, {'start': 917, 'end': 920, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 1022, 'end': 1026, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 2148, 'end': 2152, 'text': '[14]', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Our phylogenetic analysis showed that all isolates in this study were closely related to BAstV-B76-2/HK, BAstV-B18/ HK, CcAstV-1/DNK/2010 and CcAstV-2/DNK/2010, but highly divergent from a BAstV NeuroS1 isolate previously associated with neurologic disease in cattle in the U.S.A. [10] . Nonetheless, our results support that proposal [21] that BAstV and CcAstV may be different strains of the same virus, and water buffalo may be a new host of the BAstV variant of this virus. Moreover, most sequences derived from one farm belonged to one subgroup, although sequence analysis clearly demonstrated origins from different strains. In addition, no significant genetic differences were observed between the bovine and water buffalo astrovirus strains investigated in this study (Table 4 ). These results further support previous evidence that one farm could serve as a reservoir of different bovine astrovirus strains, suggesting possible outbreaks of novel astroviruses due to mutation or recombination events. Notably, considering the history of astroviruses, recombination events have been described in cattle, swine, humans and poultry [19, 21, 22] , and coinfection of two different astroviruses in one head of cattle has been previously reported as well [21] . Consequently, it is important to screen for and control astrovirus infection in order to prevent eventual outbreaks of highly pathogenic astroviruses resulting in mutation or recombination events on farms. Furthermore, the astrovirus isolates from cattle and water buffalo isolated in this study displayed relatively close relationships, indicating that these animals were infected with diverse astroviruses, which probably evolved from the same viral ancestor. Consequently, given these close relationships, evidence exists of possible cross-infection between the two hosts; therefore, control measures against bovine astrovirus should also be taken into consideration when screening of viruses in water buffalo populations.', 'cite_spans': [{'start': 281, 'end': 285, 'text': '[10]', 'ref_id': 'BIBREF11'}, {'start': 335, 'end': 339, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 1138, 'end': 1142, 'text': '[19,', 'ref_id': 'BIBREF20'}, {'start': 1143, 'end': 1146, 'text': '21,', 'ref_id': 'BIBREF22'}, {'start': 1147, 'end': 1150, 'text': '22]', 'ref_id': 'BIBREF23'}, {'start': 1258, 'end': 1262, 'text': '[21]', 'ref_id': 'BIBREF22'}], 'ref_spans': [{'start': 776, 'end': 784, 'text': '(Table 4', 'ref_id': None}], 'section': 'DISCUSSION'}, {'text': 'Appreciation of the genetic diversity and evolution of astroviruses among wild and domestic animal populations is important to fully understand this challenging gastrointestinal virus [21] . However, the organization of the BAstV genome has not yet been fully described. In this study, a sequence motif upstream of ORF2 was predicted to be the signal of the putative promoter for subgenomic RNA (sgRNA) synthesis in bovine astrovirus as well as that for the ORF1b/ORF2 overlap sequence and the most 3′-end of ORF2. It has been suggested that in astroviruses [13, 23] , a conserved sequence acts as a putative promoter for sgRNA synthesis upstream of ORF2. In human astroviruses, the ORF1b/ORF2 overlap is 8 nt in length, while in duck astroviruses, the ORF1b/ORF2 junctions are not overlapped [6, 13, 23] . In contrast, the overlap in the ORF1b/ ORF2 junction of bovine astroviruses may be longer (56 nt) than that of the other known astroviruses. Moreover, compared Fig. 1 . Phylogenetic relationships between the Guangxi bovine astroviruses and other mammalian astroviruses retrieved from the NCBI database. Phylogenetic trees were constructed based on both predicted partial ORF2 (Fig.1a) and full-length ORF2 (Fig.1b) amino acid sequences of the Guangxi bovine astrovirus and documented full-length ORF2 sequences from other mammal astroviruses. The phylogenetic trees were generated using the Bootstrap Test Phylogeny algorithm with the neighbor-joining method included in the MEGA 4.1 software package. Each genotype of the genus Mamastrovirus was represented at least by one or more prototype strains, and genotypes are highlighted. Classification was based on the Taxonomic Proposals submitted to the ICTV by the Astroviridae Study Group in 2010. The Guangxi isolates derived from cattle are marked by (•), and isolates derived from water buffalo are marked by (■). a with a previous report [12] , the 3′-end of ORF2 of bovine astroviruses was highly conserved, although our results suggested further studies and analysis of more sequences from several novel bovine astroviruses to fully characterize ORF2 of bovine astrovirus. In summary, this study is of interest at both the epidemiological and genetic levels. These results will certainly contribute to the understanding of the evolution and pathol-b ogy of bovine astrovirus in cattle and water buffalo, as not only did we provide useful reference material for further studies, but also isolated bovine astrovirus in water buffalo for the first time. The present study is thus far among the largest epidemiological investigations of bovine astrovirus conducted at the farm level in the dairy industry in China.', 'cite_spans': [{'start': 184, 'end': 188, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 558, 'end': 562, 'text': '[13,', 'ref_id': 'BIBREF14'}, {'start': 563, 'end': 566, 'text': '23]', 'ref_id': 'BIBREF24'}, {'start': 793, 'end': 796, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 797, 'end': 800, 'text': '13,', 'ref_id': 'BIBREF14'}, {'start': 801, 'end': 804, 'text': '23]', 'ref_id': 'BIBREF24'}, {'start': 1899, 'end': 1903, 'text': '[12]', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 967, 'end': 973, 'text': 'Fig. 1', 'ref_id': None}, {'start': 1183, 'end': 1191, 'text': '(Fig.1a)', 'ref_id': None}, {'start': 1213, 'end': 1221, 'text': '(Fig.1b)', 'ref_id': None}], 'section': 'DISCUSSION'}, {'text': 'ACKNOWLEDGMENTS. This study was supported by grants from the China Agriculture Research System, Guangxi Piggery Industry Innovation Experts Team Contract (no.: nycytxgxcxtd-03-15-1), National Natural Science Foundation of China (no.: 31460671) and the Swine Principal Epidemic Diseases Prevention and Control Techniques Research Contract (no.: 112333007-3A). Fig. 2 . a: Alignment of the Guangxi cattle and water buffalo astrovirus isolates and NCBI sequences comprising the ORF1b/ORF2 junction identified a highly conserved sequence motif upstream of the ORF2 start codon. Given its site and conservation among strains, this sequence was predicted to be related with the putative promoter for sgRNA synthesis in bovine astroviruses (DNAstar, MegAlign Program: ClustalW Method). b: Alignment of the Guangxi cattle and water buffalo astrovirus isolates and bovine astroviruses fulllength ORF2 sequences retrieved from the NCBI database with a 42-nt, highly conserved sequence in the most 3′-end of ORF2 (DNAstar, MegAlign Program: ClustalW Method).', 'cite_spans': [], 'ref_spans': [{'start': 359, 'end': 365, 'text': 'Fig. 2', 'ref_id': None}], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Letter: Viruses and gastroenteritis in infants', 'authors': [{'first': 'H', 'middle': [], 'last': 'Appleton', 'suffix': ''}, {'first': 'P', 'middle': ['G'], 'last': 'Higgins', 'suffix': ''}], 'year': 1975, 'venue': 'Lancet', 'volume': '1', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1016/S0140-6736(75)92581-7']}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Major foodborne illness causing viruses and current status of vaccines against the diseases', 'authors': [{'first': 'C', 'middle': ['D'], 'last': 'Atreya', 'suffix': ''}], 'year': 2004, 'venue': 'Foodborne Pathog. Dis', 'volume': '1', 'issn': '', 'pages': '89--96', 'other_ids': {'DOI': ['10.1089/153531404323143602']}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Detection of a novel astrovirus in brain tissue of mink suffering from shaking mink syndrome by use of viral metagenomics', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Blomström', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Widén', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Hammer', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Belák', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Berg', 'suffix': ''}], 'year': 2010, 'venue': 'J. Clin. Microbiol', 'volume': '48', 'issn': '', 'pages': '4392--4396', 'other_ids': {'DOI': ['10.1128/JCM.01040-10']}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Characterization of a calici-like virus (Newbury agent) found in association with astrovirus in bovine diarrhea', 'authors': [{'first': 'J', 'middle': ['C'], 'last': 'Bridger', 'suffix': ''}, {'first': 'G', 'middle': ['A'], 'last': 'Hall', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Brown', 'suffix': ''}], 'year': 1984, 'venue': 'Infect. Immun', 'volume': '43', 'issn': '', 'pages': '133--138', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Astrovirus infections in humans and animals -molecular biology, genetic diversity, and interspecies transmissions', 'authors': [{'first': 'P', 'middle': [], 'last': 'De Benedictis', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schultz-Cherry', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Burnham', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Cattoli', 'suffix': ''}], 'year': 2011, 'venue': 'Infect. Genet. Evol', 'volume': '11', 'issn': '', 'pages': '1529--1544', 'other_ids': {'DOI': ['10.1016/j.meegid.2011.07.024']}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Complete sequence of a duck astrovirus associated with fatal hepatitis in ducklings', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Fu', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Pan', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Xu', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Xie', 'suffix': ''}, {'first': 'N', 'middle': ['J'], 'last': 'Knowles', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Zhang', 'suffix': ''}], 'year': 2009, 'venue': 'J. Gen. Virol', 'volume': '90', 'issn': '', 'pages': '1104--1108', 'other_ids': {'DOI': ['10.1099/vir.0.008599-0']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Detection of bovine torovirus in neonatal calf diarrhoea in Lower Austria and Styria (Austria)', 'authors': [{'first': 'B', 'middle': [], 'last': 'Haschek', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Klein', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Benetka', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Herrera', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Sommerfeld-Stur', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Vilcek', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Moestl', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Baumgartner', 'suffix': ''}], 'year': 2006, 'venue': 'J. Vet. Med. B Infect. Dis. Vet. Public Health', 'volume': '53', 'issn': '', 'pages': '160--165', 'other_ids': {'DOI': ['10.1111/j.1439-0450.2006.00936.x']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Survey of bovine enterovirus in biological and environmental samples by a highly sensitive real-time reverse transcription-PCR', 'authors': [{'first': 'J', 'middle': ['C'], 'last': 'Sáiz', 'suffix': ''}], 'year': 2005, 'venue': 'Appl. Environ. Microbiol', 'volume': '71', 'issn': '', 'pages': '3536--3543', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Comparison of capsid sequences from human and animal astroviruses', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Jonassen', 'suffix': ''}, {'first': 'T', 'middle': ['O'], 'last': 'Jonassen', 'suffix': ''}, {'first': 'Y', 'middle': ['M'], 'last': 'Saif', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Snodgrass', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Ushijima', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Shimizu', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Grinde', 'suffix': ''}], 'year': 2001, 'venue': 'J. Gen. Virol', 'volume': '82', 'issn': '', 'pages': '1061--1067', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Divergent astrovirus associated with neurologic disease in cattle', 'authors': [{'first': 'L', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Diab', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mcgraw', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Barr', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Traslavina', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Higgins', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Talbot', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Blanchard', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Rimoldi', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Fahsbender', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Page', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Phan', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Deng', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Pesavento', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Delwart', 'suffix': ''}], 'year': 2013, 'venue': 'Emerg. Infect. Dis', 'volume': '19', 'issn': '', 'pages': '1385--1392', 'other_ids': {'DOI': ['10.3201/eid1909.130682']}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Detection of bovine Coronavirus by RT-PCR in a field study', 'authors': [{'first': 'K', 'middle': [], 'last': 'Mohammad', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ahmad', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Hadi', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Farhid', 'suffix': ''}], 'year': 2006, 'venue': 'Vet. Arhiv', 'volume': '76', 'issn': '', 'pages': '296--296', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Molecular characterisation of the 3′-end of the astrovirus genome', 'authors': [{'first': 'C', 'middle': [], 'last': 'Monceyron', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Grinde', 'suffix': ''}, {'first': 'T', 'middle': ['O'], 'last': 'Jonassen', 'suffix': ''}], 'year': 1997, 'venue': 'Arch. Virol', 'volume': '142', 'issn': '', 'pages': '699--706', 'other_ids': {'DOI': ['10.1007/s007050050112']}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Subgenomic RNA sequence of human astrovirus supports classification of Astroviridae as a new family of RNA viruses', 'authors': [{'first': 'S', 'middle': ['S'], 'last': 'Monroe', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Jiang', 'suffix': ''}, {'first': 'S', 'middle': ['E'], 'last': 'Stine', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koopmans', 'suffix': ''}, {'first': 'R', 'middle': ['I'], 'last': 'Glass', 'suffix': ''}], 'year': 1993, 'venue': 'J. Virol', 'volume': '67', 'issn': '', 'pages': '3611--3614', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Phylogenetic analysis of bovine astrovirus in Korean cattle', 'authors': [{'first': 'J', 'middle': ['K'], 'last': 'Oem', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'An', 'suffix': ''}], 'year': 2014, 'venue': 'Virus Genes', 'volume': '48', 'issn': '', 'pages': '372--375', 'other_ids': {'DOI': ['10.1007/s11262-013-1013-0']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Identification of a novel astrovirus in domestic sheep in Hungary', 'authors': [{'first': 'G', 'middle': [], 'last': 'Reuter', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Pankovics', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Delwart', 'suffix': ''}, {'first': 'Á', 'middle': [], 'last': 'Boros', 'suffix': ''}], 'year': 2012, 'venue': 'Arch. Virol', 'volume': '157', 'issn': '', 'pages': '323--327', 'other_ids': {'DOI': ['10.1007/s00705-011-1151-4']}}, 'BIBREF17': {'ref_id': 'b17', 'title': '3′ end cDNA amplification using classic RACE', 'authors': [{'first': 'E', 'middle': [], 'last': 'Scotto-Lavino', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Du', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Frohman', 'suffix': ''}], 'year': 2006, 'venue': 'Nat. Protoc', 'volume': '1', 'issn': '', 'pages': '2742--2745', 'other_ids': {'DOI': ['10.1038/nprot.2006.481']}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Identification and characterization of deer astroviruses', 'authors': [{'first': 'S', 'middle': ['L'], 'last': 'Smits', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Van Leeuwen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Kuiken', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Hammer', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Simon', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Osterhaus', 'suffix': ''}], 'year': 2010, 'venue': 'J. Gen. Virol', 'volume': '91', 'issn': '', 'pages': '2719--2722', 'other_ids': {'DOI': ['10.1099/vir.0.024067-0']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Complete genome sequence of an astrovirus identified in a domestic rabbit (Oryctolagus cuniculus) with gastroenteritis', 'authors': [{'first': 'M', 'middle': ['D'], 'last': 'Stenglein', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Velazquez', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Greenacre', 'suffix': ''}, {'first': 'R', 'middle': ['P'], 'last': 'Wilkes', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Ruby', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Lankton', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Ganem', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Kennedy', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Derisi', 'suffix': ''}], 'year': 2012, 'venue': 'Virol. J', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1743-422X-9-216']}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Genomic analysis of closely related astroviruses', 'authors': [{'first': 'E', 'middle': [], 'last': 'Strain', 'suffix': ''}, {'first': 'L', 'middle': ['A'], 'last': 'Kelley', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schultz-Cherry', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Muse', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Koci', 'suffix': ''}], 'year': 2008, 'venue': 'J. Virol', 'volume': '82', 'issn': '', 'pages': '5099--5103', 'other_ids': {'DOI': ['10.1128/JVI.01993-07']}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Detection of group A Bovine Rotavirus in diarrhoeic calves by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and electropherotyping', 'authors': [{'first': 'T', 'middle': [], 'last': 'Suresh', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Rai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Dhama', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Bhattl', 'suffix': ''}, {'first': 'P', 'middle': ['M'], 'last': 'Sawant', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Sharma', 'suffix': ''}], 'year': 2011, 'venue': 'Vet. Pract', 'volume': '12', 'issn': '', 'pages': '133--137', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Rediscovery and genomic characterization of bovine astroviruses', 'authors': [{'first': 'H', 'middle': [], 'last': 'Tse', 'suffix': ''}, {'first': 'W', 'middle': ['M'], 'last': 'Chan', 'suffix': ''}, {'first': 'H', 'middle': ['W'], 'last': 'Tsoi', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Fan', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Lau', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Lau', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Woo', 'suffix': ''}, {'first': 'K', 'middle': ['Y'], 'last': 'Yuen', 'suffix': ''}], 'year': 2011, 'venue': 'J. Gen. Virol', 'volume': '92', 'issn': '', 'pages': '1888--1898', 'other_ids': {'DOI': ['10.1099/vir.0.030817-0']}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Genomic analysis of two ORF2 segments of new porcine astrovirus isolates and their close relationship with human astroviruses', 'authors': [{'first': 'J', 'middle': ['C'], 'last': 'Ulloa', 'suffix': ''}, {'first': 'M', 'middle': ['F'], 'last': 'Gutiérrez', 'suffix': ''}], 'year': 2010, 'venue': 'Can. J. Microbiol', 'volume': '56', 'issn': '', 'pages': '569--577', 'other_ids': {'DOI': ['10.1139/W10-042']}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Identification and sequence determination of the capsid protein gene of human astrovirus serotype 1', 'authors': [{'first': 'M', 'middle': ['M'], 'last': 'Willcocks', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Carter', 'suffix': ''}], 'year': 1993, 'venue': 'FEMS Microbiol. Lett', 'volume': '114', 'issn': '', 'pages': '1--7', 'other_ids': {'DOI': ['10.1111/j.1574-6968.1993.tb06542.x']}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves', 'authors': [{'first': 'G', 'middle': ['N'], 'last': 'Woode', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Bridger', 'suffix': ''}], 'year': 1978, 'venue': 'J. Med. Microbiol', 'volume': '11', 'issn': '', 'pages': '441--452', 'other_ids': {'DOI': ['10.1099/00222615-11-4-441']}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Serotypes of bovine astrovirus', 'authors': [{'first': 'G', 'middle': ['N'], 'last': 'Woode', 'suffix': ''}, {'first': 'N', 'middle': ['E'], 'last': 'Gourley', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Pohlenz', 'suffix': ''}, {'first': 'E', 'middle': ['M'], 'last': 'Liebler', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Mathews', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Hutchinson', 'suffix': ''}], 'year': 1985, 'venue': 'J. Clin. Microbiol', 'volume': '22', 'issn': '', 'pages': '668--670', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Astrovirus and Breda virus infections of dome cell epithelium of bovine ileum', 'authors': [{'first': 'G', 'middle': ['N'], 'last': 'Woode', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Pohlenz', 'suffix': ''}, {'first': 'N', 'middle': ['E'], 'last': 'Gourley', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Fagerland', 'suffix': ''}], 'year': 1984, 'venue': 'J. Clin. Microbiol', 'volume': '19', 'issn': '', 'pages': '623--630', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Establishment and Application of a RT-PCR Assay for Detection of Bovine Viral Diarrhea Virus', 'authors': [{'first': 'S', 'middle': ['Q'], 'last': 'Zhang', 'suffix': ''}, {'first': 'Li', 'middle': [], 'last': 'Guo', 'suffix': ''}, {'first': 'T', 'middle': ['T'], 'last': 'Zhang', 'suffix': ''}, {'first': 'Y', 'middle': ['W'], 'last': 'Wu', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wu', 'suffix': ''}], 'year': 2011, 'venue': 'China Animal Husbandry Vet. Med', 'volume': '38', 'issn': '', 'pages': '159--162', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Detection of diverse astroviruses from bats in China', 'authors': [{'first': 'H', 'middle': ['C'], 'last': 'Zhu', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Chu', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'B', 'middle': ['Q'], 'last': 'Dong', 'suffix': ''}, {'first': 'S', 'middle': ['Y'], 'last': 'Zhang', 'suffix': ''}, {'first': 'J', 'middle': ['X'], 'last': 'Zhang', 'suffix': ''}, {'first': 'L', 'middle': ['F'], 'last': 'Li', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Vijaykrishna', 'suffix': ''}, {'first': 'G', 'middle': ['J'], 'last': 'Smith', 'suffix': ''}, {'first': 'H', 'middle': ['L'], 'last': 'Chen', 'suffix': ''}, {'first': 'L', 'middle': ['L'], 'last': 'Poon', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Peiris', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Guan', 'suffix': ''}], 'year': 2009, 'venue': 'J. Gen. Virol', 'volume': '90', 'issn': '', 'pages': '883--887', 'other_ids': {'DOI': ['10.1099/vir.0.007732-0']}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Pair distances of nucleotide sequences between bovine and water buffalo astrovirus strains', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': '(forward, B-GSP2-2F) 5′-AACAGC ACAGGGAGAGGTATAAGCA-3′ and (reverse, B5130R) 5′-TGGCACGTGTTTCATAGGTCT-3′ (expected product length, 1,850 bp); and (2) (forward, B1350F) 5′-ATCATA CAGGCGGGCACGAGT-3′ and (reverse, B1205R) 5′-CCCTTCACCTATGCTAATCAAATC-3′ (expected product length, 1,426 bp). For PCR, the final reaction volume of 25 µl consisted of 2.5 µl of 10x L.A Taq Polymerase buffer, 4.0 µl of dNTP mixture (2.5 mM each), 0.25 µl of LA Taq Polymerase (Takara Bio, Inc.), 0.5 µl forward (DPF) and reverse (DPF) primers each, 2.5 µl of cDNA template, and 14.75 µl of ddH2O.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Sample collection and RT-PCR detection of BAstV', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Primer sequences used for detection of other bovine gastrointestinal viruses', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'The status of co-infection of BAstV with other bovine gastrointestinal viruses', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715f044face1332c3d135'), 'paper_id': '0a29d54d90d636472416f889c10f12062425bc76', 'metadata': {'title': '', 'authors': []}, 'abstract': [{'text': \"The large outbreak of coronavirus disease 2019 (COVID-19) that started in Wuhan, China has now spread to many countries worldwide. Current epidemiologic knowledge suggests that relatively few cases are seen among children, which limits opportunities to address pediatric specific issues on infection control and the children's contribution to viral spread in the community. Here, we report the first pediatric case of COVID-19 in Korea. The 10-year-old girl was a close contact of her uncle and mother who were confirmed to have COVID-19. In this report, we present mild clinical course of her pneumonia that did not require antiviral treatment and serial viral test results from multiple specimens. Lastly, we raise concerns on the optimal strategy of self-quarantine and patient care in a negative isolation room for children.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': \"hospital. From February 2, 2020, self-quarantine was resumed by the remaining five family members. Although the patient's father, aunt and cousin stayed in separate rooms, the patient shared the same room with her mother. On February 5, 2020, her mother was confirmed with COVID-19. Because the patient closely contacted her uncle and her mother, she was screened for COVID-19, and three screening tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were all negative on day 1 and 4 since her uncle's diagnosis (February 1) and day 2 from the last exposure (February 5) to her mother. She remained well without subjective symptoms until the 13th day from the last exposure when she developed slightly elevated temperature of 37.3°C, which led to a confirmed diagnosis of her COVID-19 on February 18, 2020. A small amount of sputum for the previous three days was later reported. No other symptoms such as diarrhea or vomiting were reported.\", 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'On admission, she was not dyspneic nor cyanotic with a body temperature of 37.7°C. Initial laboratory results were as follows: white blood cell count 4,080/μL (37.3% lymphocytes), hemoglobin 13.5 g/dL, platelet count 251,000/μL, and C-reactive protein < 0.40 mg/dL. Real-time reverse transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 (Supplementary Data 1) was serially tested for the samples from nasopharynx, throat, saliva, serum, stool, and urine. Viral tests were positive in the samples from nasopharynx, throat, and stool ( Fig. 2A) . Serum, saliva, and urine tested negative on hospital days 3 and 8. Because the RT-PCR was developed for the qualitative assay, the cycle threshold values of RT-PCR could not be converted to viral load kinetics in this report. It is noteworthy, however, that stool samples were positive until the 17th day since symptom onset.', 'cite_spans': [], 'ref_spans': [{'start': 545, 'end': 553, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF0'}], 'section': ''}, {'text': 'No infiltrations were noted on the initial and 3 follow-up chest X-ray images (Fig. 2B) . However, chest computed tomography (CT) showed patchy or nodular consolidations with peripheral ground glass opacities in subpleural areas of the right lower lobe (Fig. 2C) . The patient had no underlying disease and the only symptoms she presented with were low-grade fever and a small amount of sputum. Although chest CT showed mild pneumonia, antiviral therapy was not required. This 10-year old girl took care of herself during the first 7 days spent alone in a negative isolation room. When her mother was discharged from her own negative isolation room, her mother joined her for care. She was transferred to a cohorting facility on the 15th hospital day to allow her isolation room to be used by another confirmed case in a more severe condition.', 'cite_spans': [], 'ref_spans': [{'start': 78, 'end': 87, 'text': '(Fig. 2B)', 'ref_id': 'FIGREF0'}, {'start': 253, 'end': 262, 'text': '(Fig. 2C)', 'ref_id': 'FIGREF0'}], 'section': ''}, {'text': 'Very little research on COVID-19 in children has been published in China or elsewhere. Most of the COVID-19 cases in children resulted from close contacts with COVID-19 cases or were found among family cluster cases. 5, 6 Most of the infected children had mild or difficult to recognize symptoms and some were even asymptomatic. Fever and cough were the most common symptoms, and some had runny nose, or gastrointestinal symptoms such as diarrhea, or vomiting. All of the cases improved, and no deaths have been reported so far.', 'cite_spans': [{'start': 220, 'end': 221, 'text': '6', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': ''}, {'text': \"We do not fully understand why children are less infected and less ill. Low infection rate and mild symptoms in children have also been observed in the previous SARS epidemic in 2003 and the Middle East respiratory syndrome (MERS) since 2012. 7-9 One of the explanations of COVID-19 sparing the pediatric populations might be because children are less exposed to the virus in the first place. Children are less likely to be exposed to the virus because this novel virus is initially transmitted among travelers and their close contacts. Children might also have fewer chances to be tested for SARS-CoV-2 because they only present mild symptoms similar to common cold. Meanwhile, the role of innate immunity to respiratory tract infection is greater in early life because the adaptive immune response is underdeveloped in young children. 10 Given that both young children and adults lack adaptive specific immunity to this novel virus, mild clinical course in young children may be explained by their dominant innate immune response compared to adults. Weaker ability to trigger an acute inflammatory response to SARS-CoV-2 might also contribute to the children's better outcome. This, however, does not completely rule out the possibility of severe cases and even death especially in children with underlying diseases, as observed in the previous MERS epidemics. 8, 9 Korea is now experiencing significant outbreaks and became the most-affected country after China. 2 The nation's biggest cluster has connections to Shincheonji religious group in Daegu. Another worrisome cluster has been linked to the patients hospitalized in Daenam Hospital in Cheongdo. 11 Viral tests are being run on massive scales in Korea. Thus, we may be able to diagnose more pediatric cases compared to other countries and have a unique opportunity to define the clinical features of COVID-19 in the pediatric population and the role of children in the transmission in child-care settings, schools and the community. Starting from several imported cases from Wuhan in January 2020, subsequent human-to-human transmissions occurred initially among their close contacts and family members. However, as the community spreads progress, we will see more cases among children. Among 3,526 confirmed cases, as of March 1, 2020, 164 children and adolescents under 20 years of age were diagnosed with COVID-19, comprising approximately 4.7% of the total confirmed cases. 11 The percentage of the confirmed child cases in Korea is higher than that in China and has risen from 1.5% to 4.7% in just one week. These findings are worrisome. It is well known that children contribute to the community spread of seasonal influenza by introducing influenza to the family and by disseminating influenza in the community. 12 To mitigate community spread of COVID-19, all school closures are justified in the current situation in Korea. To provide a scientific evidence for the effectiveness of school closures, we should not miss the opportunity to learn children's role in spreading SARS-CoV-2 to the community.\", 'cite_spans': [{'start': 837, 'end': 839, 'text': '10', 'ref_id': 'BIBREF16'}, {'start': 1363, 'end': 1365, 'text': '8,', 'ref_id': 'BIBREF12'}, {'start': 1366, 'end': 1367, 'text': '9', 'ref_id': 'BIBREF14'}, {'start': 1466, 'end': 1467, 'text': '2', 'ref_id': 'BIBREF2'}, {'start': 2439, 'end': 2441, 'text': '11', 'ref_id': 'BIBREF17'}, {'start': 2780, 'end': 2782, 'text': '12', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': ''}, {'text': 'It is interesting to note that although this case had mild symptoms only, patchy or nodular consolidations with peripheral ground glass opacities were observed on chest CT. A recent study in China analyzed the CT images of 15 children with COVID-19, 10 of whom were asymptomatic and 5 had fever. 13 Among the 15 children, pulmonary inflammatory lesions were observed in 9. Small nodular ground glass opacity was the most common finding and subpleural patchy opacities were also observable, with all lesions limited to a single lung segment. Adults generally have ground-glass and consolidative opacities in both lungs at chest CT. 14 Chest CT is a highly sensitive diagnostic tool to detect pneumonia and the sensitivity for COVID-19 is reported to be 97.5%. 15 However, considering the favorable clinical course in children with COVID-19, the necessity of performing CT scans on children should be judged with consideration of the potential health risks of radiation.', 'cite_spans': [{'start': 296, 'end': 298, 'text': '13', 'ref_id': 'BIBREF20'}, {'start': 759, 'end': 761, 'text': '15', 'ref_id': 'BIBREF25'}], 'ref_spans': [], 'section': ''}, {'text': 'Meanwhile, one of the issues regarding pediatric patients with COVID-19 is quarantine. While in self-quarantine, the present patient shared the same room with her mother who was soon confirmed with COVID-19. Ideally, any close contacts should stay at home in a separate room and refrain from going out. However, unlike adults, self-isolating young children by themselves is almost impossible because infants and young children must be taken care of by their caregivers. Considering the circumstances, the Korean Centers for Disease Control and Prevention and the Korean Society of Pediatric Infectious Diseases recommend one of the family members to be assigned as a caregiver for infants and young children who are suspected or confirmed with COVID-19, and the caregiver not to contact other family members. 16 Most importantly, caregivers should take all possible precautions to avoid being exposed to the virus. Thus, further pediatric-specific guidelines on the isolation and adequate personal protective equipment for caregivers should be prepared.', 'cite_spans': [{'start': 809, 'end': 811, 'text': '16', 'ref_id': None}], 'ref_spans': [], 'section': ''}, {'text': 'This 10-year old girl is the first pediatric case of COVID-19 in Korea. As this is only a single case, we cannot say much about clinical manifestations of childhood COVID-19 and viral load as a whole but can provide a model to pediatricians on which samples to test and what to consider in caring for children with COVID-19. As the number of confirmed cases surges in Korea, data on pediatric patients need to be comprehensively analyzed to further describe the clinical findings and to learn the role of children in a COVID-19 pandemic.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Seoul National University Bundang Hospital Institutional Review Board approved this study (No. B-2003-603-701) and written consent was waived because the patient and her mother were isolated in a negative-pressure room and her father was in self-quarantine. The patient and her mother agreed to the publication of this report.', 'cite_spans': [], 'ref_spans': [], 'section': 'ETHICS STATEMENT'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'A novel coronavirus from patients with pneumonia in China', 'authors': [{'first': 'N', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Song', 'suffix': ''}], 'year': 2019, 'venue': 'N Engl J Med', 'volume': '382', 'issn': '8', 'pages': '727--760', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'World Health Organization. Coronavirus disease (COVID-19) situation report-41', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'World Health Organization. Coronavirus disease (COVID-19) situation report-39', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention', 'authors': [{'first': 'Z', 'middle': [], 'last': 'Wu', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Mcgoogan', 'suffix': ''}], 'year': 2020, 'venue': 'JAMA. Forthcoming', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1001/jama.2020.2648']}}, 'BIBREF6': {'ref_id': 'b6', 'title': \"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement\", 'authors': [{'first': 'K', 'middle': [], 'last': 'Shen', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Jiang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Jin', 'suffix': ''}], 'year': 2020, 'venue': 'World J Pediatr. Forthcoming', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1007/s12519-020-00343-7']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China', 'authors': [{'first': 'D', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': ['L'], 'last': 'Ju', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Xie', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Lu', 'suffix': ''}, {'first': 'F', 'middle': ['Y'], 'last': 'Li', 'suffix': ''}, {'first': 'H', 'middle': ['H'], 'last': 'Huang', 'suffix': ''}], 'year': 2020, 'venue': 'Zhonghua Er Ke Za Zhi', 'volume': '58', 'issn': '4', 'pages': '', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update', 'authors': [{'first': 'M', 'middle': ['R'], 'last': 'Denison', 'suffix': ''}], 'year': 2004, 'venue': 'Pediatr Infect Dis J', 'volume': '23', 'issn': '11', 'pages': '207--221', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Middle East respiratory syndrome coronavirus disease in children', 'authors': [{'first': 'Z', 'middle': ['A'], 'last': 'Memish', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Al-Tawfiq', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Assiri', 'suffix': ''}, {'first': 'F', 'middle': ['A'], 'last': 'Alrabiah', 'suffix': ''}, {'first': 'Al', 'middle': [], 'last': 'Hajjar', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Albarrak', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Pediatr Infect Dis J', 'volume': '33', 'issn': '9', 'pages': '904--910', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Middle East respiratory syndrome coronavirus in children', 'authors': [{'first': 'F', 'middle': [], 'last': 'Thabet', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Chehab', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Bafaqih', 'suffix': ''}, {'first': 'Al', 'middle': [], 'last': 'Mohaimeed', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2015, 'venue': 'Saudi Med J', 'volume': '36', 'issn': '4', 'pages': '484--490', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Innate immunity to respiratory infection in early life', 'authors': [{'first': 'L', 'middle': [], 'last': 'Lambert', 'suffix': ''}, {'first': 'F', 'middle': ['J'], 'last': 'Culley', 'suffix': ''}], 'year': 2017, 'venue': 'Front Immunol', 'volume': '8', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.3389/fimmu.2017.01570']}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Korea Centers for Disease Control & Prevention. The updates of COVID-19 in the Republic of Korea', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren', 'authors': [{'first': 'A', 'middle': ['S'], 'last': 'Monto', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Davenport', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Napier', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Francis', 'suffix': ''}], 'year': 1970, 'venue': 'J Infect Dis', 'volume': '122', 'issn': '1', 'pages': '16--25', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Analysis of CT features of 15 children with 2019 novel coronavirus infection', 'authors': [{'first': 'K', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'Y', 'middle': ['X'], 'last': 'Yun', 'suffix': ''}, {'first': 'X', 'middle': ['F'], 'last': 'Wang', 'suffix': ''}, {'first': 'G', 'middle': ['D'], 'last': 'Yang', 'suffix': ''}, {'first': 'Y', 'middle': ['J'], 'last': 'Zheng', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Lin', 'suffix': ''}], 'year': 2020, 'venue': 'Zhonghua Er Ke Za Zhi', 'volume': '58', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'CT imaging features of 2019 novel coronavirus (2019-nCoV)', 'authors': [{'first': 'M', 'middle': [], 'last': 'Chung', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bernheim', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Mei', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Zeng', 'suffix': ''}], 'year': 2020, 'venue': 'Radiology', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases', 'authors': [{'first': 'T', 'middle': [], 'last': 'Ai', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Hou', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Zhan', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Chen', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Lv', 'suffix': ''}], 'year': 2020, 'venue': 'Radiology', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Korean Centers for Disease Control and Prevention. Management guideline for children and adolescents on COVID-19', 'authors': [{'first': '', 'middle': [], 'last': 'Pubmed | Crossref 16', 'suffix': ''}], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1148/radiol.2020200642']}}}, 'ref_entries': {'FIGREF0': {'text': 'Serial viral test results of multiple specimens and chest imaging of the patient. (A) Serial viral test results of the RNA-dependent RNA polymerase region of the ORF1b gene on real-time reverse transcription polymerase chain reaction are shown for multiple specimens according to the onset of symptoms. (B) Chest X-ray shows no infiltrations on admission, day 3 since symptom onset. (C) Chest CT performed on the fourth day since symptom onset demonstrates patchy nodular consolidations with peripheral ground glass opacities in subpleural areas of the right lower lobe in axial and sagittal views of CT. CT = computed tomography, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.', 'latex': None, 'type': 'figure'}}, 'back_matter': [{'text': 'We would like to thank all the staff and their families at the isolation unit and the office of Infection Control in the Seoul National University Bundang Hospital for their tireless efforts. We appreciate the hard work of all the members at Gyeonggi Infectious Disease Control Center. We thank Professor Hoan Jong Lee for his critical comments on this report. We also thank all the members of the Korean Society of Pediatric Infectious Diseases for their valuable advice on the management of this case. Lastly, we would like to thank the Korea', 'cite_spans': [], 'ref_spans': [], 'section': 'ACKNOWLEDGMENTS'}]}\n",
      "{'_id': ObjectId('5ea715f09e4506753119f22c'), 'paper_id': '0a2ded6cbd632857d491140a57f2773c3610b10b', 'metadata': {'title': 'MRI findings of neuronal ceroid lipofuscinosis in a cat', 'authors': [{'first': 'Crystal', 'middle': [], 'last': 'White', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': 'crwhite@alumni.rvc.ac.uk'}, {'first': 'Jeremy', 'middle': [], 'last': 'Mortier', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}, {'first': 'Ranieri', 'middle': [], 'last': 'Verin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}, {'first': 'Thomas', 'middle': [], 'last': 'Maddox', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}, {'first': 'Rita', 'middle': [], 'last': 'Goncalves', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}, {'first': 'Daniel', 'middle': [], 'last': 'Sanchez-Masian', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}]}, 'abstract': [{'text': 'Case summary A 2-year-old male domestic shorthair cat presented to the University of Liverpool Small Animal Teaching Hospital with a 2 week history of altered mentation, blindness and focal epileptic seizures. MRI examination revealed generalised cerebral and cerebellar atrophy, diffuse T2-weighted hyperintensity of the white matter and meningeal thickening. Neuronal ceroid lipofuscinosis was confirmed on post-mortem examination. Relevance and novel information This is the first report of the MRI findings of neuronal ceroid lipofuscinosis in a cat.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'This paper was handled and processed by the European Editorial Office (ISFM) for publication in JFMS Open Reports', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': \"A 2-year-old, 3.4 kg male neutered domestic shorthair cat presented to the University of Liverpool Small Animal Teaching Hospital with a 2 week history of progressive weight loss, altered mentation, blindness and suspected focal epileptic seizures. Relevant history included a single visit to the referring veterinary surgeon 6 months prior to presentation for nonspecific behavioural changes. On neurological examination, the cat's mentation was obtunded and disorientated. The menace response was markedly reduced bilaterally with intact pupillary light reflexes. Jaw clattering and hypersalivation were demonstrated intermittently, consistent with focal epileptic seizure activity. Stimulus resulted in hyper-reactivity and hypertonicity of all limbs, thus hindering a comprehensive neurological examination, including ophthalmological and visual assessment. Gait analysis was not possible owing to the cat's obtunded status and hyper-reactivity. The remaining general examination was unremarkable. Based on the clinical signs and limited neurological examination, a diffuse forebrain neurolocalisation was suspected. The main differential diagnoses for a 2-year-old cat with diffuse forebrain neurolocalisation included metabolic disease (lysosomal storage disease, thiamine deficiency, hepatic encephalopathy), infectious causes (feline infectious peritonitis, toxoplasmosis, bacterial meningitis), immune-mediated disease (meningoencephalitis of unknown origin), developmental disease (lissencephaly, microencephaly) and degenerative disease (neuroaxonal dystrophy and leukoencephalomyelopathy). Biochemistry, including fasting ammonia and preprandial bile acids, and haematology were within normal limits. Serological testing for feline leukaemia virus, feline immunodeficiency virus, feline coronavirus and toxoplasmosis were negative. Cerebrospinal fluid analysis, including total protein, total nucleated cell count and cytology, was unremarkable.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': 'MRI of the brain was performed using a 1.5 T magnet (Philips Ingenia CX). All slices were 3 mm thick with a 0.3 mm slice gap. Sagittal, dorsal and transverse T2-weighted (T2W) images were acquired. Transverse images for fluid-attenuated inversion recovery (FLAIR), T2*W, T1-weighted before and after intravenous administration of contrast medium (gadobutrol 0.1 mmol/kg bodyweight [Gadovist;', 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': 'Bayer]) and proton-density weighted sequences were obtained.', 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': 'On all sequences there was thinning of the cerebral and cerebellar cortices with widening of the corresponding sulci, demonstrating diffuse cortical atrophy. The corpus callosum was markedly thin and only partially visualised with absence of a visible rostrum, genu and body. Moderate, generalised symmetrical dilation of the ventricular system was present, with complete suppression of contents on FLAIR, indicating that the cerebrospinal fluid was not markedly abnormal. Mild, generalised, symmetrical and homogeneous increased T2W signal intensity of the cerebral white matter was visible, with consequent decrease in the distinction between the white and grey matter ( Figure 1 ). The pachymeninges were mildly and diffusely thickened.', 'cite_spans': [], 'ref_spans': [{'start': 673, 'end': 681, 'text': 'Figure 1', 'ref_id': 'FIGREF0'}], 'section': 'Case description'}, {'text': 'There were no regions of abnormal contrast enhancement. Generalised and marked thickening of the calvarium and osseous tentorium cerebelli was visible (calvarial hyperostosis) with reduction of the fat signal of the diploe ( Figure 2 ). The remaining bones of the skull were normal. Given the MRI findings and the signalment of the cat the presumptive diagnosis was an inherited neurodegenerative disorder, most likely neuronal ceroid lipofuscinosis or other lysosomal storage disease.', 'cite_spans': [], 'ref_spans': [{'start': 225, 'end': 233, 'text': 'Figure 2', 'ref_id': 'FIGREF2'}], 'section': 'Case description'}, {'text': \"Following the presumptive diagnosis of neurodegenerative lysosomal storage disease and worsening of clinical signs the cat was euthanased on humane grounds and underwent a full post-mortem examination. Grossly, the meninges were diffusely moderately thickened and the brain showed moderate diffuse and bilateral cortical atrophy with narrowing of gyri and widening of sulci The cat's left is on the right. Symmetric ventriculomegaly is apparent (*). There is poor white matter/grey matter distinction owing to diffuse hyperintensity of the white matter on T2W sequence. Marked cortical atrophy and widening of the cerebral sulci are visible (black arrow). Generalised, even calvarial hyperostosis is noted (white arrow) ( Figure 3a ). Subjectively, a mild dilation of the ventricular system was observed. Sections of meninges and relevant areas of the brain and cerebellum, including motor, somatosensory, limbic, vestibular and visual system, were sampled for histopathology and transmission electron microscopy (TEM). Samples of the spinal cord at the level of the cervical and lumbosacral intumescences (C5-T1 and L3-L6, respectively) were also obtained for histopathology.\", 'cite_spans': [], 'ref_spans': [{'start': 722, 'end': 731, 'text': 'Figure 3a', 'ref_id': 'FIGREF3'}], 'section': 'Case description'}, {'text': \"Meninges showed diffuse moderate thickening due to deposition of palely eosinophilic mature collagen interpreted as fibrosis and confirmed with Masson's trichrome stain. All cerebral areas examined showed mildto-moderate gliosis and moderate loss of neurons (more severe in cortical areas) with numerous neurons distended and enlarged by botryoid, palely acidophilic to glassy cytoplasmic inclusions (Figure 3b (Figure 3i ), consistent morphologically with previously described intra-neuronal lipofuscins in cats. [1] [2] [3] [4] No further gross and histopathological changes were observed in the main thoracic and abdominal organs, including autonomic ganglia. Furthermore, both eyes were thoroughly examined to rule out the presence of retinal neuronal inclusions and to confirm the suspect of central blindness. Neither eye showed histopathological changes.\", 'cite_spans': [{'start': 514, 'end': 517, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 518, 'end': 521, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 522, 'end': 525, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 526, 'end': 529, 'text': '[4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [{'start': 400, 'end': 410, 'text': '(Figure 3b', 'ref_id': 'FIGREF3'}, {'start': 411, 'end': 421, 'text': '(Figure 3i', 'ref_id': 'FIGREF3'}], 'section': 'Case description'}, {'text': 'To our knowledge this is the first report of MRI findings in a cat with confirmed neuronal ceroid lipofuscinosis. The neuronal ceroid lipofuscinoses represent a heterogeneous group of genetically determined neurodegenerative lysosomal storage diseases. The disease is characterised by abnormal accumulation of autofluorescent lipopigments within the neuronal and extraneural tissue. 5 Neuronal ceroid lipofuscinosis has been described in several domestic species, including dogs, cats, cattle, sheep, goats, monkeys and mice. [6] [7] [8] [9] [10] [11] [12] [13] Clinical signs are similar in all species, including humans, and involve progressive cognitive decline, motor dysfunction, vision deficits and epileptic seizures, ultimately resulting in death or euthanasia. Symptomatic management is generally the mainstay of treatment. 14 Encouraging results have, however, been seen using enzyme-replacement therapy and gene therapy. 15 Carnitine is a breakdown product of subunit c protein, a major component of the storage material that accumulates in a number of neuronal ceroid lipofuscinoses. Delays in cognitive dysfunction have been reported in English Springer Spaniels supplemented long term with carnitine. 15 However, despite these therapeutic advances, neuronal ceroid lipofuscinoses remain an incurable group of diseases.', 'cite_spans': [{'start': 383, 'end': 384, 'text': '5', 'ref_id': 'BIBREF4'}, {'start': 526, 'end': 529, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 530, 'end': 533, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 534, 'end': 537, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 538, 'end': 541, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 542, 'end': 546, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 547, 'end': 551, 'text': '[11]', 'ref_id': 'BIBREF10'}, {'start': 552, 'end': 556, 'text': '[12]', 'ref_id': 'BIBREF11'}, {'start': 557, 'end': 561, 'text': '[13]', 'ref_id': 'BIBREF12'}, {'start': 833, 'end': 835, 'text': '14', 'ref_id': 'BIBREF13'}, {'start': 932, 'end': 934, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 1215, 'end': 1217, 'text': '15', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The cat in this case demonstrated generalised and symmetrical brain cortical atrophy and secondary dilation of the ventricular system and intracranial subarachnoid space (hydrocephalus ex vacuo). These MRI findings have been consistently described in humans and dogs and are considered cardinal signs for neuronal ceroid lipofuscinosis. 10, [16] [17] [18] [19] The cat in this report also showed moderate meningeal thickening. This finding, not described in the human form of the disease, was also reported in three Chihuahuas and a Dachshund with neuronal ceroid lipofuscinosis. 9,20 An autoimmune cause of meningeal thickening has been alluded to; however, in the case of the Dachshund, a subdural haematoma was also identified and the findings of thickened meninges could represent reactive meningitis. In our case, the moderate meningeal thickening was due to the diffuse moderate hypertrophy and fibrosis, and could be interpreted as an adaptive change due to brain atrophy. Hyperostosis of the osseous tentorium cerebelli and calvarium is visible (black arrow). There is mild widening of the cerebellar sulci (<) due to cerebellar atrophy Diffuse T2W white matter hyperintensity with reduction in the white/grey matter distinction has not been previously described in the veterinary literature. A possible explanation for this could be that animals previously reported were scanned with lower field strength MRI magnets. Better contrast resolution of higher field magnets and newer MRI systems could account for this new finding. In humans, periventricular white matter T2W hyperintensity is a common finding in neuronal ceroid lipofuscinosis, confirmed as gliosis and demyelination on histology. In one study, the authors also described a diffuse increase in T2W signal intensity of the white matter. 21 Our patient showed a thinned and partially visualised corpus callosum, which, in this case, likely resulted from the generalised brain atrophy. Atrophy of the corpus callosum has also been described in dogs and humans with neuronal ceroid lipofuscinosis. 18, 22 The cat in our report had generalised calvarial hyperostosis. No skeletal abnormality has been previously described in the human or animal form of the disease. We believe calvarial hyperostosis developed in response to the chronic ex vacuo negative pressure induced by the brain cortical atrophy. Gross and histopathological findings were consistent with previous cases of neuronal ceroid lipofuscinosis in cats, [1] [2] [3] [4] and confirmed the presence of lysosomal storage neuronal disease with autofluorescent material. TEM showed the presence of characteristic small curvilinear lamellar stacks and electron-dense granular material, consistent morphologically with previously described intra-neuronal lipofuscins in cats, making the diagnosis of neuronal ceroid lipofuscinosis highly likely in this case. Ultrastructural intraneuronal deposits consistent with lipofuscins in cats have been described as granular osmophilic deposits (electron-dense granules), curved lamellar stacks and fingerprint profiles, although this latter, ultrastructural organisation was not observed in our case.', 'cite_spans': [{'start': 337, 'end': 340, 'text': '10,', 'ref_id': 'BIBREF9'}, {'start': 341, 'end': 345, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 346, 'end': 350, 'text': '[17]', 'ref_id': 'BIBREF16'}, {'start': 351, 'end': 355, 'text': '[18]', 'ref_id': 'BIBREF17'}, {'start': 356, 'end': 360, 'text': '[19]', 'ref_id': 'BIBREF18'}, {'start': 1808, 'end': 1810, 'text': '21', 'ref_id': 'BIBREF20'}, {'start': 2066, 'end': 2069, 'text': '18,', 'ref_id': 'BIBREF17'}, {'start': 2070, 'end': 2072, 'text': '22', 'ref_id': 'BIBREF21'}, {'start': 2486, 'end': 2489, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 2490, 'end': 2493, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 2494, 'end': 2497, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 2498, 'end': 2501, 'text': '[4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The cat in this case, and those reported in previous studies, 1, 2, 11 presented with neurological features in common with neuronal ceroid lipofuscinosis seen in other species, including humans. Initial manifestations of neuronal ceroid lipofuscinosis in humans occur typically between birth and young adulthood. This is mirrored in dogs and cats, with most reported cases presenting under 2 years of age, as seen in this cat. A case series of feline neuronal ceroid lipofuscinosis in three cats reported disorientation, focal (facial twitching) and generalised epileptic seizures, tactile hyperaesthesia and blindness; signs seen in this cat. 4 Similar signs are seen in humans, with a combination of retinopathy, dementia and epilepsy almost always being present. 23 In this case no lesions were observed bilaterally in the retina and therefore the blindness reported in this cat was likely central in origin.', 'cite_spans': [{'start': 62, 'end': 64, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 65, 'end': 67, 'text': '2,', 'ref_id': 'BIBREF1'}, {'start': 68, 'end': 70, 'text': '11', 'ref_id': 'BIBREF10'}, {'start': 644, 'end': 645, 'text': '4', 'ref_id': 'BIBREF3'}, {'start': 766, 'end': 768, 'text': '23', 'ref_id': 'BIBREF22'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'To date, 14 different genes have been implemented in the development of the human form of neuronal ceroid lipofuscinosis (CLN1-CLN14). Traditionally and still commonly encountered in the literature, nomenclature was based on the age of clinical presentation, for example infantile/juvenile/adult. The storage material, along with its ultrastructure, is variable for each neuronal ceroid lipofuscinosis type, and, although similar, the clinical course is slightly altered for each one. Molecular analysis has identified the genetic loci for the neuronal ceroid lipofuscinosis types in humans, with the exception of the CLN9 gene, which remains elusive. 23 The differences in the mutations account for the variable phenotypes between the types. 24 Mutations in nine different genes have been identified in dogs, eight of which are orthologues to the human causative mutations. 23, [25] [26] [27] [28] Sequencing of the exons of CLN1, CLN3, CLN5, CLN8 and CLN10 in a confirmed case of feline neuronal ceroid lipofuscinosis failed to identify the molecular cause in that patient. 4 The genes involved in the development of feline neuronal ceroid lipofuscinosis remain unidentified.', 'cite_spans': [{'start': 652, 'end': 654, 'text': '23', 'ref_id': 'BIBREF22'}, {'start': 743, 'end': 745, 'text': '24', 'ref_id': 'BIBREF23'}, {'start': 875, 'end': 878, 'text': '23,', 'ref_id': 'BIBREF22'}, {'start': 879, 'end': 883, 'text': '[25]', 'ref_id': 'BIBREF24'}, {'start': 884, 'end': 888, 'text': '[26]', 'ref_id': 'BIBREF25'}, {'start': 889, 'end': 893, 'text': '[27]', 'ref_id': 'BIBREF26'}, {'start': 894, 'end': 898, 'text': '[28]', 'ref_id': 'BIBREF27'}, {'start': 1076, 'end': 1077, 'text': '4', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'In humans and dogs, neuronal ceroid lipofuscinosis has been shown to be a recessively inherited disease with the progeny of two carrier parents having a one in four chance of developing the disease. 14 A second cat, from the same litter as the cat in this case, developed similar clinical signs 4 weeks after its littermate and was euthansed owing to severity of clinical signs. Histopathology and TEM confirmed neuronal ceroid lipofuscinosis in this second cat with central nervous system morphological changes similar to the cat described in this case. MRI was not performed in this second case, but pathological findings and the relationship between the two littermates reinforce the hypothesis of an inherited mutation in cats. 3 ', 'cite_spans': [{'start': 732, 'end': 733, 'text': '3', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Without knowledge of the causative genes involved in feline neuronal ceroid lipofuscinosis, definitive diagnosis is based on necropsy and histopathology results alone. MRI findings, combined with clinical signs, are the mainstay of the ante-mortem presumptive diagnosis. To support the use of this imaging modality in the ante-mortem diagnosis of feline neuronal ceroid lipofuscinosis, recruitment of more feline subjects with confirmed disease into similar descriptive studies is essential in identifying distinct MRI findings within this population. Owing to the similarities in the MRI findings in this cat and those seen in humans and dogs it could be assumed that the imaging features would be the same or similar in other cases of feline neuronal ceroid lipofuscinosis. It would seem prudent, therefore, to consider neuronal ceroid lipofuscinosis within the list of differentials when faced with a cat showing similar neurological signs as our case, with evidence of generalised cerebral and cerebellar atrophy and diffuse T2W hyperintensity of the white matter on MRI.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusions'}, {'text': 'The authors declared no potential conflicts of interest with respect to the research, authorship, and/ or publication of this article.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conflict of interest'}, {'text': 'The authors received no financial support for the research, authorship, and/or publication of this article.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Neuronal ceroid-lipofuscinosis in a domestic cat: clinical, morphological and immunohistochemical findings', 'authors': [{'first': 'H', 'middle': [], 'last': 'Weissenbeck', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Rossel', 'suffix': ''}], 'year': 1997, 'venue': 'J Comp Pathol', 'volume': '117', 'issn': '', 'pages': '17--24', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Neuronal ceroid-lipofuscinosis in a Japanese domestic shorthair cat', 'authors': [{'first': 'M', 'middle': [], 'last': 'Kuwamura', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nakagawa', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nabe', 'suffix': ''}], 'year': 2009, 'venue': 'J Vet Med Sci', 'volume': '71', 'issn': '', 'pages': '665--667', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Mutational analysis of the feline CLN3 gene and an ultrastructural evaluation of lysosomal storage material in a cat with neuronal ceroid lipofuscinosis: an investigation into the molecular basis of the disease', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Furusawa', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Mizukami', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yabuki', 'suffix': ''}], 'year': 2012, 'venue': 'Vet J', 'volume': '194', 'issn': '', 'pages': '425--428', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Characterization of neuronal ceroid-lipofuscinosis in 3 cats', 'authors': [{'first': 'M', 'middle': ['D'], 'last': 'Chalkley', 'suffix': ''}, {'first': 'A', 'middle': ['G'], 'last': 'Armien', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Gilliam', 'suffix': ''}], 'year': 2014, 'venue': 'Vet Pathol', 'volume': '51', 'issn': '', 'pages': '796--804', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Towards understanding the neuronal ceroid lipofuscinoses', 'authors': [{'first': 'A', 'middle': [], 'last': 'Kohlschutter', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Schulz', 'suffix': ''}], 'year': 2009, 'venue': 'Brain Dev', 'volume': '31', 'issn': '', 'pages': '499--502', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'A missensce mutation (c. 184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA', 'authors': [{'first': 'I', 'middle': [], 'last': 'Tammen', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Houweling', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Frugier', 'suffix': ''}], 'year': 2006, 'venue': 'Acta Biochim Biophys', 'volume': '1762', 'issn': '', 'pages': '898--905', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Neuronal ceroid-lipofuscinosis in Nubian goats', 'authors': [{'first': 'R', 'middle': ['A'], 'last': 'Fiske', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Storts', 'suffix': ''}], 'year': 1988, 'venue': 'Vet Pathol', 'volume': '25', 'issn': '', 'pages': '173--174', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Neurovisceral ceroid lipofuscinosis in blind Devon cattle', 'authors': [{'first': 'P', 'middle': ['A'], 'last': 'Harper', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Walker', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Healy', 'suffix': ''}], 'year': 1988, 'venue': 'Acta Neuropathol', 'volume': '75', 'issn': '', 'pages': '632--636', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Neuronal ceroidlipofuscinosis in longhaired Chihuahuas: clinical, pathological, and MRI findings', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Nakamoto', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Yamato', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Uchida', 'suffix': ''}], 'year': 2011, 'venue': 'J Am Anim Hosp Assoc', 'volume': '47', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Neuronal ceroid lipofuscinosis in 3 Australian shepherd littermates', 'authors': [{'first': 'D', 'middle': ['P'], 'last': 'O&apos;brien', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Katz', 'suffix': ''}], 'year': 2008, 'venue': 'J Vet Intern Med', 'volume': '22', 'issn': '', 'pages': '472--475', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Neuronal ceroidlipofuscinosis in a cat', 'authors': [{'first': 'R', 'middle': [], 'last': 'Bildfell', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Matwichuk', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mitchell', 'suffix': ''}], 'year': 1995, 'venue': 'Vet Pathol', 'volume': '32', 'issn': '', 'pages': '485--488', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': \"Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Battens's disease)\", 'authors': [{'first': 'R', 'middle': ['T'], 'last': 'Bronson', 'suffix': ''}, {'first': 'B', 'middle': ['D'], 'last': 'Lake', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Cook', 'suffix': ''}], 'year': 1993, 'venue': 'Ann Neurol', 'volume': '33', 'issn': '', 'pages': '381--385', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'An unsual case of generalized ceroid-lipofuscinosis in a Cynomolgus monkey', 'authors': [{'first': 'V', 'middle': [], 'last': 'Jasty', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Kowalski', 'suffix': ''}, {'first': 'E', 'middle': ['H'], 'last': 'Fonseca', 'suffix': ''}], 'year': 1984, 'venue': 'Vet Pathol', 'volume': '21', 'issn': '', 'pages': '46--50', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'The neuronal ceroidliposfusinoses', 'authors': [{'first': 'M', 'middle': [], 'last': 'Bennett', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Rakheja', 'suffix': ''}], 'year': 2013, 'venue': 'Dev Disabil Res Rev', 'volume': '17', 'issn': '', 'pages': '254--259', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Canine neuronal ceroid lipofusicnosis: a promising model for preclinical testing of therapeutic interventions', 'authors': [{'first': 'M', 'middle': ['L'], 'last': 'Katza', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Rustad', 'suffix': ''}, {'first': 'G', 'middle': ['O'], 'last': 'Robinson', 'suffix': ''}], 'year': 2017, 'venue': 'Neurobiol Dis', 'volume': '108', 'issn': '', 'pages': '277--287', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion)', 'authors': [{'first': 'I', 'middle': [], 'last': 'Jarvela', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Autti', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Lamminranta', 'suffix': ''}], 'year': 1997, 'venue': 'Ann Neurol', 'volume': '42', 'issn': '', 'pages': '799--802', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'MRI in neuronal ceroid lipofuscinosis', 'authors': [{'first': 'L', 'middle': [], 'last': 'D&apos;incerti', 'suffix': ''}], 'year': 2000, 'venue': 'Neurol Sci', 'volume': '21', 'issn': '', 'pages': '71--73', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'MRI of neuronal ceroid lipofuscinosis', 'authors': [{'first': 'T', 'middle': [], 'last': 'Autti', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Ranininko', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Vanhanen', 'suffix': ''}], 'year': 1996, 'venue': 'Neuroradiol', 'volume': '38', 'issn': '', 'pages': '476--482', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Magnetic resonance of neuronal ceroid lipofuscinosis in a Border collie', 'authors': [{'first': 'H', 'middle': [], 'last': 'Koie', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Shibuya', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Sato', 'suffix': ''}], 'year': 2004, 'venue': 'J Vet Med Sci', 'volume': '66', 'issn': '', 'pages': '1453--1456', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Neuronal ceroid lipofuscinosis with a chronic subdural hematoma', 'authors': [{'first': 'M', 'middle': ['G'], 'last': 'Asakawa', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Mackillop', 'suffix': ''}, {'first': 'N', 'middle': ['J'], 'last': 'Olby', 'suffix': ''}], 'year': 2010, 'venue': 'Vet Radiol Ultrasound', 'volume': '51', 'issn': '', 'pages': '155--158', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Neuroimaging of lipid storage disorders', 'authors': [{'first': 'D', 'middle': [], 'last': 'Rieger', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Auerbach', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Robinson', 'suffix': ''}], 'year': 2013, 'venue': 'Dev Disabil Res Rev', 'volume': '17', 'issn': '', 'pages': '269--282', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Magnetic resonance findings of the corpus callosum in canine and feline lysosomal storage diseases', 'authors': [{'first': 'D', 'middle': [], 'last': 'Hasegawa', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Tamura', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Nakamoto', 'suffix': ''}], 'year': 2013, 'venue': 'PLOS One', 'volume': '8', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Neuronal ceroid lipofuscinoses', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Nita', 'suffix': ''}, {'first': 'Mole', 'middle': [], 'last': 'Se', 'suffix': ''}, {'first': 'B', 'middle': ['A'], 'last': 'Minassian', 'suffix': ''}], 'year': 2016, 'venue': 'Epileptic Disord', 'volume': '18', 'issn': '2', 'pages': '73--88', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Correlations between genotype, ultrastructural morphology and clinical phenotype in neuronal ceroid lipofuscinoses', 'authors': [{'first': 'S', 'middle': ['E'], 'last': 'Mole', 'suffix': ''}, {'first': 'Williams', 'middle': [], 'last': 'Re', 'suffix': ''}, {'first': 'H', 'middle': ['H'], 'last': 'Goebel', 'suffix': ''}], 'year': 2005, 'venue': 'Neurogenetics', 'volume': '6', 'issn': '', 'pages': '107--126', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Sanders', 'suffix': ''}, {'first': 'F', 'middle': ['H'], 'last': 'Farias', 'suffix': ''}, {'first': 'G', 'middle': ['S'], 'last': 'Johnson', 'suffix': ''}], 'year': 2010, 'venue': 'Mol Genet Metab', 'volume': '100', 'issn': '', 'pages': '349--356', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Melville', 'suffix': ''}, {'first': 'C', 'middle': ['L'], 'last': 'Wilson', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Chiang', 'suffix': ''}], 'year': 2005, 'venue': 'Genomics', 'volume': '86', 'issn': '', 'pages': '287--294', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid lipofuscinosis', 'authors': [{'first': 'M', 'middle': ['L'], 'last': 'Katz', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Khan', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Awano', 'suffix': ''}], 'year': 2005, 'venue': 'Biochem Biophys Res Commun', 'volume': '327', 'issn': '', 'pages': '541--547', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier', 'authors': [{'first': 'A', 'middle': [], 'last': 'Wohlke', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Philipp', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Bock', 'suffix': ''}], 'year': 2001, 'venue': 'PLoS One', 'volume': '7', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': '(a) T2-weighted (T2W), (b) fluid-attenuated inversion recovery, (c) T1-weighted (T1W) and (d) T1W post-contrast transverse images of the brain at the level of the third ventricle.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': \"), with frequent marginalisation of nuclei. Intracytoplasmic vacuoles resulted markedly positive to Luxol fast blue stain (Figure 3c), moderately positive to periodic acid-Schiff (Figure 3d) and stained red with Masson's trichrome (Figure 3e). When observed under a fluorescent microscope (excitation 465-495 nm) the cytoplasmic material showed green autofluorescence (Figure 3f). The cerebellum and the spinal cord were the least affected areas with well-represented neuronal cells showing few (very rare in the spinal cord) intracytoplasmic inclusions. Ultrastructural examination of the intracytoplasmic neuronal deposits in the occipital cortex showed electrondense, membrane-bound material (Figure 3g) composed of small curvilinear lamellar stacks (Figure 3h) and electron-dense, variably sized granular material\", 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'T2-weighted sagittal image of the brain. Moderate dilation of the third and fourth ventricles is apparent.', 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': \"(a) Gross appearance of fresh cross section of the brain at the level of the hippocampus showing moderate atrophy with widening of sulci. (b) Hippocampus, cornu ammonis with pyramidal neurons (arrows) showing intracytoplasmic botryoid deposits of eosinophilic glassy material often associated with marginalisation of nuclei (inset). (c-e) Intracytoplasmic deposits are markedly positive to (c) Luxol fast blue, (d) moderately positive to periodic acid-Schiff stain and (e) red stained with Masson's trichrome stain. (f) Pyramidal neurons show green autofluorescence when observed under the fluorescent microscope (excitation 465-495 nm). (g-i) Transmission electron microscopy of occipital cortical neurons showing (g) membrane-bound material composed of (h) small curvilinear lamellar stacks and (i) electron-dense variably sized granular material morphologically consistent with lipofuscins\", 'latex': None, 'type': 'figure'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715f0b5af3feae5e75cdb'), 'paper_id': '0a449e173239afb38816257e1a53811b47bf13f4', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'sion was diagnosed between 1 and 19 months after discharge from an Ebola treatment center among survivors of EVD in Conakry. 7 Several studies have reported mental health issues in MERSrelated patients. In a study of subjects who had been isolated because they had had contact with a MERS patient, 7.6% showed anxiety and 16.6% had developed feelings of anger during the isolation period. 8 A cross-sectional study that examined the mental health of nurses working at a governmentdesignated hospital during a MERS-Coronavirus (CoV) outbreak revealed that the influences of stigma and hardiness on mental health are partially mediated through stress. 9 Psychological trauma of MERS victims and bereaved families has also been anecdotally reported, 10 as many patients suffer from rumors and discrimination even after being treated and cleared of the disease.', 'cite_spans': [{'start': 125, 'end': 126, 'text': '7', 'ref_id': 'BIBREF6'}, {'start': 389, 'end': 390, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 650, 'end': 651, 'text': '9', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': ''}, {'text': 'However, few studies have addressed chronic fatigue and mental health among survivors after a MERS infection in South Korea. Moreover, the relationship between them is unclear, although understanding their relationship is important to identify EID survivors who are at high risk for chronic fatigue and mental health problems and to provide targeted interventions and treatments.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Thus, we investigated symptoms of chronic fatigue, PTSD, and depression in survivors after a MERS epidemic and the relationships among them. A serial multiple mediation model with one independent variable was used. The purpose of this study is to examine the longitudinal mediating effects of depressions between chronic fatigue and later PTSSs for the MERS survivors. Through this, we will reveal predictive factors of PTSSs and we would utilize practical interventions for improving the PTSSs through the development of programs. Furthermore, this study will be utilized as a basis to establish the policy to improve the detrimental mental health effects of the EID infection to survivors.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'The study data were obtained from a multi-centered prospective follow-up study of MERS survivors in the Republic of Korea. All survivors with confirmed MERS infection were invited to participate in the study 12 months after the MERS outbreak had ended and follow-up in every 6 months later. Personalized letters and subsequent telephone contact were made to invite subjects to participate, and assessments were arranged.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participants and procedures'}, {'text': 'Of 148 survivors, 72 (48.65%) consented to be registered. The assessments were performed 12 months (T1) and 18 months (T2) after the MERS outbreak in five hospitals: National Medi-cal Center (n=15), Seoul National University Hospital (n=17), Chungnam National University Hospital (n=13), Seoul Medical Center (n=12), and Dankook University Hospital (n=6). All participants visited the hospitals for regular health checkups and completed self-report questionnaires. The complete responses from 63 and 54 participants were gathered at T1 and T2, respectively. Only data from 52 subjects who completed both assessments were analyzed to examine the relationships among the relevant psychological variables.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participants and procedures'}, {'text': 'Data on demographic variables including sex, age, job, and marriage were gathered. Data on medical illnesses prior to MERS and a psychiatric history were also collected. Participants completed several scales, including the Fatigue Severity Scale (FSS), the Patient Health Questionnaire-9 (PHQ-9), and the Impact of Event Scale-Revised (IES-R).', 'cite_spans': [], 'ref_spans': [], 'section': 'Variables and measurements'}, {'text': 'The FSS is a Likert scale consisting of nine items that assess fatigue severity and functionality during the past one week. 11 Items are rated on a scale of 1 to 7 according to their level of agreement with a given statement, and include such statements as \"I am easily fatigued\" or \"fatigue interferes with carrying out certain duties and responsibilities. \" Values for each item were averaged for a composite score, with higher scores indicating higher levels of impairment from fatigue and fatigue was largely independent of self-reported depressive symptoms. 11 Using the Korean FSS 12 index of 3.22 as the cutoff point, sensitivity was 84.1% and specificity was 85.7% for the fatigue and control groups, respectively. Factor analysis showed first factor was recognition of fatigue and second factor was the interference of fatigue on functioning in physical, family and social area. 12 The PHQ-9 13 is used to monitor depression severity. The questionnaire consists of nine items based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria for depression, scored from 0 to 3, providing a severity score ranging from 0 to 27. Accordingly, depression severity was defined as no depression (1-4), mild depression (5-9), moderate depression (10) (11) (12) (13) (14) , moderately severe depression (15) (16) (17) (18) (19) , and severe depression (20) (21) (22) (23) (24) (25) (26) (27) . The Korean version of the PHQ-9 is a reliable and valid tool for screening and assessing depressed patients (Cronbach\\'s alpha coefficient=0.81). 14 The IES-R was designed to assess symptoms associated with PTSD following a traumatic life event (MERS infection in our study). Symptoms are measured on 22 self-reported items for a total subjective stress assessment that can be further divided into intrusion, avoidance, and hyperarousal subscales. Individual items describe difficulties associated with stressful events, and participants were asked to indicate the extent to which each item distressed or bothered them over the last 7 days using a rating scale of 0-4. A total score ≥25 is considered clinically significant. 15', 'cite_spans': [{'start': 124, 'end': 126, 'text': '11', 'ref_id': 'BIBREF10'}, {'start': 563, 'end': 565, 'text': '11', 'ref_id': 'BIBREF10'}, {'start': 888, 'end': 890, 'text': '12', 'ref_id': 'BIBREF11'}, {'start': 1274, 'end': 1278, 'text': '(10)', 'ref_id': 'BIBREF9'}, {'start': 1279, 'end': 1283, 'text': '(11)', 'ref_id': 'BIBREF10'}, {'start': 1284, 'end': 1288, 'text': '(12)', 'ref_id': 'BIBREF11'}, {'start': 1289, 'end': 1293, 'text': '(13)', 'ref_id': 'BIBREF12'}, {'start': 1294, 'end': 1298, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 1330, 'end': 1334, 'text': '(15)', 'ref_id': 'BIBREF14'}, {'start': 1335, 'end': 1339, 'text': '(16)', 'ref_id': 'BIBREF15'}, {'start': 1340, 'end': 1344, 'text': '(17)', 'ref_id': 'BIBREF16'}, {'start': 1345, 'end': 1349, 'text': '(18)', 'ref_id': 'BIBREF17'}, {'start': 1350, 'end': 1354, 'text': '(19)', 'ref_id': 'BIBREF18'}, {'start': 1379, 'end': 1383, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 1384, 'end': 1388, 'text': '(21)', 'ref_id': 'BIBREF20'}, {'start': 1389, 'end': 1393, 'text': '(22)', 'ref_id': 'BIBREF21'}, {'start': 1394, 'end': 1398, 'text': '(23)', 'ref_id': 'BIBREF22'}, {'start': 1399, 'end': 1403, 'text': '(24)', 'ref_id': 'BIBREF23'}, {'start': 1404, 'end': 1408, 'text': '(25)', 'ref_id': 'BIBREF24'}, {'start': 1409, 'end': 1413, 'text': '(26)', 'ref_id': None}, {'start': 1414, 'end': 1418, 'text': '(27)', 'ref_id': None}, {'start': 1566, 'end': 1568, 'text': '14', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Variables and measurements'}, {'text': \"All statistical analyses were performed using the Statistical Package for Social Science 18.0 software (SPSS Inc., Chicago, IL, USA). We performed Paired T-test to examine significant changes in all mean scores over the time period. Pearson's correlation analyses were used to determine the relationships among chronic fatigue (T1 FSS), depression (T1 PHQ, T2 PHQ), and PTSS (T2 IES). The hypothesis that chronic fatigue affects PTSS through depression was examined using the serial multiple mediation model, which is a kind of multiple regression in the SPSS PROCESS macro. 16, 17 Serial multiple-mediated-effects analyses were conducted with 5,000 bootstrap-ping repetitions. Confidence intervals that did not include 0 were considered significant. All tests were two-sided. A pvalue <0.05 was considered significant.\", 'cite_spans': [{'start': 575, 'end': 578, 'text': '16,', 'ref_id': 'BIBREF15'}, {'start': 579, 'end': 581, 'text': '17', 'ref_id': 'BIBREF16'}], 'ref_spans': [], 'section': 'Statistical analyses'}, {'text': 'The present study protocol was reviewed and approved by the Institutional Review Board of the National Medical Center (IRB No. H-1510-059-007). Informed consent was submitted by all subjects when they were enrolled. All participants were informed that they could withdraw from the study at any time. Table 1 presents the demographic and clinical characteris- In all, 23.08% of cases were healthcare workers when they were infected with MERS. The mean number of hospitalization days was 21.00 (SD=21.76). The mean number of days from symptoms to the confirmed diagnosis was 4.50 (SD=4.12), and the mean total days of illness was 23.00 (SD=27.11). About 36.54% (n=19) of participants had suffered from pneumonia, 19 .23% (n=10) had been treated with a ventilator, and 3.85% (n=2) had been treated with extracorporeal membrane oxygenation during the acute MERS treatment period.', 'cite_spans': [{'start': 711, 'end': 713, 'text': '19', 'ref_id': 'BIBREF18'}], 'ref_spans': [{'start': 300, 'end': 307, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'Ethics statement'}, {'text': 'Changes in the number of subjects with clinically relevant symptoms over time are shown in Table 1 . The PHQ-9 scores indicated that 26.92% (T1), 17.31% (T2) of subjects had clinically relevant depressive symptoms. In addition, 48.08% (T1), 32.69% (T2) had clinically relevant chronic fatigue according to their FSS scores. In terms of the IES-R assessment, 42.31% (T1), 26.92% (T2) had scores above the cut-off point for PTSD. Table 2 shows the correlations among the variables of interest included in the hypothetical model. All correlations across the variables of interest were significant. FSS (T1) scores were positively correlated with scores on the PHQ-9 (T1, T2) and the IES-R (T2). Mean scores of all of the scales were lower at T2 than at T1. The mean FSS score changed significantly from 3.50 (SD=1.88) to 2.78 (SD=1.89), and that of the IES-R decreased significantly from 25.83 (SD=20.05) to 19 .29 (SD=21.03). The mean score of the PHQ-9 decreased from 6.50 (SD=5.69) to 5.42 (SD=5.71) but we could not find significance.', 'cite_spans': [{'start': 905, 'end': 907, 'text': '19', 'ref_id': 'BIBREF18'}], 'ref_spans': [{'start': 91, 'end': 98, 'text': 'Table 1', 'ref_id': 'TABREF0'}, {'start': 428, 'end': 435, 'text': 'Table 2', 'ref_id': 'TABREF1'}], 'section': 'RESULTS'}, {'text': 'The serial multiple-mediation model, which included T1 FSS, T1 PHQ-9, and T2 PHQ-9, accounted for 34.19% of the Moreover, bootstrap analyses revealed that the positive indirect effects of T1 FSS on T2 IES-R through T1 PHQ-9 and T2 PHQ-9 were significant (B=2.1601, SE=1.3268, 95% confidence interval=0.4250-6.1307) ( Table 3) . These results indicate that both T1 PHQ and T2 PHQ-9 fully mediated the effects of T1 FSS on T2 IES-R (Figure 1 ), which suggests that both T1 PHQ and T2 PHQ-9 eliminated the direct effects of T1 FSS on T2 IES-R.', 'cite_spans': [], 'ref_spans': [{'start': 317, 'end': 325, 'text': 'Table 3)', 'ref_id': 'TABREF2'}, {'start': 430, 'end': 439, 'text': '(Figure 1', 'ref_id': 'FIGREF1'}], 'section': 'RESULTS'}, {'text': 'Chronic fatigue 12 months post-MERS had indirect effects on prolonged PTSSs 18 months post-MERS via persisting depression in MERS survivors. This is in agreement with a longitudinal study 18 of anxiety, depression, and fatigue in patients with multiple sclerosis that showed that depression strongly predicts anxiety and fatigue, and that anxiety and fatigue strongly predict subsequent depression. Moreover, previous studies conducted on subjects who had experienced disasters noted that current depression is a predictor of PTSSs. 19 The rate of participants reported clinically significant symptoms in CFS (32.7-48.1%), depression (17.3-26.9%), and PTSD (26.9-42.3%) was comparable to that following SARS. 4 In a 4-year survey in Hong Kong, more than 40% of the respondents had active psychiatric illness, and 40.3% reported a chronic fatigue problem. 20 In addition, a cohort study that investigated psychiatric complications among SARS survivors 30 months after infection found that the prevalence of any psychiatric disorder was 33.3%; 25.6% of patients had PTSD and 15.6% had depressive disorders. 21 Moreover, MERS survivors shared similar psychopathologies as other disaster survivors 22 who reported varying rates of PTSD (30-40%), 23 depression (25%), and fatigue symptoms (50%). These findings suggest that EIDs result not only in physical problems but also psychiatric sequelae in infected persons because they might experience those as disastrous events.', 'cite_spans': [{'start': 188, 'end': 190, 'text': '18', 'ref_id': 'BIBREF17'}, {'start': 533, 'end': 535, 'text': '19', 'ref_id': 'BIBREF18'}, {'start': 709, 'end': 710, 'text': '4', 'ref_id': 'BIBREF3'}, {'start': 855, 'end': 857, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 1105, 'end': 1107, 'text': '21', 'ref_id': 'BIBREF20'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Fatigue is a prominent disabling symptom in a variety of medical and neurologic disorders. In EIDs survivors, the Coronavirus itself may have directly caused sleep disorders, fatigue, and behavioral symptoms, which in turn may have resulted in chronic post-inflammatory central nervous system pathologies that adversely affected sleep, pain sensitivity, and energy. 2 It is noteworthy that chronic fatigue syndrome (CFS) shares many symptoms with depression and the two are frequently co-diagnosed. 24 However, according to the study which measure the fatigue severity among patients with multiple sclerosis, patients with systemic lupus erythematosus, and healthy adults, fatigue was largely independent of self-reported depressive symptoms. 11 Despite this, the current study appears to be the only longitudinal examination of chronic fatigue, depression, and PTSSs in EIDs survivors.', 'cite_spans': [{'start': 366, 'end': 367, 'text': '2', 'ref_id': 'BIBREF1'}, {'start': 499, 'end': 501, 'text': '24', 'ref_id': 'BIBREF23'}, {'start': 743, 'end': 745, 'text': '11', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'We found that the severities of chronic fatigue and PTSS improved significantly but that of depression relatively unchanged throughout the study period. Although this was the short-term follow-up study, these results suggest we should give attention to the persisting depression during recovery period in MERS survivors. It would be important for clinicians to assess depression among EIDs survivors with CFS. Furthermore our findings suggest the need to promote interventional programs for MERS survivors with chronic fatigue to prevent prolonged PTSSs by ameliorate depression. Two pos- sible treatments for chronic fatigue syndrome (CFS) are cognitive behavioral therapy and graded exercise therapy. 25 There is less clear evidence of the benefit of drug therapy for CFS in patients without comorbid depression or anxiety disorders. There were several limitations to this study. First, some sampling bias may have occurred, as <50% of the MERS survivors in Korea consented to participate in the study. It is possible that people who were heavily affected by MERS or who were experiencing mental health difficulties were more prone to participate in the research. In addition, mental health and fatigue symptoms were evaluated using self-reported measures that are not diagnostic in nature but result in assessments of symptomatology. However, these measures have demonstrated validity and reliability in Korea and are consistently correlated with more comprehensive diagnostic tools used to assess corresponding symptoms. Despite these limitations, the present study is the first to examine the relationships among chronic fatigue, depression, and PTSSs in survivors after the MERS epidemic in Korea.', 'cite_spans': [{'start': 703, 'end': 705, 'text': '25', 'ref_id': 'BIBREF24'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In summary, this longitudinal study revealed that many MERS survivors suffered from chronic fatigue and mental health problems even more than 1 year after the outbreak in South Korea, although three scores showed a decreasing trend. The prevalence rates of CFS, depression, and PTSD were 32.7%, 17.3%, and 26.9%, respectively, 18 months after the MERS outbreak. Furthermore, chronic fatigue 12 months post-MERS had an indirect effect on prolonged PTSS 18 months post-MERS through depression among survivors. Our findings may inform future strategies for detecting survivors who are at high risk for PTSD and for promoting long-term mental health outcomes in the event of other EIDs.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study', 'authors': [{'first': 'S', 'middle': ['Y'], 'last': 'Cho', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Kang', 'suffix': ''}, {'first': 'Y', 'middle': ['E'], 'last': 'Ha', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Park', 'suffix': ''}, {'first': 'J', 'middle': ['Y'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Ko', 'suffix': ''}], 'year': 2016, 'venue': 'Lancet', 'volume': '388', 'issn': '', 'pages': '994--1001', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study', 'authors': [{'first': 'H', 'middle': [], 'last': 'Moldofsky', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Patcai', 'suffix': ''}], 'year': 2011, 'venue': 'BMC Neurol', 'volume': '11', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Tansey', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Louie', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Loeb', 'suffix': ''}, {'first': 'W', 'middle': ['L'], 'last': 'Gold', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Muller', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'De Jager', 'suffix': ''}], 'year': 2007, 'venue': 'Arch Intern Med', 'volume': '167', 'issn': '', 'pages': '1312--1320', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Stress and psychological distress among SARS survivors 1 year after the outbreak', 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Wong', 'suffix': ''}, {'first': 'G', 'middle': ['M'], 'last': 'Mcalonan', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Cheung', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Cheung', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Sham', 'suffix': ''}], 'year': 2007, 'venue': 'Can J Psychiatry', 'volume': '52', 'issn': '', 'pages': '233--240', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Mental health impact of severe acute respiratory syndrome: a prospective study', 'authors': [{'first': 'Y', 'middle': ['K'], 'last': 'Wing', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Leung', 'suffix': ''}], 'year': 2012, 'venue': 'Hong Kong Med J', 'volume': '18', 'issn': '', 'pages': '24--27', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'An evaluation of psychological distress and social support of survivors and contacts of Ebola virus disease infection and their relatives in Lagos, Nigeria: a cross sectional study--2014', 'authors': [{'first': 'A', 'middle': [], 'last': 'Mohammed', 'suffix': ''}, {'first': 'T', 'middle': ['L'], 'last': 'Sheikh', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Gidado', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Poggensee', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Nguku', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Olayinka', 'suffix': ''}], 'year': 2015, 'venue': 'BMC Public Health', 'volume': '15', 'issn': '', 'pages': '1--8', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort', 'authors': [{'first': 'M', 'middle': ['M'], 'last': 'Keita', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Taverne', 'suffix': ''}, {'first': 'Sy', 'middle': [], 'last': 'Savané', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'March', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Doukoure', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sow', 'suffix': ''}, {'first': 'M', 'middle': ['S'], 'last': '', 'suffix': ''}], 'year': 2017, 'venue': 'BMC Psychiatry', 'volume': '17', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Mental health status of people isolated due to Middle East Respiratory Syndrome', 'authors': [{'first': 'H', 'middle': [], 'last': 'Jeong', 'suffix': ''}, {'first': 'H', 'middle': ['W'], 'last': 'Yim', 'suffix': ''}, {'first': 'Y', 'middle': ['J'], 'last': 'Song', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ki', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Min', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Cho', 'suffix': ''}], 'year': 2016, 'venue': 'Epidemiol Health', 'volume': '38', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Mental health of nurses working at a government-designated hospital during a MERS-CoV outbreak: a cross-sectional study', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Park', 'suffix': ''}, {'first': 'E', 'middle': ['H'], 'last': 'Lee', 'suffix': ''}, {'first': 'N', 'middle': ['R'], 'last': 'Park', 'suffix': ''}, {'first': 'Y', 'middle': ['H'], 'last': 'Choi', 'suffix': ''}], 'year': 2018, 'venue': 'Arch Psychiatr Nurs', 'volume': '32', 'issn': '', 'pages': '2--6', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Psychological trauma of Middle East Respiratory Syndrome victims and bereaved families', 'authors': [{'first': 'M', 'middle': [], 'last': 'Sim', 'suffix': ''}], 'year': 2016, 'venue': 'Epidemiol Health', 'volume': '38', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus', 'authors': [{'first': 'L', 'middle': ['B'], 'last': 'Krupp', 'suffix': ''}, {'first': 'N', 'middle': ['G'], 'last': 'Larocca', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Muir-Nash', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Steinberg', 'suffix': ''}], 'year': 1989, 'venue': 'Arch Neurol', 'volume': '46', 'issn': '', 'pages': '1121--1123', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression', 'authors': [{'first': 'K', 'middle': ['I'], 'last': 'Chung', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Song', 'suffix': ''}], 'year': 2001, 'venue': 'Korean J Psychosom Med', 'volume': '9', 'issn': '', 'pages': '164--173', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'The PHQ-9: validity of a brief depression severity measure', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kroenke', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Spitzer', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Williams', 'suffix': ''}], 'year': 2001, 'venue': 'J Gen Intern Med', 'volume': '16', 'issn': '', 'pages': '606--613', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'The PHQ-9: a new depression diagnostic and severity measure', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kroenke', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Spitzer', 'suffix': ''}], 'year': 2002, 'venue': 'Psychiatr Ann', 'volume': '32', 'issn': '', 'pages': '509--515', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'A study on reliability and validity of the Korean version of impact of event scale-revised', 'authors': [{'first': 'H', 'middle': ['J'], 'last': 'Eun', 'suffix': ''}, {'first': 'T', 'middle': ['W'], 'last': 'Kwon', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Lee', 'suffix': ''}, {'first': 'T', 'middle': ['H'], 'last': 'Kim', 'suffix': ''}, {'first': 'M', 'middle': ['R'], 'last': 'Choi', 'suffix': ''}, {'first': 'S', 'middle': ['J'], 'last': 'Cho', 'suffix': ''}], 'year': 2005, 'venue': 'J Korean Neuropsychiatr Assoc', 'volume': '44', 'issn': '', 'pages': '303--310', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'PROCESS: a versatile computational tool for observed variable mediation, moderation, and conditional process modeling (White paper)', 'authors': [{'first': 'A', 'middle': ['F'], 'last': 'Hayes', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Introduction to Mediation, Moderation, and Conditional Process Analysis: a Regression-Based Approach', 'authors': [{'first': 'A', 'middle': ['F'], 'last': 'Hayes', 'suffix': ''}], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis', 'authors': [{'first': 'R', 'middle': ['F'], 'last': 'Brown', 'suffix': ''}, {'first': 'E', 'middle': ['M'], 'last': 'Valpiani', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Tennant', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Dunn', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sharrock', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Hodgkinson', 'suffix': ''}], 'year': 2009, 'venue': 'Psychol Psychother', 'volume': '82', 'issn': '', 'pages': '41--56', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Predictors of posttraumatic outcomes following the 1999 Taiwan earthquake', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Chang', 'suffix': ''}, {'first': 'K', 'middle': ['M'], 'last': 'Connor', 'suffix': ''}, {'first': 'T', 'middle': ['J'], 'last': 'Lai', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Davidson', 'suffix': ''}], 'year': 2005, 'venue': 'J Nerv Ment Dis', 'volume': '193', 'issn': '', 'pages': '40--46', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up', 'authors': [{'first': 'M', 'middle': ['H'], 'last': 'Lam', 'suffix': ''}, {'first': 'Y', 'middle': ['K'], 'last': 'Wing', 'suffix': ''}, {'first': 'M', 'middle': ['W'], 'last': 'Yu', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Leung', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Ma', 'suffix': ''}, {'first': 'A', 'middle': ['P'], 'last': 'Kong', 'suffix': ''}], 'year': 2009, 'venue': 'Arch Intern Med', 'volume': '169', 'issn': '', 'pages': '2142--2147', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Long-term psychiatric morbidities among SARS survivors', 'authors': [{'first': 'Iwc', 'middle': [], 'last': 'Mak', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Chu', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Pan', 'suffix': ''}, {'first': 'Mgc', 'middle': [], 'last': 'Yiu', 'suffix': ''}, {'first': 'V', 'middle': ['L'], 'last': 'Chan', 'suffix': ''}], 'year': 2009, 'venue': 'Gen Hosp Psychiatry', 'volume': '31', 'issn': '', 'pages': '318--326', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Post-disaster mental health problems and the utilization of mental health services: a four-year longitudinal comparative study', 'authors': [{'first': 'Pgv', 'middle': [], 'last': 'Velden', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Grievink', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Kleber', 'suffix': ''}, {'first': 'A', 'middle': ['N'], 'last': 'Drogendijk', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Roskam', 'suffix': ''}, {'first': 'F', 'middle': ['G'], 'last': 'Marcelissen', 'suffix': ''}], 'year': 2006, 'venue': 'Adm Policy Ment Health', 'volume': '33', 'issn': '', 'pages': '279--288', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Post-traumatic stress disorder following disasters: a systematic review', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Neria', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Nandi', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Galea', 'suffix': ''}], 'year': 2008, 'venue': 'Psychol Med', 'volume': '38', 'issn': '', 'pages': '467--480', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey', 'authors': [{'first': 'E', 'middle': [], 'last': 'Fuller-Thomson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Nimigon', 'suffix': ''}], 'year': 2008, 'venue': 'Fam Pract', 'volume': '25', 'issn': '', 'pages': '414--422', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Chronic fatigue syndrome: diagnosis and treatment', 'authors': [{'first': 'J', 'middle': ['R'], 'last': 'Yancey', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Thomas', 'suffix': ''}], 'year': 2012, 'venue': 'Am Fam Physician', 'volume': '86', 'issn': '', 'pages': '741--746', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'p<0.001. FSS: Fatigue Severity Scale, PHQ: Patient Health Questionnaire-9, IES: Impact of Event Scale, T1: 12 months after MERS, T2: 18 months after MERS. MERS: Middle East respiratory syndrome, SD: standard deviation', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': \"Model depicting the effect of severe fatigue, depression on post-trauma of MERS. **p<0.01, ***p<0.001. FSS: Fatigue Severity Scale, PHQ: Patient Health Quetionnaire-9, IES: Impact of Event Scale, T1: 12 months after MERS, T2: 18 months after MERS, c': direct effect of X on Y (X=T1 FSS; Y=T2 IES), ns: not significant. MERS: Middle East respiratory syndrome.\", 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Demographic and clinical characteristics of participants', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Descriptive data and correlations among variables (N=52)', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'The Bootstrap results for the indirect effect of 12 months severe fatigue on 18 months impact of traumatic event between 12 and 18 months depression', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715f02ba8aca292fc6272'), 'paper_id': '0a64b2c55fc2091358da4f83ac6fdc7701ddb46e', 'metadata': {'title': 'A rapid, inexpensive yeast-based dual-fluorescence assay of programmed-1 ribosomal frameshifting for high-throughput screening', 'authors': [{'first': 'Rasa', 'middle': [], 'last': 'Rakauskaite', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Maryland', 'location': {'postCode': '20742', 'settlement': 'College Park', 'region': 'MD'}}, 'email': ''}, {'first': 'Pei-Yu', 'middle': [], 'last': 'Liao', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Delaware', 'location': {'postCode': '19716', 'settlement': 'Newark', 'region': 'DE', 'country': 'USA'}}, 'email': ''}, {'first': 'Michael', 'middle': ['H J'], 'last': 'Rhodin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Maryland', 'location': {'postCode': '20742', 'settlement': 'College Park', 'region': 'MD'}}, 'email': ''}, {'first': 'Kelvin', 'middle': [], 'last': 'Lee', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Delaware', 'location': {'postCode': '19716', 'settlement': 'Newark', 'region': 'DE', 'country': 'USA'}}, 'email': ''}, {'first': 'Jonathan', 'middle': ['D'], 'last': 'Dinman', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Maryland', 'location': {'postCode': '20742', 'settlement': 'College Park', 'region': 'MD'}}, 'email': ''}]}, 'abstract': [{'text': 'Programmed À1 ribosomal frameshifting (À1 PRF) is a mechanism that directs elongating ribosomes to shift-reading frame by 1 base in the 5 0 direction that is utilized by many RNA viruses. Importantly, rates of À1 PRF are fine-tuned by viruses, including Retroviruses, Coronaviruses, Flavivriuses and in two endogenous viruses of the yeast Saccharomyces cerevisiae, to deliver the correct ratios of different viral proteins for efficient replication. Thus, À1 PRF presents a novel target for antiviral therapeutics. The underlying molecular mechanism of À1 PRF is conserved from yeast to mammals, enabling yeast to be used as a logical platform for high-throughput screens. Our understanding of the strengths and pitfalls of assays to monitor À1 PRF have evolved since the initial discovery of À1 PRF. These include controlling for the effects of drugs on protein expression and mRNA stability, as well as minimizing costs and the requirement for multiple processing steps. Here we describe the development of an automated yeast-based dual fluorescence assay of À1 PRF that provides a rapid, inexpensive automated pipeline to screen for compounds that alter rates of À1 PRF which will help to pave the way toward the discovery and development of novel antiviral therapeutics.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Programmed À1 ribosomal frameshifting (À1 PRF) is a mechanism by which cis-acting elements in an mRNA can direct elongating ribosomes to shift reading frame by 1 base in the 5 0 direction (1-3). Many RNA viruses utilize À1 PRF, including most Retroviruses, Coronaviruses, Flaviviruses and Totiviruses. In Retroviruses and Totiviruses, the open reading frame (ORF) encoding the major viral nucleocapsid proteins (e.g. Gag) is located at the 5 0 -end of the mRNA whereas the ORFs encoding proteins with enzymatic functions (typically Pro and Pol) are located 3 0 of, and out of frame with, the Gag ORF. The mRNAs transcribed from these viral templates contain two overlapping ORFs. The enzymatic proteins are only translated as a result of a programmed ribosomal frameshift event that occurs with an efficiency of 1-40% depending on the specific virus and assay system employed (4) . Thus, the majority of translational events result in the production of the Gag protein, while a minority of frameshifts yield viral enzymatic proteins. The ratio of Gag to Gag-pol synthesized in viruses as a consequence of programmed frameshifting varies between a narrow window of 20:1 to 60:1 (2) . In Coronaviruses and Flaviviruses, frameshift events occur over a wider dynamic range to regulate the relative ratios of non-structural proteins (5) (6) (7) .', 'cite_spans': [{'start': 876, 'end': 879, 'text': '(4)', 'ref_id': 'BIBREF3'}, {'start': 1177, 'end': 1180, 'text': '(2)', 'ref_id': 'BIBREF1'}, {'start': 1328, 'end': 1331, 'text': '(5)', 'ref_id': 'BIBREF4'}, {'start': 1332, 'end': 1335, 'text': '(6)', 'ref_id': 'BIBREF5'}, {'start': 1336, 'end': 1339, 'text': '(7)', 'ref_id': 'BIBREF6'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"The importance of maintaining precise ratios of viral proteins on virus propagation has been demonstrated in Retroviruses, Coronaviruses, Flavivriuses and in two endogenous viruses of the yeast Saccharomyces cerevisiae (5) (6) (7) (8) . Starting with the yeast 'killer' virus, we have extensively documented that small alterations in programmed frameshifting efficiencies promote rapid loss of the yeast dsRNA L-A 'killer' virus (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . In L-A, Gag-pol dimerization nucleates formation of the virus particle (21) (22) (23) (24) . Increasing the amount of Gag-pol protein synthesized may cause too many particles to initiate non-productively while producing too little may prevent efficient dimerization (9) .\", 'cite_spans': [{'start': 219, 'end': 222, 'text': '(5)', 'ref_id': 'BIBREF4'}, {'start': 223, 'end': 226, 'text': '(6)', 'ref_id': 'BIBREF5'}, {'start': 227, 'end': 230, 'text': '(7)', 'ref_id': 'BIBREF6'}, {'start': 231, 'end': 234, 'text': '(8)', 'ref_id': 'BIBREF7'}, {'start': 429, 'end': 432, 'text': '(9)', 'ref_id': 'BIBREF8'}, {'start': 433, 'end': 437, 'text': '(10)', 'ref_id': 'BIBREF9'}, {'start': 438, 'end': 442, 'text': '(11)', 'ref_id': 'BIBREF10'}, {'start': 443, 'end': 447, 'text': '(12)', 'ref_id': 'BIBREF11'}, {'start': 448, 'end': 452, 'text': '(13)', 'ref_id': 'BIBREF12'}, {'start': 453, 'end': 457, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 458, 'end': 462, 'text': '(15)', 'ref_id': 'BIBREF14'}, {'start': 463, 'end': 467, 'text': '(16)', 'ref_id': 'BIBREF15'}, {'start': 468, 'end': 472, 'text': '(17)', 'ref_id': 'BIBREF16'}, {'start': 473, 'end': 477, 'text': '(18)', 'ref_id': 'BIBREF17'}, {'start': 478, 'end': 482, 'text': '(19)', 'ref_id': 'BIBREF18'}, {'start': 483, 'end': 487, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 561, 'end': 565, 'text': '(21)', 'ref_id': 'BIBREF20'}, {'start': 566, 'end': 570, 'text': '(22)', 'ref_id': 'BIBREF21'}, {'start': 571, 'end': 575, 'text': '(23)', 'ref_id': 'BIBREF22'}, {'start': 576, 'end': 580, 'text': '(24)', 'ref_id': 'BIBREF23'}, {'start': 756, 'end': 759, 'text': '(9)', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Similarly, increasing or decreasing the efficiency of the +1 ribosomal frameshift in the Ty1 retrotransposable element of yeast results in reduced retrotransposition frequencies (11, 17, (25) (26) (27) (28) (29) (30) . Proteolytic processing of the TyA-TyB (Gag-pol equivalent) polyprotein of Ty1 is analogous to Gag-pol processing in retroviruses. In Ty1, increasing the amount of Gag-pol protein synthesized inhibited proteolytic processing of the polyprotein (25) . As a consequence, formation of the mature forms of RNase H, integrase and reverse transcriptase is blocked (25) . Similarly, changing the ratio of Gag to Gag-pol proteins in retroviruses like HIV or Moloney Murine Leukemia Virus interferes with virus-particle formation (31) (32) (33) (34) (35) (36) . In these cases, overexpression of the Gag-pol protein results in inefficient processing of the polyprotein and inhibition of virus production. Although the products produced by À1 PRF are different in Coronaviruses and Flaviviruses, the consequences of changes in À1 PRF efficiency are similar: in Coronaviruses, small changes in À1 PRF negatively impact on production of infectious virus (7), while in the Japanese encephalitis flavivirus, changes in À1 PRF are important for neuroinvasiveness (5) . In sum, viral PRF efficiencies have been finely tuned to deliver the precise ratios of proteins required for efficient viral particle assembly: too much or too little frameshifting alters this ratio, with detrimental consequences.', 'cite_spans': [{'start': 178, 'end': 182, 'text': '(11,', 'ref_id': 'BIBREF10'}, {'start': 183, 'end': 186, 'text': '17,', 'ref_id': 'BIBREF16'}, {'start': 187, 'end': 191, 'text': '(25)', 'ref_id': 'BIBREF24'}, {'start': 192, 'end': 196, 'text': '(26)', 'ref_id': 'BIBREF25'}, {'start': 197, 'end': 201, 'text': '(27)', 'ref_id': 'BIBREF26'}, {'start': 202, 'end': 206, 'text': '(28)', 'ref_id': 'BIBREF27'}, {'start': 207, 'end': 211, 'text': '(29)', 'ref_id': 'BIBREF28'}, {'start': 212, 'end': 216, 'text': '(30)', 'ref_id': 'BIBREF29'}, {'start': 462, 'end': 466, 'text': '(25)', 'ref_id': 'BIBREF24'}, {'start': 576, 'end': 580, 'text': '(25)', 'ref_id': 'BIBREF24'}, {'start': 739, 'end': 743, 'text': '(31)', 'ref_id': 'BIBREF30'}, {'start': 744, 'end': 748, 'text': '(32)', 'ref_id': 'BIBREF31'}, {'start': 749, 'end': 753, 'text': '(33)', 'ref_id': 'BIBREF32'}, {'start': 754, 'end': 758, 'text': '(34)', 'ref_id': 'BIBREF33'}, {'start': 759, 'end': 763, 'text': '(35)', 'ref_id': 'BIBREF34'}, {'start': 764, 'end': 768, 'text': '(36)', 'ref_id': 'BIBREF35'}, {'start': 1266, 'end': 1269, 'text': '(5)', 'ref_id': 'BIBREF4'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Based on these studies, it has been proposed that À1 PRF presents a novel target for prevention of viral propagation (8) . To this end, development of simple, cost effective assay systems would hasten identification of therapeutic agents that target this molecular mechanism. A number of quantitative assays have been employed to monitor À1 PRF. Cell free in vitro translation assays have the advantage of directly monitoring product formation, providing accurate readouts of the amounts and molecular weights of frameshift products. However, direct product monitoring presents numerous roadblocks to highthroughput screening (HTS) applications including the requirement for in vitro translation systems and radioactive labeling, the relatively small amount of products and the requirement for multiple secondary processing steps including SDS-PAGE, autoradiography, and/or immunoprecipitation. Mass spectrophotometric methods, while highly accurate, are also problematic for the same reasons. Enzymatic assays have been the preferred route, as they can be performed in either live cells or cell extracts, they do not require direct monitoring of the frameshift products, and they do not require use of radioactive materials or extensive handling. The first such assays employing monocistronic reporter systems were confounded by effects on reporter mRNA stability, producing false positive results; this was corrected by development of dual-reporter constructs which internally control for effects on mRNA stability and differences in rates of transcription (37) (38) (39) . These second generation systems utilize lacZ and/or luciferases as reporter enzymes, which poses two drawbacks with regard to their utility in highthroughput screens: they require numerous manipulation steps, and they are not cost-effective. More recently, a mammalian cell in vivo dual-fluorescent protein-based system was described that enables rapid and accurate screening of compounds without the requirement for labor-intensive manipulations and expensive reagents (40) . However the costs associated with producing and maintaining reporter cells using this system remain prohibitive. Here, we describe the development of a yeastbased dual-fluorescence system that can accurately detect even very slight changes in À1 PRF caused by mutations and drugs. This single plate assay is rapid, inexpensive and amenable to HTS applications.', 'cite_spans': [{'start': 117, 'end': 120, 'text': '(8)', 'ref_id': 'BIBREF7'}, {'start': 1559, 'end': 1563, 'text': '(37)', 'ref_id': 'BIBREF36'}, {'start': 1564, 'end': 1568, 'text': '(38)', 'ref_id': 'BIBREF37'}, {'start': 1569, 'end': 1573, 'text': '(39)', 'ref_id': 'BIBREF38'}, {'start': 2046, 'end': 2050, 'text': '(40)', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'JD932 (MATa ade 2-1 trp1-1 ura3-1 leu2-3, 112 his3-11, 15 can1-100) was used for anisomycin studies. The wild-type L11 yeast strain was JD1381 (MAT ura3-52 leu2D1 trp1D63 his3D200 rpl11a::HIS3 rpl11b::HIS3+ YCpRPL11B-TRP1). Isogenic rpl11 mutant strains were based on JD1381, but contained low copy TRP1-CEN6based plasmids expressing mutant versions of ribosomal protein L11. These were: JD1382 (rpl11-Y52Á), and JD1433 (rpl11-92-6A). All dual fluorescence plasmids used in this study were based on pRS426 (41), a high copy 2m, URA3 vector. Transcription was directed from a yeast G6PD promoter into the monomeric Ds-Red ORF followed by the EGFP ORF reporter mRNAs. In pJD0980, the Ds-Red ORF was followed by the yeast L-A virus derived À1 PRF signal, which was in turn followed by the EGFP ORF, which was in the À1 reading frame relative to Ds-Red, so that synthesis of EGFP protein was contingent upon a À1 PRF event. pJD0981 was the same as pJD0980 except that one nucleotide was inserted immediately 5 0 of the L-A À1 PRF signal, inactivating the À1 PRF signal and placing the EGFP ORF in the same frame as Ds-Red: this was used as the 0-frame control). Similarly, pJD1197 harbored the HIV-1 M type -1 PRF signal with EGFP in the À1 frame, while and pJD1198 was used as the HIV-1 M type 0-frame control. pJD0395 (a.k.a. pRS426) was used as the empty vector control.', 'cite_spans': [], 'ref_spans': [], 'section': 'Yeast strains and plasmids'}, {'text': 'Yeast cells were transformed with empty vector plasmid (vector without fluorescence protein-coding sequences or frameshifting signal), control reporter plasmid (0-frame) and test reporter plasmid (À1 frame). Transformants were selected for on H-Ura plates for 3 days at 30 C. Colonies were transferred to 2 ml of liquid H-Ura medium and grown overnight in a 30 C shaker. Cultures were diluted 50-fold in H-Ura medium with or without 60 mg/ml anisomycin, mixed and aliquots of 150 ml were placed in 96-well plates. In the assays presented here, each reporter was represented by six replicates per plate per strain. The outer wells of each plate did not contain samples, but were filled instead with 150 ml of water to evenly account for evaporation and condensation rates among sample wells. Plates were covered with lids, sealed with parafilm and incubated in a Synergy HT microplate reader at 30 C for 46 h without shaking. Cell density was monitored by absorbance at 595 nm every 20 min over a period of 46 h. Simultaneously, green (excitation 485 nm, emission 530 nm) and red (excitation 550 nm, emission 640 nm) fluorescence readings were taken.', 'cite_spans': [], 'ref_spans': [], 'section': 'Dual fluorescence assay'}, {'text': 'À1 PRF (FS%) was calculated as follows:', 'cite_spans': [], 'ref_spans': [], 'section': 'Dual fluorescence assay'}, {'text': 'where G is the green fluorescence for yeast transformed with test or control vector; G ev is green fluorescence for yeast transformed with empty vector; R is red fluorescence for yeast transformed with test or control vector; R ev is red fluorescence for yeast transformed with empty vector; OD is the optical density of cells transformed with reporter plasmid, and OD ev is optical density of cells transformed with empty vector.', 'cite_spans': [], 'ref_spans': [], 'section': 'Dual fluorescence assay'}, {'text': \"Yeast were transformed with the Renilla-firefly dual luciferase control and test plasmids: pJD0419 (L-A 0 frame control), pJD420 (L-A À1 PRF tester), pJD0375 (HIV 0 frame control) and pJD0378 (HIV À1 PRF tester) (39) . Yeast were plated onto selective media for 3 days and then transferred to 4 ml of selective media with or without 60 mg/ml anisomycin. Cells were incubated overnight in a 30 C shaker till mid-logarithmic growth at an OD 595 of 0.6-1.5. Yeast were washed three times and lysed with PBS plus 1 mM PMSF using 0.5 mm glass beads and a bead beater followed by centrifugation to clarify the lysate. Each strain was measured seven times for each reporter by sequentially mixing 10 ml of lysate with 50 ml of Promega's LARII reagent followed by 50 ml of Stop and Glo dual luciferase reagent, quantifying each step using a 96-well plate-reading Turner BioSystems Modulus microplate luminometer. Assays of À1 PRF and statistical analyses were performed as previously described (42) .\", 'cite_spans': [{'start': 212, 'end': 216, 'text': '(39)', 'ref_id': 'BIBREF38'}, {'start': 986, 'end': 990, 'text': '(42)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Dual luciferase assays'}, {'text': 'While the dual luciferase reporters are excellent for monitoring À1 PRF in small numbers of samples, there are three reasons why it is not particularly amenable for HTS applications. The first is cost: each sample costs approximately $2 ($1 each for test and control). Second, it is labor and time intensive: cells have to be lysed and cleared, lysates have to be spectrophotometrically read and normalized for protein content and two sets of reagents have to be sequentially introduced into lysates and read. With these limitations in mind, we developed a dual-fluorescent À1 PRF assay system for use in live yeast cells. A control reporter, in which monomeric Ds-Red and EGFP are in frame, provides baseline data ( Figure 1A ). In the frameshift reporter plasmid, EGFP production is dependent on À1 PRF, while Ds-Red serves as the internal control ( Figure 1B) . Figure 1C shows that high levels of Ds-Red and EGFP can be expressed using these vectors. Figure 2A shows a timecourse experiment monitoring HIV-1 promoted À1 PRF monitored every 20 min for a total of 46 h in the presence (pink traces) or absence (blue traces) of 60 mg/ml anisomycin, a drug that inhibits À1 PRF (13) . Note that the signals were extremely noisy during the first $12 h. This is likely due to a combination of two factors: low cell densities and the time-dependent requirement for the two reporter proteins to mature, especially in the low-oxygen environment of this assay. As the proteins matured and densities increased, frameshift efficiencies began to become discernable, tending to stabilize at $30 h. At the 46-h endpoint, HIV-1 promoted À1 PRF efficiency in untreated cells leveled off at $13%, a value that is comparable to À1 PRF measured using the dual luciferase reporter in yeast cells (39) . Notably, this assay was also able to recapitulate the inhibitory effect of anisomycin, which promoted $8% À1 PRF at the 46-h timepoint. Figure 2B shows a plot of the effects of anisomycin on À1 PRF as fold wild-type levels, demonstrating that this drug inhibits À1 PRF by $40%, consistent with previous findings (13) .', 'cite_spans': [{'start': 1178, 'end': 1182, 'text': '(13)', 'ref_id': 'BIBREF12'}, {'start': 1779, 'end': 1783, 'text': '(39)', 'ref_id': 'BIBREF38'}, {'start': 2098, 'end': 2102, 'text': '(13)', 'ref_id': 'BIBREF12'}], 'ref_spans': [{'start': 717, 'end': 726, 'text': 'Figure 1A', 'ref_id': 'FIGREF0'}, {'start': 852, 'end': 862, 'text': 'Figure 1B)', 'ref_id': 'FIGREF0'}, {'start': 865, 'end': 874, 'text': 'Figure 1C', 'ref_id': 'FIGREF0'}, {'start': 955, 'end': 964, 'text': 'Figure 2A', 'ref_id': 'FIGREF2'}, {'start': 1922, 'end': 1931, 'text': 'Figure 2B', 'ref_id': 'FIGREF2'}], 'section': 'A simple and inexpensive assay of À1 PRF in yeast'}, {'text': 'Next, we tested the ability of this system to identify changes in À1 PRF encoded by the yeast L-A virus À1 PRF signal due to either the presence of 60 mg/ml anisomycin or consequent to cellular mutations known to affect À1 PRF. Specifically, anisomycin and the yeast rpl11-92-96A mutant were expected to promote decreased rates of À1 PRF, while the rpl11-Y52Á mutant was expected to promote increased À1 PRF (43, M.H.J. Rhodin and J.D. Dinman, unpublished data). Figure 3A shows a plot of À1 PRF (as fold wild-type) monitored every 20 min for 46 h. Again, the system was noisy for the first $12 h and began to stabilize at $30 h. Taking 46 h as the endpoint, Figure 3B shows that the system produced the expected results. Specifically, anisomycin inhibited both HIV-1 (data duplicated from Figure 2B ) and L-Amediated À1 PRF. Further, L-A-mediated À1 PRF was decreased in the rpl11-92-96A mutant, and it was increased in the rpl11-Y52Á strain.', 'cite_spans': [], 'ref_spans': [{'start': 463, 'end': 472, 'text': 'Figure 3A', 'ref_id': 'FIGREF1'}, {'start': 659, 'end': 668, 'text': 'Figure 3B', 'ref_id': 'FIGREF1'}, {'start': 790, 'end': 799, 'text': 'Figure 2B', 'ref_id': 'FIGREF2'}], 'section': 'A simple and inexpensive assay of À1 PRF in yeast'}, {'text': 'The dual-fluorescent reporter system recapitulates data obtained using a dual-luciferase reporter system', 'cite_spans': [], 'ref_spans': [], 'section': 'A simple and inexpensive assay of À1 PRF in yeast'}, {'text': 'The experiments were repeated using our previously described dual luciferase assay system (39) to compare the results obtained using the dual fluorescent reporter system. Side by side comparisons shown in Figure 3B demonstrate strong agreement between the two assay systems. These results match our previous findings for these conditions where 60 mg/ml anisomycin inhibited À1 PRF, rpl11-Y52Á promoted increased À1 PRF and rpl11-92-6A promoted decreased À1 PRF. This independent validation underscores the potential for the less expensive and scalable dual fluorescence methodology to accurately detect changes in frameshifting.', 'cite_spans': [{'start': 90, 'end': 94, 'text': '(39)', 'ref_id': 'BIBREF38'}], 'ref_spans': [{'start': 205, 'end': 214, 'text': 'Figure 3B', 'ref_id': 'FIGREF1'}], 'section': 'A simple and inexpensive assay of À1 PRF in yeast'}, {'text': \"The findings described here demonstrate the production of a robust and inexpensive assay that faithfully reproduces changes in À1 PRF due to cellular mutations and addition of drugs. An advantage to using the multiple well format is that it enables the data collected by the reader to be directly transferred into an excel spreadsheet, where À1 PRF rates are automatically calculated (42) . Importantly, this software also determines standard errors, and flags samples with statistically significant Z-scores, rendering it ideal for HTS applications. Features inherent in the calculation of À1 PRF efficiency using the yeast-based in vivo dual-fluorescence assay also have two critical built in advantages with respect to counter screening. First, since the assay requires normalization of cell density by measuring OD 595 , this parameter can be used to monitor the effects of compounds on cell growth, that is, to flag potential cell toxicity. Second, since it requires normalization to an in-frame control, these measurements can be used to identify deleterious effects on overall protein synthesis. While we have only monitored À1 PRF from the L-A and HIV-1 frameshift signals, the modular nature of the reporter vectors renders insertion of À1 PRF signals from other human pathogenic viruses e.g. HTLV-I (Retrovirus (8)], we suggest that initial cut-offs be set at >1.2-fold and <0.8-fold of wild type. These liberal cut-off values allow for a higher rate of false positives rather than false negatives, thus allowing false positives to be identified later with secondary assays. In addition, this basic format should be amenable for assays of other translational recoding mechanisms, for example, +1 PRF and termination codon suppression. Once candidates are identified using this platform, secondary assays will be required to validate hits. Here we suggest two such assays. (i) Maintenance of the yeast 'killer' virus. We have shown that maintenance of this virus is critically dependent on À1 PRF, and have extensively used this property to validate changes in À1 PRF due to cellular mutations and drugs (8, 44) . Importantly, this assay provides an independent means to screen for antiviral effects of compounds that can be correlated with effects due to changes in À1 PRF. The killer assay involves replica-plating test cells onto a lawn of uninfected indicator yeast cells seeded onto 4.7 MB plates (yeast rich medium containing 0.5% methylene blue, pH 4.7). Cells are grown at 20 C for 4 days, and then visually inspected for the presence of a zone of growth inhibition due to production of the virus-encoded killer toxin. These assays are very simple and inexpensive, requiring only yeast cells, media and petri dishes. Currently, the dual fluorescence assay can screen up to 20 samples per 96-well plate if forgoing multiple replicates. Assuming initial identification of 500 compounds, these assays could be performed on as few as 25 plates when controls are included. The killer assay can be either performed manually (in the case of a few hits), or can be scaled up for high-throughput robotic screening. We believe that robotic technology currently used for high-throughput yeast 2-hybrid screens can be adapted to the killer assay. A potential disadvantage of this assay is that it may require serial passage of yeast cells to multiple rounds of drug exposure. For example, we have found that curing of killer by anisomycin requires at least two serial passages in the presence of this drug. Loss of the killer virus is further validated by extracting total RNA from cells, followed by non-denaturing 1.2% agarose gel electrophoresis, which detects the presence or absence of the viral dsRNA genome. (ii) Dual luciferase assays. In order to validate potential hits, À1 PRF values can be determined using both in vivo (live yeast cells and in HeLa cells), in vitro (rabbit reticulocyte lysates) dualluciferase assays as previously described (39, 45) . These can be used to confirm the À1 PRF data obtained using dual-fluorescence reporters. The dual-luminescence assay as a secondary assay is also advantageous in that it enables identification of compounds that truly affect À1 PRF, as opposed to those that affect production or activity of the Ds-Red or EGFP reporter proteins. A further advantage of the in vitro assay is that it can identify compounds that directly affect À1 PRF as opposed to compounds that affect transcription of the reporter mRNAs.\", 'cite_spans': [{'start': 384, 'end': 388, 'text': '(42)', 'ref_id': 'BIBREF41'}, {'start': 2113, 'end': 2116, 'text': '(8,', 'ref_id': 'BIBREF7'}, {'start': 2117, 'end': 2120, 'text': '44)', 'ref_id': 'BIBREF43'}, {'start': 3960, 'end': 3964, 'text': '(39,', 'ref_id': 'BIBREF38'}, {'start': 3965, 'end': 3968, 'text': '45)', 'ref_id': 'BIBREF44'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'There are a number of parameters that remain to be refined. One is automation, specifically plate seeding. In an industrial setting, this can easily be addressed using a robotic pipettor. Robotic pipetting can also solve the problem of interference of OD and fluorescence readings due to the presence of condensation on the plate lid at the end of the incubation period. Robotic transfer of cells to new plates just prior to reading will solve this problem. Data integrity is another problem that can be addressed by automation coupled with plate bar-coding, which will also assure that the worklist downloaded to the robot has 100% integrity. The data also have to be organized into a query-able format. However, the software that we developed to flag statistically significant Z-scores address this issue, and can also address the issue of operator bias. Process bottlenecks are also a common problem with HTS. In this case, the major bottleneck is the time required for maturation of the reporter proteins, hence the decision to take the 46 h endpoint. However, growth conditions may be further optimizable by incubating in a more humid and oxygenated environment, potentially reducing the time required for signal stabilization. Additionally, parallel processing of multiple plates can speed this process, rendering this bottleneck insignificant. For HTS, each plate must contain internal controls. We suggest that rpl11-Y52Á mutant cells and rpl11-92-6A mutant cells or a sample containing anisomycin can be used as quality control for up-and down-frameshifting, respectively. Pooling is also commonly used in HTS. Although the idea is attractive, our experience is that this leads to mistakes, and we would recommend against this approach. Cell wall permeability is a common issue associated with yeast-based HTS because yeast cell walls are impermeable to many small molecules. However, yeast cells easily tolerate DMSO to concentrations of up to 0.8%. Thus, this reagent could be used to rectify this potential problem. Finally, most HTS technologies utilize 384 or 1536 well plates, and thus there are questions about ability to scale up this assay. However, there is a priori no reason for why scaling up to more wells will not work, although it is possible that scaling-up to higher density formats may present issues with oxygen transfer needed to support cell growth for this in vivo assay. Assuming this oxygen limitation is a problem, the incubator could easily be designed to increase the ambient oxygen content, thus mitigating any such problem.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Regulation of Termination and Recoding', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Berry', 'suffix': ''}], 'year': 2006, 'venue': 'Translational Control in Biology and Medicine', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Programmed Alternative Reading of the Genetic Code', 'authors': [{'first': 'P', 'middle': ['J'], 'last': 'Farabaugh', 'suffix': ''}], 'year': 1997, 'venue': 'R.G. Landes Company', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV', 'authors': [{'first': 'I', 'middle': [], 'last': 'Brierley', 'suffix': ''}, {'first': 'F', 'middle': ['J'], 'last': 'Dos Ramos', 'suffix': ''}], 'year': 2006, 'venue': 'Virus Res', 'volume': '119', 'issn': '', 'pages': '29--42', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Ribosomal frameshifting on viral RNAs', 'authors': [{'first': 'I', 'middle': [], 'last': 'Brierley', 'suffix': ''}], 'year': 1995, 'venue': 'J.Gen.Virol', 'volume': '76', 'issn': '', 'pages': '1885--1892', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': \"NS1' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness\", 'authors': [{'first': 'E', 'middle': ['B'], 'last': 'Melian', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Hinzman', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Nagasaki', 'suffix': ''}, {'first': 'A', 'middle': ['E'], 'last': 'Firth', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Wills', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Nouwens', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Blitvich', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Leung', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Funk', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Atkins', 'suffix': ''}], 'year': 2010, 'venue': 'J.Virol', 'volume': '84', 'issn': '', 'pages': '1641--1647', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Evidence for ribosomal frameshifting and a novel overlapping gene in the genomes of insect-specific flaviviruses', 'authors': [{'first': 'A', 'middle': ['E'], 'last': 'Firth', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Blitvich', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Wills', 'suffix': ''}, {'first': 'C', 'middle': ['L'], 'last': 'Miller', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Atkins', 'suffix': ''}], 'year': 2010, 'venue': 'Virology', 'volume': '399', 'issn': '', 'pages': '153--166', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Achieving a golden mean: mechanisms by which coronaviruses ensure synthesis of the correct stoichiometric ratios of viral proteins', 'authors': [{'first': 'E', 'middle': ['P'], 'last': 'Plant', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Rakauskaite', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Taylor', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2010, 'venue': 'J.Virol', 'volume': '84', 'issn': '', 'pages': '4330--4340', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Translating old drugs into new treatments: Identifying compounds that modulate programmed -1 ribosomal frameshifting and function as potential antiviral agents', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Ruiz-Echevarria', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Peltz', 'suffix': ''}], 'year': 1998, 'venue': 'Trends Biotech', 'volume': '16', 'issn': '', 'pages': '190--196', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Ribosomal frameshifting efficiency and Gag/Gag-pol ratio are critical for yeast M 1 double-stranded RNA virus propagation', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Wickner', 'suffix': ''}], 'year': 1992, 'venue': 'J.Virol', 'volume': '66', 'issn': '', 'pages': '3669--3676', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Translational maintenance of frame: mutants of Saccharomyces cerevisiae with altered -1 ribosomal frameshifting efficiencies', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Wickner', 'suffix': ''}], 'year': 1994, 'venue': 'Genetics', 'volume': '136', 'issn': '', 'pages': '75--86', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': '5S rRNA is involved in fidelity of translational reading frame', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Wickner', 'suffix': ''}], 'year': 1995, 'venue': 'Genetics', 'volume': '141', 'issn': '', 'pages': '95--105', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'is an allele of the UPF1/IFS2 gene which affects both mRNA turnover and -1 ribosomal frameshifting efficiency', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Cui', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Peltz', 'suffix': ''}], 'year': 1996, 'venue': 'EMBO J', 'volume': '15', 'issn': '', 'pages': '5726--5736', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Peptidyl transferase inhibitors have antiviral properties by altering programmed -1 ribosomal frameshifting efficiencies: development of model systems', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Ruiz-Echevarria', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Czaplinski', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Peltz', 'suffix': ''}], 'year': 1997, 'venue': 'Proc. Natl Acad. Sci. USA', 'volume': '94', 'issn': '', 'pages': '6606--6611', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'The Upf3p is a component of the surveillance complex that monitors both translation and mRNA turnover and affects viral maintenance', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Ruiz-Echevarria', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Yasenchak', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Han', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Peltz', 'suffix': ''}], 'year': 1998, 'venue': 'Proc. Natl Acad. Sci. USA', 'volume': '95', 'issn': '', 'pages': '8721--8726', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'The Mof2/Sui1 protein is a general monitor of translational accuracy', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Cui', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Kinzy', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Peltz', 'suffix': ''}], 'year': 1998, 'venue': 'Mol. Cell Biol', 'volume': '18', 'issn': '', 'pages': '1506--1516', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Ribosomal protein L3 mutants alter translational fidelity and promote rapid loss of the yeast killer virus', 'authors': [{'first': 'S', 'middle': ['W'], 'last': 'Peltz', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Hammell', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Cui', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Yasenchak', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Puljanowski', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 1999, 'venue': 'Mol. Cell Biol', 'volume': '19', 'issn': '', 'pages': '384--391', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Ribosomal protein L5 helps anchor peptidyl-tRNA to the P-site in Saccharomyces cerevisiae', 'authors': [{'first': 'A', 'middle': [], 'last': 'Meskauskas', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2001, 'venue': 'RNA', 'volume': '7', 'issn': '', 'pages': '1084--1096', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'New targets for antivirals: the ribosomal A-site and the factors that interact with it', 'authors': [{'first': 'T', 'middle': ['G'], 'last': 'Kinzy', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Harger', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Carr-Schmid', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kwon', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Shastry', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Justice', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2002, 'venue': 'Virology', 'volume': '300', 'issn': '', 'pages': '60--70', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Decreased peptidyltransferase activity correlates with increased programmed -1 ribosomal frameshifting and viral maintenance defects in the yeast Saccharomyces cerevisiae', 'authors': [{'first': 'A', 'middle': [], 'last': 'Meskauskas', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Harger', 'suffix': ''}, {'first': 'K', 'middle': ['L M'], 'last': 'Jacobs', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2003, 'venue': 'RNA', 'volume': '9', 'issn': '', 'pages': '982--992', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Delayed rRNA processing results in significant ribosome biogenesis and functional defects', 'authors': [{'first': 'A', 'middle': [], 'last': 'Meskauskas', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Baxter', 'suffix': ''}, {'first': 'E', 'middle': ['A'], 'last': 'Carr', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Yasenchak', 'suffix': ''}, {'first': 'J', 'middle': ['E G'], 'last': 'Gallagher', 'suffix': ''}, {'first': 'S', 'middle': ['J'], 'last': 'Baserga', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2003, 'venue': 'Mol. Cell Biol', 'volume': '23', 'issn': '', 'pages': '1602--1613', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Virus-like particle of yeast', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Bruenn', 'suffix': ''}], 'year': 1980, 'venue': 'Annu. Rev. Microbiol', 'volume': '34', 'issn': '', 'pages': '49--68', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Three different M 1 RNA-containing viruslike particle types in Saccharomyces cerevisiae: in vitro M 1 double-stranded RNA synthesis', 'authors': [{'first': 'R', 'middle': [], 'last': 'Esteban', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Wickner', 'suffix': ''}], 'year': 1986, 'venue': 'Mol. Cell Biol', 'volume': '6', 'issn': '', 'pages': '1552--1561', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Fungal virus capsids, cytoplasmic compartments for the replication of double-stranded RNA, formed as icosahedral shells of asymmetric Gag dimers', 'authors': [{'first': 'R', 'middle': ['H'], 'last': 'Cheng', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Caston', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Gu', 'suffix': ''}, {'first': 'T', 'middle': ['J'], 'last': 'Smith', 'suffix': ''}, {'first': 'T', 'middle': ['S'], 'last': 'Baker', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Bozarth', 'suffix': ''}, {'first': 'B', 'middle': ['L'], 'last': 'Trus', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Cheng', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Wickner', 'suffix': ''}], 'year': 1994, 'venue': 'J. Mol. Biol', 'volume': '244', 'issn': '', 'pages': '255--258', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Structure of L-A virus: a specialized compartment for the transcription and replication of double-stranded RNA', 'authors': [{'first': 'J', 'middle': ['R'], 'last': 'Caston', 'suffix': ''}, {'first': 'B', 'middle': ['L'], 'last': 'Trus', 'suffix': ''}, {'first': 'F', 'middle': ['P'], 'last': 'Booy', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Wickner', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Wall', 'suffix': ''}, {'first': 'A', 'middle': ['C'], 'last': 'Steven', 'suffix': ''}], 'year': 1997, 'venue': 'J. Cell Biol', 'volume': '138', 'issn': '', 'pages': '975--985', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'A rare tRNA-Arg(CCU) that regulates Ty1 element ribosomal frameshifting is essential for Ty1 retrotransposition in Saccharomyces cerevisiae', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kawakami', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Paned', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Faioa', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Moore', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Boeke', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Farabaugh', 'suffix': ''}, {'first': 'J', 'middle': ['N'], 'last': 'Strathern', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Nakamura', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Garfinkel', 'suffix': ''}], 'year': 1993, 'venue': 'Genetics', 'volume': '135', 'issn': '', 'pages': '309--320', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Spermidine deficiency increases +1 ribosomal frameshifting efficiency and inhibits Ty1 retrotransposition in Saccharomyces cerevisiae', 'authors': [{'first': 'D', 'middle': [], 'last': 'Balasundaram', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Wickner', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Tabor', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Tabor', 'suffix': ''}], 'year': 1994, 'venue': 'Proc. Natl Acad. Sci. USA', 'volume': '91', 'issn': '', 'pages': '172--176', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Translational misreading: Mutations in translation elongation factor 1a differentially affect programmed ribosomal frameshifting and drug sensitivity', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Kinzy', 'suffix': ''}], 'year': 1997, 'venue': 'RNA', 'volume': '3', 'issn': '', 'pages': '870--881', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Pokeweed antiviral protein specifically inhibits Ty1 directed +1 ribosomal frameshifting and Ty1 retrotransposition in Saccharomyces cerevisiae', 'authors': [{'first': 'N', 'middle': ['E'], 'last': 'Tumer', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Parikh', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 1998, 'venue': 'J. Virol', 'volume': '72', 'issn': '', 'pages': '1036--1042', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Ty1 retrotransposition and programmed +1 ribosomal frameshifting require the integrity of the protein synthetic translocation step', 'authors': [{'first': 'J', 'middle': ['W'], 'last': 'Harger', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Meskauskas', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Nielsen', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Justice', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2001, 'venue': 'Virology', 'volume': '286', 'issn': '', 'pages': '216--224', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'A C-terminal deletion mutant of pokeweed antiviral protein inhibits programmed +1 ribosomal frameshifting and Ty1 retrotransposition without depurinating the sarcin/ricin loop of rRNA', 'authors': [{'first': 'K', 'middle': ['A'], 'last': 'Hudak', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Hammell', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Yasenchak', 'suffix': ''}, {'first': 'N', 'middle': ['E'], 'last': 'Tumer', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2001, 'venue': 'Virology', 'volume': '279', 'issn': '', 'pages': '292--301', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Overexpression of the gag-pol precursor from human immunodeficiency virus type-I proviral genomes results in efficient proteolytic processing in the absence of virion production', 'authors': [{'first': 'J', 'middle': [], 'last': 'Park', 'suffix': ''}, {'first': 'C', 'middle': ['D'], 'last': 'Morrow', 'suffix': ''}], 'year': 1991, 'venue': 'J. Virol', 'volume': '65', 'issn': '', 'pages': '5111--5117', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Expression of the gag-pol fusion protein of moloney murine leukemia virus without gag protein does not induce viron formation or proteolytic processing', 'authors': [{'first': 'K', 'middle': ['M'], 'last': 'Felsenstein', 'suffix': ''}, {'first': 'S', 'middle': ['P'], 'last': 'Goff', 'suffix': ''}], 'year': 1988, 'venue': 'J. Virol', 'volume': '62', 'issn': '', 'pages': '2179--2182', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles', 'authors': [{'first': 'V', 'middle': [], 'last': 'Karacostas', 'suffix': ''}, {'first': 'E', 'middle': ['J'], 'last': 'Wolffe', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Nagashima', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Gonda', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Moss', 'suffix': ''}], 'year': 1993, 'venue': 'Virology', 'volume': '193', 'issn': '', 'pages': '661--671', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Importance of ribosomal frameshifting for human immumodeficiency virus type 1 assembly and replication', 'authors': [{'first': 'M', 'middle': [], 'last': 'Hung', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Patel', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Davis', 'suffix': ''}, {'first': 'S', 'middle': ['R'], 'last': 'Green', 'suffix': ''}], 'year': 1998, 'venue': 'J. Virol', 'volume': '72', 'issn': '', 'pages': '4819--4824', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure', 'authors': [{'first': 'A', 'middle': [], 'last': 'Telenti', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martinez', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Munoz', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Bleiber', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Sanglard', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Peters', 'suffix': ''}], 'year': 2002, 'venue': 'J. Virol', 'volume': '76', 'issn': '', 'pages': '7868--7873', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy', 'authors': [{'first': 'P', 'middle': [], 'last': 'Biswas', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Jiang', 'suffix': ''}, {'first': 'A', 'middle': ['L'], 'last': 'Pacchia', 'suffix': ''}, {'first': 'J', 'middle': ['P'], 'last': 'Dougherty', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Peltz', 'suffix': ''}], 'year': 2004, 'venue': 'J. Virol', 'volume': '78', 'issn': '', 'pages': '2082--2087', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'A dual-luciferase reporter system for studying recoding signals', 'authors': [{'first': 'G', 'middle': [], 'last': 'Grentzmann', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Ingram', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Kelly', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Gesteland', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Atkins', 'suffix': ''}], 'year': 1998, 'venue': 'RNA', 'volume': '4', 'issn': '', 'pages': '479--486', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Nonsense-mediated decay mutants do not affect programmed -1 frameshifting', 'authors': [{'first': 'L', 'middle': [], 'last': 'Bidou', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Stahl', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Hatin', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Namy', 'suffix': ''}, {'first': 'J', 'middle': ['P'], 'last': 'Rousset', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Farabaugh', 'suffix': ''}], 'year': 2000, 'venue': 'RNA', 'volume': '6', 'issn': '', 'pages': '952--961', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae', 'authors': [{'first': 'J', 'middle': ['W'], 'last': 'Harger', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2003, 'venue': 'RNA', 'volume': '9', 'issn': '', 'pages': '1019--1024', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'A homogeneous cell-based bicistronic fluorescence assay for high-throughput identification of drugs that perturb viral gene recoding and read-through of nonsense stop codons', 'authors': [{'first': 'T', 'middle': ['S'], 'last': 'Cardno', 'suffix': ''}, {'first': 'E', 'middle': ['S'], 'last': 'Poole', 'suffix': ''}, {'first': 'S', 'middle': ['F'], 'last': 'Mathew', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Graves', 'suffix': ''}, {'first': 'W', 'middle': ['P'], 'last': 'Tate', 'suffix': ''}], 'year': 2009, 'venue': 'RNA', 'volume': '15', 'issn': '', 'pages': '1614--1621', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Multifunctional yeast high-copy-number shuttle vectors', 'authors': [{'first': 'T', 'middle': ['W'], 'last': 'Christianson', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Sikorski', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Dante', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Shero', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Hieter', 'suffix': ''}], 'year': 1992, 'venue': 'Yeast', 'volume': '110', 'issn': '', 'pages': '119--122', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Systematic analysis of bicistronic reporter assay data', 'authors': [{'first': 'J', 'middle': ['L'], 'last': 'Jacobs', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2004, 'venue': 'Nucleic Acids Res', 'volume': '32', 'issn': '', 'pages': '160--170', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'A flexible loop in yeast ribosomal protein L11 coordinates P-site tRNA binding', 'authors': [{'first': 'M', 'middle': ['H'], 'last': 'Rhodin', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2010, 'venue': 'Nucleic Acids Res', 'volume': '38', 'issn': '', 'pages': '8377--8389', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'Ribosomal frameshifting in yeast viruses', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 1995, 'venue': 'Yeast', 'volume': '11', 'issn': '', 'pages': '1115--1127', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Comparative study of the effects of heptameric slippry site composition on -1 frameshifting among different translational assay systems', 'authors': [{'first': 'E', 'middle': ['P'], 'last': 'Plant', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2006, 'venue': 'RNA', 'volume': '12', 'issn': '', 'pages': '666--673', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'Dual-fluorescence reporter system. (A) Read-through control plasmid contains Ds-Red and EGFP ORFs. Note that insertion of one nucleotide 5 0 of the À1 PRF signal inactivates frameshifting, and places the EGFP ORF in frame with the Ds-Red ORF to produce the Ds-Red/EGFP fusion protein. (B) À1 PRF test plasmid is the same as the control plasmid except that the EGFP ORF is in the À1 frame with respect to the Ds-Red ORF. No frameshift results in production of Ds-Red only, while a frameshift event results in production of the Ds-Red/EGFP fusion protein. (C) Microscopic images of cells transformed with the control plasmid.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'Effects of anisomycin and host cell mutants on HIV-1 and L-A promoted À1 PRF. (A) Time course assay. Wild-type cells harboring either HIV-1 or L-A À1 PRF reporters were treated with 60 mg/ml anisomycin. In parallel, isogenic rpl11 mutant strains were assayed using the L-A À1 PRF reporter. Data are normalized to no-drug or isogenic wild-type RPL11 cells. (B) Comparison of data obtained using dual fluorescence or dual luciferase reporters. Solid colored bars indicate 46-h endpoint measurements of À1 PRF expressed as fold wild-type or untreated cells. Striped bars represent fold wild-type results using dual luciferase reporter system for same cell types and testing conditions. Error bars indicate standard error.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': '(A) Time course assay of HIV-1-promoted À1 PRF in yeast cells in the presence or absence of 60 mg/ml anisomycin. Error bars indicate standard error. (B) The effect of 60 mg/ml anisomycin on HIV-1 À1 PRF determined as fold untreated cells.', 'latex': None, 'type': 'figure'}}, 'back_matter': [{'text': 'We wish to thank Ashton Trey Belew for help with software development.', 'cite_spans': [], 'ref_spans': [], 'section': 'ACKNOWLEDGEMENTS'}, {'text': 'Conflict of interest statement. Preliminary disclosure documents have been filed with the University of Maryland and University of Delaware in pursuit of a patent application for this assay system.', 'cite_spans': [], 'ref_spans': [], 'section': 'annex'}]}\n",
      "{'_id': ObjectId('5ea715f0fbd8d74cfcfef48d'), 'paper_id': '0a92a878b6603cb88dfc8c597e2a84407a0059ab', 'metadata': {'title': 'Position Paper', 'authors': [{'first': 'Vivek', 'middle': [], 'last': 'Chauhan', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Sagar', 'middle': [], 'last': 'Galwankar', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Sarasota Memorial Hospital', 'location': {'settlement': 'Sarasota', 'region': 'FL'}}, 'email': ''}, {'first': 'Bonnie', 'middle': [], 'last': 'Arquilla', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'SUNY Downstate Medical Center', 'location': {}}, 'email': ''}, {'first': 'Manish', 'middle': [], 'last': 'Garg', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Columbia University Vagelos College of Physicians and Surgeons', 'location': {'settlement': 'New York City', 'region': 'NY'}}, 'email': ''}, {'first': 'Salvatore', 'middle': ['Di'], 'last': 'Somma', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Ayman', 'middle': [], 'last': 'El-Menyar', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Weill Cornell Medical College', 'location': {'settlement': 'Ar-Rayyan', 'country': 'Qatar'}}, 'email': ''}, {'first': 'Vimal', 'middle': [], 'last': 'Krishnan', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'KMC Manipal', 'location': {'settlement': 'Manipal', 'region': 'Karnataka', 'country': 'India'}}, 'email': ''}, {'first': 'Joel', 'middle': [], 'last': 'Gerber', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Sarasota Memorial Hospital', 'location': {'settlement': 'Sarasota', 'region': 'FL'}}, 'email': ''}, {'first': 'Reuben', 'middle': [], 'last': 'Holland', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Sarasota Memorial Hospital', 'location': {'settlement': 'Sarasota', 'region': 'FL'}}, 'email': ''}, {'first': 'Stanislaw', 'middle': ['P'], 'last': 'Stawicki', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': \"St. Luke's University Health Network\", 'location': {'addrLine': '23 Pennsylvania', 'settlement': 'Fountain Hill', 'country': 'USA'}}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': 'The following Joint Position Statement represents a collective contribution of emergency and acute care experts from the World Academic Council of Emergency Medicine and the American College of Academic International Medicine Task Force on Telemedicine for COVID-19 Pandemic.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': \"Over the past 3 months, the world witnessed historic and dramatic developments related to the rapid emergence of a novel coronavirus. Real-time, detailed global media coverage brought live updates on the infection to every corner of the planet. Social media outlets are abuzz with minute-to-minute alerts, reflections, witness accounts, and personal reactions. We are witnessing stories of human suffering, including overwhelmed health-care systems, limited access to emergency care, vacationing passengers stranded on cruise ships, large-scale evacuations, overnight economic shutdown, and empty streets in China and Italy. [1] [2] [3] The imagery is comparable to an epic movie depicting martial law with large populations confined to their homes in the wake of a deadly virus. This time, it is a novel coronavirus, and the associated disease has been named COVID- 19 . Moreover, the current world-wide event has now been declared a pandemic by the World Health Organization (WHO). [4, 5] Pneumonia of unknown cause detected in Wuhan, China, was first reported to the WHO on December 31, 2019. In turn, the WHO declared the event a Public Health Emergency of International Concern (PHEIC) on January 30, 2020. [5] Soon, there was a total shutdown of free travel between China and the rest of the world, expanding the human and medical dimensions of the outbreak into the economic and political spheres. [6, 7] The epicenter of the current outbreak was the city of Wuhan in China's Hubei province. In an attempt to contain the spread of COVID-19, the Chinese government has implemented metropolitan-wide quarantine of Wuhan and several nearby cities, effectively forcing millions of people to remain indoors and avoid unnecessary outdoor travel. [8] In a record period of 10 days, a massive 1000-bed hospital was built to help cope with the rapidly increasing number of cases. [9] Despite these efforts, as of February 25 th , there were 78,064 confirmed infections, 8752 patients in serious condition, and 2715 reported mortalities in Mainland China alone. Moreover, Chinese authorities estimate a total of 647,406 people who had close contact/proximity with infected people, and more than 79,000 individuals who are under medical observation. [10] There is also a case of a Chinese person who may face a jail sentence for lying about his movements in Singapore during the mandatory quarantine period. [11] Finally, there is a real possibility that the Federal Emergency Management Agency in the United States (US) may declare emergency over the COVID-19 infection. [12] At the time of this commentary, COVID-19 has spread throughout the world and has infected 37,371 confirmed cases in 113 countries with 1130 deaths outside of China. [5] A sudden increase in cases has been reported in Iran, Italy, and South Korea. Cases linked to travel to/from Iran have been found in Bahrain, Iraq, Kuwait, and Oman. Similarly, cases related to Italy have been found in Algeria, Austria, Croatia, Germany, Spain, and Switzerland. [5, 13] Most recently, Nigeria confirmed its first case in Sub-Saharan Africa, whereas the US reported its first coronavirus-related death in Washington state. [14, 15] Thus, COVID-19 has established itself outside of China and now appears to be spreading across new regions, countries, and continents. The geographic diversity of the above locations suggested that a pandemic was imminent and ultimately, on 11th of March, 2020 WHO declared COVID-19 a pandemic. [5, 16] In the meanwhile, various international and regional authorities are following the footsteps of China to impose movement restrictions on their populations with an aim to curb the human-to-human spread of the virus.\", 'cite_spans': [{'start': 625, 'end': 628, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 629, 'end': 632, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 633, 'end': 636, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 984, 'end': 987, 'text': '[4,', 'ref_id': 'BIBREF3'}, {'start': 988, 'end': 990, 'text': '5]', 'ref_id': 'BIBREF4'}, {'start': 1212, 'end': 1215, 'text': '[5]', 'ref_id': 'BIBREF4'}, {'start': 1405, 'end': 1408, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 1409, 'end': 1411, 'text': '7]', 'ref_id': 'BIBREF6'}, {'start': 1747, 'end': 1750, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 1878, 'end': 1881, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 2246, 'end': 2250, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 2404, 'end': 2408, 'text': '[11]', 'ref_id': 'BIBREF10'}, {'start': 2568, 'end': 2572, 'text': '[12]', 'ref_id': 'BIBREF11'}, {'start': 2738, 'end': 2741, 'text': '[5]', 'ref_id': 'BIBREF4'}, {'start': 3021, 'end': 3024, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 3025, 'end': 3028, 'text': '13]', 'ref_id': None}, {'start': 3181, 'end': 3185, 'text': '[14,', 'ref_id': 'BIBREF12'}, {'start': 3186, 'end': 3189, 'text': '15]', 'ref_id': 'BIBREF13'}, {'start': 3484, 'end': 3487, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 3488, 'end': 3491, 'text': '16]', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': ''}, {'text': \"Few health-care systems around the world are equipped to deal with the potentially massive numbers of infections, acutely ill patients, as well as population-level anxiety related to both COVID-19 and the restrictions put into place to help contain its spread. [17] [18] [19] In China, COVID-19 infections escalated quickly and without warning, with little time for emergency procedures or other mitigation efforts. Other provinces in China have not shown similar massive increase in infections and deaths as seen in the Hubei province. However, this was achieved at a great cost for the 40-60 million residents of Wuhan and 15 other surrounding cities within Hubei Province who were subjected to community containment measures. [13, 20] The human movement restrictions may be prolonged for now as approximately 14% of recovered coronavirus patients in China's Guangdong have tested positive again after being declared virus free and there is no consensus on the optimal length of the quarantine. [21] Like any other defining challenge in human history, the current emergence of COVID-19 comes with its own unique opportunities and innovative solutions. Technological advances provide humanity with new, previously unavailable\", 'cite_spans': [{'start': 261, 'end': 265, 'text': '[17]', 'ref_id': 'BIBREF15'}, {'start': 266, 'end': 270, 'text': '[18]', 'ref_id': None}, {'start': 271, 'end': 275, 'text': '[19]', 'ref_id': 'BIBREF17'}, {'start': 729, 'end': 733, 'text': '[13,', 'ref_id': None}, {'start': 734, 'end': 737, 'text': '20]', 'ref_id': 'BIBREF18'}, {'start': 997, 'end': 1001, 'text': '[21]', 'ref_id': 'BIBREF19'}], 'ref_spans': [], 'section': ''}, {'text': 'options. Although the ultimate solution to the COVID-19 infection will be multifaceted, one important avenue that has not yet been explored fully is to leverage existing technologies to facilitate optimal care delivery while minimizing the risk of direct human-to-human exposure. In this context, telemedicine represents an attractive, effective, and affordable option. Moreover, this technology is of critical importance when one considers the consequences of health-care providers contracting COVID-19 as a result of direct exposure; something that can be especially devastating in low-resource areas or under the circumstances of massive stress to the existing health-care infrastructure and staff. [22] When movement is restricted throughout the world and entire cities are quarantined, affected populations are susceptible to increased stresses of daily life, unexpected economic burdens, communicable and noncommunicable diseases, and various mental health sequelae. [23] [24] [25] Consequently, unique and innovative solutions are called for to help address the critical needs of not only those acutely ill with COVID-19 but also all others who may require medical attention but are unable to receive it due to limited access or lack of resources. Under such conditions, telemedicine services (TMSs) become a critical asset, with important implications across the entire health-care delivery spectrum. The use of TMS offers several advantages, especially in the setting of nonurgent/routine care and in situations where services do not require direct provider-patient interaction, such as focused/abbreviated medical consultations or mental health visits. [26] [27] [28] This, in turn, reduces resource use across the already stressed health-care infrastructure, improves access to care, and at the same time minimizes the risk of direct person-to-person transmission of the infectious agent. [29] [30] [31] [32] Furthermore, the associated reduction in resource consumption due to the lower need for personal protective equipment can amount to substantial financial savings when considered at national, continental, or global scale. [33, 34] Based on the above rationale, the availability of TMS can become a critical need for populations and patients affected by the COVID-19 infection, especially when under active quarantine. Enabling patients to consult a health-care provider via teleconferencing, in real-time, to allay one\\'s fear and anxiety, seek advice regarding their routine health problems, and learn self-care, all become critically important in the setting of hospitals and clinics being overwhelmed with more acute complaints. [35] [36] [37] Using tailored approaches, TMS providers can remotely identify patients who may require further escalation of care. Thus, TMS can be a powerful gate-keeping and coordination mechanism to ensure more appropriate use of provider offices, emergency departments (EDs), and hospitals, as understood within the above broader context. [36, [38] [39] [40] The overall emergency implementation of TMS can also be augmented by the addition of point-of-care clinical assessment and diagnostic testing, further strengthening the efficacy of the emergency response infrastructure. [41, 42] Spatiotemporal analyses of telehealth data, specifically those focusing on calls regarding the complaint of \"fever,\" have in the past provided a timely and useful picture of the evolution of a national influenza outbreak in the United Kingdom (UK). [43] The high burden of seasonal influenza outbreaks prompted the implementation of innovative TMS-based solutions as first-line approaches to reduce patient visits to the ED. [44] Taking a cue from the fight against influenza, a robust and responsive health-care system should consider adopting similar innovative TMS-based approaches in the setting of COVID-19. For countries and regions with limited or no identified transmission of COVID-19, rapid adoption of TMS and appropriate training of the health-care workforce in use of TMS should be considered among the top priorities. The level of urgency increases further in the presence of active and/or accelerating viral spread.', 'cite_spans': [{'start': 702, 'end': 706, 'text': '[22]', 'ref_id': 'BIBREF20'}, {'start': 973, 'end': 977, 'text': '[23]', 'ref_id': 'BIBREF21'}, {'start': 978, 'end': 982, 'text': '[24]', 'ref_id': 'BIBREF22'}, {'start': 983, 'end': 987, 'text': '[25]', 'ref_id': 'BIBREF23'}, {'start': 1663, 'end': 1667, 'text': '[26]', 'ref_id': 'BIBREF24'}, {'start': 1668, 'end': 1672, 'text': '[27]', 'ref_id': 'BIBREF25'}, {'start': 1673, 'end': 1677, 'text': '[28]', 'ref_id': 'BIBREF26'}, {'start': 1900, 'end': 1904, 'text': '[29]', 'ref_id': 'BIBREF27'}, {'start': 1905, 'end': 1909, 'text': '[30]', 'ref_id': 'BIBREF28'}, {'start': 1910, 'end': 1914, 'text': '[31]', 'ref_id': 'BIBREF29'}, {'start': 1915, 'end': 1919, 'text': '[32]', 'ref_id': 'BIBREF30'}, {'start': 2141, 'end': 2145, 'text': '[33,', 'ref_id': 'BIBREF31'}, {'start': 2146, 'end': 2149, 'text': '34]', 'ref_id': 'BIBREF32'}, {'start': 2650, 'end': 2654, 'text': '[35]', 'ref_id': 'BIBREF33'}, {'start': 2655, 'end': 2659, 'text': '[36]', 'ref_id': 'BIBREF34'}, {'start': 2660, 'end': 2664, 'text': '[37]', 'ref_id': 'BIBREF35'}, {'start': 2993, 'end': 2997, 'text': '[36,', 'ref_id': 'BIBREF34'}, {'start': 2998, 'end': 3002, 'text': '[38]', 'ref_id': 'BIBREF36'}, {'start': 3003, 'end': 3007, 'text': '[39]', 'ref_id': 'BIBREF37'}, {'start': 3008, 'end': 3012, 'text': '[40]', 'ref_id': 'BIBREF38'}, {'start': 3233, 'end': 3237, 'text': '[41,', 'ref_id': 'BIBREF39'}, {'start': 3238, 'end': 3241, 'text': '42]', 'ref_id': 'BIBREF40'}, {'start': 3491, 'end': 3495, 'text': '[43]', 'ref_id': 'BIBREF41'}, {'start': 3667, 'end': 3671, 'text': '[44]', 'ref_id': 'BIBREF42'}], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'When evaluating options for rapid mass-scale implementation of TMS capabilities across the entire regions, countries, or even continents, important logistical issues must be taken into consideration. With the rapid evolution and miniaturization of portable electronic devices, most households own at least one digital device that is capable of rudimentary TMS patientprovider interactions. [45] [46] [47] Moreover, most regions of the world have some form of connectivity, even if intermittent, thus enabling the use of patient-or community-owned devices over the existing infrastructure.', 'cite_spans': [{'start': 390, 'end': 394, 'text': '[45]', 'ref_id': 'BIBREF43'}, {'start': 395, 'end': 399, 'text': '[46]', 'ref_id': 'BIBREF44'}, {'start': 400, 'end': 404, 'text': '[47]', 'ref_id': 'BIBREF45'}], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'During the current COVID-19 pandemic, the WHO has asked nations to increase their preparedness, suggesting the following three priorities: [13] • First, all countries must prioritize protecting health-care workers • Second, communities must actively work on ways to protect people who are most at risk of severe disease, particularly the elderly and individuals with pre-existing health conditions • Third, the global community must protect the most vulnerable countries, by doing everything possible to effectively contain the epidemic and/or minimize its spread.', 'cite_spans': [{'start': 139, 'end': 143, 'text': '[13]', 'ref_id': None}], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'Within the context of the above WHO priorities, TMSs are perfectly positioned to help achieve the objectives for all three priorities, as follows:', 'cite_spans': [], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': '• First, TMS use actively protects health-care workers by reducing nonacute patient-provider interactions, thus minimizing the risk of COVID-19 transmission involving infected but mildly symptomatic individuals • Second, TMS will assist communities with protecting high-risk individuals (i.e., elderly and those with comorbid health conditions) by reducing their exposure to hospitals and other health-care locations that may be frequented by those with acute COVID-19 infection • Third, countries or regions with ample health-care staffing and resources will be able to help countries or regions with limited access to staffing and/or resources by providing TMS-based services within an established, agreed-upon framework.', 'cite_spans': [], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': \"One of the Israel's medical centers has reported the use of TMS to more effectively care for the 12 Israeli COVID-19 patients received from the cruise ship that was quarantined in Japan for several weeks. [1, 48] The various TMS platforms and modalities tested include remote patient examination without medical staff presence, robotic telemedicine cart equipped with a camera, screen and medical equipment controlled by doctors and nurses, and remote monitoring using a thermometer, blood pressure instruments and pulse oximetry, without additional human presence. [48] Approximately 1700 health-care personnel have been reported infected with COVID-19 in China and 14.8% have been classified as severe or critically ill, with a total of 5 associated deaths. [49] Fortunately, infection rates appear to be lower than the 2002-2003 severe acute respiratory syndrome (SARS) outbreak where 30% of infections occurred in health-care workers; furthermore, the case fatality rate among health-care workers for SARS was 11% and with COVID-19 it is 0.3%. [50] COVID-19 is demonstrating an estimated reproduction number of 2.2, which signifies that, on average, every patient with COVID-19 will infect just over 2 other individuals. [51, 52] Until the reproduction number is below 1, the pandemic will continue to escalate unless transmission strategies (i.e., containment or technological innovations like TMS) prevail.\", 'cite_spans': [{'start': 205, 'end': 208, 'text': '[1,', 'ref_id': 'BIBREF0'}, {'start': 209, 'end': 212, 'text': '48]', 'ref_id': 'BIBREF46'}, {'start': 566, 'end': 570, 'text': '[48]', 'ref_id': 'BIBREF46'}, {'start': 760, 'end': 764, 'text': '[49]', 'ref_id': 'BIBREF47'}, {'start': 1048, 'end': 1052, 'text': '[50]', 'ref_id': 'BIBREF48'}, {'start': 1225, 'end': 1229, 'text': '[51,', 'ref_id': 'BIBREF49'}, {'start': 1230, 'end': 1233, 'text': '52]', 'ref_id': 'BIBREF50'}], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'In Italy as on March 5 more than 3000 positive cases have been reported, 50% of whom are hospitalized, including 10% in intensive care units with severe respiratory manifestations. Also the mortality in Italy is somewhat higher (107 cases) at around 3.5% and this is probably due to the primary infection clusters that are located in small towns in remote part of North of Italy, far from larger hospitals where the availability of testing for COVID-19 detection is greater. [53] On planetary scale, as the number of documented cases of COVID-19 continues to rise, health officials and providers are exploring virtual care delivery to screen patients for infection away from crowded EDs and provide a safer care alternative for those in isolation after a positive diagnosis. In addition to TMS being beneficial by keeping unaffected individuals safe, including the general public, patients and health workers, another crucial advantage is its ability to provide a powerful \"force multiplier\" that dramatically extends the reach of caregivers. Medical professionals such as triage nurses and emergency medical technicians can quickly screen larger numbers of patients and lessen the burden on physicians and specialists who can perform remote consults when needed.', 'cite_spans': [{'start': 475, 'end': 479, 'text': '[53]', 'ref_id': 'BIBREF51'}], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'This is not the first time that telemedicine has been considered as an adjunct in the treatment of infectious disease outbreak, but growing concerns over the emergence of a pandemic are certainly pushing TMS to the forefront. Health organizations can employ digital health in a number of ways in preparation for COVID-19 cases -ranging from transitioning patients with cold and flu symptoms into virtual appointments, installing telemedicine stations in isolation units, to setting up dedicated triage units off-site to send patients for screening and specialist consults.', 'cite_spans': [], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'Decision-making algorithms incorporating telemedicine, designed through the utilization of artificial intelligence tools, could also be used in order to assist with definitive disposition of the evaluated patients by remote analysis.', 'cite_spans': [], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'Our working group believes that innovative TMS solutions need to be adopted and promoted worldwide to safeguard health-care workers and high-risk patient populations, as well as to provide supplemental care for nations and regions where resources are insufficient to cope with cumulative burdens of the COVID-19 pandemic.', 'cite_spans': [], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'Based on the current reports from around the world, the management of COVID-19 infections should be based on multidisciplinary team approaches. The number and causes of mortality are somewhat variable, with multiple organ failure and myocarditis featuring prominently on the list. Moreover, the left ventricular ejection fraction is affected negatively and cardiac biomarkers have been significantly elevated in a substantial number of cases. [54] Such complex scenarios necessitate collaborative strategies involving multi-specialty teams. In addition to bringing much needed expertise to the patient, the adoption of TMS based consultations for such cases also helps reduce direct COVID-19 exposure among health-care experts.', 'cite_spans': [{'start': 443, 'end': 447, 'text': '[54]', 'ref_id': 'BIBREF52'}], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}, {'text': 'The real risk of COVID-19 extends well beyond the current period. In fact, the true game changer scenario would be the transition of COVID-19 from a one-time pandemic event into an endemic phenomenon, circulating permanently within the human population. [54] Under such as yet hypothetical circumstances, the endemic coronavirus would co-exist with seasonal influenza, leading to potentially permanent new equilibrium state. In this context, TMS in conjunction with point-of-care testing will become an important asset, allowing early differentiation between influenza and coronavirus infections and facilitating targeted therapeutic approaches while reducing viral transmission risk. [55] In summary, the WHO and other global health care organizations should take into account and issue directions to countries to adopt and strengthen TMS services that will augment and optimize the planetary effort to extinguish the COVID-19 pandemic.', 'cite_spans': [{'start': 254, 'end': 258, 'text': '[54]', 'ref_id': 'BIBREF52'}, {'start': 685, 'end': 689, 'text': '[55]', 'ref_id': 'BIBREF53'}], 'ref_spans': [], 'section': 'Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Wuhan Novel Coronavirus', 'authors': [], 'year': 2019, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.31646/gbio.52/']}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Flights Carrying Roughly 300 Coronavirus Evacuees Scheduled to Arrive in US, 31,400 Infected Globally | Fox News', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Joining Hands to Fight the 2019-nCov Epidemic. The Jakarta Post', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Post', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Not a virus, but an upgrade\": The ethics of epidemic evolution in Greg Bear\\'s Darwin\\'s Radio', 'authors': [{'first': 'L', 'middle': [], 'last': 'Lynch', 'suffix': ''}], 'year': 2001, 'venue': 'Lit Med', 'volume': '20', 'issn': '', 'pages': '71--93', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Novel Coronavirus (2019-nCoV) Situation Reports. Available from', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'The Effect of Travel Restrictions on the Domestic Spread of the Wuhan Coronavirus 2019-nCov', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Economic impacts of Wuhan 2019-nCoV on China and the world', 'authors': [{'first': 'F', 'middle': ['K'], 'last': 'Ayittey', 'suffix': ''}, {'first': 'M', 'middle': ['K'], 'last': 'Ayittey', 'suffix': ''}, {'first': 'N', 'middle': ['B'], 'last': 'Chiwero', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Kamasah', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Dzuvor', 'suffix': ''}], 'year': 2020, 'venue': 'J Med Virol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['Doi:10.1002/jmv.25706']}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study', 'authors': [{'first': 'J', 'middle': ['T'], 'last': 'Wu', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Leung', 'suffix': ''}, {'first': 'G', 'middle': ['M'], 'last': 'Leung', 'suffix': ''}], 'year': 2020, 'venue': 'Lancet', 'volume': '395', 'issn': '', 'pages': '689--97', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': \"Inside Wuhan's lockdown\", 'authors': [{'first': 'D', 'middle': [], 'last': 'Lu', 'suffix': ''}], 'year': 2020, 'venue': 'New Sci', 'volume': '245', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Daily Briefing on Novel Coronavirus Cases in China', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Coronavirus Carrier Faces Jail in Singapore for Lying Over Movements. The Jakarta Post', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Post', 'suffix': ''}], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'who-director-general-s-opening-remarks-at-the-mission-briefingon-covid', 'authors': [], 'year': 2020, 'venue': 'FEMA Preparing for Possible Coronavirus Emergency Declaration', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Nigeria Confirms First Coronavirus Case', 'authors': [], 'year': None, 'venue': 'BBC News', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'First Death from Coronavirus in the United States Confirmed in Washington State -CNN', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Novel coronavirus, poor quarantine, and the risk of pandemic', 'authors': [{'first': 'S', 'middle': [], 'last': 'Khan', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Siddique', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Ali', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Xue', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Nabi', 'suffix': ''}], 'year': 2020, 'venue': 'J Hosp Infect', 'volume': '', 'issn': '20', 'pages': '30048--30055', 'other_ids': {'DOI': ['Doi:10.1016/j.jhin.2020.02.002']}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Outbreak of coronavirus disease 2019', 'authors': [{'first': 'T', 'middle': [], 'last': 'Burki', 'suffix': ''}], 'year': 2020, 'venue': 'Lancet Infect Dis', 'volume': '20', 'issn': '', 'pages': '292--295', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Estimated effectiveness of traveller screening to prevent international spread of 2019 novel coronavirus (2019-nCoV)', 'authors': [{'first': 'K', 'middle': [], 'last': 'Gostic', 'suffix': ''}, {'first': 'A', 'middle': ['C'], 'last': 'Gomez', 'suffix': ''}, {'first': 'R', 'middle': ['O'], 'last': 'Mummah', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Kucharski', 'suffix': ''}, {'first': 'Lloyd-Smith', 'middle': [], 'last': 'Ll', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '2020', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China', 'authors': [{'first': 'W', 'middle': [], 'last': 'Chen', 'suffix': ''}, {'first': 'Q', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'Y', 'middle': ['Q'], 'last': 'Li', 'suffix': ''}, {'first': 'H', 'middle': ['L'], 'last': 'Yu', 'suffix': ''}, {'first': 'Y', 'middle': ['Y'], 'last': 'Xia', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Zhang', 'suffix': ''}], 'year': 2020, 'venue': 'Zhonghua Yu Fang Yi Xue Za Zhi', 'volume': '54', 'issn': '', 'pages': '1--6', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': \"14% of Recovered Coronavirus Patients in China's Guangdong Tested Positive Again. The Straits Times\", 'authors': [], 'year': 2020, 'venue': '', 'volume': '2020', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients', 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Wax', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Christian', 'suffix': ''}], 'year': 2020, 'venue': 'Can J Anaesth', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['Doi:10.1007/s12630-020-01591-x]']}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Ethics of outbreaks position statement. Part 2: family-centered care', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Papadimos', 'suffix': ''}, {'first': 'E', 'middle': ['G'], 'last': 'Marcolini', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Hadian', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Hardart', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Ward', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Levy', 'suffix': ''}], 'year': 2018, 'venue': 'Crit Care Med', 'volume': '46', 'issn': '', 'pages': '1856--60', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Reflections on the Ebola public health emergency of international concern, Part 2: The unseen epidemic of posttraumatic stress among health-care personnel and survivors of the 2014-2016 Ebola outbreak', 'authors': [{'first': 'L', 'middle': [], 'last': 'Paladino', 'suffix': ''}, {'first': 'R', 'middle': ['P'], 'last': 'Sharpe', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Galwankar', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Sholevar', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Marchionni', 'suffix': ''}, {'first': 'T', 'middle': ['J'], 'last': 'Papadimos', 'suffix': ''}], 'year': 2017, 'venue': 'J Glob Infect Dis', 'volume': '9', 'issn': '', 'pages': '45--50', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'SARS control and psychological effects of quarantine', 'authors': [{'first': 'L', 'middle': [], 'last': 'Hawryluck', 'suffix': ''}, {'first': 'W', 'middle': ['L'], 'last': 'Gold', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Robinson', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pogorski', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Galea', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Styra', 'suffix': ''}], 'year': 2004, 'venue': 'Canada. Emerg Infect Dis', 'volume': '10', 'issn': '', 'pages': '1206--1218', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Telemedicine: A new health care delivery system', 'authors': [{'first': 'R', 'middle': ['L'], 'last': 'Bashshur', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Reardon', 'suffix': ''}, {'first': 'G', 'middle': ['W'], 'last': 'Shannon', 'suffix': ''}], 'year': 2000, 'venue': 'Annu Rev Public Health', 'volume': '21', 'issn': '', 'pages': '613--650', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Telemedicine improved diabetic management', 'authors': [{'first': 'W', 'middle': ['L'], 'last': 'Whitlock', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Brown', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Moore', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Pavliscsak', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Dingbaum', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Lacefield', 'suffix': ''}], 'year': 2000, 'venue': 'Mil Med', 'volume': '165', 'issn': '', 'pages': '579--84', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'A randomized trial of telemedicine-based collaborative care for depression', 'authors': [{'first': 'J', 'middle': ['C'], 'last': 'Fortney', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Pyne', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Edlund', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Williams', 'suffix': ''}, {'first': 'D', 'middle': ['E'], 'last': 'Robinson', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Mittal', 'suffix': ''}], 'year': 2007, 'venue': 'J Gen Intern Med', 'volume': '22', 'issn': '', 'pages': '1086--93', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Telemedicine can lower costs and improve access', 'authors': [{'first': 'B', 'middle': ['L'], 'last': 'Charles', 'suffix': ''}], 'year': 2000, 'venue': 'Healthc Financ Manage', 'volume': '54', 'issn': '', 'pages': '66--75', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Telemedicine: A cost-reducing means of delivering psychotherapy to rural combat veterans with PTSD', 'authors': [{'first': 'L', 'middle': ['A'], 'last': 'Morland', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Raab', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Mackintosh', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Rosen', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Dismuke', 'suffix': ''}, {'first': 'C', 'middle': ['J'], 'last': 'Greene', 'suffix': ''}], 'year': 2013, 'venue': 'Telemed J E Health', 'volume': '19', 'issn': '', 'pages': '754--763', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Use of telemedicine in evading cholera outbreak in Mahakumbh Mela, Prayag, UP, India: An encouraging experience', 'authors': [{'first': 'A', 'middle': [], 'last': 'Ayyagari', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bhargava', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Agarwal', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Mishra', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Mishra', 'suffix': ''}, {'first': 'S', 'middle': ['R'], 'last': 'Das', 'suffix': ''}], 'year': 2003, 'venue': 'Telemed J E Health', 'volume': '9', 'issn': '', 'pages': '89--94', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Telemedicine: Potential applications in epidemic situations', 'authors': [{'first': 'R', 'middle': [], 'last': 'Ohannessian', 'suffix': ''}], 'year': 2015, 'venue': 'Eur Res Telemed Rech Eur En Télémédecine', 'volume': '4', 'issn': '', 'pages': '95--103', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Cost-effectiveness analysis of hospital infection control response to an epidemic respiratory virus threat', 'authors': [{'first': 'Y', 'middle': ['Y'], 'last': 'Dan', 'suffix': ''}, {'first': 'P', 'middle': ['A'], 'last': 'Tambyah', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Sim', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Lim', 'suffix': ''}, {'first': 'L', 'middle': ['Y'], 'last': 'Hsu', 'suffix': ''}, {'first': 'W', 'middle': ['L'], 'last': 'Chow', 'suffix': ''}], 'year': 2009, 'venue': 'Emerg Infect Dis', 'volume': '15', 'issn': '', 'pages': '1909--1925', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Stockpile of personal protective equipment in hospital settings: Preparedness for influenza pandemics', 'authors': [{'first': 'M', 'middle': [], 'last': 'Hashikura', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kizu', 'suffix': ''}], 'year': 2009, 'venue': 'Am J Infect Control', 'volume': '37', 'issn': '', 'pages': '703--710', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Telemedicine Use Decreases Rural Emergency Department Length of Stay for Transferred North Dakota Trauma Patients', 'authors': [{'first': 'N', 'middle': ['M'], 'last': 'Mohr', 'suffix': ''}, {'first': 'J', 'middle': ['P'], 'last': 'Vakkalanka', 'suffix': ''}, {'first': 'K', 'middle': ['K'], 'last': 'Harland', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bell', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Skow', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Shane', 'suffix': ''}], 'year': 2018, 'venue': 'Telemed J E Health', 'volume': '24', 'issn': '', 'pages': '194--202', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Does Telemedicine Reduce ED Congestion? Evidence from New York State: HICSS', 'authors': [{'first': 'S', 'middle': [], 'last': 'Sun', 'suffix': ''}, {'first': 'S', 'middle': ['F'], 'last': 'Lu', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Rui', 'suffix': ''}], 'year': 2019, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Reducing Emergency Department Utilization Through Engagement in Telemedicine by Senior Living Communities', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Gillespie', 'suffix': ''}, {'first': 'M', 'middle': ['N'], 'last': 'Shah', 'suffix': ''}, {'first': 'E', 'middle': ['B'], 'last': 'Wasserman', 'suffix': ''}, {'first': 'N', 'middle': ['E'], 'last': 'Wood', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Noyes', 'suffix': ''}], 'year': 2016, 'venue': 'Telemed J E Health', 'volume': '22', 'issn': '', 'pages': '489--96', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Does a mandatory telemedicine call prior to visiting a physician reduce costs or simply attract good risks?', 'authors': [{'first': 'C', 'middle': [], 'last': 'Grandchamp', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Gardiol', 'suffix': ''}], 'year': 2011, 'venue': 'Health Econ', 'volume': '20', 'issn': '', 'pages': '1257--67', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Appropriateness of disposition following telemedicine consultations in rural emergency departments', 'authors': [{'first': 'N', 'middle': ['H'], 'last': 'Yang', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Dharmar', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Kuppermann', 'suffix': ''}, {'first': 'P', 'middle': ['S'], 'last': 'Romano', 'suffix': ''}, {'first': 'T', 'middle': ['S'], 'last': 'Nesbitt', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Hojman', 'suffix': ''}], 'year': 2015, 'venue': 'Pediatr Crit Care Med', 'volume': '16', 'issn': '', 'pages': '59--64', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Potential of telemedicine to provide acute medical care for adults in senior living communities', 'authors': [{'first': 'M', 'middle': ['N'], 'last': 'Shah', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Mcdermott', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Gillespie', 'suffix': ''}, {'first': 'E', 'middle': ['B'], 'last': 'Philbrick', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Nelson', 'suffix': ''}], 'year': 2013, 'venue': 'Acad Emerg Med', 'volume': '20', 'issn': '', 'pages': '162--170', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': \"Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network\", 'authors': [{'first': 'S', 'middle': ['P'], 'last': 'Stawicki', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Stoltzfus', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Aggarwal', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Bhoi', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Bhatt', 'suffix': ''}, {'first': 'O', 'middle': ['P'], 'last': 'Kalra', 'suffix': ''}], 'year': 2014, 'venue': 'Int J Crit Illn Inj Sci', 'volume': '4', 'issn': '', 'pages': '200--208', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'The Emergence of Zika Virus as a Global Health Security Threat: A Review and a Consensus Statement of the INDUSEM Joint working Group (JWG)', 'authors': [{'first': 'V', 'middle': [], 'last': 'Sikka', 'suffix': ''}, {'first': 'V', 'middle': ['K'], 'last': 'Chattu', 'suffix': ''}, {'first': 'R', 'middle': ['K'], 'last': 'Popli', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Galwankar', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Kelkar', 'suffix': ''}, {'first': 'S', 'middle': ['G'], 'last': 'Sawicki', 'suffix': ''}], 'year': 2016, 'venue': 'J Glob Infect Dis', 'volume': '8', 'issn': '', 'pages': '3--15', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Tracking the spatial diffusion of influenza and norovirus using telehealth data: A spatiotemporal analysis of syndromic data', 'authors': [{'first': 'D', 'middle': ['L'], 'last': 'Cooper', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Smith', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Regan', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Large', 'suffix': ''}, {'first': 'P', 'middle': ['P'], 'last': 'Groenewegen', 'suffix': ''}], 'year': 2008, 'venue': 'BMC Med', 'volume': '6', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'Telemedicine Emerging as a First Line of Defense during Flu Season. Physicians Practice', 'authors': [{'first': 'Sylvia', 'middle': [], 'last': 'Romm', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': '', 'suffix': ''}], 'year': 2019, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'Application of Telemedicine in Acute-Onset Disaster Situations', 'authors': [{'first': 'A', 'middle': [], 'last': 'Jivraj', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Mastouri', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Turnock', 'suffix': ''}], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Smart-TV Based Integrated E-Health Monitoring System with Agent Technology', 'authors': [{'first': 'G', 'middle': [], 'last': 'Sorwar', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hasan', 'suffix': ''}], 'year': 2012, 'venue': '26 th International Conference on Advanced Information Networking and Applications Workshops', 'volume': '', 'issn': '', 'pages': '406--417', 'other_ids': {}}, 'BIBREF45': {'ref_id': 'b45', 'title': 'Using TV white space spectrum to practise telemedicine: A promising technology to enhance broadband internet connectivity within healthcare facilities in rural regions of developing countries', 'authors': [{'first': 'A', 'middle': [], 'last': 'Chavez', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Littman-Quinn', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Ndlovu', 'suffix': ''}, {'first': 'C', 'middle': ['L'], 'last': 'Kovarik', 'suffix': ''}], 'year': 2016, 'venue': 'J Telemed Telecare', 'volume': '22', 'issn': '', 'pages': '260--263', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': \"Israel's Sheba Hospital Turns to Telehealth to Treat Incoming Coronavirus-Exposed Patients. MobiHealthNews; 2020\", 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention', 'authors': [{'first': 'Z', 'middle': [], 'last': 'Wu', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Mcgoogan', 'suffix': ''}], 'year': None, 'venue': 'JAMA', 'volume': '2020', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['Doi:10.1001/jama.2020.2648']}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Schwartz', 'suffix': ''}, {'first': 'A', 'middle': ['L'], 'last': 'Graham', 'suffix': ''}], 'year': 2020, 'venue': 'Viruses', 'volume': '12', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'Covid-19 -Navigating the Uncharted', 'authors': [{'first': 'A', 'middle': ['S'], 'last': 'Fauci', 'suffix': ''}, {'first': 'H', 'middle': ['C'], 'last': 'Lane', 'suffix': ''}, {'first': 'R', 'middle': ['R'], 'last': 'Redfield', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['Doi:10.1056/NEJMe2002387']}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'First Case of 2019 Novel Coronavirus in the United States', 'authors': [{'first': 'M', 'middle': ['L'], 'last': 'Holshue', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Debolt', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Lindquist', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Lofy', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Wiesman', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Bruce', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '382', 'issn': '', 'pages': '929--965', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': \"Italy's Elderly Suffer Heavy Toll as Coronavirus Spreads-The New York Times\", 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study', 'authors': [{'first': 'N', 'middle': [], 'last': 'Chen', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Zhou', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Dong', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Qu', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Gong', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Han', 'suffix': ''}], 'year': 2020, 'venue': 'Lancet', 'volume': '395', 'issn': '', 'pages': '507--520', 'other_ids': {}}, 'BIBREF53': {'ref_id': 'b53', 'title': \"Experts Envision Two Scenarios if New Coronavirus isn't Contained. STAT; 2020\", 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715f00871978ef2dac306'), 'paper_id': '0aa3eda0fb09bf9f55864fc2b9157b9317f62323', 'metadata': {'title': 'Centers for Disease Control and Prevention, Division of Global Migration and Quarantine San Diego, California, USA Epidemiological surveillance of land borders in North and South America: a case study', 'authors': [{'first': 'Robson', 'middle': [], 'last': 'Bruniera-Oliveira', 'suffix': '', 'affiliation': {'laboratory': 'Fundação Oswaldo Cruz, Vice-Presidência de Pesquisa e Laboratórios de Referência', 'institution': 'Universidade de São Paulo', 'location': {'addrLine': 'Secretaria de Vigilância em Saúde', 'settlement': 'São Paulo, São Paulo, Rio de Janeiro, Rio de Janeiro, Brasília', 'country': 'Brazil, Brazil, Brazil ('}}, 'email': ''}, {'first': 'Marco', 'middle': ['Aurélio'], 'last': 'Pereira Horta', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Aiden', 'middle': [], 'last': 'Varan', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Sonia', 'middle': [], 'last': 'Montiel', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Eduardo', 'middle': ['Hage'], 'last': 'Carmo', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Stephen', 'middle': ['H'], 'last': 'Waterman', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'José', 'middle': [], 'last': 'Fernando De Souza Verani', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidade de São Paulo', 'location': {'addrLine': 'Av. Dr. Arnaldo, 715, CEP 03178-200, São Paulo', 'settlement': 'Rio de Janeiro, Rio de Janeiro', 'region': 'SP', 'country': 'Brazil, Brazil'}}, 'email': ''}]}, 'abstract': [{'text': 'This study aims to analyze the different binational/multinational activities, programs, and structures taking place on the borders of Brazil and the U.S. between 2013 and 2015. A descriptive exploratory study of two border epidemiological surveillance (BES) systems has been performed. Two approaches were used to collect data: i) technical visits to the facilities involved with border surveillance and application of a questionnaire survey; ii) application of an online questionnaire survey. It was identified that, for both surveillance systems, more than 55% of the technicians had realized that the BES and its activities have high priority. Eighty percent of North American and 71% of Brazilian border jurisdictions reported an exchange of information between countries. Less than half of the jurisdictions reported that the necessary tools to carry out information exchange were available. Operational attributes of completeness, feedback, reciprocity, and quality of information were identified as weak or of low quality in both systems. Statements, guidelines, and protocols to develop surveillance activities are available at the U.S.-Mexico border area. The continuous systematic development of surveillance systems at these borders will create more effective actions and responses.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'The epidemics of severe acute respiratory syndrome (SARS), pandemic influenza (H1N1) and Middle Eastern Respiratory Syndrome (MERS-CoV) hit the world with a high pathogenic potential in recent years, providing a warning to nations of the speed with which these epidemics can move across the globe 1-3 . Everyday, nations are more internationally connected 4 . On February 1, 2016, for the fourth time in history, the World Health Organization (WHO) declared a public health emergency of international concern (PHEIC) to make a joint global effort to control the outbreak caused by Zika virus (ZIKV) in Latin America and the Caribbean 5,6 . These facts reiterated the need for governments and international agencies to build and strengthen the surveillance of infectious diseases at all levels, from national to international, thus facilitating the timely detection, response, and communication of disease outbreaks on a global scale 4 .', 'cite_spans': [{'start': 356, 'end': 357, 'text': '4', 'ref_id': 'BIBREF3'}, {'start': 933, 'end': 934, 'text': '4', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'The International Health Regulations (IHR) recommends that countries sharing borders and having common interests consider establishing multilateral agreements 7 . This aims to facilitate the implementation of IHR, consolidating the direct and rapid exchange of public health information and the application of health measures at borders. This effort may prevent and/or control the international transmission of disease at the crossing point 7 . Land borders are physical spaces with peculiar characteristics including large historical, cultural, ethnic, economic, and social heterogeneities. In many cases, these spaces have intense population flows, which create special conditions for disease transmission 8 . Several studies [9] [10] [11] [12] [13] [14] have indicated that these border areas possess different dynamics and patterns of occurrence of disease when compared to other areas within countries.', 'cite_spans': [{'start': 159, 'end': 160, 'text': '7', 'ref_id': None}, {'start': 441, 'end': 442, 'text': '7', 'ref_id': None}, {'start': 708, 'end': 709, 'text': '8', 'ref_id': 'BIBREF8'}, {'start': 728, 'end': 731, 'text': '[9]', 'ref_id': 'BIBREF9'}, {'start': 732, 'end': 736, 'text': '[10]', 'ref_id': 'BIBREF10'}, {'start': 737, 'end': 741, 'text': '[11]', 'ref_id': 'BIBREF11'}, {'start': 742, 'end': 746, 'text': '[12]', 'ref_id': 'BIBREF12'}, {'start': 747, 'end': 751, 'text': '[13]', 'ref_id': 'BIBREF13'}, {'start': 752, 'end': 756, 'text': '[14]', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"Brazil and the United States of America (U.S.) are countries with large extensions of land borders. Brazil's border is 15,719 km long and is shared with ten countries, all with different health policies. The border fringe occupies an area of 2,300,000 km 2 (27.6% of the country), with 588 municipalities and nearly 10 million people (6% of the population) 15 . The U.S. Southern border with Mexico extends for 3,141 km, with a fringe of 100 km (62.5 miles) on each side of the border and an estimated population of 13 million people 16, 17 .\", 'cite_spans': [{'start': 357, 'end': 359, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 534, 'end': 537, 'text': '16,', 'ref_id': 'BIBREF16'}, {'start': 538, 'end': 540, 'text': '17', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Due to the long length of land borders, with intense population flows and different epidemiological and social scenarios, the vulnerability to the introduction and rapid spread of potential threats to public health is a fact that must be taken into consideration. Therefore, the development of systems and activities focusing on border epidemiological surveillance (BES) is essential both for domestic and global health security 18 . Based on the hypothesis that border surveillances must promote binational communication, an exchange of epidemiologic information in a timely and dynamic manner to improve the cross-border public health infrastructure through collaboration, this study aimed to analyze the different binational/multinational activities, programs, and structures to identify challenges and to suggest improvements of binational and/or multinational epidemiological surveillance partnerships on the borders of Brazil and the U.S.', 'cite_spans': [{'start': 429, 'end': 431, 'text': '18', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'A descriptive exploratory study about border epidemiological surveillance (BES) systems was performed in South and North America between 2013 and 2015. A total of 47 interviews at every operational level of the BES were conducted at the United States-Mexico border (US-MX border applied from February 2014 to September 2014) and Brazil (November 2014 to March 2015).', 'cite_spans': [], 'ref_spans': [], 'section': 'MATERIAL AND METHODS'}, {'text': \"In South America, the study focused on the border between Brazil and the America's Southern Cone countries (Argentina, Paraguay, and Uruguay). This border area is defined as the area of land situated 150 km North and South from the International Boundary Line. This region is divided into six subregions (XII-XVII) with 441 municipalities, an area of 329,943 km 2 and a population of 6,893,804 inhabitants 19 ( Figure 1 ).\", 'cite_spans': [], 'ref_spans': [{'start': 411, 'end': 419, 'text': 'Figure 1', 'ref_id': 'FIGREF0'}], 'section': 'Description of the study area'}, {'text': 'As for North America, the study was carried out on the Southern U.S. border with Mexico. This border has a length of approximately 3,141 km. The border region is defined as the area of land situated 100 km (62.5 miles) North and South from the international boundary. The area includes four U.S. States (California, Arizona, New Mexico, and Texas) and six Mexican States (Baja California, Sonora, Chihuahua, Coahuila, Nuevo Leon, and Tamaulipas) with an estimated population of about 13 million people 17 ( Figure 2 ). Data collection and analysis BES operational data were collected using a developed semi-structured questionnaire with a focus on information exchange between jurisdictions, domestically and internationally. The instrument was based on previous surveys by the CDC 20 , Bruniera-Oliveira et al. 21 and Varan et al. 22 and was structured with four dimensions: organizational priorities and resources, information exchange, laboratory, and challenges.', 'cite_spans': [{'start': 812, 'end': 814, 'text': '21', 'ref_id': 'BIBREF21'}, {'start': 832, 'end': 834, 'text': '22', 'ref_id': 'BIBREF22'}], 'ref_spans': [{'start': 507, 'end': 515, 'text': 'Figure 2', 'ref_id': 'FIGREF1'}], 'section': 'Description of the study area'}, {'text': 'Because of long geographical distances, two approaches were used for data collection: i) technical visits to the facilities involved with border surveillance, which included questionnaire applications and direct observations of the operational procedures and facility structures; ii) application of online questionnaires for those facilities that could not be visited. For both approaches, questionnaires were developed in English and, subsequently, translated into Spanish and Portuguese.', 'cite_spans': [], 'ref_spans': [], 'section': 'Description of the study area'}, {'text': \"A draft questionnaire was shared with stakeholders in all operational levels working directly or indirectly on border surveillance activities in the U.S. for comments and suggestions. A pilot test of a final version of the tool was conducted with U.S. and Mexico stakeholders to evaluate its effectiveness to collect information. A Likert scale was used to measure the outcomes [23] [24] [25] . The final version of the English questionnaire was translated and back-translated by native speakers of Spanish and Portuguese, which subsequently went through the same validation process by experts. For the questionnaire application by digital media, an online survey development software, SurveyMonkey, was used (Research SurveyMonkey ® ). Its distribution and monitoring were done through links distributed by e-mail to the participants' e-mails.\", 'cite_spans': [{'start': 378, 'end': 382, 'text': '[23]', 'ref_id': 'BIBREF24'}, {'start': 383, 'end': 387, 'text': '[24]', 'ref_id': 'BIBREF25'}, {'start': 388, 'end': 392, 'text': '[25]', 'ref_id': 'BIBREF26'}], 'ref_spans': [], 'section': 'Description of the study area'}, {'text': 'Technical visits were carried out at agencies, institutions and partners (such as health surveillance agencies, immigration departments, national or multinational committees/groups, laboratories, etc.), proceeding with document analysis, organization observation, and operational structure and involvement of professionals with surveillance activities. During the visits, interviews were conducted with BES stakeholders in their various operational levels using the questionnaire that had been developed. In the absence of the technician in charge in the facilities visited or in areas where visit was not possible, the stakeholders were invited to answer the online questionnaire.', 'cite_spans': [], 'ref_spans': [], 'section': 'Description of the study area'}, {'text': 'When a respondent had questions about the questionnaire or the researcher had questions about responses, a phone interview or web conference was conducted. The scope of the questionnaire included some operational attributes of surveillance, such as completeness, reciprocity, opportunity, feedback, and the quality of information. These attributes were analyzed from the perspective of the respondents using the Likert scale for measurement. This research was approved by the Research Ethics Committee of the National School of Public Health Sergio Arouca (CEP / ENSP), under the Nº 699.241.', 'cite_spans': [], 'ref_spans': [], 'section': 'Description of the study area'}, {'text': 'A total of 47 stakeholders were interviewed. Thirty of these technicians were from the North-American BES (20 technicians from the U.S. and 10 from Mexico), while in South America all the 17 technicians were from Brazil. The majority of respondents in Brazil and half in the United States belonged to the local health municipalities, whereas the State level in Mexico was the most frequent in the interviews (Table 1) .', 'cite_spans': [], 'ref_spans': [{'start': 408, 'end': 417, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Operational profile of the respondents'}, {'text': 'The U.S. has developed programs and specialized structures in border surveillance, such as the Borders Office, quarantine stations (QS), and important partnerships with several agencies that provide support with any suspected case of an important binational disease (Table 1) . Brazil does not have such structures. However, it does have Customs and Border Protection (CBP) and border offices in its structural organization, and organization stations called the Health Surveillance Stations of Ports, Airports, Borders and Customs Enclosures (PVPAF) of the Brazilian Sanitary Surveillance Agency (ANVISA). These stations are located at strategic points in Brazil, 17 of which are on land borders. Surveillance activities and sanitary control of goods, people, and animals are carried out at these stations, and some facilities have agreements with regional hospitals for the displacement and isolation of suspected cases of infectious diseases of public health concern. In addition, some of these stations are located on borders that have bior multinational facilities, a fact that makes the interaction between countries easier and more timely (Table 1) .', 'cite_spans': [], 'ref_spans': [{'start': 266, 'end': 275, 'text': '(Table 1)', 'ref_id': 'TABREF0'}, {'start': 1145, 'end': 1154, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Operational characteristics of the systems'}, {'text': 'In both surveillance systems, more than 55% of the technicians at several operational levels realize that the BES and their activities (detection, investigation, and binational or multinational notification) are high priority. Nevertheless, for these technicians, the nonexistence and/ or availability of a formal protocol with the neighboring country is considered a limiting factor for the development of appropriate actions. Only 38% of respondents in South America are familiar with the contact points involved in the notification and binational investigation. This proportion increases to 55% on the U.S.-Mexico border where there are available statements, guidelines, and protocols to develop joint activities in the border areas (Table 2) . A specific document, the \"U.S. Mexico Binational Communication Pathways Protocol,\" for the land border deserves to be highlighted. This document has been improved since 2002 by several technicians at several operational levels of the two countries and proposes to systematize and enhance the exchange of information mechanisms 26 .', 'cite_spans': [{'start': 1075, 'end': 1077, 'text': '26', 'ref_id': 'BIBREF27'}], 'ref_spans': [{'start': 736, 'end': 745, 'text': '(Table 2)', 'ref_id': 'TABREF1'}], 'section': 'Operational characteristics of the systems'}, {'text': \"Information exchange between countries occurs in more than 80% of North American jurisdictions and 71% percent of the Brazilian jurisdictions; however, only the U.S. and Mexico's technicians consider this exchange timely. Brazilian and U.S. technicians identified the reciprocity of sending information as a failure. The feedback and followup of epidemiological information was considered low by all stakeholders. The quality and completeness of exchanged information were considered medium to weak in the scale used. Less than half of the jurisdictions have the necessary tools to carry out information exchange. Telephone and electronic means of communication, such as e-mail, are most commonly used for information exchange. Over 50% of respondents reported a lack of mechanisms for sharing personally identifiable information (PII), such as encrypted e-mails (Table 2) .\", 'cite_spans': [], 'ref_spans': [{'start': 863, 'end': 872, 'text': '(Table 2)', 'ref_id': 'TABREF1'}], 'section': 'Operational characteristics of the systems'}, {'text': \"In both investigated systems, the priorities and actions are defined in binational meetings involving various partners. In South America, the Comitê Interfronteiriço and the Grupo Técnico de Itaipu Saúde are important mechanisms to outline surveillance activities. On the U.S.-MX border, groups and meetings, such as the Binational Joint Operational Meeting, the Epi Meeting, the Border Epidemiology and Surveillance Team (BEST) meeting, as well as the Consejo Binacional de Salud, among others, are important mechanisms used to share data to collaborate. It should be stressed that, in South America, there was no evidence of participation of organizations, such as the Pan American Health Organization (PAHO), MERCOSUR, or the Union of South American Nations (UNASUR) in any local border activities. The U.S.-MX border used to have a PAHO's border office in El Paso, which acted as facilitator of the collaboration between the U. S. and Mexico. However, this office ceased its activities in 2014. \", 'cite_spans': [], 'ref_spans': [], 'section': 'Organizational priorities'}, {'text': 'The limited availability of funds and specific resources is a major obstacle in the development of BES in Brazil and Mexico. Eighty percent of U.S. respondents reported the availability of financial and human resources from the three operational levels of administration. The training for technicians, including laboratory workers, is present in both systems. The respondents in the two surveyed areas consider that the U.S. and Brazil (for having more economic and financial capacity) should provide more support to the activities of their neighboring countries. Differences between countries make the border actions being implemented often only on the U.S. or Brazilian side (Table 3) .', 'cite_spans': [], 'ref_spans': [{'start': 677, 'end': 686, 'text': '(Table 3)', 'ref_id': 'TABREF2'}], 'section': 'Human, financial resources and inputs'}, {'text': \"In the U.S.-MX border review, local laboratories mainly process samples of cases under investigation. In Brazil, an emphasis should be given to the Border Laboratories' Network, coordinated by the Brazilian Health Surveillance Secretariat (SVS/MS), which consists of 12 laboratories located along the Brazilian border ( Figure 3 ). This network was created to develop the capacity and opportunity for detection of major communicable diseases, lowering the demands on the Central Laboratory of Public Health (LACEN).\", 'cite_spans': [], 'ref_spans': [{'start': 320, 'end': 328, 'text': 'Figure 3', 'ref_id': None}], 'section': 'Laboratories'}, {'text': \"Regarding the laboratory support to BES, some similarities between the two areas' borders were identified. Diagnostic and quality control panels testing methods are standardized and harmonized among laboratories within the countries, but it is not standardized among counterpart laboratories. Technology and cooperation exchange was observed between countries, but at a low frequency. Respondents believe that the financial resources and inputs are not sufficient to conduct all laboratory activities. However, on the Brazilian side, those technicians believed that they had the sufficient number of technicians to respond to all the demands of their laboratories -a fact not observed in U.S. and Mexican laboratories. The low frequency of training was cited as a major obstacle. Documents that regulate the flow of information and samples of binational cases in the two borders were not identified (Table 3) .\", 'cite_spans': [], 'ref_spans': [{'start': 899, 'end': 908, 'text': '(Table 3)', 'ref_id': 'TABREF2'}], 'section': 'Laboratories'}, {'text': 'Although the countries involved in this study have different health organization systems and speak different languages, few technicians identified these differences as barriers to develop BES activities. In general, the major obstacle highlighted to the exchange of information and joint activities was the lack of guidelines describing the steps of binational disease notification and investigation (Table 3) .', 'cite_spans': [], 'ref_spans': [{'start': 400, 'end': 409, 'text': '(Table 3)', 'ref_id': 'TABREF2'}], 'section': 'Main challenges identified by respondents'}, {'text': 'Acknowledging the vulnerability of introducing and spreading potential public health events through land borders, the International Health Regulations (IHR) recommends that countries sharing common borders should consider establishing bilateral or multilateral agreements about strengthening surveillance actions at ground crossings 7 .', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In larger border areas, such as those of the U.S. and Brazil, there are large numbers of residents. Together with the intense population flow, this provides a favorable scenario for the occurrence and spread of communicable and noncommunicable diseases 8, 27 . Ferraz et al. 28 and Spradling et al. 29 pointed toward different profiles of tuberculosis and acute viral hepatitis in the border regions of Brazil and the United States, respectively, when compared with States and national rates. Thus, the inclusion and prioritization of BES activities, mainly at the local and federal levels, are an important step toward consolidation of health surveillance systems reflecting the recognition of the importance of the issue by the governments.', 'cite_spans': [{'start': 253, 'end': 255, 'text': '8,', 'ref_id': 'BIBREF8'}, {'start': 256, 'end': 258, 'text': '27', 'ref_id': 'BIBREF28'}, {'start': 275, 'end': 277, 'text': '28', 'ref_id': 'BIBREF29'}, {'start': 299, 'end': 301, 'text': '29', 'ref_id': 'BIBREF30'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'However, as observed in this study (particularly in South America), findings show that it lacks certain protocols. These protocols, as observed at the U.S.-MX border, define the actions and communication flows between public health agencies involved with binational notifications and may support adequate responses to the occurrence of public health events. Wang et al. 30 , studying vaccine-derived poliovirus (VDPV) outbreaks, noted that surveillance based on solid international collaboration and agreements with clear and well-defined paths allows for an exchange of information in a timely and dynamic manner. The contribution of such agreements was critical to avoid the VDPV outbreaks from reaching China through its land borders. The inadequacy of many surveillance indicators (lack of opportunity for the exchange of epidemiological information, quality of the epidemiological information, reciprocity, feedback, and incompleteness of information) may be related to the informality of the BES operational articulation.', 'cite_spans': [{'start': 370, 'end': 372, 'text': '30', 'ref_id': None}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'BES systems in North and South America have taken important steps toward systematizing their activities. Both international borders are defining their priorities and actions in these regions together with stakeholders and partners of the neighboring countries. North American countries have developed and distributed a document detailing the step-by-step operational flow of information and actions because these countries place a higher priority on their actions. BES services that have developed and implemented such protocols and plans result in more clear and efficient conduction, evaluation, and review of operational procedures. In addition, the activities are not linked to specific individuals, but are rather institutionalized, allowing the continuity of standard procedures and minimizing disruptions to required actions.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"A lack of human, technical, and financial resources were major obstacles in Brazil and Mexico. Scarcity of primarily financial resources to hire technicians weakens the systems of these two countries. The lack of technicians and high personnel turnover at the jurisdiction level creates a burden on the technical staff, affecting the necessary epidemiological actions. In this respect, Bruniera-Oliveira et al. 21 evaluated Brazil's rotavirus epidemiological surveillance, noting that the limited number of technicalities and high turnover caused a delay in the process, transfer and response of the rotavirus surveillance.\", 'cite_spans': [{'start': 411, 'end': 413, 'text': '21', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The need for a greater investment in human, technical, and financial resources was unanimous by respondents in both of the studied areas. It is possible that many of the process difficulties, particularly information exchange, are due to structural differences between the countries involved. While, in Brazil there is a system that facilitates mechanisms to carry out information exchange quickly and confidentially, other countries are using unsafe means for information exchange. This structural discrepancy generates resistance, especially when health services are dealing with personal information. Furthermore, there are mechanism incompatibilities, such as differences in software versions used or even lack of such mechanisms. Therefore, countries with available resources should seek ways to standardize communication mechanisms 26 .', 'cite_spans': [{'start': 838, 'end': 840, 'text': '26', 'ref_id': 'BIBREF27'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Particular attention should be given to laboratories, which provide support for border surveillance. For most of the infectious diseases of public health concern, laboratory confirmation is essential for planning and triggering the control and prevention actions. Thus, the organization of a laboratory network able to meet demands of the border areas would increase sensitivity, opportunity, and system specificity 31 . In North America, due to the systems developed at the borders, such as the Border Infectious Disease Surveillance (BIDS), there was a substantial reduction in disparities with surveillance capabilities in incompatibility of used case definitions. This resulted in increased diagnostic capacity and laboratory capability in the region 9 .', 'cite_spans': [{'start': 416, 'end': 418, 'text': '31', 'ref_id': 'BIBREF33'}, {'start': 755, 'end': 756, 'text': '9', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"In Brazil, the Border Laboratories Network can be considered innovative as it seeks to reduce the differences in laboratory capacity between countries. However, despite what has been developed so far, significant obstacles were identified, such as a lack of support from federal laboratories and no standardization of techniques among countries. This hindered comparisons and the planning of binational actions. A study about the occurrence of public health emergencies in Brazil proved that, in the border areas, laboratory confirmation remains low for suspected cases 21 . This lack of diagnosis can be attributed to the high testing demand that these laboratories have, which requires additional investment for its expansion and an increase of capacity to become a robust border network. Although one of the response pillars to the Ebola outbreak in West Africa has been the laboratory support, the lack of capacity during the early stages of the epidemic was undoubtedly a factor that contributed to Ebola's rapid expansion, reinforcing the idea of consolidating a prepared network to respond to any type of threat 32, 33 . Such difficulties in the BES development, including laboratory services, may have contributed to a weak capacity to detect and respond in a timely manner to public health events, as observed for the Brazilian international border municipalities 34 . The analysis of their capacity to report infectious diseases with a potential to generate an epidemic demonstrated a very low proportion (16,6%) of cases of these diseases being reported in a timely manner (< 24 hours -as established nationally).\", 'cite_spans': [{'start': 570, 'end': 572, 'text': '21', 'ref_id': 'BIBREF21'}, {'start': 1119, 'end': 1122, 'text': '32,', 'ref_id': 'BIBREF35'}, {'start': 1123, 'end': 1125, 'text': '33', 'ref_id': 'BIBREF36'}, {'start': 1373, 'end': 1375, 'text': '34', 'ref_id': 'BIBREF37'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"The political organization of different countries for the entry and movement of people through borders are relevant factors in the comparison of surveillance systems and in the design of health systems for the border regions. The Treaty of Asunción, which gave rise to MERCOSUR, establishes that the States' parties have the freedom of movement for people, goods, and services among them 35 . Hence, the Brazilian Southern Border Arc has an extremely high daily porosity for people entry and exit, once the crossing between countries can be taken without any impediment. As evidenced by the research, there are numerous points of entry, where there are no checkpoints, such as health inspection points or customs. On the other hand, in North America, in addition to the physical barriers along the border, all entry points are controlled by U.S. Customs and Border Protection (CBP). This agency first screens incoming international travelers with the CDC and has the power to detain for the enforcement of isolation and quarantine of individuals with any signs and/or symptoms of infectious diseases 36 . The presence of such agencies as the CBP plays an important role in the containment of infectious diseases entering the United States. Countries that applied travel restrictions on their borders during the epidemic of the influenza virus A (H1N1) observed that both the restriction and the isolation and quarantine of the cases played an important contribution in the delay of the virus in their countries 37, 38 .\", 'cite_spans': [{'start': 388, 'end': 390, 'text': '35', 'ref_id': 'BIBREF38'}, {'start': 1100, 'end': 1102, 'text': '36', 'ref_id': 'BIBREF39'}, {'start': 1511, 'end': 1514, 'text': '37,', 'ref_id': 'BIBREF40'}, {'start': 1515, 'end': 1517, 'text': '38', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The lack of a screening process at the border crossing points temporarily makes the detection of potential suspect cases very passive, dependent on volunteers seeking health assistance. The receiving health facility of a suspected case must be prepared to provide the initial care to isolate the case when necessary or make the transport to the place of isolation. They must then communicate in a timely manner with the respective authorities in the neighboring country to begin the binational investigation. Moreover, all health facilities in the border region, including laboratories, must be notified about the possible suspect cases. An online system for binational notification would be the tool of choice. All levels involved in the response could then input, search, and follow up in real time on all the epidemiological information of cases, thus creating increased transparency and dynamism to the response process. Inside this network, an important movement should be made to bring international organizations closer, such as PAHO and multilateral mechanisms, as MERCOSUR and UNASUR. These structures and mechanisms should have important tools that have been created for international health dialogue so they can act as front ambassadors to stalemates when an urgent international response is required. Forums and mechanisms created by these agencies are important health authorities of the participating countries. Due to the previous meetings, they already have affinities, which facilitate and streamline the dialogue and target the most controversial issues.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'One of the limitations of this study was the voluntary participation, which made some of the invited stakeholders/ key coordinators not available to answer the survey. Another limitation was the financial aspect, which restricted the field visit to just one point of entry into South America. Specifically, in the South Arc, obtaining responses from Paraguayan technicians would have enhanced and contributed much to the technical discussion. However, despite numerous contacts and invitations, this did not materialize. This limitation has highlighted the lack of multinational mechanisms that could facilitate and would promote dialogue with BES structures.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"Taking from the results observed in this study, the following concluding points can be highlighted: i) availability of a protocol to North American borders; international borders are defining their priorities and actions at these regions together with stakeholders and partners from neighboring countries and the existence of border laboratories; ii) because this is a study, among the few, focused on border epidemiological surveillance in the Americas' Southern Cone countries, this research has raised questions about borders that require special attention to delineate and help the flow of work processes; iii) the continuous, systematic development of surveillance systems at the borders will provide more effectiveness to the implementation of actions and responses; thus, countries can improve their mechanisms to respond in future outbreaks; iv) considering the external validity of this study, the results achieved do not necessarily apply to the reality of other borders; however, the instrument used in this research can be adapted to be used in studies that deal with border surveillance in other parts of the world.\", 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Pandemic preparedness and response -lessons from the H1N1 influenza of 2009', 'authors': [{'first': 'H', 'middle': ['V'], 'last': 'Fineberg', 'suffix': ''}], 'year': 2014, 'venue': 'N Engl J Med', 'volume': '370', 'issn': '', 'pages': '1335--1377', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management', 'authors': [{'first': 'R', 'middle': ['D'], 'last': 'Smith', 'suffix': ''}], 'year': 2006, 'venue': 'Soc Sci Med', 'volume': '63', 'issn': '', 'pages': '3113--3136', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Updated information on the epidemiology of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection and guidance for the public, clinicians, and public health authorities', 'authors': [], 'year': 2013, 'venue': 'Centers for Disease Control and Prevention (CDC)', 'volume': '62', 'issn': '', 'pages': '793--799', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The evolution and expansion of regional disease surveillance networks and their role in mitigating the threat of infectious disease outbreaks', 'authors': [{'first': 'K', 'middle': ['C'], 'last': 'Bond', 'suffix': ''}, {'first': 'S', 'middle': ['B'], 'last': 'Macfarlane', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Burke', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Ungchusak', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Wibulpolprasert', 'suffix': ''}], 'year': 2013, 'venue': 'Emerg Health Threats J', 'volume': '6', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'World Health Organization. WHO statement on the first meeting of the International Health Regulations', 'authors': [], 'year': 2005, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations', 'authors': [], 'year': 2016, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Rapid spread of Zika virus in the Americas -implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games', 'authors': [{'first': 'E', 'middle': [], 'last': 'Petersen', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Wilson', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Touch', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Mccloskey', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Mwaba', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Bates', 'suffix': ''}], 'year': 2016, 'venue': 'Int J Infect Dis', 'volume': '44', 'issn': '', 'pages': '11--16', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Doenças transmissíveis na Faixa de Fronteira Amazônica: o caso da malária', 'authors': [{'first': 'P', 'middle': [], 'last': 'Peiter', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Machado', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Iñiguez', 'suffix': ''}], 'year': 2008, 'venue': 'Miranda AC, Barcellos C, Moreira JC, Monken M, organizadores. Território, ambiente e saúde', 'volume': '', 'issn': '', 'pages': '257--72', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Border Infectious Disease Surveillance project: establishing bi-national border surveillance', 'authors': [{'first': 'M', 'middle': [], 'last': 'Weinberg', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Waterman', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Lucas', 'suffix': ''}, {'first': 'V', 'middle': ['C'], 'last': 'Falcon', 'suffix': ''}, {'first': 'P', 'middle': ['K'], 'last': 'Morales', 'suffix': ''}, {'first': 'L', 'middle': ['A'], 'last': 'Lopez', 'suffix': ''}], 'year': 2003, 'venue': 'Emerg Infect Dis', 'volume': '9', 'issn': '', 'pages': '97--102', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Quantifying cross-border movements and migrations for guiding the strategic planning of malaria control and elimination', 'authors': [{'first': 'D', 'middle': ['K'], 'last': 'Pindolia', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Garcia', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fik', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Smith', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Tatem', 'suffix': ''}], 'year': 2014, 'venue': 'Malar J', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border', 'authors': [{'first': 'P', 'middle': [], 'last': 'Becerril-Montes', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Said-Fernández', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Luna-Herrera', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Caballero-Olín', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Enciso-Moreno', 'suffix': ''}, {'first': 'H', 'middle': ['G'], 'last': 'Martínez-Rodríguez', 'suffix': ''}], 'year': 2013, 'venue': 'Mem Inst Oswaldo Cruz', 'volume': '108', 'issn': '', 'pages': '160--166', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Delays in the diagnosis of tuberculosis in a town at the triple border of Brazil, Paraguay, and Argentina', 'authors': [{'first': 'R', 'middle': ['A'], 'last': 'Silva-Sobrinho', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Andrade', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Ponce', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Wysockiii', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Brunello', 'suffix': ''}, {'first': 'L', 'middle': ['M'], 'last': 'Scatena', 'suffix': ''}], 'year': 2012, 'venue': 'Rev Panam Salud Publica', 'volume': '31', 'issn': '', 'pages': '461--469', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Emergências em saúde pública de importância nacional e internacional no brasil', 'authors': [{'first': 'R', 'middle': ['B'], 'last': 'Oliveira', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Horta', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Barbosa', 'suffix': ''}, {'first': 'V', 'middle': ['S'], 'last': 'Belo', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Verani', 'suffix': ''}], 'year': 2006, 'venue': 'Rev Saude Publica Santa Catarina', 'volume': '7', 'issn': '', 'pages': '17--32', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Local cross-border disease surveillance and control: experiences from the Mekong Basin', 'authors': [{'first': 'M', 'middle': [], 'last': 'Moore', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Dausey', 'suffix': ''}], 'year': 2015, 'venue': 'BMC Res Notes', 'volume': '8', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Condiciones de vida, situación de la salud y disponibilidad de servicios de salud en La frontera de Brasil: un enfoque geográfico', 'authors': [{'first': 'P', 'middle': ['C'], 'last': 'Peiter', 'suffix': ''}], 'year': 2007, 'venue': 'Cad. Saude Publica', 'volume': '23', 'issn': '2', 'pages': '237--50', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'The La Paz Agreement 30 years on', 'authors': [{'first': 'S', 'middle': ['P'], 'last': 'Mumme', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Collins', 'suffix': ''}], 'year': 2014, 'venue': 'J Environ Dev', 'volume': '23', 'issn': '', 'pages': '303--333', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'United States-Mexico Border Health Commission. Border region', 'authors': [], 'year': 2016, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Surveillance and control of Aedes albopictus in the Swiss-Italian border region: differences in egg densities between intervention and non-intervention areas', 'authors': [{'first': 'T', 'middle': ['T'], 'last': 'Suter', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Flacio', 'suffix': ''}, {'first': 'F', 'middle': ['B'], 'last': 'Feijoó', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Engeler', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Tonolla', 'suffix': ''}, {'first': 'L', 'middle': ['N'], 'last': 'Regis', 'suffix': ''}], 'year': 2016, 'venue': 'PLoS Negl Trop Dis', 'volume': '10', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Brasília: IBGE', 'authors': [{'first': '', 'middle': [], 'last': 'Instituto Brasileiro De Geografia E Estatística', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Censo', 'suffix': ''}], 'year': 2010, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Center for Disease Control and Prevention. Framework for program evaluation in public health', 'authors': [], 'year': 1999, 'venue': 'MMWR Recomm Rep', 'volume': '48', 'issn': '11', 'pages': '1--40', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Avaliação da vigilância epidemiológica ampliada do rotavírus. Rev Bras Promoç Saúde', 'authors': [{'first': 'R', 'middle': [], 'last': 'Bruniera-Oliveira', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Horta', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Verani', 'suffix': ''}], 'year': 2014, 'venue': '', 'volume': '27', 'issn': '', 'pages': '140--148', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Multinational disease surveillance programs: promoting global information exchange for infectious diseases', 'authors': [{'first': 'A', 'middle': [], 'last': 'Varan', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Bruniera-Oliveira', 'suffix': ''}, {'first': 'C', 'middle': ['R'], 'last': 'Peter', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Fonseca-Ford', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Waterman', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Technique for the measurement of attitudes', 'authors': [{'first': 'R', 'middle': ['A'], 'last': 'Likert', 'suffix': ''}], 'year': 1932, 'venue': 'Arch Psychol', 'volume': '22', 'issn': '', 'pages': '1--55', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Likert-type scale response anchors', 'authors': [{'first': 'W', 'middle': ['M'], 'last': 'Vagias', 'suffix': ''}], 'year': 2006, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Likert scales and data analyses. Qual Prog', 'authors': [{'first': 'I', 'middle': ['E'], 'last': 'Allen', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Seaman', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Technical guidelines for United States-Mexico coordination on public health events of mutual interest', 'authors': [], 'year': 2016, 'venue': 'Center for Disease Control and Prevention', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': \"Health at the borders: Bayesian multilevel analysis of women's malnutrition determinants in Ethiopia\", 'authors': [{'first': 'T', 'middle': ['D'], 'last': 'Delbiso', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Rodriguez-Llanes', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Altare', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Masquelier', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Guha-Sapir', 'suffix': ''}], 'year': 2016, 'venue': 'Glob Health Action', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Epidemiological aspects of pulmonar tuberculosis in Mato Grosso do Sul', 'authors': [{'first': 'A', 'middle': ['F'], 'last': 'Ferraz', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Valente', 'suffix': ''}], 'year': 2014, 'venue': 'Brazil. Rev Bras Epidemiol', 'volume': '17', 'issn': '', 'pages': '255--66', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project', 'authors': [{'first': 'P', 'middle': ['R'], 'last': 'Spradling', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Xing', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Phippard', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Fonseca-Ford', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Montiel', 'suffix': ''}, {'first': 'N', 'middle': ['L'], 'last': 'Guzmán', 'suffix': ''}], 'year': 2000, 'venue': 'J Immigr Minor Health', 'volume': '15', 'issn': '', 'pages': '390--397', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Cross-border collaboration between China and Myanmar for emergency response to imported vaccine derived poliovirus case', 'authors': [], 'year': 2015, 'venue': 'BMC Infect Dis', 'volume': '15', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Gabinete do Ministro. Portaria nº 2.761, de 18 de novembro de 2008. Aprova a Resolução GMC nº 22', 'authors': [{'first': '', 'middle': [], 'last': 'Brasil', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ministério Da Saúde', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Diário Oficial da União', 'authors': [{'first': '', 'middle': [], 'last': 'Mercosul', 'suffix': ''}], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Laboratory support during and after the Ebola virus endgame: towards a sustained laboratory infrastructure', 'authors': [{'first': 'I', 'middle': [], 'last': 'Goodfellow', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Reusken', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koopmans', 'suffix': ''}], 'year': 2015, 'venue': 'Euro Surveill', 'volume': '20', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Active monitoring of travelers arriving from Ebola-affected countries', 'authors': [{'first': 'A', 'middle': ['J'], 'last': 'Millman', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Chamany', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Guthartz', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Thihalolipavan', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Porter', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Schroeder', 'suffix': ''}], 'year': 2014, 'venue': 'MMWR Morb Mortal Wkly Rep', 'volume': '653', 'issn': '', 'pages': '51--55', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Magnitude das doenças de notificação compulsória e avaliação dos indicadores de vigilância epidemiológica em municípios da linha de fronteira do Brasil', 'authors': [{'first': 'M', 'middle': ['P'], 'last': 'Cerroni', 'suffix': ''}, {'first': 'E', 'middle': ['H'], 'last': 'Carmo', 'suffix': ''}], 'year': 2007, 'venue': 'Epidemiol Serv Saude', 'volume': '24', 'issn': '', 'pages': '617--645', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Montevidéo: MERCOSUR', 'authors': [{'first': 'Del', 'middle': [], 'last': 'Mercado Común', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Sur', 'suffix': ''}], 'year': 2015, 'venue': 'En pocas palabras', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'A new paradigm for quarantine and public health activities at land borders: opportunities and challenges', 'authors': [{'first': 'S', 'middle': ['H'], 'last': 'Waterman', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Escobedo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Wilson', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Edelson', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Bethel', 'suffix': ''}, {'first': 'D', 'middle': ['B'], 'last': 'Fishbein', 'suffix': ''}], 'year': 2009, 'venue': 'Public Health Rep', 'volume': '124', 'issn': '', 'pages': '203--214', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Human mobility networks, travel restrictions, and the global spread of 2009 H1N1 pandemic', 'authors': [{'first': 'P', 'middle': [], 'last': 'Bajardi', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Poletto', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Ramasco', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Tizzoni', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Colizza', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Vespignani', 'suffix': ''}], 'year': 2011, 'venue': 'PloS One', 'volume': '6', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Mateus', 'suffix': ''}, {'first': 'H', 'middle': ['E'], 'last': 'Otete', 'suffix': ''}, {'first': 'C', 'middle': ['R'], 'last': 'Beck', 'suffix': ''}, {'first': 'G', 'middle': ['P'], 'last': 'Dolan', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Nguyen-Van-Tam', 'suffix': ''}], 'year': 2014, 'venue': 'Bull World Health Organ', 'volume': '92', 'issn': '', 'pages': '868--80', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'Map -illustrating the border regions between Brazil and the Mercosur member countries. Source: Peiter15', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'US-Mexico border. Source: http://www.borderhealth.org/border_region.php', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Profile of the respondents, geographic and operational characteristics of the Borders Epidemiological Surveillance System', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Organizational priorities, information exchange and Binational Notification of the Borders Epidemiological Surveillance System', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'Human, financial and technical support, Laboratory and Challenges of the Borders Epidemiological Surveillance System US-Mexico Border Brazilian Border Human, Financial Resources and technical support.', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715f0fafb95b570014dc4'), 'paper_id': '0aa4edc168fd9bf7ba7efee20dbeb007c26b1beb', 'metadata': {'title': 'Phylogeny of bovine norovirus in Egypt based on VP2 gene', 'authors': [{'first': 'Fakry', 'middle': ['F'], 'last': 'Mohamed', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Zagazig University', 'location': {'postCode': '44511', 'settlement': 'Zagazig', 'region': 'Sharkia', 'country': 'Egypt'}}, 'email': ''}, {'first': 'Gamelat', 'middle': ['K F'], 'last': 'Ktob', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Zagazig University', 'location': {'postCode': '44511', 'settlement': 'Zagazig', 'region': 'Sharkia', 'country': 'Egypt'}}, 'email': ''}, {'first': 'Mohamed', 'middle': ['E A'], 'last': 'Ismaeil', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Zagazig University', 'location': {'postCode': '44511', 'settlement': 'Zagazig', 'region': 'Sharkia', 'country': 'Egypt'}}, 'email': ''}, {'first': 'Ahmed', 'middle': ['A H'], 'last': 'Ali', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Zagazig University', 'location': {'postCode': '44511', 'settlement': 'Zagazig', 'region': 'Sharkia', 'country': 'Egypt'}}, 'email': ''}, {'first': 'Sagar', 'middle': ['M'], 'last': 'Goyal', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Minnesota', 'location': {'postCode': '55108', 'settlement': 'St. Paul', 'region': 'Minnesota', 'country': 'USA'}}, 'email': ''}]}, 'abstract': [{'text': 'Bovine norovirus (BNoV) has emerged as a viral pathogen that causes a gastrointestinal illness and diarrhea in cattle. Despite its worldwide distribution, very little information is known about BNoV in Africa. In this study, BNoV was detected in 27.6% (8/29) of tested fecal materials, collected from sporadic cases of diarrheic calves, using the reverse transcription-polymerase chain reaction (RT-PCR) and primers that target RNA dependent RNA polymerase gene. Additionally, one primer pair was designed to flank the BNoV-VP2 (small capsid protein) gene for molecular analysis. Study VP2 sequences were phylogenetically-related to BNoV-GIII.2 (Newbury2-like) genotype, which is highly prevalent all over the world. However, they were separated within the cluster and one strain (41FR) grouped with recombinant GIII.P1/GIII.2 strains. Compared to reference VP2 sequences, 14 amino acid substitution mutations were found to be unique to our strains. The study confirms that BNoV is currently circulating among diarrheic calves of Egypt and also characterizes its ORF3 (VP2) genetically. The status of BNoV should be continuously evaluated in Egypt for effective prevention and control.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'T 1 The BNoV-RdRp targeting primers were used in one step RT-PCR for the purpose of BNoV detection. 2 The BNoV-VP2 targeting primers were used in one step RT-PCR for the purpose of sequencing and molecular analysis. 3 F; forward (sense) primer, R; reverse (antisense) primer. 4 The VP2 specific primers were designed based on the GenBank reference sequence (Bo/Newbury2/1976/UK/ AF097917).', 'cite_spans': [{'start': 276, 'end': 277, 'text': '4', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Calf diarrhea is considered a significant contributor to economic losses worldwide. Bovine norovirus (BNoV) is an important cause of diarrhea in cattle [1] either alone or with other viral entero-pathogens. BNoV was found in the feces of both diarrheic and healthy animals [2] [3] [4] . On experimental infection, gnotobiotic calves infected with BNoV showed various degrees of diarrhea and anorexia as a result of gastroenteritis [5, 6] .', 'cite_spans': [{'start': 152, 'end': 155, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 273, 'end': 276, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 277, 'end': 280, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 281, 'end': 284, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 431, 'end': 434, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 435, 'end': 437, 'text': '6]', 'ref_id': 'BIBREF5'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The BNoV is a small, non-enveloped, and positive sense singlestranded RNA virus, which belongs to the family Caliciviridae. The viral genome is 7.3 to 7.5 kb in size and consists of three open reading frames (ORF1, ORF2, and ORF3), which encode for large polyprotein, major capsid protein (VP1) and small basic protein (VP2), respectively [7] . Based on the phylogeny of deduced amino acids (aa) of VP1 protein, noroviruses are classified into seven genogroups (GI-GVII); GI, GII, and GIV infect humans while GIII infects bovine and sheep [8] . Each genogroup is further divided into several genotypes. For example, GIII is divided into GIII.1 (Bo/Jena/1980/DE) and GIII.2 (Bo/Newbury-2/ 1976/UK) originally discovered in Germany [9] and England [10] , respectively. Ovine norovirus and recombinant BNoV strains represent newer genotypes in GIII [11, 12] .', 'cite_spans': [{'start': 339, 'end': 342, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 539, 'end': 542, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 730, 'end': 733, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 746, 'end': 750, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 846, 'end': 850, 'text': '[11,', 'ref_id': 'BIBREF10'}, {'start': 851, 'end': 854, 'text': '12]', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The reverse transcription-polymerase chain reaction (RT-PCR) is commonly used for norovirus detection. The RT-PCR usually targets the RNA dependent RNA polymerase (BNoV-RdRp) gene because it contains highly conserved regions. For phylogenetic classification, RT-PCR targets the BNoV-VP1 gene. Recently, several recombination events have been detected at the ORF1/ORF2 junction, thus imposing a new genotyping strategy within the Norovirus genus. It was reported that GIII.P1/GIII.2 had a GIII.1-related RdRp and a GIII.2-related VP1 while GIII.P2/GIII.1 had a GIII.2-related RdRp and a GIII.1-related VP1. This indicates that both BNoV-RdRp and BNoV-VP1 should be determined for phylogenetic purposes [13] .', 'cite_spans': [{'start': 701, 'end': 705, 'text': '[13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In noroviruses, VP2 is not essential for virion production but it is mainly responsible for virion stability and genome encapsidation. Besides, VP2 interacts with VP1 and, in turn, enhances the expression of capsid proteins [14] . At the molecular level, VP2 is highly variable and can express different types of mutations [15, 16] . Little is known about BNoV-VP2 due to the limited number of available sequences.', 'cite_spans': [{'start': 224, 'end': 228, 'text': '[14]', 'ref_id': 'BIBREF13'}, {'start': 323, 'end': 327, 'text': '[15,', 'ref_id': 'BIBREF14'}, {'start': 328, 'end': 331, 'text': '16]', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In Egypt, few data are available on the newly emerging enteric viruses of cattle, including BNoV. Only one study described BNoV infection in two cattle farms in Egypt [17] . The present study was conducted to (i) report the existence of BNoV among diarrheic calves in Sharkia province of Egypt and (ii) to study the phylogenesis of these BNoV strains on the basis of VP2 gene.', 'cite_spans': [{'start': 167, 'end': 171, 'text': '[17]', 'ref_id': 'BIBREF16'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'This article does not contain any studies with human participants or animals performed by any of the authors.', 'cite_spans': [], 'ref_spans': [], 'section': 'Ethical statement'}, {'text': \"Twenty-nine fecal specimens were collected aseptically from sporadic cases of diarrheic calves in Sharkia province of Egypt between late 2016 and early 2017. Calves had diarrhea, dehydration, and weakness with different degrees. The age of calves ranged from 3 weeks to 3 months. No deaths were observed at the time of sample collection. According to the case history, animals were not vaccinated against locally-identified enteric viruses, including bovine rotavirus (BRV) and bovine viral diarrhea virus (BVDV). All samples were diluted in phosphate buffer saline (10×) and centrifuged at 2500×g for 10 min. The viral RNA was extracted from the supernatant fluid of each sample (140 µL) by following the manufacturer's instructions of the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA).\", 'cite_spans': [], 'ref_spans': [], 'section': 'Samples and RNA extraction'}, {'text': 'Initially, the one-step RT-PCR (QIAGEN, Valencia, CA, USA) was carried out to detect the BNoV RNA in tested fecal samples by targeting a conserved area in BNoV-RdRp gene (4543-5074) using the primer pair CBECu-F/R [18] . The PCR cyclic conditions were 50°C/30 min for reverse transcription, 95°C/15 min for PCR activation, and 35 cycles of 94°C/1 min for denaturation, 51°C/45 s for annealing, and 72°C/1 min for elongation followed by a final cycle of extension at 72°C/10 min. Then, another primer pair (BNoV-VP2-F/R) was designed to flank the BNoV-VP2 gene from base 6432 to base 7257 (826 bp) in the positive samples. The design of these primers was made based on the VP2 region of the GenBank reference sequence (Newbury2/UK/AF097917). The previous PCR cycle was used except for annealing that was changed to 55°C for 1 min. The PCR reactions were 25 μL in volume (1 μL enzyme mix, 12.5 μL buffer, 1 μL forward primer, 1 μL reverse primer, 2.5 μL of extracted RNA, and 7 μL RNase-free water). In negative controls, a 9.5 μL of RNase-free water was added with no RNA. The PCR amplicons were allowed to run through agarose gel by electrophoresis and then were visualized on UV transilluminator to visualize the band size. The oligonucleotide primers used in this study are listed in Table 1 .', 'cite_spans': [{'start': 214, 'end': 218, 'text': '[18]', 'ref_id': 'BIBREF17'}], 'ref_spans': [{'start': 1286, 'end': 1293, 'text': 'Table 1', 'ref_id': None}], 'section': 'Reverse transcription-polymerase chain reaction (RT-PCR)'}, {'text': 'The PCR products of BNoV-VP2 were purified using a QIAquick PCR purification kit (QIAGEN, Valencia, CA, USA) and sequenced, directly in both directions using the same primers previously used in RT-PCR, at the University of Minnesota Genomics Center (UMGC). Using Sequencher 5.1 software (http://genecodes.com/), contigs were generated using forward and reverse sequences. The obtained sequences were further identified by online nucleotide BLAST tool (http://www.ncbi.nlm.nih.gov/BLAST).', 'cite_spans': [], 'ref_spans': [], 'section': 'Sanger sequencing'}, {'text': 'The study sequences had the accession numbers of MF784575 and MF784576 in GenBank. Using the MEGA 6 software [19] , nucleotide (nt) sequences of BNoV-VP2 were comparatively aligned to reference strains using the Clustal W option. The phylogenetic tree was constructed using the neighbor-joining statistical method (1.000 bootstrap replicates). The identities of nt and aa were calculated using the pdistance method. The aa were deduced from BNoV-VP2 nt sequences and analyzed using the DNASTAR Lasergene 7.2 software [20] .', 'cite_spans': [{'start': 109, 'end': 113, 'text': '[19]', 'ref_id': 'BIBREF18'}, {'start': 517, 'end': 521, 'text': '[20]', 'ref_id': 'BIBREF19'}], 'ref_spans': [], 'section': 'Sequence and phylogenetic analysis'}, {'text': 'Using the RT-PCR with BNoV-RdRp specific primers, 8 of 29 fecal samples (27.6%) were confirmed positive for BNoV-RNA. Positive samples showed specific bands of 532 bp on 1.5% agarose gel under UV rays (Fig. 1) . The previous step aimed to rule out the negative samples for BNoV as the RdRp is highly conserved and commonly used for BNoV detection. Furthermore, positive RNA samples were retested by RT-PCR but with BNoV-VP2 targeting primers in order to characterize the VP2 gene molecularly. The designed primers annealed successively to their sites; nt 6432-6449 on the plus strand for the forward primer and nt 7257-7237 on the minus strand for the reverse primer and the expected bands (826 bp) were demonstrated on the gel. Samples tested negative for BRV, BVDV, and bovine coronavirus (data not shown).', 'cite_spans': [], 'ref_spans': [{'start': 201, 'end': 209, 'text': '(Fig. 1)', 'ref_id': 'FIGREF1'}], 'section': 'Molecular detection of BNoV in diarrheic fecal samples'}, {'text': 'The molecular characters of BNoV-VP2 strains were investigated by sequencing an 826 bp region. Homogenous hits were obtained from GenBank upon blasting and used in the phylogenetic tree, which revealed that study strains (41FR and 42FR) clustered within BNoV-GIII.2 genotype (Newbury2-like). However, they were separated from each other within the same major cluster. The 41FR strain grouped with BV416/Belgium and Thirsk10/UK (recombinant GIII.P1/GIII.2 strains) but the 42FR strain grouped with CV186-OH/USA and Penrith55/UK (Fig. 2) .', 'cite_spans': [], 'ref_spans': [{'start': 527, 'end': 535, 'text': '(Fig. 2)', 'ref_id': 'FIGREF2'}], 'section': 'Sequence and phylogenetic analysis of study BNoV-VP2 strains'}, {'text': 'At nt and aa levels, 41FR and 42FR had identities of 81.8% and 88.5%, respectively. The 41FR was closely related to BV416/Belgium (84.3% nt identity and 89.7% aa identity) while 42FR was more related to CV186-OH/USA (identities of 89.5% and 89.9% at nt and aa levels, respectively). In relation to Newbury2/UK/AF097917, 41FR and 42FR shared nt identities of 79.1-86.5% and aa identities of 86.7-88.9% ( Table 2) .', 'cite_spans': [], 'ref_spans': [{'start': 403, 'end': 411, 'text': 'Table 2)', 'ref_id': 'TABREF1'}], 'section': 'Sequence and phylogenetic analysis of study BNoV-VP2 strains'}, {'text': 'The VP2 regions from BNoV-GIII.2 reference strains (n = 13) were obtained from blast hits. Their deduced aa sequences were aligned with those of 41FR and 42FR to detect substitution mutations in our strains.', 'cite_spans': [], 'ref_spans': [], 'section': 'Sequence and phylogenetic analysis of study BNoV-VP2 strains'}, {'text': 'The oligonucleotide primers used in this study.', 'cite_spans': [], 'ref_spans': [], 'section': 'Table 1'}, {'text': 'Primer sequence (5′-3′) 3 Amplicon size (bp) Target gene/s Reference ', 'cite_spans': [{'start': 24, 'end': 25, 'text': '3', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Primer name'}, {'text': 'Noroviruses are one of the leading causes of human and animal gastroenteritis. The circulation of BNoV has been reported in Europe, America, Asia, and Africa [21] . However, BNoV is usually not included in diagnostic algorithms of calf diarrhea. Accordingly, its impact on livestock industries is unknown. In Africa, the reports of BNoV-infections came only from Egypt and Tunisia [17, 22] .', 'cite_spans': [{'start': 158, 'end': 162, 'text': '[21]', 'ref_id': 'BIBREF20'}, {'start': 381, 'end': 385, 'text': '[17,', 'ref_id': 'BIBREF16'}, {'start': 386, 'end': 389, 'text': '22]', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The results of this study confirm those of Mohamed et al. [17] , who found the detection rates of BNoV at 24% in Egyptian cattle as compared to 27.6% in this study. The results of both studies collectively indicate the endemic nature of BNoV infection in Egyptian cattle. The detected BNoV strains were genetically-related to BNoV-GIII.2 genotype (Newbury2-like), either based on BNoV-RdRp [17] or based on BNoV-VP2 (this study). BNoV-GIII.2 has a worldwide distribution, unlike BNoV-GIII.1 [23] . Calves under the age of one month were the most affected with BNoV (data not shown).', 'cite_spans': [{'start': 58, 'end': 62, 'text': '[17]', 'ref_id': 'BIBREF16'}, {'start': 390, 'end': 394, 'text': '[17]', 'ref_id': 'BIBREF16'}, {'start': 491, 'end': 495, 'text': '[23]', 'ref_id': 'BIBREF22'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'To address BNoV-VP2 molecularly, representative strains from GenBank (n = 23) were used to construct a neighbor-joining phylogenetic tree (Fig. 2) . BNoV strains were phylogenetically-distinct from human norovirus (HuNoV) strains, excluding the possibility of interspecies transmission. Although being classified as BNoV-GIII.2, study strains (41FR and 42FR) were separated from each other. Studies on HuNoVs in Egypt suggested that ORF3 (VP2) followed ORF2 (VP1) in its genetic and phylogenetic characters. However, due to the slightly different topologies between ORF2 and ORF3, BNoV-VP2 may have distinct evolutionary strategies [24] . Interestingly, the 41FR was related to recombinant GIII.P1/GIII.2 strains (BV416/Belgium and Thirsk10/UK), raising questions about the presence of intra-genotypic recombinations. We are planning for complete genome sequencing of 41FR strain to detect possible recombination breakpoints.', 'cite_spans': [{'start': 632, 'end': 636, 'text': '[24]', 'ref_id': 'BIBREF23'}], 'ref_spans': [{'start': 138, 'end': 146, 'text': '(Fig. 2)', 'ref_id': 'FIGREF2'}], 'section': 'Discussion'}, {'text': 'Fourteen unique aa substitution mutations were detected in both strains (Fig. 3) . Neither insertions nor deletions were observed. Such variations may play a role in classifying closely-related BNoV strains. Study strains shared identities of 81.8% and 88.5% at nt and aa, respectively. The nt and aa identities ( Table 2 ) further confirm the clustering made by the phylogenetic tree. It is expected for norovirus capsid proteins, particularly the VP2, to exhibit broad sequence variability [15] . The hypervariability of VP2 sequences was assumed to be functionally-related to those occurring in the P2 domain of VP1 protein [25] and this may affect the viral pathogenesis. ', 'cite_spans': [{'start': 492, 'end': 496, 'text': '[15]', 'ref_id': 'BIBREF14'}, {'start': 627, 'end': 631, 'text': '[25]', 'ref_id': 'BIBREF24'}], 'ref_spans': [{'start': 72, 'end': 80, 'text': '(Fig. 3)', 'ref_id': 'FIGREF3'}, {'start': 314, 'end': 321, 'text': 'Table 2', 'ref_id': 'TABREF1'}], 'section': 'Discussion'}, {'text': 'The study reported the presence of BNoV-GIII.2 for the second time in Egypt as well as the phylogenetic properties of BNoV-VP2. It is concluded that BNoV is circulating among diarrheic cattle of Egypt. The genetic diversity of BNoV strains should be monitored to prevent future economic losses related to the virus.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusions'}, {'text': 'The content of this paper is not related personally or financially to other people or organizations.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing interests'}, {'text': 'FM provided the study specimens (sample source) and initiated their preparation. SG supervised the project. FM, SG conceived and planned the experiments, contributed to reagents/materials/analysis tools. FM, GK, SG contributed to the interpretation of the results. FM carried out the experiments and took the lead in writing the manuscript in consultation with others.', 'cite_spans': [], 'ref_spans': [], 'section': 'Author contributions'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Animal noroviruses', 'authors': [{'first': 'A', 'middle': [], 'last': 'Scipioni', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Mauroy', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Vinje', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Thiry', 'suffix': ''}], 'year': 2008, 'venue': 'Vet J', 'volume': '178', 'issn': '', 'pages': '32--45', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Epidemiology of Norwalk-like virus infections in cattle in The Netherlands', 'authors': [{'first': 'W', 'middle': ['H'], 'last': 'Van Der Poel', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Van Der Heide', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Verschoor', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Gelderblom', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Vinjé', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Koopmans', 'suffix': ''}], 'year': 2003, 'venue': 'Vet Microbiol', 'volume': '92', 'issn': '', 'pages': '297--309', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'SYBR Green based real-time RT-PCR assay for detection and genotype prediction of bovine noroviruses and assessment of clinical significance in Norway', 'authors': [{'first': 'E', 'middle': [], 'last': 'Jor', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Myrmel', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Jonassen', 'suffix': ''}], 'year': 2010, 'venue': 'J Virol Methods', 'volume': '169', 'issn': '', 'pages': '1--7', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Genetic heterogeneity of bovine noroviruses in Italy', 'authors': [{'first': 'Di', 'middle': [], 'last': 'Martino', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Di', 'middle': [], 'last': 'Profio', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Di', 'middle': [], 'last': 'Felice', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Melegari', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Ceci', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Mauroy', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Arch Virol', 'volume': '159', 'issn': '', 'pages': '2717--2739', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Infection of calves with bovine norovirus GIII. 1 strain Jena virus: an experimental model to study the pathogenesis of norovirus infection', 'authors': [{'first': 'P', 'middle': ['H'], 'last': 'Otto', 'suffix': ''}, {'first': 'I', 'middle': ['N'], 'last': 'Clarke', 'suffix': ''}, {'first': 'P', 'middle': ['R'], 'last': 'Lambden', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Salim', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Reetz', 'suffix': ''}, {'first': 'E', 'middle': ['M'], 'last': 'Liebler-Tenorio', 'suffix': ''}], 'year': 2011, 'venue': 'J Virol', 'volume': '85', 'issn': '', 'pages': '12013--12034', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Pathogenesis of GIII. 2 bovine norovirus, CV186-OH/00/US strain in gnotobiotic calves', 'authors': [{'first': 'K', 'middle': [], 'last': 'Jung', 'suffix': ''}, {'first': 'K', 'middle': ['A'], 'last': 'Scheuer', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'Q', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Saif', 'suffix': ''}], 'year': 2014, 'venue': 'Vet Microbiol', 'volume': '168', 'issn': '', 'pages': '202--209', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Complete genomic characterization and antigenic relatedness of genogroup III, genotype 2 bovine noroviruses', 'authors': [{'first': 'S', 'middle': ['L'], 'last': 'Oliver', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Asobayire', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Charpilienne', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Cohen', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Bridger', 'suffix': ''}], 'year': 2007, 'venue': 'Arch Virol', 'volume': '152', 'issn': '', 'pages': '257--72', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Caliciviridae: the noroviruses', 'authors': [{'first': 'K', 'middle': ['Y'], 'last': 'Green', 'suffix': ''}], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '582--608', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Zackenvirus\" (Jena agent 117/ 80)-a new diarrhea pathogen in calves', 'authors': [{'first': 'H', 'middle': [], 'last': 'Günther', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Otto', 'suffix': ''}], 'year': 1987, 'venue': 'Arch Exp Veterinarmed', 'volume': '7', 'issn': '', 'pages': '934--942', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves', 'authors': [{'first': 'G', 'middle': ['N'], 'last': 'Woode', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Bridger', 'suffix': ''}], 'year': 1978, 'venue': 'J Med Microbiol', 'volume': '11', 'issn': '', 'pages': '441--52', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Molecular detection of norovirus in sheep and pigs in New Zealand farms', 'authors': [{'first': 'S', 'middle': [], 'last': 'Wolf', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Williamson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Hewitt', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Lin', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Rivera-Aban', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Ball', 'suffix': ''}], 'year': 2009, 'venue': 'Vet Microbiol', 'volume': '133', 'issn': '', 'pages': '184--193', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Norovirus recombination', 'authors': [{'first': 'R', 'middle': ['A'], 'last': 'Bull', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Tanaka', 'suffix': ''}, {'first': 'P', 'middle': ['A'], 'last': 'White', 'suffix': ''}], 'year': 2007, 'venue': 'J Gen Virol', 'volume': '88', 'issn': '', 'pages': '3347--59', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Molecular detection of bovine Noroviruses in Argentinean dairy calves: Circulation of a tentative new genotype', 'authors': [{'first': 'F', 'middle': [], 'last': 'Ferragut', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Vega', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Mauroy', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Conceição-Neto', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Zeller', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Heylen', 'suffix': ''}], 'year': 2016, 'venue': 'Infect Genet Evol', 'volume': '40', 'issn': '', 'pages': '144--50', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain', 'authors': [{'first': 'S', 'middle': [], 'last': 'Vongpunsawad', 'suffix': ''}, {'first': 'B', 'middle': ['V'], 'last': 'Prasad', 'suffix': ''}, {'first': 'M', 'middle': ['K'], 'last': 'Estes', 'suffix': ''}], 'year': 2013, 'venue': 'J Virol', 'volume': '87', 'issn': '', 'pages': '4818--4843', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Variation in ORF3 of genogroup 2 Norwalk-like viruses', 'authors': [{'first': 'E', 'middle': ['L'], 'last': 'Seah', 'suffix': ''}, {'first': 'I', 'middle': ['C'], 'last': 'Gunesekere', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Marshall', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Wright', 'suffix': ''}], 'year': 1999, 'venue': 'Arch Virol', 'volume': '144', 'issn': '', 'pages': '1007--1021', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Evolutionary dynamics of GII. 4 noroviruses over a 34-year period', 'authors': [{'first': 'K', 'middle': [], 'last': 'Bok', 'suffix': ''}, {'first': 'E', 'middle': ['J'], 'last': 'Abente', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Realpe-Quintero', 'suffix': ''}, {'first': 'Mitra', 'middle': ['T'], 'last': 'Sosnovtsev', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Kapikian', 'suffix': ''}, {'first': 'A', 'middle': ['Z'], 'last': '', 'suffix': ''}], 'year': 2009, 'venue': 'J Virol', 'volume': '83', 'issn': '', 'pages': '11890--901', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Molecular detection of enteric viruses from diarrheic calves in Egypt', 'authors': [{'first': 'F', 'middle': ['F'], 'last': 'Mohamed', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Mansour', 'suffix': ''}, {'first': 'I', 'middle': ['E'], 'last': 'El-Araby', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Mor', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Goyal', 'suffix': ''}], 'year': 2017, 'venue': 'Arch Virol', 'volume': '162', 'issn': '', 'pages': '129--166', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Reverse transcription-PCR assays for detection of bovine enteric caliciviruses (BEC) and analysis of the genetic relationships among BEC and human caliciviruses', 'authors': [{'first': 'J', 'middle': ['R'], 'last': 'Smiley', 'suffix': ''}, {'first': 'A', 'middle': ['E'], 'last': 'Hoet', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Tråvén', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Tsunemitsu', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Saif', 'suffix': ''}], 'year': 2003, 'venue': 'J Clin Microbiol', 'volume': '41', 'issn': '', 'pages': '3089--99', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'MEGA6: molecular evolutionary genetics analysis version 6.0', 'authors': [{'first': 'K', 'middle': [], 'last': 'Tamura', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Stecher', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Peterson', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Filipski', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Kumar', 'suffix': ''}], 'year': 2013, 'venue': 'Mol Biol Evol', 'volume': '30', 'issn': '', 'pages': '2725--2734', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': \"DNASTAR's Lasergene sequence analysis software\", 'authors': [{'first': 'T', 'middle': ['G'], 'last': 'Burland', 'suffix': ''}], 'year': 2000, 'venue': 'Methods Mol Biol', 'volume': '132', 'issn': '', 'pages': '71--91', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Bovine noroviruses: a missing component of calf diarrhoea diagnosis', 'authors': [{'first': 'E', 'middle': [], 'last': 'Di Felice', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Mauroy', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Dal Pozzo', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Thiry', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Ceci', 'suffix': ''}, {'first': 'Di', 'middle': [], 'last': 'Martino', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2016, 'venue': 'Vet J', 'volume': '207', 'issn': '', 'pages': '53--62', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Molecular prevalence of bovine noroviruses and neboviruses detected in centraleastern Tunisia', 'authors': [{'first': 'M', 'middle': [], 'last': 'Hassine-Zaafrane', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kaplon', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Sdiri-Loulizi', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Aouni', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Pothier', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Aouni', 'suffix': ''}], 'year': 2012, 'venue': 'Arch Virol', 'volume': '157', 'issn': '', 'pages': '1599--604', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Genetic and evolutionary perspectives on genogroup III, genotype 2 bovine noroviruses', 'authors': [{'first': 'A', 'middle': [], 'last': 'Mauroy', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Scipioni', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Mathijs', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Ziant', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Daube', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Thiry', 'suffix': ''}], 'year': 2014, 'venue': 'Arch Virol', 'volume': '159', 'issn': '', 'pages': '39--49', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Predominance and circulation of enteric viruses in the region of Greater Cairo', 'authors': [{'first': 'A', 'middle': ['H'], 'last': 'Kamel', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Ali', 'suffix': ''}, {'first': 'H', 'middle': ['G'], 'last': 'El-Nady', 'suffix': ''}, {'first': 'De', 'middle': [], 'last': 'Rougemont', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Pothier', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Belliot', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2009, 'venue': 'J Clin Microbiol', 'volume': '47', 'issn': '', 'pages': '1037--1082', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains', 'authors': [{'first': 'Mcw', 'middle': [], 'last': 'Chan', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'W', 'middle': ['S'], 'last': 'Ho', 'suffix': ''}, {'first': 'Cok', 'middle': [], 'last': 'Law', 'suffix': ''}, {'first': 'Tck', 'middle': [], 'last': 'Lau', 'suffix': ''}, {'first': 'Skw', 'middle': [], 'last': 'Tsui', 'suffix': ''}], 'year': 2012, 'venue': 'J Virol', 'volume': '86', 'issn': '', 'pages': '1227--1259', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'Substitutions at positions 171 (Q to R), 173 (R to Q), 209 (S to T), 255 (S to T) and 277 (N to K) were found only in 41FR. Meanwhile, mutations at positions 29 (T to N), 100 (S to N), 139 (G to E), 144 (D to G), 197 (P to L), 214 (S to T) and 269 (T to V) were found only in 42FR. Both 41FR and 42FR shared two unique substitutions at positions 275 (F to C) and 276 (A to Q) as shown in Fig. 3.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'The RT-PCR amplification of BNoV-RdRp genes from study fecal RNA samples. Lane M; DNA marker (50-10.000 bp). Lane 12 (Ctrl-); negative control. Lanes 2, 5, 7, and 11; BNoV positive samples (532 bp).', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'The neighbor-joining phylogenetic tree of BNoV-VP2 nt sequences. Bootstrap values of > 50% are shown above the branches. The study strains (41FR and 42FR) are indicated with black circles. Strains of Nebovirus genus were chosen as an outgroup.', 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'Residue substitutions in deduced amino acids (aa) of BNoV-GIII.2 strains compared to the consensus sequence. Majority is the consensus represented on the ruler. Points mean identical aa while dashes mean unresolved aa. Unique aa substitutions in the study strains are marked with red arrows.', 'latex': None, 'type': 'figure'}, 'TABREF1': {'text': 'The nucleotide (nt) and amino acid (aa) identities between study strains (41FR and 42FR) and reference BNoV-GIII.2 strains.', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'The authors thank the Ministry of Higher Education and Scientific Research (MHESR) in Egypt for providing a visiting grant to FFM.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}]}\n",
      "{'_id': ObjectId('5ea715f0412a7dfaab633a60'), 'paper_id': '0ace222a6c33986dfe57d3f24779fe5f674724c7', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'Please begin by providing some general information about your role and experience: Rank the most important topic area as 5, and the least important topic area as 1. Only one ranking is permitted per topic.', 'cite_spans': [], 'ref_spans': [], 'section': 'Supplementary File 3: eDelphi survey questions -Rounds 1-3 Round 1 eDelphi'}, {'text': \"For those working in a regional role, answer in relation to all the countries you know well, or pick a specific country and answer all questions in relation to that country 1. Community engagement 2. Service delivery models (numbers and type of health workers) 3. Speciality services and integration of disease specific programs 4. Continuity of patient care 5. Partnerships with non-government service providers Topics scored 4 and 5 will automatically appear, and panel members asked to suggest at least 1 and up to 3 specific areas where additional evidence would be useful for each of these two 'most important' topic areas.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Supplementary File 3: eDelphi survey questions -Rounds 1-3 Round 1 eDelphi'}, {'text': 'Each of the following cross-cutting themes may impact the accessibility and acceptability of primary health care services. From your perspective, how relevant is it to incorporate each of these themes in the design of primary health care research in your country?', 'cite_spans': [], 'ref_spans': [], 'section': '2.'}, {'text': 'Rank the most relevant theme 5, and the least relevant theme 1. Only one ranking is permitted per theme.', 'cite_spans': [], 'ref_spans': [], 'section': '2.'}, {'text': 'Round 2 eDelphi 1. The evidence gaps in the following three screens relate to the organisation and models of primary health care in the Asia-Pacific region.', 'cite_spans': [], 'ref_spans': [], 'section': '2.'}, {'text': 'Please rank each of these research topics from 1 to 3.', 'cite_spans': [], 'ref_spans': [], 'section': '2.'}, {'text': 'Tier 1 should include those topics of highest priority, and Tier 3 should include those topics of least priority. Use the following definition of priority tiers to guide your ranking:', 'cite_spans': [], 'ref_spans': [], 'section': '2.'}, {'text': 'Tier 1: Includes research gaps of high potential leverage, in which more evidence is likely to have a significant impact on strengthening PHC performance. Tier 2: Includes research gaps of moderate potential leverage, in which more evidence is somewhat likely to have an impact on strengthening PHC performance. Tier 3: Includes research gaps for which more evidence is unlikely to have an impact on strengthening PHC performance.', 'cite_spans': [], 'ref_spans': [], 'section': 'Priority Tiers:'}, {'text': 'What package of primary health care services is the most effective and appropriate for the population? What is the optimum mix of health workers at primary health care level?', 'cite_spans': [], 'ref_spans': [], 'section': 'i. Primary health care team composition, structure and services'}, {'text': 'What is the most effective and sustainable primary health care service delivery model for the management of chronic diseases in a resource-constrained setting? How can we integrate electronic health records into mobile primary health care services?', 'cite_spans': [], 'ref_spans': [], 'section': 'i. Primary health care team composition, structure and services'}, {'text': 'How can task-shifting (e.g. use of non-physician health workers) be used to support the delivery of primary health care? What incentives will ensure the long-term availability of doctors at the primary health care level?', 'cite_spans': [], 'ref_spans': [], 'section': 'i. Primary health care team composition, structure and services'}, {'text': 'What are the support needs of doctors who are caring for rural and remote communities?', 'cite_spans': [], 'ref_spans': [], 'section': 'i. Primary health care team composition, structure and services'}, {'text': 'What systems of quality control and improvement can be effectively and sustainably implemented at the primary health care level? What is the difference between the expected and actual workload of individual members of the primary health care team? ii. Patient management tools How can we apply mHealth/eHealth technology to provide supportive supervision for community health workers? How can we use mHealth technology at the village level to improve preventative and promotive services?', 'cite_spans': [], 'ref_spans': [], 'section': 'i. Primary health care team composition, structure and services'}, {'text': 'What are the limits placed on use of mHealth/eHealth by coverage of mobile networks, ownership of mobile phones, and literacy of those receiving messages? What strategies will improve co-ordination and communication between providers, including between public and private providers, and between rural and urban settings? How can we address the different barriers to continuity of patient care in urban and rural/remote areas?', 'cite_spans': [], 'ref_spans': [], 'section': 'i. Primary health care team composition, structure and services'}, {'text': 'iii. Integration of disease specific programs What is the impact on the wellbeing, motivation and workload of community health workers when integrating a new primary health care program? What are sustainable models of disease integration that would a) make best use of existing vertical programs, and b) strengthen primary health care? How should payers work with providers to design funding models that better support integrated care? How can administrators engage donors to better support integration through their funding models?', 'cite_spans': [], 'ref_spans': [], 'section': 'i. Primary health care team composition, structure and services'}, {'text': 'What approaches to treating communicable diseases can be effectively transferred to the management of chronic diseases? How can we best integrate primary, secondary and tertiary care across the health sector?', 'cite_spans': [], 'ref_spans': [], 'section': 'i. Primary health care team composition, structure and services'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'How can we best integrate primary, secondary and tertiary care across the health sector? What is the optimum mix of health workers at primary health care level? How can we apply mHealth/eHealth technology to provide supportive supervision for community health workers? How can health services be more culturally competent and responsive to diverse communities? What systems of quality control and improvement can be effectively and sustainably implemented at the primary health care level? How do we ensure that essential drugs and diagnostics are always available in primary health care services? How can administrators and providers effectively involve the community in the design and oversight of primary health care packages and service delivery? What is the difference between the expected and actual workload of individual members of the primary health care team? How do we use routine health information', 'authors': [], 'year': None, 'venue': 'What strategies will improve co-ordination and communication between providers, including between public and private providers, and between rural and urban settings', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': '1.Thinking about how primary health care services are organized and delivered in the country where you work, where is more research evidence needed?', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'These final evidence gaps relate to planning and accountability in primary health care.Please rank each of these research topics from 1 to 3. Tier 1 should include those topics of highest priority, and Tier 3 should include those topics of least priority.How can we project the primary health care needs of the future?How do we ensure that essential drugs and diagnostics are always available in primary health care services? How do we use routine health information, survey data and surveillance data to identify and address inequities in service coverage? How to ensure that cost-effectiveness data are locally relevant and applied in decision-making?Why do the majority of successful pilots not get scaled-up?How can administrators and providers effectively involve the community in the design and oversight of primary health care packages and service delivery? How can health services be more culturally competent and responsive to diverse communities?How do primary health care managers assess and manage staff performance?How can the health literacy of individuals and organisations be measured and improved?', 'cite_spans': [], 'ref_spans': [], 'section': '2.'}, {'text': 'In Round 2 of the Delphi exercise, Expert Panel members prioritised evidence and research gaps in two areas: i) organisation and models of primary health care, and ii) financing of primary health care.Responses from all panel members were combined to group research gaps into three priority tiers. Research gaps ranked in the top two tiers are presented on the following two screens for final prioritisation.Through this final round we aim to achieve consensus agreement among Asia Pacific stakeholders on the top 10 primary health care research priorities within each area.', 'cite_spans': [], 'ref_spans': [], 'section': 'Round 3 eDelphi'}, {'text': 'In relation to the organisation of primary health care, the Expert Panel ranked the following 19 questions as top priorities during Round 2.Give a priority score of 1 to 5 to each of these research questions. Consider, would better evidence on this topic be useful in your country? For those working in a regional role, answer in relation to all the countries you know well, or pick a specific country and answer all questions in relation to that country.5=high priority 1=low priorityWhat are sustainable models of disease integration that would a) make best use of existing vertical programs, and b) strengthen primary health care? What is the most effective and sustainable primary health care service delivery model for the management of chronic diseases in a resource-constrained setting? How can task-shifting (e.g. use of non-physician health workers) be used to support the delivery of primary health care? How can we address the different barriers to continuity of patient care in urban and rural/remote areas? How should payers work with providers to design funding models that better support integrated care? What is the impact on the wellbeing, motivation and workload of community health workers when integrating a new primary health care program? How can we project the primary health care needs of the future? What approaches to treating communicable diseases can be effectively transferred to the management of chronic diseases? What package of primary health care services is the most effective and appropriate for the population?', 'cite_spans': [], 'ref_spans': [], 'section': '1.'}]}\n",
      "{'_id': ObjectId('5ea715f0923163408701aa08'), 'paper_id': '0ad29b032fe87db2641893f4cc880c22f2107712', 'metadata': {'title': 'Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial', 'authors': [{'first': 'Chang-Seop', 'middle': [], 'last': 'Lee', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chonbuk National University Hospital', 'location': {'settlement': 'Jeonju'}}, 'email': ''}, {'first': 'Ju-Hyung', 'middle': [], 'last': 'Lee', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chonbuk National University Medical School', 'location': {'settlement': 'Jeonju'}}, 'email': ''}, {'first': 'Mira', 'middle': [], 'last': 'Oh', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chonbuk National University and Chonbuk National University Hospital', 'location': {'settlement': 'Jeonju'}}, 'email': ''}, {'first': 'Kyung-Min', 'middle': [], 'last': 'Choi', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Mi', 'middle': ['Ran'], 'last': 'Jeong', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Jong-Dae', 'middle': [], 'last': 'Park', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'R & D Center of CheonJiYang Co., Ltd', 'location': {'settlement': 'Seoul'}}, 'email': ''}, {'first': 'Young', 'middle': [], 'last': 'Kwon', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Korea Food Research Institute', 'location': {'settlement': 'Seongnam'}}, 'email': ''}, {'first': 'Ki-Chan', 'middle': [], 'last': 'Ha', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Healthcare Claims and Management', 'location': {'settlement': 'Jeonju', 'country': 'Korea'}}, 'email': ''}, {'first': 'Eun-Ock', 'middle': [], 'last': 'Park', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chonbuk National University Hospital', 'location': {'settlement': 'Jeonju'}}, 'email': ''}, {'first': 'Nuri', 'middle': [], 'last': 'Lee', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chonbuk National University Hospital', 'location': {'settlement': 'Jeonju'}}, 'email': ''}, {'first': 'Sun-Young', 'middle': [], 'last': 'Kim', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chonbuk National University Hospital', 'location': {'settlement': 'Jeonju'}}, 'email': ''}, {'first': 'Eun-Kyung', 'middle': [], 'last': 'Choi', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chonbuk National University Hospital', 'location': {'settlement': 'Jeonju'}}, 'email': ''}, {'first': 'Min-Gul', 'middle': [], 'last': 'Kim', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Soo-Wan', 'middle': [], 'last': 'Chae', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chonbuk National University Hospital', 'location': {'settlement': 'Jeonju'}}, 'email': ''}]}, 'abstract': [{'text': 'Korean Red Ginseng (KRG) is a functional food and has been well known for keeping good health due to its anti-fatigue and immunomodulating activities. However, there is no data on Korean red ginseng for its preventive activity against acute respiratory illness (ARI). The study was conducted in a randomized, double-blinded, placebo-controlled trial in healthy volunteers (Clinical Trial Number: NCT01478009). Our primary efficacy end point was the number of ARI reported and secondary efficacy end point was severity of symptoms, number of symptoms, and duration of ARI. A total of 100 volunteers were enrolled in the study. Fewer subjects in the KRG group reported contracting at least 1 ARI than in the placebo group (12 [24.5%] vs 22 [44.9%], P = 0.034), the difference was statistically significant between the two groups. The symptom duration of the subjects who experienced the ARI, was similar between the two groups (KRG vs placebo; 5.2 ± 2.3 vs 6.3 ± 5.0, P = 0.475). The symptom scores were low tendency in KRG group (KRG vs placebo; 9.5 ± 4.5 vs 17.6 ± 23.1, P = 0.241). The study suggests that KRG may be effective in protecting subjects from contracting ARI, and may have the tendency to decrease the duration and scores of ARI symptoms.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Acute respiratory illness (ARI) is a self-limiting viral disease that causes mild symptoms such as fever, shivering, chills, malaise, and dry cough. Rhinovirus and coronavirus (50%-70%) are the most common viruses, followed by influenza virus (20%-35%), and adenovirus (5%-10%) (1, 2) . Most influenza-associated deaths occur in persons aged 65 yr or older with associated chronic disease (3) . Vaccination to prevent influenza is particularly important for elderly persons who are at an increased risk for severe complications from influenza (4) .', 'cite_spans': [{'start': 278, 'end': 281, 'text': '(1,', 'ref_id': 'BIBREF0'}, {'start': 282, 'end': 284, 'text': '2)', 'ref_id': 'BIBREF1'}, {'start': 389, 'end': 392, 'text': '(3)', 'ref_id': 'BIBREF2'}, {'start': 543, 'end': 546, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Dietary supplements represent the most rapidly growing segment of the market and their use range from the treatment and prevention of common illnesses to cancer treatment and prevention (5, 6) . A well-designed study to evaluate the effectiveness of dietary supplements on reduction of the severity of symp-toms and duration of upper respiratory tract infections has not been approved to date (6) .', 'cite_spans': [{'start': 186, 'end': 189, 'text': '(5,', 'ref_id': 'BIBREF4'}, {'start': 190, 'end': 192, 'text': '6)', 'ref_id': 'BIBREF5'}, {'start': 393, 'end': 396, 'text': '(6)', 'ref_id': 'BIBREF5'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Korea red ginseng (KRG) is commercially available 4 to 6-yr old Panax ginseng root that has been steamed unpeeled and dried to prepare light yellow-brown, or light red-brown ginseng. During its manufacturing process, thirteen kinds of active ingredients characteristic of red ginseng were obtained as some partly deglycosylated saponins. This process is conducted to store red ginseng longer and to increase its medicinal efficacies.', 'cite_spans': [], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Recently, KRG was shown to be capable of enhancing cellmediated immune responses by T lymphocytes and activating natural killer cells in immunomodulation and anticancer pathways. Two clinical studies for the immune response with ginseng or KRG have been conducted (7) (8) (9) . In addition, treatment of Pseudomonas aeruginosa pneumonia in rats with ginseng was found to reduce bacterial load and lung pathology, as well http://dx.doi.org/10.3346/jkms.2012.27. 12.1472 as to increase immunoglobulin G2a in serum. They suggest that the antimicrobial properties of ginseng are due to its induction of Th1-like responses (10) .', 'cite_spans': [{'start': 264, 'end': 267, 'text': '(7)', 'ref_id': 'BIBREF6'}, {'start': 268, 'end': 271, 'text': '(8)', 'ref_id': 'BIBREF7'}, {'start': 272, 'end': 275, 'text': '(9)', 'ref_id': 'BIBREF8'}, {'start': 461, 'end': 468, 'text': '12.1472', 'ref_id': None}, {'start': 618, 'end': 622, 'text': '(10)', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Other studies have shown that taking American ginseng extract as a prophylaxis during the influenza season in older adults reduced the incidence of acute respiratory illness in vaccinated (11) and non-vaccinated subjects (12, 13) . These results suggest that ginseng extract was effective for the prevention of upper respiratory illnesses caused by various viruses.', 'cite_spans': [{'start': 188, 'end': 192, 'text': '(11)', 'ref_id': 'BIBREF10'}, {'start': 221, 'end': 225, 'text': '(12,', 'ref_id': 'BIBREF11'}, {'start': 226, 'end': 229, 'text': '13)', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Until now, ginseng has been well known for improving general quality-of-life, for exhibiting immuonmodulating effects, and for antidiabetic effects (14) (15) (16) (17) (18) . However, there has been no data accumulated Korean red ginseng for its preventive activity against ARI, as has shown in American ginseng. In this study, to investigate the effectiveness of KRG for its preventive activity against ARI, we administered KRG and placebo to healthy volunteers for 12 weeks.', 'cite_spans': [{'start': 148, 'end': 152, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 153, 'end': 157, 'text': '(15)', 'ref_id': 'BIBREF14'}, {'start': 158, 'end': 162, 'text': '(16)', 'ref_id': 'BIBREF15'}, {'start': 163, 'end': 167, 'text': '(17)', 'ref_id': 'BIBREF16'}, {'start': 168, 'end': 172, 'text': '(18)', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'This study was a 12 weeks, randomized, double-blind, placebocontrolled clinical trial at the onset of the influenza season at the Chonbuk National University Hospital (Fig. 1 ). Subjects who responded and met the inclusion criteria during a telephone screening interview were scheduled for a baseline visit. The evaluation included a physical examination, electrocardiogram, and screening blood parameter study. In addition, subjects were scheduled for a screening visit (within 3 weeks) where the informed consent was reviewed and signed. A random number between 1 and 100 was generated by a computer for each subject. The randomization codes were hidden from all subjects, research staff, investigators and pharmacists until all the data were analyzed.', 'cite_spans': [], 'ref_spans': [{'start': 167, 'end': 174, 'text': '(Fig. 1', 'ref_id': 'FIGREF0'}], 'section': 'Study design'}, {'text': 'The enrolled subjects were scheduled for the first visit, and subjects were randomly assigned to one of two groups, the concentrated red ginseng (n = 50) or placebo (n = 50) group. The prescription of the study products were 1.0 g 3 times a day (3.0 grams per day) for 12 weeks. Placebos were made with the same taste and appearance but without the principal ingredients that present in the red ginseng extract. The study products were provided to subjects every 4 weeks.', 'cite_spans': [], 'ref_spans': [], 'section': 'Study design'}, {'text': 'During the intervention period of 12 weeks, subjects were asked to continue their usual diets and activity and were asked not to take any other functional foods or dietary supplements. Anthropometric, biochemical parameters, and vital signs were measured before and after the intervention period for both groups. Every fourth week, the subjects were asked to report for assessment of any adverse events or any changes in training, lifestyle, or eating patterns and to assess the compliance. The mercury thermometer was used to check body temperature in their places.', 'cite_spans': [], 'ref_spans': [], 'section': 'Study design'}, {'text': \"The study subjects were recruited between October to November 2010 in Clinical Trial Center for Functional Foods via a local newspaper advertisement. A total of 115 volunteers who responded to the advertisements were pre-screened via telephone interview and screened for the inclusion and exclusion criteria. The study subjects were required to be in good general health, between 30 and 70 yr of age. To avoid the confounding effects of vaccination, subjects were excluded if they had been vaccinated against influenza within 6 months. Other exclusion criteria for the study were: 1) HIV infected or cancer patients; 2) cardiovascular disease, neurologic or psychiatric disease, and renal, pulmonary and hepatic abnormalities; 3) upper respiratory infection within two weeks prior to the study; 4) active tuberculosis treated; 5) history of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease (Crohn's disease) or gastrointestinal surgery (a appendicitis or enterocele surgery were included); 6) participation in any other clinical trials within the past 2 months; 7) abnormal liver function test (ALT > 60 IU/L); 8) connective tissue disease patients; 9) multiple sclerosis disease patients; 10) taking medications such as immunosuppressive drugs, corticosteroids, warfarin, phenelzine, pentobarbital, haloperidol, cyclosporine; 11) allergic or hypersensitive to ginseng; 12) antipsychosis drugs therapy within the past 2 months; 13) laboratory tests, and medical or psychological conditions deemed by the investigators to interfere with successful participation in the study; 14) history of alcohol or substance abuse; 15) pregnancy or breast feeding; and 16) being judged by the responsible physician of the local study center as unfit to participate in the study.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Subjects'}, {'text': 'Korean red ginseng was produced by the process of steaming and drying from fresh ginseng cultivated in Jinan-Gun, Korea. The standardized red ginseng (Panax ginseng C.A. Meyer) extract was obtained through an industrial process under the strict quality control. Namely, fresh ginseng was steamed for 2 to 3 hr at 95°C and dried under the sun or with hot air. After ethanol extract (90°C, 24 hr, 70% ethanol solution) was made in a highly concentrated form to give a 60% or more solid content. The sum of ginsenosides Rg1 and Rb1, used as quality control marker, was above 7 mg/g. Placebo was made to maintain in its flavor and taste of red ginseng extract, and also contained 30% hop extracts and 45% soybean oil. Red ginseng extract and placebo were both prepared at the CheonJiYang Co. Ltd., Seoul, Korea.', 'cite_spans': [], 'ref_spans': [], 'section': 'Study drugs'}, {'text': 'The ARI defined by following symptoms; fever (temperature > 38.0°C), cough, sore throat, nasal congestion, or body aches in the absence of a known cause other than influenza. The primary efficacy end point was the frequency rate of ARI. The secondary end point included 1) the frequency rate of each clinical symptoms such as fever, rhinorrhea, nasal congestion, sore throat, cough, sputum, dyspnea, diarrhea, nausea, vomiting, headache, and myalgia 2) symptom duration; and 3) severity of symptom (total symptom score).', 'cite_spans': [], 'ref_spans': [], 'section': 'The study endpoint and safety assessment'}, {'text': 'This assessment was conducted by telephone weekly or selfreported during the intervention period. The symptom score was average, and the range was from 0 to 3. All subjects were asked to complete a daily log at about the same time every morning to document the severity of their influenza-related symptoms on a 4-point scale sheet (0 = no symptom, 1 = mild symptom, 2 = moderate symptom and 3 = severe symptom) (6, 12) . The total number of days of symptoms was calculated through telephone interviews every day until the symptoms disappeared.', 'cite_spans': [{'start': 411, 'end': 414, 'text': '(6,', 'ref_id': 'BIBREF5'}, {'start': 415, 'end': 418, 'text': '12)', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'The study endpoint and safety assessment'}, {'text': 'Safety assessments were in the case of adverse events, and included laboratory tests (hematology, biochemistry, and urinalysis) and vital sign assessments (systolic blood pressure, diastolic blood pressure, and pulse rate).', 'cite_spans': [], 'ref_spans': [], 'section': 'The study endpoint and safety assessment'}, {'text': \"Statistical analysis was done by a statistician under blinded conditions. The efficacy analysis was done only with subjects who completed the study (per protocol, PP group), whereas the frequency rate of ARI was done using the Fisher's exact test. Symptom duration and score were analyzed with the Mann Whitney U test and Fisher's exact test. The safety assessment was also done only with subjects that completed the study (per protocol, PP group), and the analysis between the two groups were done using the Mann Whitney U test and Fisher's exact test. We used the repeated measure analysis of variance (ANOVA) to compare the laboratory findings between two groups before and after clinical trial. SPSS software ver 19.0 (SPSS Inc., Chicago, IL, USA) was used for all analyses and P values of less than 0.05 were considered statistically significant.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Statistics'}, {'text': 'All subjects gave their written, informed consent before entering the study, which was conducted in accordance with the international conference on harmonization guidelines for good clinical practice and was approved by the functional foods institutional review board of Chonbuk National University Hospital (IRB number; IJRG-INFL-KRG, 2012-02-016). ', 'cite_spans': [], 'ref_spans': [], 'section': 'Ethics statement'}, {'text': 'After screening, a total of 100 subjects were enrolled in this study and randomly assigned to the KRG and placebo group (male 38, female 62). During the study period, 2 subjects failed to complete the study (KRG 1, placebo 1) (Fig. 2) . The mean age of subjects was 46.0 ± 9.0 yr old (KRG group 45.5 ± 8.3, placebo 46.6 ± 9.6, P = 0.537). There were no significant differences in general characteristics of the study population between the two groups ( Table 1 ). Alcohol and smoking was more frequent in the KRG group, but there were no significant differences between the two groups (P = 0.110, P = 0.059).', 'cite_spans': [], 'ref_spans': [{'start': 226, 'end': 234, 'text': '(Fig. 2)', 'ref_id': 'FIGREF2'}, {'start': 453, 'end': 460, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'General characteristics of study subjects'}, {'text': 'The total number of prescribed capsules was 768.6 ± 30.9 (P = 0.141) and total intakes were 727.4 ± 55.8 (P = 0.888), which was not significant between the two groups. Compliance reported taking more than 75% of the medication was high in both groups; 95.2 ± 4.7% in KRG, 94.0 ± 7.2% in placebo group. No subject failed to complete the study due to under compliance (Table 2) . Blinding was also maintained adequately during the study period. After the study, 26.7% of those taking KRG and 21.3% of those taking placebo thought they had been given the KRG.', 'cite_spans': [], 'ref_spans': [{'start': 366, 'end': 375, 'text': '(Table 2)', 'ref_id': 'TABREF1'}], 'section': 'Compliance'}, {'text': 'During the study period, subjects who experienced ARI at least one time were 34 in total (Table 3 ). In these, KRG and placebo was 12 (24.5%), and 22 (44.9%), respectively. The frequency of ARI in the KRG group was lower than in the placebo group and these findings were statistically significant (P = 0.034). In this study, the absolute risk reduction that absolute rate difference between two groups was 20.4% (95% confidence interval [CI], 1.6%-37.4%) and the relative risk reduction which means that giving KRG reduces the ARI was 45.5% (95% CI, 2.5%-69.5%).', 'cite_spans': [], 'ref_spans': [{'start': 89, 'end': 97, 'text': '(Table 3', 'ref_id': 'TABREF2'}], 'section': 'Frequency rate of ARI'}, {'text': 'Among the 34 subjects that experienced ARI, the symptom duration was 5.2 ± 2.3 day in the KRG group and 6.3 ± 5.0 day in the placebo group (P = 0.475). The symptom duration in the KRG group was short, but there was no statistical difference between the two groups ( Table 3 ). The symptom score (KRG 9.5 ± 4.5 vs placebo 17.6 ± 23.1) was lower in the KRG group than in the placebo group. However, no statistical significance was observed (P = 0.241). Among the symptoms, the frequency rate of cough (P = 0.045) in the KRG group was significantly lower than in the placebo group. The nasal congestion (P = 0.064) and headache (P = 0.059) in the KRG group was lower than in the placebo group, which was marginally significant.', 'cite_spans': [], 'ref_spans': [{'start': 266, 'end': 273, 'text': 'Table 3', 'ref_id': 'TABREF2'}], 'section': 'Symptom duration and score of ARI'}, {'text': 'There was no statistical difference between the two groups for adverse events and specific severe adverse events were not observed during the study period (P = 0.378) ( Table 4 ). The laboratory findings for safety, which included hematology, biochemistry, and urinalysis, was not statistical difference between the two groups (Table 5 ). Supplementary medications, particulary NSAIDs, were used by 10.2% (5/49) and 16.3% (8/49) of the subjects in the KRG and placebo groups, respectively (P = 0.372). Antibiotics (placebo vs KRG, 18.4% vs 6.1%, P = 0.064), and anti-histamine (placebo vs KRG, 12.2% vs 4.1%, P = 0.004) were used for colds and flu respectively. The differences in the inci- dence of NSAIDs usage between the two groups were not found to be statistically significant. The incidence of antibiotics usage was marginally more common in the placebo than in the KRG group. Anti-histamine usage was significantly more common in the placebo than in the KRG group.', 'cite_spans': [], 'ref_spans': [{'start': 169, 'end': 176, 'text': 'Table 4', 'ref_id': 'TABREF3'}, {'start': 327, 'end': 335, 'text': '(Table 5', 'ref_id': None}], 'section': 'Safety assessment'}, {'text': 'The frequency rate of ARI was significantly lower in the KRG group than in the placebo group in this study. The symptom duration was short and the symptom score was lower in KRG group than placebo group. However, the statistical significance was not observed. Regarding the safety of KRG, there were no specific clinical and laboratory side effects after 12 weeks for the healthy subjects.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"In the process of steaming and drying for manufacturing red ginseng, it occurs various chemical reactions that eventually lead to the production of effective components, not found in fresh ginseng. And also, the effective absorption and digestion of various active compounds are considered to be the strength of red ginseng. Red ginseng was shown to have a various immunomodulatory actions such as activation of natural killer cells, inhibitory action of food allergy, antagonistic reaction for immunosuppressive agents, and activation of innate immunity (14) (15) (16) (19) (20) (21) (22) . It has been proven to have a broad range of biological activities including T-cell mediated immune reaction, as well as antioxidant and anti-tumor actions (7, 8, 23, 24) . Recently, Kim et al. (14) reported the effect of oral administration of KRG on influenza A (H1N1) virus infection. In the study, they investigated the inhibitory effect of KRG extract on plaque formation by influenza A virus in a cell-based plaque assay, and the effect of orally administered KRG on influenza A virus infection in mice. They suggested that KRG could potentially be used as a complementary treatment of influenza A virus. Kaneko and Nakanishi Variables were presented as number (percentage) and mean ± SD. Analyzed by Mann Whitney U test and chi-square test or Fisher's exact test. The duration and the score of each symptom were calculated by sum during symptoms. Variables were presented as number (percentage) and mean ± SD. *Analyzed by repeated measure ANOVA and the P value means the significant level between KRG group and placebo group. WBC, white blood cell; RBC, red blood cell; PLT, platelet; ALP, alkaline phosphatase; AST, aspartate transaminase; ALT, alanine transaminase; γ -GT, gamma glutamyl transferase; BUN, blood urea nitrogen; HPF, high power field.\", 'cite_spans': [{'start': 555, 'end': 559, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 560, 'end': 564, 'text': '(15)', 'ref_id': 'BIBREF14'}, {'start': 565, 'end': 569, 'text': '(16)', 'ref_id': 'BIBREF15'}, {'start': 570, 'end': 574, 'text': '(19)', 'ref_id': 'BIBREF18'}, {'start': 575, 'end': 579, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 580, 'end': 584, 'text': '(21)', 'ref_id': 'BIBREF20'}, {'start': 585, 'end': 589, 'text': '(22)', 'ref_id': 'BIBREF21'}, {'start': 747, 'end': 750, 'text': '(7,', 'ref_id': 'BIBREF6'}, {'start': 751, 'end': 753, 'text': '8,', 'ref_id': 'BIBREF7'}, {'start': 754, 'end': 757, 'text': '23,', 'ref_id': 'BIBREF22'}, {'start': 758, 'end': 761, 'text': '24)', 'ref_id': 'BIBREF23'}, {'start': 774, 'end': 789, 'text': 'Kim et al. (14)', 'ref_id': None}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': '(25) performed a retrospective study of long term use of KRG in the staff of geriatric hospital. They also reported that KRG has preventive effects on the common cold symptom complex, including flu. However, there was no well designed clinical trial regarding the effect of ARI for KRG. McElbaney et al. (11) compared American ginseng with a placebo in preventing acute respiratory illness in an institutional setting during influenza seasons. In their study, the mean age of volunteers was over 80 yr old, 74% female, and approximately 90% had received influenza vaccine in each of the 2 yr. Confirmation of viral acute respiratory illness was conducted by culture or serology for influenza. They showed that the incidence of laboratory confirmed influenza illness was lower in American ginseng groups than in placebo groups (odds ratio [OR], 0.14; 95% CI, 0.02-0.97). Combined data for laboratory confirmed influenza illness and respiratory syncytial virus illness (OR, 0.11; 95% CI, 0.01-0.86) were also lower in American ginseng study groups than in placebo groups. This suggests that American ginseng is potentially effective for preventing acute respiratory illness. Predy et al. (12, 26) performed a clinical trial that was very similar to our study. The mean age of volunteers was 43, 60% female, and subjects were excluded if they had been vaccinated against influenza in the previous 6 months. The mean number of colds per person was lower in the ginseng group than in the placebo group (ginseng vs placebo, 0.68% vs 0.82%, 95% CI, 0.04-0.45). The proportion of subjects with 2 or more Jackson-verified colds (ginseng vs placebo, 10.0% vs 22.8%, P = 0.004) was significantly lower in the ginseng group than in the placebo group, as were the total symptom score (ginseng vs placebo, 77.5 vs 112.3, P = 0.002), and the total number of days that cold symptoms were reported (ginseng vs placebo, 10.8 vs 16.5, P < 0.001). These results showed that American ginseng had protective effects for ARI. However, the effect of KRG on ARI has not been studied although it is known to have a broad range of biological activities and effect of KRG on influenza A (H1N1) virus infection. In this study, we showed that KRG has a significant protective effect for ARI and decreases the symptom duration and symptom score similar to American ginseng.', 'cite_spans': [{'start': 304, 'end': 308, 'text': '(11)', 'ref_id': 'BIBREF10'}, {'start': 1186, 'end': 1190, 'text': '(12,', 'ref_id': 'BIBREF11'}, {'start': 1191, 'end': 1194, 'text': '26)', 'ref_id': None}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Herbal medicine, together with the declining numbers of new antimicrobials that are being certified and introduced into clinical practice, is one of the fastest growing alternative therapies. The uses of herbal medication range from the treatment and prevention of common illnesses to cancer treatment and prevention (5, 6). Most herbal medicine or dietary supplements appear to be safe, and the medical literature supports their effectiveness for certain conditions (5 one of the most well studied herbal medicines. KRG has a broad range of activity as well as protective effect against ARI, and hence is potentially more effective in combating different emerging strains of virus.', 'cite_spans': [{'start': 467, 'end': 469, 'text': '(5', 'ref_id': 'BIBREF4'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In our study, anti-histamine and antibiotics were used more frequently in the placebo group compared to the KRG group.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'There are several limitations in this study. First, we did not calculate the number of subjects statistically because this was a preliminary study. We need more extensive clinical studies with clear statistical numberings. Second, we did not conduct microbiological analysis of ARI. Therefore we are not certain of the nature of the virus or the number of strains. Third, we included only healthy volunteers without influenza vaccinations. Clinical trials on healthy volunteers with influenza vaccination vs without vaccination and various age groups are required.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In conclusion, KRG have a protective effect against contracting ARI, and may have a tendency to decrease the duration and scores of ARI symptoms. However, we need further studies with statistically powered subjects and children, vaccinated subjects, and immuonocompromised subjects.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Principles and practice of infectious disease', 'authors': [{'first': 'R', 'middle': ['B'], 'last': 'Turner', 'suffix': ''}, {'first': 'G', 'middle': ['L'], 'last': 'Mandell', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Bennett', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Dolin', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Editors', 'suffix': ''}], 'year': 2010, 'venue': '', 'volume': '1', 'issn': '', 'pages': '809--822', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Pharyngitis, sinusitis, otitis, and other upper respiratory tract infectiions', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Rubin', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Sande', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Fauci', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Braunwald', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Kasper', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Hauser', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Longo', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Jameson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Loscalzo', 'suffix': ''}], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '205--219', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Mortality associated with influenza and respiratory syncytial virus in the United States', 'authors': [{'first': 'W', 'middle': ['W'], 'last': 'Thompson', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Shay', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Weintraub', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Brammer', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Cox', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Anderson', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Fukuda', 'suffix': ''}], 'year': 2003, 'venue': 'JAMA', 'volume': '289', 'issn': '', 'pages': '179--86', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Prevention and control of influenza with: recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'authors': [{'first': 'A', 'middle': ['E'], 'last': 'Fiore', 'suffix': ''}, {'first': 'T', 'middle': ['M'], 'last': 'Uyeki', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Broder', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Finelli', 'suffix': ''}, {'first': 'G', 'middle': ['L'], 'last': 'Euler', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Singleton', 'suffix': ''}, {'first': 'J', 'middle': ['K'], 'last': 'Iskander', 'suffix': ''}, {'first': 'P', 'middle': ['M'], 'last': 'Wortley', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Shay', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Bresee', 'suffix': ''}], 'year': 2010, 'venue': '', 'volume': '59', 'issn': '', 'pages': '1--62', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Dietary supplement users: demographics, product use, and medical system interaction', 'authors': [{'first': 'B', 'middle': ['C'], 'last': 'Eliason', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kruger', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Mark', 'suffix': ''}, {'first': 'D', 'middle': ['N'], 'last': 'Rasmann', 'suffix': ''}], 'year': 1997, 'venue': 'J Am Board Fam Pract', 'volume': '10', 'issn': '', 'pages': '265--71', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial', 'authors': [{'first': 'S', 'middle': ['H'], 'last': 'Yale', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Liu', 'suffix': ''}], 'year': 2004, 'venue': 'Arch Intern Med', 'volume': '164', 'issn': '', 'pages': '1237--1278', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Protective effect of fermented red ginseng on a transient focal ischemic rats', 'authors': [{'first': 'E', 'middle': ['A'], 'last': 'Bae', 'suffix': ''}, {'first': 'Y', 'middle': ['J'], 'last': 'Hyun', 'suffix': ''}, {'first': 'M', 'middle': ['K'], 'last': 'Choo', 'suffix': ''}, {'first': 'J', 'middle': ['K'], 'last': 'Oh', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Ryu', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Kim', 'suffix': ''}], 'year': 2004, 'venue': 'Arch Pharm Res', 'volume': '27', 'issn': '', 'pages': '1136--1176', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold', 'authors': [{'first': 'F', 'middle': [], 'last': 'Scaglione', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Cattaneo', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Alessandria', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Cogo', 'suffix': ''}], 'year': 1996, 'venue': 'Drugs Exp Clin Res', 'volume': '22', 'issn': '', 'pages': '65--72', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds', 'authors': [{'first': 'T', 'middle': ['K'], 'last': 'Yun', 'suffix': ''}, {'first': 'Y', 'middle': ['S'], 'last': 'Lee', 'suffix': ''}, {'first': 'Y', 'middle': ['H'], 'last': 'Lee', 'suffix': ''}, {'first': 'S', 'middle': ['I'], 'last': 'Kim', 'suffix': ''}, {'first': 'H', 'middle': ['Y'], 'last': 'Yun', 'suffix': ''}], 'year': 2001, 'venue': 'J Korean Med Sci', 'volume': '16', 'issn': '', 'pages': '6--18', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats', 'authors': [{'first': 'Z', 'middle': [], 'last': 'Song', 'suffix': ''}, {'first': 'H', 'middle': ['K'], 'last': 'Johansen', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Faber', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Moser', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kharazmi', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Rygaard', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Høiby', 'suffix': ''}], 'year': 1997, 'venue': 'Antimicrob Agents Chemother', 'volume': '41', 'issn': '', 'pages': '961--965', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Mcelhaney', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Gravenstein', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Cole', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Davidson', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'O&apos;neill', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Petitjean', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Rumble', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Shan', 'suffix': ''}], 'year': 2004, 'venue': 'J Am Geriatr Soc', 'volume': '52', 'issn': '', 'pages': '13--22', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosylsaccharides for preventing upper respiratory tract infections: a randomized controlled trial', 'authors': [{'first': 'G', 'middle': ['N'], 'last': 'Predy', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Goel', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Lovlin', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Donner', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Stitt', 'suffix': ''}, {'first': 'T', 'middle': ['K'], 'last': 'Basu', 'suffix': ''}], 'year': 2005, 'venue': 'CMAJ', 'volume': '173', 'issn': '', 'pages': '1043--1051', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Mcelhaney', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Goel', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Toane', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Hooten', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Shan', 'suffix': ''}], 'year': 2006, 'venue': 'J Altern Complement Med', 'volume': '12', 'issn': '', 'pages': '153--160', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Effects of oral administration of Korean red ginseng on influenza A (H1N1) virus infection', 'authors': [{'first': 'J', 'middle': ['Y'], 'last': 'Kim', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Kim', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Kim', 'suffix': ''}], 'year': 2011, 'venue': 'J Ginseng Res', 'volume': '35', 'issn': '', 'pages': '104--114', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection', 'authors': [{'first': 'F', 'middle': ['S'], 'last': 'Quan', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Compans', 'suffix': ''}, {'first': 'Y', 'middle': ['K'], 'last': 'Cho', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Kang', 'suffix': ''}], 'year': 2007, 'venue': 'Vaccine', 'volume': '25', 'issn': '', 'pages': '272--82', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium)', 'authors': [{'first': 'M', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Guilbert', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ling', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wu', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Xu', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Pang', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Shan', 'suffix': ''}], 'year': 2001, 'venue': 'J Pharm Pharmacol', 'volume': '53', 'issn': '', 'pages': '1515--1538', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Double-blind study of a multivitamin complex supplemented with ginseng extract', 'authors': [{'first': 'Caso', 'middle': [], 'last': 'Marasco', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Vargas', 'middle': [], 'last': 'Ruiz', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Salas', 'middle': [], 'last': 'Villagomez', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Begoña', 'middle': [], 'last': 'Infante', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': '', 'suffix': ''}], 'year': 1996, 'venue': 'Drugs Exp Clin Res', 'volume': '22', 'issn': '', 'pages': '323--332', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Ginseng total saponin improves podocyte hyperpermeability induced by high glucose and advanced glycosylation endproducts', 'authors': [{'first': 'T', 'middle': ['S'], 'last': 'Ha', 'suffix': ''}, {'first': 'J', 'middle': ['Y'], 'last': 'Choi', 'suffix': ''}, {'first': 'H', 'middle': ['Y'], 'last': 'Park', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Lee', 'suffix': ''}], 'year': 2011, 'venue': 'J Korean Med Sci', 'volume': '26', 'issn': '', 'pages': '1316--1337', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Panax ginseng as a potential immunomodulator: studies in mice', 'authors': [{'first': 'J', 'middle': ['Y'], 'last': 'Kim', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Germolec', 'suffix': ''}, {'first': 'M', 'middle': ['I'], 'last': 'Luster', 'suffix': ''}], 'year': 1990, 'venue': 'Immunopharmacol Immunotoxicol', 'volume': '12', 'issn': '', 'pages': '257--76', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Effect of subcutaneous injection of ginseng on cows with subclinical Staphylococcus aureus mastitis', 'authors': [{'first': 'S', 'middle': [], 'last': 'Hu', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Concha', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Johannisson', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Meglia', 'suffix': ''}, {'first': 'K', 'middle': ['P'], 'last': 'Waller', 'suffix': ''}], 'year': 2001, 'venue': 'J Vet Med B Infect Dis Vet Public Health', 'volume': '48', 'issn': '', 'pages': '519--547', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Effects of ginseng root saponins and ginsenoside Rb1 on immunity in cold water swim stress mice and rats. Zhongguo Yao Li Xue Bao', 'authors': [{'first': 'Y', 'middle': ['M'], 'last': 'Luo', 'suffix': ''}, {'first': 'X', 'middle': ['J'], 'last': 'Cheng', 'suffix': ''}, {'first': 'W', 'middle': ['X'], 'last': 'Yuan', 'suffix': ''}], 'year': 1993, 'venue': '', 'volume': '14', 'issn': '', 'pages': '401--405', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Effects of Red Ginseng extract on allergic reactions to food in Balb/c mice', 'authors': [{'first': 'M', 'middle': [], 'last': 'Sumiyoshi', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sakanaka', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Kimura', 'suffix': ''}], 'year': 2010, 'venue': 'J Ethnopharmacol', 'volume': '132', 'issn': '', 'pages': '206--218', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Immune system effects of echinacea, ginseng, and astragalus: a review', 'authors': [{'first': 'K', 'middle': ['I'], 'last': 'Block', 'suffix': ''}, {'first': 'M', 'middle': ['N'], 'last': 'Mead', 'suffix': ''}], 'year': 2003, 'venue': 'Integr Cancer Ther', 'volume': '2', 'issn': '', 'pages': '247--67', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng', 'authors': [{'first': 'Y', 'middle': ['S'], 'last': 'Keum', 'suffix': ''}, {'first': 'K', 'middle': ['K'], 'last': 'Park', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Lee', 'suffix': ''}, {'first': 'K', 'middle': ['S'], 'last': 'Chun', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Park', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Lee', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Kwon', 'suffix': ''}, {'first': 'Y', 'middle': ['J'], 'last': 'Surh', 'suffix': ''}], 'year': 2000, 'venue': 'Cancer Lett', 'volume': '150', 'issn': '', 'pages': '41--49', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, Korean red ginseng: specifically, its anti-stress action for prevention of disease', 'authors': [{'first': 'H', 'middle': [], 'last': 'Kaneko', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Nakanishi', 'suffix': ''}], 'year': 2004, 'venue': 'J Pharmacol Sci', 'volume': '95', 'issn': '', 'pages': '158--62', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'The design of this study.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': '//dx.doi.org/10.3346/jkms.2012.27.12.1472', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'Schematic representation of this study. ITT, intention to treat; PP, per protocol. Enrollment Excluded (n = 15) ♦ Not meeting inclusion criteria (n = 14) ♦ Declined to participate (n = 1) KRG group (n = 49) Placebo group (n = 49) PP (n = 98) dx.doi.org/10.3346/jkms.2012.27.12.1472', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': \"General characteristics of the study population Data were presented as mean ± SD or number (percentage). Analyzed by Student's t-test or chi-square test, Fisher's exact test. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate.\", 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Compliance of the Korean red ginseng (KRG) group and the placebo group', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'The frequency, symptom duration and severity score of subjects that experienced ARI', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': 'Adverse', 'latex': None, 'type': 'table'}, 'TABREF4': {'text': '). Among them, ginseng is http://dx.doi.org/10.3346/jkms.2012.27.12.1472', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715f09d6eaadb18b3fdee'), 'paper_id': '0adc0c7498f0ebbb3c8f1c662da34605d5f91fe2', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'COPD has become a major cause of chronic morbidity and mortality throughout the world, and the economic and social burden are projected to increase in the coming decades. 1 Hospitalization for acute exacerbation of COPD (AECOPD) is recognized as a major event in the natural history of COPD due to its adverse effect on lung function, survival, risk of readmission, and quality of life. [2] [3] [4] [5] [6] It is generally believed that exacerbations are important targets for treatments and prevention of disease progression of COPD. 7 Exploration of causative phenotypes of exacerbations would identify differences in population characteristics and clinical outcomes, which can lead to therapeutic consequences. 8 Respiratory infection is recognized as an important trigger for AECOPD, and has also been shown to be associated with more severe disease. However, little is known about the spectrum of virus and bacteria of respiratory tract of AECOPD.', 'cite_spans': [{'start': 171, 'end': 172, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 387, 'end': 390, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 391, 'end': 394, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 395, 'end': 398, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 399, 'end': 402, 'text': '[5]', 'ref_id': 'BIBREF4'}, {'start': 403, 'end': 406, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 535, 'end': 536, 'text': '7', 'ref_id': 'BIBREF6'}, {'start': 714, 'end': 715, 'text': '8', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The prolonged length of stay (LOS) indicates more fragile patients who need more attention from healthy subjects. 7 However, there is a lack of identified predictors of long LOS. Although previous studies suggest that there was a correlation of LOS with respiratory infection, 9 the respiratory infectious phenotypes in LOS have not been explored in AECOPD. The COPD Assessment Test (CAT) with good internal consistency and test-retest reliability is suitable for routine clinical use for both stable and exacerbating COPD in recent years. [10] [11] [12] [13] However, there was no information about the correlation between CAT and respiratory infectious phenotypes as well as LOS.', 'cite_spans': [{'start': 114, 'end': 115, 'text': '7', 'ref_id': 'BIBREF6'}, {'start': 277, 'end': 278, 'text': '9', 'ref_id': 'BIBREF8'}, {'start': 540, 'end': 544, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 545, 'end': 549, 'text': '[11]', 'ref_id': 'BIBREF10'}, {'start': 550, 'end': 554, 'text': '[12]', 'ref_id': 'BIBREF11'}, {'start': 555, 'end': 559, 'text': '[13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Our current study, therefore, is to explore respiratory infectious phenotypes and their impact on LOS and the CAT scale during the exacerbations of COPD, which provides a better understanding of the disease and health-care planning.', 'cite_spans': [], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In all, 110 patients with clinician-diagnosed COPD exacerbation were screened according to the strategies illustrated in Figure 1 from January to June 2014 in our hospital. Among them, 81 eligible patients were enrolled. The AECOPD is defined as an acute event characterized by a worsening of respiratory symptoms (dyspnea, sputum purulence, or sputum volume) that is beyond normal day-to-day variations, and leads to a change in medication. 7 Patients with an established history of COPD were recruited, with a post-bronchodilator forced expiratory volume in 1 second (FEV 1 ) to forced vital capacity (FVC) ratio ,70% at diagnosis. Standardized pulmonary function test was performed with a dry spirometer device (Erich Jaeger GmbH, Hoechberg, Germany) at 15 minutes after inhaling salbutamol 400 µg (Ventolin, GlaxoS-mithKline, London, UK), and the FVC, FEV 1 , and FEV 1 /FVC ratio were recorded. In addition, the patients should be able to understand and complete the CAT independently. Exclusion criteria were as follows: patients with a primary diagnosis of asthma, bronchiectasis or other active chronic respiratory disease requiring treatments, interventions or diagnostics, or any other severe or uncontrolled co-morbidities; patients with mental disorders or any other condition associated with an immuno-inflammatory response; and patients who had received antibiotic or corticosteroids during the past 4 weeks. This study was approved by the ethical committee of Anhui Medical University, and written informed consent was obtained from all patients.', 'cite_spans': [{'start': 442, 'end': 443, 'text': '7', 'ref_id': 'BIBREF6'}], 'ref_spans': [{'start': 121, 'end': 129, 'text': 'Figure 1', 'ref_id': 'FIGREF0'}], 'section': 'Materials and methods study population'}, {'text': \"Clinical characteristics of the patients were recorded, including demographic information, smoking history, Charlson's index, the new Global initiative for chronic Obstructive Lung Disease (GOLD) staging system (grades A-D) using spirometry, exacerbation history, modified British Medical Research Council, and/or CAT results, long-term oxygen therapy, CAT scale, and LOS (Table 1) . Co-morbidities included hypertension, diabetes mellitus, cerebral infarction, coronary artery disease, and these co-morbidities were in stable state which was confirmed by physicians from related departments. LOS was defined as the duration from admission to discharge from our hospital. 7\", 'cite_spans': [], 'ref_spans': [{'start': 372, 'end': 381, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Clinical parameters'}, {'text': \"During collecting samples, a pharyngeal swab was rotated five to six times and allowed to remain for 5 seconds. 14 The swab was then immediately immersed in 3 mL viral preservation liquid (Youkang Technology Co., Beijing, People's Republic of China) and stored at -80°C until examined. Total nucleic acids (DNA and RNA) were extracted and purified using mini kit (QIAamp MinElute Virus Spin Kit, Cat. No 57704, Hilden, Germany) and stored at -70°C until use. All pharyngeal swabs were analyzed consecutively for the presence of respiratory viruses upon arrival at the Department of Clinical Laboratory in the First Affiliated Hospital of Anhui Medical University. Analyses included influenza A (H1, H3, and H1N1), influenza B, respiratory syncytial virus, human metapneumovirus, parainfluenza virus types 1, 2, 3, and 4, coronaviruses (CoV OC43, CoV 229E, CoV NL-63, and HKU1), enterovirus/rhinovirus, adenovirus, and human bocavirus by a Respiratory Viral Panel FAST v2 kit which is based on the multiplex polymerase chain reaction (PCR), Flexible Multi-Analyte Profiling (xMAP), and xTAG techniques (Luminex, Toronto, Canada).\", 'cite_spans': [], 'ref_spans': [], 'section': 'Microbiological analyses Virological assays'}, {'text': 'Spontaneously, sputum was obtained in a sterile container prior to the initiation of AECOPD treatment and examined within 30 minutes. The bacterial analysis was performed at the Department of Clinical Laboratory in the First Affiliated Hospital of Anhui Medical University. The analyses consisted of bacterium culture, identification, and antibiotic susceptibility testing. Evaluation of bacterial content of the sample was done following the normal procedure. Gram-staining of sputum was evaluated by technicians and microbiologists. Secretions containing epithelium from the deeper parts of the airways by microscopic evaluation were considered sufficient materials. Bacteria in association with such epithelium were considered as being possible pathogens. Cultures of these diluted samples were made on blood agar and chocolate agar. The plates were incubated at 37°C in an incubator in the atmosphere of 10% CO 2 . After overnight incubation, the plates were studied by standard techniques and all pathogenic organisms were subjected to antibiotic sensitivity (Micro Scan Walk Away 96, West Sacramento, CA, USA).', 'cite_spans': [], 'ref_spans': [], 'section': 'Bacteriological assays'}, {'text': \"Demographic and clinical characteristics of patients were summarized descriptively. Data were expressed as mean ± standard deviation. SPSS Statistics version 16.0 was used for statistical analysis. Group comparisons were tested using analysis of variance test or Chi-squared test. Pearson's \", 'cite_spans': [], 'ref_spans': [], 'section': 'statistical analyses'}, {'text': 'Dai et al regression was used to analyze the correlation between CAT score and LOS. Groups were compared using analysis of variance. A P-value ,0.05 was considered significant in all statistical analyses.', 'cite_spans': [], 'ref_spans': [], 'section': '2260'}, {'text': \"From January to June 2014, a total of 110 patients were screened at admission to our study. In all, 81 patients were eligible, 29 patients were excluded, and two patients died from acute respiratory failure (Figure 1 ). We categorized those 81 patients into four groups (viral infection, bacterial infection, coinfection, and non-infectious groups) based on the pathogens isolated from respiratory tract specimens. Coinfection was defined as both viral and bacterial infection. There were no differences among the baseline characteristics in terms of sex distribution, age, body mass index, pack-years of smoking, current smoking status, Charlson's index, and long-term oxygen therapy ( Table 1) .\", 'cite_spans': [], 'ref_spans': [{'start': 207, 'end': 216, 'text': '(Figure 1', 'ref_id': 'FIGREF0'}, {'start': 687, 'end': 695, 'text': 'Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Patient characteristics'}, {'text': 'Viral assays of the 81 pharyngeal swabs showed an overall positivity rate of 47% (n=38). Influenza virus was the most frequently detected virus (n=21), followed by enterovirus/ rhinovirus (n=11), coronavirus (n=9), bocavirus (n=6), metapneumovirus (n=5), parainfluenza virus types 1, 2, 3, and 4 (n=3), and respiratory syncytial virus (n=3) (Figure 2 ). In addition, 12 patients were found with multiple viral infections. We found that 17 of 81 had a positive sputum culture for the following bacteria: Pseudomonas aeruginosa (n=6), Acinetobacter baumannii (n=5), Klebsiella (n=4), Escherichia coli (n=1), and Streptococcus pneumoniae (n=1). Ten patients with coinfection were found. . We found no significant difference between patients with virus and bacteria infection in terms of CAT scores ( Figure 4) . Finally, we also found that CAT scores was positively correlated with LOS during AECOPD (r=0.372, P,0.001, Figure 5 ). relationships between the respiratory infectious phenotypes and FeV 1 and the new gOlD staging system Data of FEV 1 is shown in Table 1 . We found no statistically significant difference in FEV 1 among different infectious ', 'cite_spans': [], 'ref_spans': [{'start': 341, 'end': 350, 'text': '(Figure 2', 'ref_id': 'FIGREF2'}, {'start': 797, 'end': 806, 'text': 'Figure 4)', 'ref_id': 'FIGREF4'}, {'start': 916, 'end': 924, 'text': 'Figure 5', 'ref_id': 'FIGREF5'}, {'start': 1056, 'end': 1063, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'spectrum of respiratory virus and bacteria'}, {'text': 'AECOPD often facilitate the progressive course of COPD, mainly due to infection. 14, 15 Several studies have measured the burden of viral or bacterial infections in COPD exacerbation. However, little information is available about the respiratory infectious phenotypes as causative agent of exacerbations of COPD, and their relationships with LOS and CAT scale.', 'cite_spans': [{'start': 81, 'end': 84, 'text': '14,', 'ref_id': 'BIBREF13'}, {'start': 85, 'end': 87, 'text': '15', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': \"In the present study, 81 cases were examined. The results showed that 38 cases were viral infection, 17 were bacterial infection, and seven had both (Figure 2 ). Our detection rates of respiratory viruses were in line with recent reports, but two to three times higher than that using the conventional viral culture methods. 16, 17 The discrepancy could be explained by the use of Luminex multiplex PCR technique since this examining system allows the inclusion of new viruses such as human metapneumovirus and bocavirus in the more recent studies. Our study found that influenza virus is the most common virus associated with AECOPD, consistent with our results, a study from Hong Kong has shown influenza to be the most detected virus in exacerbations of COPD, 18 which supports our results that influenza virus might be the most causative agent in the exacerbations of COPD in Asia. However, picornavirus was the most common one in studies from Western countries. 16 This disparity in distribution of virus could be related to the geographical variation or different strains circulating at that particular year and time. Alternatively, the wider coverage of influenza vaccination in Western countries compared to Asia may also contribute to the difference of virus seen in the study. 19, 20 Interestingly, our study also detected five patients infected with human metapneumovirus and six patients with bocavirus in AECOPD for the first time, which provides a new insight into understanding of etiological agents in AECOPD. Further studies are needed to explore these less well-studied etiological pathogens for AECOPD. Potential bacterium was detected in 21% of acute exacerbation events, demonstrating the predominance of P. aeruginosa, A. baumannii, and Klebsiella. Although we strictly followed the standard procedure to collect specimens, the detection rate with conventional examination method was relatively lower than modern culture-independent molecular approach, which could identify many unrecognized bacterial species in samples from COPD patients that may be clinically relevant. 21 This bacterial spectrum was generally in agreement with those reported previously in People's Republic of China. 22 The difference with that of Western countries could be due to the regional disparity of bacterial infection.\", 'cite_spans': [{'start': 325, 'end': 328, 'text': '16,', 'ref_id': 'BIBREF15'}, {'start': 329, 'end': 331, 'text': '17', 'ref_id': 'BIBREF16'}, {'start': 763, 'end': 765, 'text': '18', 'ref_id': 'BIBREF17'}, {'start': 967, 'end': 969, 'text': '16', 'ref_id': 'BIBREF15'}, {'start': 1287, 'end': 1290, 'text': '19,', 'ref_id': 'BIBREF18'}, {'start': 1291, 'end': 1293, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 2095, 'end': 2097, 'text': '21', 'ref_id': 'BIBREF20'}, {'start': 2211, 'end': 2213, 'text': '22', 'ref_id': 'BIBREF21'}], 'ref_spans': [{'start': 149, 'end': 158, 'text': '(Figure 2', 'ref_id': 'FIGREF2'}], 'section': 'Discussion'}, {'text': 'The other main aim of this study was to evaluate the potential relationship between respiratory tract infectious phenotypes and LOS as well as the CAT scale. LOS has been widely used to measure the acute impact on patients with AECOPD. 23 Our results showed the longest LOS for coinfection group and shortest LOS for the non-infectious group, which was consistent with previously reports. 8, 24 Wilkinson et al 25 had demonstrated that exacerbation symptoms and FEV 1 decline were more severe in the presence of bacteria and colds (as a surrogate of viral infection) than with a cold or bacterial pathogen alone. Exacerbations associated with human rhinovirus and Haemophilus influenzae coinfection exhibited a greater bacterial load and inflammation than those with no infection or viral or bacterial infection alone. These results showed that viral and bacterial coinfection would lead to a more severe symptom and longer LOS for patients to recover, which inversely increases chances of nosocomial infection, and also social and economic burden dramatically. Therefore, we may conclude that the different infectious phenotypes are closely associated with different LOS and health status in AECOPD patients. It is worth mentioning that some researches have found that cardiovascular events, pulmonary embolism, and blood stream infections may also contribute to the prolonged stay in patients with COPD. 9,26 However, we did not check all of the relevant factors or diseases associated with prolonged stay in hospital which may have an impact on our results. We will take it into consideration in future study.', 'cite_spans': [{'start': 236, 'end': 238, 'text': '23', 'ref_id': 'BIBREF22'}, {'start': 392, 'end': 394, 'text': '24', 'ref_id': 'BIBREF23'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'CAT is a recently introduced, patient-completed instrument to assess and quantify symptom and inflammation burden in patients of COPD. Therefore, we hypothesized that there may be a correlation between respiratory infectious phenotypes and CAT, which has not been explored yet. Since patients with coinfection exhibited a greater inflammation than those with single infection or non-infection, we infer that coinfection would lead to a higher CAT score, which was supported by our results. Furthermore, we also found that CAT was positively correlated with LOS, which makes CAT a useful tool to assess the impact of AECOPD symptoms on health status.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'In our study, coinfection group has a lower FEV 1 than the other three groups. There was, however, no statistically significant difference which was in agreement with some previous researches. [27] [28] [29] Wark et al 30 has demonstrated that there was no difference in acute FEV 1 between those with and without virus infection. At review 6 weeks following their admission, those with virus infection had a greater decline in lung function compared with those without a virus having been isolated. How this occurs still need further investigation. Furthermore, a study investigating the relationship between potentially pathogenic bacteria isolation frequency and GOLD stages in AECOPD found no relationship between stage and bacteria isolation, which bear some resemblance to our research. 28 Mortality is the most important parameter in predicting prognosis. Two patients infected with influenza virus died in our study. Researches had showed that influenza virus pandemic poses a potentially grave public health threat because of the high mortality rates observed in infected people. 31 Therefore, whether respiratory influenza viral infection could be attributed to mortality of COPD exacerbations still needs further investigation.', 'cite_spans': [{'start': 193, 'end': 197, 'text': '[27]', 'ref_id': 'BIBREF26'}, {'start': 198, 'end': 202, 'text': '[28]', 'ref_id': 'BIBREF27'}, {'start': 203, 'end': 207, 'text': '[29]', 'ref_id': 'BIBREF28'}, {'start': 793, 'end': 795, 'text': '28', 'ref_id': 'BIBREF27'}, {'start': 1089, 'end': 1091, 'text': '31', 'ref_id': 'BIBREF30'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Respiratory infectious phenotypes are associated with LOS and severity of symptoms in AECOPD. Furthermore, respiratory viral infection plays an important role in exacerbations of COPD. CAT may be a predictor of longer LOS with coinfection.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusion'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Chronic obstructive pulmonary disease: current burden and future projections', 'authors': [{'first': 'A', 'middle': ['D'], 'last': 'Lopez', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Shibuya', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Rao', 'suffix': ''}], 'year': 2006, 'venue': 'Eur Respir J', 'volume': '27', 'issn': '2', 'pages': '397--412', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease', 'authors': [{'first': 'T', 'middle': ['A'], 'last': 'Seemungal', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Donaldson', 'suffix': ''}, {'first': 'E', 'middle': ['A'], 'last': 'Paul', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Bestall', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Jeffries', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Wedzicha', 'suffix': ''}], 'year': 1998, 'venue': 'Am J Respir Crit Care Med', 'volume': '157', 'issn': '5', 'pages': '1418--1422', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUP-PORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)', 'authors': [{'first': 'A', 'middle': ['F'], 'last': 'Connors', 'suffix': ''}, {'first': 'N', 'middle': ['V'], 'last': 'Dawson', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Thomas', 'suffix': ''}], 'year': 1996, 'venue': 'Am J Respir Crit Care Med', 'volume': '154', 'issn': '4', 'pages': '959--967', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease', 'authors': [{'first': 'G', 'middle': ['C'], 'last': 'Donaldson', 'suffix': ''}, {'first': 'T', 'middle': ['A'], 'last': 'Seemungal', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bhowmik', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Wedzicha', 'suffix': ''}], 'year': 2002, 'venue': 'Thorax', 'volume': '57', 'issn': '10', 'pages': '847--852', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respir', 'authors': [{'first': 'P', 'middle': [], 'last': 'Almagro', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Barreiro', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Ochoa De Echaguen', 'suffix': ''}], 'year': 2006, 'venue': 'Int Rev Thoracic Dis', 'volume': '73', 'issn': '3', 'pages': '311--317', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Risk factors of readmission to hospital for a COPD exacerbation: a prospective study', 'authors': [{'first': 'J', 'middle': [], 'last': 'Garcia-Aymerich', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Farrero', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Felez', 'suffix': ''}], 'year': 2003, 'venue': 'Thorax', 'volume': '58', 'issn': '2', 'pages': '100--105', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary', 'authors': [{'first': 'J', 'middle': [], 'last': 'Vestbo', 'suffix': ''}, {'first': 'S', 'middle': ['S'], 'last': 'Hurd', 'suffix': ''}, {'first': 'A', 'middle': ['G'], 'last': 'Agusti', 'suffix': ''}], 'year': 2013, 'venue': 'Am J Respir Crit Care Med', 'volume': '187', 'issn': '4', 'pages': '347--365', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Exacerbation phenotyping in chronic obstructive pulmonary disease', 'authors': [{'first': 'M', 'middle': [], 'last': 'Macdonald', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Korman', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'King', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Hamza', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Bardin', 'suffix': ''}], 'year': 2013, 'venue': 'Respirology', 'volume': '18', 'issn': '8', 'pages': '1280--1281', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD)', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Stavem', 'suffix': ''}, {'first': 'F', 'middle': ['A'], 'last': 'Dahl', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Humerfelt', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Haugen', 'suffix': ''}], 'year': 2014, 'venue': 'Int J Chron Obstruct Pulmon Dis', 'volume': '9', 'issn': '', 'pages': '99--105', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Evaluation of the COPD Assessment Test in patients with stable COPD', 'authors': [{'first': 'E', 'middle': [], 'last': 'Marchand', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Maury', 'suffix': ''}], 'year': 2012, 'venue': 'Rev Mal Respir', 'volume': '29', 'issn': '3', 'pages': '391--397', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respir: Int Rev Thoracic Dis', 'authors': [{'first': 'J', 'middle': ['L'], 'last': 'Kelly', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Bamsey', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Smith', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '84', 'issn': '', 'pages': '193--199', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation', 'authors': [{'first': 'P', 'middle': ['W'], 'last': 'Jones', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Harding', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Wiklund', 'suffix': ''}], 'year': 2012, 'venue': 'Chest', 'volume': '142', 'issn': '1', 'pages': '134--140', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations', 'authors': [{'first': 'A', 'middle': ['J'], 'last': 'Mackay', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Donaldson', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Patel', 'suffix': ''}, {'first': 'P', 'middle': ['W'], 'last': 'Jones', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Hurst', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Wedzicha', 'suffix': ''}], 'year': 2012, 'venue': 'Am J Respir Crit Care Med', 'volume': '185', 'issn': '11', 'pages': '1218--1224', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Upper-respiratory viral infection, biomarkers, and COPD exacerbations', 'authors': [{'first': 'O', 'middle': [], 'last': 'Kherad', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Kaiser', 'suffix': ''}, {'first': 'P', 'middle': ['O'], 'last': 'Bridevaux', 'suffix': ''}], 'year': 2010, 'venue': 'Chest', 'volume': '138', 'issn': '4', 'pages': '896--904', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Infection in the pathogenesis and course of chronic obstructive pulmonary disease', 'authors': [{'first': 'S', 'middle': [], 'last': 'Sethi', 'suffix': ''}, {'first': 'T', 'middle': ['F'], 'last': 'Murphy', 'suffix': ''}], 'year': 2008, 'venue': 'New Engl J Med', 'volume': '359', 'issn': '22', 'pages': '2355--2365', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review', 'authors': [{'first': 'A', 'middle': [], 'last': 'Mohan', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Chandra', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Agarwal', 'suffix': ''}], 'year': 2010, 'venue': 'Respirology', 'volume': '15', 'issn': '3', 'pages': '536--542', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Role of infection in chronic bronchitis', 'authors': [{'first': 'I', 'middle': [], 'last': 'Tager', 'suffix': ''}, {'first': 'F', 'middle': ['E'], 'last': 'Speizer', 'suffix': ''}], 'year': 1975, 'venue': 'New Engl J Med', 'volume': '292', 'issn': '11', 'pages': '563--571', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Viral etiology of acute exacerbations of COPD in Hong Kong', 'authors': [{'first': 'F', 'middle': ['W'], 'last': 'Ko', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ip', 'suffix': ''}, {'first': 'P', 'middle': ['K'], 'last': 'Chan', 'suffix': ''}], 'year': 2007, 'venue': 'Chest', 'volume': '132', 'issn': '3', 'pages': '900--908', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease', 'authors': [{'first': 'C', 'middle': ['A'], 'last': 'Camargo', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Ginde', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Clark', 'suffix': ''}, {'first': 'C', 'middle': ['P'], 'last': 'Cartwright', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Falsey', 'suffix': ''}, {'first': 'D', 'middle': ['E'], 'last': 'Niewoehner', 'suffix': ''}], 'year': 2008, 'venue': 'Intern Emerg Med', 'volume': '3', 'issn': '4', 'pages': '355--359', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'A communitybased, time-matched, case-control study of respiratory viruses and exacerbations of COPD', 'authors': [{'first': 'A', 'middle': ['F'], 'last': 'Hutchinson', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Ghimire', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Thompson', 'suffix': ''}], 'year': 2007, 'venue': 'Respir Med', 'volume': '101', 'issn': '12', 'pages': '2472--2481', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches', 'authors': [{'first': 'G', 'middle': ['B'], 'last': 'Rogers', 'suffix': ''}, {'first': 'T', 'middle': ['W'], 'last': 'Daniels', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Tuck', 'suffix': ''}], 'year': 2009, 'venue': 'BMC Pulm Med', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China', 'authors': [{'first': 'F', 'middle': [], 'last': 'Ye', 'suffix': ''}, {'first': 'L', 'middle': ['X'], 'last': 'He', 'suffix': ''}, {'first': 'B', 'middle': ['Q'], 'last': 'Cai', 'suffix': ''}], 'year': 2013, 'venue': 'Chin Med J', 'volume': '126', 'issn': '12', 'pages': '2207--2214', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Predictors of outcome after exacerbation of chronic obstructive pulmonary disease', 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Tsimogianni', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Papiris', 'suffix': ''}, {'first': 'G', 'middle': ['T'], 'last': 'Stathopoulos', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Manali', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Roussos', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kotanidou', 'suffix': ''}], 'year': 2009, 'venue': 'J Gen Intern Med', 'volume': '24', 'issn': '9', 'pages': '1043--1048', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Wong', 'suffix': ''}, {'first': 'W', 'middle': ['Q'], 'last': 'Gan', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Burns', 'suffix': ''}, {'first': 'D', 'middle': ['D'], 'last': 'Sin', 'suffix': ''}, {'first': 'S', 'middle': ['F'], 'last': 'Van Eeden', 'suffix': ''}], 'year': 2008, 'venue': 'Can Respir J: J Can Thorac Soc', 'volume': '15', 'issn': '7', 'pages': '361--364', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD', 'authors': [{'first': 'T', 'middle': ['M'], 'last': 'Wilkinson', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Hurst', 'suffix': ''}, {'first': 'W', 'middle': ['R'], 'last': 'Perera', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Wilks', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Donaldson', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Wedzicha', 'suffix': ''}], 'year': 2006, 'venue': 'Chest', 'volume': '129', 'issn': '2', 'pages': '317--324', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Incidence and impact outcome of pulmonary embolism in critically ill patients with severe exacerbation of chronic obstructive pulmonary diseases', 'authors': [{'first': 'M', 'middle': [], 'last': 'Bahloul', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Chaari', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Tounsi', 'suffix': ''}], 'year': 2015, 'venue': 'Clin Respir J', 'volume': '9', 'issn': '3', 'pages': '270--277', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease', 'authors': [{'first': 'T', 'middle': [], 'last': 'Seemungal', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Harper-Owen', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bhowmik', 'suffix': ''}], 'year': 2001, 'venue': 'Am J Respir Crit Care Med', 'volume': '164', 'issn': '9', 'pages': '1618--1623', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Relationship between the GOLD combined COPD assessment staging system and bacterial isolation', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Aydemir', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Aydemir', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Kalem', 'suffix': ''}], 'year': 2014, 'venue': 'Int J Chron Obstruct Pulmon Dis', 'volume': '9', 'issn': '', 'pages': '1045--1051', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study', 'authors': [{'first': 'J', 'middle': ['M'], 'last': 'Perotin', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Dury', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Renois', 'suffix': ''}], 'year': 2013, 'venue': 'J Med Virol', 'volume': '85', 'issn': '5', 'pages': '866--873', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission', 'authors': [{'first': 'P', 'middle': ['A'], 'last': 'Wark', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Tooze', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Powell', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Parsons', 'suffix': ''}], 'year': 2013, 'venue': 'Respirology', 'volume': '18', 'issn': '6', 'pages': '996--1002', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients', 'authors': [{'first': 'F', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Guo', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Zou', 'suffix': ''}], 'year': 2014, 'venue': 'Nature Commun', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'strategies for screening patients with aeCOPD. Abbreviations: aeCOPD, acute exacerbation of COPD; CaT, COPD assessment Test. International Journal of COPD 2015:10 submit your manuscript | www.dovepress.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'Mean LOS was 9.6±4.1 days as a whole. Coinfection with virus and bacteria resulted in statistically significant longer LOS (coinfection 16.9±5.2 days vs bacterial 11.3±4.0 days [P=0.041], coinfection vs viral 10.1±3.0 days [P=0.000], coinfection vs non-infectious 7.0±2.0 days [P=0.004]). We found no significant difference in LOS between patients with virus and bacteria infection in AECOPD (viral vs bacterial, P.0.05). Consistently, LOS of non-infectious group was shorter than the other groups (Figure 3). CAT scores are shown inTable 1. Coinfection with virus and bacteria resulted in a statistically significant increase in CAT score as compared with other groups (coinfection 32.0±4.5 vs bacterial 25.1±5.5 [P=0.019], coinfection vs viral 25.5±7.0 [P=0.009], coinfection vs non-infectious 25.0±5.6 [P=0.004])', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'Viruses detected by RVP kit from the nasopharyngeal samples of 81 patients admitted for AECOPD were influenza virus (n=21), enterovirus/rhinovirus (n=11), coronavirus (n=9), bocavirus (n=6), metapneumovirus (n=5), parainfluenza virus types 1, 2, 3, and 4 (n=3), and rsV (n=3). Abbreviations: rVP, respiratory virus panel; aeCOPD, acute exacerbation of COPD; rsV, respiratory syncytial virus. International Journal of COPD 2015:10 submit your manuscript | www.dovepress.com Dovepress Dovepress 2261 respiratory infectious phenotypes in aeCOPD phenotypes (P.0.05). Moreover, there was no statistically significant difference in the classification of patients according to the new GOLD staging system among the four groups.', 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'statistical distribution (box plot) of lOs according to the four respiratory infectious phenotypes: 0 -non-infectious group, 1 -viral infection, 2 -bacterial infection, 3 -coinfection. Notes: The longitudinal axis of the picture above represents the days of stay in hospital. The central box represents the value from the lower to the upper quartile (25%-75%). The middle line inside the box represents the median value. The lines extend from the minimum to the maximum values, excluding outliers that are displayed as separate points. An outlier is defined as a value that is smaller than the lower quartile minus 1.5 times the interquartile range, or larger than the upper quartile plus 1.5 times the interquartile range. These values are plotted with a \\uf09f marker. Abbreviation: lOs, length of stay.', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'statistical distribution (box plot) of CaT scores according to the four respiratory infectious phenotypes: 0 -non-infectious group, 1 -viral infection, 2bacterial infection, 3 -coinfection. Abbreviation: CaT, COPD assessment Test.', 'latex': None, 'type': 'figure'}, 'FIGREF5': {'text': \"Pearson's correlations between CaT and lOs. Note: solid line, CaT vs lOs: r=0.372, P,0.05. Abbreviations: lOs, length of stay; CaT, COPD assessment Test. International Journal of COPD 2015:10 submit your manuscript | www.dovepress.\", 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Baseline characteristics, clinical features at study entry, and outcomes in 81 patients with COPD exacerbation Notes: Data are presented as number (%) or mean ± sD. *(number of cigarettes per day × number of years of smoking)/20. Abbreviations: BMI, body mass index; gOlD, global initiative for chronic Obstructive lung Disease; lTOT, long-term oxygen therapy; lOs, length of stay; CaT, COPD assessment Test; FeV 1 , forced expiratory volume in 1 second; FVC, forced vital capacity.', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'The authors would like to sincerely thank Jing Li, You-Hui Tu, Wen Chen, Rui Xu, Xian-Wei Hu, and Yong-Huai Li for the assistance with recruitment and clinical assessment of participants. This work was funded by the Natural Science Foundation of China (NSFC grant 81270081).', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}, {'text': 'All authors participated in the conception and design of experiment. Meng-Yuan Dai carried out the experiment, drafted the manuscript, and performed the statistical analysis. Luminex multi-PCR and conventional sputum culture were carried out by Jin-Ping Qiao and Yuan-Hong Xu. The manuscript was revised coordination and critically by Guang-He Fei. All authors contributed toward data analysis, drafting and revising the paper and agree to be accountable for all aspects of the work. All authors read and approved the final manuscript.', 'cite_spans': [], 'ref_spans': [], 'section': 'Author contributions'}]}\n",
      "{'_id': ObjectId('5ea715f032251793b1739a81'), 'paper_id': '0adc2dfd5f26656ce3527dbb5dec379d44d0601e', 'metadata': {'title': 'Open Forum Infectious Diseases Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy', 'authors': [{'first': 'Marisa', 'middle': ['H'], 'last': 'Miceli', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Michigan Health System', 'location': {'country': 'Ann Arbor'}}, 'email': 'mmiceli@med.umich.edu.'}, {'first': 'Kathleen', 'middle': ['A'], 'last': 'Linder', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Michigan Health System', 'location': {'country': 'Ann Arbor'}}, 'email': ''}, {'first': 'Philip', 'middle': ['J'], 'last': 'Mcdonald', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Wayne State University School of Medicine', 'location': {'settlement': 'Detroit', 'region': 'Michigan'}}, 'email': ''}, {'first': 'Carol', 'middle': ['A'], 'last': 'Kauffman', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Michigan Health System', 'location': {'country': 'Ann Arbor'}}, 'email': ''}, {'first': 'Sanjay', 'middle': ['G'], 'last': 'Revankar', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Wayne State University School of Medicine', 'location': {'settlement': 'Detroit', 'region': 'Michigan'}}, 'email': ''}, {'first': 'Pranatharthi', 'middle': ['H'], 'last': 'Chandrasekar', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Wayne State University School of Medicine', 'location': {'settlement': 'Detroit', 'region': 'Michigan'}}, 'email': ''}]}, 'abstract': [{'text': 'Background. Umbilical cord blood transplant (UCBT) is used for patients who do not have a matched donor, but engraftment often takes longer than with a standard allogeneic transplant, likely increasing the risk for infection. We characterized specific infections and outcomes in adults undergoing UCBT at our 2 centers.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'Methods. All adults who underwent UCBT between January 1, 2006 and December 31, 2015 were included. Infectious episodes from 6 months before to 2 years after UCBT were reviewed.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'Results. Fifty-seven patients underwent UCBT; 47 had neutrophil engraftment. A total of 179 infectious episodes occurred in 55 patients, 73 (41%) within 30 days post-UCBT. Viruses caused 85 (47%) infections. Cytomegalovirus caused 32 infectious episodes and was most common from day 30 to 100. Human herpesvirus 6 occurred in 28 episodes, was most common within 30 days, and caused 1 death. Bacteria were responsible for 82 (46%) infections, most commonly bacteremias due to Staphylococcus spp, Enterococcus spp, and Enterobacteriaceae. Of 11 invasive fungal infections, 9 were aspergillosis, 4 of which were fatal. Overall mortality was 56% in the first year. Thirteen deaths were from infection; 11 occurred in the first 100 days and 7 in the first 30 days post-UCBT. Of 10 patients who never engrafted, 9 died, 6 from infection, within 100 days post-UCBT.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'Conclusions. Infectious complications were common after UCBT, especially in the first 30 days. Deaths from viral infections were fewer than expected. Delayed engraftment and nonengraftment continue to convey increased risk for fatal bacterial and fungal infections post-UCBT.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Umbilical cord blood (UCB) cells are a suitable source of stem cells for patients who require hematopoietic cell transplantation (HCT) and who do not have a matched donor [1] . The use of UCB cells has been mostly studied in children with hematological malignancies, but it has extended to the adult population because of the paucity of related or matched donors [1, 2] . Advantages to using UCB cells for HCT include the ability to use human leukocyte antigen (HLA)-mismatched cells without significant adverse effects on graft function and the decreased incidence of graft-versus-host disease (GVHD) after transplantation [1, 3] . However, both the decreased quantity of cells available for transplantation and the immunological immaturity of UCB cells have been linked to delayed engraftment after UCB transplant (UCBT) [3, 4] .', 'cite_spans': [{'start': 171, 'end': 174, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 363, 'end': 366, 'text': '[1,', 'ref_id': 'BIBREF0'}, {'start': 367, 'end': 369, 'text': '2]', 'ref_id': 'BIBREF1'}, {'start': 624, 'end': 627, 'text': '[1,', 'ref_id': 'BIBREF0'}, {'start': 628, 'end': 630, 'text': '3]', 'ref_id': 'BIBREF2'}, {'start': 823, 'end': 826, 'text': '[3,', 'ref_id': 'BIBREF2'}, {'start': 827, 'end': 829, 'text': '4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': ''}, {'text': 'Prolonged neutropenia is a well recognized risk factor for severe infections [5] . Patients receiving UCBT appear to be at increased risk compared with allogeneic HCT recipients, perhaps due to delayed engraftment [6] [7] [8] . Infection is estimated to cause 35%-50% of nonrelapse mortality in patients after UCBT, compared with 8%-22% after allogeneic HCT [2, 5, 6, [9] [10] [11] [12] . Viral infections, especially cytomegalovirus (CMV), and human herpesvirus 6 (HHV- 6) , have been associated with increased morbidity and mortality post-UCBT [6, 13] . We sought to characterize the infectious complications and outcomes of patients who received a UCBT in our institutions over a 10-year period.', 'cite_spans': [{'start': 77, 'end': 80, 'text': '[5]', 'ref_id': 'BIBREF4'}, {'start': 214, 'end': 217, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 218, 'end': 221, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 222, 'end': 225, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 358, 'end': 361, 'text': '[2,', 'ref_id': 'BIBREF1'}, {'start': 362, 'end': 364, 'text': '5,', 'ref_id': 'BIBREF4'}, {'start': 365, 'end': 367, 'text': '6,', 'ref_id': 'BIBREF5'}, {'start': 368, 'end': 371, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 372, 'end': 376, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 377, 'end': 381, 'text': '[11]', 'ref_id': 'BIBREF10'}, {'start': 382, 'end': 386, 'text': '[12]', 'ref_id': 'BIBREF11'}, {'start': 546, 'end': 549, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 550, 'end': 553, 'text': '13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': ''}, {'text': 'This retrospective study was conducted at the University of Michigan Health System (Ann Arbor, MI) and Karmanos Cancer Center (Detroit, MI). Approval was granted by the institutional review board at each center.', 'cite_spans': [], 'ref_spans': [], 'section': 'METHODS'}, {'text': 'All adult patients ≥18 years of age who underwent UCBT at the 2 study centers between January 1, 2006 and December 31, 2015 were included in this study. Medical records were reviewed to identify infectious complications from 6 months before UCBT and for 2 years after transplantation; demographic information, underlying hematologic diseases, conditioning regimens, prophylaxis, time to engraftment, episodes of infection, their treatment, and outcomes were collected. Patients who experienced relapse of underlying malignancy after UCBT were excluded from further analysis from the date relapse was documented. Study data were collected and managed using REDCap electronic data capture tools.', 'cite_spans': [], 'ref_spans': [], 'section': 'METHODS'}, {'text': 'Infectious episodes were defined as episodes of fever or hemodynamic instability for which antimicrobial therapy was initiated and which were separated by at least 48 hours from previous episodes. Day of episode was counted as the first day of antimicrobial administration. The timing of neutrophil engraftment after UCBT was defined as the first of 3 consecutive days when the absolute neutrophil count was >500/μL. Graft-versushost disease, veno-occlusive disease, and other complications related to the transplant, including infection, were defined in accordance with NCCN Guidelines [14] . Conditioning regimens were classified as either myeloablative or reduced-intensity using criteria proposed by Bacigalupo et al [15] . National Institute of Allergy and Infectious Diseases Mycoses Study Group criteria were used for the definition of invasive fungal infections [16] . Cytomegalovirus infection and end-organ disease were defined by current consensus definitions [17] . Routine screening for CMV viremia was not performed; molecular testing for CMV, HHV-6, and Epstein-Barr virus was performed with febrile episodes.', 'cite_spans': [{'start': 587, 'end': 591, 'text': '[14]', 'ref_id': 'BIBREF13'}, {'start': 721, 'end': 725, 'text': '[15]', 'ref_id': 'BIBREF14'}, {'start': 870, 'end': 874, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 971, 'end': 975, 'text': '[17]', 'ref_id': 'BIBREF16'}], 'ref_spans': [], 'section': 'METHODS'}, {'text': 'Patients received antibacterial prophylaxis, typically with a fluoroquinolone, starting on the day of transplant and continuing until engraftment; antibacterial prophylaxis was restarted with subsequent neutropenia or GVHD. Antifungal prophylaxis was initiated by day 5 posttransplant and was continued through engraftment. Viral prophylaxis with acyclovir was started on the day of transplant and continued for at least 1 year; routine prophylaxis for CMV was not given. Pneumocystis prophylaxis with either pentamidine or trimethoprim/sulfamethoxazole was started at day 30, provided neutrophil engraftment had occurred.', 'cite_spans': [], 'ref_spans': [], 'section': 'METHODS'}, {'text': \"We conducted descriptive data analyses for all variables. Student's t test, Fisher's exact test, and one-way analysis of variance were used to determine differences between groups. All statistical analyses were completed using SPSS software, version 24.0 (SPSS, Inc., Chicago, IL).\", 'cite_spans': [], 'ref_spans': [], 'section': 'METHODS'}, {'text': 'There were 57 adult patients who underwent UCBT from January 2006 through December 2015. The mean age was 43 ± 13.6 years; 34 (60%) were women. Thirty-nine (68%) patients received a UCBT for myelodysplastic syndrome or acute myeloid leukemia, 12 for a lymphoid malignancy and 6 for another hematological malignancy (Table 1) .', 'cite_spans': [], 'ref_spans': [{'start': 315, 'end': 324, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Pretransplant Patient Characteristics'}, {'text': 'Ten patients had a prior autologous HCT, and 1 patient had a prior UCBT at a different institution. Twenty-three (40%) patients had an infection in the preceding 6 months before UCBT (Table 1) . Bacteremia and Clostridium difficile infection were the most common documented infections before UCBT. Twenty-seven (47%) patients had at least 1 episode of febrile neutropenia in the 6 months before transplant. Thirty-eight (67%) patients were CMV antibody positive before transplant.', 'cite_spans': [], 'ref_spans': [{'start': 183, 'end': 192, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Pretransplant Patient Characteristics'}, {'text': 'Conditioning was myeloablative in 31 (54%) patients and reduced-intensity in 26 (46%) ( Table 1) . A double-unit UCBT was received by 35 (61%) patients, and a single-unit UCBT was received by 21 (37%) patients. For 1 patient, the number of units received was not recorded. The median UCB cell volume infused was 4.2 × 10 7 cells (range, 1.4 × 10 7 -35.7 × 10 7 cells), with a median of 5.5 × 10 5 nucleated cells per kilogram body weight. Forty-eight (84%) patients had >1 HLA mismatch.', 'cite_spans': [], 'ref_spans': [{'start': 88, 'end': 96, 'text': 'Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Pretransplant Patient Characteristics'}, {'text': 'Fifty-six patients were on antibacterial prophylaxis at the time of and after UCBT; for 45, this consisted of a fluoroquinolone ( Table 2 ). Ten patients received a β-lactam and 1 received clindamycin. Three of the 10 patients on a β-lactam were given secondary prophylaxis for infection that occurred before transplantation. All patients received antiviral prophylaxis with acyclovir, 400 mg twice daily. Antifungal prophylaxis consisted of an azole or an echinocandin ( Table 2) . Forty-seven patients (82%) received Pneumocystis prophylaxis after engraftment; the remaining 10 patients did not have neutrophil engraftment. All patients received GVHD prophylaxis, with tacrolimus/ mycophenolate mofetil (n = 52), cyclosporine/mycophenolate mofetil (n = 3), tacrolimus alone (n = 1), or sirolimus/mycophenolate mofetil (n = 1).', 'cite_spans': [], 'ref_spans': [{'start': 130, 'end': 137, 'text': 'Table 2', 'ref_id': 'TABREF1'}, {'start': 472, 'end': 480, 'text': 'Table 2)', 'ref_id': 'TABREF1'}], 'section': 'Posttransplant Patient Characteristics'}, {'text': 'All patients developed profound neutropenia and thrombocytopenia post-UCBT. Forty-seven (82%) patients had neutrophil engraftment at a mean of 20.8 ± 7.0 days. Of the 10 patients who never achieved engraftment, 9 died within 100 days of UCBT, and 1 was lost to follow up at day 60. Platelet engraftment occurred in 40 patients with a mean time of 47.9 ± 34.2 days. Time to engraftment did not differ between patients who received a single versus a double UCBT.', 'cite_spans': [], 'ref_spans': [], 'section': 'Posttransplant Patient Characteristics'}, {'text': 'Graft-versus-host disease occurred in 35 (61%) patients. Twenty-seven had acute GVHD (14 with skin involvement and 18 with gastrointestinal involvement) and 3 had chronic GVHD (1 with skin involvement and 2 with gastrointestinal involvement); 5 additional patients had acute followed by chronic GVHD. Mean time to development of acute GVHD was 40 ± 27 days and for chronic GVHD was 218 ± 79 days.', 'cite_spans': [], 'ref_spans': [], 'section': 'Posttransplant Patient Characteristics'}, {'text': 'A total of 179 episodes of infection were reported in 55 patients; the median number of episodes per patient was 3 (range, 0-11). The greatest number of infections occurred within 30 days post-UCBT (73 episodes in 50 patients). Among these early infections, 57 (78%) occurred before neutrophil engraftment. Although fewer in number, infections continued to occur throughout the 2-year follow-up period post-UCBT; there were 51 episodes between days 30 and 100 and 55 episodes after day 100. Viral infections were most common, followed by bacterial and fungal infections. There were no episodes of infection with protozoal or helminthic pathogens. Several different infections were present concurrently in 64 (36%) of infectious episodes, irrespective of the time posttransplant. The mean number of infectious episodes per patient ranged between 2 and 3.8 per year over the 10-year period of the study.', 'cite_spans': [], 'ref_spans': [], 'section': 'Infectious Episodes'}, {'text': 'Eighty-five episodes of viral infection were identified in 39 patients (Table 3) . Cytomegalovirus and HHV-6 were the most common viral infections, but their onset varied post-UCBT.', 'cite_spans': [], 'ref_spans': [{'start': 71, 'end': 80, 'text': '(Table 3)', 'ref_id': 'TABREF3'}], 'section': 'Viral Infections.'}, {'text': 'Cytomegalovirus infection was uncommon early after transplant, but it was the most common pathogen found from days 31 to 100 post-UCBT. Of the total of 32 episodes of CMV noted in 22 patients over all time periods, 24 were characterized by viremia alone, and 8 involved end-organ disease, which included colitis in 3, pneumonia in 4, and both in 1. Antiviral treatment with either foscarnet or ganciclovir was administered in 31 of the 32 episodes (97%). In 21 episodes, CMV infection occurred concurrently with other infections; most commonly, the coinfection was with vancomycin-resistant Enterococcus (VRE), which occurred in 5 episodes. All 22 patients who developed CMV infection had antibodies to CMV before UCBT. The remaining 16 seropositive patients, including 2 who had received antithymocyte globulin (ATG), did not develop CMV infection.', 'cite_spans': [], 'ref_spans': [], 'section': 'Viral Infections.'}, {'text': 'Human to engraftment did not differ significantly between patients with HHV-6 viremia and those without HHV-6 viremia.', 'cite_spans': [], 'ref_spans': [], 'section': 'Viral Infections.'}, {'text': 'Other viral infections were seen less commonly than CMV and HHV-6. BK virus infection was noted in 18 episodes and was characterized by viruria in all 18 and hemorrhagic cystitis in 10. All 57 patients were on acyclovir prophylaxis for HSV, but 8 infectious episodes involved HSV reactivation, 2 of which were severe; 1 patient had meningoencephalitis, and the other had widespread dissemination with a virus that became increasingly resistant to acyclovir and foscarnet. Most other viral infections involved the respiratory tract, most occurred >100 days post-UCBT, and only 1, a coronavirus infection, was severe.', 'cite_spans': [], 'ref_spans': [], 'section': 'Viral Infections.'}, {'text': 'A total of 82 episodes of bacterial infection were reported in 41 patients ( Table 4 ). The most common bacterial infection after UCBT was bloodstream infection (BSI), occurring in 41 episodes in 29 patients. Central line-associated BSIs (CLABSI) accounted for 22 (54%) BSIs. The predominant organism was coagulase-negative Staphylococcus, accounting for 21 episodes, 17 of which were CLABSI. Vancomycin-resistant Enterococcus was the pathogen in 10 BSI episodes, 4 of which were CLABSI, and Gram-negative bacilli accounted for another 7 BSI episodes, including 5 CLABSI. Polymicrobial bacteremia was noted on 8 occasions.', 'cite_spans': [], 'ref_spans': [{'start': 77, 'end': 84, 'text': 'Table 4', 'ref_id': 'TABREF2'}], 'section': 'Bacterial Infections.'}, {'text': 'Clostridium difficile infection accounted for 21 (26%) episodes in 16 patients. There was a trend for VRE infections and C difficile infections to occur more often in the first 30 days posttransplant, but time to occurrence was not significantly different for any bacterial pathogen. Other bacterial infections are noted in Table 4 .', 'cite_spans': [], 'ref_spans': [{'start': 324, 'end': 331, 'text': 'Table 4', 'ref_id': 'TABREF2'}], 'section': 'Bacterial Infections.'}, {'text': 'Three patients had mycobacterial infection. One patient, an immigrant from Malaysia, developed fulminant pulmonary tuberculosis 83 days after UCBT and died several weeks later. Two patients had pneumonia due to nontuberculous mycobacteria; 1 patient, whose course was complicated by bronchiolitis obliterans syndrome, developed pulmonary infection with Mycobacterium avium 1.5 years after UCBT and then pulmonary infection with Mycobacterium abscessus 6 months later. Another patient developed pneumonia 32 days after UCBT, and bronchoalveolar lavage cultures yielded Mycobacterium chelonae after her death.', 'cite_spans': [], 'ref_spans': [], 'section': 'Bacterial Infections.'}, {'text': 'Eleven episodes of invasive fungal infections were recorded in 10 patients after UCBT. Invasive aspergillosis was noted in 9 patients. One other patient had 2 episodes of Candida glabrata fungemia. The median time from UCBT to the diagnosis of aspergillosis was 16 days (range, 4-102 days), and the 2 episodes of candidemia occurred on day 38 and day 140 after UCBT. Aspergillosis was defined as proven in 3, probable in 2, and possible in 4; 8 patients had pulmonary infection, 1 with spread to the central nervous system, and 1 had isolated central nervous system infection. Of the 9 patients who developed invasive aspergillosis, 4 had received fluconazole for antifungal prophylaxis, 2 had received micafungin, 2 initially had received voriconazole but had been switched to micafungin before development of infection, and only 1 had received voriconazole throughout the post-UCBT period.', 'cite_spans': [], 'ref_spans': [], 'section': 'Fungal Infections.'}, {'text': 'Of the 23 patients who had infections before UCBT, only 4 had documented recurrence of that same infection in the first 30 days post-UCBT. One patient had recurrence of C difficile infection, and another had recurrent VRE urinary tract infection. Two patients had recurrent BSI, with VRE and Escherichia coli in one and Streptococcus spp in the other. One additional patient was treated for possible invasive aspergillosis in the setting of pneumonia 3 months before UCBT, and a computed tomography scan demonstrated full resolution of airspace opacities before transplant; she later developed probable invasive aspergillosis on day 18 after UCBT while on micafungin prophylaxis.', 'cite_spans': [], 'ref_spans': [], 'section': 'Recurrent Infections.'}, {'text': 'Overall mortality in the first year post-UCBT was 56% (32 patients); 3 additional patients died in year 2. Thirteen of the 35 (37%) deaths were attributed to infection (Table 5) . Malignancy relapse occurred in 18 patients, and death from relapse occurred in 14, including the 3 patients who died in year 2. Other causes of death were complications of severe/ refractory GVHD in 5, sinusoidal obstruction syndrome in 1, graft failure in 1, and hemophagocytic lymphohistiocytosis in 1. The median time from UCBT to death from infection was 49 days (range, , and the median time to death from malignancy relapse was 223 days (range, 21-468) (P = .002). Among the 10 patients who never achieved neutrophil engraftment, 9 died within 100 days of UCBT, 6 of those from infection between days 18 and 52 post-UCBT. Seven of the 13 infections that led to death occurred in the first 30 days post-UCBT, and 4 patients who died developed infection between days 30 and 100 post-UCBT. Patients who died <100 days after UCBT (n = 17) had more early infections due to invasive fungi (P = .04), VRE (P = .03), and Enterobacteriaceae (P = .03) compared with those who survived more than 100 days after transplant (n = 40).', 'cite_spans': [], 'ref_spans': [{'start': 168, 'end': 177, 'text': '(Table 5)', 'ref_id': 'TABREF4'}], 'section': 'Outcomes'}, {'text': 'Even though CMV and HHV-6 were the most common infections post-UCBT, only 1 death, in the patient with HHV-6 limbic encephalitis, was attributed to these viruses.', 'cite_spans': [], 'ref_spans': [], 'section': 'Outcomes'}, {'text': 'In the current study, we describe the burden of infectious complications in adult patients after UCBT. Prior studies have demonstrated the high infection risk in children after this procedure, but there are contradictory studies regarding the risk of infection in adult patients after UCBT [5, 6, 18] . Viral infections have been associated with excess morbidity and mortality after UCBT [6, 13, 19] . Cytomegalovirus reactivation has been of particular concern. Positive CMV serostatus of the recipient and use of ATG or monoclonal T-cell antibodies during conditioning are known risk factors for CMV reactivation and increased mortality after UCBT [6, [20] [21] [22] . Previous studies of infection after UCBT found rates of CMV reactivation from 21% to 64% and noted that these rates were higher than those noted after allogeneic HCT [13, 18, [22] [23] [24] . The use of ATG at conditioning in UCBT recipients has previously been associated with increased risk of CMV reactivation [13] . In our study, CMV reactivation was not associated with ATG use, but only 3 patients had received this agent. Cytomegalovirus infection did not contribute to the death of any patient in our cohort.', 'cite_spans': [{'start': 290, 'end': 293, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 294, 'end': 296, 'text': '6,', 'ref_id': 'BIBREF5'}, {'start': 297, 'end': 300, 'text': '18]', 'ref_id': 'BIBREF17'}, {'start': 388, 'end': 391, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 392, 'end': 395, 'text': '13,', 'ref_id': 'BIBREF12'}, {'start': 396, 'end': 399, 'text': '19]', 'ref_id': 'BIBREF18'}, {'start': 650, 'end': 653, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 654, 'end': 658, 'text': '[20]', 'ref_id': 'BIBREF19'}, {'start': 659, 'end': 663, 'text': '[21]', 'ref_id': 'BIBREF20'}, {'start': 664, 'end': 668, 'text': '[22]', 'ref_id': 'BIBREF21'}, {'start': 837, 'end': 841, 'text': '[13,', 'ref_id': 'BIBREF12'}, {'start': 842, 'end': 845, 'text': '18,', 'ref_id': 'BIBREF17'}, {'start': 846, 'end': 850, 'text': '[22]', 'ref_id': 'BIBREF21'}, {'start': 851, 'end': 855, 'text': '[23]', 'ref_id': 'BIBREF22'}, {'start': 856, 'end': 860, 'text': '[24]', 'ref_id': 'BIBREF23'}, {'start': 984, 'end': 988, 'text': '[13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In our cohort, HHV-6 was the second most frequent pathogen observed, consistent with prior reports [6, 13] . Most often, HHV-6 presented as viremia without end-organ disease and occurred early after UCBT. The clinical significance of asymptomatic HHV-6 viremia remains controversial; however, HHV-6 reactivation has been independently associated with graft failure after UCBT [25] . We did not find a significant relationship between HHV-6 and graft failure in our patients. With the onset of viremia, patients were treated with foscarnet, and this may have blocked the development of end-organ disease due to HHV-6. Human herpesvirus 6 was responsible for the death of 1 patient, who developed limbic encephalitis more than 100 days after UCBT; this patient had been previously treated with foscarnet for 2 episodes of HHV-6 viremia, 1 of which was accompanied by pneumonitis. Receipt of an UCBT has been described previously as a risk factor for the development of limbic encephalitis; this condition is associated with high plasma HHV-6 viral loads, which were observed in this patient [26] .', 'cite_spans': [{'start': 99, 'end': 102, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 103, 'end': 106, 'text': '13]', 'ref_id': 'BIBREF12'}, {'start': 376, 'end': 380, 'text': '[25]', 'ref_id': 'BIBREF24'}, {'start': 1089, 'end': 1093, 'text': '[26]', 'ref_id': 'BIBREF25'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"Universal prophylaxis for HSV is a common practice after UCBT, and all 57 patients in our study were on standard-dose acyclovir. Despite appropriate antiviral prophylaxis, we observed 8 episodes of HSV reactivation, 2 of which were severe and led to the patient's death. Acyclovir resistance was confirmed in 1 patient who died of disseminated HSV-1 infection. Acyclovir resistance appears to be more common after HCT, particularly in the setting of T-cell depletion, and may be related to prolonged use of acyclovir for prophylaxis [27, 28] . None of our patients were on high-dose acyclovir, which is used at some centers for antiviral prophylaxis after HCT; this raises the question of whether this prophylaxis strategy might have prevented these fatal herpesvirus infections [29] .\", 'cite_spans': [{'start': 533, 'end': 537, 'text': '[27,', 'ref_id': 'BIBREF26'}, {'start': 538, 'end': 541, 'text': '28]', 'ref_id': 'BIBREF27'}, {'start': 779, 'end': 783, 'text': '[29]', 'ref_id': 'BIBREF28'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Increased emphasis on screening for reactivation of CMV and HHV-6 whenever fever occurred and prompt treatment is likely responsible for decreased mortality from viral pathogens, but deaths due to bacterial and fungal pathogens remained high after UCBT. Six of the 13 infectious deaths in our patient population were due to bacteremias or invasive aspergillosis that occurred in the first 30 days after transplantation.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Not surprisingly, bacterial infections were common throughout all time periods, and many were likely related to the presence of indwelling catheters. Infections with Enterobacteriaceae and VRE within the first 30 days after UCBT were associated with increased mortality. The prolonged time to neutrophil engraftment after UCBT increases the period at which recipients are at high risk of life-threatening bacterial infections. Although antibacterial prophylaxis is standard of care after HCT, increasing antimicrobial resistance limits the efficacy of several existing oral prophylactic regimens [30] . In some centers, VRE has become the most common cause of bacteremia in allogeneic HCT recipients and also has emerged as a problem among UCBT recipients in some centers [13, [30] [31] [32] [33] [34] .', 'cite_spans': [{'start': 596, 'end': 600, 'text': '[30]', 'ref_id': 'BIBREF29'}, {'start': 772, 'end': 776, 'text': '[13,', 'ref_id': 'BIBREF12'}, {'start': 777, 'end': 781, 'text': '[30]', 'ref_id': 'BIBREF29'}, {'start': 782, 'end': 786, 'text': '[31]', 'ref_id': 'BIBREF30'}, {'start': 787, 'end': 791, 'text': '[32]', 'ref_id': 'BIBREF31'}, {'start': 792, 'end': 796, 'text': '[33]', 'ref_id': 'BIBREF32'}, {'start': 797, 'end': 801, 'text': '[34]', 'ref_id': 'BIBREF33'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Infections with mycobacteria are uncommon among HCT recipients. The reported frequency of nontuberculous mycobacterial infections is 0.4%-4.9% in several reports, and most cases have been related to infection of central venous catheters [35] . Structural lung changes, such as bronchiectasis associated with bronchiolitis obliterans syndrome, likely predispose patients to infection with nontuberculous mycobacteria late after transplant, as was the case in one of our patients [35] . Pulmonary tuberculosis is less common after HCT with estimated rates between 0.1% and 0.5%, although one report from Japan noted an incidence of 2.5% among UCBT recipients [36, 37] .', 'cite_spans': [{'start': 237, 'end': 241, 'text': '[35]', 'ref_id': 'BIBREF34'}, {'start': 478, 'end': 482, 'text': '[35]', 'ref_id': 'BIBREF34'}, {'start': 657, 'end': 661, 'text': '[36,', 'ref_id': 'BIBREF35'}, {'start': 662, 'end': 665, 'text': '37]', 'ref_id': 'BIBREF36'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Invasive mold infections were a major cause of death in our cohort, but invasive Candida infections were rare; only 1 patient had 2 episodes of candidemia. The widespread use of azoles for prophylaxis for allogeneic HCT recipients likely has changed the epidemiology of invasive fungal infections in this population [19, 38] . The 4 patients in our cohort who died of invasive aspergillosis did so before neutrophil engraftment, and none were receiving prophylaxis with a mold-active azole. This high burden of disease early after UCBT underscores the need for aggressive surveillance for fungal infections and the need for mold-active azole prophylaxis.', 'cite_spans': [{'start': 316, 'end': 320, 'text': '[19,', 'ref_id': 'BIBREF18'}, {'start': 321, 'end': 324, 'text': '38]', 'ref_id': 'BIBREF37'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Despite prior pediatric studies that have demonstrated decreased risk of GVHD after UCBT, we saw a high rate of GVHD in our cohort (61%), and 5 patients died from sequelae of severe/refractory GVHD [3] . We observed a higher rate of acute GVHD than chronic GVHD in this population, as has been previously described [39] . It is possible that higher rates of acute GVHD after UCBT are associated with greater HLA mismatch; however, the exact mechanisms remain unclear [39, 40] .', 'cite_spans': [{'start': 198, 'end': 201, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 315, 'end': 319, 'text': '[39]', 'ref_id': 'BIBREF38'}, {'start': 467, 'end': 471, 'text': '[39,', 'ref_id': 'BIBREF38'}, {'start': 472, 'end': 475, 'text': '40]', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The limitations of our study include its retrospective nature and the relatively small sample size. In addition, over the 10-year time span of our study, changes in practice, particularly regarding prophylaxis and infection monitoring protocols, likely impacted the risk for and outcomes of infection.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In summary, the implementation of the strategy to screen for infection with CMV and HHV-6 with the onset of fever and to treat promptly has evolved over time, changing the landscape of infectious complications after UCBT. Cytomegalovirus and HHV-6 were common after UCBT, but they were not associated with increased mortality. Delayed neutrophil engraftment increases the risk for bacterial and fungal infections early after UCBT and is associated with increased mortality. Multiple concurrent infections were present in more than one third of episodes, and diagnosis of one infection should not prohibit further testing for other possible infections.', 'cite_spans': [], 'ref_spans': [], 'section': 'CONCLUSIONS'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Adult umbilical cord blood transplantation: a comprehensive review', 'authors': [{'first': 'H', 'middle': [], 'last': 'Schoemans', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Theunissen', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Maertens', 'suffix': ''}], 'year': 2006, 'venue': 'Bone Marrow Transplant', 'volume': '38', 'issn': '', 'pages': '83--93', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Laughlin', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Eapen', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Rubinstein', 'suffix': ''}], 'year': 2004, 'venue': 'N Engl J Med', 'volume': '351', 'issn': '', 'pages': '2265--75', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients', 'authors': [{'first': 'W', 'middle': ['Y'], 'last': 'Hwang', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Samuel', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Tan', 'suffix': ''}], 'year': 2007, 'venue': 'Biol Blood Marrow Transplant', 'volume': '13', 'issn': '', 'pages': '444--53', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The kinetics of immune reconstitution after cord blood transplantation and selected CD34+ stem cell transplantation in children: comparison with bone marrow transplantation', 'authors': [{'first': 'H', 'middle': [], 'last': 'Inoue', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Yasuda', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Hattori', 'suffix': ''}], 'year': 2003, 'venue': 'Int J Hematol', 'volume': '77', 'issn': '', 'pages': '399--407', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation', 'authors': [{'first': 'R', 'middle': [], 'last': 'Parody', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martino', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Rovira', 'suffix': ''}], 'year': 2006, 'venue': 'Biol Blood Marrow Transplant', 'volume': '12', 'issn': '', 'pages': '734--782', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Infectious complications following unrelated cord blood transplantation', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Van Burik', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Brunstein', 'suffix': ''}], 'year': 2007, 'venue': 'Vox Sang', 'volume': '92', 'issn': '', 'pages': '289--96', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation', 'authors': [{'first': 'S', 'middle': [], 'last': 'Servais', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Lengline', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Porcher', 'suffix': ''}], 'year': 2014, 'venue': 'Biol Blood Marrow Transplant', 'volume': '20', 'issn': '', 'pages': '507--524', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience', 'authors': [{'first': 'P', 'middle': [], 'last': 'Giraud', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Thuret', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Reviron', 'suffix': ''}], 'year': 2000, 'venue': 'Bone Marrow Transplant', 'volume': '25', 'issn': '', 'pages': '53--60', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases', 'authors': [{'first': 'S', 'middle': [], 'last': 'Miyakoshi', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Kusumi', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Matsumura', 'suffix': ''}], 'year': 2007, 'venue': 'Biol Blood Marrow Transplant', 'volume': '13', 'issn': '', 'pages': '771--778', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time', 'authors': [{'first': 'A', 'middle': [], 'last': 'Gratwohl', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Brand', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Frassoni', 'suffix': ''}], 'year': 2005, 'venue': 'Bone Marrow Transplant', 'volume': '36', 'issn': '', 'pages': '757--69', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution', 'authors': [{'first': 'R', 'middle': [], 'last': 'Martino', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kerguelen', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Valcárcel', 'suffix': ''}], 'year': 2011, 'venue': 'Bone Marrow Transplant', 'volume': '46', 'issn': '', 'pages': '690--701', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Tanaka', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Kurosawa', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Tajima', 'suffix': ''}], 'year': 2016, 'venue': 'Bone Marrow Transplant', 'volume': '51', 'issn': '', 'pages': '553--562', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin', 'authors': [{'first': 'C', 'middle': [], 'last': 'Sauter', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Abboud', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Jia', 'suffix': ''}], 'year': 2011, 'venue': 'Biol Blood Marrow Transplant', 'volume': '17', 'issn': '', 'pages': '1460--71', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology', 'authors': [{'first': 'L', 'middle': ['R'], 'last': 'Baden', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Swaminathan', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Angarone', 'suffix': ''}], 'year': 2016, 'venue': 'J Natl Compr Canc Netw', 'volume': '14', 'issn': '', 'pages': '882--913', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Defining the intensity of conditioning regimens: working definitions', 'authors': [{'first': 'A', 'middle': [], 'last': 'Bacigalupo', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Ballen', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Rizzo', 'suffix': ''}], 'year': 2009, 'venue': 'Biol Blood Marrow Transplant', 'volume': '15', 'issn': '', 'pages': '1628--1661', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group', 'authors': [{'first': 'B', 'middle': [], 'last': 'De Pauw', 'suffix': ''}, {'first': 'T', 'middle': ['J'], 'last': 'Walsh', 'suffix': ''}, {'first': 'J', 'middle': ['P'], 'last': 'Donnelly', 'suffix': ''}], 'year': 2008, 'venue': 'Clin Infect Dis', 'volume': '46', 'issn': '', 'pages': '1813--1834', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials', 'authors': [{'first': 'P', 'middle': [], 'last': 'Ljungman', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Boeckh', 'suffix': ''}, {'first': 'H', 'middle': ['H'], 'last': 'Hirsch', 'suffix': ''}], 'year': 2017, 'venue': 'Clin Infect Dis', 'volume': '64', 'issn': '', 'pages': '87--91', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies', 'authors': [{'first': 'X', 'middle': [], 'last': 'Cahu', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Rialland', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Touzeau', 'suffix': ''}], 'year': 2009, 'venue': 'Biol Blood Marrow Transplant', 'volume': '15', 'issn': '', 'pages': '1531--1538', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH)', 'authors': [{'first': 'R', 'middle': [], 'last': 'Martino', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Bautista', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Parody', 'suffix': ''}], 'year': 2015, 'venue': 'Transpl Infect Dis', 'volume': '17', 'issn': '', 'pages': '221--254', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Eurocord transplant group and the European blood and marrow transplantation group', 'authors': [{'first': 'E', 'middle': [], 'last': 'Gluckman', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Rocha', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Boyer-Chammard', 'suffix': ''}], 'year': 1997, 'venue': 'N Engl J Med', 'volume': '337', 'issn': '', 'pages': '373--81', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Wagner', 'suffix': ''}, {'first': 'J', 'middle': ['N'], 'last': 'Barker', 'suffix': ''}, {'first': 'T', 'middle': ['E'], 'last': 'Defor', 'suffix': ''}], 'year': 2002, 'venue': 'Blood', 'volume': '100', 'issn': '', 'pages': '1611--1619', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Walker', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Van Burik', 'suffix': ''}, {'first': 'De', 'middle': [], 'last': 'For', 'suffix': ''}, {'first': 'T', 'middle': ['E'], 'last': 'Weisdorf', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': '', 'suffix': ''}], 'year': 2007, 'venue': 'Biol Blood Marrow Transplant', 'volume': '13', 'issn': '', 'pages': '1106--1121', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus', 'authors': [{'first': 'M', 'middle': [], 'last': 'Mikulska', 'suffix': ''}, {'first': 'A', 'middle': ['M'], 'last': 'Raiola', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Bruzzi', 'suffix': ''}], 'year': 2012, 'venue': 'Biol Blood Marrow Transplant', 'volume': '18', 'issn': '', 'pages': '92--101', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation', 'authors': [{'first': 'J', 'middle': ['C'], 'last': 'Beck', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Wagner', 'suffix': ''}, {'first': 'T', 'middle': ['E'], 'last': 'Defor', 'suffix': ''}], 'year': 2010, 'venue': 'Biol Blood Marrow Transplant', 'volume': '16', 'issn': '', 'pages': '215--237', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults', 'authors': [{'first': 'Le', 'middle': [], 'last': 'Bourgeois', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Labopin', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Guillaume', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Exp Hematol', 'volume': '42', 'issn': '', 'pages': '945--54', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Hill', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Koo', 'suffix': ''}, {'first': 'Guzman', 'middle': [], 'last': 'Suarez', 'suffix': ''}, {'first': 'B', 'middle': ['B'], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Biol Blood Marrow Transplant', 'volume': '18', 'issn': '', 'pages': '1638--1686', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Association of the emergence of acyclovir-resistant herpes simplex virus type 1 with prognosis in hematopoietic stem cell transplantation patients', 'authors': [{'first': 'S', 'middle': [], 'last': 'Kakiuchi', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Tsuji', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Nishimura', 'suffix': ''}], 'year': 2017, 'venue': 'J Infect Dis', 'volume': '215', 'issn': '', 'pages': '865--73', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Akahoshi', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kanda', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Ohno', 'suffix': ''}], 'year': 2017, 'venue': 'J Infect Chemother', 'volume': '23', 'issn': '', 'pages': '485--492', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients', 'authors': [{'first': 'F', 'middle': [], 'last': 'Milano', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Pergam', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Xie', 'suffix': ''}], 'year': 2011, 'venue': 'Blood', 'volume': '118', 'issn': '', 'pages': '5689--96', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Satlin', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Soave', 'suffix': ''}, {'first': 'A', 'middle': ['C'], 'last': 'Racanelli', 'suffix': ''}], 'year': 2014, 'venue': 'Leuk Lymphoma', 'volume': '55', 'issn': '', 'pages': '2858--65', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients', 'authors': [{'first': 'M', 'middle': [], 'last': 'Kamboj', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Chung', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Seo', 'suffix': ''}], 'year': 2010, 'venue': 'Biol Blood Marrow Transplant', 'volume': '16', 'issn': '', 'pages': '1576--81', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Kang', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Vicente', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Parsad', 'suffix': ''}], 'year': 2013, 'venue': 'Transpl Infect Dis', 'volume': '15', 'issn': '', 'pages': '466--73', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation', 'authors': [{'first': 'J', 'middle': [], 'last': 'Vydra', 'suffix': ''}, {'first': 'R', 'middle': ['M'], 'last': 'Shanley', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'George', 'suffix': ''}], 'year': 2012, 'venue': 'Clin Infect Dis', 'volume': '55', 'issn': '', 'pages': '764--70', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Risk factors for vancomycin-resistant Enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation', 'authors': [{'first': 'M', 'middle': [], 'last': 'Tavadze', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Rybicki', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mossad', 'suffix': ''}], 'year': 2014, 'venue': 'Bone Marrow Transplant', 'volume': '49', 'issn': '', 'pages': '1310--1316', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients', 'authors': [{'first': 'J', 'middle': ['Y'], 'last': 'Kang', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Ha', 'suffix': ''}, {'first': 'H', 'middle': ['S'], 'last': 'Kang', 'suffix': ''}], 'year': 2015, 'venue': 'Int J Hematol', 'volume': '101', 'issn': '', 'pages': '505--518', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review', 'authors': [{'first': 'V', 'middle': [], 'last': 'Roy', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Weisdorf', 'suffix': ''}], 'year': 1997, 'venue': 'Bone Marrow Transplant', 'volume': '19', 'issn': '', 'pages': '467--70', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients', 'authors': [{'first': 'C', 'middle': [], 'last': 'Cordonnier', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martino', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Trabasso', 'suffix': ''}], 'year': 2004, 'venue': 'Clin Infect Dis', 'volume': '38', 'issn': '', 'pages': '1229--1265', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients', 'authors': [{'first': 'D', 'middle': ['P'], 'last': 'Kontoyiannis', 'suffix': ''}, {'first': 'K', 'middle': ['A'], 'last': 'Marr', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Park', 'suffix': ''}], 'year': 2001, 'venue': 'Clin Infect Dis', 'volume': '50', 'issn': '', 'pages': '1091--100', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Risk factors for acute and chronic graftversus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors', 'authors': [{'first': 'A', 'middle': [], 'last': 'Lazaryan', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Weisdorf', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Defor', 'suffix': ''}], 'year': 2016, 'venue': 'Biol Blood Marrow Transplant', 'volume': '22', 'issn': '', 'pages': '134--174', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors', 'authors': [{'first': 'M', 'middle': ['L'], 'last': 'Macmillan', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Weisdorf', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Brunstein', 'suffix': ''}], 'year': 2009, 'venue': 'Blood', 'volume': '113', 'issn': '', 'pages': '2410--2415', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'BMI, body mass index. a Follicular lymphoma (3), diffuse large B-cell lymphoma (3), marginal zone lymphoma (2), anaplastic large cell lymphoma (1), angioimmunoblastic T-cell lymphoma (1), Hodgkin lymphoma (2). b Many patients had more than 1 infection. c Enterococcus spp (3), Klebsiella pneumoniae (2), Escherichia coli (1), Staphylococcus aureus (3), Enterobacter cloacae (1), Micrococcus luteus (1), Streptococcus spp (2), Staphylococcus epidermidis (2). d Fludarabine/melphalan (1), etoposide (2), carmustine/etoposide/cytarabine/melphalan (1).', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'herpesvirus 6 was the most common infection noted within the first 30 days post-UCBT. Twenty-eight episodes of HHV-6 infection were identified in 21 patients; 18 occurred within the first 30 days post-UCBT, and 11 occurred before neutrophil engraftment. The manifestations of infection were viremia alone in 24 episodes, meningitis in 2, and pneumonia and posttransplant acute limbic encephalitis, each in 1 episode. Treatment was initiated in 25 episodes; treatment consisted of foscarnet in 21 episodes and ganciclovir in 4 episodes. Human herpesvirus 6 infection occurred concomitantly with another infection in 18 episodes; the most common coinfections were CMV viremia and BK viruria in 4 patients each. Among the 10 patients who did not engraft neutrophils, only 1 developed HHV-6 infection. Time', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'c Includes Acinetobacter baumanii (n = 3), Clostridium perfringens (n = 1), Micrococcus spp (n = 1), and Streptococcus spp (n = 3).', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Demographics, Underlying Conditions, and Pretransplant Conditioning Regimens of 57 Patients Who Received an Umbilical Cord Blood Transplant', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Antimicrobial Prophylaxis Regimens in 57 Patients Who Received an Umbilical Cord Blood Transplant', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'Eighty-Two Bacterial Infectious Episodes, Grouped by Date of Onset, That Occurred in 41 Patients Who Received an Umbilical Cord Blood TransplantIncludes Escherichia coli, Klebsiella spp, Citrobacter spp, Enterobacter spp, and Proteus spp.', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': 'Eighty-Five Viral Infectious Episodes, Grouped by Date of Onset, in 39 Patients Who Had Received an Umbilical Cord Blood Transplant Includes adenovirus, coronavirus, human metapneumovirus, influenza A, influenza B, parainfluenza, and respiratory syncytial virus.', 'latex': None, 'type': 'table'}, 'TABREF4': {'text': 'Death Attributed to Infection After Umbilical Cord Blood Transplant', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}]}\n",
      "{'_id': ObjectId('5ea715f0f4c4e1c405600df8'), 'paper_id': '0ae7bedff3dfbfc1ccaeb5b662bbace00ae16b33', 'metadata': {'title': \"Follow-up monitoring in a cat with leishmaniosis and coinfections with Hepatozoon felis and 'Candidatus Mycoplasma haemominutum'\", 'authors': [{'first': 'Charalampos', 'middle': [], 'last': 'Attipa', 'suffix': '', 'affiliation': {'laboratory': 'Molecular Diagnostic Unit, Diagnostic Laboratories', 'institution': 'University of Bristol', 'location': {'settlement': 'Bristol', 'country': 'UK'}}, 'email': 'attipacy@gmail.com'}, {'first': 'Kyriaki', 'middle': [], 'last': 'Neofytou', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Christos', 'middle': [], 'last': 'Yiapanis', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Pamela', 'middle': [], 'last': 'Martínez-Orellana', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universitat Autònoma de Barcelona', 'location': {'country': 'Spain'}}, 'email': ''}, {'first': 'Gad', 'middle': [], 'last': 'Baneth', 'suffix': '', 'affiliation': {'laboratory': 'Charalampos Attipa DVM, Royal Veterinary College Diagnostic Laboratory Services', 'institution': 'Hebrew University of Jerusalem', 'location': {'addrLine': 'Hawkshead Lane, Hatfield, Hertfordshire', 'postCode': 'AL9 7TA', 'settlement': 'Rehovot', 'country': 'Israel, UK'}}, 'email': ''}, {'first': 'Yaarit', 'middle': [], 'last': 'Nachum-Biala', 'suffix': '', 'affiliation': {'laboratory': 'Charalampos Attipa DVM, Royal Veterinary College Diagnostic Laboratory Services', 'institution': 'Hebrew University of Jerusalem', 'location': {'addrLine': 'Hawkshead Lane, Hatfield, Hertfordshire', 'postCode': 'AL9 7TA', 'settlement': 'Rehovot', 'country': 'Israel, UK'}}, 'email': ''}, {'first': 'Harriet', 'middle': [], 'last': 'Brooks-Brownlie', 'suffix': '', 'affiliation': {'laboratory': 'Molecular Diagnostic Unit, Diagnostic Laboratories', 'institution': 'University of Bristol', 'location': {'settlement': 'Bristol', 'country': 'UK'}}, 'email': ''}, {'first': 'Laia', 'middle': [], 'last': 'Solano-Gallego', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universitat Autònoma de Barcelona', 'location': {'country': 'Spain'}}, 'email': ''}, {'first': 'Séverine', 'middle': [], 'last': 'Tasker', 'suffix': '', 'affiliation': {'laboratory': 'Molecular Diagnostic Unit, Diagnostic Laboratories', 'institution': 'University of Bristol', 'location': {'settlement': 'Bristol', 'country': 'UK'}}, 'email': ''}]}, 'abstract': [{'text': \"Case summary A 6-year-old female neutered domestic shorthair cat from Cyprus was presented with multiple ulcerated skin nodules. Cytology and histopathology of the lesions revealed granulomatous dermatitis with intracytoplasmic organisms, consistent with amastigotes of Leishmania species. Biochemistry identified a mild hyperproteinaemia. Blood extraction and PCR detected Leishmania species, Hepatozoon species and 'Candidatus Mycoplasma haemominutum' (CMhm) DNA. Subsequent sequencing identified Hepatozoon felis. Additionally, the rRNA internal transcribed spacer 1 locus of Leishmania infantum was partially sequenced and phylogeny showed it to cluster with species derived from dogs in Italy and Uzbekistan, and a human in France. Allopurinol treatment was administered for 6 months. Clinical signs resolved in the second month of treatment with no deterioration 8 months post-treatment cessation. Quantitative PCR and ELISA were used to monitor L infantum blood DNA and antibody levels. The cat had high L infantum DNA levels pretreatment that gradually declined during treatment but increased 8 months post-treatment cessation. Similarly, ELISA revealed high levels of antibodies pretreatment, which gradually declined during treatment and increased slightly 8 months post-treatment cessation. The cat remained PCR positive for CMhm and Hepatozoon species throughout the study. There was no clinical evidence of relapse 24 months post-treatment. Relevance and novel information To our knowledge, this is the first clinical report of a cat with leishmaniosis with H felis and CMhm coinfections. The high L infantum DNA levels post-treatment cessation might indicate that although the lesions had resolved, prolonged or an alternative treatment could have been considered.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': \"Leishmania infantum, the causative agent of canine leishmaniosis in Europe and a zoonotic vector-borne pathogen, has been increasingly reported in cats in the Mediterranean basin, providing mounting evidence that cats may act as a secondary reservoir. 1 Experimental and case-control studies on feline leishmaniosis (FeL) are lacking, limiting our knowledge of this disease; thus epidemiological studies, case series and case descriptions are required to establish a better understanding of the clinicopathological presentations, treatment, monitoring and prevention of FeL. 2 Herein, we describe the clinical, laboratory and molecular findings, as well as treatment and prolonged monitoring data, from an adult domestic shorthair cat from Cyprus diagnosed with leishmaniosis caused by Leishmania infantum and coinfections with Hepatozoon felis and 'Candidatus Mycoplasma haemominutum' (CMhm).\", 'cite_spans': [{'start': 252, 'end': 253, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 575, 'end': 576, 'text': '2', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'A 6-year-old female neutered domestic shorthair cat was presented at the end of September 2014 to Cyvets Veterinary Centre, Paphos, Cyprus, owing to multiple ulcerated skin nodules on the forelimbs noted by the owner 1 day before presentation when the cat had returned having been missing for 2 weeks. The cat lived mainly outdoors in a rural area, had no travel history, was fully vaccinated and had occasional fipronil spot-on (Effipro; Virbac) ectoparasiticide application.', 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': \"At presentation, the cat's body condition score was 5/9 and the only abnormalities detected were three round, ulcerated skin nodules; two of them were on the dorsal aspect of each forelimb, above the carpus ( Figure  1a ) and the third was on the left scapula ( Figure 1b ). Owing to a recent diagnosis of cutaneous leprosy in a different cat from the same household, the lesion from the scapula was surgically excised for histopathological examination and imprint smears from one of the forelimb lesions were made for cytological examination. The latter revealed high numbers of macrophages, with an epithelioid appearance and occasional giant multinucleated macrophages, as well as low numbers of plasma cells and small lymphocytes. Numerous organisms consistent with Leishmania species amastigotes were noted in parasitophorous vacuoles of the macrophages and freely in the background (Figure 2a ). Histopathological examination of the lesion (Figure 2b ) revealed mild acanthosis and focal ulceration of the epidermis. Within the subjacent dermis, extending from the denuded surface to the deep dermis/panniculus, was an irregular, densely cellular area composed of macrophages, with low numbers of multinucleated forms. The macrophages contained numerous intracytoplasmic vacuoles (5-7 μm in diameter) within which were densely amphophilic round-to-oval organisms (approximately 1 μm diameter). The macrophages were mostly in random array; rarely groups of the cells were aggregated to form small granulomas. There were lighter admixtures of neutrophils, lymphocytes and plasma cells. The cytological and histopathological diagnosis was granulomatous dermatitis with intralesional intracytoplasmic amastigotes consistent with Leishmania species.\", 'cite_spans': [], 'ref_spans': [{'start': 209, 'end': 219, 'text': 'Figure  1a', 'ref_id': 'FIGREF0'}, {'start': 262, 'end': 271, 'text': 'Figure 1b', 'ref_id': 'FIGREF0'}, {'start': 888, 'end': 898, 'text': '(Figure 2a', 'ref_id': 'FIGREF1'}, {'start': 946, 'end': 956, 'text': '(Figure 2b', 'ref_id': 'FIGREF1'}], 'section': 'Case description'}, {'text': 'Blood samples were collected into EDTA and heparin and analysed by an automated haematology impedance analyser (Vet ABC; Scil) and by a VetScan VS2 chemistry analyser (Abaxis), respectively. Only mild hyperproteinaemia (84.0 g/l; reference interval 54-82 g/l) was present. Blood smear examination and urine analysis were unremarkable.', 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': \"The cat was also enrolled into an epidemiology study, 3 thus surplus EDTA-blood and plasma available were submitted for testing for the presence of infectious, including vector-borne, organisms. The cat was PCR positive for Hepatozoon species using conventional PCR, as well as positive for Leishmania species and CMhm using quantitative PCR (qPCR). Subsequent sequencing identified H felis and L infantum. 3 Owing to the small size of the amplicon generated by the initial Leishmania species PCR 4 an additional PCR was performed, targeting the rRNA ITS1 locus of L infantum, 5 followed by sequencing. The forward and reverse sequences of the L infantum were assembled and constructed into a consensus sequence, which was deposited in the GenBank database (MF140257). The DNA sequence was 100% identical to a partial 18S rRNA ITS1 sequence of L infantum (GenBank KX664454) over 258 bp, as found by BLAST analysis (http://www.ncbi.nlm.nih.gov/BLAST). Phylogeny (Figure 3 ) showed the L infantum from this Cypriot cat to cluster with species derived from dogs in Italy and Uzbekistan, a sandfly in Iran and a human in France. The cat was PCR negative for Mycoplasma haemofelis, 'Candidatus Mycoplasma turicensis' (CMt), Bartonella henselae and Ehrlichia/Anaplasma species, and seronegative for feline leukaemia virus antigen and feline immunodeficiency virus antibodies.\", 'cite_spans': [{'start': 407, 'end': 408, 'text': '3', 'ref_id': 'BIBREF2'}], 'ref_spans': [{'start': 961, 'end': 970, 'text': '(Figure 3', 'ref_id': 'FIGREF2'}], 'section': 'Case description'}, {'text': 'Treatment with allopurinol at 10 mg/kg PO q12h was started (month 0) and administered for 6 months. The cat was examined every 2 months during treatment and then 8 months post-treatment cessation (month 14), with blood samples collected each time for haematology and biochemistry analysis. An ELISA was used to monitor L infantum-specific antibodies in serum, 6 as well as qPCR 4 for calculating the L infantum DNA levels in the blood as previously described (Table 1) . 7 The L infantum DNA level of the surgically excised skin nodule was high (approximately 3.48 × 10 10 relative copy numbers). Additionally, PCR assays were repeated for CMhm and Hepatozoon species.', 'cite_spans': [{'start': 360, 'end': 361, 'text': '6', 'ref_id': 'BIBREF5'}, {'start': 378, 'end': 379, 'text': '4', 'ref_id': 'BIBREF3'}, {'start': 471, 'end': 472, 'text': '7', 'ref_id': 'BIBREF6'}], 'ref_spans': [{'start': 459, 'end': 468, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Case description'}, {'text': 'The clinical signs gradually improved by month 1 (Figure 4a ) and resolved by month 2, with no clinical relapses evident at the completion of treatment (Figure 4b ) nor up until the end of the follow-up period at month 14.', 'cite_spans': [], 'ref_spans': [{'start': 49, 'end': 59, 'text': '(Figure 4a', 'ref_id': None}, {'start': 152, 'end': 162, 'text': '(Figure 4b', 'ref_id': None}], 'section': 'Case description'}, {'text': 'The cat had high L infantum DNA and antibody levels pretreatment at month 0. This DNA level had decreased by approximately 40-fold at month 2, and by approximately 5000-fold at month 6, compared with month 0. At month 14 the L infantum DNA level had approximately a 500-fold increase compared with month 6. The L infantum antibodies showed a more subtle gradual decrease, reaching a nadir at month 4, with approximately a three-fold decrease compared with month 0. From months 6 -14 the antibodies remained at similar levels with approximately a two-fold elevation compared with the levels at month 4.', 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': 'The cat remained PCR positive for CMhm and Hepatozoon species throughout the study and apart from the initial hyperproteinaemia, which resolved during month 2, no other haematological or biochemical abnormalities were detected. At month 30, while no PCR was performed, the cat remained clinically healthy with no evidence of clinical signs or relapse.', 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': 'The first case of FeL was reported in 1912 in Algeria, 8 and it was not until the past two decades that case reports and epidemiological studies established a description of clinical FeL including skin or mucocutaneous lesions and lymphadenomegaly. 1 In contrast, fewer data are available regarding the treatment, monitoring and prognosis of FeL.', 'cite_spans': [{'start': 55, 'end': 56, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 249, 'end': 250, 'text': '1', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The LeishVet Group 1 and the Advisory Board on Cat Diseases Guidelines 9 both recommend allopurinol treatment (10-20 mg/kg q24h or q12h) for FeL, based on the extensive clinical use of this medication in previous cases. In contrast, meglumine antimoniate has only been described in a few cases of FeL. 10, 11 Additionally, a combination of allopurinol and N-methyl-glucamine antimoniate in a cat with FeL due to L infantum was reported to have led to successful clinical resolution and significant reduction of the parasitic load, suggesting that this therapeutic protocol could also be considered for FeL. 12 The cat in this case had complete clinical resolution of the cutaneous lesions during the treatment period with no relapse by month 24 after completion of the 6 months of allopurinol treatment. However, the PCR results post-treatment showed that elimination of L infantum had not occurred, indicating progressive subclinical infection. Given the potential role of the cat as a secondary reservoir and the zoonotic nature of L infantum, an alternative treatment could have been implemented for this patient, such as a combination of allopurinol with meglumine antimoniate or N-methylglucamine antimoniate.', 'cite_spans': [{'start': 302, 'end': 305, 'text': '10,', 'ref_id': 'BIBREF9'}, {'start': 306, 'end': 308, 'text': '11', 'ref_id': 'BIBREF11'}, {'start': 607, 'end': 609, 'text': '12', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'There are only a few case reports that provided prolonged follow-up for FeL, [12] [13] [14] [15] and only in one case did this comprise measurement of L infantum DNA levels and serology. 12 In the current case, while the ELISA results followed a similar pattern to the DNA levels during treatment, they both failed to do the same during the monitoring period, in which the clinical signs resolved but parasitaemia persisted (Table 1) . Persichetti et al reported in a recent study that although ELISA serology was better for diagnosing clinical FeL compared with the immunofluorescent antibody test (IFAT), the latter was more sensitive than ELISA to detect subclinical infection. 16 The same study also recommended Western blot as the preferable serological test for FeL since it yielded a higher sensitivity and specificity in comparison to ELISA and IFAT. The pathogens infecting this cat were recently found to have a PCR prevalence of 3.1% for L infantum, 58.0% for Hepatozoon species and 33.0% for CMhm in nonhealthy Cypriot cats, 3 with L infantum and Hepatozoon canis also being reported in the canine population of this island. 17 Significant associations between L infantum infection and H felis and CMt infections in cats using multivariable logistic regression have been reported, suggesting impaired host immune response due to the multiple coinfections. 3 This could have been a component leading to the persistent L infantum parasitaemia in this cat in the face of the Hepatozoon species and CMhm coinfections.', 'cite_spans': [{'start': 77, 'end': 81, 'text': '[12]', 'ref_id': 'BIBREF12'}, {'start': 82, 'end': 86, 'text': '[13]', 'ref_id': 'BIBREF13'}, {'start': 87, 'end': 91, 'text': '[14]', 'ref_id': 'BIBREF14'}, {'start': 92, 'end': 96, 'text': '[15]', 'ref_id': 'BIBREF15'}, {'start': 187, 'end': 189, 'text': '12', 'ref_id': 'BIBREF12'}, {'start': 681, 'end': 683, 'text': '16', 'ref_id': 'BIBREF16'}, {'start': 1037, 'end': 1038, 'text': '3', 'ref_id': 'BIBREF2'}, {'start': 1137, 'end': 1139, 'text': '17', 'ref_id': 'BIBREF17'}, {'start': 1368, 'end': 1369, 'text': '3', 'ref_id': 'BIBREF2'}], 'ref_spans': [{'start': 424, 'end': 433, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Discussion'}, {'text': 'To the best of our knowledge, this is the first clinical report of FeL caused by L infantum, with H felis and CMhm coinfection. While allopurinol treatment led to a complete resolution of the clinical signs, it failed to eliminate the parasite, leading to persistent L infantum subclinical infection. Thus, more aggressive treatment could be considered in future cases, potentially with the combination of allopurinol with meglumine antimoniate or N-methyl-glucamine antimoniate, in order to achieve a more efficient control of L infantum.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusions'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'LeishVet update and recommendations on feline leishmaniosis', 'authors': [{'first': 'M', 'middle': ['G'], 'last': 'Pennisi', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Cardoso', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Baneth', 'suffix': ''}], 'year': 2015, 'venue': 'Parasit Vectors', 'volume': '8', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'What do we know about feline leishmaniosis?', 'authors': [{'first': 'C', 'middle': ['S'], 'last': 'Soares', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Duarte', 'suffix': ''}, {'first': 'S', 'middle': ['R'], 'last': 'Sousa', 'suffix': ''}], 'year': 2016, 'venue': 'J Feline Med Surg', 'volume': '18', 'issn': '', 'pages': '435--442', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Prevalence study and risk factor analysis of selected bacterial, protozoal and viral, including vector-borne, pathogens in cats from Cyprus', 'authors': [{'first': 'C', 'middle': [], 'last': 'Attipa', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Papasouliotis', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Solano-Gallego', 'suffix': ''}], 'year': 2017, 'venue': 'Parasit Vectors', 'volume': '10', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Canine leishmaniosis in the United Kingdom: a zoonotic disease waiting for a vector?', 'authors': [{'first': 'S', 'middle': ['E'], 'last': 'Shaw', 'suffix': ''}, {'first': 'D', 'middle': ['A'], 'last': 'Langton', 'suffix': ''}, {'first': 'T', 'middle': ['J'], 'last': 'Hillman', 'suffix': ''}], 'year': 2009, 'venue': 'Vet Parasitol', 'volume': '163', 'issn': '', 'pages': '281--285', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Detection and identification of old world Leishmania by high resolution melt analysis', 'authors': [{'first': 'D', 'middle': [], 'last': 'Talmi-Frank', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Nasereddin', 'suffix': ''}, {'first': 'L', 'middle': ['F'], 'last': 'Schnur', 'suffix': ''}], 'year': 2010, 'venue': 'PLOS Negl Trop Dis', 'volume': '4', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Cross-sectional serosurvey of feline leishmaniasis in ecoregions around the Northwestern Mediterranean', 'authors': [{'first': 'L', 'middle': [], 'last': 'Solano-Gallego', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Rodríguez-Cortés', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Iniesta', 'suffix': ''}], 'year': 2007, 'venue': 'Am J Trop Med Hyg', 'volume': '76', 'issn': '', 'pages': '676--680', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis', 'authors': [{'first': 'E', 'middle': [], 'last': 'Porter', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Tasker', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Day', 'suffix': ''}], 'year': 2014, 'venue': 'Vet Res', 'volume': '45', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': \"Infection simultanée d'un enfant, d'un chien et d'un chat dans la même habitation\", 'authors': [{'first': 'E', 'middle': [], 'last': 'Sergent', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Sergent', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Lombard', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Quilichini', 'suffix': ''}], 'year': 1912, 'venue': 'Bull Soc Pathol Exot', 'volume': '5', 'issn': '', 'pages': '93--98', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Leishmaniosis in cats: ABCD guidelines on prevention and management', 'authors': [{'first': 'M', 'middle': ['G'], 'last': 'Pennisi', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Hartmann', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Lloret', 'suffix': ''}], 'year': 2013, 'venue': 'J Feline Med Surg', 'volume': '15', 'issn': '', 'pages': '638--642', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Primeiro caso de leishmaniose em gato doméstico (Felis catus domesticus) detectado em Portugal (Concelho de Sesimbra). Nota preliminar', 'authors': [{'first': 'J', 'middle': [], 'last': 'Costa-Durão', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Rebelo', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Peleteiro', 'suffix': ''}], 'year': 1994, 'venue': 'Rev Port Cienc Vet', 'volume': '89', 'issn': '', 'pages': '140--144', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Figure 4 Skin lesion (arrow) on the left forelimb (a) at month 1 and (b) at month 6', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Two cases of feline visceral and cutaneous leishmaniosis in Spain', 'authors': [{'first': 'J', 'middle': [], 'last': 'Hervás', 'suffix': ''}, {'first': 'Fc-Md', 'middle': [], 'last': 'Lara', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Sánchez-Isarria', 'suffix': ''}], 'year': 1999, 'venue': 'J Feline Med Surg', 'volume': '1', 'issn': '', 'pages': '101--105', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Successful treatment of feline leishmaniosis using a combination of allopurinol and N-methyl-glucamine antimoniate', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Basso', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Marques', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Santos', 'suffix': ''}], 'year': 2016, 'venue': 'JFMS Open Rep', 'volume': '2', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1177/2055116916630002']}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Infection of sandflies by a cat naturally infected with Leishmania infantum', 'authors': [{'first': 'M', 'middle': [], 'last': 'Maroli', 'suffix': ''}, {'first': 'M', 'middle': ['G'], 'last': 'Pennisi', 'suffix': ''}, {'first': 'Di', 'middle': [], 'last': 'Muccio', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2007, 'venue': 'Vet Parasitol', 'volume': '145', 'issn': '', 'pages': '357--360', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Case report of leishmaniasis in four cats', 'authors': [{'first': 'M', 'middle': ['G'], 'last': 'Pennisi', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Venza', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Reale', 'suffix': ''}], 'year': 2004, 'venue': 'Vet Res Commun', 'volume': '28', 'issn': '', 'pages': '363--366', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Ocular signs, diagnosis and long-term treatment with allopurinol in a cat with leishmaniasis', 'authors': [{'first': 'M', 'middle': [], 'last': 'Richter', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Schaarschmidt', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Krudewig', 'suffix': ''}], 'year': 2014, 'venue': 'Schweiz Arch Tierheilkd', 'volume': '156', 'issn': '', 'pages': '289--294', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Diagnostic performance of ELISA, IFAT and Western blot for the detection of anti-Leishmania infantum antibodies in cats using a Bayesian analysis without a gold standard', 'authors': [{'first': 'M', 'middle': ['F'], 'last': 'Persichetti', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Solano-Gallego', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Vullo', 'suffix': ''}], 'year': 2017, 'venue': 'Parasit Vectors', 'volume': '10', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Canine tick-borne pathogens in Cyprus and a unique canine case of multiple co-infections', 'authors': [{'first': 'C', 'middle': [], 'last': 'Attipa', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Hicks', 'suffix': ''}, {'first': 'E', 'middle': ['N'], 'last': 'Barker', 'suffix': ''}], 'year': 2017, 'venue': 'Ticks Tick Borne Dis', 'volume': '8', 'issn': '', 'pages': '341--346', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'Ulcerated cutaneous skin nodules on the (a) left forelimb and (b) left scapula, month 0', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': '(a) Imprint smears from an ulcerated skin nodule revealed multinucleated macrophages (large arrow) with numerous intracellular organisms consistent with Leishmania species amastigotes (small arrows). Diff-Quik stain, scale bar = 10 μm. (b) Histopathological examination of a section of the nodule removed from the left scapula showed marked granulomatous dermatitis with intracytoplasmic organisms consistent with Leishmania species amastigotes in the macrophages (arrows). Haematoxylin and eosin stain, scale bar = 50 μm', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'Maximum likelihood phylogenetic tree of Leishmania genera, based on rRNA ITS1 locus sequences and showing the position of the sequence derived from the Leishmania species found in the blood in the Cypriot cat (sample C174) with clinical leishmaniosis described in this report (MF140257). Species and strains are listed, followed by their GenBank accession numbers', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': \"Serological and PCR results of Leishmania infantum in a cat with clinical leishmaniosis and coinfections with Hepatozoon felis and 'Candidatus Mycoplasma haemominutum' during and after treatment with allopurinol at 10 mg/kg PO q12h for 6 months, which was started at month 0\", 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'The authors would like to thank the veterinarian Dr Tryfon A Chochlios, from Cyvets Veterinary Centre, Paphos, Cyprus, for aiding in the collection of followup clinical records.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgements'}, {'text': 'Author note The work described in this paper was presented at the 2017 ACVP/ASVCP Concurrent Annual Meeting in Vancouver as an oral presentation.', 'cite_spans': [], 'ref_spans': [], 'section': 'annex'}, {'text': 'The authors declared no potential conflicts of interest with respect to the research, authorship, and/ or publication of this article.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conflict of interest'}, {'text': 'The authors received no specific grant from any funding agency in the public, commercial or not-for-profit sectors for the preparation of this case report.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding'}]}\n",
      "{'_id': ObjectId('5ea715f0c3994e44c15ff43e'), 'paper_id': '0afa3ea846396533c7ca515968abcfea3f895082', 'metadata': {'title': 'Bone Marrow Dendritic Cells from Mice with an Altered Microbiota Provide Interleukin 17A-Dependent Protection against Entamoeba histolytica Colitis', 'authors': [{'first': 'Stacey', 'middle': ['L'], 'last': 'Burgess', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Erica', 'middle': [], 'last': 'Buonomo', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Maureen', 'middle': [], 'last': 'Carey', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Carrie', 'middle': [], 'last': 'Cowardin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Caitlin', 'middle': [], 'last': 'Naylor', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Zannatun', 'middle': [], 'last': 'Noor', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Marsha', 'middle': [], 'last': 'Wills-Karp', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'William', 'middle': ['A'], 'last': 'Petri', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Johns Hopkins Bloomberg School of Public Health', 'location': {'settlement': 'Baltimore', 'region': 'Maryland', 'country': 'USA'}}, 'email': ''}, {'first': 'Burgess', 'middle': [], 'last': 'Sl', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Buonomo', 'middle': ['E'], 'last': '', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Carey', 'middle': ['M'], 'last': 'Cowardin', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'C', 'middle': [], 'last': '', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Naylor', 'middle': ['C'], 'last': '', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Noor', 'middle': ['Z'], 'last': 'Wills-Karp M', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': '', 'middle': [], 'last': 'Petri', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [{'text': 'There is an emerging paradigm that the human microbiome is central to many aspects of health and may have a role in preventing enteric infection. Entamoeba histolytica is a major cause of amebic diarrhea in developing countries. It colonizes the colon lumen in close proximity to the gut microbiota. Interestingly, not all individuals are equally susceptible to E. histolytica infection. Therefore, as the microbiota is highly variable within individuals, we sought to determine if a component of the microbiota could regulate susceptibility to infection. In studies utilizing a murine model, we demonstrated that colonization of the gut with the commensal Clostridia-related bacteria known as segmented filamentous bacteria (SFB) is protective during E. histolytica infection. SFB colonization in this model was associated with elevated cecal levels of interleukin 17A (IL-17A), dendritic cells, and neutrophils. Bone marrow-derived dendritic cells (BMDCs) from SFB-colonized mice had higher levels of IL-23 production in response to stimulation with trophozoites. Adoptive transfer of BMDCs from an SFB ؉ to an SFB ؊ mouse was sufficient to provide protection against E. histolytica. IL-17A induction during BMDC transfer was necessary for this protection.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'IMPORTANCE Entamoeba histolytica is the causative agent of amebiasis, an infectious disease that contributes significantly to morbidity and mortality due to diarrhea in the developing world. We showed in a murine model that colonization with the commensal members of the Clostridia known as SFB provides protection against E. histolytica and that dendritic cells from SFBcolonized mice alone can recapitulate protection. Understanding interactions between enteropathogens, commensal intestinal bacteria, and the mucosal immune response, including dendritic cells, will help in the development of effective treatments for this disease and other infectious and inflammatory diseases. The demonstration of immune-mediated protection due to communication from the microbiome to the bone marrow represents an emerging field of study that will yield unique approaches to the development of these treatments. ., WA. 2014. Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis. mBio 5(6):e01817-14.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'port neutrophil infiltration in inflammatory-disease models (10) (11) (12) (13) . Neutrophils play a central role in cell-mediated clearance of parasites and may be important in clearance of E. histolytica (14) . IgA was also implicated in protection against E. histolytica infection in a childhood cohort and thus may be involved in immunity against the parasite (15) . Given that IL-17A and downstream mediators are important in immunity to E. histolytica, components of the intestinal microbiota that elicit exogenous IL-17A in the absence of intestinal pathology might prove to be protective during amebiasis.', 'cite_spans': [{'start': 60, 'end': 64, 'text': '(10)', 'ref_id': 'BIBREF9'}, {'start': 65, 'end': 69, 'text': '(11)', 'ref_id': 'BIBREF10'}, {'start': 70, 'end': 74, 'text': '(12)', 'ref_id': 'BIBREF11'}, {'start': 75, 'end': 79, 'text': '(13)', 'ref_id': 'BIBREF12'}, {'start': 206, 'end': 210, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 364, 'end': 368, 'text': '(15)', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': ''}, {'text': 'Segmented filamentous bacteria (SFB), or \"Candidatus Savagella,\" are genetically and morphologically unique members of the Clostridia. They represent an uncultivable component of the mammalian intestinal microbiota, reported to colonize both humans and mice (16) (17) (18) . It has been demonstrated that SFB colonization induces a potent Th17 helper response in the intestine that is dependent on intestinal dendritic cells (19, 20) . SFB colonization is associated with higher intestinal levels of both IL-17A and the damage-associated molecular pattern molecule and antimicrobial peptide serum amyloid A (SAA) (20) . SFB infection influences many models of intestinal and extraintestinal inflammatory disease, suggesting that it may have a systemic influence on the immune response (21) (22) (23) . Indeed, a growing body of literature suggests that intestinal colonization with commensal microorganisms can have extraintestinal effects on dendritic-cell precursors that influence susceptibility to pathogens (24) (25) (26) . It is also quite possible that mediators induced by the intestinal microbiota in the serum might influence the bone marrow in such a way as to prime DCs to provide protection against, or exacerbate, enteropathogen infections (27, 28) .', 'cite_spans': [{'start': 258, 'end': 262, 'text': '(16)', 'ref_id': 'BIBREF15'}, {'start': 263, 'end': 267, 'text': '(17)', 'ref_id': 'BIBREF16'}, {'start': 268, 'end': 272, 'text': '(18)', 'ref_id': 'BIBREF17'}, {'start': 425, 'end': 429, 'text': '(19,', 'ref_id': 'BIBREF18'}, {'start': 430, 'end': 433, 'text': '20)', 'ref_id': 'BIBREF19'}, {'start': 613, 'end': 617, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 785, 'end': 789, 'text': '(21)', 'ref_id': 'BIBREF20'}, {'start': 790, 'end': 794, 'text': '(22)', 'ref_id': 'BIBREF21'}, {'start': 795, 'end': 799, 'text': '(23)', 'ref_id': 'BIBREF22'}, {'start': 1012, 'end': 1016, 'text': '(24)', 'ref_id': 'BIBREF23'}, {'start': 1017, 'end': 1021, 'text': '(25)', 'ref_id': 'BIBREF24'}, {'start': 1022, 'end': 1026, 'text': '(26)', 'ref_id': 'BIBREF25'}, {'start': 1254, 'end': 1258, 'text': '(27,', 'ref_id': 'BIBREF26'}, {'start': 1259, 'end': 1262, 'text': '28)', 'ref_id': 'BIBREF27'}], 'ref_spans': [], 'section': ''}, {'text': 'Bone marrow dendritic cells (BMDCs) are known to be able to recapitulate effector functions of some in vivo antigen-presentingcell populations, and lipopolysaccharide (LPS)-matured BMDCs have been effectively utilized in adoptive transfer experiments to examine the influence of dendritic cells in infection models (28) (29) (30) . Thus, to begin to examine the influence of changes in the microbiota on resistance to amebic infection, we utilized a murine model and BMDCs to explore what influence colonization with SFB had on intestinal infection with E. histolytica. Here we dem-onstrate that colonization with SFB provided protection against E. histolytica colitis and that bone marrow dendritic cells (BM-DCs) derived from SFB-colonized mice were able to recapitulate protection in mice that had not been colonized with the bacteria. Protection mediated by BMDCs from SFB ϩ mice was IL-17A dependent. These data suggest that intestinal colonization with a commensal bacterium can alter bone marrow in such a way as to provide protection against parasite infection.', 'cite_spans': [{'start': 315, 'end': 319, 'text': '(28)', 'ref_id': 'BIBREF27'}, {'start': 320, 'end': 324, 'text': '(29)', 'ref_id': 'BIBREF28'}, {'start': 325, 'end': 329, 'text': '(30)', 'ref_id': 'BIBREF29'}], 'ref_spans': [], 'section': ''}, {'text': 'Cohousing Charles River (SFB ؉ ) and Jackson mice (SFB ؊ ) protected Jackson CBA mice from E. histolytica infection. To test if alteration if the intestinal microbiota could alter susceptibility to E. histolytica infection, mice from two different animal vendors, Charles River and Jackson Laboratories, were cohoused (31, 32) . The SFB status of mice after 3 weeks of cohousing was measured via qPCR and Gram stains. The cohoused mice were then challenged with E. histolytica trophozoites (2 ϫ 10 6 ) via intracecal injection. Seven days later, E. histolytica and SFB burden were measured by qPCR. Cohousing mice transferred SFB (Fig. 1A) , and potentially many other bacteria, and provided protection against E. histolytica infection (Fig. 1B) .', 'cite_spans': [{'start': 318, 'end': 322, 'text': '(31,', 'ref_id': 'BIBREF30'}, {'start': 323, 'end': 326, 'text': '32)', 'ref_id': 'BIBREF31'}], 'ref_spans': [{'start': 630, 'end': 639, 'text': '(Fig. 1A)', 'ref_id': 'FIGREF0'}, {'start': 736, 'end': 745, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'RESULTS'}, {'text': 'Segmented filamentous bacteria specifically protect against E. histolytica and induce increased IL-17A, IL-23, neutrophils, and dendritic cells in the intestine and SAA in the blood. As cohousing of mice both transferred SFB and was protective against E. histolytica infection, we sought to determine if SFB specifically provided protection against the ameba. We directly colonized CBA/J mice from Jackson Laboratories with SFB by orogastric gavage with SFB-monoassociated feces resuspended in phosphate-buffered saline (PBS), provided by the Yakult Central Institute for Microbiological Studies, 1 week prior to E. histolytica infection. Mice became colonized with SFB following gavage ( Fig. 2A) and were protected from infection with the ameba (Fig. 2B) . Additionally, there was increased IL-17A and IL-23 expression before ( onized mice after E. histolytica infection. We also observed increased SAA in serum in SFB-colonized mice after ameba infection (Fig. 2G ). BMDCs derived from SFB-colonized mice have an increased capacity to produce IL-23 that is partially recapitulated with SAA treatment. IL-23 is a key cytokine in the generation and maintenance of IL-17A-producing cells (33) . SAA can directly induce IL-23 from both DCs and macrophages (20, 34) and is known to upregulate an epigenetic mediator, JMJD3 (33) , that specifically increases IL-23 production in a macrophage cell line. Thus, as SFB increased frequency of intestinal DCs, IL-23, IL-17A expression, and circulating serum SAA, we examined the capacity of bone marrow DCs from SFB-infected mice to produce IL-23 in response to trophozoites. BMDCs were generated from SFB-free and SFB-infected mice and treated with trophozoites for 24 h. BMDCs and trophozoites were cocultured in RPMI with 10% fetal bovine serum (FBS) under aerobic conditions rather than in ameba culture medium under anaerobic conditions, as both DCs and trophozoites were viable after 24 h in these media; however, some cell death had occurred, as observed via trypan blue. Cytokines in the supernatants were then determined by enzyme-linked immunosorbent assay (ELISA) (IL-23; R&D Systems). BMDCs derived from mice that were colonized with SFB produced significantly more IL-23 in response to trophozoites (Fig. 3A) . These data suggested that SFB altered bone marrow cells in such a way as to favor increased IL-23 production. We hypothesized that SAA induced in the serum by intestinal SFB colonization could influence BMDCs to produce increased IL-23. Therefore, we wanted to test if the presence of SAA during the differentiation of SFB-free BMDCs might alter them in such a way that they also would produce more IL-23. Thus, SAA (10 g/l) was added for the first 4 days of bone marrow DC culture. Addition of SAA to BMDC culture from SFB-free mice partially recapitulated the increased IL-23 seen in BMDCs derived from SFB ϩ mice (Fig. 3B ). This suggested that SAA might be at least partially responsible for alteration of bone marrow DCs in this model. BMDCs from SFB ؉ but not SFB ؊ mice migrated to the intestine. To test if the increase in DCs in the gut of SFB ϩ mice was due to a direct effect on the bone marrow, BMDCs from SFBcolonized and SFB-free mice were adoptively transferred to SFB Ϫ mice. For in vivo transfers, day 6 BMDC from SFB Ϫ and SFB ϩ mice were matured with LPS (1 g/ml), and 16 h later, cells were stained with carboxyfluorescein succinimidyl ester (CFSE; 10 nM), and 5 ϫ 10 5 cells were administered via intraperitoneal injection. CFSE ϩ BMDC were detected in the lamina propria but only from SFB ϩ mice (Fig. 4) . The ability of SFB ϩ BMDCs to home to the gut may help explain the increased numbers of DCs seen in the lamina propria of SFB-colonized mice during E. histolytica infection (Fig. 2E) . These results were consistent with other studies that have shown that adoptive transfer of LPS-matured BMDCs results in DC trafficking to the intestine (28, 29, 35) .', 'cite_spans': [{'start': 1188, 'end': 1192, 'text': '(33)', 'ref_id': 'BIBREF32'}, {'start': 1255, 'end': 1259, 'text': '(20,', 'ref_id': 'BIBREF19'}, {'start': 1260, 'end': 1263, 'text': '34)', 'ref_id': 'BIBREF33'}, {'start': 1321, 'end': 1325, 'text': '(33)', 'ref_id': 'BIBREF32'}, {'start': 3932, 'end': 3936, 'text': '(28,', 'ref_id': 'BIBREF27'}, {'start': 3937, 'end': 3940, 'text': '29,', 'ref_id': 'BIBREF28'}, {'start': 3941, 'end': 3944, 'text': '35)', 'ref_id': 'BIBREF34'}], 'ref_spans': [{'start': 689, 'end': 697, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF1'}, {'start': 747, 'end': 756, 'text': '(Fig. 2B)', 'ref_id': 'FIGREF1'}, {'start': 958, 'end': 966, 'text': '(Fig. 2G', 'ref_id': 'FIGREF1'}, {'start': 2254, 'end': 2263, 'text': '(Fig. 3A)', 'ref_id': None}, {'start': 2882, 'end': 2890, 'text': '(Fig. 3B', 'ref_id': None}, {'start': 3584, 'end': 3592, 'text': '(Fig. 4)', 'ref_id': None}, {'start': 3768, 'end': 3777, 'text': '(Fig. 2E)', 'ref_id': 'FIGREF1'}], 'section': 'RESULTS'}, {'text': 'Adoptive transfer of BMDCs from SFB colonized mice was sufficient to provide protection against infection in an IL-17Adependent manner. We hypothesized that BMDCs from SFBcolonized mice may provide protection against amebiasis and that the mechanism of this protection might be via downstream induction of IL-17A. To explore this idea, we adoptively transferred BMDCs (5 ϫ 10 5 cells) from SFB Ϫ or SFB ϩ mice to SFB Ϫ mice prior to E. histolytica infection. Indeed, we found that BMDCs from SFB ϩ mice were sufficient both to confer protection (Fig. 5A) and to recapitulate the increase in neutrophils (Fig. 5B ) observed with SFB colonization alone. Blockade of IL-17A during transfer abrogated protection (Fig. 5C ) and neutrophil influx (Fig. 5D ) and led to a decrease in IgA induction (Fig. 5E ). We concluded that IL-17A and downstream innate and perhaps adaptive immune responses underlie the protection observed during adoptive transfer of BMDCs from SFB ϩ mice.', 'cite_spans': [], 'ref_spans': [{'start': 545, 'end': 554, 'text': '(Fig. 5A)', 'ref_id': 'FIGREF3'}, {'start': 603, 'end': 611, 'text': '(Fig. 5B', 'ref_id': 'FIGREF3'}, {'start': 708, 'end': 716, 'text': '(Fig. 5C', 'ref_id': 'FIGREF3'}, {'start': 741, 'end': 749, 'text': '(Fig. 5D', 'ref_id': 'FIGREF3'}, {'start': 791, 'end': 799, 'text': '(Fig. 5E', 'ref_id': 'FIGREF3'}], 'section': 'RESULTS'}, {'text': 'We have demonstrated that alteration of the microbiota via introduction of the commensal bacteria SFB impacts susceptibility to amebic infection in a murine model, likely via its impact on the mucosal immune system (36) . There was an increase in IL-17A and IL-23 expression in the intestines of SFB-colonized mice prior to and following amebic infection and a relative increase in neu- trophils after amebic infection. Our laboratory and others have shown that these effectors may provide protection against E. histolytica (14) . We also observed increased CD11c ϩ MHCII ϩ cells in the intestines of mice, suggesting that dendritic cells induced by SFB may also help mediate protection against infection. This is not surprising given that Goto et al. recently demonstrated that major histocompatibility complex class II (MHC-II)-dependent presentation of SFB antigens by intestinal DCs is crucial for Th17 cell induction (37) . Interestingly, protection in our model appeared to involve not only the mucosal immune response in the gut but also the bone marrow. Resistance to amebic colitis was adoptively transferred to SFB-free mice with bone marrow-derived dendritic cells (BM-DCs) from SFB-colonized mice. This suggested that SFB alteration of bone marrow cells might underlie protection against amebic colitis. BMDCs derived from SFB colonized mice produced more IL-23 in response to E. histolytica trophozoites than BMDCs from mice that were not colonized with the bacteria. However, this response was not specific to E. histolytica, as increased IL-23 production from SFB ϩ BMDCs was also seen with LPS and SAA treatment (data not shown). This suggests that SFB colonization of the intestine has conditioned bone marrow cells to be more responsive to stimulation with pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs), such as SAA, or, alternatively, that there were shifts in the populations of dendritic-cell precursors present in the bone marrow prior to BMDC culture in SFB-colonized mice.', 'cite_spans': [{'start': 215, 'end': 219, 'text': '(36)', 'ref_id': 'BIBREF35'}, {'start': 524, 'end': 528, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 922, 'end': 926, 'text': '(37)', 'ref_id': 'BIBREF36'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Therefore, in this model of SFB-induced alteration of the microbiome, it is not yet clear how SFB altered bone marrow cells. Future studies will be required to examine the possibility of shifts in dendritic-cell precursors or changes in responsiveness to DAMPS and PAMPS. In this context, intestinal inflammation or colonization with commensal organisms has been shown to alter populations of bone marrow progenitor cells (25, 26, 38) . However, exactly how cross talk occurs between the intestine and bone marrow is not well understood. Recent work has shown that gut microbiota metabolism of dietary fiber can increase the concentration of circulating short-chain fatty acids (SCFAs) and that treatment of mice with the SCFA propionate led to alterations in bone marrow hematopoiesis (39) . A similar mechanism might underlie protection in our model of E. histolytica/SFB coinfection. However, SFB-mediated alteration of the metabolome has not been explored. SFB do, however, have an intimate association with the gut intestinal mucosa, likely due to their limited metabolic capability (40, 41) . These bacteria are thus known to alter host gene expression in the intestine (41) . SAA has been shown to be upregulated in the intestines of mice colonized with SFB (20) , and we have demonstrated that SAA is also increased in the serum of E. histolytica/SFB-infected mice. SAA is known to be produced by many cell types, including epithelial cells (3), and SFB tightly associate with the intestinal mucosa (4). SAA-dependent induction of Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression has also been described (33) , including IL-23, in SAA-stimulated macrophages. It is thus not hard to imagine that circulating SAA might act on bone marrow cells to alter IL-23 induction via epigenetic mechanisms (33) . Indeed, we cultured BMDCs from SFB Ϫ mice in the presence of SAA for the first 4 days of culture and then removed the mediator, and the resulting differentiated BMDCs produced significantly more IL-23 than BMDCs from SFB Ϫ mice alone. However, this did not fully recapitulate the increase in IL-23 production seen in BMDCs from SFB-colonized mice. This study is not conclusive, however, and multiple mechanisms, perhaps including alteration of metabolic by-products, may underlie the increased IL-23 production seen in BMDCs from SFBcolonized mice. We propose a model in which intestinal colonization with SFB leads to induction of systemically circulating me-diators, perhaps including SAA, that alter bone marrow dendriticcell precursors so that they provide protection against E. histolytica via induction of downstream effectors, which may include IL-17A, neutrophils, and IgA (Fig. 6) .', 'cite_spans': [{'start': 422, 'end': 426, 'text': '(25,', 'ref_id': 'BIBREF24'}, {'start': 427, 'end': 430, 'text': '26,', 'ref_id': 'BIBREF25'}, {'start': 431, 'end': 434, 'text': '38)', 'ref_id': 'BIBREF37'}, {'start': 786, 'end': 790, 'text': '(39)', 'ref_id': 'BIBREF38'}, {'start': 1088, 'end': 1092, 'text': '(40,', 'ref_id': 'BIBREF39'}, {'start': 1093, 'end': 1096, 'text': '41)', 'ref_id': 'BIBREF40'}, {'start': 1176, 'end': 1180, 'text': '(41)', 'ref_id': 'BIBREF40'}, {'start': 1265, 'end': 1269, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 1641, 'end': 1645, 'text': '(33)', 'ref_id': 'BIBREF32'}, {'start': 1830, 'end': 1834, 'text': '(33)', 'ref_id': 'BIBREF32'}], 'ref_spans': [{'start': 2718, 'end': 2726, 'text': '(Fig. 6)', 'ref_id': 'FIGREF4'}], 'section': 'DISCUSSION'}, {'text': 'In conclusion, we have demonstrated that colonization with a specific component of the intestinal microbiota, SFB, provided protection against infection with the protozoan pathogen E. histolytica and that BMDCs and downstream IL-17A induction recapitulated this protection. This work therefore suggests that alteration of the microbiome can mediate resistance to intestinal infection via extraintestinal effects on bone marrow cells. Future studies will be required to describe and understand the underlying mechanisms of these microbiome-induced changes in bone marrow dendritic-cell precursors.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Male 5-week-old CBA/J mice (Jackson Laboratories, Charles River) were housed in a specific-pathogen-free facility in micro-isolator cages and provided autoclaved food (Lab Diet 5010) and water ad libitum. All procedures were approved by the Institutional Animal Care and Use Committee of the University of Virginia.', 'cite_spans': [], 'ref_spans': [], 'section': 'Mice.'}, {'text': 'E. histolytica culture and intracecal injection. Animal-passaged HM1:IMSS E. histolytica trophozoites were cultured from cecal contents of infected mice in complete trypsin-yeast-iron (TYI-33) medium supplemented with Diamond vitamin mix (JRH Biosciences), 100 U/ml of penicillin and streptomycin, and bovine serum (Sigma-Aldrich). Prior to injection, trophozoites were grown to log phase, and 2 ϫ 10 6 parasites were suspended in 150 l culture medium and injected intracecally (42) .', 'cite_spans': [{'start': 478, 'end': 482, 'text': '(42)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Mice.'}, {'text': 'SFB colonization. Mice were colonized with SFB by cohousing for 3 weeks with SFB ϩ age-matched mice or directly colonized with SFB by orogastric gavage with SFB-monoassociated feces (a kind gift from the Yakult Central Institute for Microbiological Studies) 1 week prior to E. histolytica infection. SFB-monoassociated feces were independently confirmed to be associated with SFB only, with no presence of other bacteria or fungal contamination, by both Y. Umesaki and us via qPCR, Sanger sequencing, and culture (43) . Quantitative real-time RT-PCR. SFB and E. histolytica colonization were measured by real-time PCR. For SFB colonization, qPCR with Sybr green was performed, and data were normalized to expression of a conserved Eubacteria 16S RNA gene (EUB). Primer sequences are as follows: EUB forward, 5=-ACTCCTACGGGAGGCAGCAGT-3=; EUB reverse, 5=-ATTACCGCGGCTGCTGGC-3=; SFB forward, 5=-GACGCTGAGGCAT GAGAGCAT-3=; SFB reverse, 5=-GACGGCACGGATTGTTATTCA-3=. A 6-carboxyfluorescein (FAM)-labeled probe (44), a standard curve prepared from trophozoites, and quantitative PCR (qPCR) were utilized for E. histolytica quantification; the primer and probe sequences are as follows: Eh-f, AAC AGT AAT AGT TTC TTT GGT TAG TAA AA; Eh-r, CTT AGA ATG TCA TTT CTC AAT TCA T; Eh-YYT, ATT AGT ACA AAA TGG CCA ATT CAT TCA-dark quencher; IL-17A F, 5=-ACTACCTCAA CCGTTCCACG-3=; IL-17A R, 5=-AGAATTCATGTGGTGGTCCAG-3=. Cytokines were measured via qPCR with Sybr green, and data were normalized to expression of S14: IL-23p19F, 5=-GACCCACAAGGACTCAA GGA-3=; IL-23p19 R, 5=-CATGGGGCTATCAGGGAGTA-3=; S14 F, 5=-T GGTGTCTGCCACATCTTTGCATC-3=; S14 R, 5=-AGTCACTCGGCAG ATGGTTTCCTT-3=. Melting temperatures were 60°C for EUB, SFB, IL-17A, and IL-23 and for E. histolytica (44) . Primers and probes were purchased from Integrated DNA Technologies, Coralville, IA, USA.', 'cite_spans': [{'start': 513, 'end': 517, 'text': '(43)', 'ref_id': 'BIBREF42'}, {'start': 1746, 'end': 1750, 'text': '(44)', 'ref_id': 'BIBREF43'}], 'ref_spans': [], 'section': 'Mice.'}, {'text': 'Serum SAA was measured by ELISA (ab157723; Abcam, Cambridge, England).', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'Bone marrow-derived-dendritic-cell (BMDC) culture. Bone marrow cells were harvested from 4 weeks old male CBA/J mice from Jackson Laboratories that had been treated by gavage with PBS or SFB the week prior. Cells were cultured in RPMI with 10% FBS supplemented on days 0 and 3 with granulocyte-macrophage colony-stimulating factor (GM-CSF) (10 ng/ml; Peprotech) and harvested on day 6. For in vitro experiments, 2.5 ϫ 10 5 cells were plated per well of a flat-bottom 96-well dish and treated with trophozoites for 24 h. Cytokines in the supernatants were determined by ELISA (IL-23; R&D Systems).', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'DC transfer. For in vivo transfers, day 6 BMDCs were stimulated with LPS (1 g/ml); 16 h later, cells were washed in PBS, and 5 ϫ 10 5 cells were administered intraperitoneally. For CFSE experiments, cells were stained with CFSE in PBS for 10 min (10 nM) and then washed twice in PBS prior to adoptive transfer.', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'IL-17A blockade. Four-week-old CBA/J mice were treated with 200 g rat anti-mouse IL-17A monoclonal antibody (MAb) (clone M210; Amgen) or rat IgG2a isotype control (clone 2A3; BioXcell) at 3 days before and on the day of BMDC transfer (500,000 intraperitoneally from mice receiving SFB gavage or those not receiving SFB gavage). Mice were challenged intracecally with 2 ϫ 10 6 trophozoites 7 days after BMDC transfer.', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'In vitro culture and flow cytometry of intestinal cells. For intracellular staining, intestinal tissue was digested in Liberase TL (0.17 mg/ml Roche) and DNase (0.5 mg/ml; Sigma) for 45 min at 37°C and processed into a single-cell suspension. A total of 1 ϫ 10 6 cells were incubated with CD16/CD32 MAb (BD Biosciences) to block Fc binding, followed by staining with CD11V-BV421, MHCII-FITC, TCR-beta-APC, B220-APC, CD45.2-APC, Ly6G-PE, Ly6C-Percp Cy 5.5, or CD11b-Pacific Blue and run on an LSR Fortessa cell analyzer (BD Biosciences). The data were analyzed with FlowJo (Tree Star Inc.).', 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': \"Statistical analysis. An analysis of variance (ANOVA) followed by the Tukey-Kramer test was used for analysis of differences among multiple groups. Student's t test was used for comparisons between two groups. P values of less than 0.05 were considered significant. Results of representative experiments are shown; all experiments were replicated 2 to 4 times, with 4 to 12 individuals per group.\", 'cite_spans': [], 'ref_spans': [], 'section': 'SFB'}, {'text': 'Supplemental material for this article may be found at http://mbio.asm.org /lookup/suppl/doi:10.1128/mBio.01817-14/-/DCSupplemental. Figure S1 , EPS file, 1.8 MB.', 'cite_spans': [], 'ref_spans': [{'start': 133, 'end': 142, 'text': 'Figure S1', 'ref_id': 'FIGREF0'}], 'section': 'SUPPLEMENTAL MATERIAL'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'WHO/PAHO informal consultation on intestinal protozoal infections. World Health Organization', 'authors': [{'first': 'O', 'middle': ['M'], 'last': 'De La Sante', 'suffix': ''}], 'year': 2004, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Update on human infections caused by intestinal protozoa', 'authors': [{'first': 'K', 'middle': ['K'], 'last': 'Pierce', 'suffix': ''}, {'first': 'B', 'middle': ['D'], 'last': 'Kirkpatrick', 'suffix': ''}], 'year': 2009, 'venue': 'Curr. Opin. Gastroenterol', 'volume': '25', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh', 'authors': [{'first': 'D', 'middle': [], 'last': 'Mondal', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Minak', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Alam', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Dai', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Korpe', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Haque', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}], 'year': 2012, 'venue': 'Clin. Infect. Dis', 'volume': '54', 'issn': '', 'pages': '185--192', 'other_ids': {'DOI': ['10.1093/cid/cir807']}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study', 'authors': [{'first': 'K', 'middle': ['L'], 'last': 'Kotloff', 'suffix': ''}, {'first': 'J', 'middle': ['P'], 'last': 'Nataro', 'suffix': ''}, {'first': 'W', 'middle': ['C'], 'last': 'Blackwelder', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Nasrin', 'suffix': ''}, {'first': 'T', 'middle': ['H'], 'last': 'Farag', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Panchalingam', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wu', 'suffix': ''}, {'first': 'S', 'middle': ['O'], 'last': 'Sow', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Sur', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Breiman', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Faruque', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Zaidi', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Saha', 'suffix': ''}, {'first': 'P', 'middle': ['L'], 'last': 'Alonso', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Tamboura', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Sanogo', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Onwuchekwa', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Manna', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ramamurthy', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Kanungo', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Ochieng', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Omore', 'suffix': ''}, {'first': 'J', 'middle': ['O'], 'last': 'Oundo', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Hossain', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Das', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ahmed', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Qureshi', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Quadri', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Adegbola', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Antonio', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Hossain', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Akinsola', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Mandomando', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Nhampossa', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Acácio', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Biswas', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'O&apos;reilly', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Mintz', 'suffix': ''}, {'first': 'L', 'middle': ['Y'], 'last': 'Berkeley', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Muhsen', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Sommerfelt', 'suffix': ''}, {'first': 'R', 'middle': ['M'], 'last': 'Robins-Browne', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Levine', 'suffix': ''}], 'year': 2013, 'venue': 'Lancet', 'volume': '382', 'issn': '13', 'pages': '60844--60846', 'other_ids': {'DOI': ['10.1016/S0140-6736(13)60844-2']}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'The dynamic interdependence of amebiasis, innate immunity, and undernutrition. Semin. Immunopathol', 'authors': [{'first': 'H', 'middle': ['P'], 'last': 'Verkerke', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Marie', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '34', 'issn': '', 'pages': '771--785', 'other_ids': {'DOI': ['10.1007/s00281-012-0349-1']}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study', 'authors': [{'first': 'D', 'middle': [], 'last': 'Mondal', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Sack', 'suffix': ''}, {'first': 'B', 'middle': ['D'], 'last': 'Kirkpatrick', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Haque', 'suffix': ''}], 'year': 2006, 'venue': 'Trans. R. Soc. Trop. Med. Hyg', 'volume': '100', 'issn': '', 'pages': '1032--1038', 'other_ids': {'DOI': ['10.1016/j.trstmh.2005.12.012']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Interactions between parasites and microbial communities in the human gut', 'authors': [{'first': 'F', 'middle': [], 'last': 'Berrilli', 'suffix': ''}, {'first': 'Di', 'middle': [], 'last': 'Cave', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Cavallero', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'D&apos;amelio', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Front. Cell. Infect. Microbiol', 'volume': '2', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.3389/fcimb.2012.00141']}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'CD4 ϩ and CD8 ϩ T cell-and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine', 'authors': [{'first': 'X', 'middle': [], 'last': 'Guo', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Barroso', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Lyerly', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}, {'first': 'E', 'middle': ['R'], 'last': 'Houpt', 'suffix': ''}], 'year': 2011, 'venue': 'Vaccine', 'volume': '29', 'issn': '', 'pages': '772--777', 'other_ids': {'DOI': ['10.1016/j.vaccine.2010.11.013']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis', 'authors': [{'first': 'A', 'middle': ['T'], 'last': 'Cao', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Yao', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Gong', 'suffix': ''}, {'first': 'C', 'middle': ['O'], 'last': 'Elson', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Cong', 'suffix': ''}], 'year': 2012, 'venue': 'J. Immunol', 'volume': '189', 'issn': '', 'pages': '4666--4673', 'other_ids': {'DOI': ['10.4049/jimmunol.1200955']}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Th17 cytokines and the gut mucosal barrier', 'authors': [{'first': 'C', 'middle': [], 'last': 'Blaschitz', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Raffatellu', 'suffix': ''}], 'year': 2010, 'venue': 'J. Clin. Immunol', 'volume': '30', 'issn': '', 'pages': '196--203', 'other_ids': {'DOI': ['10.1007/s10875-010-9368-7']}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm', 'authors': [{'first': 'T', 'middle': [], 'last': 'Fujisawa', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Velichko', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Thai', 'suffix': ''}, {'first': 'L', 'middle': ['Y'], 'last': 'Hung', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Wu', 'suffix': ''}], 'year': 2009, 'venue': 'J. Immunol', 'volume': '183', 'issn': '', 'pages': '6236--6243', 'other_ids': {'DOI': ['10.4049/jimmunol.0900614']}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice', 'authors': [{'first': 'J', 'middle': [], 'last': 'Mei', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Dai', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hoffmann', 'suffix': ''}, {'first': 'K', 'middle': ['M'], 'last': 'Hudock', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'S', 'middle': ['H'], 'last': 'Guttentag', 'suffix': ''}, {'first': 'J', 'middle': ['K'], 'last': 'Kolls', 'suffix': ''}, {'first': 'P', 'middle': ['M'], 'last': 'Oliver', 'suffix': ''}, {'first': 'F', 'middle': ['D'], 'last': 'Bushman', 'suffix': ''}, {'first': 'G', 'middle': ['S'], 'last': 'Worthen', 'suffix': ''}], 'year': 2012, 'venue': 'J. Clin. Invest', 'volume': '122', 'issn': '', 'pages': '974--986', 'other_ids': {'DOI': ['10.1172/JCI60588']}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies', 'authors': [{'first': 'M', 'middle': ['S'], 'last': 'Maddur', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Miossec', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Kaveri', 'suffix': ''}, {'first': 'J', 'middle': ['T'], 'last': 'Bayry', 'suffix': ''}], 'year': 2012, 'venue': 'Am. J. Pathol', 'volume': '181', 'issn': '', 'pages': '8--18', 'other_ids': {'DOI': ['10.1016/j.ajpath.2012.03.044']}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1ϩ cells', 'authors': [{'first': 'A', 'middle': [], 'last': 'Asgharpour', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Gilchrist', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Baba', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Hamano', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Houpt', 'suffix': ''}], 'year': 2005, 'venue': 'Infect. Immun', 'volume': '73', 'issn': '', 'pages': '4522--4529', 'other_ids': {'DOI': ['10.1128/IAI.73.8.4522-4529.2005']}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children', 'authors': [{'first': 'R', 'middle': [], 'last': 'Haque', 'suffix': ''}, {'first': 'I', 'middle': ['M'], 'last': 'Ali', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Sack', 'suffix': ''}, {'first': 'B', 'middle': ['M'], 'last': 'Farr', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Ramakrishnan', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}], 'year': 2001, 'venue': 'J. Infect. Dis', 'volume': '183', 'issn': '', 'pages': '1787--1793', 'other_ids': {'DOI': ['10.1086/320740']}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Singlecell sequencing provides clues about the host interactions of segmented filamentous bacteria (SFB)', 'authors': [{'first': 'S', 'middle': ['J'], 'last': 'Pamp', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Harrington', 'suffix': ''}, {'first': 'S', 'middle': ['R'], 'last': 'Quake', 'suffix': ''}, {'first': 'D', 'middle': ['A'], 'last': 'Relman', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Blainey', 'suffix': ''}], 'year': None, 'venue': 'Genome Res', 'volume': '22', 'issn': '', 'pages': '1107--1119', 'other_ids': {'DOI': ['10.1101/gr.131482.111']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Comparative analysis of the distribution of segmented filamentous bacteria in humans, mice and chickens', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Yin', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Liao', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Jiang', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'H', 'middle': ['D'], 'last': 'Yu', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Xiang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Wang', 'suffix': ''}], 'year': 2012, 'venue': 'ISME J', 'volume': '7', 'issn': '', 'pages': '615--621', 'other_ids': {'DOI': ['10.1038/ismej.2012.128']}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Habitat, succession, attachment, and morphology of segmented, filamentous microbes indigenous to the murine gastrointestinal tract', 'authors': [{'first': 'C', 'middle': ['P'], 'last': 'Davis', 'suffix': ''}, {'first': 'D', 'middle': ['C'], 'last': 'Savage', 'suffix': ''}], 'year': 1974, 'venue': 'Infect Immun', 'volume': '10', 'issn': '', 'pages': '948--956', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Goto', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Panea', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Nakato', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Cebula', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'M', 'middle': ['G'], 'last': 'Diez', 'suffix': ''}, {'first': 'T', 'middle': ['M'], 'last': 'Laufer', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ignatowicz', 'suffix': ''}, {'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}], 'year': 2014, 'venue': 'Immunity', 'volume': '40', 'issn': '', 'pages': '594--607', 'other_ids': {'DOI': ['10.1016/j.immuni.2014.03.005']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Induction of intestinal Th17 cells by segmented filamentous bacteria', 'authors': [{'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Atarashi', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Manel', 'suffix': ''}, {'first': 'E', 'middle': ['L'], 'last': 'Brodie', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Shima', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Karaoz', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Wei', 'suffix': ''}, {'first': 'K', 'middle': ['C'], 'last': 'Goldfarb', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Santee', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Lynch', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Tanoue', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Imaoka', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Itoh', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Takeda', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Umesaki', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Honda', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Littman', 'suffix': ''}], 'year': 2009, 'venue': 'Cell', 'volume': '139', 'issn': '', 'pages': '485--498', 'other_ids': {'DOI': ['10.1016/j.cell.2009.09.033']}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Kriegel', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Sefik', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Hill', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Wu', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Benoist', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Mathis', 'suffix': ''}], 'year': 2011, 'venue': 'Proc. Natl. Acad. Sci. U. S. A', 'volume': '108', 'issn': '', 'pages': '11548--11553', 'other_ids': {'DOI': ['10.1073/pnas.1108924108']}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells', 'authors': [{'first': 'H', 'middle': ['J'], 'last': 'Wu', 'suffix': ''}, {'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Darce', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Hattori', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Shima', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Umesaki', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Littman', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Benoist', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Mathis', 'suffix': ''}], 'year': 2010, 'venue': 'Immunity', 'volume': '32', 'issn': '', 'pages': '815--827', 'other_ids': {'DOI': ['10.1016/j.immuni.2010.06.001']}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis', 'authors': [{'first': 'Y', 'middle': ['K'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Menezes', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Umesaki', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Mazmanian', 'suffix': ''}], 'year': 2011, 'venue': 'Proc. Natl. Acad. Sci. U. S. A', 'volume': '108', 'issn': '', 'pages': '4615--4622', 'other_ids': {'DOI': ['10.1073/pnas.1000082107']}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Gut microbiota promote hematopoiesis to control bacterial infection', 'authors': [{'first': 'A', 'middle': [], 'last': 'Khosravi', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yáñez', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Price', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Chow', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Merad', 'suffix': ''}, {'first': 'H', 'middle': ['S'], 'last': 'Goodridge', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Mazmanian', 'suffix': ''}], 'year': 2014, 'venue': 'Cell Host Microbe', 'volume': '15', 'issn': '', 'pages': '374--381', 'other_ids': {'DOI': ['10.1016/j.chom.2014.02.006']}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Hill', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Siracusa', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Abt', 'suffix': ''}, {'first': 'B', 'middle': ['S'], 'last': 'Kim', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Kobuley', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Kubo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Kambayashi', 'suffix': ''}, {'first': 'D', 'middle': ['F'], 'last': 'Larosa', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Renner', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Orange', 'suffix': ''}, {'first': 'F', 'middle': ['D'], 'last': 'Bushman', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Artis', 'suffix': ''}], 'year': 2012, 'venue': 'Nat. Med', 'volume': '18', 'issn': '', 'pages': '538--546', 'other_ids': {'DOI': ['10.1038/nm.2657']}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation', 'authors': [{'first': 'T', 'middle': [], 'last': 'Griseri', 'suffix': ''}, {'first': 'B', 'middle': ['S'], 'last': 'Mckenzie', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Schiering', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Powrie', 'suffix': ''}], 'year': 2012, 'venue': 'Immunity', 'volume': '37', 'issn': '', 'pages': '1116--1129', 'other_ids': {'DOI': ['10.1016/j.immuni.2012.08.025']}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'The intestinal metabolome: an intersection between microbiota and host', 'authors': [{'first': 'L', 'middle': ['K'], 'last': 'Ursell', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Haiser', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Van Treuren', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Garg', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Reddivari', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Vanamala', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Dorrestein', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Turnbaugh', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Knight', 'suffix': ''}], 'year': 2014, 'venue': 'Gastroenterology', 'volume': '146', 'issn': '', 'pages': '1470--1476', 'other_ids': {'DOI': ['10.1053/j.gastro.2014.03.001']}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis', 'authors': [{'first': 'E', 'middle': [], 'last': 'Pastille', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Didovic', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Brauckmann', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Rani', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Agrawal', 'suffix': ''}, {'first': 'F', 'middle': ['U'], 'last': 'Schade', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'S', 'middle': ['B'], 'last': 'Flohé', 'suffix': ''}], 'year': 2011, 'venue': 'J. Immunol', 'volume': '186', 'issn': '', 'pages': '977--986', 'other_ids': {'DOI': ['10.4049/jimmunol.1001147']}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10 ϩ CD4 ϩ T cells', 'authors': [{'first': 'S', 'middle': [], 'last': 'Stäger', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Maroof', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Zubairi', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Sanos', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Kopf', 'suffix': ''}, {'first': 'P', 'middle': ['M'], 'last': 'Kaye', 'suffix': ''}], 'year': 2006, 'venue': 'Eur. J. Immunol', 'volume': '36', 'issn': '', 'pages': '1764--1771', 'other_ids': {'DOI': ['10.1002/eji.200635937']}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice', 'authors': [{'first': 'J', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Van Rooijen', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Perlman', 'suffix': ''}], 'year': 2009, 'venue': 'PLoS Pathog', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.ppat.1000636']}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors', 'authors': [{'first': 'M', 'middle': ['R'], 'last': 'Hufeldt', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Nielsen', 'suffix': ''}, {'first': 'F', 'middle': ['K'], 'last': 'Vogensen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Midtvedt', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Hansen', 'suffix': ''}], 'year': 2010, 'venue': 'Comp. Med', 'volume': '60', 'issn': '', 'pages': '336--347', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Temporal stability of the mouse gut microbiota in relation to innate and adaptive immunity', 'authors': [{'first': 'P', 'middle': ['A'], 'last': 'Dimitriu', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Boyce', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Samarakoon', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Hartmann', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Johnson', 'suffix': ''}, {'first': 'W', 'middle': ['W'], 'last': 'Mohn', 'suffix': ''}], 'year': 2013, 'venue': 'Environ. Microbiol. Rep', 'volume': '5', 'issn': '', 'pages': '200--210', 'other_ids': {'DOI': ['10.1111/j.1758-2229.2012.00393.x']}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages', 'authors': [{'first': 'Q', 'middle': [], 'last': 'Yan', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Sun', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Ye', 'suffix': ''}], 'year': 2014, 'venue': 'Cell. Signal', 'volume': '26', 'issn': '', 'pages': '1783--1791', 'other_ids': {'DOI': ['10.1016/j.cellsig.2014.03.025']}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice', 'authors': [{'first': 'J', 'middle': ['L'], 'last': 'Ather', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Ckless', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martin', 'suffix': ''}, {'first': 'K', 'middle': ['L'], 'last': 'Foley', 'suffix': ''}, {'first': 'B', 'middle': ['T'], 'last': 'Suratt', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Boyson', 'suffix': ''}, {'first': 'K', 'middle': ['A'], 'last': 'Fitzgerald', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Flavell', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Eisenbarth', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Poynter', 'suffix': ''}], 'year': 2011, 'venue': 'J. Immunol', 'volume': '187', 'issn': '', 'pages': '64--73', 'other_ids': {'DOI': ['10.4049/jimmunol.1100500']}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells', 'authors': [{'first': '-O&apos;', 'middle': [], 'last': 'Sheasley', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Neill', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Brinkman', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Ferguson', 'suffix': ''}, {'first': 'M', 'middle': ['C'], 'last': 'Dispenza', 'suffix': ''}], 'year': 2007, 'venue': 'J. Immunol', 'volume': '178', 'issn': '', 'pages': '1512--1522', 'other_ids': {'DOI': ['10.4049/jimmunol.178.3.1512']}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Human nutrition, the gut microbiome and the immune system', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Kau', 'suffix': ''}, {'first': 'P', 'middle': ['P'], 'last': 'Ahern', 'suffix': ''}, {'first': 'N', 'middle': ['W'], 'last': 'Griffin', 'suffix': ''}, {'first': 'A', 'middle': ['L'], 'last': 'Goodman', 'suffix': ''}, {'first': 'J', 'middle': ['I'], 'last': 'Gordon', 'suffix': ''}], 'year': 2011, 'venue': 'Nature', 'volume': '474', 'issn': '', 'pages': '327--336', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Goto', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Panea', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Nakato', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Cebula', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'M', 'middle': ['G'], 'last': 'Diez', 'suffix': ''}, {'first': 'T', 'middle': ['M'], 'last': 'Laufer', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ignatowicz', 'suffix': ''}, {'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}], 'year': 2014, 'venue': 'Immunity', 'volume': '40', 'issn': '', 'pages': '594--607', 'other_ids': {'DOI': ['10.1016/j.immuni.2014.03.005']}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Gut microbiota promote hematopoiesis to control bacterial Infection', 'authors': [{'first': 'A', 'middle': [], 'last': 'Khosravi', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yáñez', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Price', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Chow', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Merad', 'suffix': ''}, {'first': 'H', 'middle': ['S'], 'last': 'Goodridge', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Mazmanian', 'suffix': ''}], 'year': 2014, 'venue': 'Cell Host Microbe', 'volume': '15', 'issn': '', 'pages': '374--381', 'other_ids': {'DOI': ['10.1016/j.chom.2014.02.006']}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis', 'authors': [{'first': 'A', 'middle': [], 'last': 'Trompette', 'suffix': ''}, {'first': 'E', 'middle': ['S'], 'last': 'Gollwitzer', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Yadava', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Sichelstiel', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Sprenger', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Ngom-Bru', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Blanchard', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Junt', 'suffix': ''}, {'first': 'L', 'middle': ['P'], 'last': 'Nicod', 'suffix': ''}, {'first': 'N', 'middle': ['L'], 'last': 'Harris', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Marsland', 'suffix': ''}], 'year': 2014, 'venue': 'Nat. Med', 'volume': '20', 'issn': '', 'pages': '159--166', 'other_ids': {'DOI': ['10.1038/nm.3444']}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'The genome of Th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment', 'authors': [{'first': 'A', 'middle': [], 'last': 'Sczesnak', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Segata', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Qin', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Gevers', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Petrosino', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Huttenhower', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Littman', 'suffix': ''}, {'first': 'I', 'middle': ['I'], 'last': 'Ivanov', 'suffix': ''}], 'year': 2011, 'venue': 'Cell Host Microbe', 'volume': '10', 'issn': '', 'pages': '260--272', 'other_ids': {'DOI': ['10.1016/j.chom.2011.08.005']}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing', 'authors': [{'first': 'T', 'middle': [], 'last': 'Kuwahara', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Ogura', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Oshima', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kurokawa', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ooka', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Hirakawa', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Itoh', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Nakayama-Imaohji', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ichimura', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Itoh', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Ishifune', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Maekawa', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Yasutomo', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Hattori', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Hayashi', 'suffix': ''}], 'year': 2011, 'venue': 'DNA Res', 'volume': '18', 'issn': '', 'pages': '291--303', 'other_ids': {'DOI': ['10.1093/dnares/dsr022']}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4 ϩ T cells', 'authors': [{'first': 'E', 'middle': ['R'], 'last': 'Houpt', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Glembocki', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Obrig', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Moskaluk', 'suffix': ''}, {'first': 'L', 'middle': ['A'], 'last': 'Lockhart', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Wright', 'suffix': ''}, {'first': 'R', 'middle': ['M'], 'last': 'Seaner', 'suffix': ''}, {'first': 'T', 'middle': ['R'], 'last': 'Keepers', 'suffix': ''}, {'first': 'T', 'middle': ['D'], 'last': 'Wilkins', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}], 'year': 2002, 'venue': 'J. Immunol', 'volume': '169', 'issn': '', 'pages': '4496--4503', 'other_ids': {'DOI': ['10.4049/jimmunol.169.8.4496']}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Umesaki', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Okada', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Matsumoto', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Imaoka', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Setoyama', 'suffix': ''}], 'year': 1995, 'venue': 'Microbiol Immunol', 'volume': '39', 'issn': '', 'pages': '555--562', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'Realtime-PCR assay for diagnosis of Entamoeba histolytica infection', 'authors': [{'first': 'S', 'middle': [], 'last': 'Roy', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Kabir', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Mondal', 'suffix': ''}, {'first': 'I', 'middle': ['K'], 'last': 'Ali', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Petri', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Haque', 'suffix': ''}], 'year': 2005, 'venue': 'J. Clin. Microbiol', 'volume': '43', 'issn': '', 'pages': '2168--2172', 'other_ids': {'DOI': ['10.1128/JCM.43.5.2168-2172.2005']}}}, 'ref_entries': {'FIGREF0': {'text': 'Fig. S1) and after (Fig. 2Cand D) E. histolytica infection. Neutrophils (Fig. 2E; also, seeFig. S1cin the supplemental material) and DCs (Fig. 2F; also, seeFig. S1din the supplemental material) were also elevated in the intestine of SFB col-Cohousing mice from different vendors transfers SFB and confers protection against Entamoeba histolytica infection. qPCR was used to quantify relative expression compared to total bacteria and trophozoites of SFB (A) and Entamoeba histolytica (B), respectively, in cecal lysate from SFB Ϫ CBA/J mice that were cohoused with SFB ϩ C3H mice and noncohoused mice; mice were infected with 2 million E. histolytica trophozoites via cecal laparotomy. *, P Ͻ 0.05.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'SFB-colonized mice are protected from E. histolytica infection, have increased IL-17A, IL-23, neutrophils, and DCs in their intestines, and have more serum amyloid A (SAA) in their serum. Quantification via qPCR of SFB relative expression compared to total bacteria (A) and enumeration of trophozoites (B) was performed in cecal lysate from mice given gavages with PBS or SFB-monoassociated feces (Yakult) 7 days prior to intracecal infection with E. histolytica. IL-17A (C) and IL-23 (D) induction in ceca (lamina propria) was measured via qPCR, and neutrophil and DC infiltration was measured by flow cytometry and indicated markers (E and F). (G) Serum SAA was measured by ELISA. *, P Ͻ 0.05.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': \"Bone marrow-derived DCs from mice colonized with SFB produce more IL-23 in response to E. histolytica trophozoites, and increased IL-23 production can be partially recapitulated in non-SFB-colonized mice with addition of SAA. Bone marrow cells were harvested from 4-week-old male CBA/J mice infected with or free of SFB, and cells were cultured in RPMI with 10% FBS, supplemented on days 0 and 3 with GM-CSF (10 ng/ml; Peprotech), and harvested on day 6. (A) A total of 2.5 ϫ 10 5 cells were plated per well of a flat-bottom 96-well dish and treated with medium or trophozoites (Trophs) for 24 h. IL-23 in the supernatants was measured by ELISA. (B) BMDCs were cultured as described above with the addition of a third group with BMDCs from SFB-naive mice in which SAA was added to GM-CSF-containing medium for the first 4 days of culture only. Cells were washed and then plated with 2,500 trophozoites, and IL-23 was measured after 24 hours as described above. *, P Ͻ 0.05. BMDCS from SFB-colonized mice migrated to the lamina propria of SFB-free mice upon adoptive transfer via the intraperitoneal route. Bone marrow cells (500,000) from SFB ϩ or SFB Ϫ mice were CFSE stained and adoptively transferred to 5-week-old CBA/J mice free of SFB. Flow cytometry for CFSE staining was performed on single cells isolated from spleens, Peyer's patches (PP), mesenteric lymph nodes (MLN), and lamina propria (LP). *, P Ͻ 0.05.\", 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'BMDCs from mice colonized with SFB are sufficient to confer protection against E. histolytica colonization and recapitulate protective immune response, and blockade of IL-17A during adoptive transfer abrogates this protection. A total of 500,000 bone marrow cells from SFB ϩ or SFB Ϫ mice prepared as described in Materials and Methods were adoptively transferred to 5-week-old CBA/J mice free of SFB 1 week prior to infection with 2 million E. histolytica trophozoites via cecal laparotomy. E. histolytica (A) organisms in cecal lysate were quantified via qPCR. (B) Neutrophil infiltration in cecum by indicated markers. Fourweek-old CBA/J mice were treated with 200 g rat anti-mouse IL-17A MAb (clone M210; Amgen) or rat IgG2a isotype control (clone 2A3; BioXcell) 3 days before BMDC transfer (500,000 intraperitoneally from mice that received SFB gavage and mice that did not) and 7 days after and then infected with 2 million trophozoites that day. (C) E. histolytica in cecal lysate from mice was quantified via qPCR. (D) Neutrophil infiltration was measured via flow cytometry by indicated markers. (E) Total serum IgA was measured by ELISA. *, P Ͻ 0.05.', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'Model for SFB-mediated protection against E. histolytica colonization. SFB colonization of the intestine may induce soluble mediators, including SAA, which can have local effects as well as trigger systemic changes in bone marrow that support increased IL-23 production from dendritic-cell subsets and downstream IL-17A-mediated innate and adaptive immune responses. These effectors may then protect against intestinal E. histolytica infection.', 'latex': None, 'type': 'figure'}}, 'back_matter': [{'text': 'This work was supported by NIH grant 5R01 AI026649-25 to W.P. We thank Yoshinori Umesaki, from the Yakult Central Institute for Microbial Research (Tokyo, Japan) for supplying the SFB-monocolonized feces. We also gratefully acknowledge the gift of anti-IL-17A monoclonal antibodies from Alison Budelsky at Amgen Incorporated (Seattle, WA) and Florent Ginhoux, Brian Kelsall, and Tom Braciale for helpful discussions.S.B., W.P., and M.W.-K. contributed to the design, analysis and interpretation of the data. S.B., E.B., M.C., C.C., C.N., and Z.N. conducted experiments and critiqued the work. S.B. and W.P. wrote the manuscript.', 'cite_spans': [], 'ref_spans': [], 'section': 'ACKNOWLEDGMENTS'}]}\n"
     ]
    }
   ],
   "source": [
    "for c in db.pmc_content.find():\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen'}}\n",
      "{'metadata': {'title': 'Bone Marrow Dendritic Cells from Mice with an Altered Microbiota Provide Interleukin 17A-Dependent Protection against Entamoeba histolytica Colitis'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'The outbreak of COVID-19: An overview'}}\n",
      "{'metadata': {'title': 'VIRUS ON T H E CEREBRAL ACTIVITY OF P L E U R O P N E U M O N I A -L I K E ORGANISMS I N M I C E'}}\n",
      "{'metadata': {'title': 'TNF-α − 308 G N A and IFN-γ + 874 A N T gene polymorphisms in Egyptian patients with lupus erythematosus'}}\n",
      "{'metadata': {'title': 'Molecular epidemiology and phylogenetic analysis of diverse bovine astroviruses associated with diarrhea in cattle and water buffalo calves in China'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'MRI findings of neuronal ceroid lipofuscinosis in a cat'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'A rapid, inexpensive yeast-based dual-fluorescence assay of programmed-1 ribosomal frameshifting for high-throughput screening'}}\n",
      "{'metadata': {'title': 'Position Paper'}}\n",
      "{'metadata': {'title': 'Centers for Disease Control and Prevention, Division of Global Migration and Quarantine San Diego, California, USA Epidemiological surveillance of land borders in North and South America: a case study'}}\n",
      "{'metadata': {'title': 'Phylogeny of bovine norovirus in Egypt based on VP2 gene'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Open Forum Infectious Diseases Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy'}}\n",
      "{'metadata': {'title': \"Follow-up monitoring in a cat with leishmaniosis and coinfections with Hepatozoon felis and 'Candidatus Mycoplasma haemominutum'\"}}\n",
      "{'metadata': {'title': 'Bone Marrow Dendritic Cells from Mice with an Altered Microbiota Provide Interleukin 17A-Dependent Protection against Entamoeba histolytica Colitis'}}\n"
     ]
    }
   ],
   "source": [
    "# to print the titles only and suppress the id\n",
    "\n",
    "for c in db.pmc_content.find({},{ 'metadata.title': 1, '_id': 0 }):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5ea71355b3c4f60e9b93e8f9'), 'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Editorial'}, {'text': \"The Middle East Respiratory Syndrome (MERS) crisis in Korea is coming to an end, but that's not the end of the story. The World Health Organization (WHO) has warned that the MERS crisis was a 'wakeup call. ' Like Severe Acute Respiratory Syndrome (SARS) in 2003 and swine flu in 2009, epidemic outbreaks will continue to happen anywhere. Korea was simply unlucky. In retrospect, it is regrettable to say that we could have done much better. Scholars and colleagues in the medical informatics field should take a moment and think hard about how we can work to fight against another epidemic invasion in the future.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'The Ebola epidemic of 2013 is the largest such outbreak on record, influencing many nations in Africa as well as other countries [1] . The WHO expert panel has pointed out the inadequate emergency care response and has recommended more effective mechanisms for research and development. Others have strongly recommended WHO to innovate because recent Ebola outbreaks have been radically different from previous events, and they have tended to be simultaneous and parallel: \"Highly mobile populations, the spread of Ebola into densely populated cities ... made this epidemic of many outbreaks difficult to control [2] . \"', 'cite_spans': [{'start': 129, 'end': 132, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 613, 'end': 616, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': \"Other criticisms also include outdated therapeutic protocols, irrelevant information, untimely communication, delays in decision-making due to uncoordinated leadership, unreasonable social behavior, and so on. The recom- tems. The NEDSS can be called a medical informatics leader, which provides a standardized information infrastructure with HL7, LOINC, and SNOMED-CT. Highly useful information is well organized and ready to be used in the US-CDC [6] , so we don't have to reinvent the wheel. All we need is to find a conduit for connection. For example, the task of disease surveillance for MERS is relatively small compared to NEDSS. Using the cell phone data network, we can instantly establish a real-time patient tracking system to monitor 3-tuple data (time, location, temperature) in the country. Cell phone rental can help track down suspicious foreign visitors from arrival to departure. With the support of ISO standards, global healthcare networking is not a hard nut to crack.\", 'cite_spans': [{'start': 449, 'end': 452, 'text': '[6]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'When the MERS epidemic outbreak was on the headline news, many attempts were made to compare MERS with tuberculosis. That is, the mortality rate of MERS is far below that of tuberculosis, so it was argued that there was no need to worry about it. The point was clear, but the timing was not right. Have you ever got a thorn stuck under your fingernail? Saying that \"It\\'s OK you\\'re not bleeding\" or \"You won\\'t die from it\" would not comfort anybody at all. I would venture to say that it is surely mistaken to compare the pain at present with a probable outcome yet to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': 'When hospital visitors became MERS patients, a typical example of nosocomial infection was demonstrated. It was a surprise attack, and the whole country was shaken and panicked. The WHO experts reminded us that hospital shopping greatly contributed to the rapid spread of MERS in Korea. We have to understand why patients pursue hospital shopping. The death of professionalism may be an unexpected result of the fashionable social network services (SNS). Patients use SNSs to data-mine their own diagnosis and prescription and then seek medical advice to compare with their own ideas about their personal health. However, such patients suggesting their own diagnoses and treatments can be described as \"Jack of all trades, master of none\". Medical informatics leadership was nowhere to be found. When the MERS epidemic turned fatal, SNS was the only rescue. MERS was unknown to the general public, and the cure was uncertain, so chaos was bound to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In Korea medical informatics is on trial. We are standing in front of a river that runs medicine. IT has been trying to cross the river but has never been successful, especially in medical expert systems. The other side of the river is not the land of promise. Because the river of medicine eventu-ally runs into the ocean of the human race, why don't we go with the river instead? There is no doubt that doctors and nurses were the final frontiers in the MERS battle. Despite all the wonderful scientific accomplishments, the MERS crisis reminds us that clinical expertise is the most important value as clearly as ever. Technology can help medicine, not the other way around; that is the way medical informatics should go in between.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"Taoism states that dynamic balance can be obtained from two opposite powers competing with each other, unifying as a complete energy. Similarly, medical informatics should be able to balance between analog medicine and digital technology to create a new value. Medicine is composed of oldfashioned values, such as rapport, which is fading out slowly. Digital technology should help clinicians restore the humanistic flavor of medicine by eliminating managerial overload in healthcare settings. Technology can start from there. Neither Cyclops (the single-eyed monster in Homer's Odyssey) nor Argus (the 100-eyed giant in Greek mythology) is ideal to find the right path. Two-eyed medical informaticians must walk through the path on the mountain ridge, carefully looking at both sides of IT and medicine for balance.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In 1347, the first biological warfare took place in the siege of Caffa (now Feodosia in Ukraine) on the Black Sea coast. The Mongol army with bubonic plague catapulted corpse of those who had died from the Black Death over the city walls. Fleeing from central trading ports along the coast, infected inhabitants and rats may have carried the disease throughout Europe [7] (The plague might have killed more than 25 million people). A few regions survived. They simply closed their ports of entry and isolated patients in remote places. The same principle still applies. When in doubt, isolate an infection until it's clear. Time goes by, technology advances, but the basic principle never changes. Medicine should stay analog with a little hint of digital. That's all it takes to fight against any epidemic or pandemic attack in the future.\", 'cite_spans': [{'start': 368, 'end': 371, 'text': '[7]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Report of the Ebola Interim Assessment Panel', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"What we've learned about fighting Ebola\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Dhillon', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Srikrishna', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Harvard Business Review; c2015', 'authors': [{'first': '(', 'middle': [], 'last': 'Boston', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ma)', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The next epidemic: lessons from Ebola', 'authors': [{'first': 'B', 'middle': [], 'last': 'Gates', 'suffix': ''}], 'year': 2015, 'venue': 'N Engl J Med', 'volume': '372', 'issn': '15', 'pages': '1381--1385', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'US Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Centers for Disease Control and Prevention; c2015', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Digital disease detection: harnessing the Web for public health surveillance', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Brownstein', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Freifeld', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Madoff', 'suffix': ''}], 'year': 2009, 'venue': 'N Engl J Med', 'volume': '360', 'issn': '21', 'pages': '2153--2160', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'History of biological warfare and bioterrorism', 'authors': [{'first': 'V', 'middle': [], 'last': 'Barras', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Microbiol Infect', 'volume': '20', 'issn': '6', 'pages': '497--502', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': 'Hune Cho http://dx.doi.org/10.4258/hir.2015.21.3.141', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715ef46e78c4e9dc70804'), 'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Editorial'}, {'text': \"The Middle East Respiratory Syndrome (MERS) crisis in Korea is coming to an end, but that's not the end of the story. The World Health Organization (WHO) has warned that the MERS crisis was a 'wakeup call. ' Like Severe Acute Respiratory Syndrome (SARS) in 2003 and swine flu in 2009, epidemic outbreaks will continue to happen anywhere. Korea was simply unlucky. In retrospect, it is regrettable to say that we could have done much better. Scholars and colleagues in the medical informatics field should take a moment and think hard about how we can work to fight against another epidemic invasion in the future.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'The Ebola epidemic of 2013 is the largest such outbreak on record, influencing many nations in Africa as well as other countries [1] . The WHO expert panel has pointed out the inadequate emergency care response and has recommended more effective mechanisms for research and development. Others have strongly recommended WHO to innovate because recent Ebola outbreaks have been radically different from previous events, and they have tended to be simultaneous and parallel: \"Highly mobile populations, the spread of Ebola into densely populated cities ... made this epidemic of many outbreaks difficult to control [2] . \"', 'cite_spans': [{'start': 129, 'end': 132, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 613, 'end': 616, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': \"Other criticisms also include outdated therapeutic protocols, irrelevant information, untimely communication, delays in decision-making due to uncoordinated leadership, unreasonable social behavior, and so on. The recom- tems. The NEDSS can be called a medical informatics leader, which provides a standardized information infrastructure with HL7, LOINC, and SNOMED-CT. Highly useful information is well organized and ready to be used in the US-CDC [6] , so we don't have to reinvent the wheel. All we need is to find a conduit for connection. For example, the task of disease surveillance for MERS is relatively small compared to NEDSS. Using the cell phone data network, we can instantly establish a real-time patient tracking system to monitor 3-tuple data (time, location, temperature) in the country. Cell phone rental can help track down suspicious foreign visitors from arrival to departure. With the support of ISO standards, global healthcare networking is not a hard nut to crack.\", 'cite_spans': [{'start': 449, 'end': 452, 'text': '[6]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'When the MERS epidemic outbreak was on the headline news, many attempts were made to compare MERS with tuberculosis. That is, the mortality rate of MERS is far below that of tuberculosis, so it was argued that there was no need to worry about it. The point was clear, but the timing was not right. Have you ever got a thorn stuck under your fingernail? Saying that \"It\\'s OK you\\'re not bleeding\" or \"You won\\'t die from it\" would not comfort anybody at all. I would venture to say that it is surely mistaken to compare the pain at present with a probable outcome yet to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': 'When hospital visitors became MERS patients, a typical example of nosocomial infection was demonstrated. It was a surprise attack, and the whole country was shaken and panicked. The WHO experts reminded us that hospital shopping greatly contributed to the rapid spread of MERS in Korea. We have to understand why patients pursue hospital shopping. The death of professionalism may be an unexpected result of the fashionable social network services (SNS). Patients use SNSs to data-mine their own diagnosis and prescription and then seek medical advice to compare with their own ideas about their personal health. However, such patients suggesting their own diagnoses and treatments can be described as \"Jack of all trades, master of none\". Medical informatics leadership was nowhere to be found. When the MERS epidemic turned fatal, SNS was the only rescue. MERS was unknown to the general public, and the cure was uncertain, so chaos was bound to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In Korea medical informatics is on trial. We are standing in front of a river that runs medicine. IT has been trying to cross the river but has never been successful, especially in medical expert systems. The other side of the river is not the land of promise. Because the river of medicine eventu-ally runs into the ocean of the human race, why don't we go with the river instead? There is no doubt that doctors and nurses were the final frontiers in the MERS battle. Despite all the wonderful scientific accomplishments, the MERS crisis reminds us that clinical expertise is the most important value as clearly as ever. Technology can help medicine, not the other way around; that is the way medical informatics should go in between.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"Taoism states that dynamic balance can be obtained from two opposite powers competing with each other, unifying as a complete energy. Similarly, medical informatics should be able to balance between analog medicine and digital technology to create a new value. Medicine is composed of oldfashioned values, such as rapport, which is fading out slowly. Digital technology should help clinicians restore the humanistic flavor of medicine by eliminating managerial overload in healthcare settings. Technology can start from there. Neither Cyclops (the single-eyed monster in Homer's Odyssey) nor Argus (the 100-eyed giant in Greek mythology) is ideal to find the right path. Two-eyed medical informaticians must walk through the path on the mountain ridge, carefully looking at both sides of IT and medicine for balance.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In 1347, the first biological warfare took place in the siege of Caffa (now Feodosia in Ukraine) on the Black Sea coast. The Mongol army with bubonic plague catapulted corpse of those who had died from the Black Death over the city walls. Fleeing from central trading ports along the coast, infected inhabitants and rats may have carried the disease throughout Europe [7] (The plague might have killed more than 25 million people). A few regions survived. They simply closed their ports of entry and isolated patients in remote places. The same principle still applies. When in doubt, isolate an infection until it's clear. Time goes by, technology advances, but the basic principle never changes. Medicine should stay analog with a little hint of digital. That's all it takes to fight against any epidemic or pandemic attack in the future.\", 'cite_spans': [{'start': 368, 'end': 371, 'text': '[7]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Report of the Ebola Interim Assessment Panel', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"What we've learned about fighting Ebola\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Dhillon', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Srikrishna', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Harvard Business Review; c2015', 'authors': [{'first': '(', 'middle': [], 'last': 'Boston', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ma)', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The next epidemic: lessons from Ebola', 'authors': [{'first': 'B', 'middle': [], 'last': 'Gates', 'suffix': ''}], 'year': 2015, 'venue': 'N Engl J Med', 'volume': '372', 'issn': '15', 'pages': '1381--1385', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'US Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Centers for Disease Control and Prevention; c2015', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Digital disease detection: harnessing the Web for public health surveillance', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Brownstein', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Freifeld', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Madoff', 'suffix': ''}], 'year': 2009, 'venue': 'N Engl J Med', 'volume': '360', 'issn': '21', 'pages': '2153--2160', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'History of biological warfare and bioterrorism', 'authors': [{'first': 'V', 'middle': [], 'last': 'Barras', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Microbiol Infect', 'volume': '20', 'issn': '6', 'pages': '497--502', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': 'Hune Cho http://dx.doi.org/10.4258/hir.2015.21.3.141', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n"
     ]
    }
   ],
   "source": [
    "# find one paper by paper_id\n",
    "\n",
    "for c in db.pmc_content.find({'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24'}):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5ea713694867d6c5a9bc5a31'), 'paper_id': '0a003aa69f43cee4357f1e943df79a8b87c0a88e', 'metadata': {'title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen', 'authors': [{'first': 'Paula', 'middle': [], 'last': 'Tucci', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Verónica', 'middle': [], 'last': 'Estevez', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Lorena', 'middle': [], 'last': 'Becco', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Florencia', 'middle': [], 'last': 'Cabrera-Cabrera', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Germán', 'middle': [], 'last': 'Grotiuz', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Eduardo', 'middle': [], 'last': 'Reolon', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Mónica', 'middle': [], 'last': 'Marín', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': 'marin@fcien.edu.uym.marín.'}]}, 'abstract': [{'text': 'Bovine Respiratory Disease is the most costly disease that affects beef and dairy cattle industry. Its etiology is multifactorial, arising from predisposing environmental stress conditions as well as the action of several different respiratory pathogens. This situation has hindered the development of effective control strategies. Although different type of vaccines are available, many currently marketed vaccines are based on inactivated cultures of the main viral and bacterial agents involved in this pathology. The molecular composition of commercial veterinary vaccines is a critical issue. The present work aims to define at the proteomic level the most relevant valence of a line of commercial respiratory vaccines widely used in Central and South America. Since Mannheimia haemolytica is responsible for most of the disease associated morbid-mortality, we focused on the main proteins secreted by this pathogen, in particular Leukotoxin A, its main virulence factor. By Western blot analysis and mass spectrometry, Leukotoxin A was identified as a major component of (http://creativecommons.org/licenses/by-nc-nd/4.0/). M. haemolytica culture supernatants. We also identified other ten M. haemolytica proteins, including outer membrane proteins, periplasmic transmembrane solute transporters and iron binding proteins, which are relevant to achieve protective immunity against the pathogen. This work allowed a detailed molecular characterization of this vaccine component, providing evidence of its quality and efficacy. Furthermore, our results contributed to the identification of several proteins of interest as subunit vaccine candidates.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Bovine Respiratory Disease (BRD) is one of the leading causes of death and economic loss for the beef and dairy cattle industry. It has an estimated annual cost to the worldwide cattle industry of over $3 billion (Potter, 2015) . This multifactorial syndrome can be caused either by viral or bacterial pathogens. Viral agents include bovine respiratory syncytial virus (BRSV) (Gershwin et al., 2000) , parainfluenza III virus (PI-3) (Fulton et al., 2000) , bovine viral diarrhea virus (BVDV) (Ridpath, 2010) and bovine corona virus (BCV) (Autio et al., 2007) . These respiratory viruses along with some mycoplasmal agents are generally the primary infectious agents involved in BRD (Potter, 2015) . This initial infection establishes a respiratory environment predisposing to the colonization and replication of pathogenic bacteria, including Mannheimia haemolytica (Al-Ghamdi et al., 2000) , Pasteurella multocida (Dabo et al., 2007) and Histophilus somni (Corbeil, 2007) , the former being responsible for up to 50% of the disease associated mortality (Narayanan et al., 2002; Potter, 2015) . M. haemolytica is a Gram negative opportunistic bacterium. Although it is a common bacterium of the upper respiratory tract and nasopharynx of healthy ruminants, it can also act as an opportunistic pathogen infecting the lower respiratory tract under stressful situations such as shipping, adverse environmental conditions or previous respiratory viral infection (Youssef et al., 2004; Orouji et al., 2012) .', 'cite_spans': [{'start': 213, 'end': 227, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 376, 'end': 399, 'text': '(Gershwin et al., 2000)', 'ref_id': 'BIBREF22'}, {'start': 433, 'end': 454, 'text': '(Fulton et al., 2000)', 'ref_id': 'BIBREF19'}, {'start': 492, 'end': 507, 'text': '(Ridpath, 2010)', 'ref_id': 'BIBREF43'}, {'start': 538, 'end': 558, 'text': '(Autio et al., 2007)', 'ref_id': 'BIBREF4'}, {'start': 682, 'end': 696, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 866, 'end': 890, 'text': '(Al-Ghamdi et al., 2000)', 'ref_id': 'BIBREF1'}, {'start': 915, 'end': 934, 'text': '(Dabo et al., 2007)', 'ref_id': 'BIBREF14'}, {'start': 957, 'end': 972, 'text': '(Corbeil, 2007)', 'ref_id': 'BIBREF12'}, {'start': 1054, 'end': 1078, 'text': '(Narayanan et al., 2002;', 'ref_id': 'BIBREF37'}, {'start': 1079, 'end': 1092, 'text': 'Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 1458, 'end': 1480, 'text': '(Youssef et al., 2004;', 'ref_id': 'BIBREF52'}, {'start': 1481, 'end': 1501, 'text': 'Orouji et al., 2012)', 'ref_id': None}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Being BRD a multifactorial disease, the development of effective control strategies has been difficult to accomplish. Vaccination against viral and bacterial pathogens involved in BRD is a useful tool to reduce the risk of this disease. Many commercial respiratory vaccines are composed by inactivated cultures of the most relevant pathogens (Edwards, 2010; Rodrigues et al., 2015) . These multivalent formulations are designed to reduce the impact of viral infections and to neutralize the severe associated bacterial infections. Therefore, to guarantee the efficacy of BRD vaccines, it is important to achieve a complete characterization of the antigens included in the vaccine and to verify the presence of those molecules critical for establishing an efficient immunological protection.', 'cite_spans': [{'start': 342, 'end': 357, 'text': '(Edwards, 2010;', 'ref_id': 'BIBREF16'}, {'start': 358, 'end': 381, 'text': 'Rodrigues et al., 2015)', 'ref_id': 'BIBREF44'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In this work we attempt to characterize the main proteins of M. haemolytica in a polyvalent inactivated BRD line of vaccines currently commercialized in Central and South America (Neumosan, Virbac Uruguay S.A. (former Santa Elena), http:// www.santaelena.com.uy). Among them we emphasize the study of Leukotoxin A (LKT), its main virulence factor, which has been shown to play an important role in the development of a protective immunity against the pathogen (Confer et al., 2009 ).', 'cite_spans': [{'start': 460, 'end': 480, 'text': '(Confer et al., 2009', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'LKT is a potent cytolytic toxin, with an apparent molecular weight (MW) of 105 kDa, actively secreted by all serotypes of the bacterium during the logarithmic phase of in vitro growth (Shewen and Wilkie, 1985; Chang et al., 1987) . It belongs to the family of the RTX (repeat in toxin) pore-forming cytolysins, which have been linked with the virulence of other bacterial species (Lo et al., 1987; Lainson et al., 1996) . It specifically targets ruminant leukocytes and plays a major role in pathogenesis of BRD by impairing the primary lung defense mechanism and by inducing inflammation as a consequence of leukocyte lysis (Conlon et al., 1991) . This phenomenon has been correlated with its ability to bind and interact with the ruminant beta2-integrin Lymphocyte Function-associated Antigen 1 (LFA-1) (CD11a/CD18) (Zecchinon et al., 2005; Singh et al., 2011) . Neutralizing antibodies generation against the cytolytic toxin is relevant for achieving a high level of protection (Mosier et al., 1989) . Immunity against M. haemolytica also requires antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988) and iron-regulated outer membrane proteins (Potter et al., 1999) .', 'cite_spans': [{'start': 184, 'end': 209, 'text': '(Shewen and Wilkie, 1985;', 'ref_id': 'BIBREF47'}, {'start': 210, 'end': 229, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 380, 'end': 397, 'text': '(Lo et al., 1987;', 'ref_id': 'BIBREF34'}, {'start': 398, 'end': 419, 'text': 'Lainson et al., 1996)', 'ref_id': 'BIBREF28'}, {'start': 625, 'end': 646, 'text': '(Conlon et al., 1991)', 'ref_id': 'BIBREF11'}, {'start': 818, 'end': 842, 'text': '(Zecchinon et al., 2005;', 'ref_id': 'BIBREF53'}, {'start': 843, 'end': 862, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}, {'start': 981, 'end': 1002, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 1102, 'end': 1127, 'text': '(Shewen and Wilkie, 1988)', 'ref_id': 'BIBREF48'}, {'start': 1171, 'end': 1192, 'text': '(Potter et al., 1999)', 'ref_id': 'BIBREF40'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Our aim is to bring more insight into the molecular composition of a M. haemolytica inactivated antigen used in bovine commercial vaccines, focusing on the identification of relevant secreted or surface-exposed proteins. This knowledge will support the development of specific quality control techniques to assist the optimization and standardization of the industrial vaccine production process.', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': '2.1. Laboratory scale M. haemolytica culture A seed culture was prepared by inoculation of an aliquot of master seed bank (MSB) of M. haemolytica serotype A1 (production strain code B059) in TSB-BHI (Tryptic Soy Broth, Brain Heart Infusion, Porcine) and incubation at 37.0 ± 1.0°C, for 12 h with orbital agitation (220 rpm). Inoculum was prepared by a 1:100 dilution of the seed culture in TSB-BHI and further incubation at 37.0 ± 1.0°C with orbital agitation until an optical density at 600 nm (OD 600nm ) of 0.2 to 0.3 units was reached. A benchtop fermentor (Biostat A, New Brunswick) with 2 L of fermentation media (TSB-BHI supplemented with 0.4% glucose) was inoculated with 20 mL of the inoculum culture (1:100 dilution). The fermentation culture was grown at 37.0 ± 1.0°C with dissolved oxygen set above 40% and variable Article No~e00158 agitation. During fermentation, samples were taken every one hour to measure OD 600nm , dissolved oxygen (%), glucose concentration (mg/dL) and pH. The culture was harvested when it reached stationary growth phase. Samples and the final culture were centrifuged at 8000×g for 30 min at 4°C and culture supernatants were stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Materials and methods'}, {'text': 'M. haemolytica culture for vaccine antigen preparation was performed following the industrial standardized protocol. Culture media used was developed by Virbac Uruguay S.A. and is based on protein hydrolysates, yeast extract, dextrose, and sodium and potassium salts. The inoculum was prepared as previously described using 1 vial of production seed of M. haemolytica serotype A1 (production strain code B059). The production fermentor was inoculated with a 1:100 dilution of the inoculum and the culture was performed at 37°C with automatic agitation and aeration until the end of the logarithmic growth phase. After harvesting, culture was inactivated by incubation at 37°C with formaldehyde 0.5% (v/v) during 24 h. To obtain culture supernatant the inactivated culture was centrifuged at 8000×g for 30 min at 4°C. Inactivated culture supernatant was stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Industrial M. haemolytica antigen preparation'}, {'text': 'Specific primers were designed to amplify a portion of LKT which contains the Cterminal domain of the protein. An in silico prediction of the location of linear Bcell epitopes was performed using Bepipred algorithm (Larsen et al., 2006) . As previously reported (Lee et al., 2001) , the portion of LktA with more immunogenic epitopes was the C-terminal domain. Therefore, a sequence including the main predicted epítopes (amino acid 713 to 873) was selected. M. haemolytica (production strain code B059) was cultured as the seed culture described above.', 'cite_spans': [{'start': 215, 'end': 236, 'text': '(Larsen et al., 2006)', 'ref_id': 'BIBREF29'}, {'start': 262, 'end': 280, 'text': '(Lee et al., 2001)', 'ref_id': None}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Culture was centrifuged at 10000×g and the cell pellet was stored at −70°C. M. haemolytica genomic DNA was extracted using a standard protocol (Ausubel et al., 1999) and partial LKT sequence was amplified by PCR. For LKT expression, restriction sites were included in primers for a directional cloning of LKT sequence in pET28a(+) vector (Novagen). E. coli BL21 DE3 (Novagen) competent cells were transformed with the construct and stored at −70°C in 15% glycerol. Plasmid DNA was isolated from E. coli using a commercial kit (QiaPrep Spin Miniprep, Qiagen). Plasmid sequence was confirmed by DNA sequencing at Institut Pasteur Montevideo (Uruguay). For LKT expression, a culture was performed in ZYM-5052 auto induction medium (Studier, 2005) for 18-20 h at 37.0 ± 1.0°C. As expected, by SDS-PAGE a band of approximately 40 kDa corresponding to the recombinant protein was observed. The protein was purified by IMAC chromatography (HisTrap HP, GE Healthcare) in an ÄKTA Purifier 100 (GE Healthcare). The Article No~e00158 purified protein was dialyzed against PBS 1X pH 7.4 and quantified by BCA (Pierce BCA Protein Assay Kit, Thermo Scientific).', 'cite_spans': [{'start': 143, 'end': 165, 'text': '(Ausubel et al., 1999)', 'ref_id': None}, {'start': 728, 'end': 743, 'text': '(Studier, 2005)', 'ref_id': 'BIBREF50'}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Two New Zealand white rabbits (2.5 Kg body weight) were maintained in the experimental animal facility (Instituto de Higiene, Universidad de la República, Uruguay) in accordance with animal procedures approved by the Honorary Commission of Animal Experimentation (CHEA protocol No 071140-000771-11).', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Both rabbits were immunized subcutaneously with 50 ug of recombinant LKT, on days 0 and 21 of the immunization protocol. Blood samples were taken on days 21, 45 and 115, and sera were prepared and stored at −20°C. Serum titers were determined by ELISA using 0.1 μg/well of recombinant LKT for coating, serum dilutions of 1:100 to 1:100.000, and conjugate dilution of 1:10.000 (Goat antirabbit IgG (whole molecule)-Peroxidase, Sigma). High titer sera were pooled and purified by protein A chromatography (HiTraprProtein A, GE Healthcare). Purified IgG reactivity against native and recombinant LKT was evaluated by Western blot as described below.', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Culture supernatants were analyzed by 12% SDS-PAGE and coomassie blue staining (Ausubel et al., 1999) . Molecular weight markers used were PageRuler Prestained Protein Ladder (Thermo Scientific) and Prestained Protein Ladder Broad Range (NEB).', 'cite_spans': [{'start': 79, 'end': 101, 'text': '(Ausubel et al., 1999)', 'ref_id': None}], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For Western blot analysis, proteins were transferred onto a nitrocellulose membrane (Hybond-C Extra, Amersham Biosciences) for one hour at 400 mA.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Rabbit antibodies against recombinant LKT, produced and purified by our work group, were used to identify LKT in culture supernatants. Briefly, membranes were incubated for 1 h at room temperature with anti-LKT antibodies at final concentration of 17.5 μg/mL in PBS 1X pH 7.4, 5% low fat milk, with gentle agitation. For antigen-antibody detection membranes were incubated for 1 h at room temperature with a 1:5000 dilution of anti-rabbit IgG (whole molecule)alkaline phosphatase antibody produced in goat (Sigma) in PBS 1X pH 7.4, 5% low fat milk. The intensity of resulting bands was quantified using a Molecular Imaging Software (Carestream Health Inc).', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For immune response evaluation bovine sera obtained from a calf infected with M. haemolytica and from a healthy calf were gently provided by Virbac Uruguay.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Inactivated and non inactivated culture supernatant samples analyzed by SDS-PAGE were transferred onto membranes, as previously described. Membranes were incubated for 1 h at room temperature with a 1:500 dilution of each serum and afterwards for 1 h at room temperature with a 1:5000 dilution of anti-bovine', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'IgG-HRP (Novex), all in PBS 1X pH 7.4, 5% low fat milk. Detection was performed using TMB liquid substrate system for membranes (Sigma).', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Inactivated culture supernatant obtained from the industrial process was concentrated 20X by ultrafiltration (Vivaspin 500, 5 kDa, GE Healthcare) and analyzed by SDS-PAGE and coomassie blue staining. The most defined and intense bands were identified by peptide mass fingerprinting at Institut Pasteur Montevideo (Uruguay) using a 4800 MALDI TOF/TOF Analyzer (Applied Biosystems). Peptides from each sample were obtained by trypsin treatment (Sequencing Grade, Promega) overnight at 37°C. Peptide mass spectra were acquired as previously described (Lima et al., 2011) and MS/MS collision induced dissociation experiments of selected peptides were performed. Proteins were identified by NCBInr database searching with peptide m/z values using MASCOT search engine (Matrix Science) (Perkins et al., 1999) with the following searching parameters: monoisotopic mass tolerance, 0.08 Da; fragment mass tolerance, 0.45 Da and one missing tryptic cleavage allowed. Significant scores (p < 0.05) were used as criteria for positive protein identification.', 'cite_spans': [{'start': 548, 'end': 567, 'text': '(Lima et al., 2011)', 'ref_id': 'BIBREF32'}, {'start': 780, 'end': 802, 'text': '(Perkins et al., 1999)', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'Mass spectrometry (MS)'}, {'text': 'During M. haemolytica laboratory scale fermentation, parameters such as glucose concentration, dissolved oxygen, optical density (OD 600nm ) and pH were determined in samples taken every one hour of culture. This fermentation showed a kinetic profile compatible with typical bacterial growth in a batch system (Fig. 1B) . Culture was harvested ten hours after fermentation start, at the beginning of the stationary growth phase.', 'cite_spans': [], 'ref_spans': [{'start': 310, 'end': 319, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'Supernatant samples of a M. haemolytica laboratory scale culture were analyzed in order to evaluate the LKT accumulation in the supernatant. To identify LKT specific anti-LKT antibodies were produced. In preliminary evaluation experiments, we confirmed that these antibodies showed the expected reactivity against native and recombinant LKT and a good specific antibody titer. By means of these antibodies we identified LKT as a single defined band of approximately 110 kDa in culture supernatant samples of M. haemolytica (Fig. 1A) . In parallel, the presence of LKT in this protein band was confirmed by MS analysis (MS/MS protein score 408, protein sequence coverage 36%).', 'cite_spans': [], 'ref_spans': [{'start': 523, 'end': 532, 'text': '(Fig. 1A)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'The intensity of the specific LKT band detected by Western blot was determined by molecular imaging software. This analysis showed that LKT expression Article No~e00158 correlates with growth kinetics, being associated with exponential growth phase of M. haemolytica (Fig. 1B) , as previously reported (Chang et al., 1987) . Therefore, the presence of LKT was verified in the culture supernatant of the M. haemolytica production strain, during the exponential growth phase of the culture.', 'cite_spans': [{'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 267, 'end': 276, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'For proteomic analysis, industrial antigen was prepared according to vaccine production protocol. Culture supernatant was obtained and concentrated by ultrafiltration. After SDS-PAGE electrophoresis and coomassie blue staining, selected bands were recovered for MS identification ( Fig. 2A) . This approach allowed the statistically significant identification of 11 proteins of M. haemolytica in the industrial antigen (Table 1) . LKT was identified, in accordance with previous results of laboratory scale fermentation, among other relevant proteins.', 'cite_spans': [], 'ref_spans': [{'start': 282, 'end': 290, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF1'}, {'start': 419, 'end': 428, 'text': '(Table 1)', 'ref_id': None}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Some of these are outer membrane proteins (OMPs), which along with LKT are critical to achieve a protective immunity to the pathogen Singh et al., 2011) . Subcellular in silico localization, predicted using free access PSORTb software (available at http://psort.hgc.jp/), indicated that most of the identified proteins are periplasmic (7/11), with others being extracellular (1/11) or located in the outer cell membrane (2/11).', 'cite_spans': [{'start': 133, 'end': 152, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}], 'ref_spans': [], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Although most proteins coincided with their theoretical MW (Table 1) Article No~e00158 (Fig. 2B ). This behavior of LKT in electrophoresis could be explained by crosslinking caused by formaldehyde treatment leading to high molecular weight structures.', 'cite_spans': [], 'ref_spans': [{'start': 59, 'end': 68, 'text': '(Table 1)', 'ref_id': None}, {'start': 87, 'end': 95, 'text': '(Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Immune reactivity of a serum obtained from a M. haemolytica infected calf against culture supernatant was addressed by Western blot. As shown in Fig. 2B several bands of both inactivated and non inactivated culture supernatant were specifically recognized by infected bovine serum and not by healthy bovine serum. Among them, LKT was the more reactive band. Ayalew et al., 2011) . (Rabus et al., 1999; Eidam et al., 2013) .', 'cite_spans': [{'start': 358, 'end': 378, 'text': 'Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}, {'start': 381, 'end': 401, 'text': '(Rabus et al., 1999;', 'ref_id': 'BIBREF42'}, {'start': 402, 'end': 421, 'text': 'Eidam et al., 2013)', 'ref_id': None}], 'ref_spans': [{'start': 145, 'end': 152, 'text': 'Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': '10 HisJ-like histidine ABC transport system-periplasmic binding protein MHH_RS14805 328 M9WWE6 28.0 kDa Periplasmic ABC transporter system component involved in molecule export through bacterial membrane (Eidam et al., 2013) . Belongs to ompA family (Eidam et al., 2013) . Ortholog Omp P6 reported as immunogen in other species (Roier et al., 2013; Alvarez et al., 2015) . * For this search protein scores greater than 87 are significant (p < 0.05).', 'cite_spans': [{'start': 204, 'end': 224, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 250, 'end': 270, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 328, 'end': 348, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 349, 'end': 370, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'disease associated morbid-mortality (Potter, 2015) , this kind of information is of utmost importance.', 'cite_spans': [{'start': 36, 'end': 50, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Available data demonstrate that the protective immunity against M. haemolytica can be acquired by neutralizing antibodies against Leukotoxin A (Mosier et al., 1989) , as well as antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988; Confer et al., 1995; Confer et al., 2009) . In order to promote an effective immune response, the presence of these pivotal elements in a BRD vaccine formulation is crucial.', 'cite_spans': [{'start': 143, 'end': 164, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 229, 'end': 254, 'text': '(Shewen and Wilkie, 1988;', 'ref_id': 'BIBREF48'}, {'start': 255, 'end': 275, 'text': 'Confer et al., 1995;', 'ref_id': 'BIBREF10'}, {'start': 276, 'end': 296, 'text': 'Confer et al., 2009)', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Based on previous reports that detected Leukotoxin A activity in bacterium-free culture supernatant from logarithmic-phase cultures (Chang et al., 1987) , Neumosan line of vaccines includes inactivated culture supernatants of an industrial optimized M. haemolytica culture. In this work we confirmed that LKT secretion is linked to the exponential growth phase during the antigen production culture, representing one of the primary secreted components. In culture supernatant, LKT was detected as a single band with the expected MW (approx. 110 kDa) (Lo et al., 1985; Chang et al., 1987) . Interestingly, after formaldehyde treatment, LKT was detected as a higher MW band (>230 kDa),', 'cite_spans': [{'start': 132, 'end': 152, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 550, 'end': 567, 'text': '(Lo et al., 1985;', 'ref_id': 'BIBREF33'}, {'start': 568, 'end': 587, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'suggesting that the toxin could be arranged as a high order structure, which could be fixed by this cross-linking agent (Klockenbusch and Kast, 2010) . This finding is in agreement with previous reports that showed that the molecular weight of native LKT in culture supernatant was higher than 400 kDa (Chang et al., 1987) .', 'cite_spans': [{'start': 120, 'end': 149, 'text': '(Klockenbusch and Kast, 2010)', 'ref_id': 'BIBREF27'}, {'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Besides LKT identification, we delved further into the characterization of the culture supernatant protein profile. By MS we identified other 10 proteins of M. haemolytica. Most of them are periplasmic and outer membrane proteins, which due to their extracellular location and exposure to the host immune system could represent interesting candidates to play a key role in the protection against this pathogen. It is worth mentioning that we also identified a cytoplasmic protein involved in carbohydrate metabolism (Formate C-acetyltransferase). This finding could be explained by some cellular lysis that could occur during bacterial growth and inactivation (Derzelle et al., 2005) , hence we cannot rule out that the culture supernatant may contain some cytoplasmic proteins.', 'cite_spans': [{'start': 660, 'end': 683, 'text': '(Derzelle et al., 2005)', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Some of the outer membrane proteins identified in this work have been reported as important immunogens and have been evaluated as recombinant subunit antigens due to their protective vaccine potential (Ayalew et al., 2011; Guzman-Brambila et al., 2012) . In particular, vaccination of mice and cattle with recombinant serotype specific antigen 1 (rSsa1) stimulated high antibody responses (Ayalew et al., 2011) . Besides, a \"Best-Reciprocal-Blast-Hit\" approach was performed in order to determine that M. haemolytica outer membrane protein P6 identified in this work, is ortholog to Omp P6 of H. somni and P. multocida, both reported as Article No~e00158', 'cite_spans': [{'start': 201, 'end': 222, 'text': '(Ayalew et al., 2011;', 'ref_id': 'BIBREF8'}, {'start': 223, 'end': 252, 'text': 'Guzman-Brambila et al., 2012)', 'ref_id': None}, {'start': 389, 'end': 410, 'text': '(Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'immunogenic in recent reports (Roier et al., 2013; Alvarez et al., 2015) . In that sense, the natural occurrence of these proteins in the inactivated vaccine antigen indicates that the vaccine contains the main components required for protection against M. haemolytica.', 'cite_spans': [{'start': 30, 'end': 50, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 51, 'end': 72, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Different proteins belonging to the ATP-binding cassette (ABC) transporter superfamily were identified in the commercial antigen. ABC transport systems are essential for many processes of the cell, such as uptake of amino acids, peptides, carbohydrates and metal ions in an ATP coupled process. There is increasing evidence that these transport systems play either direct or indirect roles in the virulence and pathogenicity of bacteria (Garmory and Titball, 2004) . In a recent work, other ABC transporters were identified as immunodominant proteins from M. haemolytica and H. somni in cattle immunized with a commercial cellular vaccine, confirming that the surface exposed transporters of these species are immunogenic (Alvarez et al., 2015) . Interestingly, our results evidence that ABC transporters are relevant components in the vaccine antigen, and therefore could be potential targets for the development of antibacterial subunit vaccines (Garmory and Titball, 2004) .', 'cite_spans': [{'start': 437, 'end': 464, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}, {'start': 722, 'end': 744, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 948, 'end': 975, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Finally, we also identified an iron-regulated periplasmic protein YfeA, previously described as immunodominant in animals immunized with a cellular M. haemolytica vaccine (Alvarez et al., 2015) , as well as with an OMP-enriched fraction of M. haemolytica (Ayalew et al., 2010) .', 'cite_spans': [{'start': 171, 'end': 193, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 255, 'end': 276, 'text': '(Ayalew et al., 2010)', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Taken together, these observations support the protective potential of several of the proteins indentified in the M. haemolytica antigen. As an additional outcome anti-LKT antibodies developed for LKT identification can be used in routine quantitative assays in order to establish acceptance criteria of antigen commercial batches.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Author contribution statement Contributed reagents, materials, analysis tools or data.', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}, {'text': 'Article No~e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}], 'bib_entries': {'BIBREF1': {'ref_id': 'b1', 'title': 'Serotyping of Mannheimia (Pasteurella) haemolytica isolates from the upper Midwest United States', 'authors': [{'first': 'G', 'middle': ['M'], 'last': 'Al-Ghamdi', 'suffix': ''}, {'first': 'T', 'middle': ['R'], 'last': 'Ames', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Baker', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Walker', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Chase', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Frank', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}], 'year': 2000, 'venue': 'J. Vet. Diagn. Invest', 'volume': '12', 'issn': '6', 'pages': '576--578', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach', 'authors': [{'first': 'A', 'middle': ['H'], 'last': 'Alvarez', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Gutierrez-Ortega', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hernandez-Gutierrez', 'suffix': ''}], 'year': 2015, 'venue': 'Can. J. Vet. Res', 'volume': '79', 'issn': '4', 'pages': '339--342', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds', 'authors': [{'first': 'T', 'middle': [], 'last': 'Autio', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pohjanvirta', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Holopainen', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Rikula', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Pentikainen', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Huovilainen', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Rusanen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Soveri', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Sihvonen', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pelkonen', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': ['D'], 'last': 'Hartson', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}], 'year': 2010, 'venue': 'Proteomics', 'volume': '10', 'issn': '11', 'pages': '2151--2164', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'A', 'middle': ['E'], 'last': 'Wilson', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Clin. Vaccine Immunol', 'volume': '18', 'issn': '12', 'pages': '2067--2074', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Step', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Wray', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Hansen', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 2009, 'venue': 'Vaccine', 'volume': '27', 'issn': '11', 'pages': '1771--1776', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Mccraw', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Durham', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Morton', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 1995, 'venue': 'Vet. Immunol. Immunopathol', 'volume': '47', 'issn': '1-2', 'pages': '101--110', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Conlon', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '2', 'pages': '587--591', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Histophilus somni host-parasite relationships', 'authors': [{'first': 'L', 'middle': ['B'], 'last': 'Corbeil', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '151--160', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Identification and characterization of the Pasteurella haemolytica leukotoxin', 'authors': [{'first': 'Y', 'middle': ['F'], 'last': 'Chang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Young', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Post', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Struck', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '10', 'pages': '2348--2354', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Pasteurella multocida and bovine respiratory disease', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Dabo', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Taylor', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '129--150', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein', 'authors': [{'first': 'S', 'middle': [], 'last': 'Derzelle', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bolotin', 'suffix': ''}, {'first': 'M', 'middle': ['Y'], 'last': 'Mistou', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Rul', 'suffix': ''}], 'year': 2005, 'venue': 'Appl. Environ. Microbiol', 'volume': '71', 'issn': '12', 'pages': '8597--8605', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Control methods for bovine respiratory disease for feedlot cattle', 'authors': [{'first': 'T', 'middle': ['A'], 'last': 'Edwards', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '273--284', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Complete genome sequence of Mannheimia haemolytica strain 42548 from a case of bovine respiratory disease', 'authors': [{'first': 'S', 'middle': [], 'last': 'Schwarz', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Fulton', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Purdy', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'J', 'middle': ['T'], 'last': 'Saliki', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Loan', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Burge', 'suffix': ''}], 'year': 2000, 'venue': 'Can. J. Vet. Res', 'volume': '64', 'issn': '3', 'pages': '151--159', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies', 'authors': [{'first': 'H', 'middle': ['S'], 'last': 'Garmory', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Titball', 'suffix': ''}], 'year': 2004, 'venue': 'Infect. Immun', 'volume': '72', 'issn': '12', 'pages': '6757--6763', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves', 'authors': [{'first': 'L', 'middle': ['J'], 'last': 'Gershwin', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Gunther', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Anderson', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Woolums', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Mcarthur-Vaughan', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Randel', 'suffix': ''}, {'first': 'G', 'middle': ['A'], 'last': 'Boyle', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Friebertshauser', 'suffix': ''}, {'first': 'P', 'middle': ['S'], 'last': 'Mcinturff', 'suffix': ''}], 'year': 2000, 'venue': 'Am. J. Vet. Res', 'volume': '61', 'issn': '3', 'pages': '291--298', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge', 'authors': [{'first': 'A', 'middle': ['E'], 'last': 'Ortuno-Sahagun', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Res. Vet. Sci', 'volume': '93', 'issn': '3', 'pages': '1293--1300', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Complete closed genome sequences of Mannheimia haemolytica serotypes A1 and A6, isolated from cattle', 'authors': [{'first': 'G', 'middle': ['P'], 'last': 'Harhay', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Koren', 'suffix': ''}, {'first': 'A', 'middle': ['M'], 'last': 'Phillippy', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Mcvey', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kuszak', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Clawson', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Harhay', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Heaton', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Chitko-Mckown', 'suffix': ''}, {'first': 'T', 'middle': ['P'], 'last': 'Smith', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2 Isolates D171 and D35 recovered from bovine pneumonia', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Hauglund', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Tatum', 'suffix': ''}, {'first': 'D', 'middle': ['O'], 'last': 'Bayles', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}], 'year': 2015, 'venue': 'Genome Announc', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1', 'authors': [{'first': 'C', 'middle': [], 'last': 'Klockenbusch', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kast', 'suffix': ''}], 'year': 2010, 'venue': 'J. Biomed. Biotechnol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin', 'authors': [{'first': 'F', 'middle': ['A'], 'last': 'Lainson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Murray', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Davies', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Donachie', 'suffix': ''}], 'year': 1996, 'venue': 'Microbiology', 'volume': '142', 'issn': '', 'pages': '2499--2507', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Improved method for predicting linear B-cell epitopes', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Larsen', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Lund', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nielsen', 'suffix': ''}], 'year': 2006, 'venue': 'Immunome Res', 'volume': '2', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2: ovine and bovine isolates', 'authors': [{'first': 'P', 'middle': ['K'], 'last': 'Lawrence', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Kittichotirat', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Bumgarner', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Mcdermott', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Herndon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Knowles', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Srikumaran', 'suffix': ''}], 'year': 2010, 'venue': 'J. Bacteriol', 'volume': '192', 'issn': '4', 'pages': '1167--1168', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches', 'authors': [{'first': 'A', 'middle': [], 'last': 'Lima', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Duran', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Schujman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Marchissio', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Portela', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Obal', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Pritsch', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'De Mendoza', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Cervenansky', 'suffix': ''}], 'year': 2011, 'venue': 'J. Proteomics', 'volume': '74', 'issn': '9', 'pages': '1720--1734', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'C', 'middle': ['N'], 'last': 'Greer', 'suffix': ''}], 'year': 1985, 'venue': 'Infect. Immun', 'volume': '50', 'issn': '3', 'pages': '667--671', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '9', 'pages': '1987--1996', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Cooney', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '10', 'pages': '3398--3406', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Mosier', 'suffix': ''}, {'first': 'K', 'middle': ['R'], 'last': 'Simons', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}, {'first': 'K', 'middle': ['D'], 'last': 'Clinkenbeard', 'suffix': ''}], 'year': 1989, 'venue': 'Infect. Immun', 'volume': '57', 'issn': '3', 'pages': '711--716', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Leukotoxins of gram-negative bacteria', 'authors': [{'first': 'S', 'middle': ['K'], 'last': 'Narayanan', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Nagaraja', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Chengappa', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Stewart', 'suffix': ''}], 'year': 2002, 'venue': 'Vet. Microbiol', 'volume': '84', 'issn': '4', 'pages': '337--356', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Probability-based protein identification by searching sequence databases using mass spectrometry data', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Perkins', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Pappin', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Creasy', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Cottrell', 'suffix': ''}], 'year': 1999, 'venue': 'Electrophoresis', 'volume': '20', 'issn': '18', 'pages': '3551--3567', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb', 'authors': [{'first': 'A', 'middle': ['A'], 'last': 'Potter', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Schryvers', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Ogunnariwo', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Hutchins', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Watts', 'suffix': ''}], 'year': 1999, 'venue': 'Pathogenesis', 'volume': '27', 'issn': '4', 'pages': '197--206', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Bovine respiratory disease', 'authors': [{'first': 'T', 'middle': [], 'last': 'Potter', 'suffix': ''}], 'year': 2015, 'venue': 'Livestock (Electronic)', 'volume': '20', 'issn': '1', 'pages': '14--18', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'TRAP transporters: an ancient family of extracytoplasmic solute-receptor-dependent secondary active transporters', 'authors': [{'first': 'R', 'middle': [], 'last': 'Rabus', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Jack', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Kelly', 'suffix': ''}, {'first': 'M', 'middle': ['H'], 'last': 'Saier', 'suffix': ''}], 'year': 1999, 'venue': 'Microbiology', 'volume': '145', 'issn': '', 'pages': '3431--3445', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The contribution of infections with bovine viral diarrhea viruses to bovine respiratory disease', 'authors': [{'first': 'J', 'middle': [], 'last': 'Ridpath', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '335--348', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Effects of vaccination against respiratory Article No~e00158 pathogens on feed intake, metabolic, and inflammatory responses in beef heifers', 'authors': [{'first': 'M', 'middle': ['C'], 'last': 'Rodrigues', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Cooke', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Marques', 'suffix': ''}, {'first': 'B', 'middle': ['I'], 'last': 'Cappellozza', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Arispe', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Keisler', 'suffix': ''}, {'first': 'D', 'middle': ['W'], 'last': 'Bohnert', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': 'Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles', 'authors': [{'first': 'S', 'middle': [], 'last': 'Roier', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Fenninger', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Leitner', 'suffix': ''}, {'first': 'G', 'middle': ['N'], 'last': 'Rechberger', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Reidl', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schild', 'suffix': ''}], 'year': 2013, 'venue': 'Int. J. Med. Microbiol', 'volume': '303', 'issn': '5', 'pages': '247--256', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1985, 'venue': 'Am. J. Vet. Res', 'volume': '46', 'issn': '5', 'pages': '1212--1214', 'other_ids': {}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1988, 'venue': 'Can. J. Vet. Res', 'volume': '52', 'issn': '1', 'pages': '30--36', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'Mannheimia haemolytica: bacterial-host interactions in bovine pneumonia', 'authors': [{'first': 'K', 'middle': [], 'last': 'Singh', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Ritchey', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Vet. Pathol', 'volume': '48', 'issn': '2', 'pages': '338--348', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'Protein production by auto-induction in high density shaking cultures', 'authors': [{'first': 'F', 'middle': ['W'], 'last': 'Studier', 'suffix': ''}], 'year': 2005, 'venue': 'Protein Expr. Purif', 'volume': '41', 'issn': '1', 'pages': '207--234', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Sequence diversity of the leukotoxin (lktA) gene in caprine and ovine strains of Mannheimia haemolytica', 'authors': [{'first': 'C', 'middle': [], 'last': 'Vougidou', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Sandalakis', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Psaroulaki', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Petridou', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ekateriniadou', 'suffix': ''}], 'year': 2013, 'venue': 'Vet. Rec', 'volume': '172', 'issn': '16', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Effect of bovine granulocyte colony-stimulating factor on the development of pneumonia caused by Mannheimia haemolytica', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Youssef', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Clark', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Caswell', 'suffix': ''}], 'year': 2004, 'venue': 'Vet. Pathol', 'volume': '41', 'issn': '6', 'pages': '649--657', 'other_ids': {}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'How Mannheimia haemolytica defeats host defence through a kiss of death mechanism', 'authors': [{'first': 'L', 'middle': [], 'last': 'Zecchinon', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fett', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Desmecht', 'suffix': ''}], 'year': 2005, 'venue': 'Vet. Res', 'volume': '36', 'issn': '2', 'pages': '133--156', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': ', LKT was identified by MS in a higher than expected MW band (>230 kDa). This result was confirmed by Western blot of inactivated supernatant using anti-LKT antibodies M. haemolytica culture growth and LKT secretion profile. A. Anti-LKT Western blot of M. haemolytica culture supernatant samples from different fermentation time points. M: fermentation media, T1-T10: samples from culture kinetics (1-10 h). MW: Molecular weight marker. B. M. haemolytica culture growth curve and kinetics of Leukotoxin secretion. Optical density (OD) at 600 nm, glucose concentration (mg/dL) and band intensity of LKT expressed in arbitrary units (AU) are plotted versus culture growth time measured in hours.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'This work provides an exhaustive molecular characterization of an inactivated culture supernatant of M. haemolytica included in a line of polyvalent commercial bovine vaccines (Neumosan, Virbac Uruguay). Since M. haemolytica is the main etiological agent of BRD and is also responsible for a high proportion of the Identification of M. haemolytica culture supernatant proteins. A. M. haemolytica proteins of inactivated culture supernatant (iCSN) resolved in SDS-PAGE and stained with coomassie blue. Bands corresponding to the proteins analyzed by MS (MALDI TOF/TOF) are numbered and referred to on Table 1. For complete image see Fig. S1 (Supplementary material). B. Analysis of culture supernatant proteins by Western blot. Left: M. haemolytica inactivated (iCSN) and non inactivated culture supernatant (CSN) proteins probed with anti-rLKT rabbit serum. Middle: Reactivity of bovine M. haemolytica infected serum against M. haemolytica iCSN and CSN. Right: Reactivity of bovine healthy serum against M. haemolytica iCSN and CSN. MW: Molecular weight marker.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Proteins identified in culture supernatant of M. haemolytica.', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': 'Paula Tucci: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Verónica Estevez, Lorena Becco: Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Florencia Cabrera-Cabrera: Performed the experiments; Analyzed and interpreted the data. Germán Grotiuz: Performed the experiments; Analyzed and interpreted the data;', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We thank Viviana Sánchez for critical reading of the manuscript, Danilo Segovia for assistance in cloning techniques and Florencia Arezzo for technical assistance during M. haemolytica laboratory scale fermentation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}, {'text': 'This work was partially financed by Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing interest statement'}, {'text': 'This work was partially supported by Agencia Nacional de Investigación e Innovación (ANII, Uruguay), Alianzas para la Innovación (ALI_2_2013_1_4783) and Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding statement'}, {'text': 'Supplementary content related to this article has been published online at http://dx. doi.org/10.1016/j.heliyon.2016.e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Additional information'}]}\n",
      "{'_id': ObjectId('5ea715efc7f7cfde7827d5af'), 'paper_id': '0a003aa69f43cee4357f1e943df79a8b87c0a88e', 'metadata': {'title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen', 'authors': [{'first': 'Paula', 'middle': [], 'last': 'Tucci', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Verónica', 'middle': [], 'last': 'Estevez', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Lorena', 'middle': [], 'last': 'Becco', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Florencia', 'middle': [], 'last': 'Cabrera-Cabrera', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Germán', 'middle': [], 'last': 'Grotiuz', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Eduardo', 'middle': [], 'last': 'Reolon', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Mónica', 'middle': [], 'last': 'Marín', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': 'marin@fcien.edu.uym.marín.'}]}, 'abstract': [{'text': 'Bovine Respiratory Disease is the most costly disease that affects beef and dairy cattle industry. Its etiology is multifactorial, arising from predisposing environmental stress conditions as well as the action of several different respiratory pathogens. This situation has hindered the development of effective control strategies. Although different type of vaccines are available, many currently marketed vaccines are based on inactivated cultures of the main viral and bacterial agents involved in this pathology. The molecular composition of commercial veterinary vaccines is a critical issue. The present work aims to define at the proteomic level the most relevant valence of a line of commercial respiratory vaccines widely used in Central and South America. Since Mannheimia haemolytica is responsible for most of the disease associated morbid-mortality, we focused on the main proteins secreted by this pathogen, in particular Leukotoxin A, its main virulence factor. By Western blot analysis and mass spectrometry, Leukotoxin A was identified as a major component of (http://creativecommons.org/licenses/by-nc-nd/4.0/). M. haemolytica culture supernatants. We also identified other ten M. haemolytica proteins, including outer membrane proteins, periplasmic transmembrane solute transporters and iron binding proteins, which are relevant to achieve protective immunity against the pathogen. This work allowed a detailed molecular characterization of this vaccine component, providing evidence of its quality and efficacy. Furthermore, our results contributed to the identification of several proteins of interest as subunit vaccine candidates.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Bovine Respiratory Disease (BRD) is one of the leading causes of death and economic loss for the beef and dairy cattle industry. It has an estimated annual cost to the worldwide cattle industry of over $3 billion (Potter, 2015) . This multifactorial syndrome can be caused either by viral or bacterial pathogens. Viral agents include bovine respiratory syncytial virus (BRSV) (Gershwin et al., 2000) , parainfluenza III virus (PI-3) (Fulton et al., 2000) , bovine viral diarrhea virus (BVDV) (Ridpath, 2010) and bovine corona virus (BCV) (Autio et al., 2007) . These respiratory viruses along with some mycoplasmal agents are generally the primary infectious agents involved in BRD (Potter, 2015) . This initial infection establishes a respiratory environment predisposing to the colonization and replication of pathogenic bacteria, including Mannheimia haemolytica (Al-Ghamdi et al., 2000) , Pasteurella multocida (Dabo et al., 2007) and Histophilus somni (Corbeil, 2007) , the former being responsible for up to 50% of the disease associated mortality (Narayanan et al., 2002; Potter, 2015) . M. haemolytica is a Gram negative opportunistic bacterium. Although it is a common bacterium of the upper respiratory tract and nasopharynx of healthy ruminants, it can also act as an opportunistic pathogen infecting the lower respiratory tract under stressful situations such as shipping, adverse environmental conditions or previous respiratory viral infection (Youssef et al., 2004; Orouji et al., 2012) .', 'cite_spans': [{'start': 213, 'end': 227, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 376, 'end': 399, 'text': '(Gershwin et al., 2000)', 'ref_id': 'BIBREF22'}, {'start': 433, 'end': 454, 'text': '(Fulton et al., 2000)', 'ref_id': 'BIBREF19'}, {'start': 492, 'end': 507, 'text': '(Ridpath, 2010)', 'ref_id': 'BIBREF43'}, {'start': 538, 'end': 558, 'text': '(Autio et al., 2007)', 'ref_id': 'BIBREF4'}, {'start': 682, 'end': 696, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 866, 'end': 890, 'text': '(Al-Ghamdi et al., 2000)', 'ref_id': 'BIBREF1'}, {'start': 915, 'end': 934, 'text': '(Dabo et al., 2007)', 'ref_id': 'BIBREF14'}, {'start': 957, 'end': 972, 'text': '(Corbeil, 2007)', 'ref_id': 'BIBREF12'}, {'start': 1054, 'end': 1078, 'text': '(Narayanan et al., 2002;', 'ref_id': 'BIBREF37'}, {'start': 1079, 'end': 1092, 'text': 'Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 1458, 'end': 1480, 'text': '(Youssef et al., 2004;', 'ref_id': 'BIBREF52'}, {'start': 1481, 'end': 1501, 'text': 'Orouji et al., 2012)', 'ref_id': None}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Being BRD a multifactorial disease, the development of effective control strategies has been difficult to accomplish. Vaccination against viral and bacterial pathogens involved in BRD is a useful tool to reduce the risk of this disease. Many commercial respiratory vaccines are composed by inactivated cultures of the most relevant pathogens (Edwards, 2010; Rodrigues et al., 2015) . These multivalent formulations are designed to reduce the impact of viral infections and to neutralize the severe associated bacterial infections. Therefore, to guarantee the efficacy of BRD vaccines, it is important to achieve a complete characterization of the antigens included in the vaccine and to verify the presence of those molecules critical for establishing an efficient immunological protection.', 'cite_spans': [{'start': 342, 'end': 357, 'text': '(Edwards, 2010;', 'ref_id': 'BIBREF16'}, {'start': 358, 'end': 381, 'text': 'Rodrigues et al., 2015)', 'ref_id': 'BIBREF44'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In this work we attempt to characterize the main proteins of M. haemolytica in a polyvalent inactivated BRD line of vaccines currently commercialized in Central and South America (Neumosan, Virbac Uruguay S.A. (former Santa Elena), http:// www.santaelena.com.uy). Among them we emphasize the study of Leukotoxin A (LKT), its main virulence factor, which has been shown to play an important role in the development of a protective immunity against the pathogen (Confer et al., 2009 ).', 'cite_spans': [{'start': 460, 'end': 480, 'text': '(Confer et al., 2009', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'LKT is a potent cytolytic toxin, with an apparent molecular weight (MW) of 105 kDa, actively secreted by all serotypes of the bacterium during the logarithmic phase of in vitro growth (Shewen and Wilkie, 1985; Chang et al., 1987) . It belongs to the family of the RTX (repeat in toxin) pore-forming cytolysins, which have been linked with the virulence of other bacterial species (Lo et al., 1987; Lainson et al., 1996) . It specifically targets ruminant leukocytes and plays a major role in pathogenesis of BRD by impairing the primary lung defense mechanism and by inducing inflammation as a consequence of leukocyte lysis (Conlon et al., 1991) . This phenomenon has been correlated with its ability to bind and interact with the ruminant beta2-integrin Lymphocyte Function-associated Antigen 1 (LFA-1) (CD11a/CD18) (Zecchinon et al., 2005; Singh et al., 2011) . Neutralizing antibodies generation against the cytolytic toxin is relevant for achieving a high level of protection (Mosier et al., 1989) . Immunity against M. haemolytica also requires antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988) and iron-regulated outer membrane proteins (Potter et al., 1999) .', 'cite_spans': [{'start': 184, 'end': 209, 'text': '(Shewen and Wilkie, 1985;', 'ref_id': 'BIBREF47'}, {'start': 210, 'end': 229, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 380, 'end': 397, 'text': '(Lo et al., 1987;', 'ref_id': 'BIBREF34'}, {'start': 398, 'end': 419, 'text': 'Lainson et al., 1996)', 'ref_id': 'BIBREF28'}, {'start': 625, 'end': 646, 'text': '(Conlon et al., 1991)', 'ref_id': 'BIBREF11'}, {'start': 818, 'end': 842, 'text': '(Zecchinon et al., 2005;', 'ref_id': 'BIBREF53'}, {'start': 843, 'end': 862, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}, {'start': 981, 'end': 1002, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 1102, 'end': 1127, 'text': '(Shewen and Wilkie, 1988)', 'ref_id': 'BIBREF48'}, {'start': 1171, 'end': 1192, 'text': '(Potter et al., 1999)', 'ref_id': 'BIBREF40'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Our aim is to bring more insight into the molecular composition of a M. haemolytica inactivated antigen used in bovine commercial vaccines, focusing on the identification of relevant secreted or surface-exposed proteins. This knowledge will support the development of specific quality control techniques to assist the optimization and standardization of the industrial vaccine production process.', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': '2.1. Laboratory scale M. haemolytica culture A seed culture was prepared by inoculation of an aliquot of master seed bank (MSB) of M. haemolytica serotype A1 (production strain code B059) in TSB-BHI (Tryptic Soy Broth, Brain Heart Infusion, Porcine) and incubation at 37.0 ± 1.0°C, for 12 h with orbital agitation (220 rpm). Inoculum was prepared by a 1:100 dilution of the seed culture in TSB-BHI and further incubation at 37.0 ± 1.0°C with orbital agitation until an optical density at 600 nm (OD 600nm ) of 0.2 to 0.3 units was reached. A benchtop fermentor (Biostat A, New Brunswick) with 2 L of fermentation media (TSB-BHI supplemented with 0.4% glucose) was inoculated with 20 mL of the inoculum culture (1:100 dilution). The fermentation culture was grown at 37.0 ± 1.0°C with dissolved oxygen set above 40% and variable Article No~e00158 agitation. During fermentation, samples were taken every one hour to measure OD 600nm , dissolved oxygen (%), glucose concentration (mg/dL) and pH. The culture was harvested when it reached stationary growth phase. Samples and the final culture were centrifuged at 8000×g for 30 min at 4°C and culture supernatants were stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Materials and methods'}, {'text': 'M. haemolytica culture for vaccine antigen preparation was performed following the industrial standardized protocol. Culture media used was developed by Virbac Uruguay S.A. and is based on protein hydrolysates, yeast extract, dextrose, and sodium and potassium salts. The inoculum was prepared as previously described using 1 vial of production seed of M. haemolytica serotype A1 (production strain code B059). The production fermentor was inoculated with a 1:100 dilution of the inoculum and the culture was performed at 37°C with automatic agitation and aeration until the end of the logarithmic growth phase. After harvesting, culture was inactivated by incubation at 37°C with formaldehyde 0.5% (v/v) during 24 h. To obtain culture supernatant the inactivated culture was centrifuged at 8000×g for 30 min at 4°C. Inactivated culture supernatant was stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Industrial M. haemolytica antigen preparation'}, {'text': 'Specific primers were designed to amplify a portion of LKT which contains the Cterminal domain of the protein. An in silico prediction of the location of linear Bcell epitopes was performed using Bepipred algorithm (Larsen et al., 2006) . As previously reported (Lee et al., 2001) , the portion of LktA with more immunogenic epitopes was the C-terminal domain. Therefore, a sequence including the main predicted epítopes (amino acid 713 to 873) was selected. M. haemolytica (production strain code B059) was cultured as the seed culture described above.', 'cite_spans': [{'start': 215, 'end': 236, 'text': '(Larsen et al., 2006)', 'ref_id': 'BIBREF29'}, {'start': 262, 'end': 280, 'text': '(Lee et al., 2001)', 'ref_id': None}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Culture was centrifuged at 10000×g and the cell pellet was stored at −70°C. M. haemolytica genomic DNA was extracted using a standard protocol (Ausubel et al., 1999) and partial LKT sequence was amplified by PCR. For LKT expression, restriction sites were included in primers for a directional cloning of LKT sequence in pET28a(+) vector (Novagen). E. coli BL21 DE3 (Novagen) competent cells were transformed with the construct and stored at −70°C in 15% glycerol. Plasmid DNA was isolated from E. coli using a commercial kit (QiaPrep Spin Miniprep, Qiagen). Plasmid sequence was confirmed by DNA sequencing at Institut Pasteur Montevideo (Uruguay). For LKT expression, a culture was performed in ZYM-5052 auto induction medium (Studier, 2005) for 18-20 h at 37.0 ± 1.0°C. As expected, by SDS-PAGE a band of approximately 40 kDa corresponding to the recombinant protein was observed. The protein was purified by IMAC chromatography (HisTrap HP, GE Healthcare) in an ÄKTA Purifier 100 (GE Healthcare). The Article No~e00158 purified protein was dialyzed against PBS 1X pH 7.4 and quantified by BCA (Pierce BCA Protein Assay Kit, Thermo Scientific).', 'cite_spans': [{'start': 143, 'end': 165, 'text': '(Ausubel et al., 1999)', 'ref_id': None}, {'start': 728, 'end': 743, 'text': '(Studier, 2005)', 'ref_id': 'BIBREF50'}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Two New Zealand white rabbits (2.5 Kg body weight) were maintained in the experimental animal facility (Instituto de Higiene, Universidad de la República, Uruguay) in accordance with animal procedures approved by the Honorary Commission of Animal Experimentation (CHEA protocol No 071140-000771-11).', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Both rabbits were immunized subcutaneously with 50 ug of recombinant LKT, on days 0 and 21 of the immunization protocol. Blood samples were taken on days 21, 45 and 115, and sera were prepared and stored at −20°C. Serum titers were determined by ELISA using 0.1 μg/well of recombinant LKT for coating, serum dilutions of 1:100 to 1:100.000, and conjugate dilution of 1:10.000 (Goat antirabbit IgG (whole molecule)-Peroxidase, Sigma). High titer sera were pooled and purified by protein A chromatography (HiTraprProtein A, GE Healthcare). Purified IgG reactivity against native and recombinant LKT was evaluated by Western blot as described below.', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Culture supernatants were analyzed by 12% SDS-PAGE and coomassie blue staining (Ausubel et al., 1999) . Molecular weight markers used were PageRuler Prestained Protein Ladder (Thermo Scientific) and Prestained Protein Ladder Broad Range (NEB).', 'cite_spans': [{'start': 79, 'end': 101, 'text': '(Ausubel et al., 1999)', 'ref_id': None}], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For Western blot analysis, proteins were transferred onto a nitrocellulose membrane (Hybond-C Extra, Amersham Biosciences) for one hour at 400 mA.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Rabbit antibodies against recombinant LKT, produced and purified by our work group, were used to identify LKT in culture supernatants. Briefly, membranes were incubated for 1 h at room temperature with anti-LKT antibodies at final concentration of 17.5 μg/mL in PBS 1X pH 7.4, 5% low fat milk, with gentle agitation. For antigen-antibody detection membranes were incubated for 1 h at room temperature with a 1:5000 dilution of anti-rabbit IgG (whole molecule)alkaline phosphatase antibody produced in goat (Sigma) in PBS 1X pH 7.4, 5% low fat milk. The intensity of resulting bands was quantified using a Molecular Imaging Software (Carestream Health Inc).', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For immune response evaluation bovine sera obtained from a calf infected with M. haemolytica and from a healthy calf were gently provided by Virbac Uruguay.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Inactivated and non inactivated culture supernatant samples analyzed by SDS-PAGE were transferred onto membranes, as previously described. Membranes were incubated for 1 h at room temperature with a 1:500 dilution of each serum and afterwards for 1 h at room temperature with a 1:5000 dilution of anti-bovine', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'IgG-HRP (Novex), all in PBS 1X pH 7.4, 5% low fat milk. Detection was performed using TMB liquid substrate system for membranes (Sigma).', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Inactivated culture supernatant obtained from the industrial process was concentrated 20X by ultrafiltration (Vivaspin 500, 5 kDa, GE Healthcare) and analyzed by SDS-PAGE and coomassie blue staining. The most defined and intense bands were identified by peptide mass fingerprinting at Institut Pasteur Montevideo (Uruguay) using a 4800 MALDI TOF/TOF Analyzer (Applied Biosystems). Peptides from each sample were obtained by trypsin treatment (Sequencing Grade, Promega) overnight at 37°C. Peptide mass spectra were acquired as previously described (Lima et al., 2011) and MS/MS collision induced dissociation experiments of selected peptides were performed. Proteins were identified by NCBInr database searching with peptide m/z values using MASCOT search engine (Matrix Science) (Perkins et al., 1999) with the following searching parameters: monoisotopic mass tolerance, 0.08 Da; fragment mass tolerance, 0.45 Da and one missing tryptic cleavage allowed. Significant scores (p < 0.05) were used as criteria for positive protein identification.', 'cite_spans': [{'start': 548, 'end': 567, 'text': '(Lima et al., 2011)', 'ref_id': 'BIBREF32'}, {'start': 780, 'end': 802, 'text': '(Perkins et al., 1999)', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'Mass spectrometry (MS)'}, {'text': 'During M. haemolytica laboratory scale fermentation, parameters such as glucose concentration, dissolved oxygen, optical density (OD 600nm ) and pH were determined in samples taken every one hour of culture. This fermentation showed a kinetic profile compatible with typical bacterial growth in a batch system (Fig. 1B) . Culture was harvested ten hours after fermentation start, at the beginning of the stationary growth phase.', 'cite_spans': [], 'ref_spans': [{'start': 310, 'end': 319, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'Supernatant samples of a M. haemolytica laboratory scale culture were analyzed in order to evaluate the LKT accumulation in the supernatant. To identify LKT specific anti-LKT antibodies were produced. In preliminary evaluation experiments, we confirmed that these antibodies showed the expected reactivity against native and recombinant LKT and a good specific antibody titer. By means of these antibodies we identified LKT as a single defined band of approximately 110 kDa in culture supernatant samples of M. haemolytica (Fig. 1A) . In parallel, the presence of LKT in this protein band was confirmed by MS analysis (MS/MS protein score 408, protein sequence coverage 36%).', 'cite_spans': [], 'ref_spans': [{'start': 523, 'end': 532, 'text': '(Fig. 1A)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'The intensity of the specific LKT band detected by Western blot was determined by molecular imaging software. This analysis showed that LKT expression Article No~e00158 correlates with growth kinetics, being associated with exponential growth phase of M. haemolytica (Fig. 1B) , as previously reported (Chang et al., 1987) . Therefore, the presence of LKT was verified in the culture supernatant of the M. haemolytica production strain, during the exponential growth phase of the culture.', 'cite_spans': [{'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 267, 'end': 276, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'For proteomic analysis, industrial antigen was prepared according to vaccine production protocol. Culture supernatant was obtained and concentrated by ultrafiltration. After SDS-PAGE electrophoresis and coomassie blue staining, selected bands were recovered for MS identification ( Fig. 2A) . This approach allowed the statistically significant identification of 11 proteins of M. haemolytica in the industrial antigen (Table 1) . LKT was identified, in accordance with previous results of laboratory scale fermentation, among other relevant proteins.', 'cite_spans': [], 'ref_spans': [{'start': 282, 'end': 290, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF1'}, {'start': 419, 'end': 428, 'text': '(Table 1)', 'ref_id': None}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Some of these are outer membrane proteins (OMPs), which along with LKT are critical to achieve a protective immunity to the pathogen Singh et al., 2011) . Subcellular in silico localization, predicted using free access PSORTb software (available at http://psort.hgc.jp/), indicated that most of the identified proteins are periplasmic (7/11), with others being extracellular (1/11) or located in the outer cell membrane (2/11).', 'cite_spans': [{'start': 133, 'end': 152, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}], 'ref_spans': [], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Although most proteins coincided with their theoretical MW (Table 1) Article No~e00158 (Fig. 2B ). This behavior of LKT in electrophoresis could be explained by crosslinking caused by formaldehyde treatment leading to high molecular weight structures.', 'cite_spans': [], 'ref_spans': [{'start': 59, 'end': 68, 'text': '(Table 1)', 'ref_id': None}, {'start': 87, 'end': 95, 'text': '(Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Immune reactivity of a serum obtained from a M. haemolytica infected calf against culture supernatant was addressed by Western blot. As shown in Fig. 2B several bands of both inactivated and non inactivated culture supernatant were specifically recognized by infected bovine serum and not by healthy bovine serum. Among them, LKT was the more reactive band. Ayalew et al., 2011) . (Rabus et al., 1999; Eidam et al., 2013) .', 'cite_spans': [{'start': 358, 'end': 378, 'text': 'Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}, {'start': 381, 'end': 401, 'text': '(Rabus et al., 1999;', 'ref_id': 'BIBREF42'}, {'start': 402, 'end': 421, 'text': 'Eidam et al., 2013)', 'ref_id': None}], 'ref_spans': [{'start': 145, 'end': 152, 'text': 'Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': '10 HisJ-like histidine ABC transport system-periplasmic binding protein MHH_RS14805 328 M9WWE6 28.0 kDa Periplasmic ABC transporter system component involved in molecule export through bacterial membrane (Eidam et al., 2013) . Belongs to ompA family (Eidam et al., 2013) . Ortholog Omp P6 reported as immunogen in other species (Roier et al., 2013; Alvarez et al., 2015) . * For this search protein scores greater than 87 are significant (p < 0.05).', 'cite_spans': [{'start': 204, 'end': 224, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 250, 'end': 270, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 328, 'end': 348, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 349, 'end': 370, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'disease associated morbid-mortality (Potter, 2015) , this kind of information is of utmost importance.', 'cite_spans': [{'start': 36, 'end': 50, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Available data demonstrate that the protective immunity against M. haemolytica can be acquired by neutralizing antibodies against Leukotoxin A (Mosier et al., 1989) , as well as antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988; Confer et al., 1995; Confer et al., 2009) . In order to promote an effective immune response, the presence of these pivotal elements in a BRD vaccine formulation is crucial.', 'cite_spans': [{'start': 143, 'end': 164, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 229, 'end': 254, 'text': '(Shewen and Wilkie, 1988;', 'ref_id': 'BIBREF48'}, {'start': 255, 'end': 275, 'text': 'Confer et al., 1995;', 'ref_id': 'BIBREF10'}, {'start': 276, 'end': 296, 'text': 'Confer et al., 2009)', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Based on previous reports that detected Leukotoxin A activity in bacterium-free culture supernatant from logarithmic-phase cultures (Chang et al., 1987) , Neumosan line of vaccines includes inactivated culture supernatants of an industrial optimized M. haemolytica culture. In this work we confirmed that LKT secretion is linked to the exponential growth phase during the antigen production culture, representing one of the primary secreted components. In culture supernatant, LKT was detected as a single band with the expected MW (approx. 110 kDa) (Lo et al., 1985; Chang et al., 1987) . Interestingly, after formaldehyde treatment, LKT was detected as a higher MW band (>230 kDa),', 'cite_spans': [{'start': 132, 'end': 152, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 550, 'end': 567, 'text': '(Lo et al., 1985;', 'ref_id': 'BIBREF33'}, {'start': 568, 'end': 587, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'suggesting that the toxin could be arranged as a high order structure, which could be fixed by this cross-linking agent (Klockenbusch and Kast, 2010) . This finding is in agreement with previous reports that showed that the molecular weight of native LKT in culture supernatant was higher than 400 kDa (Chang et al., 1987) .', 'cite_spans': [{'start': 120, 'end': 149, 'text': '(Klockenbusch and Kast, 2010)', 'ref_id': 'BIBREF27'}, {'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Besides LKT identification, we delved further into the characterization of the culture supernatant protein profile. By MS we identified other 10 proteins of M. haemolytica. Most of them are periplasmic and outer membrane proteins, which due to their extracellular location and exposure to the host immune system could represent interesting candidates to play a key role in the protection against this pathogen. It is worth mentioning that we also identified a cytoplasmic protein involved in carbohydrate metabolism (Formate C-acetyltransferase). This finding could be explained by some cellular lysis that could occur during bacterial growth and inactivation (Derzelle et al., 2005) , hence we cannot rule out that the culture supernatant may contain some cytoplasmic proteins.', 'cite_spans': [{'start': 660, 'end': 683, 'text': '(Derzelle et al., 2005)', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Some of the outer membrane proteins identified in this work have been reported as important immunogens and have been evaluated as recombinant subunit antigens due to their protective vaccine potential (Ayalew et al., 2011; Guzman-Brambila et al., 2012) . In particular, vaccination of mice and cattle with recombinant serotype specific antigen 1 (rSsa1) stimulated high antibody responses (Ayalew et al., 2011) . Besides, a \"Best-Reciprocal-Blast-Hit\" approach was performed in order to determine that M. haemolytica outer membrane protein P6 identified in this work, is ortholog to Omp P6 of H. somni and P. multocida, both reported as Article No~e00158', 'cite_spans': [{'start': 201, 'end': 222, 'text': '(Ayalew et al., 2011;', 'ref_id': 'BIBREF8'}, {'start': 223, 'end': 252, 'text': 'Guzman-Brambila et al., 2012)', 'ref_id': None}, {'start': 389, 'end': 410, 'text': '(Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'immunogenic in recent reports (Roier et al., 2013; Alvarez et al., 2015) . In that sense, the natural occurrence of these proteins in the inactivated vaccine antigen indicates that the vaccine contains the main components required for protection against M. haemolytica.', 'cite_spans': [{'start': 30, 'end': 50, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 51, 'end': 72, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Different proteins belonging to the ATP-binding cassette (ABC) transporter superfamily were identified in the commercial antigen. ABC transport systems are essential for many processes of the cell, such as uptake of amino acids, peptides, carbohydrates and metal ions in an ATP coupled process. There is increasing evidence that these transport systems play either direct or indirect roles in the virulence and pathogenicity of bacteria (Garmory and Titball, 2004) . In a recent work, other ABC transporters were identified as immunodominant proteins from M. haemolytica and H. somni in cattle immunized with a commercial cellular vaccine, confirming that the surface exposed transporters of these species are immunogenic (Alvarez et al., 2015) . Interestingly, our results evidence that ABC transporters are relevant components in the vaccine antigen, and therefore could be potential targets for the development of antibacterial subunit vaccines (Garmory and Titball, 2004) .', 'cite_spans': [{'start': 437, 'end': 464, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}, {'start': 722, 'end': 744, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 948, 'end': 975, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Finally, we also identified an iron-regulated periplasmic protein YfeA, previously described as immunodominant in animals immunized with a cellular M. haemolytica vaccine (Alvarez et al., 2015) , as well as with an OMP-enriched fraction of M. haemolytica (Ayalew et al., 2010) .', 'cite_spans': [{'start': 171, 'end': 193, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 255, 'end': 276, 'text': '(Ayalew et al., 2010)', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Taken together, these observations support the protective potential of several of the proteins indentified in the M. haemolytica antigen. As an additional outcome anti-LKT antibodies developed for LKT identification can be used in routine quantitative assays in order to establish acceptance criteria of antigen commercial batches.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Author contribution statement Contributed reagents, materials, analysis tools or data.', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}, {'text': 'Article No~e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}], 'bib_entries': {'BIBREF1': {'ref_id': 'b1', 'title': 'Serotyping of Mannheimia (Pasteurella) haemolytica isolates from the upper Midwest United States', 'authors': [{'first': 'G', 'middle': ['M'], 'last': 'Al-Ghamdi', 'suffix': ''}, {'first': 'T', 'middle': ['R'], 'last': 'Ames', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Baker', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Walker', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Chase', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Frank', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}], 'year': 2000, 'venue': 'J. Vet. Diagn. Invest', 'volume': '12', 'issn': '6', 'pages': '576--578', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach', 'authors': [{'first': 'A', 'middle': ['H'], 'last': 'Alvarez', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Gutierrez-Ortega', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hernandez-Gutierrez', 'suffix': ''}], 'year': 2015, 'venue': 'Can. J. Vet. Res', 'volume': '79', 'issn': '4', 'pages': '339--342', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds', 'authors': [{'first': 'T', 'middle': [], 'last': 'Autio', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pohjanvirta', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Holopainen', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Rikula', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Pentikainen', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Huovilainen', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Rusanen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Soveri', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Sihvonen', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pelkonen', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': ['D'], 'last': 'Hartson', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}], 'year': 2010, 'venue': 'Proteomics', 'volume': '10', 'issn': '11', 'pages': '2151--2164', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'A', 'middle': ['E'], 'last': 'Wilson', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Clin. Vaccine Immunol', 'volume': '18', 'issn': '12', 'pages': '2067--2074', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Step', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Wray', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Hansen', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 2009, 'venue': 'Vaccine', 'volume': '27', 'issn': '11', 'pages': '1771--1776', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Mccraw', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Durham', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Morton', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 1995, 'venue': 'Vet. Immunol. Immunopathol', 'volume': '47', 'issn': '1-2', 'pages': '101--110', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Conlon', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '2', 'pages': '587--591', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Histophilus somni host-parasite relationships', 'authors': [{'first': 'L', 'middle': ['B'], 'last': 'Corbeil', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '151--160', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Identification and characterization of the Pasteurella haemolytica leukotoxin', 'authors': [{'first': 'Y', 'middle': ['F'], 'last': 'Chang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Young', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Post', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Struck', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '10', 'pages': '2348--2354', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Pasteurella multocida and bovine respiratory disease', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Dabo', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Taylor', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '129--150', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein', 'authors': [{'first': 'S', 'middle': [], 'last': 'Derzelle', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bolotin', 'suffix': ''}, {'first': 'M', 'middle': ['Y'], 'last': 'Mistou', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Rul', 'suffix': ''}], 'year': 2005, 'venue': 'Appl. Environ. Microbiol', 'volume': '71', 'issn': '12', 'pages': '8597--8605', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Control methods for bovine respiratory disease for feedlot cattle', 'authors': [{'first': 'T', 'middle': ['A'], 'last': 'Edwards', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '273--284', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Complete genome sequence of Mannheimia haemolytica strain 42548 from a case of bovine respiratory disease', 'authors': [{'first': 'S', 'middle': [], 'last': 'Schwarz', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Fulton', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Purdy', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'J', 'middle': ['T'], 'last': 'Saliki', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Loan', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Burge', 'suffix': ''}], 'year': 2000, 'venue': 'Can. J. Vet. Res', 'volume': '64', 'issn': '3', 'pages': '151--159', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies', 'authors': [{'first': 'H', 'middle': ['S'], 'last': 'Garmory', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Titball', 'suffix': ''}], 'year': 2004, 'venue': 'Infect. Immun', 'volume': '72', 'issn': '12', 'pages': '6757--6763', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves', 'authors': [{'first': 'L', 'middle': ['J'], 'last': 'Gershwin', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Gunther', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Anderson', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Woolums', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Mcarthur-Vaughan', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Randel', 'suffix': ''}, {'first': 'G', 'middle': ['A'], 'last': 'Boyle', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Friebertshauser', 'suffix': ''}, {'first': 'P', 'middle': ['S'], 'last': 'Mcinturff', 'suffix': ''}], 'year': 2000, 'venue': 'Am. J. Vet. Res', 'volume': '61', 'issn': '3', 'pages': '291--298', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge', 'authors': [{'first': 'A', 'middle': ['E'], 'last': 'Ortuno-Sahagun', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Res. Vet. Sci', 'volume': '93', 'issn': '3', 'pages': '1293--1300', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Complete closed genome sequences of Mannheimia haemolytica serotypes A1 and A6, isolated from cattle', 'authors': [{'first': 'G', 'middle': ['P'], 'last': 'Harhay', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Koren', 'suffix': ''}, {'first': 'A', 'middle': ['M'], 'last': 'Phillippy', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Mcvey', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kuszak', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Clawson', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Harhay', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Heaton', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Chitko-Mckown', 'suffix': ''}, {'first': 'T', 'middle': ['P'], 'last': 'Smith', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2 Isolates D171 and D35 recovered from bovine pneumonia', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Hauglund', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Tatum', 'suffix': ''}, {'first': 'D', 'middle': ['O'], 'last': 'Bayles', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}], 'year': 2015, 'venue': 'Genome Announc', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1', 'authors': [{'first': 'C', 'middle': [], 'last': 'Klockenbusch', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kast', 'suffix': ''}], 'year': 2010, 'venue': 'J. Biomed. Biotechnol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin', 'authors': [{'first': 'F', 'middle': ['A'], 'last': 'Lainson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Murray', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Davies', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Donachie', 'suffix': ''}], 'year': 1996, 'venue': 'Microbiology', 'volume': '142', 'issn': '', 'pages': '2499--2507', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Improved method for predicting linear B-cell epitopes', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Larsen', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Lund', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nielsen', 'suffix': ''}], 'year': 2006, 'venue': 'Immunome Res', 'volume': '2', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2: ovine and bovine isolates', 'authors': [{'first': 'P', 'middle': ['K'], 'last': 'Lawrence', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Kittichotirat', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Bumgarner', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Mcdermott', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Herndon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Knowles', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Srikumaran', 'suffix': ''}], 'year': 2010, 'venue': 'J. Bacteriol', 'volume': '192', 'issn': '4', 'pages': '1167--1168', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches', 'authors': [{'first': 'A', 'middle': [], 'last': 'Lima', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Duran', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Schujman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Marchissio', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Portela', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Obal', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Pritsch', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'De Mendoza', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Cervenansky', 'suffix': ''}], 'year': 2011, 'venue': 'J. Proteomics', 'volume': '74', 'issn': '9', 'pages': '1720--1734', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'C', 'middle': ['N'], 'last': 'Greer', 'suffix': ''}], 'year': 1985, 'venue': 'Infect. Immun', 'volume': '50', 'issn': '3', 'pages': '667--671', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '9', 'pages': '1987--1996', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Cooney', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '10', 'pages': '3398--3406', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Mosier', 'suffix': ''}, {'first': 'K', 'middle': ['R'], 'last': 'Simons', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}, {'first': 'K', 'middle': ['D'], 'last': 'Clinkenbeard', 'suffix': ''}], 'year': 1989, 'venue': 'Infect. Immun', 'volume': '57', 'issn': '3', 'pages': '711--716', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Leukotoxins of gram-negative bacteria', 'authors': [{'first': 'S', 'middle': ['K'], 'last': 'Narayanan', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Nagaraja', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Chengappa', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Stewart', 'suffix': ''}], 'year': 2002, 'venue': 'Vet. Microbiol', 'volume': '84', 'issn': '4', 'pages': '337--356', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Probability-based protein identification by searching sequence databases using mass spectrometry data', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Perkins', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Pappin', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Creasy', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Cottrell', 'suffix': ''}], 'year': 1999, 'venue': 'Electrophoresis', 'volume': '20', 'issn': '18', 'pages': '3551--3567', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb', 'authors': [{'first': 'A', 'middle': ['A'], 'last': 'Potter', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Schryvers', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Ogunnariwo', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Hutchins', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Watts', 'suffix': ''}], 'year': 1999, 'venue': 'Pathogenesis', 'volume': '27', 'issn': '4', 'pages': '197--206', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Bovine respiratory disease', 'authors': [{'first': 'T', 'middle': [], 'last': 'Potter', 'suffix': ''}], 'year': 2015, 'venue': 'Livestock (Electronic)', 'volume': '20', 'issn': '1', 'pages': '14--18', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'TRAP transporters: an ancient family of extracytoplasmic solute-receptor-dependent secondary active transporters', 'authors': [{'first': 'R', 'middle': [], 'last': 'Rabus', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Jack', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Kelly', 'suffix': ''}, {'first': 'M', 'middle': ['H'], 'last': 'Saier', 'suffix': ''}], 'year': 1999, 'venue': 'Microbiology', 'volume': '145', 'issn': '', 'pages': '3431--3445', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The contribution of infections with bovine viral diarrhea viruses to bovine respiratory disease', 'authors': [{'first': 'J', 'middle': [], 'last': 'Ridpath', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '335--348', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Effects of vaccination against respiratory Article No~e00158 pathogens on feed intake, metabolic, and inflammatory responses in beef heifers', 'authors': [{'first': 'M', 'middle': ['C'], 'last': 'Rodrigues', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Cooke', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Marques', 'suffix': ''}, {'first': 'B', 'middle': ['I'], 'last': 'Cappellozza', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Arispe', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Keisler', 'suffix': ''}, {'first': 'D', 'middle': ['W'], 'last': 'Bohnert', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': 'Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles', 'authors': [{'first': 'S', 'middle': [], 'last': 'Roier', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Fenninger', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Leitner', 'suffix': ''}, {'first': 'G', 'middle': ['N'], 'last': 'Rechberger', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Reidl', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schild', 'suffix': ''}], 'year': 2013, 'venue': 'Int. J. Med. Microbiol', 'volume': '303', 'issn': '5', 'pages': '247--256', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1985, 'venue': 'Am. J. Vet. Res', 'volume': '46', 'issn': '5', 'pages': '1212--1214', 'other_ids': {}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1988, 'venue': 'Can. J. Vet. Res', 'volume': '52', 'issn': '1', 'pages': '30--36', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'Mannheimia haemolytica: bacterial-host interactions in bovine pneumonia', 'authors': [{'first': 'K', 'middle': [], 'last': 'Singh', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Ritchey', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Vet. Pathol', 'volume': '48', 'issn': '2', 'pages': '338--348', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'Protein production by auto-induction in high density shaking cultures', 'authors': [{'first': 'F', 'middle': ['W'], 'last': 'Studier', 'suffix': ''}], 'year': 2005, 'venue': 'Protein Expr. Purif', 'volume': '41', 'issn': '1', 'pages': '207--234', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Sequence diversity of the leukotoxin (lktA) gene in caprine and ovine strains of Mannheimia haemolytica', 'authors': [{'first': 'C', 'middle': [], 'last': 'Vougidou', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Sandalakis', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Psaroulaki', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Petridou', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ekateriniadou', 'suffix': ''}], 'year': 2013, 'venue': 'Vet. Rec', 'volume': '172', 'issn': '16', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Effect of bovine granulocyte colony-stimulating factor on the development of pneumonia caused by Mannheimia haemolytica', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Youssef', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Clark', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Caswell', 'suffix': ''}], 'year': 2004, 'venue': 'Vet. Pathol', 'volume': '41', 'issn': '6', 'pages': '649--657', 'other_ids': {}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'How Mannheimia haemolytica defeats host defence through a kiss of death mechanism', 'authors': [{'first': 'L', 'middle': [], 'last': 'Zecchinon', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fett', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Desmecht', 'suffix': ''}], 'year': 2005, 'venue': 'Vet. Res', 'volume': '36', 'issn': '2', 'pages': '133--156', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': ', LKT was identified by MS in a higher than expected MW band (>230 kDa). This result was confirmed by Western blot of inactivated supernatant using anti-LKT antibodies M. haemolytica culture growth and LKT secretion profile. A. Anti-LKT Western blot of M. haemolytica culture supernatant samples from different fermentation time points. M: fermentation media, T1-T10: samples from culture kinetics (1-10 h). MW: Molecular weight marker. B. M. haemolytica culture growth curve and kinetics of Leukotoxin secretion. Optical density (OD) at 600 nm, glucose concentration (mg/dL) and band intensity of LKT expressed in arbitrary units (AU) are plotted versus culture growth time measured in hours.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'This work provides an exhaustive molecular characterization of an inactivated culture supernatant of M. haemolytica included in a line of polyvalent commercial bovine vaccines (Neumosan, Virbac Uruguay). Since M. haemolytica is the main etiological agent of BRD and is also responsible for a high proportion of the Identification of M. haemolytica culture supernatant proteins. A. M. haemolytica proteins of inactivated culture supernatant (iCSN) resolved in SDS-PAGE and stained with coomassie blue. Bands corresponding to the proteins analyzed by MS (MALDI TOF/TOF) are numbered and referred to on Table 1. For complete image see Fig. S1 (Supplementary material). B. Analysis of culture supernatant proteins by Western blot. Left: M. haemolytica inactivated (iCSN) and non inactivated culture supernatant (CSN) proteins probed with anti-rLKT rabbit serum. Middle: Reactivity of bovine M. haemolytica infected serum against M. haemolytica iCSN and CSN. Right: Reactivity of bovine healthy serum against M. haemolytica iCSN and CSN. MW: Molecular weight marker.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Proteins identified in culture supernatant of M. haemolytica.', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': 'Paula Tucci: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Verónica Estevez, Lorena Becco: Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Florencia Cabrera-Cabrera: Performed the experiments; Analyzed and interpreted the data. Germán Grotiuz: Performed the experiments; Analyzed and interpreted the data;', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We thank Viviana Sánchez for critical reading of the manuscript, Danilo Segovia for assistance in cloning techniques and Florencia Arezzo for technical assistance during M. haemolytica laboratory scale fermentation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}, {'text': 'This work was partially financed by Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing interest statement'}, {'text': 'This work was partially supported by Agencia Nacional de Investigación e Innovación (ANII, Uruguay), Alianzas para la Innovación (ALI_2_2013_1_4783) and Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding statement'}, {'text': 'Supplementary content related to this article has been published online at http://dx. doi.org/10.1016/j.heliyon.2016.e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Additional information'}]}\n"
     ]
    }
   ],
   "source": [
    "# query on nested documents\n",
    "# see: https://docs.mongodb.com/manual/tutorial/query-embedded-documents/\n",
    "\n",
    "for c in db.pmc_content.find({'metadata.title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen'}):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5ea713694867d6c5a9bc5a31'), 'paper_id': '0a003aa69f43cee4357f1e943df79a8b87c0a88e', 'metadata': {'title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen', 'authors': [{'first': 'Paula', 'middle': [], 'last': 'Tucci', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Verónica', 'middle': [], 'last': 'Estevez', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Lorena', 'middle': [], 'last': 'Becco', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Florencia', 'middle': [], 'last': 'Cabrera-Cabrera', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Germán', 'middle': [], 'last': 'Grotiuz', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Eduardo', 'middle': [], 'last': 'Reolon', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Mónica', 'middle': [], 'last': 'Marín', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': 'marin@fcien.edu.uym.marín.'}]}, 'abstract': [{'text': 'Bovine Respiratory Disease is the most costly disease that affects beef and dairy cattle industry. Its etiology is multifactorial, arising from predisposing environmental stress conditions as well as the action of several different respiratory pathogens. This situation has hindered the development of effective control strategies. Although different type of vaccines are available, many currently marketed vaccines are based on inactivated cultures of the main viral and bacterial agents involved in this pathology. The molecular composition of commercial veterinary vaccines is a critical issue. The present work aims to define at the proteomic level the most relevant valence of a line of commercial respiratory vaccines widely used in Central and South America. Since Mannheimia haemolytica is responsible for most of the disease associated morbid-mortality, we focused on the main proteins secreted by this pathogen, in particular Leukotoxin A, its main virulence factor. By Western blot analysis and mass spectrometry, Leukotoxin A was identified as a major component of (http://creativecommons.org/licenses/by-nc-nd/4.0/). M. haemolytica culture supernatants. We also identified other ten M. haemolytica proteins, including outer membrane proteins, periplasmic transmembrane solute transporters and iron binding proteins, which are relevant to achieve protective immunity against the pathogen. This work allowed a detailed molecular characterization of this vaccine component, providing evidence of its quality and efficacy. Furthermore, our results contributed to the identification of several proteins of interest as subunit vaccine candidates.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Bovine Respiratory Disease (BRD) is one of the leading causes of death and economic loss for the beef and dairy cattle industry. It has an estimated annual cost to the worldwide cattle industry of over $3 billion (Potter, 2015) . This multifactorial syndrome can be caused either by viral or bacterial pathogens. Viral agents include bovine respiratory syncytial virus (BRSV) (Gershwin et al., 2000) , parainfluenza III virus (PI-3) (Fulton et al., 2000) , bovine viral diarrhea virus (BVDV) (Ridpath, 2010) and bovine corona virus (BCV) (Autio et al., 2007) . These respiratory viruses along with some mycoplasmal agents are generally the primary infectious agents involved in BRD (Potter, 2015) . This initial infection establishes a respiratory environment predisposing to the colonization and replication of pathogenic bacteria, including Mannheimia haemolytica (Al-Ghamdi et al., 2000) , Pasteurella multocida (Dabo et al., 2007) and Histophilus somni (Corbeil, 2007) , the former being responsible for up to 50% of the disease associated mortality (Narayanan et al., 2002; Potter, 2015) . M. haemolytica is a Gram negative opportunistic bacterium. Although it is a common bacterium of the upper respiratory tract and nasopharynx of healthy ruminants, it can also act as an opportunistic pathogen infecting the lower respiratory tract under stressful situations such as shipping, adverse environmental conditions or previous respiratory viral infection (Youssef et al., 2004; Orouji et al., 2012) .', 'cite_spans': [{'start': 213, 'end': 227, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 376, 'end': 399, 'text': '(Gershwin et al., 2000)', 'ref_id': 'BIBREF22'}, {'start': 433, 'end': 454, 'text': '(Fulton et al., 2000)', 'ref_id': 'BIBREF19'}, {'start': 492, 'end': 507, 'text': '(Ridpath, 2010)', 'ref_id': 'BIBREF43'}, {'start': 538, 'end': 558, 'text': '(Autio et al., 2007)', 'ref_id': 'BIBREF4'}, {'start': 682, 'end': 696, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 866, 'end': 890, 'text': '(Al-Ghamdi et al., 2000)', 'ref_id': 'BIBREF1'}, {'start': 915, 'end': 934, 'text': '(Dabo et al., 2007)', 'ref_id': 'BIBREF14'}, {'start': 957, 'end': 972, 'text': '(Corbeil, 2007)', 'ref_id': 'BIBREF12'}, {'start': 1054, 'end': 1078, 'text': '(Narayanan et al., 2002;', 'ref_id': 'BIBREF37'}, {'start': 1079, 'end': 1092, 'text': 'Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 1458, 'end': 1480, 'text': '(Youssef et al., 2004;', 'ref_id': 'BIBREF52'}, {'start': 1481, 'end': 1501, 'text': 'Orouji et al., 2012)', 'ref_id': None}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Being BRD a multifactorial disease, the development of effective control strategies has been difficult to accomplish. Vaccination against viral and bacterial pathogens involved in BRD is a useful tool to reduce the risk of this disease. Many commercial respiratory vaccines are composed by inactivated cultures of the most relevant pathogens (Edwards, 2010; Rodrigues et al., 2015) . These multivalent formulations are designed to reduce the impact of viral infections and to neutralize the severe associated bacterial infections. Therefore, to guarantee the efficacy of BRD vaccines, it is important to achieve a complete characterization of the antigens included in the vaccine and to verify the presence of those molecules critical for establishing an efficient immunological protection.', 'cite_spans': [{'start': 342, 'end': 357, 'text': '(Edwards, 2010;', 'ref_id': 'BIBREF16'}, {'start': 358, 'end': 381, 'text': 'Rodrigues et al., 2015)', 'ref_id': 'BIBREF44'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In this work we attempt to characterize the main proteins of M. haemolytica in a polyvalent inactivated BRD line of vaccines currently commercialized in Central and South America (Neumosan, Virbac Uruguay S.A. (former Santa Elena), http:// www.santaelena.com.uy). Among them we emphasize the study of Leukotoxin A (LKT), its main virulence factor, which has been shown to play an important role in the development of a protective immunity against the pathogen (Confer et al., 2009 ).', 'cite_spans': [{'start': 460, 'end': 480, 'text': '(Confer et al., 2009', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'LKT is a potent cytolytic toxin, with an apparent molecular weight (MW) of 105 kDa, actively secreted by all serotypes of the bacterium during the logarithmic phase of in vitro growth (Shewen and Wilkie, 1985; Chang et al., 1987) . It belongs to the family of the RTX (repeat in toxin) pore-forming cytolysins, which have been linked with the virulence of other bacterial species (Lo et al., 1987; Lainson et al., 1996) . It specifically targets ruminant leukocytes and plays a major role in pathogenesis of BRD by impairing the primary lung defense mechanism and by inducing inflammation as a consequence of leukocyte lysis (Conlon et al., 1991) . This phenomenon has been correlated with its ability to bind and interact with the ruminant beta2-integrin Lymphocyte Function-associated Antigen 1 (LFA-1) (CD11a/CD18) (Zecchinon et al., 2005; Singh et al., 2011) . Neutralizing antibodies generation against the cytolytic toxin is relevant for achieving a high level of protection (Mosier et al., 1989) . Immunity against M. haemolytica also requires antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988) and iron-regulated outer membrane proteins (Potter et al., 1999) .', 'cite_spans': [{'start': 184, 'end': 209, 'text': '(Shewen and Wilkie, 1985;', 'ref_id': 'BIBREF47'}, {'start': 210, 'end': 229, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 380, 'end': 397, 'text': '(Lo et al., 1987;', 'ref_id': 'BIBREF34'}, {'start': 398, 'end': 419, 'text': 'Lainson et al., 1996)', 'ref_id': 'BIBREF28'}, {'start': 625, 'end': 646, 'text': '(Conlon et al., 1991)', 'ref_id': 'BIBREF11'}, {'start': 818, 'end': 842, 'text': '(Zecchinon et al., 2005;', 'ref_id': 'BIBREF53'}, {'start': 843, 'end': 862, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}, {'start': 981, 'end': 1002, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 1102, 'end': 1127, 'text': '(Shewen and Wilkie, 1988)', 'ref_id': 'BIBREF48'}, {'start': 1171, 'end': 1192, 'text': '(Potter et al., 1999)', 'ref_id': 'BIBREF40'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Our aim is to bring more insight into the molecular composition of a M. haemolytica inactivated antigen used in bovine commercial vaccines, focusing on the identification of relevant secreted or surface-exposed proteins. This knowledge will support the development of specific quality control techniques to assist the optimization and standardization of the industrial vaccine production process.', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': '2.1. Laboratory scale M. haemolytica culture A seed culture was prepared by inoculation of an aliquot of master seed bank (MSB) of M. haemolytica serotype A1 (production strain code B059) in TSB-BHI (Tryptic Soy Broth, Brain Heart Infusion, Porcine) and incubation at 37.0 ± 1.0°C, for 12 h with orbital agitation (220 rpm). Inoculum was prepared by a 1:100 dilution of the seed culture in TSB-BHI and further incubation at 37.0 ± 1.0°C with orbital agitation until an optical density at 600 nm (OD 600nm ) of 0.2 to 0.3 units was reached. A benchtop fermentor (Biostat A, New Brunswick) with 2 L of fermentation media (TSB-BHI supplemented with 0.4% glucose) was inoculated with 20 mL of the inoculum culture (1:100 dilution). The fermentation culture was grown at 37.0 ± 1.0°C with dissolved oxygen set above 40% and variable Article No~e00158 agitation. During fermentation, samples were taken every one hour to measure OD 600nm , dissolved oxygen (%), glucose concentration (mg/dL) and pH. The culture was harvested when it reached stationary growth phase. Samples and the final culture were centrifuged at 8000×g for 30 min at 4°C and culture supernatants were stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Materials and methods'}, {'text': 'M. haemolytica culture for vaccine antigen preparation was performed following the industrial standardized protocol. Culture media used was developed by Virbac Uruguay S.A. and is based on protein hydrolysates, yeast extract, dextrose, and sodium and potassium salts. The inoculum was prepared as previously described using 1 vial of production seed of M. haemolytica serotype A1 (production strain code B059). The production fermentor was inoculated with a 1:100 dilution of the inoculum and the culture was performed at 37°C with automatic agitation and aeration until the end of the logarithmic growth phase. After harvesting, culture was inactivated by incubation at 37°C with formaldehyde 0.5% (v/v) during 24 h. To obtain culture supernatant the inactivated culture was centrifuged at 8000×g for 30 min at 4°C. Inactivated culture supernatant was stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Industrial M. haemolytica antigen preparation'}, {'text': 'Specific primers were designed to amplify a portion of LKT which contains the Cterminal domain of the protein. An in silico prediction of the location of linear Bcell epitopes was performed using Bepipred algorithm (Larsen et al., 2006) . As previously reported (Lee et al., 2001) , the portion of LktA with more immunogenic epitopes was the C-terminal domain. Therefore, a sequence including the main predicted epítopes (amino acid 713 to 873) was selected. M. haemolytica (production strain code B059) was cultured as the seed culture described above.', 'cite_spans': [{'start': 215, 'end': 236, 'text': '(Larsen et al., 2006)', 'ref_id': 'BIBREF29'}, {'start': 262, 'end': 280, 'text': '(Lee et al., 2001)', 'ref_id': None}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Culture was centrifuged at 10000×g and the cell pellet was stored at −70°C. M. haemolytica genomic DNA was extracted using a standard protocol (Ausubel et al., 1999) and partial LKT sequence was amplified by PCR. For LKT expression, restriction sites were included in primers for a directional cloning of LKT sequence in pET28a(+) vector (Novagen). E. coli BL21 DE3 (Novagen) competent cells were transformed with the construct and stored at −70°C in 15% glycerol. Plasmid DNA was isolated from E. coli using a commercial kit (QiaPrep Spin Miniprep, Qiagen). Plasmid sequence was confirmed by DNA sequencing at Institut Pasteur Montevideo (Uruguay). For LKT expression, a culture was performed in ZYM-5052 auto induction medium (Studier, 2005) for 18-20 h at 37.0 ± 1.0°C. As expected, by SDS-PAGE a band of approximately 40 kDa corresponding to the recombinant protein was observed. The protein was purified by IMAC chromatography (HisTrap HP, GE Healthcare) in an ÄKTA Purifier 100 (GE Healthcare). The Article No~e00158 purified protein was dialyzed against PBS 1X pH 7.4 and quantified by BCA (Pierce BCA Protein Assay Kit, Thermo Scientific).', 'cite_spans': [{'start': 143, 'end': 165, 'text': '(Ausubel et al., 1999)', 'ref_id': None}, {'start': 728, 'end': 743, 'text': '(Studier, 2005)', 'ref_id': 'BIBREF50'}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Two New Zealand white rabbits (2.5 Kg body weight) were maintained in the experimental animal facility (Instituto de Higiene, Universidad de la República, Uruguay) in accordance with animal procedures approved by the Honorary Commission of Animal Experimentation (CHEA protocol No 071140-000771-11).', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Both rabbits were immunized subcutaneously with 50 ug of recombinant LKT, on days 0 and 21 of the immunization protocol. Blood samples were taken on days 21, 45 and 115, and sera were prepared and stored at −20°C. Serum titers were determined by ELISA using 0.1 μg/well of recombinant LKT for coating, serum dilutions of 1:100 to 1:100.000, and conjugate dilution of 1:10.000 (Goat antirabbit IgG (whole molecule)-Peroxidase, Sigma). High titer sera were pooled and purified by protein A chromatography (HiTraprProtein A, GE Healthcare). Purified IgG reactivity against native and recombinant LKT was evaluated by Western blot as described below.', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Culture supernatants were analyzed by 12% SDS-PAGE and coomassie blue staining (Ausubel et al., 1999) . Molecular weight markers used were PageRuler Prestained Protein Ladder (Thermo Scientific) and Prestained Protein Ladder Broad Range (NEB).', 'cite_spans': [{'start': 79, 'end': 101, 'text': '(Ausubel et al., 1999)', 'ref_id': None}], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For Western blot analysis, proteins were transferred onto a nitrocellulose membrane (Hybond-C Extra, Amersham Biosciences) for one hour at 400 mA.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Rabbit antibodies against recombinant LKT, produced and purified by our work group, were used to identify LKT in culture supernatants. Briefly, membranes were incubated for 1 h at room temperature with anti-LKT antibodies at final concentration of 17.5 μg/mL in PBS 1X pH 7.4, 5% low fat milk, with gentle agitation. For antigen-antibody detection membranes were incubated for 1 h at room temperature with a 1:5000 dilution of anti-rabbit IgG (whole molecule)alkaline phosphatase antibody produced in goat (Sigma) in PBS 1X pH 7.4, 5% low fat milk. The intensity of resulting bands was quantified using a Molecular Imaging Software (Carestream Health Inc).', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For immune response evaluation bovine sera obtained from a calf infected with M. haemolytica and from a healthy calf were gently provided by Virbac Uruguay.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Inactivated and non inactivated culture supernatant samples analyzed by SDS-PAGE were transferred onto membranes, as previously described. Membranes were incubated for 1 h at room temperature with a 1:500 dilution of each serum and afterwards for 1 h at room temperature with a 1:5000 dilution of anti-bovine', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'IgG-HRP (Novex), all in PBS 1X pH 7.4, 5% low fat milk. Detection was performed using TMB liquid substrate system for membranes (Sigma).', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Inactivated culture supernatant obtained from the industrial process was concentrated 20X by ultrafiltration (Vivaspin 500, 5 kDa, GE Healthcare) and analyzed by SDS-PAGE and coomassie blue staining. The most defined and intense bands were identified by peptide mass fingerprinting at Institut Pasteur Montevideo (Uruguay) using a 4800 MALDI TOF/TOF Analyzer (Applied Biosystems). Peptides from each sample were obtained by trypsin treatment (Sequencing Grade, Promega) overnight at 37°C. Peptide mass spectra were acquired as previously described (Lima et al., 2011) and MS/MS collision induced dissociation experiments of selected peptides were performed. Proteins were identified by NCBInr database searching with peptide m/z values using MASCOT search engine (Matrix Science) (Perkins et al., 1999) with the following searching parameters: monoisotopic mass tolerance, 0.08 Da; fragment mass tolerance, 0.45 Da and one missing tryptic cleavage allowed. Significant scores (p < 0.05) were used as criteria for positive protein identification.', 'cite_spans': [{'start': 548, 'end': 567, 'text': '(Lima et al., 2011)', 'ref_id': 'BIBREF32'}, {'start': 780, 'end': 802, 'text': '(Perkins et al., 1999)', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'Mass spectrometry (MS)'}, {'text': 'During M. haemolytica laboratory scale fermentation, parameters such as glucose concentration, dissolved oxygen, optical density (OD 600nm ) and pH were determined in samples taken every one hour of culture. This fermentation showed a kinetic profile compatible with typical bacterial growth in a batch system (Fig. 1B) . Culture was harvested ten hours after fermentation start, at the beginning of the stationary growth phase.', 'cite_spans': [], 'ref_spans': [{'start': 310, 'end': 319, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'Supernatant samples of a M. haemolytica laboratory scale culture were analyzed in order to evaluate the LKT accumulation in the supernatant. To identify LKT specific anti-LKT antibodies were produced. In preliminary evaluation experiments, we confirmed that these antibodies showed the expected reactivity against native and recombinant LKT and a good specific antibody titer. By means of these antibodies we identified LKT as a single defined band of approximately 110 kDa in culture supernatant samples of M. haemolytica (Fig. 1A) . In parallel, the presence of LKT in this protein band was confirmed by MS analysis (MS/MS protein score 408, protein sequence coverage 36%).', 'cite_spans': [], 'ref_spans': [{'start': 523, 'end': 532, 'text': '(Fig. 1A)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'The intensity of the specific LKT band detected by Western blot was determined by molecular imaging software. This analysis showed that LKT expression Article No~e00158 correlates with growth kinetics, being associated with exponential growth phase of M. haemolytica (Fig. 1B) , as previously reported (Chang et al., 1987) . Therefore, the presence of LKT was verified in the culture supernatant of the M. haemolytica production strain, during the exponential growth phase of the culture.', 'cite_spans': [{'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 267, 'end': 276, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'For proteomic analysis, industrial antigen was prepared according to vaccine production protocol. Culture supernatant was obtained and concentrated by ultrafiltration. After SDS-PAGE electrophoresis and coomassie blue staining, selected bands were recovered for MS identification ( Fig. 2A) . This approach allowed the statistically significant identification of 11 proteins of M. haemolytica in the industrial antigen (Table 1) . LKT was identified, in accordance with previous results of laboratory scale fermentation, among other relevant proteins.', 'cite_spans': [], 'ref_spans': [{'start': 282, 'end': 290, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF1'}, {'start': 419, 'end': 428, 'text': '(Table 1)', 'ref_id': None}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Some of these are outer membrane proteins (OMPs), which along with LKT are critical to achieve a protective immunity to the pathogen Singh et al., 2011) . Subcellular in silico localization, predicted using free access PSORTb software (available at http://psort.hgc.jp/), indicated that most of the identified proteins are periplasmic (7/11), with others being extracellular (1/11) or located in the outer cell membrane (2/11).', 'cite_spans': [{'start': 133, 'end': 152, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}], 'ref_spans': [], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Although most proteins coincided with their theoretical MW (Table 1) Article No~e00158 (Fig. 2B ). This behavior of LKT in electrophoresis could be explained by crosslinking caused by formaldehyde treatment leading to high molecular weight structures.', 'cite_spans': [], 'ref_spans': [{'start': 59, 'end': 68, 'text': '(Table 1)', 'ref_id': None}, {'start': 87, 'end': 95, 'text': '(Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Immune reactivity of a serum obtained from a M. haemolytica infected calf against culture supernatant was addressed by Western blot. As shown in Fig. 2B several bands of both inactivated and non inactivated culture supernatant were specifically recognized by infected bovine serum and not by healthy bovine serum. Among them, LKT was the more reactive band. Ayalew et al., 2011) . (Rabus et al., 1999; Eidam et al., 2013) .', 'cite_spans': [{'start': 358, 'end': 378, 'text': 'Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}, {'start': 381, 'end': 401, 'text': '(Rabus et al., 1999;', 'ref_id': 'BIBREF42'}, {'start': 402, 'end': 421, 'text': 'Eidam et al., 2013)', 'ref_id': None}], 'ref_spans': [{'start': 145, 'end': 152, 'text': 'Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': '10 HisJ-like histidine ABC transport system-periplasmic binding protein MHH_RS14805 328 M9WWE6 28.0 kDa Periplasmic ABC transporter system component involved in molecule export through bacterial membrane (Eidam et al., 2013) . Belongs to ompA family (Eidam et al., 2013) . Ortholog Omp P6 reported as immunogen in other species (Roier et al., 2013; Alvarez et al., 2015) . * For this search protein scores greater than 87 are significant (p < 0.05).', 'cite_spans': [{'start': 204, 'end': 224, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 250, 'end': 270, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 328, 'end': 348, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 349, 'end': 370, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'disease associated morbid-mortality (Potter, 2015) , this kind of information is of utmost importance.', 'cite_spans': [{'start': 36, 'end': 50, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Available data demonstrate that the protective immunity against M. haemolytica can be acquired by neutralizing antibodies against Leukotoxin A (Mosier et al., 1989) , as well as antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988; Confer et al., 1995; Confer et al., 2009) . In order to promote an effective immune response, the presence of these pivotal elements in a BRD vaccine formulation is crucial.', 'cite_spans': [{'start': 143, 'end': 164, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 229, 'end': 254, 'text': '(Shewen and Wilkie, 1988;', 'ref_id': 'BIBREF48'}, {'start': 255, 'end': 275, 'text': 'Confer et al., 1995;', 'ref_id': 'BIBREF10'}, {'start': 276, 'end': 296, 'text': 'Confer et al., 2009)', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Based on previous reports that detected Leukotoxin A activity in bacterium-free culture supernatant from logarithmic-phase cultures (Chang et al., 1987) , Neumosan line of vaccines includes inactivated culture supernatants of an industrial optimized M. haemolytica culture. In this work we confirmed that LKT secretion is linked to the exponential growth phase during the antigen production culture, representing one of the primary secreted components. In culture supernatant, LKT was detected as a single band with the expected MW (approx. 110 kDa) (Lo et al., 1985; Chang et al., 1987) . Interestingly, after formaldehyde treatment, LKT was detected as a higher MW band (>230 kDa),', 'cite_spans': [{'start': 132, 'end': 152, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 550, 'end': 567, 'text': '(Lo et al., 1985;', 'ref_id': 'BIBREF33'}, {'start': 568, 'end': 587, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'suggesting that the toxin could be arranged as a high order structure, which could be fixed by this cross-linking agent (Klockenbusch and Kast, 2010) . This finding is in agreement with previous reports that showed that the molecular weight of native LKT in culture supernatant was higher than 400 kDa (Chang et al., 1987) .', 'cite_spans': [{'start': 120, 'end': 149, 'text': '(Klockenbusch and Kast, 2010)', 'ref_id': 'BIBREF27'}, {'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Besides LKT identification, we delved further into the characterization of the culture supernatant protein profile. By MS we identified other 10 proteins of M. haemolytica. Most of them are periplasmic and outer membrane proteins, which due to their extracellular location and exposure to the host immune system could represent interesting candidates to play a key role in the protection against this pathogen. It is worth mentioning that we also identified a cytoplasmic protein involved in carbohydrate metabolism (Formate C-acetyltransferase). This finding could be explained by some cellular lysis that could occur during bacterial growth and inactivation (Derzelle et al., 2005) , hence we cannot rule out that the culture supernatant may contain some cytoplasmic proteins.', 'cite_spans': [{'start': 660, 'end': 683, 'text': '(Derzelle et al., 2005)', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Some of the outer membrane proteins identified in this work have been reported as important immunogens and have been evaluated as recombinant subunit antigens due to their protective vaccine potential (Ayalew et al., 2011; Guzman-Brambila et al., 2012) . In particular, vaccination of mice and cattle with recombinant serotype specific antigen 1 (rSsa1) stimulated high antibody responses (Ayalew et al., 2011) . Besides, a \"Best-Reciprocal-Blast-Hit\" approach was performed in order to determine that M. haemolytica outer membrane protein P6 identified in this work, is ortholog to Omp P6 of H. somni and P. multocida, both reported as Article No~e00158', 'cite_spans': [{'start': 201, 'end': 222, 'text': '(Ayalew et al., 2011;', 'ref_id': 'BIBREF8'}, {'start': 223, 'end': 252, 'text': 'Guzman-Brambila et al., 2012)', 'ref_id': None}, {'start': 389, 'end': 410, 'text': '(Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'immunogenic in recent reports (Roier et al., 2013; Alvarez et al., 2015) . In that sense, the natural occurrence of these proteins in the inactivated vaccine antigen indicates that the vaccine contains the main components required for protection against M. haemolytica.', 'cite_spans': [{'start': 30, 'end': 50, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 51, 'end': 72, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Different proteins belonging to the ATP-binding cassette (ABC) transporter superfamily were identified in the commercial antigen. ABC transport systems are essential for many processes of the cell, such as uptake of amino acids, peptides, carbohydrates and metal ions in an ATP coupled process. There is increasing evidence that these transport systems play either direct or indirect roles in the virulence and pathogenicity of bacteria (Garmory and Titball, 2004) . In a recent work, other ABC transporters were identified as immunodominant proteins from M. haemolytica and H. somni in cattle immunized with a commercial cellular vaccine, confirming that the surface exposed transporters of these species are immunogenic (Alvarez et al., 2015) . Interestingly, our results evidence that ABC transporters are relevant components in the vaccine antigen, and therefore could be potential targets for the development of antibacterial subunit vaccines (Garmory and Titball, 2004) .', 'cite_spans': [{'start': 437, 'end': 464, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}, {'start': 722, 'end': 744, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 948, 'end': 975, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Finally, we also identified an iron-regulated periplasmic protein YfeA, previously described as immunodominant in animals immunized with a cellular M. haemolytica vaccine (Alvarez et al., 2015) , as well as with an OMP-enriched fraction of M. haemolytica (Ayalew et al., 2010) .', 'cite_spans': [{'start': 171, 'end': 193, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 255, 'end': 276, 'text': '(Ayalew et al., 2010)', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Taken together, these observations support the protective potential of several of the proteins indentified in the M. haemolytica antigen. As an additional outcome anti-LKT antibodies developed for LKT identification can be used in routine quantitative assays in order to establish acceptance criteria of antigen commercial batches.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Author contribution statement Contributed reagents, materials, analysis tools or data.', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}, {'text': 'Article No~e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}], 'bib_entries': {'BIBREF1': {'ref_id': 'b1', 'title': 'Serotyping of Mannheimia (Pasteurella) haemolytica isolates from the upper Midwest United States', 'authors': [{'first': 'G', 'middle': ['M'], 'last': 'Al-Ghamdi', 'suffix': ''}, {'first': 'T', 'middle': ['R'], 'last': 'Ames', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Baker', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Walker', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Chase', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Frank', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}], 'year': 2000, 'venue': 'J. Vet. Diagn. Invest', 'volume': '12', 'issn': '6', 'pages': '576--578', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach', 'authors': [{'first': 'A', 'middle': ['H'], 'last': 'Alvarez', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Gutierrez-Ortega', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hernandez-Gutierrez', 'suffix': ''}], 'year': 2015, 'venue': 'Can. J. Vet. Res', 'volume': '79', 'issn': '4', 'pages': '339--342', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds', 'authors': [{'first': 'T', 'middle': [], 'last': 'Autio', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pohjanvirta', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Holopainen', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Rikula', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Pentikainen', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Huovilainen', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Rusanen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Soveri', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Sihvonen', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pelkonen', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': ['D'], 'last': 'Hartson', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}], 'year': 2010, 'venue': 'Proteomics', 'volume': '10', 'issn': '11', 'pages': '2151--2164', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'A', 'middle': ['E'], 'last': 'Wilson', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Clin. Vaccine Immunol', 'volume': '18', 'issn': '12', 'pages': '2067--2074', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Step', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Wray', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Hansen', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 2009, 'venue': 'Vaccine', 'volume': '27', 'issn': '11', 'pages': '1771--1776', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Mccraw', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Durham', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Morton', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 1995, 'venue': 'Vet. Immunol. Immunopathol', 'volume': '47', 'issn': '1-2', 'pages': '101--110', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Conlon', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '2', 'pages': '587--591', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Histophilus somni host-parasite relationships', 'authors': [{'first': 'L', 'middle': ['B'], 'last': 'Corbeil', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '151--160', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Identification and characterization of the Pasteurella haemolytica leukotoxin', 'authors': [{'first': 'Y', 'middle': ['F'], 'last': 'Chang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Young', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Post', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Struck', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '10', 'pages': '2348--2354', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Pasteurella multocida and bovine respiratory disease', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Dabo', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Taylor', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '129--150', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein', 'authors': [{'first': 'S', 'middle': [], 'last': 'Derzelle', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bolotin', 'suffix': ''}, {'first': 'M', 'middle': ['Y'], 'last': 'Mistou', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Rul', 'suffix': ''}], 'year': 2005, 'venue': 'Appl. Environ. Microbiol', 'volume': '71', 'issn': '12', 'pages': '8597--8605', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Control methods for bovine respiratory disease for feedlot cattle', 'authors': [{'first': 'T', 'middle': ['A'], 'last': 'Edwards', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '273--284', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Complete genome sequence of Mannheimia haemolytica strain 42548 from a case of bovine respiratory disease', 'authors': [{'first': 'S', 'middle': [], 'last': 'Schwarz', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Fulton', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Purdy', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'J', 'middle': ['T'], 'last': 'Saliki', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Loan', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Burge', 'suffix': ''}], 'year': 2000, 'venue': 'Can. J. Vet. Res', 'volume': '64', 'issn': '3', 'pages': '151--159', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies', 'authors': [{'first': 'H', 'middle': ['S'], 'last': 'Garmory', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Titball', 'suffix': ''}], 'year': 2004, 'venue': 'Infect. Immun', 'volume': '72', 'issn': '12', 'pages': '6757--6763', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves', 'authors': [{'first': 'L', 'middle': ['J'], 'last': 'Gershwin', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Gunther', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Anderson', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Woolums', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Mcarthur-Vaughan', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Randel', 'suffix': ''}, {'first': 'G', 'middle': ['A'], 'last': 'Boyle', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Friebertshauser', 'suffix': ''}, {'first': 'P', 'middle': ['S'], 'last': 'Mcinturff', 'suffix': ''}], 'year': 2000, 'venue': 'Am. J. Vet. Res', 'volume': '61', 'issn': '3', 'pages': '291--298', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge', 'authors': [{'first': 'A', 'middle': ['E'], 'last': 'Ortuno-Sahagun', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Res. Vet. Sci', 'volume': '93', 'issn': '3', 'pages': '1293--1300', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Complete closed genome sequences of Mannheimia haemolytica serotypes A1 and A6, isolated from cattle', 'authors': [{'first': 'G', 'middle': ['P'], 'last': 'Harhay', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Koren', 'suffix': ''}, {'first': 'A', 'middle': ['M'], 'last': 'Phillippy', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Mcvey', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kuszak', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Clawson', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Harhay', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Heaton', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Chitko-Mckown', 'suffix': ''}, {'first': 'T', 'middle': ['P'], 'last': 'Smith', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2 Isolates D171 and D35 recovered from bovine pneumonia', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Hauglund', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Tatum', 'suffix': ''}, {'first': 'D', 'middle': ['O'], 'last': 'Bayles', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}], 'year': 2015, 'venue': 'Genome Announc', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1', 'authors': [{'first': 'C', 'middle': [], 'last': 'Klockenbusch', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kast', 'suffix': ''}], 'year': 2010, 'venue': 'J. Biomed. Biotechnol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin', 'authors': [{'first': 'F', 'middle': ['A'], 'last': 'Lainson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Murray', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Davies', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Donachie', 'suffix': ''}], 'year': 1996, 'venue': 'Microbiology', 'volume': '142', 'issn': '', 'pages': '2499--2507', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Improved method for predicting linear B-cell epitopes', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Larsen', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Lund', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nielsen', 'suffix': ''}], 'year': 2006, 'venue': 'Immunome Res', 'volume': '2', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2: ovine and bovine isolates', 'authors': [{'first': 'P', 'middle': ['K'], 'last': 'Lawrence', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Kittichotirat', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Bumgarner', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Mcdermott', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Herndon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Knowles', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Srikumaran', 'suffix': ''}], 'year': 2010, 'venue': 'J. Bacteriol', 'volume': '192', 'issn': '4', 'pages': '1167--1168', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches', 'authors': [{'first': 'A', 'middle': [], 'last': 'Lima', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Duran', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Schujman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Marchissio', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Portela', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Obal', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Pritsch', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'De Mendoza', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Cervenansky', 'suffix': ''}], 'year': 2011, 'venue': 'J. Proteomics', 'volume': '74', 'issn': '9', 'pages': '1720--1734', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'C', 'middle': ['N'], 'last': 'Greer', 'suffix': ''}], 'year': 1985, 'venue': 'Infect. Immun', 'volume': '50', 'issn': '3', 'pages': '667--671', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '9', 'pages': '1987--1996', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Cooney', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '10', 'pages': '3398--3406', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Mosier', 'suffix': ''}, {'first': 'K', 'middle': ['R'], 'last': 'Simons', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}, {'first': 'K', 'middle': ['D'], 'last': 'Clinkenbeard', 'suffix': ''}], 'year': 1989, 'venue': 'Infect. Immun', 'volume': '57', 'issn': '3', 'pages': '711--716', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Leukotoxins of gram-negative bacteria', 'authors': [{'first': 'S', 'middle': ['K'], 'last': 'Narayanan', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Nagaraja', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Chengappa', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Stewart', 'suffix': ''}], 'year': 2002, 'venue': 'Vet. Microbiol', 'volume': '84', 'issn': '4', 'pages': '337--356', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Probability-based protein identification by searching sequence databases using mass spectrometry data', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Perkins', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Pappin', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Creasy', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Cottrell', 'suffix': ''}], 'year': 1999, 'venue': 'Electrophoresis', 'volume': '20', 'issn': '18', 'pages': '3551--3567', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb', 'authors': [{'first': 'A', 'middle': ['A'], 'last': 'Potter', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Schryvers', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Ogunnariwo', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Hutchins', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Watts', 'suffix': ''}], 'year': 1999, 'venue': 'Pathogenesis', 'volume': '27', 'issn': '4', 'pages': '197--206', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Bovine respiratory disease', 'authors': [{'first': 'T', 'middle': [], 'last': 'Potter', 'suffix': ''}], 'year': 2015, 'venue': 'Livestock (Electronic)', 'volume': '20', 'issn': '1', 'pages': '14--18', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'TRAP transporters: an ancient family of extracytoplasmic solute-receptor-dependent secondary active transporters', 'authors': [{'first': 'R', 'middle': [], 'last': 'Rabus', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Jack', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Kelly', 'suffix': ''}, {'first': 'M', 'middle': ['H'], 'last': 'Saier', 'suffix': ''}], 'year': 1999, 'venue': 'Microbiology', 'volume': '145', 'issn': '', 'pages': '3431--3445', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The contribution of infections with bovine viral diarrhea viruses to bovine respiratory disease', 'authors': [{'first': 'J', 'middle': [], 'last': 'Ridpath', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '335--348', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Effects of vaccination against respiratory Article No~e00158 pathogens on feed intake, metabolic, and inflammatory responses in beef heifers', 'authors': [{'first': 'M', 'middle': ['C'], 'last': 'Rodrigues', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Cooke', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Marques', 'suffix': ''}, {'first': 'B', 'middle': ['I'], 'last': 'Cappellozza', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Arispe', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Keisler', 'suffix': ''}, {'first': 'D', 'middle': ['W'], 'last': 'Bohnert', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': 'Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles', 'authors': [{'first': 'S', 'middle': [], 'last': 'Roier', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Fenninger', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Leitner', 'suffix': ''}, {'first': 'G', 'middle': ['N'], 'last': 'Rechberger', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Reidl', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schild', 'suffix': ''}], 'year': 2013, 'venue': 'Int. J. Med. Microbiol', 'volume': '303', 'issn': '5', 'pages': '247--256', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1985, 'venue': 'Am. J. Vet. Res', 'volume': '46', 'issn': '5', 'pages': '1212--1214', 'other_ids': {}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1988, 'venue': 'Can. J. Vet. Res', 'volume': '52', 'issn': '1', 'pages': '30--36', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'Mannheimia haemolytica: bacterial-host interactions in bovine pneumonia', 'authors': [{'first': 'K', 'middle': [], 'last': 'Singh', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Ritchey', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Vet. Pathol', 'volume': '48', 'issn': '2', 'pages': '338--348', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'Protein production by auto-induction in high density shaking cultures', 'authors': [{'first': 'F', 'middle': ['W'], 'last': 'Studier', 'suffix': ''}], 'year': 2005, 'venue': 'Protein Expr. Purif', 'volume': '41', 'issn': '1', 'pages': '207--234', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Sequence diversity of the leukotoxin (lktA) gene in caprine and ovine strains of Mannheimia haemolytica', 'authors': [{'first': 'C', 'middle': [], 'last': 'Vougidou', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Sandalakis', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Psaroulaki', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Petridou', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ekateriniadou', 'suffix': ''}], 'year': 2013, 'venue': 'Vet. Rec', 'volume': '172', 'issn': '16', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Effect of bovine granulocyte colony-stimulating factor on the development of pneumonia caused by Mannheimia haemolytica', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Youssef', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Clark', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Caswell', 'suffix': ''}], 'year': 2004, 'venue': 'Vet. Pathol', 'volume': '41', 'issn': '6', 'pages': '649--657', 'other_ids': {}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'How Mannheimia haemolytica defeats host defence through a kiss of death mechanism', 'authors': [{'first': 'L', 'middle': [], 'last': 'Zecchinon', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fett', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Desmecht', 'suffix': ''}], 'year': 2005, 'venue': 'Vet. Res', 'volume': '36', 'issn': '2', 'pages': '133--156', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': ', LKT was identified by MS in a higher than expected MW band (>230 kDa). This result was confirmed by Western blot of inactivated supernatant using anti-LKT antibodies M. haemolytica culture growth and LKT secretion profile. A. Anti-LKT Western blot of M. haemolytica culture supernatant samples from different fermentation time points. M: fermentation media, T1-T10: samples from culture kinetics (1-10 h). MW: Molecular weight marker. B. M. haemolytica culture growth curve and kinetics of Leukotoxin secretion. Optical density (OD) at 600 nm, glucose concentration (mg/dL) and band intensity of LKT expressed in arbitrary units (AU) are plotted versus culture growth time measured in hours.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'This work provides an exhaustive molecular characterization of an inactivated culture supernatant of M. haemolytica included in a line of polyvalent commercial bovine vaccines (Neumosan, Virbac Uruguay). Since M. haemolytica is the main etiological agent of BRD and is also responsible for a high proportion of the Identification of M. haemolytica culture supernatant proteins. A. M. haemolytica proteins of inactivated culture supernatant (iCSN) resolved in SDS-PAGE and stained with coomassie blue. Bands corresponding to the proteins analyzed by MS (MALDI TOF/TOF) are numbered and referred to on Table 1. For complete image see Fig. S1 (Supplementary material). B. Analysis of culture supernatant proteins by Western blot. Left: M. haemolytica inactivated (iCSN) and non inactivated culture supernatant (CSN) proteins probed with anti-rLKT rabbit serum. Middle: Reactivity of bovine M. haemolytica infected serum against M. haemolytica iCSN and CSN. Right: Reactivity of bovine healthy serum against M. haemolytica iCSN and CSN. MW: Molecular weight marker.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Proteins identified in culture supernatant of M. haemolytica.', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': 'Paula Tucci: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Verónica Estevez, Lorena Becco: Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Florencia Cabrera-Cabrera: Performed the experiments; Analyzed and interpreted the data. Germán Grotiuz: Performed the experiments; Analyzed and interpreted the data;', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We thank Viviana Sánchez for critical reading of the manuscript, Danilo Segovia for assistance in cloning techniques and Florencia Arezzo for technical assistance during M. haemolytica laboratory scale fermentation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}, {'text': 'This work was partially financed by Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing interest statement'}, {'text': 'This work was partially supported by Agencia Nacional de Investigación e Innovación (ANII, Uruguay), Alianzas para la Innovación (ALI_2_2013_1_4783) and Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding statement'}, {'text': 'Supplementary content related to this article has been published online at http://dx. doi.org/10.1016/j.heliyon.2016.e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Additional information'}]}\n",
      "{'_id': ObjectId('5ea715efc7f7cfde7827d5af'), 'paper_id': '0a003aa69f43cee4357f1e943df79a8b87c0a88e', 'metadata': {'title': 'Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen', 'authors': [{'first': 'Paula', 'middle': [], 'last': 'Tucci', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Verónica', 'middle': [], 'last': 'Estevez', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Lorena', 'middle': [], 'last': 'Becco', 'suffix': '', 'affiliation': {'laboratory': 'Laboratorios Celsius', 'institution': '', 'location': {'postCode': '6201', 'settlement': 'Montevideo', 'country': 'S.A. Avenida Italia, Uruguay'}}, 'email': ''}, {'first': 'Florencia', 'middle': [], 'last': 'Cabrera-Cabrera', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Germán', 'middle': [], 'last': 'Grotiuz', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Eduardo', 'middle': [], 'last': 'Reolon', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Virbac Uruguay, S.A. Avda. Millán 4175', 'location': {'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': ''}, {'first': 'Mónica', 'middle': [], 'last': 'Marín', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidad de la República', 'location': {'addrLine': 'Iguá 4225', 'settlement': 'Montevideo', 'country': 'Uruguay'}}, 'email': 'marin@fcien.edu.uym.marín.'}]}, 'abstract': [{'text': 'Bovine Respiratory Disease is the most costly disease that affects beef and dairy cattle industry. Its etiology is multifactorial, arising from predisposing environmental stress conditions as well as the action of several different respiratory pathogens. This situation has hindered the development of effective control strategies. Although different type of vaccines are available, many currently marketed vaccines are based on inactivated cultures of the main viral and bacterial agents involved in this pathology. The molecular composition of commercial veterinary vaccines is a critical issue. The present work aims to define at the proteomic level the most relevant valence of a line of commercial respiratory vaccines widely used in Central and South America. Since Mannheimia haemolytica is responsible for most of the disease associated morbid-mortality, we focused on the main proteins secreted by this pathogen, in particular Leukotoxin A, its main virulence factor. By Western blot analysis and mass spectrometry, Leukotoxin A was identified as a major component of (http://creativecommons.org/licenses/by-nc-nd/4.0/). M. haemolytica culture supernatants. We also identified other ten M. haemolytica proteins, including outer membrane proteins, periplasmic transmembrane solute transporters and iron binding proteins, which are relevant to achieve protective immunity against the pathogen. This work allowed a detailed molecular characterization of this vaccine component, providing evidence of its quality and efficacy. Furthermore, our results contributed to the identification of several proteins of interest as subunit vaccine candidates.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Bovine Respiratory Disease (BRD) is one of the leading causes of death and economic loss for the beef and dairy cattle industry. It has an estimated annual cost to the worldwide cattle industry of over $3 billion (Potter, 2015) . This multifactorial syndrome can be caused either by viral or bacterial pathogens. Viral agents include bovine respiratory syncytial virus (BRSV) (Gershwin et al., 2000) , parainfluenza III virus (PI-3) (Fulton et al., 2000) , bovine viral diarrhea virus (BVDV) (Ridpath, 2010) and bovine corona virus (BCV) (Autio et al., 2007) . These respiratory viruses along with some mycoplasmal agents are generally the primary infectious agents involved in BRD (Potter, 2015) . This initial infection establishes a respiratory environment predisposing to the colonization and replication of pathogenic bacteria, including Mannheimia haemolytica (Al-Ghamdi et al., 2000) , Pasteurella multocida (Dabo et al., 2007) and Histophilus somni (Corbeil, 2007) , the former being responsible for up to 50% of the disease associated mortality (Narayanan et al., 2002; Potter, 2015) . M. haemolytica is a Gram negative opportunistic bacterium. Although it is a common bacterium of the upper respiratory tract and nasopharynx of healthy ruminants, it can also act as an opportunistic pathogen infecting the lower respiratory tract under stressful situations such as shipping, adverse environmental conditions or previous respiratory viral infection (Youssef et al., 2004; Orouji et al., 2012) .', 'cite_spans': [{'start': 213, 'end': 227, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 376, 'end': 399, 'text': '(Gershwin et al., 2000)', 'ref_id': 'BIBREF22'}, {'start': 433, 'end': 454, 'text': '(Fulton et al., 2000)', 'ref_id': 'BIBREF19'}, {'start': 492, 'end': 507, 'text': '(Ridpath, 2010)', 'ref_id': 'BIBREF43'}, {'start': 538, 'end': 558, 'text': '(Autio et al., 2007)', 'ref_id': 'BIBREF4'}, {'start': 682, 'end': 696, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 866, 'end': 890, 'text': '(Al-Ghamdi et al., 2000)', 'ref_id': 'BIBREF1'}, {'start': 915, 'end': 934, 'text': '(Dabo et al., 2007)', 'ref_id': 'BIBREF14'}, {'start': 957, 'end': 972, 'text': '(Corbeil, 2007)', 'ref_id': 'BIBREF12'}, {'start': 1054, 'end': 1078, 'text': '(Narayanan et al., 2002;', 'ref_id': 'BIBREF37'}, {'start': 1079, 'end': 1092, 'text': 'Potter, 2015)', 'ref_id': 'BIBREF41'}, {'start': 1458, 'end': 1480, 'text': '(Youssef et al., 2004;', 'ref_id': 'BIBREF52'}, {'start': 1481, 'end': 1501, 'text': 'Orouji et al., 2012)', 'ref_id': None}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Being BRD a multifactorial disease, the development of effective control strategies has been difficult to accomplish. Vaccination against viral and bacterial pathogens involved in BRD is a useful tool to reduce the risk of this disease. Many commercial respiratory vaccines are composed by inactivated cultures of the most relevant pathogens (Edwards, 2010; Rodrigues et al., 2015) . These multivalent formulations are designed to reduce the impact of viral infections and to neutralize the severe associated bacterial infections. Therefore, to guarantee the efficacy of BRD vaccines, it is important to achieve a complete characterization of the antigens included in the vaccine and to verify the presence of those molecules critical for establishing an efficient immunological protection.', 'cite_spans': [{'start': 342, 'end': 357, 'text': '(Edwards, 2010;', 'ref_id': 'BIBREF16'}, {'start': 358, 'end': 381, 'text': 'Rodrigues et al., 2015)', 'ref_id': 'BIBREF44'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In this work we attempt to characterize the main proteins of M. haemolytica in a polyvalent inactivated BRD line of vaccines currently commercialized in Central and South America (Neumosan, Virbac Uruguay S.A. (former Santa Elena), http:// www.santaelena.com.uy). Among them we emphasize the study of Leukotoxin A (LKT), its main virulence factor, which has been shown to play an important role in the development of a protective immunity against the pathogen (Confer et al., 2009 ).', 'cite_spans': [{'start': 460, 'end': 480, 'text': '(Confer et al., 2009', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'LKT is a potent cytolytic toxin, with an apparent molecular weight (MW) of 105 kDa, actively secreted by all serotypes of the bacterium during the logarithmic phase of in vitro growth (Shewen and Wilkie, 1985; Chang et al., 1987) . It belongs to the family of the RTX (repeat in toxin) pore-forming cytolysins, which have been linked with the virulence of other bacterial species (Lo et al., 1987; Lainson et al., 1996) . It specifically targets ruminant leukocytes and plays a major role in pathogenesis of BRD by impairing the primary lung defense mechanism and by inducing inflammation as a consequence of leukocyte lysis (Conlon et al., 1991) . This phenomenon has been correlated with its ability to bind and interact with the ruminant beta2-integrin Lymphocyte Function-associated Antigen 1 (LFA-1) (CD11a/CD18) (Zecchinon et al., 2005; Singh et al., 2011) . Neutralizing antibodies generation against the cytolytic toxin is relevant for achieving a high level of protection (Mosier et al., 1989) . Immunity against M. haemolytica also requires antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988) and iron-regulated outer membrane proteins (Potter et al., 1999) .', 'cite_spans': [{'start': 184, 'end': 209, 'text': '(Shewen and Wilkie, 1985;', 'ref_id': 'BIBREF47'}, {'start': 210, 'end': 229, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 380, 'end': 397, 'text': '(Lo et al., 1987;', 'ref_id': 'BIBREF34'}, {'start': 398, 'end': 419, 'text': 'Lainson et al., 1996)', 'ref_id': 'BIBREF28'}, {'start': 625, 'end': 646, 'text': '(Conlon et al., 1991)', 'ref_id': 'BIBREF11'}, {'start': 818, 'end': 842, 'text': '(Zecchinon et al., 2005;', 'ref_id': 'BIBREF53'}, {'start': 843, 'end': 862, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}, {'start': 981, 'end': 1002, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 1102, 'end': 1127, 'text': '(Shewen and Wilkie, 1988)', 'ref_id': 'BIBREF48'}, {'start': 1171, 'end': 1192, 'text': '(Potter et al., 1999)', 'ref_id': 'BIBREF40'}], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Our aim is to bring more insight into the molecular composition of a M. haemolytica inactivated antigen used in bovine commercial vaccines, focusing on the identification of relevant secreted or surface-exposed proteins. This knowledge will support the development of specific quality control techniques to assist the optimization and standardization of the industrial vaccine production process.', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': '2.1. Laboratory scale M. haemolytica culture A seed culture was prepared by inoculation of an aliquot of master seed bank (MSB) of M. haemolytica serotype A1 (production strain code B059) in TSB-BHI (Tryptic Soy Broth, Brain Heart Infusion, Porcine) and incubation at 37.0 ± 1.0°C, for 12 h with orbital agitation (220 rpm). Inoculum was prepared by a 1:100 dilution of the seed culture in TSB-BHI and further incubation at 37.0 ± 1.0°C with orbital agitation until an optical density at 600 nm (OD 600nm ) of 0.2 to 0.3 units was reached. A benchtop fermentor (Biostat A, New Brunswick) with 2 L of fermentation media (TSB-BHI supplemented with 0.4% glucose) was inoculated with 20 mL of the inoculum culture (1:100 dilution). The fermentation culture was grown at 37.0 ± 1.0°C with dissolved oxygen set above 40% and variable Article No~e00158 agitation. During fermentation, samples were taken every one hour to measure OD 600nm , dissolved oxygen (%), glucose concentration (mg/dL) and pH. The culture was harvested when it reached stationary growth phase. Samples and the final culture were centrifuged at 8000×g for 30 min at 4°C and culture supernatants were stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Materials and methods'}, {'text': 'M. haemolytica culture for vaccine antigen preparation was performed following the industrial standardized protocol. Culture media used was developed by Virbac Uruguay S.A. and is based on protein hydrolysates, yeast extract, dextrose, and sodium and potassium salts. The inoculum was prepared as previously described using 1 vial of production seed of M. haemolytica serotype A1 (production strain code B059). The production fermentor was inoculated with a 1:100 dilution of the inoculum and the culture was performed at 37°C with automatic agitation and aeration until the end of the logarithmic growth phase. After harvesting, culture was inactivated by incubation at 37°C with formaldehyde 0.5% (v/v) during 24 h. To obtain culture supernatant the inactivated culture was centrifuged at 8000×g for 30 min at 4°C. Inactivated culture supernatant was stored at −20°C.', 'cite_spans': [], 'ref_spans': [], 'section': 'Industrial M. haemolytica antigen preparation'}, {'text': 'Specific primers were designed to amplify a portion of LKT which contains the Cterminal domain of the protein. An in silico prediction of the location of linear Bcell epitopes was performed using Bepipred algorithm (Larsen et al., 2006) . As previously reported (Lee et al., 2001) , the portion of LktA with more immunogenic epitopes was the C-terminal domain. Therefore, a sequence including the main predicted epítopes (amino acid 713 to 873) was selected. M. haemolytica (production strain code B059) was cultured as the seed culture described above.', 'cite_spans': [{'start': 215, 'end': 236, 'text': '(Larsen et al., 2006)', 'ref_id': 'BIBREF29'}, {'start': 262, 'end': 280, 'text': '(Lee et al., 2001)', 'ref_id': None}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Culture was centrifuged at 10000×g and the cell pellet was stored at −70°C. M. haemolytica genomic DNA was extracted using a standard protocol (Ausubel et al., 1999) and partial LKT sequence was amplified by PCR. For LKT expression, restriction sites were included in primers for a directional cloning of LKT sequence in pET28a(+) vector (Novagen). E. coli BL21 DE3 (Novagen) competent cells were transformed with the construct and stored at −70°C in 15% glycerol. Plasmid DNA was isolated from E. coli using a commercial kit (QiaPrep Spin Miniprep, Qiagen). Plasmid sequence was confirmed by DNA sequencing at Institut Pasteur Montevideo (Uruguay). For LKT expression, a culture was performed in ZYM-5052 auto induction medium (Studier, 2005) for 18-20 h at 37.0 ± 1.0°C. As expected, by SDS-PAGE a band of approximately 40 kDa corresponding to the recombinant protein was observed. The protein was purified by IMAC chromatography (HisTrap HP, GE Healthcare) in an ÄKTA Purifier 100 (GE Healthcare). The Article No~e00158 purified protein was dialyzed against PBS 1X pH 7.4 and quantified by BCA (Pierce BCA Protein Assay Kit, Thermo Scientific).', 'cite_spans': [{'start': 143, 'end': 165, 'text': '(Ausubel et al., 1999)', 'ref_id': None}, {'start': 728, 'end': 743, 'text': '(Studier, 2005)', 'ref_id': 'BIBREF50'}], 'ref_spans': [], 'section': 'Recombinant LKT production'}, {'text': 'Two New Zealand white rabbits (2.5 Kg body weight) were maintained in the experimental animal facility (Instituto de Higiene, Universidad de la República, Uruguay) in accordance with animal procedures approved by the Honorary Commission of Animal Experimentation (CHEA protocol No 071140-000771-11).', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Both rabbits were immunized subcutaneously with 50 ug of recombinant LKT, on days 0 and 21 of the immunization protocol. Blood samples were taken on days 21, 45 and 115, and sera were prepared and stored at −20°C. Serum titers were determined by ELISA using 0.1 μg/well of recombinant LKT for coating, serum dilutions of 1:100 to 1:100.000, and conjugate dilution of 1:10.000 (Goat antirabbit IgG (whole molecule)-Peroxidase, Sigma). High titer sera were pooled and purified by protein A chromatography (HiTraprProtein A, GE Healthcare). Purified IgG reactivity against native and recombinant LKT was evaluated by Western blot as described below.', 'cite_spans': [], 'ref_spans': [], 'section': 'Rabbit anti-LKT serum production and evaluation'}, {'text': 'Culture supernatants were analyzed by 12% SDS-PAGE and coomassie blue staining (Ausubel et al., 1999) . Molecular weight markers used were PageRuler Prestained Protein Ladder (Thermo Scientific) and Prestained Protein Ladder Broad Range (NEB).', 'cite_spans': [{'start': 79, 'end': 101, 'text': '(Ausubel et al., 1999)', 'ref_id': None}], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For Western blot analysis, proteins were transferred onto a nitrocellulose membrane (Hybond-C Extra, Amersham Biosciences) for one hour at 400 mA.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Rabbit antibodies against recombinant LKT, produced and purified by our work group, were used to identify LKT in culture supernatants. Briefly, membranes were incubated for 1 h at room temperature with anti-LKT antibodies at final concentration of 17.5 μg/mL in PBS 1X pH 7.4, 5% low fat milk, with gentle agitation. For antigen-antibody detection membranes were incubated for 1 h at room temperature with a 1:5000 dilution of anti-rabbit IgG (whole molecule)alkaline phosphatase antibody produced in goat (Sigma) in PBS 1X pH 7.4, 5% low fat milk. The intensity of resulting bands was quantified using a Molecular Imaging Software (Carestream Health Inc).', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'For immune response evaluation bovine sera obtained from a calf infected with M. haemolytica and from a healthy calf were gently provided by Virbac Uruguay.', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'Inactivated and non inactivated culture supernatant samples analyzed by SDS-PAGE were transferred onto membranes, as previously described. Membranes were incubated for 1 h at room temperature with a 1:500 dilution of each serum and afterwards for 1 h at room temperature with a 1:5000 dilution of anti-bovine', 'cite_spans': [], 'ref_spans': [], 'section': 'SDS-PAGE and Western blot analysis'}, {'text': 'IgG-HRP (Novex), all in PBS 1X pH 7.4, 5% low fat milk. Detection was performed using TMB liquid substrate system for membranes (Sigma).', 'cite_spans': [], 'ref_spans': [], 'section': 'Article No~e00158'}, {'text': 'Inactivated culture supernatant obtained from the industrial process was concentrated 20X by ultrafiltration (Vivaspin 500, 5 kDa, GE Healthcare) and analyzed by SDS-PAGE and coomassie blue staining. The most defined and intense bands were identified by peptide mass fingerprinting at Institut Pasteur Montevideo (Uruguay) using a 4800 MALDI TOF/TOF Analyzer (Applied Biosystems). Peptides from each sample were obtained by trypsin treatment (Sequencing Grade, Promega) overnight at 37°C. Peptide mass spectra were acquired as previously described (Lima et al., 2011) and MS/MS collision induced dissociation experiments of selected peptides were performed. Proteins were identified by NCBInr database searching with peptide m/z values using MASCOT search engine (Matrix Science) (Perkins et al., 1999) with the following searching parameters: monoisotopic mass tolerance, 0.08 Da; fragment mass tolerance, 0.45 Da and one missing tryptic cleavage allowed. Significant scores (p < 0.05) were used as criteria for positive protein identification.', 'cite_spans': [{'start': 548, 'end': 567, 'text': '(Lima et al., 2011)', 'ref_id': 'BIBREF32'}, {'start': 780, 'end': 802, 'text': '(Perkins et al., 1999)', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'Mass spectrometry (MS)'}, {'text': 'During M. haemolytica laboratory scale fermentation, parameters such as glucose concentration, dissolved oxygen, optical density (OD 600nm ) and pH were determined in samples taken every one hour of culture. This fermentation showed a kinetic profile compatible with typical bacterial growth in a batch system (Fig. 1B) . Culture was harvested ten hours after fermentation start, at the beginning of the stationary growth phase.', 'cite_spans': [], 'ref_spans': [{'start': 310, 'end': 319, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'Supernatant samples of a M. haemolytica laboratory scale culture were analyzed in order to evaluate the LKT accumulation in the supernatant. To identify LKT specific anti-LKT antibodies were produced. In preliminary evaluation experiments, we confirmed that these antibodies showed the expected reactivity against native and recombinant LKT and a good specific antibody titer. By means of these antibodies we identified LKT as a single defined band of approximately 110 kDa in culture supernatant samples of M. haemolytica (Fig. 1A) . In parallel, the presence of LKT in this protein band was confirmed by MS analysis (MS/MS protein score 408, protein sequence coverage 36%).', 'cite_spans': [], 'ref_spans': [{'start': 523, 'end': 532, 'text': '(Fig. 1A)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'The intensity of the specific LKT band detected by Western blot was determined by molecular imaging software. This analysis showed that LKT expression Article No~e00158 correlates with growth kinetics, being associated with exponential growth phase of M. haemolytica (Fig. 1B) , as previously reported (Chang et al., 1987) . Therefore, the presence of LKT was verified in the culture supernatant of the M. haemolytica production strain, during the exponential growth phase of the culture.', 'cite_spans': [{'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 267, 'end': 276, 'text': '(Fig. 1B)', 'ref_id': 'FIGREF0'}], 'section': 'Mannheimia haemolytica laboratory scale fermentation'}, {'text': 'For proteomic analysis, industrial antigen was prepared according to vaccine production protocol. Culture supernatant was obtained and concentrated by ultrafiltration. After SDS-PAGE electrophoresis and coomassie blue staining, selected bands were recovered for MS identification ( Fig. 2A) . This approach allowed the statistically significant identification of 11 proteins of M. haemolytica in the industrial antigen (Table 1) . LKT was identified, in accordance with previous results of laboratory scale fermentation, among other relevant proteins.', 'cite_spans': [], 'ref_spans': [{'start': 282, 'end': 290, 'text': 'Fig. 2A)', 'ref_id': 'FIGREF1'}, {'start': 419, 'end': 428, 'text': '(Table 1)', 'ref_id': None}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Some of these are outer membrane proteins (OMPs), which along with LKT are critical to achieve a protective immunity to the pathogen Singh et al., 2011) . Subcellular in silico localization, predicted using free access PSORTb software (available at http://psort.hgc.jp/), indicated that most of the identified proteins are periplasmic (7/11), with others being extracellular (1/11) or located in the outer cell membrane (2/11).', 'cite_spans': [{'start': 133, 'end': 152, 'text': 'Singh et al., 2011)', 'ref_id': 'BIBREF49'}], 'ref_spans': [], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Although most proteins coincided with their theoretical MW (Table 1) Article No~e00158 (Fig. 2B ). This behavior of LKT in electrophoresis could be explained by crosslinking caused by formaldehyde treatment leading to high molecular weight structures.', 'cite_spans': [], 'ref_spans': [{'start': 59, 'end': 68, 'text': '(Table 1)', 'ref_id': None}, {'start': 87, 'end': 95, 'text': '(Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': 'Immune reactivity of a serum obtained from a M. haemolytica infected calf against culture supernatant was addressed by Western blot. As shown in Fig. 2B several bands of both inactivated and non inactivated culture supernatant were specifically recognized by infected bovine serum and not by healthy bovine serum. Among them, LKT was the more reactive band. Ayalew et al., 2011) . (Rabus et al., 1999; Eidam et al., 2013) .', 'cite_spans': [{'start': 358, 'end': 378, 'text': 'Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}, {'start': 381, 'end': 401, 'text': '(Rabus et al., 1999;', 'ref_id': 'BIBREF42'}, {'start': 402, 'end': 421, 'text': 'Eidam et al., 2013)', 'ref_id': None}], 'ref_spans': [{'start': 145, 'end': 152, 'text': 'Fig. 2B', 'ref_id': 'FIGREF1'}], 'section': 'Proteomic characterization of M. haemolytica inactivated culture supernatant'}, {'text': '10 HisJ-like histidine ABC transport system-periplasmic binding protein MHH_RS14805 328 M9WWE6 28.0 kDa Periplasmic ABC transporter system component involved in molecule export through bacterial membrane (Eidam et al., 2013) . Belongs to ompA family (Eidam et al., 2013) . Ortholog Omp P6 reported as immunogen in other species (Roier et al., 2013; Alvarez et al., 2015) . * For this search protein scores greater than 87 are significant (p < 0.05).', 'cite_spans': [{'start': 204, 'end': 224, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 250, 'end': 270, 'text': '(Eidam et al., 2013)', 'ref_id': None}, {'start': 328, 'end': 348, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 349, 'end': 370, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'disease associated morbid-mortality (Potter, 2015) , this kind of information is of utmost importance.', 'cite_spans': [{'start': 36, 'end': 50, 'text': '(Potter, 2015)', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Available data demonstrate that the protective immunity against M. haemolytica can be acquired by neutralizing antibodies against Leukotoxin A (Mosier et al., 1989) , as well as antibodies against bacterial cell surface antigens (Shewen and Wilkie, 1988; Confer et al., 1995; Confer et al., 2009) . In order to promote an effective immune response, the presence of these pivotal elements in a BRD vaccine formulation is crucial.', 'cite_spans': [{'start': 143, 'end': 164, 'text': '(Mosier et al., 1989)', 'ref_id': 'BIBREF36'}, {'start': 229, 'end': 254, 'text': '(Shewen and Wilkie, 1988;', 'ref_id': 'BIBREF48'}, {'start': 255, 'end': 275, 'text': 'Confer et al., 1995;', 'ref_id': 'BIBREF10'}, {'start': 276, 'end': 296, 'text': 'Confer et al., 2009)', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Based on previous reports that detected Leukotoxin A activity in bacterium-free culture supernatant from logarithmic-phase cultures (Chang et al., 1987) , Neumosan line of vaccines includes inactivated culture supernatants of an industrial optimized M. haemolytica culture. In this work we confirmed that LKT secretion is linked to the exponential growth phase during the antigen production culture, representing one of the primary secreted components. In culture supernatant, LKT was detected as a single band with the expected MW (approx. 110 kDa) (Lo et al., 1985; Chang et al., 1987) . Interestingly, after formaldehyde treatment, LKT was detected as a higher MW band (>230 kDa),', 'cite_spans': [{'start': 132, 'end': 152, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}, {'start': 550, 'end': 567, 'text': '(Lo et al., 1985;', 'ref_id': 'BIBREF33'}, {'start': 568, 'end': 587, 'text': 'Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'suggesting that the toxin could be arranged as a high order structure, which could be fixed by this cross-linking agent (Klockenbusch and Kast, 2010) . This finding is in agreement with previous reports that showed that the molecular weight of native LKT in culture supernatant was higher than 400 kDa (Chang et al., 1987) .', 'cite_spans': [{'start': 120, 'end': 149, 'text': '(Klockenbusch and Kast, 2010)', 'ref_id': 'BIBREF27'}, {'start': 302, 'end': 322, 'text': '(Chang et al., 1987)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Besides LKT identification, we delved further into the characterization of the culture supernatant protein profile. By MS we identified other 10 proteins of M. haemolytica. Most of them are periplasmic and outer membrane proteins, which due to their extracellular location and exposure to the host immune system could represent interesting candidates to play a key role in the protection against this pathogen. It is worth mentioning that we also identified a cytoplasmic protein involved in carbohydrate metabolism (Formate C-acetyltransferase). This finding could be explained by some cellular lysis that could occur during bacterial growth and inactivation (Derzelle et al., 2005) , hence we cannot rule out that the culture supernatant may contain some cytoplasmic proteins.', 'cite_spans': [{'start': 660, 'end': 683, 'text': '(Derzelle et al., 2005)', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Some of the outer membrane proteins identified in this work have been reported as important immunogens and have been evaluated as recombinant subunit antigens due to their protective vaccine potential (Ayalew et al., 2011; Guzman-Brambila et al., 2012) . In particular, vaccination of mice and cattle with recombinant serotype specific antigen 1 (rSsa1) stimulated high antibody responses (Ayalew et al., 2011) . Besides, a \"Best-Reciprocal-Blast-Hit\" approach was performed in order to determine that M. haemolytica outer membrane protein P6 identified in this work, is ortholog to Omp P6 of H. somni and P. multocida, both reported as Article No~e00158', 'cite_spans': [{'start': 201, 'end': 222, 'text': '(Ayalew et al., 2011;', 'ref_id': 'BIBREF8'}, {'start': 223, 'end': 252, 'text': 'Guzman-Brambila et al., 2012)', 'ref_id': None}, {'start': 389, 'end': 410, 'text': '(Ayalew et al., 2011)', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'immunogenic in recent reports (Roier et al., 2013; Alvarez et al., 2015) . In that sense, the natural occurrence of these proteins in the inactivated vaccine antigen indicates that the vaccine contains the main components required for protection against M. haemolytica.', 'cite_spans': [{'start': 30, 'end': 50, 'text': '(Roier et al., 2013;', 'ref_id': 'BIBREF46'}, {'start': 51, 'end': 72, 'text': 'Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Different proteins belonging to the ATP-binding cassette (ABC) transporter superfamily were identified in the commercial antigen. ABC transport systems are essential for many processes of the cell, such as uptake of amino acids, peptides, carbohydrates and metal ions in an ATP coupled process. There is increasing evidence that these transport systems play either direct or indirect roles in the virulence and pathogenicity of bacteria (Garmory and Titball, 2004) . In a recent work, other ABC transporters were identified as immunodominant proteins from M. haemolytica and H. somni in cattle immunized with a commercial cellular vaccine, confirming that the surface exposed transporters of these species are immunogenic (Alvarez et al., 2015) . Interestingly, our results evidence that ABC transporters are relevant components in the vaccine antigen, and therefore could be potential targets for the development of antibacterial subunit vaccines (Garmory and Titball, 2004) .', 'cite_spans': [{'start': 437, 'end': 464, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}, {'start': 722, 'end': 744, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 948, 'end': 975, 'text': '(Garmory and Titball, 2004)', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Finally, we also identified an iron-regulated periplasmic protein YfeA, previously described as immunodominant in animals immunized with a cellular M. haemolytica vaccine (Alvarez et al., 2015) , as well as with an OMP-enriched fraction of M. haemolytica (Ayalew et al., 2010) .', 'cite_spans': [{'start': 171, 'end': 193, 'text': '(Alvarez et al., 2015)', 'ref_id': 'BIBREF2'}, {'start': 255, 'end': 276, 'text': '(Ayalew et al., 2010)', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Taken together, these observations support the protective potential of several of the proteins indentified in the M. haemolytica antigen. As an additional outcome anti-LKT antibodies developed for LKT identification can be used in routine quantitative assays in order to establish acceptance criteria of antigen commercial batches.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Author contribution statement Contributed reagents, materials, analysis tools or data.', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}, {'text': 'Article No~e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Declarations'}], 'bib_entries': {'BIBREF1': {'ref_id': 'b1', 'title': 'Serotyping of Mannheimia (Pasteurella) haemolytica isolates from the upper Midwest United States', 'authors': [{'first': 'G', 'middle': ['M'], 'last': 'Al-Ghamdi', 'suffix': ''}, {'first': 'T', 'middle': ['R'], 'last': 'Ames', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Baker', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Walker', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Chase', 'suffix': ''}, {'first': 'G', 'middle': ['H'], 'last': 'Frank', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}], 'year': 2000, 'venue': 'J. Vet. Diagn. Invest', 'volume': '12', 'issn': '6', 'pages': '576--578', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach', 'authors': [{'first': 'A', 'middle': ['H'], 'last': 'Alvarez', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Gutierrez-Ortega', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hernandez-Gutierrez', 'suffix': ''}], 'year': 2015, 'venue': 'Can. J. Vet. Res', 'volume': '79', 'issn': '4', 'pages': '339--342', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds', 'authors': [{'first': 'T', 'middle': [], 'last': 'Autio', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pohjanvirta', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Holopainen', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Rikula', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Pentikainen', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Huovilainen', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Rusanen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Soveri', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Sihvonen', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pelkonen', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': ['D'], 'last': 'Hartson', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}], 'year': 2010, 'venue': 'Proteomics', 'volume': '10', 'issn': '11', 'pages': '2151--2164', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15', 'authors': [{'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Shrestha', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'A', 'middle': ['E'], 'last': 'Wilson', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Clin. Vaccine Immunol', 'volume': '18', 'issn': '12', 'pages': '2067--2074', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ayalew', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Montelongo', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Step', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Wray', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Hansen', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 2009, 'venue': 'Vaccine', 'volume': '27', 'issn': '11', 'pages': '1771--1776', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1', 'authors': [{'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Mccraw', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Durham', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Morton', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}], 'year': 1995, 'venue': 'Vet. Immunol. Immunopathol', 'volume': '47', 'issn': '1-2', 'pages': '101--110', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1', 'authors': [{'first': 'J', 'middle': ['A'], 'last': 'Conlon', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '2', 'pages': '587--591', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Histophilus somni host-parasite relationships', 'authors': [{'first': 'L', 'middle': ['B'], 'last': 'Corbeil', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '151--160', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Identification and characterization of the Pasteurella haemolytica leukotoxin', 'authors': [{'first': 'Y', 'middle': ['F'], 'last': 'Chang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Young', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Post', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Struck', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '10', 'pages': '2348--2354', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Pasteurella multocida and bovine respiratory disease', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Dabo', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Taylor', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2007, 'venue': 'Anim. Health Res. Rev', 'volume': '8', 'issn': '2', 'pages': '129--150', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein', 'authors': [{'first': 'S', 'middle': [], 'last': 'Derzelle', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Bolotin', 'suffix': ''}, {'first': 'M', 'middle': ['Y'], 'last': 'Mistou', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Rul', 'suffix': ''}], 'year': 2005, 'venue': 'Appl. Environ. Microbiol', 'volume': '71', 'issn': '12', 'pages': '8597--8605', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Control methods for bovine respiratory disease for feedlot cattle', 'authors': [{'first': 'T', 'middle': ['A'], 'last': 'Edwards', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '273--284', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Complete genome sequence of Mannheimia haemolytica strain 42548 from a case of bovine respiratory disease', 'authors': [{'first': 'S', 'middle': [], 'last': 'Schwarz', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Fulton', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Purdy', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'J', 'middle': ['T'], 'last': 'Saliki', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Loan', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Burge', 'suffix': ''}], 'year': 2000, 'venue': 'Can. J. Vet. Res', 'volume': '64', 'issn': '3', 'pages': '151--159', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Article No~e00158', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies', 'authors': [{'first': 'H', 'middle': ['S'], 'last': 'Garmory', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Titball', 'suffix': ''}], 'year': 2004, 'venue': 'Infect. Immun', 'volume': '72', 'issn': '12', 'pages': '6757--6763', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves', 'authors': [{'first': 'L', 'middle': ['J'], 'last': 'Gershwin', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Gunther', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Anderson', 'suffix': ''}, {'first': 'A', 'middle': ['R'], 'last': 'Woolums', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Mcarthur-Vaughan', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Randel', 'suffix': ''}, {'first': 'G', 'middle': ['A'], 'last': 'Boyle', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Friebertshauser', 'suffix': ''}, {'first': 'P', 'middle': ['S'], 'last': 'Mcinturff', 'suffix': ''}], 'year': 2000, 'venue': 'Am. J. Vet. Res', 'volume': '61', 'issn': '3', 'pages': '291--298', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge', 'authors': [{'first': 'A', 'middle': ['E'], 'last': 'Ortuno-Sahagun', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': 'Res. Vet. Sci', 'volume': '93', 'issn': '3', 'pages': '1293--1300', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Complete closed genome sequences of Mannheimia haemolytica serotypes A1 and A6, isolated from cattle', 'authors': [{'first': 'G', 'middle': ['P'], 'last': 'Harhay', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Koren', 'suffix': ''}, {'first': 'A', 'middle': ['M'], 'last': 'Phillippy', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Mcvey', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kuszak', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Clawson', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Harhay', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Heaton', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Chitko-Mckown', 'suffix': ''}, {'first': 'T', 'middle': ['P'], 'last': 'Smith', 'suffix': ''}], 'year': 2013, 'venue': 'Genome Announc', 'volume': '1', 'issn': '3', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2 Isolates D171 and D35 recovered from bovine pneumonia', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Hauglund', 'suffix': ''}, {'first': 'F', 'middle': ['M'], 'last': 'Tatum', 'suffix': ''}, {'first': 'D', 'middle': ['O'], 'last': 'Bayles', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Maheswaran', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Briggs', 'suffix': ''}], 'year': 2015, 'venue': 'Genome Announc', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1', 'authors': [{'first': 'C', 'middle': [], 'last': 'Klockenbusch', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kast', 'suffix': ''}], 'year': 2010, 'venue': 'J. Biomed. Biotechnol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin', 'authors': [{'first': 'F', 'middle': ['A'], 'last': 'Lainson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Murray', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Davies', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Donachie', 'suffix': ''}], 'year': 1996, 'venue': 'Microbiology', 'volume': '142', 'issn': '', 'pages': '2499--2507', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Improved method for predicting linear B-cell epitopes', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Larsen', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Lund', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nielsen', 'suffix': ''}], 'year': 2006, 'venue': 'Immunome Res', 'volume': '2', 'issn': '2', 'pages': '', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Genome sequences of Mannheimia haemolytica serotype A2: ovine and bovine isolates', 'authors': [{'first': 'P', 'middle': ['K'], 'last': 'Lawrence', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Kittichotirat', 'suffix': ''}, {'first': 'R', 'middle': ['E'], 'last': 'Bumgarner', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Mcdermott', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Herndon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Knowles', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Srikumaran', 'suffix': ''}], 'year': 2010, 'venue': 'J. Bacteriol', 'volume': '192', 'issn': '4', 'pages': '1167--1168', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches', 'authors': [{'first': 'A', 'middle': [], 'last': 'Lima', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Duran', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Schujman', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Marchissio', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Portela', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Obal', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Pritsch', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'De Mendoza', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Cervenansky', 'suffix': ''}], 'year': 2011, 'venue': 'J. Proteomics', 'volume': '74', 'issn': '9', 'pages': '1720--1734', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Cloning and expression of the leukotoxin gene of Pasteurella haemolytica A1 in Escherichia coli K-12', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'C', 'middle': ['N'], 'last': 'Greer', 'suffix': ''}], 'year': 1985, 'venue': 'Infect. Immun', 'volume': '50', 'issn': '3', 'pages': '667--671', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}], 'year': 1987, 'venue': 'Infect. Immun', 'volume': '55', 'issn': '9', 'pages': '1987--1996', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1', 'authors': [{'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Strathdee', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['J'], 'last': 'Cooney', 'suffix': ''}], 'year': 1991, 'venue': 'Infect. Immun', 'volume': '59', 'issn': '10', 'pages': '3398--3406', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Mosier', 'suffix': ''}, {'first': 'K', 'middle': ['R'], 'last': 'Simons', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Panciera', 'suffix': ''}, {'first': 'K', 'middle': ['D'], 'last': 'Clinkenbeard', 'suffix': ''}], 'year': 1989, 'venue': 'Infect. Immun', 'volume': '57', 'issn': '3', 'pages': '711--716', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Leukotoxins of gram-negative bacteria', 'authors': [{'first': 'S', 'middle': ['K'], 'last': 'Narayanan', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Nagaraja', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Chengappa', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Stewart', 'suffix': ''}], 'year': 2002, 'venue': 'Vet. Microbiol', 'volume': '84', 'issn': '4', 'pages': '337--356', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Probability-based protein identification by searching sequence databases using mass spectrometry data', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Perkins', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Pappin', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Creasy', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Cottrell', 'suffix': ''}], 'year': 1999, 'venue': 'Electrophoresis', 'volume': '20', 'issn': '18', 'pages': '3551--3567', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microb', 'authors': [{'first': 'A', 'middle': ['A'], 'last': 'Potter', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Schryvers', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Ogunnariwo', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Hutchins', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Lo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Watts', 'suffix': ''}], 'year': 1999, 'venue': 'Pathogenesis', 'volume': '27', 'issn': '4', 'pages': '197--206', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Bovine respiratory disease', 'authors': [{'first': 'T', 'middle': [], 'last': 'Potter', 'suffix': ''}], 'year': 2015, 'venue': 'Livestock (Electronic)', 'volume': '20', 'issn': '1', 'pages': '14--18', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'TRAP transporters: an ancient family of extracytoplasmic solute-receptor-dependent secondary active transporters', 'authors': [{'first': 'R', 'middle': [], 'last': 'Rabus', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Jack', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Kelly', 'suffix': ''}, {'first': 'M', 'middle': ['H'], 'last': 'Saier', 'suffix': ''}], 'year': 1999, 'venue': 'Microbiology', 'volume': '145', 'issn': '', 'pages': '3431--3445', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The contribution of infections with bovine viral diarrhea viruses to bovine respiratory disease', 'authors': [{'first': 'J', 'middle': [], 'last': 'Ridpath', 'suffix': ''}], 'year': 2010, 'venue': 'Vet. Clin. North Am. Food Anim. Pract', 'volume': '26', 'issn': '2', 'pages': '335--348', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Effects of vaccination against respiratory Article No~e00158 pathogens on feed intake, metabolic, and inflammatory responses in beef heifers', 'authors': [{'first': 'M', 'middle': ['C'], 'last': 'Rodrigues', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Cooke', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Marques', 'suffix': ''}, {'first': 'B', 'middle': ['I'], 'last': 'Cappellozza', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Arispe', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Keisler', 'suffix': ''}, {'first': 'D', 'middle': ['W'], 'last': 'Bohnert', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': 'Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles', 'authors': [{'first': 'S', 'middle': [], 'last': 'Roier', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Fenninger', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Leitner', 'suffix': ''}, {'first': 'G', 'middle': ['N'], 'last': 'Rechberger', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Reidl', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schild', 'suffix': ''}], 'year': 2013, 'venue': 'Int. J. Med. Microbiol', 'volume': '303', 'issn': '5', 'pages': '247--256', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1985, 'venue': 'Am. J. Vet. Res', 'volume': '46', 'issn': '5', 'pages': '1212--1214', 'other_ids': {}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica', 'authors': [{'first': 'P', 'middle': ['E'], 'last': 'Shewen', 'suffix': ''}, {'first': 'B', 'middle': ['N'], 'last': 'Wilkie', 'suffix': ''}], 'year': 1988, 'venue': 'Can. J. Vet. Res', 'volume': '52', 'issn': '1', 'pages': '30--36', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'Mannheimia haemolytica: bacterial-host interactions in bovine pneumonia', 'authors': [{'first': 'K', 'middle': [], 'last': 'Singh', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Ritchey', 'suffix': ''}, {'first': 'A', 'middle': ['W'], 'last': 'Confer', 'suffix': ''}], 'year': 2011, 'venue': 'Vet. Pathol', 'volume': '48', 'issn': '2', 'pages': '338--348', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'Protein production by auto-induction in high density shaking cultures', 'authors': [{'first': 'F', 'middle': ['W'], 'last': 'Studier', 'suffix': ''}], 'year': 2005, 'venue': 'Protein Expr. Purif', 'volume': '41', 'issn': '1', 'pages': '207--234', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Sequence diversity of the leukotoxin (lktA) gene in caprine and ovine strains of Mannheimia haemolytica', 'authors': [{'first': 'C', 'middle': [], 'last': 'Vougidou', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Sandalakis', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Psaroulaki', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Petridou', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ekateriniadou', 'suffix': ''}], 'year': 2013, 'venue': 'Vet. Rec', 'volume': '172', 'issn': '16', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Effect of bovine granulocyte colony-stimulating factor on the development of pneumonia caused by Mannheimia haemolytica', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Youssef', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Clark', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Caswell', 'suffix': ''}], 'year': 2004, 'venue': 'Vet. Pathol', 'volume': '41', 'issn': '6', 'pages': '649--657', 'other_ids': {}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'How Mannheimia haemolytica defeats host defence through a kiss of death mechanism', 'authors': [{'first': 'L', 'middle': [], 'last': 'Zecchinon', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fett', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Desmecht', 'suffix': ''}], 'year': 2005, 'venue': 'Vet. Res', 'volume': '36', 'issn': '2', 'pages': '133--156', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': ', LKT was identified by MS in a higher than expected MW band (>230 kDa). This result was confirmed by Western blot of inactivated supernatant using anti-LKT antibodies M. haemolytica culture growth and LKT secretion profile. A. Anti-LKT Western blot of M. haemolytica culture supernatant samples from different fermentation time points. M: fermentation media, T1-T10: samples from culture kinetics (1-10 h). MW: Molecular weight marker. B. M. haemolytica culture growth curve and kinetics of Leukotoxin secretion. Optical density (OD) at 600 nm, glucose concentration (mg/dL) and band intensity of LKT expressed in arbitrary units (AU) are plotted versus culture growth time measured in hours.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'This work provides an exhaustive molecular characterization of an inactivated culture supernatant of M. haemolytica included in a line of polyvalent commercial bovine vaccines (Neumosan, Virbac Uruguay). Since M. haemolytica is the main etiological agent of BRD and is also responsible for a high proportion of the Identification of M. haemolytica culture supernatant proteins. A. M. haemolytica proteins of inactivated culture supernatant (iCSN) resolved in SDS-PAGE and stained with coomassie blue. Bands corresponding to the proteins analyzed by MS (MALDI TOF/TOF) are numbered and referred to on Table 1. For complete image see Fig. S1 (Supplementary material). B. Analysis of culture supernatant proteins by Western blot. Left: M. haemolytica inactivated (iCSN) and non inactivated culture supernatant (CSN) proteins probed with anti-rLKT rabbit serum. Middle: Reactivity of bovine M. haemolytica infected serum against M. haemolytica iCSN and CSN. Right: Reactivity of bovine healthy serum against M. haemolytica iCSN and CSN. MW: Molecular weight marker.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Proteins identified in culture supernatant of M. haemolytica.', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': 'Paula Tucci: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Verónica Estevez, Lorena Becco: Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Florencia Cabrera-Cabrera: Performed the experiments; Analyzed and interpreted the data. Germán Grotiuz: Performed the experiments; Analyzed and interpreted the data;', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We thank Viviana Sánchez for critical reading of the manuscript, Danilo Segovia for assistance in cloning techniques and Florencia Arezzo for technical assistance during M. haemolytica laboratory scale fermentation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}, {'text': 'This work was partially financed by Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing interest statement'}, {'text': 'This work was partially supported by Agencia Nacional de Investigación e Innovación (ANII, Uruguay), Alianzas para la Innovación (ALI_2_2013_1_4783) and Virbac Uruguay S.A.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding statement'}, {'text': 'Supplementary content related to this article has been published online at http://dx. doi.org/10.1016/j.heliyon.2016.e00158', 'cite_spans': [], 'ref_spans': [], 'section': 'Additional information'}]}\n"
     ]
    }
   ],
   "source": [
    "# query on an array of embedded documents\n",
    "# see: https://docs.mongodb.com/manual/tutorial/query-array-of-documents/\n",
    "\n",
    "for c in db.pmc_content.find({'metadata.authors.first': 'Florencia'}):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Query on a text index\n",
    "\n",
    "To query on a search phrase or word, you'll need to build a text index on the fields you want to search. For this tutorial, we'll do this with the MongoDB shell. \n",
    "\n",
    "Note - if the field is nested you'll need to put it in qoutation marks when you build the text index.\n",
    "\n",
    "To build the index:\n",
    "```\n",
    "db.pmc_content.createIndex( { \"body_text.text\": \"text\" } )\n",
    "```\n",
    "\n",
    "To list all the indexes you have on a collection\n",
    "```\n",
    "db.pmc_content.getIndexes()\n",
    "```\n",
    "\n",
    "To remove the index\n",
    "```\n",
    "db.pmc_content.dropIndex(\"body_text.text_text\")\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5ea715ef19a2fa9193482bdf'), 'paper_id': '0a17c029515e527bfad8a67810ab82f4a3d6a299', 'metadata': {'title': 'The outbreak of COVID-19: An overview', 'authors': [{'first': 'Yi-Chi', 'middle': [], 'last': 'Wu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Taipei Veterans General Hospital', 'location': {'settlement': 'Taipei', 'country': 'Taiwan, ROC'}}, 'email': ''}, {'first': 'Ching-Sung', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Taipei Veterans General Hospital', 'location': {'settlement': 'Taipei', 'country': 'Taiwan, ROC'}}, 'email': ''}, {'first': 'Yu-Jiun', 'middle': [], 'last': 'Chan', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Taipei Veterans General Hospital', 'location': {'settlement': 'Taipei', 'country': 'Taiwan, ROC'}}, 'email': 'yjchan@vghtpe.gov.twy.-j.chan.'}]}, 'abstract': [], 'body_text': [{'text': 'In late December 2019, an outbreak of a mysterious pneumonia characterized by fever, dry cough, and fatigue, and occasional gastrointestinal symptoms happened in a seafood wholesale wet market, the Huanan Seafood Wholesale Market, in Wuhan, Hubei, China. 1 The initial outbreak was reported in the market in December 2019 and involved about 66% of the staff there. The market was shut down on January 1, 2020, after the announcement of an epidemiologic alert by the local health authority on December 31, 2019. However, in the following month (January) thousands of people in China, including many provinces (such as Hubei, Zhejiang, Guangdong, Henan, Hunan, etc.) and cities (Beijing and Shanghai) were attacked by the rampant spreading of the disease. 2 Furthermore, the disease traveled to other countries, such as Thailand, Japan, Republic of Korea, Viet Nam, Germany, United States, and Singapore. The first case reported in our country was on January 21, 2019. As of February 6, 2020, a total of 28,276 confirmed cases with 565 deaths globally were documented by WHO, involving at least 25 countries. 3 The pathogen of the outbreak was later identified as a novel beta-coronavirus, named 2019 novel coronavirus (2019-nCoV) and recalled to our mind the terrible memory of the severe acute respiratory syndrome (SARS-2003, caused by another beta-coronavirus) that occurred 17 years ago.', 'cite_spans': [{'start': 255, 'end': 256, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 754, 'end': 755, 'text': '2', 'ref_id': 'BIBREF1'}, {'start': 1107, 'end': 1108, 'text': '3', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"In 2003, a new coronavirus, the etiology of a mysterious pneumonia, also originated from southeast China, especially Guangdong province, and was named SARS coronavirus that fulfilled the Koch's postulate. 4 The mortality rate caused by the virus was around 10%-15%. 5, 6 Through the years, the medical facilities have been improved; nevertheless, no proper treatment or vaccine is available for the SARS. 6 The emergence of another outbreak in 2012 of novel coronavirus in Middle East shared similar features with the outbreak in 2003. 7 Both were caused by coronavirus but the intermediate host for MERS is thought to be the dromedary camel and the mortality can be up to 37%. 5 The initial clinical manifestations for both SARS and MERS are usually nonspecific except that the majority of patients presented with fever and respiratory symptoms. Unprotected hospital staff who were exposed to patients' droplets or through contact prone to be infected and nosocomial infections ensue. 1,6 Furthermore, cases associated with travel had been identified for SARS, MERS, and COVID-19. 5, [8] [9] [10] [11] Because of global transportation and the popularity of tourism, COVID-19 is a genuine threat to Taiwan.\", 'cite_spans': [{'start': 205, 'end': 206, 'text': '4', 'ref_id': 'BIBREF4'}, {'start': 266, 'end': 268, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 269, 'end': 270, 'text': '6', 'ref_id': 'BIBREF6'}, {'start': 405, 'end': 406, 'text': '6', 'ref_id': 'BIBREF6'}, {'start': 678, 'end': 679, 'text': '5', 'ref_id': 'BIBREF5'}, {'start': 1082, 'end': 1084, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 1085, 'end': 1088, 'text': '[8]', 'ref_id': 'BIBREF8'}, {'start': 1089, 'end': 1092, 'text': '[9]', 'ref_id': 'BIBREF9'}, {'start': 1093, 'end': 1097, 'text': '[10]', 'ref_id': 'BIBREF10'}, {'start': 1098, 'end': 1102, 'text': '[11]', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Coronavirus is an enveloped, positive single-strand RNA virus. It belongs to the Orthocoronavirinae subfamily, as the name, with the characteristic \"crown-like\" spikes on their surfaces. 5 Together with SARS-CoV, bat SARS-like CoV and others also fall into the genus beta-coronavirus. COVID-19 (caused by 2019-nCoV infection) is classified as a fifth-category notifiable communicable disease in Taiwan on January 15, 2019. 12 The genus beta-coronavirus can be divided into several subgroups. The 2019-nCoV, SARS-CoV, and bat SARS-like CoV belong to Abstract: In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus # , emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020) . It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%-5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms. Sarbecovirus, while the MERS-CoV to Merbecovirus. 13 SARS-CoV, MERS-CoV, and 2019-nCoV all cause diseases in humans but each subgroup may have mild different biologic characteristic and virulence. [5] [6] [7] The exact origin, location, and natural reservoir of the 2019-nCoV remain unclear, although it is believed that the virus is zoonotic and bats may be the culprits because of sequence identity to the bat-CoV. 5, 13 According to previous studies on the SARS-and MERS-CoV, epidemiologic investigations, their natural reservoir is bat, while palm civet or raccoon dog may be the intermediate (or susceptible) host for SARS-CoV and the dromedary camel for MERS-CoV. 5, 13 A field study for the SARS-CoV on palm civet ruled out the possibility as the natural reservoir (low positive rate); instead, the prevalence of bat coronavirus among wild life is high and it shares a certain sequence identity with the human SARS-CoV. 14 Therefore, bats are considered the natural host reservoir of SARS-like coronavirus. 13 However, the origin or natural host for the 2019-nCoV is not clear, although it might come from a kind of wild life in the wet market. 1 Theoretically, if people contact or eat the reservoir or infected animal, they could be infected. However, to result in large scaled person-to-person transmission as in the past SARS outbreak, the virus must spread efficiently. Initially, the 2019-CoV outbreak was reported as limited person-to-person transmission and a contaminated source from infected or sick wild animals in the wet market may have been the common origin. 1,2 But more and more evidences came out with clusters of outbreaks among family confirmed the possibility of personto-person transmission. 8, 10, 11, 15, 16 In addition, the involvement of human angiotensin-converting enzyme 2 (hACE2) as the cellular receptor (like SARS) made droplet transmission to the lower respiratory tract possible. 5, 17 Furthermore, contact transmission like SARS is also likely although the survival time in the environment for the 2019-nCoV is not clear at present. Currently, there was no evidence of air-borne transmission. Viral RNAs could be found in nasal discharge, sputum, and sometimes blood or feces. 1, 9, 10, 13, 15 But whether oral-fecal transmission can happen has not yet been confirmed. Once people are infected by the 2019-nCoV, it is believed that, like SARS, there is no infectivity until the onset of symptoms. 15 However, one report describes infection from an asymptomatic contact but the investigation was not solid. 10 The infectious doses for 2019-nCoV is not clear, but a high viral load of up to 10 8 copies/mL in patient\\'s sputum has been reported. 10 The viral load increases initially and still can be detected 12 days after onset of symptoms. 9 Therefore, the infectivity of patients with 2019-nCoV may last for about 2 weeks. However, whether infectious viral particles from patients do exist at the later stage requires validation.', 'cite_spans': [{'start': 187, 'end': 188, 'text': '5', 'ref_id': 'BIBREF5'}, {'start': 423, 'end': 425, 'text': '12', 'ref_id': None}, {'start': 1002, 'end': 1020, 'text': 'February 11, 2020)', 'ref_id': None}, {'start': 1859, 'end': 1861, 'text': '13', 'ref_id': 'BIBREF13'}, {'start': 2006, 'end': 2009, 'text': '[5]', 'ref_id': 'BIBREF5'}, {'start': 2010, 'end': 2013, 'text': '[6]', 'ref_id': 'BIBREF6'}, {'start': 2014, 'end': 2017, 'text': '[7]', 'ref_id': 'BIBREF7'}, {'start': 2226, 'end': 2228, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 2229, 'end': 2231, 'text': '13', 'ref_id': 'BIBREF13'}, {'start': 2479, 'end': 2481, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 2482, 'end': 2484, 'text': '13', 'ref_id': 'BIBREF13'}, {'start': 2823, 'end': 2825, 'text': '13', 'ref_id': 'BIBREF13'}, {'start': 2961, 'end': 2962, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 3530, 'end': 3532, 'text': '8,', 'ref_id': 'BIBREF8'}, {'start': 3533, 'end': 3536, 'text': '10,', 'ref_id': 'BIBREF10'}, {'start': 3537, 'end': 3540, 'text': '11,', 'ref_id': 'BIBREF11'}, {'start': 3541, 'end': 3544, 'text': '15,', 'ref_id': 'BIBREF15'}, {'start': 3545, 'end': 3547, 'text': '16', 'ref_id': 'BIBREF16'}, {'start': 3730, 'end': 3732, 'text': '5,', 'ref_id': 'BIBREF5'}, {'start': 3733, 'end': 3735, 'text': '17', 'ref_id': 'BIBREF17'}, {'start': 4028, 'end': 4030, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 4031, 'end': 4033, 'text': '9,', 'ref_id': 'BIBREF9'}, {'start': 4034, 'end': 4037, 'text': '10,', 'ref_id': 'BIBREF10'}, {'start': 4038, 'end': 4041, 'text': '13,', 'ref_id': 'BIBREF13'}, {'start': 4042, 'end': 4044, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 4248, 'end': 4250, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 4357, 'end': 4359, 'text': '10', 'ref_id': 'BIBREF10'}, {'start': 4494, 'end': 4496, 'text': '10', 'ref_id': 'BIBREF10'}, {'start': 4591, 'end': 4592, 'text': '9', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'VIROLOGY'}, {'text': 'The illness onset of the first laboratory-confirmed case of 2019-nCoV infection was on December 1, 2019 in Wuhan, China (Table 1) . 1 Initially, an outbreak involving a local market, the Huanan Seafood Market, with at least 41 people was reported. 1 The local health authority issued an \"epidemiologic alert\" on December 31, 2019, and the market was shut down on January 1, 2020. A total of 59 suspected cases with fever and dry cough were referred to a designated hospital (the Jin Yin-tan Hospital). Of the 59 suspected cases, 41 patients were confirmed by nextgeneration sequencing or real-time reverse transcription-polymerase chain reaction (RT-PCR). Twenty-seven (66%, 27/41) patients had history of Huanan Seafood Market exposure. 1 However, there is a caveat that the first case on December 1 did not show history of Huanan Seafood Market exposure and the subsequent cases started on December 10, nine days later. In the following days, a burst of cases was spreading from Wuhan to the whole Hubei province. Subsequently, many cities and provinces were attacked by this virus. One of the reasons may be due to the heavy transportation load during the Chinese Lunar New Year (on January 25) period. The first exported case was into Thailand on January 13, 2020. However, the disease spread rapidly and globally. Not only familial clusters but also outbreaks in ocean liners were reported. As of February 6, 2020, a total of 28,276 confirmed cases with 565 deaths globally were documented by WHO, involving at least 25 countries. 3 The WHO issued an public health emergencies of international concern (PHEIC) alarm on January 30, 2020. Many stringent quarantine procedures and fever surveillance were underway. The initial mortality rates for patients in the hospital were estimated to be 11%-15%, 1,15 but more recent data were 2%-3%. It is very likely that person-to-person transmissions occur via droplets and contact. Nosocomial infections in the healthcare facilities did happen and stress the importance of good infection control.', 'cite_spans': [{'start': 132, 'end': 133, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 248, 'end': 249, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 738, 'end': 739, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 1536, 'end': 1537, 'text': '3', 'ref_id': 'BIBREF3'}], 'ref_spans': [{'start': 120, 'end': 129, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'EPIDEMIOLOGY'}, {'text': 'COVID-19 has a mean incubation period of 5.2 days (95% confidence interval, 4.1-7.0). 16 The infection is acute without any carrier status. Symptoms usually begin with nonspecific syndromes, including fever, dry cough, and fatigue. Multiple systems may be involved, including respiratory (cough, short of breath, sore throat, rhinorrhea, hemoptysis, and chest pain), gastrointestinal (diarrhea, nausea, and vomiting), musculoskeletal (muscle ache), and neurologic (headache or confusion). More common signs and symptoms are fever (83%-98%), cough (76%-82%), and short of breath (31%-55%). There were about 15% with fever, cough, and short of breath. 1,15 Conjunctival injection was not reported in the early series and cases with age under 18 were few. After onset of illness, the symptoms are somehow mild and the median time to first hospital admission is 7.0 days (4.0-8.0). But the disease progresses to short of breath (~8 days), acute respiratory distress syndrome (ARDS) (~9 days), and to mechanical ventilation (~10.5 days) in about 39% patients. 1 Patients with fatal disease develop ARDS and worsened in a short period of time and died of multiple organ failure. 1, 15 The mortality rate in the early series of hospitalized patients was 11%-15%, but the later statistics was 2%-3%. 1, [15] [16] [17] The 2019-nCoV virus may enter the host through respiratory tract or mucosal surfaces (such as conjunctiva). Oral-fecal transmission has not been confirmed. The virus has a preferential tropism to human airway epithelial cells and the cellular receptor, The first confirmed nCoV case in Wuhan (no Huanan seafood market exposure) December 10', 'cite_spans': [{'start': 86, 'end': 88, 'text': '16', 'ref_id': 'BIBREF16'}, {'start': 1055, 'end': 1056, 'text': '1', 'ref_id': 'BIBREF0'}, {'start': 1173, 'end': 1175, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 1176, 'end': 1178, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 1292, 'end': 1294, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 1295, 'end': 1299, 'text': '[15]', 'ref_id': 'BIBREF15'}, {'start': 1300, 'end': 1304, 'text': '[16]', 'ref_id': 'BIBREF16'}, {'start': 1305, 'end': 1309, 'text': '[17]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'The first confirmed nCoV case with Huanan seafood market exposure December 31', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'An epidemiological alert by local agency 2020 January 1 Huanan seafood market shut down January 13', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'The first nCoV case in Thailand (Wuhan history) January 15', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'A notifiable communicable disease (by Taiwan CDC) January 21', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'The first nCoV case in Taiwan (Wuhan history) January 30', 'cite_spans': [], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': 'Public health emergencies of international concern (PHEIC) alarm by WHO Review Article. (2020) 83:3 J Chin Med Assoc like SARS, is ACE2. 18 However, the pathological changes of the disease and its pathogenesis in human is not clearly elucidated. Theoretically lungs are the major involved organ. Will the virus replicate in other part of the body is not clear.', 'cite_spans': [{'start': 137, 'end': 139, 'text': '18', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'CLINICAL MANIFESTATIONS'}, {'text': \"The COVID-19 usually presents as an acute viral respiratory tract infection and many differential diagnoses related to common viral pneumonia should be considered, such as influenza, parainfluenza, adenovirus infection, respiratory syncytial virus infection, metapneumovirus infection, and atypical pathogens, such as Mycoplasma pneumoniae and Clamydophila pneumoniae infections etc. 1, 8 Therefore, it is crucial to trace the travel and exposure history when approaching a suspected patient back from an epidemic area. In addition, commercial respiratory syndromic diagnostic kits that detect multiple etiological agents (such as Filmarray Respiratory Panel) may help timely differential diagnosis. Laboratory diagnosis for COVID-19 should be performed in a well-equipped laboratory with up to biosafety level 3 facilities for the viral culture. In Taiwan, COVID-19 is a fifth-category notifiable communicable disease and should be reported to Taiwan Confirmatory laboratory diagnosis usually rely on a real-time RT-PCR assay to detect viral RNA by targeting a consensus E region of pan beta-CoV or other more specific regions (such as RdRp or N region) 1,13,15 Chest x-ray and computer tomography (CT) usually revealed bilateral pneumonia (75-98%) with multiple mottling and ground-grass opacity. 1, 15 Routine laboratory data in the early stage of COVID-19 epidemic are similar to common viral infection: lymphopenia, prolonged prothrombin time, elevated D-dimer, liver enzymes (alanine aminotransferase), total bilirubin, and lactate dehydrogenase, with worsening data in ICU cases. 1 Leukocytosis may occur if complicated with secondary bacterial infection. Considering patients' and laboratory safety, physicians should carefully evaluate the necessity of frequent blood sampling and conduct aspiration to prevent the risk of unexpected exposure.\", 'cite_spans': [{'start': 384, 'end': 386, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 387, 'end': 388, 'text': '8', 'ref_id': 'BIBREF8'}, {'start': 1299, 'end': 1301, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 1302, 'end': 1304, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 1587, 'end': 1588, 'text': '1', 'ref_id': 'BIBREF0'}], 'ref_spans': [{'start': 945, 'end': 951, 'text': 'Taiwan', 'ref_id': None}], 'section': 'DIAGNOSIS'}, {'text': 'Currently, there is no validated treatment for COVID-19. The main strategies are symptomatic and supportive care, such as keeping vital signs, maintaining oxygen saturation and blood pressure, and treating complications, such as secondary infections or organs failure.', 'cite_spans': [], 'ref_spans': [], 'section': 'TREATMENT'}, {'text': 'Because of the potential mortality of COVID-19, many investigational treatments are underway:', 'cite_spans': [], 'ref_spans': [], 'section': 'TREATMENT'}, {'text': \"1. Remdesivir: The experimental drug is a novel nucleotide analogue prodrug in development by Gilead Sciences, Inc. It is an unapproved antiviral drug being developed for Ebola and SARS. In a case report on the first case of 2019-nCoV in the United States administering remdesivir for compassionate use on day 11 after illness resulted in decreasing viral loads in nasopharyngeal and oropharyngeal samples and the patient's clinical condition improved. 9 However, randomized controlled trials are needed to determine the safety and efficacy of this drug for treatment of patients with 2019-nCoV infection. 2. Convalescent therapies (plasma from recovered COVID-19 patients): This strategy had been used to support passive immunization. Based on the studies from MERS, the therapeutic agents with potential benefits include convalescent plasma, interferon-beta/ribavirin combination therapy, and lopinavir. 19 However, there are no experience on COVID-19 and no randomized controlled clinical trials for this management at present. 3. Antiviral drugs: lopinavir/ritonavir and ribavirin had been tried to treat SARS disease with apparent favorable clinical response. 20 In vitro antiviral activity against SARS-associated coronavirus at 48 hours for lopinavir and ribavirin was demonstrated at concentrations of 4 and 50 µg/mL, respectively. A recent report found uncanny similarity of unique insertions in the 2019-nCoV spike protein to HIV-1 gp120 and Gag. 21 Will anti-HIV drugs affect the 2019-nCoV treatment outcome? Further randomized controlled trials in patients with COVID-19 are mandatory. 4. Vaccine: There is currently no vaccine available for preventing 2019-nCoV infection. The spike protein may serve as a vaccine candidate, but the effect to human requires further evaluation.\", 'cite_spans': [{'start': 453, 'end': 454, 'text': '9', 'ref_id': 'BIBREF9'}, {'start': 906, 'end': 908, 'text': '19', 'ref_id': 'BIBREF19'}, {'start': 1165, 'end': 1167, 'text': '20', 'ref_id': 'BIBREF20'}, {'start': 1457, 'end': 1459, 'text': '21', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'TREATMENT'}, {'text': 'Since there are no standard treatments for COVID-19, it is important to avoid infection or further spreading. For general population, travel to epidemic area of COVID-19 (mainly in China, especially Wuhan, and Hong Kong and Macaw), contact, or eating wild animal is dissuaded. For those who had history of travel from epidemic area in recent 14 days, body temperature monitor and self-surveillance for 14 days should be performed. If compatible symptoms developed, designated transportation is recommended to prevent unprotected exposure. For healthcare workers, personal protective equipment should be put on and taken off properly while caring a probable or confirmed patients. Stringent protection procedures should be conducted for high-risk procedures (such as endoscopy, Ambu bagging, and endotracheal tube intubation). Once exposed to blood or body fluids of the patient unprotected, the healthcare workers should flush thoroughly the exposure site by water or soap. Afterward, body temperature should be monitored for 14 days. The confirmed case should be isolated (prefer a negative pressure isolation room or, alternatively, a single room with good ventilation). Under the circumstances of resolved symptoms for 24 hours and consecutive two negative results, isolation could be released. Corpses should be burned or buried deep.', 'cite_spans': [], 'ref_spans': [], 'section': 'PREVENTION'}, {'text': 'Treatments effective against coronavirus include steam and heat. The virus is susceptible to many active ingredients (AI), such as sodium hypochlorite (0.1%-0.5%), 70% ethyl alcohol, povidone-iodine (1% iodine), chloroxylenol (0.24%), 50% isopropanol, 0.05% benzalkonium chloride, 1% cresol soap, or hydrogen peroxide (0.5%-7.0%), etc. 22 Just like the WHO recommendations for Ebola virus (RG4) disinfection, the environment with spills of blood or body fluids could be cleaned up with 1:10 dilution of 5.25% household bleach for 10 minutes. 23 In conclusion, 2019-nCoV infection is a zoonotic disease with low to moderate mortality rate. Currently, there is no standard treatment for the disease and supportive treatment was the only strategy. Although many experimental trials are on the way, the best we can do to prevent a rampant outbreak is stringent infection control operation. Clinicians should consider the possibility of 2019-nCoV virus infection in persons with travel or exposure history with compatible incubation period and presenting symptoms. First-line healthcare providers should be highly aware of appropriate infection prevention measures for suspected patients.', 'cite_spans': [{'start': 336, 'end': 338, 'text': '22', 'ref_id': 'BIBREF22'}, {'start': 542, 'end': 544, 'text': '23', 'ref_id': 'BIBREF23'}], 'ref_spans': [], 'section': 'PREVENTION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Clinical features of patients infected with 2019 novel coronavirus in Wuhan', 'authors': [{'first': 'C', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ren', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Hu Y', 'suffix': ''}], 'year': 2020, 'venue': 'China. Lancet', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['Doi:10.1016/S0140-6736(20)30183-5']}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Novel Coronavirus (2019-nCoV)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'World Health Organization. 2019-nCoV Situation Report', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': \"Koch's postulates fulfilled for SARS virus\", 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Ron', 'suffix': ''}, {'first': 'Thijs', 'middle': [], 'last': 'Fouchier', 'suffix': ''}, {'first': 'Martin', 'middle': [], 'last': 'Kuiken', 'suffix': ''}, {'first': ';', 'middle': [], 'last': 'Schutten', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Gerard', 'suffix': ''}], 'year': 2003, 'venue': 'Nature', 'volume': '423', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Another decade, another coronavirus', 'authors': [{'first': 'S', 'middle': [], 'last': 'Perlman', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMe2001126']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Peiris', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Chu', 'suffix': ''}, {'first': 'V', 'middle': ['C'], 'last': 'Cheng', 'suffix': ''}, {'first': 'K', 'middle': ['S'], 'last': 'Chan', 'suffix': ''}, {'first': 'I', 'middle': ['F'], 'last': 'Hung', 'suffix': ''}, {'first': 'L', 'middle': ['L'], 'last': 'Poon', 'suffix': ''}], 'year': 2003, 'venue': 'Lancet', 'volume': '361', 'issn': '', 'pages': '1767--72', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia', 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Zaki', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Van Boheemen', 'suffix': ''}, {'first': 'T', 'middle': ['M'], 'last': 'Bestebroer', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Osterhaus', 'suffix': ''}, {'first': 'R', 'middle': ['A'], 'last': 'Fouchier', 'suffix': ''}], 'year': 2012, 'venue': 'N Engl J Med', 'volume': '367', 'issn': '', 'pages': '1814--1834', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster', 'authors': [{'first': 'Chan', 'middle': [], 'last': 'Jasper', 'suffix': ''}, {'first': 'F', 'middle': ['W'], 'last': 'Yuan', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Kok', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': '', 'suffix': ''}, {'first': 'To', 'middle': [], 'last': 'Kelvin', 'suffix': ''}, {'first': 'K', 'middle': ['W'], 'last': 'Chu', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2020, 'venue': 'Lancet', 'volume': '', 'issn': '', 'pages': '30154--30163', 'other_ids': {'DOI': ['10.1016/S0140-6736(20']}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'First case of 2019 novel coronavirus in the United States', 'authors': [{'first': 'M', 'middle': ['L'], 'last': 'Holshue', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Debolt', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Lindquist', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Lofy', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Wiesman', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Bruce', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMoa2001191']}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Transmission of 2019-nCoV infection from an asymptomatic contact in Germany', 'authors': [{'first': 'C', 'middle': [], 'last': 'Rothe', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Schunk', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Sothmann', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Bretzel', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Froeschl', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wallrauch', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMc2001468']}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Importation and human-to-human transmission of a novel coronavirus in Vietnam', 'authors': [{'first': 'L', 'middle': ['T'], 'last': 'Pgab', 'suffix': ''}, {'first': 'T', 'middle': ['V'], 'last': 'Nguyen', 'suffix': ''}, {'first': 'Q', 'middle': ['C'], 'last': 'Luong', 'suffix': ''}, {'first': 'T', 'middle': ['V'], 'last': 'Nguyen', 'suffix': ''}, {'first': 'H', 'middle': ['Y'], 'last': 'Nguyen', 'suffix': ''}, {'first': 'H', 'middle': ['Q'], 'last': 'Le', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMc2001272']}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'A novel coronavirus from patients with pneumonia in China', 'authors': [{'first': 'N', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Song', 'suffix': ''}], 'year': 2019, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMoa2001017']}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding', 'authors': [{'first': 'R', 'middle': [], 'last': 'Lu', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Niu', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wu', 'suffix': ''}], 'year': 2020, 'venue': 'Lancet', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study', 'authors': [{'first': 'N', 'middle': [], 'last': 'Chen', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Zhou', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Dong', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Qu', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Gong', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Han', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '30211--30218', 'other_ids': {'DOI': ['10.1016/S0140-6736(20']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia', 'authors': [{'first': 'Q', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Guan', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Wu', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Zhou', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Tong', 'suffix': ''}], 'year': None, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMoa200131']}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan', 'authors': [{'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Tang', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Wei', 'suffix': ''}], 'year': 2020, 'venue': 'China. J Med Virol', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1002/jmv.25689']}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'A novel coronavirus emerging in China -Key Questions for Impact Assessment', 'authors': [{'first': 'V', 'middle': ['J'], 'last': 'Munster', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koopmans', 'suffix': ''}, {'first': 'N', 'middle': ['V'], 'last': 'Doremalen', 'suffix': ''}, {'first': 'D', 'middle': ['V'], 'last': 'Riel', 'suffix': ''}, {'first': 'E', 'middle': ['D'], 'last': 'Wit', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMp2000929']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'A review of treatment modalities for middle east respiratory syndrome', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Mo', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Fisher', 'suffix': ''}], 'year': 2016, 'venue': 'J Antimicrob Chemother', 'volume': '71', 'issn': '', 'pages': '3340--50', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Chu', 'suffix': ''}, {'first': 'V', 'middle': ['C'], 'last': 'Cheng', 'suffix': ''}, {'first': 'I', 'middle': ['F'], 'last': 'Hung', 'suffix': ''}, {'first': 'M', 'middle': ['M'], 'last': 'Wong', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Chan', 'suffix': ''}, {'first': 'K', 'middle': ['S'], 'last': 'Chan', 'suffix': ''}], 'year': 2004, 'venue': 'Thorax', 'volume': '59', 'issn': '', 'pages': '252--258', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pradhan', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Pandey', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Mishra', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Gupta', 'suffix': ''}, {'first': 'P', 'middle': ['K'], 'last': 'Tripathi', 'suffix': ''}, {'first': 'M', 'middle': ['B'], 'last': 'Menon', 'suffix': ''}], 'year': 2020, 'venue': '', 'volume': '2020', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['https:/www.biorxiv.org/content/10.1101/2020.01.30.927871v2']}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Interim Guidelines for Environmental Cleaning and Disinfection of Areas Exposed to Confirmed Case(s) of 2019 Novel Coronavirus (2019-nCoV) in Non-Healthcare Commercial Premises', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Hand Hygiene for Health Workers Caring for Ebola Patients', 'authors': [], 'year': 2020, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': '11, 2020: designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by ICTV. (ICTV=The International Committee on Taxonomy of Viruses).', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'novel coronavirus; CDC = center of disease control; WHO = the World Health Organization.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': \"Centers of Disease Control (CDC) within 24 hours. The definitions of reported COVID-19 include (as of February 7, 2020): (1) Clinical conditions, met any following one (1.1) febrile illness (≥38°C) or acute respiratory infection (1.2) clinical, radiological, or pathological evidence of pneumonia. (2) Laboratory conditions, with any of the following: (2.1) clinical specimen (nasopharyngeal swab, sputum, or lower respiratory tract aspirates, etc.) that were isolated and identified as 2019-nCoV (2.2) Clinical specimen that show positive by RT-PCR. (3) Epidemiologic conditions, with any of the following 14 days before onset of symptoms (3.1) History of travel history from or evidence of contacting patients with fever or respiratory symptoms in the first class epidemic area of COVID-19 (currently Hubei, including Wuhan and Guangdong) (3.2) history of travel from or living in other part of mainland China (including Hong Kong and Macaw) (3.3) history of contact with probable or confirmed COVID-19 cases, including health provider, under the same roof, direct contact of the mucus or body fluid. Once the case fulfills (1) any clinical and epidemiologic condition 3.1 or 3.3 or (2) clinical condition 1.2 and epidemiologic condition 3.2 or (3) any laboratory condition, the patient should be reported to Taiwan CDC within 24 hours. If the first laboratory report is negative but patients' symptoms persist without explainable etiology, a second sample should be examined 24 hours later in case of first negative to rule out initial false-negative result. (Taiwan CDC guideline)\", 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Chronological list of 2019-nCoV global outbreak', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715ef46e78c4e9dc70804'), 'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Editorial'}, {'text': \"The Middle East Respiratory Syndrome (MERS) crisis in Korea is coming to an end, but that's not the end of the story. The World Health Organization (WHO) has warned that the MERS crisis was a 'wakeup call. ' Like Severe Acute Respiratory Syndrome (SARS) in 2003 and swine flu in 2009, epidemic outbreaks will continue to happen anywhere. Korea was simply unlucky. In retrospect, it is regrettable to say that we could have done much better. Scholars and colleagues in the medical informatics field should take a moment and think hard about how we can work to fight against another epidemic invasion in the future.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'The Ebola epidemic of 2013 is the largest such outbreak on record, influencing many nations in Africa as well as other countries [1] . The WHO expert panel has pointed out the inadequate emergency care response and has recommended more effective mechanisms for research and development. Others have strongly recommended WHO to innovate because recent Ebola outbreaks have been radically different from previous events, and they have tended to be simultaneous and parallel: \"Highly mobile populations, the spread of Ebola into densely populated cities ... made this epidemic of many outbreaks difficult to control [2] . \"', 'cite_spans': [{'start': 129, 'end': 132, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 613, 'end': 616, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': \"Other criticisms also include outdated therapeutic protocols, irrelevant information, untimely communication, delays in decision-making due to uncoordinated leadership, unreasonable social behavior, and so on. The recom- tems. The NEDSS can be called a medical informatics leader, which provides a standardized information infrastructure with HL7, LOINC, and SNOMED-CT. Highly useful information is well organized and ready to be used in the US-CDC [6] , so we don't have to reinvent the wheel. All we need is to find a conduit for connection. For example, the task of disease surveillance for MERS is relatively small compared to NEDSS. Using the cell phone data network, we can instantly establish a real-time patient tracking system to monitor 3-tuple data (time, location, temperature) in the country. Cell phone rental can help track down suspicious foreign visitors from arrival to departure. With the support of ISO standards, global healthcare networking is not a hard nut to crack.\", 'cite_spans': [{'start': 449, 'end': 452, 'text': '[6]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'When the MERS epidemic outbreak was on the headline news, many attempts were made to compare MERS with tuberculosis. That is, the mortality rate of MERS is far below that of tuberculosis, so it was argued that there was no need to worry about it. The point was clear, but the timing was not right. Have you ever got a thorn stuck under your fingernail? Saying that \"It\\'s OK you\\'re not bleeding\" or \"You won\\'t die from it\" would not comfort anybody at all. I would venture to say that it is surely mistaken to compare the pain at present with a probable outcome yet to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': 'When hospital visitors became MERS patients, a typical example of nosocomial infection was demonstrated. It was a surprise attack, and the whole country was shaken and panicked. The WHO experts reminded us that hospital shopping greatly contributed to the rapid spread of MERS in Korea. We have to understand why patients pursue hospital shopping. The death of professionalism may be an unexpected result of the fashionable social network services (SNS). Patients use SNSs to data-mine their own diagnosis and prescription and then seek medical advice to compare with their own ideas about their personal health. However, such patients suggesting their own diagnoses and treatments can be described as \"Jack of all trades, master of none\". Medical informatics leadership was nowhere to be found. When the MERS epidemic turned fatal, SNS was the only rescue. MERS was unknown to the general public, and the cure was uncertain, so chaos was bound to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In Korea medical informatics is on trial. We are standing in front of a river that runs medicine. IT has been trying to cross the river but has never been successful, especially in medical expert systems. The other side of the river is not the land of promise. Because the river of medicine eventu-ally runs into the ocean of the human race, why don't we go with the river instead? There is no doubt that doctors and nurses were the final frontiers in the MERS battle. Despite all the wonderful scientific accomplishments, the MERS crisis reminds us that clinical expertise is the most important value as clearly as ever. Technology can help medicine, not the other way around; that is the way medical informatics should go in between.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"Taoism states that dynamic balance can be obtained from two opposite powers competing with each other, unifying as a complete energy. Similarly, medical informatics should be able to balance between analog medicine and digital technology to create a new value. Medicine is composed of oldfashioned values, such as rapport, which is fading out slowly. Digital technology should help clinicians restore the humanistic flavor of medicine by eliminating managerial overload in healthcare settings. Technology can start from there. Neither Cyclops (the single-eyed monster in Homer's Odyssey) nor Argus (the 100-eyed giant in Greek mythology) is ideal to find the right path. Two-eyed medical informaticians must walk through the path on the mountain ridge, carefully looking at both sides of IT and medicine for balance.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In 1347, the first biological warfare took place in the siege of Caffa (now Feodosia in Ukraine) on the Black Sea coast. The Mongol army with bubonic plague catapulted corpse of those who had died from the Black Death over the city walls. Fleeing from central trading ports along the coast, infected inhabitants and rats may have carried the disease throughout Europe [7] (The plague might have killed more than 25 million people). A few regions survived. They simply closed their ports of entry and isolated patients in remote places. The same principle still applies. When in doubt, isolate an infection until it's clear. Time goes by, technology advances, but the basic principle never changes. Medicine should stay analog with a little hint of digital. That's all it takes to fight against any epidemic or pandemic attack in the future.\", 'cite_spans': [{'start': 368, 'end': 371, 'text': '[7]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Report of the Ebola Interim Assessment Panel', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"What we've learned about fighting Ebola\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Dhillon', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Srikrishna', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Harvard Business Review; c2015', 'authors': [{'first': '(', 'middle': [], 'last': 'Boston', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ma)', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The next epidemic: lessons from Ebola', 'authors': [{'first': 'B', 'middle': [], 'last': 'Gates', 'suffix': ''}], 'year': 2015, 'venue': 'N Engl J Med', 'volume': '372', 'issn': '15', 'pages': '1381--1385', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'US Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Centers for Disease Control and Prevention; c2015', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Digital disease detection: harnessing the Web for public health surveillance', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Brownstein', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Freifeld', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Madoff', 'suffix': ''}], 'year': 2009, 'venue': 'N Engl J Med', 'volume': '360', 'issn': '21', 'pages': '2153--2160', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'History of biological warfare and bioterrorism', 'authors': [{'first': 'V', 'middle': [], 'last': 'Barras', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Microbiol Infect', 'volume': '20', 'issn': '6', 'pages': '497--502', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': 'Hune Cho http://dx.doi.org/10.4258/hir.2015.21.3.141', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea71355b3c4f60e9b93e8f9'), 'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Editorial'}, {'text': \"The Middle East Respiratory Syndrome (MERS) crisis in Korea is coming to an end, but that's not the end of the story. The World Health Organization (WHO) has warned that the MERS crisis was a 'wakeup call. ' Like Severe Acute Respiratory Syndrome (SARS) in 2003 and swine flu in 2009, epidemic outbreaks will continue to happen anywhere. Korea was simply unlucky. In retrospect, it is regrettable to say that we could have done much better. Scholars and colleagues in the medical informatics field should take a moment and think hard about how we can work to fight against another epidemic invasion in the future.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'The Ebola epidemic of 2013 is the largest such outbreak on record, influencing many nations in Africa as well as other countries [1] . The WHO expert panel has pointed out the inadequate emergency care response and has recommended more effective mechanisms for research and development. Others have strongly recommended WHO to innovate because recent Ebola outbreaks have been radically different from previous events, and they have tended to be simultaneous and parallel: \"Highly mobile populations, the spread of Ebola into densely populated cities ... made this epidemic of many outbreaks difficult to control [2] . \"', 'cite_spans': [{'start': 129, 'end': 132, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 613, 'end': 616, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': \"Other criticisms also include outdated therapeutic protocols, irrelevant information, untimely communication, delays in decision-making due to uncoordinated leadership, unreasonable social behavior, and so on. The recom- tems. The NEDSS can be called a medical informatics leader, which provides a standardized information infrastructure with HL7, LOINC, and SNOMED-CT. Highly useful information is well organized and ready to be used in the US-CDC [6] , so we don't have to reinvent the wheel. All we need is to find a conduit for connection. For example, the task of disease surveillance for MERS is relatively small compared to NEDSS. Using the cell phone data network, we can instantly establish a real-time patient tracking system to monitor 3-tuple data (time, location, temperature) in the country. Cell phone rental can help track down suspicious foreign visitors from arrival to departure. With the support of ISO standards, global healthcare networking is not a hard nut to crack.\", 'cite_spans': [{'start': 449, 'end': 452, 'text': '[6]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'When the MERS epidemic outbreak was on the headline news, many attempts were made to compare MERS with tuberculosis. That is, the mortality rate of MERS is far below that of tuberculosis, so it was argued that there was no need to worry about it. The point was clear, but the timing was not right. Have you ever got a thorn stuck under your fingernail? Saying that \"It\\'s OK you\\'re not bleeding\" or \"You won\\'t die from it\" would not comfort anybody at all. I would venture to say that it is surely mistaken to compare the pain at present with a probable outcome yet to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': 'When hospital visitors became MERS patients, a typical example of nosocomial infection was demonstrated. It was a surprise attack, and the whole country was shaken and panicked. The WHO experts reminded us that hospital shopping greatly contributed to the rapid spread of MERS in Korea. We have to understand why patients pursue hospital shopping. The death of professionalism may be an unexpected result of the fashionable social network services (SNS). Patients use SNSs to data-mine their own diagnosis and prescription and then seek medical advice to compare with their own ideas about their personal health. However, such patients suggesting their own diagnoses and treatments can be described as \"Jack of all trades, master of none\". Medical informatics leadership was nowhere to be found. When the MERS epidemic turned fatal, SNS was the only rescue. MERS was unknown to the general public, and the cure was uncertain, so chaos was bound to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In Korea medical informatics is on trial. We are standing in front of a river that runs medicine. IT has been trying to cross the river but has never been successful, especially in medical expert systems. The other side of the river is not the land of promise. Because the river of medicine eventu-ally runs into the ocean of the human race, why don't we go with the river instead? There is no doubt that doctors and nurses were the final frontiers in the MERS battle. Despite all the wonderful scientific accomplishments, the MERS crisis reminds us that clinical expertise is the most important value as clearly as ever. Technology can help medicine, not the other way around; that is the way medical informatics should go in between.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"Taoism states that dynamic balance can be obtained from two opposite powers competing with each other, unifying as a complete energy. Similarly, medical informatics should be able to balance between analog medicine and digital technology to create a new value. Medicine is composed of oldfashioned values, such as rapport, which is fading out slowly. Digital technology should help clinicians restore the humanistic flavor of medicine by eliminating managerial overload in healthcare settings. Technology can start from there. Neither Cyclops (the single-eyed monster in Homer's Odyssey) nor Argus (the 100-eyed giant in Greek mythology) is ideal to find the right path. Two-eyed medical informaticians must walk through the path on the mountain ridge, carefully looking at both sides of IT and medicine for balance.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In 1347, the first biological warfare took place in the siege of Caffa (now Feodosia in Ukraine) on the Black Sea coast. The Mongol army with bubonic plague catapulted corpse of those who had died from the Black Death over the city walls. Fleeing from central trading ports along the coast, infected inhabitants and rats may have carried the disease throughout Europe [7] (The plague might have killed more than 25 million people). A few regions survived. They simply closed their ports of entry and isolated patients in remote places. The same principle still applies. When in doubt, isolate an infection until it's clear. Time goes by, technology advances, but the basic principle never changes. Medicine should stay analog with a little hint of digital. That's all it takes to fight against any epidemic or pandemic attack in the future.\", 'cite_spans': [{'start': 368, 'end': 371, 'text': '[7]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Report of the Ebola Interim Assessment Panel', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"What we've learned about fighting Ebola\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Dhillon', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Srikrishna', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Harvard Business Review; c2015', 'authors': [{'first': '(', 'middle': [], 'last': 'Boston', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ma)', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The next epidemic: lessons from Ebola', 'authors': [{'first': 'B', 'middle': [], 'last': 'Gates', 'suffix': ''}], 'year': 2015, 'venue': 'N Engl J Med', 'volume': '372', 'issn': '15', 'pages': '1381--1385', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'US Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Centers for Disease Control and Prevention; c2015', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Digital disease detection: harnessing the Web for public health surveillance', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Brownstein', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Freifeld', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Madoff', 'suffix': ''}], 'year': 2009, 'venue': 'N Engl J Med', 'volume': '360', 'issn': '21', 'pages': '2153--2160', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'History of biological warfare and bioterrorism', 'authors': [{'first': 'V', 'middle': [], 'last': 'Barras', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Microbiol Infect', 'volume': '20', 'issn': '6', 'pages': '497--502', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': 'Hune Cho http://dx.doi.org/10.4258/hir.2015.21.3.141', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715f00871978ef2dac306'), 'paper_id': '0aa3eda0fb09bf9f55864fc2b9157b9317f62323', 'metadata': {'title': 'Centers for Disease Control and Prevention, Division of Global Migration and Quarantine San Diego, California, USA Epidemiological surveillance of land borders in North and South America: a case study', 'authors': [{'first': 'Robson', 'middle': [], 'last': 'Bruniera-Oliveira', 'suffix': '', 'affiliation': {'laboratory': 'Fundação Oswaldo Cruz, Vice-Presidência de Pesquisa e Laboratórios de Referência', 'institution': 'Universidade de São Paulo', 'location': {'addrLine': 'Secretaria de Vigilância em Saúde', 'settlement': 'São Paulo, São Paulo, Rio de Janeiro, Rio de Janeiro, Brasília', 'country': 'Brazil, Brazil, Brazil ('}}, 'email': ''}, {'first': 'Marco', 'middle': ['Aurélio'], 'last': 'Pereira Horta', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Aiden', 'middle': [], 'last': 'Varan', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Sonia', 'middle': [], 'last': 'Montiel', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Eduardo', 'middle': ['Hage'], 'last': 'Carmo', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Stephen', 'middle': ['H'], 'last': 'Waterman', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'José', 'middle': [], 'last': 'Fernando De Souza Verani', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Universidade de São Paulo', 'location': {'addrLine': 'Av. Dr. Arnaldo, 715, CEP 03178-200, São Paulo', 'settlement': 'Rio de Janeiro, Rio de Janeiro', 'region': 'SP', 'country': 'Brazil, Brazil'}}, 'email': ''}]}, 'abstract': [{'text': 'This study aims to analyze the different binational/multinational activities, programs, and structures taking place on the borders of Brazil and the U.S. between 2013 and 2015. A descriptive exploratory study of two border epidemiological surveillance (BES) systems has been performed. Two approaches were used to collect data: i) technical visits to the facilities involved with border surveillance and application of a questionnaire survey; ii) application of an online questionnaire survey. It was identified that, for both surveillance systems, more than 55% of the technicians had realized that the BES and its activities have high priority. Eighty percent of North American and 71% of Brazilian border jurisdictions reported an exchange of information between countries. Less than half of the jurisdictions reported that the necessary tools to carry out information exchange were available. Operational attributes of completeness, feedback, reciprocity, and quality of information were identified as weak or of low quality in both systems. Statements, guidelines, and protocols to develop surveillance activities are available at the U.S.-Mexico border area. The continuous systematic development of surveillance systems at these borders will create more effective actions and responses.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'The epidemics of severe acute respiratory syndrome (SARS), pandemic influenza (H1N1) and Middle Eastern Respiratory Syndrome (MERS-CoV) hit the world with a high pathogenic potential in recent years, providing a warning to nations of the speed with which these epidemics can move across the globe 1-3 . Everyday, nations are more internationally connected 4 . On February 1, 2016, for the fourth time in history, the World Health Organization (WHO) declared a public health emergency of international concern (PHEIC) to make a joint global effort to control the outbreak caused by Zika virus (ZIKV) in Latin America and the Caribbean 5,6 . These facts reiterated the need for governments and international agencies to build and strengthen the surveillance of infectious diseases at all levels, from national to international, thus facilitating the timely detection, response, and communication of disease outbreaks on a global scale 4 .', 'cite_spans': [{'start': 356, 'end': 357, 'text': '4', 'ref_id': 'BIBREF3'}, {'start': 933, 'end': 934, 'text': '4', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'The International Health Regulations (IHR) recommends that countries sharing borders and having common interests consider establishing multilateral agreements 7 . This aims to facilitate the implementation of IHR, consolidating the direct and rapid exchange of public health information and the application of health measures at borders. This effort may prevent and/or control the international transmission of disease at the crossing point 7 . Land borders are physical spaces with peculiar characteristics including large historical, cultural, ethnic, economic, and social heterogeneities. In many cases, these spaces have intense population flows, which create special conditions for disease transmission 8 . Several studies [9] [10] [11] [12] [13] [14] have indicated that these border areas possess different dynamics and patterns of occurrence of disease when compared to other areas within countries.', 'cite_spans': [{'start': 159, 'end': 160, 'text': '7', 'ref_id': None}, {'start': 441, 'end': 442, 'text': '7', 'ref_id': None}, {'start': 708, 'end': 709, 'text': '8', 'ref_id': 'BIBREF8'}, {'start': 728, 'end': 731, 'text': '[9]', 'ref_id': 'BIBREF9'}, {'start': 732, 'end': 736, 'text': '[10]', 'ref_id': 'BIBREF10'}, {'start': 737, 'end': 741, 'text': '[11]', 'ref_id': 'BIBREF11'}, {'start': 742, 'end': 746, 'text': '[12]', 'ref_id': 'BIBREF12'}, {'start': 747, 'end': 751, 'text': '[13]', 'ref_id': 'BIBREF13'}, {'start': 752, 'end': 756, 'text': '[14]', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"Brazil and the United States of America (U.S.) are countries with large extensions of land borders. Brazil's border is 15,719 km long and is shared with ten countries, all with different health policies. The border fringe occupies an area of 2,300,000 km 2 (27.6% of the country), with 588 municipalities and nearly 10 million people (6% of the population) 15 . The U.S. Southern border with Mexico extends for 3,141 km, with a fringe of 100 km (62.5 miles) on each side of the border and an estimated population of 13 million people 16, 17 .\", 'cite_spans': [{'start': 357, 'end': 359, 'text': '15', 'ref_id': 'BIBREF15'}, {'start': 534, 'end': 537, 'text': '16,', 'ref_id': 'BIBREF16'}, {'start': 538, 'end': 540, 'text': '17', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Due to the long length of land borders, with intense population flows and different epidemiological and social scenarios, the vulnerability to the introduction and rapid spread of potential threats to public health is a fact that must be taken into consideration. Therefore, the development of systems and activities focusing on border epidemiological surveillance (BES) is essential both for domestic and global health security 18 . Based on the hypothesis that border surveillances must promote binational communication, an exchange of epidemiologic information in a timely and dynamic manner to improve the cross-border public health infrastructure through collaboration, this study aimed to analyze the different binational/multinational activities, programs, and structures to identify challenges and to suggest improvements of binational and/or multinational epidemiological surveillance partnerships on the borders of Brazil and the U.S.', 'cite_spans': [{'start': 429, 'end': 431, 'text': '18', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'A descriptive exploratory study about border epidemiological surveillance (BES) systems was performed in South and North America between 2013 and 2015. A total of 47 interviews at every operational level of the BES were conducted at the United States-Mexico border (US-MX border applied from February 2014 to September 2014) and Brazil (November 2014 to March 2015).', 'cite_spans': [], 'ref_spans': [], 'section': 'MATERIAL AND METHODS'}, {'text': \"In South America, the study focused on the border between Brazil and the America's Southern Cone countries (Argentina, Paraguay, and Uruguay). This border area is defined as the area of land situated 150 km North and South from the International Boundary Line. This region is divided into six subregions (XII-XVII) with 441 municipalities, an area of 329,943 km 2 and a population of 6,893,804 inhabitants 19 ( Figure 1 ).\", 'cite_spans': [], 'ref_spans': [{'start': 411, 'end': 419, 'text': 'Figure 1', 'ref_id': 'FIGREF0'}], 'section': 'Description of the study area'}, {'text': 'As for North America, the study was carried out on the Southern U.S. border with Mexico. This border has a length of approximately 3,141 km. The border region is defined as the area of land situated 100 km (62.5 miles) North and South from the international boundary. The area includes four U.S. States (California, Arizona, New Mexico, and Texas) and six Mexican States (Baja California, Sonora, Chihuahua, Coahuila, Nuevo Leon, and Tamaulipas) with an estimated population of about 13 million people 17 ( Figure 2 ). Data collection and analysis BES operational data were collected using a developed semi-structured questionnaire with a focus on information exchange between jurisdictions, domestically and internationally. The instrument was based on previous surveys by the CDC 20 , Bruniera-Oliveira et al. 21 and Varan et al. 22 and was structured with four dimensions: organizational priorities and resources, information exchange, laboratory, and challenges.', 'cite_spans': [{'start': 812, 'end': 814, 'text': '21', 'ref_id': 'BIBREF21'}, {'start': 832, 'end': 834, 'text': '22', 'ref_id': 'BIBREF22'}], 'ref_spans': [{'start': 507, 'end': 515, 'text': 'Figure 2', 'ref_id': 'FIGREF1'}], 'section': 'Description of the study area'}, {'text': 'Because of long geographical distances, two approaches were used for data collection: i) technical visits to the facilities involved with border surveillance, which included questionnaire applications and direct observations of the operational procedures and facility structures; ii) application of online questionnaires for those facilities that could not be visited. For both approaches, questionnaires were developed in English and, subsequently, translated into Spanish and Portuguese.', 'cite_spans': [], 'ref_spans': [], 'section': 'Description of the study area'}, {'text': \"A draft questionnaire was shared with stakeholders in all operational levels working directly or indirectly on border surveillance activities in the U.S. for comments and suggestions. A pilot test of a final version of the tool was conducted with U.S. and Mexico stakeholders to evaluate its effectiveness to collect information. A Likert scale was used to measure the outcomes [23] [24] [25] . The final version of the English questionnaire was translated and back-translated by native speakers of Spanish and Portuguese, which subsequently went through the same validation process by experts. For the questionnaire application by digital media, an online survey development software, SurveyMonkey, was used (Research SurveyMonkey ® ). Its distribution and monitoring were done through links distributed by e-mail to the participants' e-mails.\", 'cite_spans': [{'start': 378, 'end': 382, 'text': '[23]', 'ref_id': 'BIBREF24'}, {'start': 383, 'end': 387, 'text': '[24]', 'ref_id': 'BIBREF25'}, {'start': 388, 'end': 392, 'text': '[25]', 'ref_id': 'BIBREF26'}], 'ref_spans': [], 'section': 'Description of the study area'}, {'text': 'Technical visits were carried out at agencies, institutions and partners (such as health surveillance agencies, immigration departments, national or multinational committees/groups, laboratories, etc.), proceeding with document analysis, organization observation, and operational structure and involvement of professionals with surveillance activities. During the visits, interviews were conducted with BES stakeholders in their various operational levels using the questionnaire that had been developed. In the absence of the technician in charge in the facilities visited or in areas where visit was not possible, the stakeholders were invited to answer the online questionnaire.', 'cite_spans': [], 'ref_spans': [], 'section': 'Description of the study area'}, {'text': 'When a respondent had questions about the questionnaire or the researcher had questions about responses, a phone interview or web conference was conducted. The scope of the questionnaire included some operational attributes of surveillance, such as completeness, reciprocity, opportunity, feedback, and the quality of information. These attributes were analyzed from the perspective of the respondents using the Likert scale for measurement. This research was approved by the Research Ethics Committee of the National School of Public Health Sergio Arouca (CEP / ENSP), under the Nº 699.241.', 'cite_spans': [], 'ref_spans': [], 'section': 'Description of the study area'}, {'text': 'A total of 47 stakeholders were interviewed. Thirty of these technicians were from the North-American BES (20 technicians from the U.S. and 10 from Mexico), while in South America all the 17 technicians were from Brazil. The majority of respondents in Brazil and half in the United States belonged to the local health municipalities, whereas the State level in Mexico was the most frequent in the interviews (Table 1) .', 'cite_spans': [], 'ref_spans': [{'start': 408, 'end': 417, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Operational profile of the respondents'}, {'text': 'The U.S. has developed programs and specialized structures in border surveillance, such as the Borders Office, quarantine stations (QS), and important partnerships with several agencies that provide support with any suspected case of an important binational disease (Table 1) . Brazil does not have such structures. However, it does have Customs and Border Protection (CBP) and border offices in its structural organization, and organization stations called the Health Surveillance Stations of Ports, Airports, Borders and Customs Enclosures (PVPAF) of the Brazilian Sanitary Surveillance Agency (ANVISA). These stations are located at strategic points in Brazil, 17 of which are on land borders. Surveillance activities and sanitary control of goods, people, and animals are carried out at these stations, and some facilities have agreements with regional hospitals for the displacement and isolation of suspected cases of infectious diseases of public health concern. In addition, some of these stations are located on borders that have bior multinational facilities, a fact that makes the interaction between countries easier and more timely (Table 1) .', 'cite_spans': [], 'ref_spans': [{'start': 266, 'end': 275, 'text': '(Table 1)', 'ref_id': 'TABREF0'}, {'start': 1145, 'end': 1154, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Operational characteristics of the systems'}, {'text': 'In both surveillance systems, more than 55% of the technicians at several operational levels realize that the BES and their activities (detection, investigation, and binational or multinational notification) are high priority. Nevertheless, for these technicians, the nonexistence and/ or availability of a formal protocol with the neighboring country is considered a limiting factor for the development of appropriate actions. Only 38% of respondents in South America are familiar with the contact points involved in the notification and binational investigation. This proportion increases to 55% on the U.S.-Mexico border where there are available statements, guidelines, and protocols to develop joint activities in the border areas (Table 2) . A specific document, the \"U.S. Mexico Binational Communication Pathways Protocol,\" for the land border deserves to be highlighted. This document has been improved since 2002 by several technicians at several operational levels of the two countries and proposes to systematize and enhance the exchange of information mechanisms 26 .', 'cite_spans': [{'start': 1075, 'end': 1077, 'text': '26', 'ref_id': 'BIBREF27'}], 'ref_spans': [{'start': 736, 'end': 745, 'text': '(Table 2)', 'ref_id': 'TABREF1'}], 'section': 'Operational characteristics of the systems'}, {'text': \"Information exchange between countries occurs in more than 80% of North American jurisdictions and 71% percent of the Brazilian jurisdictions; however, only the U.S. and Mexico's technicians consider this exchange timely. Brazilian and U.S. technicians identified the reciprocity of sending information as a failure. The feedback and followup of epidemiological information was considered low by all stakeholders. The quality and completeness of exchanged information were considered medium to weak in the scale used. Less than half of the jurisdictions have the necessary tools to carry out information exchange. Telephone and electronic means of communication, such as e-mail, are most commonly used for information exchange. Over 50% of respondents reported a lack of mechanisms for sharing personally identifiable information (PII), such as encrypted e-mails (Table 2) .\", 'cite_spans': [], 'ref_spans': [{'start': 863, 'end': 872, 'text': '(Table 2)', 'ref_id': 'TABREF1'}], 'section': 'Operational characteristics of the systems'}, {'text': \"In both investigated systems, the priorities and actions are defined in binational meetings involving various partners. In South America, the Comitê Interfronteiriço and the Grupo Técnico de Itaipu Saúde are important mechanisms to outline surveillance activities. On the U.S.-MX border, groups and meetings, such as the Binational Joint Operational Meeting, the Epi Meeting, the Border Epidemiology and Surveillance Team (BEST) meeting, as well as the Consejo Binacional de Salud, among others, are important mechanisms used to share data to collaborate. It should be stressed that, in South America, there was no evidence of participation of organizations, such as the Pan American Health Organization (PAHO), MERCOSUR, or the Union of South American Nations (UNASUR) in any local border activities. The U.S.-MX border used to have a PAHO's border office in El Paso, which acted as facilitator of the collaboration between the U. S. and Mexico. However, this office ceased its activities in 2014. \", 'cite_spans': [], 'ref_spans': [], 'section': 'Organizational priorities'}, {'text': 'The limited availability of funds and specific resources is a major obstacle in the development of BES in Brazil and Mexico. Eighty percent of U.S. respondents reported the availability of financial and human resources from the three operational levels of administration. The training for technicians, including laboratory workers, is present in both systems. The respondents in the two surveyed areas consider that the U.S. and Brazil (for having more economic and financial capacity) should provide more support to the activities of their neighboring countries. Differences between countries make the border actions being implemented often only on the U.S. or Brazilian side (Table 3) .', 'cite_spans': [], 'ref_spans': [{'start': 677, 'end': 686, 'text': '(Table 3)', 'ref_id': 'TABREF2'}], 'section': 'Human, financial resources and inputs'}, {'text': \"In the U.S.-MX border review, local laboratories mainly process samples of cases under investigation. In Brazil, an emphasis should be given to the Border Laboratories' Network, coordinated by the Brazilian Health Surveillance Secretariat (SVS/MS), which consists of 12 laboratories located along the Brazilian border ( Figure 3 ). This network was created to develop the capacity and opportunity for detection of major communicable diseases, lowering the demands on the Central Laboratory of Public Health (LACEN).\", 'cite_spans': [], 'ref_spans': [{'start': 320, 'end': 328, 'text': 'Figure 3', 'ref_id': None}], 'section': 'Laboratories'}, {'text': \"Regarding the laboratory support to BES, some similarities between the two areas' borders were identified. Diagnostic and quality control panels testing methods are standardized and harmonized among laboratories within the countries, but it is not standardized among counterpart laboratories. Technology and cooperation exchange was observed between countries, but at a low frequency. Respondents believe that the financial resources and inputs are not sufficient to conduct all laboratory activities. However, on the Brazilian side, those technicians believed that they had the sufficient number of technicians to respond to all the demands of their laboratories -a fact not observed in U.S. and Mexican laboratories. The low frequency of training was cited as a major obstacle. Documents that regulate the flow of information and samples of binational cases in the two borders were not identified (Table 3) .\", 'cite_spans': [], 'ref_spans': [{'start': 899, 'end': 908, 'text': '(Table 3)', 'ref_id': 'TABREF2'}], 'section': 'Laboratories'}, {'text': 'Although the countries involved in this study have different health organization systems and speak different languages, few technicians identified these differences as barriers to develop BES activities. In general, the major obstacle highlighted to the exchange of information and joint activities was the lack of guidelines describing the steps of binational disease notification and investigation (Table 3) .', 'cite_spans': [], 'ref_spans': [{'start': 400, 'end': 409, 'text': '(Table 3)', 'ref_id': 'TABREF2'}], 'section': 'Main challenges identified by respondents'}, {'text': 'Acknowledging the vulnerability of introducing and spreading potential public health events through land borders, the International Health Regulations (IHR) recommends that countries sharing common borders should consider establishing bilateral or multilateral agreements about strengthening surveillance actions at ground crossings 7 .', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In larger border areas, such as those of the U.S. and Brazil, there are large numbers of residents. Together with the intense population flow, this provides a favorable scenario for the occurrence and spread of communicable and noncommunicable diseases 8, 27 . Ferraz et al. 28 and Spradling et al. 29 pointed toward different profiles of tuberculosis and acute viral hepatitis in the border regions of Brazil and the United States, respectively, when compared with States and national rates. Thus, the inclusion and prioritization of BES activities, mainly at the local and federal levels, are an important step toward consolidation of health surveillance systems reflecting the recognition of the importance of the issue by the governments.', 'cite_spans': [{'start': 253, 'end': 255, 'text': '8,', 'ref_id': 'BIBREF8'}, {'start': 256, 'end': 258, 'text': '27', 'ref_id': 'BIBREF28'}, {'start': 275, 'end': 277, 'text': '28', 'ref_id': 'BIBREF29'}, {'start': 299, 'end': 301, 'text': '29', 'ref_id': 'BIBREF30'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'However, as observed in this study (particularly in South America), findings show that it lacks certain protocols. These protocols, as observed at the U.S.-MX border, define the actions and communication flows between public health agencies involved with binational notifications and may support adequate responses to the occurrence of public health events. Wang et al. 30 , studying vaccine-derived poliovirus (VDPV) outbreaks, noted that surveillance based on solid international collaboration and agreements with clear and well-defined paths allows for an exchange of information in a timely and dynamic manner. The contribution of such agreements was critical to avoid the VDPV outbreaks from reaching China through its land borders. The inadequacy of many surveillance indicators (lack of opportunity for the exchange of epidemiological information, quality of the epidemiological information, reciprocity, feedback, and incompleteness of information) may be related to the informality of the BES operational articulation.', 'cite_spans': [{'start': 370, 'end': 372, 'text': '30', 'ref_id': None}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'BES systems in North and South America have taken important steps toward systematizing their activities. Both international borders are defining their priorities and actions in these regions together with stakeholders and partners of the neighboring countries. North American countries have developed and distributed a document detailing the step-by-step operational flow of information and actions because these countries place a higher priority on their actions. BES services that have developed and implemented such protocols and plans result in more clear and efficient conduction, evaluation, and review of operational procedures. In addition, the activities are not linked to specific individuals, but are rather institutionalized, allowing the continuity of standard procedures and minimizing disruptions to required actions.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"A lack of human, technical, and financial resources were major obstacles in Brazil and Mexico. Scarcity of primarily financial resources to hire technicians weakens the systems of these two countries. The lack of technicians and high personnel turnover at the jurisdiction level creates a burden on the technical staff, affecting the necessary epidemiological actions. In this respect, Bruniera-Oliveira et al. 21 evaluated Brazil's rotavirus epidemiological surveillance, noting that the limited number of technicalities and high turnover caused a delay in the process, transfer and response of the rotavirus surveillance.\", 'cite_spans': [{'start': 411, 'end': 413, 'text': '21', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The need for a greater investment in human, technical, and financial resources was unanimous by respondents in both of the studied areas. It is possible that many of the process difficulties, particularly information exchange, are due to structural differences between the countries involved. While, in Brazil there is a system that facilitates mechanisms to carry out information exchange quickly and confidentially, other countries are using unsafe means for information exchange. This structural discrepancy generates resistance, especially when health services are dealing with personal information. Furthermore, there are mechanism incompatibilities, such as differences in software versions used or even lack of such mechanisms. Therefore, countries with available resources should seek ways to standardize communication mechanisms 26 .', 'cite_spans': [{'start': 838, 'end': 840, 'text': '26', 'ref_id': 'BIBREF27'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Particular attention should be given to laboratories, which provide support for border surveillance. For most of the infectious diseases of public health concern, laboratory confirmation is essential for planning and triggering the control and prevention actions. Thus, the organization of a laboratory network able to meet demands of the border areas would increase sensitivity, opportunity, and system specificity 31 . In North America, due to the systems developed at the borders, such as the Border Infectious Disease Surveillance (BIDS), there was a substantial reduction in disparities with surveillance capabilities in incompatibility of used case definitions. This resulted in increased diagnostic capacity and laboratory capability in the region 9 .', 'cite_spans': [{'start': 416, 'end': 418, 'text': '31', 'ref_id': 'BIBREF33'}, {'start': 755, 'end': 756, 'text': '9', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"In Brazil, the Border Laboratories Network can be considered innovative as it seeks to reduce the differences in laboratory capacity between countries. However, despite what has been developed so far, significant obstacles were identified, such as a lack of support from federal laboratories and no standardization of techniques among countries. This hindered comparisons and the planning of binational actions. A study about the occurrence of public health emergencies in Brazil proved that, in the border areas, laboratory confirmation remains low for suspected cases 21 . This lack of diagnosis can be attributed to the high testing demand that these laboratories have, which requires additional investment for its expansion and an increase of capacity to become a robust border network. Although one of the response pillars to the Ebola outbreak in West Africa has been the laboratory support, the lack of capacity during the early stages of the epidemic was undoubtedly a factor that contributed to Ebola's rapid expansion, reinforcing the idea of consolidating a prepared network to respond to any type of threat 32, 33 . Such difficulties in the BES development, including laboratory services, may have contributed to a weak capacity to detect and respond in a timely manner to public health events, as observed for the Brazilian international border municipalities 34 . The analysis of their capacity to report infectious diseases with a potential to generate an epidemic demonstrated a very low proportion (16,6%) of cases of these diseases being reported in a timely manner (< 24 hours -as established nationally).\", 'cite_spans': [{'start': 570, 'end': 572, 'text': '21', 'ref_id': 'BIBREF21'}, {'start': 1119, 'end': 1122, 'text': '32,', 'ref_id': 'BIBREF35'}, {'start': 1123, 'end': 1125, 'text': '33', 'ref_id': 'BIBREF36'}, {'start': 1373, 'end': 1375, 'text': '34', 'ref_id': 'BIBREF37'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"The political organization of different countries for the entry and movement of people through borders are relevant factors in the comparison of surveillance systems and in the design of health systems for the border regions. The Treaty of Asunción, which gave rise to MERCOSUR, establishes that the States' parties have the freedom of movement for people, goods, and services among them 35 . Hence, the Brazilian Southern Border Arc has an extremely high daily porosity for people entry and exit, once the crossing between countries can be taken without any impediment. As evidenced by the research, there are numerous points of entry, where there are no checkpoints, such as health inspection points or customs. On the other hand, in North America, in addition to the physical barriers along the border, all entry points are controlled by U.S. Customs and Border Protection (CBP). This agency first screens incoming international travelers with the CDC and has the power to detain for the enforcement of isolation and quarantine of individuals with any signs and/or symptoms of infectious diseases 36 . The presence of such agencies as the CBP plays an important role in the containment of infectious diseases entering the United States. Countries that applied travel restrictions on their borders during the epidemic of the influenza virus A (H1N1) observed that both the restriction and the isolation and quarantine of the cases played an important contribution in the delay of the virus in their countries 37, 38 .\", 'cite_spans': [{'start': 388, 'end': 390, 'text': '35', 'ref_id': 'BIBREF38'}, {'start': 1100, 'end': 1102, 'text': '36', 'ref_id': 'BIBREF39'}, {'start': 1511, 'end': 1514, 'text': '37,', 'ref_id': 'BIBREF40'}, {'start': 1515, 'end': 1517, 'text': '38', 'ref_id': 'BIBREF41'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The lack of a screening process at the border crossing points temporarily makes the detection of potential suspect cases very passive, dependent on volunteers seeking health assistance. The receiving health facility of a suspected case must be prepared to provide the initial care to isolate the case when necessary or make the transport to the place of isolation. They must then communicate in a timely manner with the respective authorities in the neighboring country to begin the binational investigation. Moreover, all health facilities in the border region, including laboratories, must be notified about the possible suspect cases. An online system for binational notification would be the tool of choice. All levels involved in the response could then input, search, and follow up in real time on all the epidemiological information of cases, thus creating increased transparency and dynamism to the response process. Inside this network, an important movement should be made to bring international organizations closer, such as PAHO and multilateral mechanisms, as MERCOSUR and UNASUR. These structures and mechanisms should have important tools that have been created for international health dialogue so they can act as front ambassadors to stalemates when an urgent international response is required. Forums and mechanisms created by these agencies are important health authorities of the participating countries. Due to the previous meetings, they already have affinities, which facilitate and streamline the dialogue and target the most controversial issues.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'One of the limitations of this study was the voluntary participation, which made some of the invited stakeholders/ key coordinators not available to answer the survey. Another limitation was the financial aspect, which restricted the field visit to just one point of entry into South America. Specifically, in the South Arc, obtaining responses from Paraguayan technicians would have enhanced and contributed much to the technical discussion. However, despite numerous contacts and invitations, this did not materialize. This limitation has highlighted the lack of multinational mechanisms that could facilitate and would promote dialogue with BES structures.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"Taking from the results observed in this study, the following concluding points can be highlighted: i) availability of a protocol to North American borders; international borders are defining their priorities and actions at these regions together with stakeholders and partners from neighboring countries and the existence of border laboratories; ii) because this is a study, among the few, focused on border epidemiological surveillance in the Americas' Southern Cone countries, this research has raised questions about borders that require special attention to delineate and help the flow of work processes; iii) the continuous, systematic development of surveillance systems at the borders will provide more effectiveness to the implementation of actions and responses; thus, countries can improve their mechanisms to respond in future outbreaks; iv) considering the external validity of this study, the results achieved do not necessarily apply to the reality of other borders; however, the instrument used in this research can be adapted to be used in studies that deal with border surveillance in other parts of the world.\", 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Pandemic preparedness and response -lessons from the H1N1 influenza of 2009', 'authors': [{'first': 'H', 'middle': ['V'], 'last': 'Fineberg', 'suffix': ''}], 'year': 2014, 'venue': 'N Engl J Med', 'volume': '370', 'issn': '', 'pages': '1335--1377', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management', 'authors': [{'first': 'R', 'middle': ['D'], 'last': 'Smith', 'suffix': ''}], 'year': 2006, 'venue': 'Soc Sci Med', 'volume': '63', 'issn': '', 'pages': '3113--3136', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Updated information on the epidemiology of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection and guidance for the public, clinicians, and public health authorities', 'authors': [], 'year': 2013, 'venue': 'Centers for Disease Control and Prevention (CDC)', 'volume': '62', 'issn': '', 'pages': '793--799', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The evolution and expansion of regional disease surveillance networks and their role in mitigating the threat of infectious disease outbreaks', 'authors': [{'first': 'K', 'middle': ['C'], 'last': 'Bond', 'suffix': ''}, {'first': 'S', 'middle': ['B'], 'last': 'Macfarlane', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Burke', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Ungchusak', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Wibulpolprasert', 'suffix': ''}], 'year': 2013, 'venue': 'Emerg Health Threats J', 'volume': '6', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'World Health Organization. WHO statement on the first meeting of the International Health Regulations', 'authors': [], 'year': 2005, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations', 'authors': [], 'year': 2016, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Rapid spread of Zika virus in the Americas -implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games', 'authors': [{'first': 'E', 'middle': [], 'last': 'Petersen', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Wilson', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Touch', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Mccloskey', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Mwaba', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Bates', 'suffix': ''}], 'year': 2016, 'venue': 'Int J Infect Dis', 'volume': '44', 'issn': '', 'pages': '11--16', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Doenças transmissíveis na Faixa de Fronteira Amazônica: o caso da malária', 'authors': [{'first': 'P', 'middle': [], 'last': 'Peiter', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Machado', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Iñiguez', 'suffix': ''}], 'year': 2008, 'venue': 'Miranda AC, Barcellos C, Moreira JC, Monken M, organizadores. Território, ambiente e saúde', 'volume': '', 'issn': '', 'pages': '257--72', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Border Infectious Disease Surveillance project: establishing bi-national border surveillance', 'authors': [{'first': 'M', 'middle': [], 'last': 'Weinberg', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Waterman', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Lucas', 'suffix': ''}, {'first': 'V', 'middle': ['C'], 'last': 'Falcon', 'suffix': ''}, {'first': 'P', 'middle': ['K'], 'last': 'Morales', 'suffix': ''}, {'first': 'L', 'middle': ['A'], 'last': 'Lopez', 'suffix': ''}], 'year': 2003, 'venue': 'Emerg Infect Dis', 'volume': '9', 'issn': '', 'pages': '97--102', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Quantifying cross-border movements and migrations for guiding the strategic planning of malaria control and elimination', 'authors': [{'first': 'D', 'middle': ['K'], 'last': 'Pindolia', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Garcia', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fik', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Smith', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Tatem', 'suffix': ''}], 'year': 2014, 'venue': 'Malar J', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border', 'authors': [{'first': 'P', 'middle': [], 'last': 'Becerril-Montes', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Said-Fernández', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Luna-Herrera', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Caballero-Olín', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Enciso-Moreno', 'suffix': ''}, {'first': 'H', 'middle': ['G'], 'last': 'Martínez-Rodríguez', 'suffix': ''}], 'year': 2013, 'venue': 'Mem Inst Oswaldo Cruz', 'volume': '108', 'issn': '', 'pages': '160--166', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Delays in the diagnosis of tuberculosis in a town at the triple border of Brazil, Paraguay, and Argentina', 'authors': [{'first': 'R', 'middle': ['A'], 'last': 'Silva-Sobrinho', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Andrade', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Ponce', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Wysockiii', 'suffix': ''}, {'first': 'M', 'middle': ['E'], 'last': 'Brunello', 'suffix': ''}, {'first': 'L', 'middle': ['M'], 'last': 'Scatena', 'suffix': ''}], 'year': 2012, 'venue': 'Rev Panam Salud Publica', 'volume': '31', 'issn': '', 'pages': '461--469', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Emergências em saúde pública de importância nacional e internacional no brasil', 'authors': [{'first': 'R', 'middle': ['B'], 'last': 'Oliveira', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Horta', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Barbosa', 'suffix': ''}, {'first': 'V', 'middle': ['S'], 'last': 'Belo', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Verani', 'suffix': ''}], 'year': 2006, 'venue': 'Rev Saude Publica Santa Catarina', 'volume': '7', 'issn': '', 'pages': '17--32', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Local cross-border disease surveillance and control: experiences from the Mekong Basin', 'authors': [{'first': 'M', 'middle': [], 'last': 'Moore', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'Dausey', 'suffix': ''}], 'year': 2015, 'venue': 'BMC Res Notes', 'volume': '8', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Condiciones de vida, situación de la salud y disponibilidad de servicios de salud en La frontera de Brasil: un enfoque geográfico', 'authors': [{'first': 'P', 'middle': ['C'], 'last': 'Peiter', 'suffix': ''}], 'year': 2007, 'venue': 'Cad. Saude Publica', 'volume': '23', 'issn': '2', 'pages': '237--50', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'The La Paz Agreement 30 years on', 'authors': [{'first': 'S', 'middle': ['P'], 'last': 'Mumme', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Collins', 'suffix': ''}], 'year': 2014, 'venue': 'J Environ Dev', 'volume': '23', 'issn': '', 'pages': '303--333', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'United States-Mexico Border Health Commission. Border region', 'authors': [], 'year': 2016, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Surveillance and control of Aedes albopictus in the Swiss-Italian border region: differences in egg densities between intervention and non-intervention areas', 'authors': [{'first': 'T', 'middle': ['T'], 'last': 'Suter', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Flacio', 'suffix': ''}, {'first': 'F', 'middle': ['B'], 'last': 'Feijoó', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Engeler', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Tonolla', 'suffix': ''}, {'first': 'L', 'middle': ['N'], 'last': 'Regis', 'suffix': ''}], 'year': 2016, 'venue': 'PLoS Negl Trop Dis', 'volume': '10', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Brasília: IBGE', 'authors': [{'first': '', 'middle': [], 'last': 'Instituto Brasileiro De Geografia E Estatística', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Censo', 'suffix': ''}], 'year': 2010, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Center for Disease Control and Prevention. Framework for program evaluation in public health', 'authors': [], 'year': 1999, 'venue': 'MMWR Recomm Rep', 'volume': '48', 'issn': '11', 'pages': '1--40', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Avaliação da vigilância epidemiológica ampliada do rotavírus. Rev Bras Promoç Saúde', 'authors': [{'first': 'R', 'middle': [], 'last': 'Bruniera-Oliveira', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Horta', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Verani', 'suffix': ''}], 'year': 2014, 'venue': '', 'volume': '27', 'issn': '', 'pages': '140--148', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Multinational disease surveillance programs: promoting global information exchange for infectious diseases', 'authors': [{'first': 'A', 'middle': [], 'last': 'Varan', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Bruniera-Oliveira', 'suffix': ''}, {'first': 'C', 'middle': ['R'], 'last': 'Peter', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Fonseca-Ford', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Waterman', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Technique for the measurement of attitudes', 'authors': [{'first': 'R', 'middle': ['A'], 'last': 'Likert', 'suffix': ''}], 'year': 1932, 'venue': 'Arch Psychol', 'volume': '22', 'issn': '', 'pages': '1--55', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Likert-type scale response anchors', 'authors': [{'first': 'W', 'middle': ['M'], 'last': 'Vagias', 'suffix': ''}], 'year': 2006, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Likert scales and data analyses. Qual Prog', 'authors': [{'first': 'I', 'middle': ['E'], 'last': 'Allen', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Seaman', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Technical guidelines for United States-Mexico coordination on public health events of mutual interest', 'authors': [], 'year': 2016, 'venue': 'Center for Disease Control and Prevention', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': \"Health at the borders: Bayesian multilevel analysis of women's malnutrition determinants in Ethiopia\", 'authors': [{'first': 'T', 'middle': ['D'], 'last': 'Delbiso', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Rodriguez-Llanes', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Altare', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Masquelier', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Guha-Sapir', 'suffix': ''}], 'year': 2016, 'venue': 'Glob Health Action', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Epidemiological aspects of pulmonar tuberculosis in Mato Grosso do Sul', 'authors': [{'first': 'A', 'middle': ['F'], 'last': 'Ferraz', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Valente', 'suffix': ''}], 'year': 2014, 'venue': 'Brazil. Rev Bras Epidemiol', 'volume': '17', 'issn': '', 'pages': '255--66', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project', 'authors': [{'first': 'P', 'middle': ['R'], 'last': 'Spradling', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Xing', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Phippard', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Fonseca-Ford', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Montiel', 'suffix': ''}, {'first': 'N', 'middle': ['L'], 'last': 'Guzmán', 'suffix': ''}], 'year': 2000, 'venue': 'J Immigr Minor Health', 'volume': '15', 'issn': '', 'pages': '390--397', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Cross-border collaboration between China and Myanmar for emergency response to imported vaccine derived poliovirus case', 'authors': [], 'year': 2015, 'venue': 'BMC Infect Dis', 'volume': '15', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Gabinete do Ministro. Portaria nº 2.761, de 18 de novembro de 2008. Aprova a Resolução GMC nº 22', 'authors': [{'first': '', 'middle': [], 'last': 'Brasil', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ministério Da Saúde', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Diário Oficial da União', 'authors': [{'first': '', 'middle': [], 'last': 'Mercosul', 'suffix': ''}], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Laboratory support during and after the Ebola virus endgame: towards a sustained laboratory infrastructure', 'authors': [{'first': 'I', 'middle': [], 'last': 'Goodfellow', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Reusken', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koopmans', 'suffix': ''}], 'year': 2015, 'venue': 'Euro Surveill', 'volume': '20', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Active monitoring of travelers arriving from Ebola-affected countries', 'authors': [{'first': 'A', 'middle': ['J'], 'last': 'Millman', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Chamany', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Guthartz', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Thihalolipavan', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Porter', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Schroeder', 'suffix': ''}], 'year': 2014, 'venue': 'MMWR Morb Mortal Wkly Rep', 'volume': '653', 'issn': '', 'pages': '51--55', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Magnitude das doenças de notificação compulsória e avaliação dos indicadores de vigilância epidemiológica em municípios da linha de fronteira do Brasil', 'authors': [{'first': 'M', 'middle': ['P'], 'last': 'Cerroni', 'suffix': ''}, {'first': 'E', 'middle': ['H'], 'last': 'Carmo', 'suffix': ''}], 'year': 2007, 'venue': 'Epidemiol Serv Saude', 'volume': '24', 'issn': '', 'pages': '617--645', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Montevidéo: MERCOSUR', 'authors': [{'first': 'Del', 'middle': [], 'last': 'Mercado Común', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Sur', 'suffix': ''}], 'year': 2015, 'venue': 'En pocas palabras', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'A new paradigm for quarantine and public health activities at land borders: opportunities and challenges', 'authors': [{'first': 'S', 'middle': ['H'], 'last': 'Waterman', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Escobedo', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Wilson', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Edelson', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Bethel', 'suffix': ''}, {'first': 'D', 'middle': ['B'], 'last': 'Fishbein', 'suffix': ''}], 'year': 2009, 'venue': 'Public Health Rep', 'volume': '124', 'issn': '', 'pages': '203--214', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Human mobility networks, travel restrictions, and the global spread of 2009 H1N1 pandemic', 'authors': [{'first': 'P', 'middle': [], 'last': 'Bajardi', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Poletto', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Ramasco', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Tizzoni', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Colizza', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Vespignani', 'suffix': ''}], 'year': 2011, 'venue': 'PloS One', 'volume': '6', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Mateus', 'suffix': ''}, {'first': 'H', 'middle': ['E'], 'last': 'Otete', 'suffix': ''}, {'first': 'C', 'middle': ['R'], 'last': 'Beck', 'suffix': ''}, {'first': 'G', 'middle': ['P'], 'last': 'Dolan', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Nguyen-Van-Tam', 'suffix': ''}], 'year': 2014, 'venue': 'Bull World Health Organ', 'volume': '92', 'issn': '', 'pages': '868--80', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'Map -illustrating the border regions between Brazil and the Mercosur member countries. Source: Peiter15', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'US-Mexico border. Source: http://www.borderhealth.org/border_region.php', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Profile of the respondents, geographic and operational characteristics of the Borders Epidemiological Surveillance System', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Organizational priorities, information exchange and Binational Notification of the Borders Epidemiological Surveillance System', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'Human, financial and technical support, Laboratory and Challenges of the Borders Epidemiological Surveillance System US-Mexico Border Brazilian Border Human, Financial Resources and technical support.', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715f0b5af3feae5e75cdb'), 'paper_id': '0a449e173239afb38816257e1a53811b47bf13f4', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'sion was diagnosed between 1 and 19 months after discharge from an Ebola treatment center among survivors of EVD in Conakry. 7 Several studies have reported mental health issues in MERSrelated patients. In a study of subjects who had been isolated because they had had contact with a MERS patient, 7.6% showed anxiety and 16.6% had developed feelings of anger during the isolation period. 8 A cross-sectional study that examined the mental health of nurses working at a governmentdesignated hospital during a MERS-Coronavirus (CoV) outbreak revealed that the influences of stigma and hardiness on mental health are partially mediated through stress. 9 Psychological trauma of MERS victims and bereaved families has also been anecdotally reported, 10 as many patients suffer from rumors and discrimination even after being treated and cleared of the disease.', 'cite_spans': [{'start': 125, 'end': 126, 'text': '7', 'ref_id': 'BIBREF6'}, {'start': 389, 'end': 390, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 650, 'end': 651, 'text': '9', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': ''}, {'text': 'However, few studies have addressed chronic fatigue and mental health among survivors after a MERS infection in South Korea. Moreover, the relationship between them is unclear, although understanding their relationship is important to identify EID survivors who are at high risk for chronic fatigue and mental health problems and to provide targeted interventions and treatments.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Thus, we investigated symptoms of chronic fatigue, PTSD, and depression in survivors after a MERS epidemic and the relationships among them. A serial multiple mediation model with one independent variable was used. The purpose of this study is to examine the longitudinal mediating effects of depressions between chronic fatigue and later PTSSs for the MERS survivors. Through this, we will reveal predictive factors of PTSSs and we would utilize practical interventions for improving the PTSSs through the development of programs. Furthermore, this study will be utilized as a basis to establish the policy to improve the detrimental mental health effects of the EID infection to survivors.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'The study data were obtained from a multi-centered prospective follow-up study of MERS survivors in the Republic of Korea. All survivors with confirmed MERS infection were invited to participate in the study 12 months after the MERS outbreak had ended and follow-up in every 6 months later. Personalized letters and subsequent telephone contact were made to invite subjects to participate, and assessments were arranged.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participants and procedures'}, {'text': 'Of 148 survivors, 72 (48.65%) consented to be registered. The assessments were performed 12 months (T1) and 18 months (T2) after the MERS outbreak in five hospitals: National Medi-cal Center (n=15), Seoul National University Hospital (n=17), Chungnam National University Hospital (n=13), Seoul Medical Center (n=12), and Dankook University Hospital (n=6). All participants visited the hospitals for regular health checkups and completed self-report questionnaires. The complete responses from 63 and 54 participants were gathered at T1 and T2, respectively. Only data from 52 subjects who completed both assessments were analyzed to examine the relationships among the relevant psychological variables.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participants and procedures'}, {'text': 'Data on demographic variables including sex, age, job, and marriage were gathered. Data on medical illnesses prior to MERS and a psychiatric history were also collected. Participants completed several scales, including the Fatigue Severity Scale (FSS), the Patient Health Questionnaire-9 (PHQ-9), and the Impact of Event Scale-Revised (IES-R).', 'cite_spans': [], 'ref_spans': [], 'section': 'Variables and measurements'}, {'text': 'The FSS is a Likert scale consisting of nine items that assess fatigue severity and functionality during the past one week. 11 Items are rated on a scale of 1 to 7 according to their level of agreement with a given statement, and include such statements as \"I am easily fatigued\" or \"fatigue interferes with carrying out certain duties and responsibilities. \" Values for each item were averaged for a composite score, with higher scores indicating higher levels of impairment from fatigue and fatigue was largely independent of self-reported depressive symptoms. 11 Using the Korean FSS 12 index of 3.22 as the cutoff point, sensitivity was 84.1% and specificity was 85.7% for the fatigue and control groups, respectively. Factor analysis showed first factor was recognition of fatigue and second factor was the interference of fatigue on functioning in physical, family and social area. 12 The PHQ-9 13 is used to monitor depression severity. The questionnaire consists of nine items based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria for depression, scored from 0 to 3, providing a severity score ranging from 0 to 27. Accordingly, depression severity was defined as no depression (1-4), mild depression (5-9), moderate depression (10) (11) (12) (13) (14) , moderately severe depression (15) (16) (17) (18) (19) , and severe depression (20) (21) (22) (23) (24) (25) (26) (27) . The Korean version of the PHQ-9 is a reliable and valid tool for screening and assessing depressed patients (Cronbach\\'s alpha coefficient=0.81). 14 The IES-R was designed to assess symptoms associated with PTSD following a traumatic life event (MERS infection in our study). Symptoms are measured on 22 self-reported items for a total subjective stress assessment that can be further divided into intrusion, avoidance, and hyperarousal subscales. Individual items describe difficulties associated with stressful events, and participants were asked to indicate the extent to which each item distressed or bothered them over the last 7 days using a rating scale of 0-4. A total score ≥25 is considered clinically significant. 15', 'cite_spans': [{'start': 124, 'end': 126, 'text': '11', 'ref_id': 'BIBREF10'}, {'start': 563, 'end': 565, 'text': '11', 'ref_id': 'BIBREF10'}, {'start': 888, 'end': 890, 'text': '12', 'ref_id': 'BIBREF11'}, {'start': 1274, 'end': 1278, 'text': '(10)', 'ref_id': 'BIBREF9'}, {'start': 1279, 'end': 1283, 'text': '(11)', 'ref_id': 'BIBREF10'}, {'start': 1284, 'end': 1288, 'text': '(12)', 'ref_id': 'BIBREF11'}, {'start': 1289, 'end': 1293, 'text': '(13)', 'ref_id': 'BIBREF12'}, {'start': 1294, 'end': 1298, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 1330, 'end': 1334, 'text': '(15)', 'ref_id': 'BIBREF14'}, {'start': 1335, 'end': 1339, 'text': '(16)', 'ref_id': 'BIBREF15'}, {'start': 1340, 'end': 1344, 'text': '(17)', 'ref_id': 'BIBREF16'}, {'start': 1345, 'end': 1349, 'text': '(18)', 'ref_id': 'BIBREF17'}, {'start': 1350, 'end': 1354, 'text': '(19)', 'ref_id': 'BIBREF18'}, {'start': 1379, 'end': 1383, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 1384, 'end': 1388, 'text': '(21)', 'ref_id': 'BIBREF20'}, {'start': 1389, 'end': 1393, 'text': '(22)', 'ref_id': 'BIBREF21'}, {'start': 1394, 'end': 1398, 'text': '(23)', 'ref_id': 'BIBREF22'}, {'start': 1399, 'end': 1403, 'text': '(24)', 'ref_id': 'BIBREF23'}, {'start': 1404, 'end': 1408, 'text': '(25)', 'ref_id': 'BIBREF24'}, {'start': 1409, 'end': 1413, 'text': '(26)', 'ref_id': None}, {'start': 1414, 'end': 1418, 'text': '(27)', 'ref_id': None}, {'start': 1566, 'end': 1568, 'text': '14', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Variables and measurements'}, {'text': \"All statistical analyses were performed using the Statistical Package for Social Science 18.0 software (SPSS Inc., Chicago, IL, USA). We performed Paired T-test to examine significant changes in all mean scores over the time period. Pearson's correlation analyses were used to determine the relationships among chronic fatigue (T1 FSS), depression (T1 PHQ, T2 PHQ), and PTSS (T2 IES). The hypothesis that chronic fatigue affects PTSS through depression was examined using the serial multiple mediation model, which is a kind of multiple regression in the SPSS PROCESS macro. 16, 17 Serial multiple-mediated-effects analyses were conducted with 5,000 bootstrap-ping repetitions. Confidence intervals that did not include 0 were considered significant. All tests were two-sided. A pvalue <0.05 was considered significant.\", 'cite_spans': [{'start': 575, 'end': 578, 'text': '16,', 'ref_id': 'BIBREF15'}, {'start': 579, 'end': 581, 'text': '17', 'ref_id': 'BIBREF16'}], 'ref_spans': [], 'section': 'Statistical analyses'}, {'text': 'The present study protocol was reviewed and approved by the Institutional Review Board of the National Medical Center (IRB No. H-1510-059-007). Informed consent was submitted by all subjects when they were enrolled. All participants were informed that they could withdraw from the study at any time. Table 1 presents the demographic and clinical characteris- In all, 23.08% of cases were healthcare workers when they were infected with MERS. The mean number of hospitalization days was 21.00 (SD=21.76). The mean number of days from symptoms to the confirmed diagnosis was 4.50 (SD=4.12), and the mean total days of illness was 23.00 (SD=27.11). About 36.54% (n=19) of participants had suffered from pneumonia, 19 .23% (n=10) had been treated with a ventilator, and 3.85% (n=2) had been treated with extracorporeal membrane oxygenation during the acute MERS treatment period.', 'cite_spans': [{'start': 711, 'end': 713, 'text': '19', 'ref_id': 'BIBREF18'}], 'ref_spans': [{'start': 300, 'end': 307, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'Ethics statement'}, {'text': 'Changes in the number of subjects with clinically relevant symptoms over time are shown in Table 1 . The PHQ-9 scores indicated that 26.92% (T1), 17.31% (T2) of subjects had clinically relevant depressive symptoms. In addition, 48.08% (T1), 32.69% (T2) had clinically relevant chronic fatigue according to their FSS scores. In terms of the IES-R assessment, 42.31% (T1), 26.92% (T2) had scores above the cut-off point for PTSD. Table 2 shows the correlations among the variables of interest included in the hypothetical model. All correlations across the variables of interest were significant. FSS (T1) scores were positively correlated with scores on the PHQ-9 (T1, T2) and the IES-R (T2). Mean scores of all of the scales were lower at T2 than at T1. The mean FSS score changed significantly from 3.50 (SD=1.88) to 2.78 (SD=1.89), and that of the IES-R decreased significantly from 25.83 (SD=20.05) to 19 .29 (SD=21.03). The mean score of the PHQ-9 decreased from 6.50 (SD=5.69) to 5.42 (SD=5.71) but we could not find significance.', 'cite_spans': [{'start': 905, 'end': 907, 'text': '19', 'ref_id': 'BIBREF18'}], 'ref_spans': [{'start': 91, 'end': 98, 'text': 'Table 1', 'ref_id': 'TABREF0'}, {'start': 428, 'end': 435, 'text': 'Table 2', 'ref_id': 'TABREF1'}], 'section': 'RESULTS'}, {'text': 'The serial multiple-mediation model, which included T1 FSS, T1 PHQ-9, and T2 PHQ-9, accounted for 34.19% of the Moreover, bootstrap analyses revealed that the positive indirect effects of T1 FSS on T2 IES-R through T1 PHQ-9 and T2 PHQ-9 were significant (B=2.1601, SE=1.3268, 95% confidence interval=0.4250-6.1307) ( Table 3) . These results indicate that both T1 PHQ and T2 PHQ-9 fully mediated the effects of T1 FSS on T2 IES-R (Figure 1 ), which suggests that both T1 PHQ and T2 PHQ-9 eliminated the direct effects of T1 FSS on T2 IES-R.', 'cite_spans': [], 'ref_spans': [{'start': 317, 'end': 325, 'text': 'Table 3)', 'ref_id': 'TABREF2'}, {'start': 430, 'end': 439, 'text': '(Figure 1', 'ref_id': 'FIGREF1'}], 'section': 'RESULTS'}, {'text': 'Chronic fatigue 12 months post-MERS had indirect effects on prolonged PTSSs 18 months post-MERS via persisting depression in MERS survivors. This is in agreement with a longitudinal study 18 of anxiety, depression, and fatigue in patients with multiple sclerosis that showed that depression strongly predicts anxiety and fatigue, and that anxiety and fatigue strongly predict subsequent depression. Moreover, previous studies conducted on subjects who had experienced disasters noted that current depression is a predictor of PTSSs. 19 The rate of participants reported clinically significant symptoms in CFS (32.7-48.1%), depression (17.3-26.9%), and PTSD (26.9-42.3%) was comparable to that following SARS. 4 In a 4-year survey in Hong Kong, more than 40% of the respondents had active psychiatric illness, and 40.3% reported a chronic fatigue problem. 20 In addition, a cohort study that investigated psychiatric complications among SARS survivors 30 months after infection found that the prevalence of any psychiatric disorder was 33.3%; 25.6% of patients had PTSD and 15.6% had depressive disorders. 21 Moreover, MERS survivors shared similar psychopathologies as other disaster survivors 22 who reported varying rates of PTSD (30-40%), 23 depression (25%), and fatigue symptoms (50%). These findings suggest that EIDs result not only in physical problems but also psychiatric sequelae in infected persons because they might experience those as disastrous events.', 'cite_spans': [{'start': 188, 'end': 190, 'text': '18', 'ref_id': 'BIBREF17'}, {'start': 533, 'end': 535, 'text': '19', 'ref_id': 'BIBREF18'}, {'start': 709, 'end': 710, 'text': '4', 'ref_id': 'BIBREF3'}, {'start': 855, 'end': 857, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 1105, 'end': 1107, 'text': '21', 'ref_id': 'BIBREF20'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Fatigue is a prominent disabling symptom in a variety of medical and neurologic disorders. In EIDs survivors, the Coronavirus itself may have directly caused sleep disorders, fatigue, and behavioral symptoms, which in turn may have resulted in chronic post-inflammatory central nervous system pathologies that adversely affected sleep, pain sensitivity, and energy. 2 It is noteworthy that chronic fatigue syndrome (CFS) shares many symptoms with depression and the two are frequently co-diagnosed. 24 However, according to the study which measure the fatigue severity among patients with multiple sclerosis, patients with systemic lupus erythematosus, and healthy adults, fatigue was largely independent of self-reported depressive symptoms. 11 Despite this, the current study appears to be the only longitudinal examination of chronic fatigue, depression, and PTSSs in EIDs survivors.', 'cite_spans': [{'start': 366, 'end': 367, 'text': '2', 'ref_id': 'BIBREF1'}, {'start': 499, 'end': 501, 'text': '24', 'ref_id': 'BIBREF23'}, {'start': 743, 'end': 745, 'text': '11', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'We found that the severities of chronic fatigue and PTSS improved significantly but that of depression relatively unchanged throughout the study period. Although this was the short-term follow-up study, these results suggest we should give attention to the persisting depression during recovery period in MERS survivors. It would be important for clinicians to assess depression among EIDs survivors with CFS. Furthermore our findings suggest the need to promote interventional programs for MERS survivors with chronic fatigue to prevent prolonged PTSSs by ameliorate depression. Two pos- sible treatments for chronic fatigue syndrome (CFS) are cognitive behavioral therapy and graded exercise therapy. 25 There is less clear evidence of the benefit of drug therapy for CFS in patients without comorbid depression or anxiety disorders. There were several limitations to this study. First, some sampling bias may have occurred, as <50% of the MERS survivors in Korea consented to participate in the study. It is possible that people who were heavily affected by MERS or who were experiencing mental health difficulties were more prone to participate in the research. In addition, mental health and fatigue symptoms were evaluated using self-reported measures that are not diagnostic in nature but result in assessments of symptomatology. However, these measures have demonstrated validity and reliability in Korea and are consistently correlated with more comprehensive diagnostic tools used to assess corresponding symptoms. Despite these limitations, the present study is the first to examine the relationships among chronic fatigue, depression, and PTSSs in survivors after the MERS epidemic in Korea.', 'cite_spans': [{'start': 703, 'end': 705, 'text': '25', 'ref_id': 'BIBREF24'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In summary, this longitudinal study revealed that many MERS survivors suffered from chronic fatigue and mental health problems even more than 1 year after the outbreak in South Korea, although three scores showed a decreasing trend. The prevalence rates of CFS, depression, and PTSD were 32.7%, 17.3%, and 26.9%, respectively, 18 months after the MERS outbreak. Furthermore, chronic fatigue 12 months post-MERS had an indirect effect on prolonged PTSS 18 months post-MERS through depression among survivors. Our findings may inform future strategies for detecting survivors who are at high risk for PTSD and for promoting long-term mental health outcomes in the event of other EIDs.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study', 'authors': [{'first': 'S', 'middle': ['Y'], 'last': 'Cho', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Kang', 'suffix': ''}, {'first': 'Y', 'middle': ['E'], 'last': 'Ha', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Park', 'suffix': ''}, {'first': 'J', 'middle': ['Y'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Ko', 'suffix': ''}], 'year': 2016, 'venue': 'Lancet', 'volume': '388', 'issn': '', 'pages': '994--1001', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study', 'authors': [{'first': 'H', 'middle': [], 'last': 'Moldofsky', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Patcai', 'suffix': ''}], 'year': 2011, 'venue': 'BMC Neurol', 'volume': '11', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Tansey', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Louie', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Loeb', 'suffix': ''}, {'first': 'W', 'middle': ['L'], 'last': 'Gold', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Muller', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'De Jager', 'suffix': ''}], 'year': 2007, 'venue': 'Arch Intern Med', 'volume': '167', 'issn': '', 'pages': '1312--1320', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Stress and psychological distress among SARS survivors 1 year after the outbreak', 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Wong', 'suffix': ''}, {'first': 'G', 'middle': ['M'], 'last': 'Mcalonan', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Cheung', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Cheung', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Sham', 'suffix': ''}], 'year': 2007, 'venue': 'Can J Psychiatry', 'volume': '52', 'issn': '', 'pages': '233--240', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Mental health impact of severe acute respiratory syndrome: a prospective study', 'authors': [{'first': 'Y', 'middle': ['K'], 'last': 'Wing', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Leung', 'suffix': ''}], 'year': 2012, 'venue': 'Hong Kong Med J', 'volume': '18', 'issn': '', 'pages': '24--27', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'An evaluation of psychological distress and social support of survivors and contacts of Ebola virus disease infection and their relatives in Lagos, Nigeria: a cross sectional study--2014', 'authors': [{'first': 'A', 'middle': [], 'last': 'Mohammed', 'suffix': ''}, {'first': 'T', 'middle': ['L'], 'last': 'Sheikh', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Gidado', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Poggensee', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Nguku', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Olayinka', 'suffix': ''}], 'year': 2015, 'venue': 'BMC Public Health', 'volume': '15', 'issn': '', 'pages': '1--8', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort', 'authors': [{'first': 'M', 'middle': ['M'], 'last': 'Keita', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Taverne', 'suffix': ''}, {'first': 'Sy', 'middle': [], 'last': 'Savané', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'March', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Doukoure', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sow', 'suffix': ''}, {'first': 'M', 'middle': ['S'], 'last': '', 'suffix': ''}], 'year': 2017, 'venue': 'BMC Psychiatry', 'volume': '17', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Mental health status of people isolated due to Middle East Respiratory Syndrome', 'authors': [{'first': 'H', 'middle': [], 'last': 'Jeong', 'suffix': ''}, {'first': 'H', 'middle': ['W'], 'last': 'Yim', 'suffix': ''}, {'first': 'Y', 'middle': ['J'], 'last': 'Song', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ki', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Min', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Cho', 'suffix': ''}], 'year': 2016, 'venue': 'Epidemiol Health', 'volume': '38', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Mental health of nurses working at a government-designated hospital during a MERS-CoV outbreak: a cross-sectional study', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Park', 'suffix': ''}, {'first': 'E', 'middle': ['H'], 'last': 'Lee', 'suffix': ''}, {'first': 'N', 'middle': ['R'], 'last': 'Park', 'suffix': ''}, {'first': 'Y', 'middle': ['H'], 'last': 'Choi', 'suffix': ''}], 'year': 2018, 'venue': 'Arch Psychiatr Nurs', 'volume': '32', 'issn': '', 'pages': '2--6', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Psychological trauma of Middle East Respiratory Syndrome victims and bereaved families', 'authors': [{'first': 'M', 'middle': [], 'last': 'Sim', 'suffix': ''}], 'year': 2016, 'venue': 'Epidemiol Health', 'volume': '38', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus', 'authors': [{'first': 'L', 'middle': ['B'], 'last': 'Krupp', 'suffix': ''}, {'first': 'N', 'middle': ['G'], 'last': 'Larocca', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Muir-Nash', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Steinberg', 'suffix': ''}], 'year': 1989, 'venue': 'Arch Neurol', 'volume': '46', 'issn': '', 'pages': '1121--1123', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression', 'authors': [{'first': 'K', 'middle': ['I'], 'last': 'Chung', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Song', 'suffix': ''}], 'year': 2001, 'venue': 'Korean J Psychosom Med', 'volume': '9', 'issn': '', 'pages': '164--173', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'The PHQ-9: validity of a brief depression severity measure', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kroenke', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Spitzer', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Williams', 'suffix': ''}], 'year': 2001, 'venue': 'J Gen Intern Med', 'volume': '16', 'issn': '', 'pages': '606--613', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'The PHQ-9: a new depression diagnostic and severity measure', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kroenke', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Spitzer', 'suffix': ''}], 'year': 2002, 'venue': 'Psychiatr Ann', 'volume': '32', 'issn': '', 'pages': '509--515', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'A study on reliability and validity of the Korean version of impact of event scale-revised', 'authors': [{'first': 'H', 'middle': ['J'], 'last': 'Eun', 'suffix': ''}, {'first': 'T', 'middle': ['W'], 'last': 'Kwon', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Lee', 'suffix': ''}, {'first': 'T', 'middle': ['H'], 'last': 'Kim', 'suffix': ''}, {'first': 'M', 'middle': ['R'], 'last': 'Choi', 'suffix': ''}, {'first': 'S', 'middle': ['J'], 'last': 'Cho', 'suffix': ''}], 'year': 2005, 'venue': 'J Korean Neuropsychiatr Assoc', 'volume': '44', 'issn': '', 'pages': '303--310', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'PROCESS: a versatile computational tool for observed variable mediation, moderation, and conditional process modeling (White paper)', 'authors': [{'first': 'A', 'middle': ['F'], 'last': 'Hayes', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Introduction to Mediation, Moderation, and Conditional Process Analysis: a Regression-Based Approach', 'authors': [{'first': 'A', 'middle': ['F'], 'last': 'Hayes', 'suffix': ''}], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis', 'authors': [{'first': 'R', 'middle': ['F'], 'last': 'Brown', 'suffix': ''}, {'first': 'E', 'middle': ['M'], 'last': 'Valpiani', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Tennant', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Dunn', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sharrock', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Hodgkinson', 'suffix': ''}], 'year': 2009, 'venue': 'Psychol Psychother', 'volume': '82', 'issn': '', 'pages': '41--56', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Predictors of posttraumatic outcomes following the 1999 Taiwan earthquake', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Chang', 'suffix': ''}, {'first': 'K', 'middle': ['M'], 'last': 'Connor', 'suffix': ''}, {'first': 'T', 'middle': ['J'], 'last': 'Lai', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Davidson', 'suffix': ''}], 'year': 2005, 'venue': 'J Nerv Ment Dis', 'volume': '193', 'issn': '', 'pages': '40--46', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up', 'authors': [{'first': 'M', 'middle': ['H'], 'last': 'Lam', 'suffix': ''}, {'first': 'Y', 'middle': ['K'], 'last': 'Wing', 'suffix': ''}, {'first': 'M', 'middle': ['W'], 'last': 'Yu', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Leung', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Ma', 'suffix': ''}, {'first': 'A', 'middle': ['P'], 'last': 'Kong', 'suffix': ''}], 'year': 2009, 'venue': 'Arch Intern Med', 'volume': '169', 'issn': '', 'pages': '2142--2147', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Long-term psychiatric morbidities among SARS survivors', 'authors': [{'first': 'Iwc', 'middle': [], 'last': 'Mak', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Chu', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Pan', 'suffix': ''}, {'first': 'Mgc', 'middle': [], 'last': 'Yiu', 'suffix': ''}, {'first': 'V', 'middle': ['L'], 'last': 'Chan', 'suffix': ''}], 'year': 2009, 'venue': 'Gen Hosp Psychiatry', 'volume': '31', 'issn': '', 'pages': '318--326', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Post-disaster mental health problems and the utilization of mental health services: a four-year longitudinal comparative study', 'authors': [{'first': 'Pgv', 'middle': [], 'last': 'Velden', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Grievink', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Kleber', 'suffix': ''}, {'first': 'A', 'middle': ['N'], 'last': 'Drogendijk', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Roskam', 'suffix': ''}, {'first': 'F', 'middle': ['G'], 'last': 'Marcelissen', 'suffix': ''}], 'year': 2006, 'venue': 'Adm Policy Ment Health', 'volume': '33', 'issn': '', 'pages': '279--288', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Post-traumatic stress disorder following disasters: a systematic review', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Neria', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Nandi', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Galea', 'suffix': ''}], 'year': 2008, 'venue': 'Psychol Med', 'volume': '38', 'issn': '', 'pages': '467--480', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey', 'authors': [{'first': 'E', 'middle': [], 'last': 'Fuller-Thomson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Nimigon', 'suffix': ''}], 'year': 2008, 'venue': 'Fam Pract', 'volume': '25', 'issn': '', 'pages': '414--422', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Chronic fatigue syndrome: diagnosis and treatment', 'authors': [{'first': 'J', 'middle': ['R'], 'last': 'Yancey', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Thomas', 'suffix': ''}], 'year': 2012, 'venue': 'Am Fam Physician', 'volume': '86', 'issn': '', 'pages': '741--746', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'p<0.001. FSS: Fatigue Severity Scale, PHQ: Patient Health Questionnaire-9, IES: Impact of Event Scale, T1: 12 months after MERS, T2: 18 months after MERS. MERS: Middle East respiratory syndrome, SD: standard deviation', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': \"Model depicting the effect of severe fatigue, depression on post-trauma of MERS. **p<0.01, ***p<0.001. FSS: Fatigue Severity Scale, PHQ: Patient Health Quetionnaire-9, IES: Impact of Event Scale, T1: 12 months after MERS, T2: 18 months after MERS, c': direct effect of X on Y (X=T1 FSS; Y=T2 IES), ns: not significant. MERS: Middle East respiratory syndrome.\", 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Demographic and clinical characteristics of participants', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Descriptive data and correlations among variables (N=52)', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'The Bootstrap results for the indirect effect of 12 months severe fatigue on 18 months impact of traumatic event between 12 and 18 months depression', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5ea715ef6864341d366a56f2'), 'paper_id': '0a098b3876e799d9b21608e26e80d05aa9ec6475', 'metadata': {'title': '', 'authors': [{'first': 'J', 'middle': ['B'], 'last': 'Bump', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': \"This paper addresses the need for conceptual and analytic clarity on nutrition governance, an essential underpinning of more effective approaches for undernutrition, the 'single greatest constraint to global development' and obesity, which already accounts for 4% of the world's disease burden and is growing rapidly. The governance of nutrition, which is essential to designing and implementing policies to realise the right to food, is among the most important and most defining duties of society. But research and action on nutrition governance are hampered by the absence of conceptual rigour, even as the continuing very high burden of undernutrition and the rapid rise in obesity highlight the need for such structures. The breadth of nutrition itself suggests that governance is both needed and sure to be complicated. This analysis explores the reasons attention has come to governance in development policy making, and why it has focused on nutrition governance in particular. It then assesses how the concept of nutrition governance has been used, finding that it has become increasingly prominent in scholarship on poor nutritional outcomes, but remains weakly specified and is invoked by different authors to mean different things. Undernutrition analysts have stressed coordination problems and structural issues related to the general functioning of government. Those studying obesity have emphasised international trade policies, regulatory issues and corporate behaviour. This paper argues that the lack of a clear, operational definition of governance is a serious obstacle to conceptualising and solving major problems in nutrition. To address this need, it develops a unified definition of nutrition governance consisting of three principles: accountability, participation and responsiveness. These are justified with reference to the social contract that defines modern nations and identifies citizens as the ultimate source of national power and legitimacy. A unified framework is then employed to explore solutions to nutrition governance problems.\", 'cite_spans': [], 'ref_spans': [], 'section': 'AbsTrACT'}, {'text': 'Nutrition is a requirement of all life and one of the most basic underpinnings of health, and as such is of great interest to all people. The right to food is therefore one of the most fundamental human entitlements and a central responsibility for all states. 1 2 The governance of nutrition, which is essential to designing and implementing policies to realise this right, 3 4 is thus among the most important and most defining duties of society. Better governance, broadly defined, has potential to improve many aspects of nutrition, for instance by coordinating actions between sectors and agencies, promoting accountability of corporate actors, improving the food supply, increasing community ownership in intervention programmes, improving the responsiveness of government to citizen demand and helping to uphold the right to food.', 'cite_spans': [{'start': 261, 'end': 264, 'text': '1 2', 'ref_id': None}, {'start': 375, 'end': 378, 'text': '3 4', 'ref_id': None}], 'ref_spans': [], 'section': 'InTroduCTIon'}, {'text': 'What is already known? ► The governance of nutrition is essential to addressing both undernutrition and obesity, but international and domestic actors have struggled in this area.', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': 'What are the new findings?', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': '► Governance has risen on donor agendas since the fall of the Berlin Wall in 1989, and has become more important with the proliferation of international actors, increasing cross-border actions and greater globalisation of commerce and disease. ► Increased prominence of nutrition governance reflects greater donor engagement, the multisectoral nature of food, increasing obesity the need for health-related regulation of trade and food crises caused by climate change and food crop diversion. ► Existing governance frameworks do not clarify their principles; this paper develops a unified conceptualisation of nutrition governance from basic philosophy to show the relationships between undernutrition and obesity, clarify the challenges and illuminate opportunities for intervention.', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': '► Nutrition governance and the right to food can be advanced by using the three elements of accountability, participation and responsiveness to assess all governance interventions and the performance of international actors.', 'cite_spans': [], 'ref_spans': [], 'section': 'What do the new findings imply?'}, {'text': \"But both research and action on nutrition governance are hampered by the absence of clarity or consensus on the meaning of this concept, even as many problems highlight the need for such structures. Undernutrition alone has been called 'the single greatest constraint facing global development' 5 and obesity accounts for nearly 4% of the entire global disease burden already and is increasing rapidly. 6 Globalisation of the food industry has been linked to rising obesity, diet-related chronic disease and the nutritional transition. 7 The breadth of nutrition itself suggests that governance is both needed and sure to be complicated. The production, distribution, sale and consumption of food engages agriculture, trade, transportation, education, health and other areas of both the public and private sectors.\", 'cite_spans': [{'start': 295, 'end': 296, 'text': '5', 'ref_id': 'BIBREF4'}, {'start': 403, 'end': 404, 'text': '6', 'ref_id': 'BIBREF5'}, {'start': 536, 'end': 537, 'text': '7', 'ref_id': 'BIBREF6'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Nonetheless, despite this need, basic questions about nutrition governance lack ready answers. For instance, what are the most important elements of governance? When planning a governance improvement intervention, where would one begin? For all the things that governance seems to be, what is it not? Is it the same as politics, or something different?', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Conceptual rigour around nutrition governance would help navigate the seemingly impenetrable tangle of issues that now characterise this topic. The range of actors includes everything from individuals to the multinational food industry. The spectrum of influences is just as wide, including everything from personal preferences to national policies and global trade regimes, each of which has different sources of authority and legitimacy. In many scenarios, the lines of accountability are not obvious and even the relevant constituencies can be challenging to identify. Despite the profound influence of governance on nutrition, Sunguya et al have found that only 40% of low-income and middle-income country (LMIC) governments even have policies in this area. And although logic suggests that having a policy would be helpful, their analysis found no association with better nutrition outcomes. 8 In many places, rapid urbanisation is exacerbating weak governance problems, 9 and unregistered informal settlements expose the dysfunction of traditional welfare state approaches when citizens become invisible to the bureaucracy. 10 11 Where citizens do participate in the policy process, they may be ambivalent about issues experts view as urgent, 12 or their opinions may be influenced by food industry marketing or sponsored research. 13 14 How would one analyse or manage these complex issues?', 'cite_spans': [{'start': 897, 'end': 898, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 976, 'end': 977, 'text': '9', 'ref_id': 'BIBREF8'}, {'start': 1130, 'end': 1135, 'text': '10 11', 'ref_id': None}, {'start': 1249, 'end': 1251, 'text': '12', 'ref_id': 'BIBREF11'}, {'start': 1338, 'end': 1343, 'text': '13 14', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The purpose of this article is to rigorously analyse nutrition governance, which is essential to more effective intervention by national and international actors striving to uphold the right to food. First, I explain the literature review methods used to gather materials for analysis. Second, I examine why governance has become prominent on the health and development agendas. Third, I investigate the meaning of nutrition governance empirically, by assessing how the concept has been used. Fourth, I develop a clear definition of nutrition governance. Fifth, I present a framework for analysing nutrition governance and characterising its major features. In the conclusion, I use the framework to illuminate governance problems and corresponding opportunities for global-level actors.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"This inquiry began with a search of literature to gather information for the analysis and to gain insights into activities related to nutrition governance. To identify publications on nutrition governance, a keyword search for 'nutrition governance' was conducted in the PubMed database. i PubMed was chosen as the starting point because it is the world's largest database of health and medical literature. To capture additional literature from the social sciences, humanities, newspapers and books, the JSTOR database was searched, as well. Searches with Google Scholar and a review of citations in the most directly relevant papers were used to complete the initial sample. ii All results were reviewed and papers were retained if they used the term nutrition governance, or focused on nutrition and included aspects of governance as defined broadly by Lee et al to include accountability, transparency, participation, responsiveness, a consensus orientation, the rule of law, effectiveness and efficiency and equity and inclusiveness. 15 Papers were excluded if they mentioned nutrition governance insubstantially or were irrelevant, for instance, as part of author affiliations, but not in the article itself. [16] [17] [18] [19] A more extensive discussion of methods is available as online supplementary annex 1.\", 'cite_spans': [{'start': 676, 'end': 678, 'text': 'ii', 'ref_id': None}, {'start': 1038, 'end': 1040, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 1214, 'end': 1218, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 1219, 'end': 1223, 'text': '[17]', 'ref_id': 'BIBREF16'}, {'start': 1224, 'end': 1228, 'text': '[18]', 'ref_id': 'BIBREF17'}, {'start': 1229, 'end': 1233, 'text': '[19]', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'MeTHods'}, {'text': 'The final sample for analysis comprised 177 papers. Table 1 presents the search strategy for each database along with the number of papers obtained:', 'cite_spans': [], 'ref_spans': [{'start': 52, 'end': 59, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'MeTHods'}, {'text': \"The limitations of this exercise include at least the following: these databases are biased towards English-language publications and western journals, and may not accurately capture governance work, even in these areas. Scholarship on governance may not have been indexed consistently or with the same keywords over the period of interest. The journals indexed by PubMed are not constant and the aggregate number has increased over this period. The searches used the keyword 'governance', which is a current term but may not have been the most commonly used term for describing its subject over the past 40 years. These limitations notwithstanding, the review is likely to have generated a reasonable sample of literature for analysing the aspects of nutrition governance of interest in this paper. \", 'cite_spans': [], 'ref_spans': [], 'section': 'MeTHods'}, {'text': 'FIndIngs And dIsCussIon Governance is such an obvious requirement for development that it is not intuitive why attention should have come to this area only in the past two or three decades, and especially in the last 10 years. I decided to investigate the reasons, hypothesising that they would help demonstrate the importance of nutrition governance and reveal the specific problems it is expected to solve.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"governance and the development policy agenda Before the fall of the Berlin Wall in 1989, most aid was conditional on geopolitical alignment rather than on how states treated their own citizens. But after the Cold War, economic and political rights issues were no longer enmeshed in the larger US-Soviet ideological struggle. Freed from this constraint, western donors began to project their own political convictions via democratisation and governance projects. The growth of the rights movement and several international agreements on rights in the early 1990s testifies further to the power of this shift. 20 When the concern for state alignment evaporated, it helped bring attention to the role of governance in translating development aid into poverty reduction. This was an important factor in the introduction and subsequent popularity of the Sector Wide Approaches (SWAps) and other general budget support mechanisms that blossomed in the 1990s. 21 After mixed results from the 1980s' Washington Consensus aid approach, it was also clear that the market alone would not solve all problems; the rise of governance was a partial retreat from that position, 22 as was the embrace of public-private partnerships. 23 Weaknesses in governance at various levels from the national to the global drew attention as constraints to health systems. 24 The proliferation of actors in global health also spurred calls for better governance because of the need for coordination and accountability. 25 Targeted aid and democratisation projects became even more closely linked after the 9/11 attacks brought emphasis in US policymaking to the problems of failed states and poor populations. After 9/11, US assistance was directed to poor people in failed states in hopes of preventing scarcity-induced radicalizsation. The emphasis on safety nets and social protection could be read as a move by donors to enhance democratic participation by the poor. 26 However, these actions also fit neatly in the long legacy of aid programmes targeting health issues primarily because of their impact on trade and markets. 27 In the last 10 years, governance has become a well-established subfield in global health, in part because many problems related to governance have become more obvious. Governance was a natural follow-on focus after the decentralisation policies widely promoted in the 1990s, particularly because many of the formal policies and institutions designed to promote local engagement had not actually democratised decision making. 28 But the growing attention to governance also reflects rapid globalisation. The rising threat of disease and the growth of interstate commerce both increase the need for shared decision making between diverse groups and entities. 29 30 Globalisation has also highlighted the need for governance over both health and trade, which since World War II have been institutionalised distinctly. 31 Large-scale disease outbreaks, such as severe acute respiratory syndrome in 2003 and Ebola in West Africa in 2014 have made visible the importance of functioning governance mechanisms in health. [32] [33] [34] Trade-related non-communicable diseases linked to tobacco, processed foods and other goods have exposed shortcomings in existing structures. 35 International actors have recognised governance in many of their projects and analyses. Beginning in 1996, the World Bank began collecting governance indicators every other year; since 2002, it has collected these data annually from 212 countries and territories. 36 World Bank projects classified as 'Public Sector Governance' have become far more numerous over the years. In the 1980s, there were 304 such projects. In the 1990s, there 20 The multiplication of new NGOs, UN entities, corporations and others engaged in nutrition has continued and represents a growing challenge for coordination. 25 39 Additionally, the complexity of nutrition and its engagement with a great many sectors-agriculture, education, trade, health and others-present many coordination challenges. Second, food and nutrition interventions could be targeted at the community level and could give voice to poor citizens by promoting their participation. Hence, they were seen as natural vehicles to advance donors' general priorities in economic and political rights, and in attempting to prevent scarcity-induced radicalisation in failed states. More broadly, donors attempted to enhance democratic participation by the poor, but questions of how donor-driven governance models were supposed to interact with existing governance structures largely went unaddressed. 26 Third, the advance of globalisation highlighted the need for supranational regulation and strengthened governance at all levels. In 1999, Lang argued that globalisation was undermining traditional governance of food because national authority was not capable to regulating multinational businesses or countering their marketing. 40 The global growth of fast food and advertising largely bypassed health authorities because it was regulated internationally only as a trade issue with little reference to health consequences. 41 Others have advanced similar points on the importance of 'food governance', 42 for food and nutrition, perhaps similar to the Framework Convention on Tobacco Control, and coordinated action by the World Bank, WHO and the UN. 35 43 44 Fourth, real food prices rose quickly in the 2000s, peaking in 2008 and 2011, driven by depreciation in the dollar, diversion of some crops to biofuel use, oil price appreciation, export restrictions, demand surges, droughts and other factors. 45 46 Between 2000 and 2011, food prices increased 183% in real terms. 47 The disastrous humanitarian consequences of this increase, including conflict and instability, 48 generated political motivation for discussing food security, agriculture and trade policy and other aspects of global nutrition, particularly with respect to undernutrition. [49] [50] [51] Fifth, multilateral organisations and academics have been active. Governance was identified as one of the principal weaknesses in global nutrition by WHO's Commission on Social Determinants of Health in 2008 52 ; a Lancet commission cited governance problems as a central obstacle to effective international intervention against undernutrition. 53 Also in 2008 (formalised 2011), the Food and Agriculture Organization, Unicef and World Food Programme (WFP) agreed to launch Renewed Efforts Against Child Hunger and undernutrition (REACH) to strengthen UN actions to fight hunger and malnutrition by coordinating actions within recipient countries. In 2009-2010, WHO and many partners launched the Scaling Up Nutrition (SUN) movement to spur progress against undernutrition. 54 In 2010, WHO's Nutrition Landscape Information System launched with a series of governance indicators, 55 which has made it easier to quantify and demonstrate the large impact of governance on nutrition. 8 Since 2011, REACH has focused on strengthening nutrition management and governance, and supporting multisectoral nutrition actions, such as nutrition-sensitive programming. 39 56 These multilateral efforts have all brought attention to governance, although some have attracted criticism for expanding the influence of the private sector in public health policy. 57 58 This historical analysis reveals why nutrition governance is so crucial. First, it is essential to realise the right to food. Second, it is a tractable place to advance development through encouraging participation and democratisation, and as such is a powerful lever to realise many rights. Third, it is needed to coordinate between the many sectors important to nutrition, and among the many agencies and entities operating domestically and internationally. Fourth, it is required to address the affects of trade on health, particularly in the globalised food industry.\", 'cite_spans': [{'start': 608, 'end': 610, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 953, 'end': 955, 'text': '21', 'ref_id': 'BIBREF20'}, {'start': 1162, 'end': 1164, 'text': '22', 'ref_id': 'BIBREF21'}, {'start': 1216, 'end': 1218, 'text': '23', 'ref_id': 'BIBREF22'}, {'start': 1343, 'end': 1345, 'text': '24', 'ref_id': 'BIBREF23'}, {'start': 1489, 'end': 1491, 'text': '25', 'ref_id': 'BIBREF24'}, {'start': 1941, 'end': 1943, 'text': '26', 'ref_id': 'BIBREF25'}, {'start': 2100, 'end': 2102, 'text': '27', 'ref_id': 'BIBREF26'}, {'start': 2528, 'end': 2530, 'text': '28', 'ref_id': 'BIBREF27'}, {'start': 2760, 'end': 2765, 'text': '29 30', 'ref_id': None}, {'start': 2918, 'end': 2920, 'text': '31', 'ref_id': 'BIBREF30'}, {'start': 3116, 'end': 3120, 'text': '[32]', 'ref_id': 'BIBREF31'}, {'start': 3121, 'end': 3125, 'text': '[33]', 'ref_id': 'BIBREF32'}, {'start': 3126, 'end': 3130, 'text': '[34]', 'ref_id': 'BIBREF33'}, {'start': 3272, 'end': 3274, 'text': '35', 'ref_id': 'BIBREF34'}, {'start': 3539, 'end': 3541, 'text': '36', 'ref_id': 'BIBREF35'}, {'start': 3713, 'end': 3715, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 3873, 'end': 3878, 'text': '25 39', 'ref_id': None}, {'start': 4620, 'end': 4622, 'text': '26', 'ref_id': 'BIBREF25'}, {'start': 4952, 'end': 4954, 'text': '40', 'ref_id': 'BIBREF39'}, {'start': 5147, 'end': 5149, 'text': '41', 'ref_id': 'BIBREF40'}, {'start': 5226, 'end': 5228, 'text': '42', 'ref_id': 'BIBREF41'}, {'start': 5375, 'end': 5377, 'text': '35', 'ref_id': 'BIBREF34'}, {'start': 5378, 'end': 5383, 'text': '43 44', 'ref_id': None}, {'start': 5628, 'end': 5633, 'text': '45 46', 'ref_id': None}, {'start': 5699, 'end': 5701, 'text': '47', 'ref_id': None}, {'start': 5974, 'end': 5978, 'text': '[49]', 'ref_id': 'BIBREF48'}, {'start': 5979, 'end': 5983, 'text': '[50]', 'ref_id': 'BIBREF49'}, {'start': 5984, 'end': 5988, 'text': '[51]', 'ref_id': 'BIBREF50'}, {'start': 6334, 'end': 6336, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 6763, 'end': 6765, 'text': '54', 'ref_id': 'BIBREF53'}, {'start': 6869, 'end': 6871, 'text': '55', 'ref_id': 'BIBREF54'}, {'start': 6970, 'end': 6971, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 7145, 'end': 7150, 'text': '39 56', 'ref_id': None}, {'start': 7334, 'end': 7339, 'text': '57 58', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The need for governance A review of the literature identified in this search finds that most authors use \\'governance\\' in explanation of their primary findings, but usually do not focus on governance itself. In this usage, one theme could be called \\'the need for governance\\', which investigates problems and BMJ Global Health explains them with reference to weak or missing governance. At the global level, this literature includes calls for better governance as global and national policy environments become more complex 59 and the globalisation of the food industry overwhelms existing governance structures. 60 Governance problems are central to the maldistribution underlying local or regional food insecurity even though global production is adequate. 61 Quality of governance was identified as an important determinant of progress towards the Millennium Development Goals and successful primary healthcare implementation, 62 and as a fundamental component of high performing states: \\'…the most effective, relevant national policies will emerge from a system of governance that firmly connects the needs of the poor to a politically responsive local government that has the technical and institutional capacity to act\\'. 3 A high-profile Lancet article focusing mainly on the global level identified accountability and participation as leading problems: \\'The international community needs to identify and establish a new global governance structure that can provide greater accountability and participation for civil society and the private sector\\'. 53 The WHO Code of Marketing of Breast Milk Substitutes has provisions for punishing violators, but governance problems have rendered the code largely unenforced and ineffective. [63] [64] [65] Donors have attempted to promote accountability and participation mechanisms, but many interventions do not translate into benefits for those not already enfranchised, such as women, 66 and many efforts have been assailed by activists for advancing private sector influence in public health processes. 58 67 68 The importance of nutrition governance is demonstrated by experiences and analyses in many national and local contexts, as well. Some of the largest are collective action problems. 69 In India, which has among the highest burdens related to suboptimal nutrition, governance problems have been deemed more significant than scientific or technical obstacles, 70 and is needed to translate economic growth into progress against undernutrition. 71 Looking at urban areas of the same country, Bhojani et al characterised the main governance problems as weak regulation of quality in the private sector; poor coordination across care providers in the public and private sectors and between clinics, health centres and hospitals; rampant bribery and the absence of systems to respond to formal grievances or provide accountability to citizens. 72 In a policy analysis of maternal and child health in Pakistan, Siddiqi et al argued that good governance is needed to translate policies into results. 73 In a discussion of food security and fisheries, weaknesses in governance were revealed in overfishing, depletion of stocks, minimal enforcement, low oversight and inadequate coordination of policies and actions between national and global authorities. 74 Understanding governance structures is also extremely important for designing strategies to advance food policy on political agendas. 75 The politics of food policy hinges both on government leadership and activism by civil society organisations. 76 Others used \\'governance\\' as an organising category to identify coordination problems, which arise from nutrition\\'s intersectoral nature, as reported in India and Brazil, to name two examples. 77 78 Coordination problems can arise at the intersection of public and private sectors-the Bangladesh Government attempted to advance governance in its policies, but the exercise\\'s impact was attributed to NGO partners. 79 Some analysts have assessed the effect of governance through comparative and synthetic investigations. In a comparison of fragile states, those with higher quality of governance were more likely to join SUN, while the \\'prevalence of malnutrition, health system functioning and level of citizen empowerment had little or no impact\\' on the decision to join. 80 A synthetic review of 58 controlled evaluations argued that \\'nutrition is now recognised to be a governance issue\\', and that better governance was associated with lower prevalence of child undernutrition. 81 A comparison of water quality in Brazil, Ecuador and Malawi found \\'…that access to safe water could be improved if certain water governance challenges were addressed: coordination and data sharing between minis-tries…; monitoring and enforcement of water quality laws; and sufficient technical capacity to improve administrative and technical management of water services…\\'\" 82 \\'Governance\\' has also been used as a general category for describing specific interventions, many of them successful. Extensive community engagement helped address governance problems in Vietnam. 83 Collaboration and coordination problems were resolved with shared governance structures in Colombia. 84 In both Australia and the UK, the clarity and transparency of governance arrangements was important to facilitating cooperation and coordination in obesity reduction efforts. 85 86 In the Philippines, long-term capacity building in both the public and private sectors has facilitated governance by collecting and analysing data to generate evidence for improving policymaking. 87 Systematic data analysis in Haiti has helped to elucidate many factors that promoted good nutrition governance, including \\'effective evidence-based advocacy, partnerships and design, implementation and scale-up of nutrition-specific and sensitive interventions\\'. 88 Another area of scholarship using governance has focused on citizen attitudes and perceptions to explore why technically sound policies are challenging to adopt and implement. Reasons include popular ambivalence towards experts\\' opinion, 12 or the shaping of debate by food industry marketing or sponsored research. 13 14 Contested views of the role of the state versus the private sector were central to the growing obesity epidemic in Australia, where many people did not want the state to counter fast food advertising. 89 Also, politicians were the least trusted group for information on food, according to a telephone survey by the same researchers (farmers were the most trusted). 90 This contest for influence is very difficult for public health advocates. Denmark introduced a saturated fat tax in 2011, supported with BMJ Global Health public health arguments, but it was opposed by the food industry and related actors. Although the tax began to change the national diet as public health advocates had hoped, the tax had no organised supporters and the food industry successfully lobbied for its abolishment the following year. 91 Calls for improved governance were not always matched by clarity about exactly what is needed, suggesting that governance can be challenging to specify and is not always discussed in meaningful detail. Given the complexity and vagueness of both \\'nutrition\\' and \\'governance\\', this finding is hardly surprising. Others have reached this same conclusion. A systematic review of health system barriers to antiretroviral therapy provision found that many authors cited governance problems, but the collective evidence was weak because individual cases included too little context to convey what this meant in detail. 92 In a systematic review of the impact of health systems and policies on behaviour change to promote child survival in LMICs, Velez et al concluded, \\'The evidence directly addressing how to improve the financing and governance of health systems was weak or not available\\'. 93 Another broad review focused on agriculture research, finding that despite vast influence of governance on the agriculture-nutrition impact, only six studies, just 4% of the sample, actually focused on governance. 94 Addressing nutrition governance directly A far smaller portion of the literature reviewed in this study focused directly on nutrition governance, typically regarding undernutrition. In historical perspective, undernutrition, hunger and food insecurity are all wellknown problems that surely predate the written record, whereas obesity has become a public health concern only very recently. In this light, it may not be surprising that a majority of the papers on nutrition governance concerned undernutrition and concentrated on the governance issues related to that problem. The major institutional actors mentioned in the literature review focus the preponderance of activities on undernutrition, including Unicef, SCN, WFP and WHO, and major initiatives such as SUN and REACH, although both Unicef and WHO have smaller portfolios targeting obesity.', 'cite_spans': [{'start': 522, 'end': 524, 'text': '59', 'ref_id': 'BIBREF57'}, {'start': 611, 'end': 613, 'text': '60', 'ref_id': 'BIBREF58'}, {'start': 757, 'end': 759, 'text': '61', 'ref_id': 'BIBREF59'}, {'start': 928, 'end': 930, 'text': '62', 'ref_id': 'BIBREF60'}, {'start': 1225, 'end': 1226, 'text': '3', 'ref_id': 'BIBREF2'}, {'start': 1554, 'end': 1556, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 1733, 'end': 1737, 'text': '[63]', 'ref_id': 'BIBREF61'}, {'start': 1738, 'end': 1742, 'text': '[64]', 'ref_id': 'BIBREF62'}, {'start': 1743, 'end': 1747, 'text': '[65]', 'ref_id': 'BIBREF63'}, {'start': 1931, 'end': 1933, 'text': '66', 'ref_id': 'BIBREF64'}, {'start': 2050, 'end': 2052, 'text': '58', 'ref_id': 'BIBREF56'}, {'start': 2053, 'end': 2058, 'text': '67 68', 'ref_id': None}, {'start': 2240, 'end': 2242, 'text': '69', 'ref_id': 'BIBREF67'}, {'start': 2416, 'end': 2418, 'text': '70', 'ref_id': 'BIBREF68'}, {'start': 2500, 'end': 2502, 'text': '71', 'ref_id': 'BIBREF69'}, {'start': 2896, 'end': 2898, 'text': '72', 'ref_id': 'BIBREF70'}, {'start': 3050, 'end': 3052, 'text': '73', 'ref_id': 'BIBREF71'}, {'start': 3305, 'end': 3307, 'text': '74', 'ref_id': 'BIBREF72'}, {'start': 3442, 'end': 3444, 'text': '75', 'ref_id': 'BIBREF73'}, {'start': 3555, 'end': 3557, 'text': '76', 'ref_id': 'BIBREF74'}, {'start': 3750, 'end': 3755, 'text': '77 78', 'ref_id': None}, {'start': 3971, 'end': 3973, 'text': '79', 'ref_id': 'BIBREF77'}, {'start': 4330, 'end': 4332, 'text': '80', 'ref_id': 'BIBREF78'}, {'start': 4538, 'end': 4540, 'text': '81', 'ref_id': 'BIBREF79'}, {'start': 4916, 'end': 4918, 'text': '82', 'ref_id': 'BIBREF80'}, {'start': 5115, 'end': 5117, 'text': '83', 'ref_id': 'BIBREF81'}, {'start': 5219, 'end': 5221, 'text': '84', 'ref_id': 'BIBREF82'}, {'start': 5397, 'end': 5402, 'text': '85 86', 'ref_id': None}, {'start': 5599, 'end': 5601, 'text': '87', 'ref_id': 'BIBREF85'}, {'start': 5865, 'end': 5867, 'text': '88', 'ref_id': 'BIBREF86'}, {'start': 6106, 'end': 6108, 'text': '12', 'ref_id': 'BIBREF11'}, {'start': 6184, 'end': 6189, 'text': '13 14', 'ref_id': None}, {'start': 6391, 'end': 6393, 'text': '89', 'ref_id': 'BIBREF88'}, {'start': 6555, 'end': 6557, 'text': '90', 'ref_id': 'BIBREF89'}, {'start': 7006, 'end': 7008, 'text': '91', 'ref_id': 'BIBREF90'}, {'start': 7621, 'end': 7623, 'text': '92', 'ref_id': 'BIBREF91'}, {'start': 7895, 'end': 7897, 'text': '93', 'ref_id': 'BIBREF92'}, {'start': 8112, 'end': 8114, 'text': '94', 'ref_id': 'BIBREF93'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Some authors defined nutrition governance using broad definitions. As illustrated by Solon's articulation, 'governance' may be simply stated: 'Governance is the process of decision-making and implementation'. 87 Pinstrup-Andersen and Watson take a similarly broad approach in writing that 'governance deals with how… conflicting interests are resolved', and may be defined as '…the exercise of authority or management of resources through institutions, policies, traditions, cultures and societal norms'. 95 In these and similar cases, the inclusiveness makes it difficult to understand what would be excluded from 'governance', and it is hard to imagine what specific interventions would follow naturally from the definitions.\", 'cite_spans': [{'start': 209, 'end': 211, 'text': '87', 'ref_id': 'BIBREF85'}, {'start': 505, 'end': 507, 'text': '95', 'ref_id': 'BIBREF94'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Other authors invoked governance to discuss or analyse a limited subset of concepts. For instance, the highly influential Lancet paper by Morris et al focused on governance barriers to international action against undernutrition that could be categorised as coordination, accountability and distributional. 53 These categories are intuitive because they are at the root of food insecurity, and have long been important in undernutrition scholarship and programming. Coordination problems are common because undernutrition often relates to complicated circumstances in which many actors operate without clear lines of authority, responsibility or accountability. Conflict, natural disaster and multiple failures of markets and/or states are all common settings for undernutrition. The UN System Standing Committee on Nutrition (SCN) was founded in 1977 (as SubCommittee on Nutrition) with the express purpose of coordinating UN actions against nutrition problems. 96 A major stated reason for launching SUN in 2010 was to harmonise views, policies and actions across a broader set of stakeholders including countries and donors. 97 98 The proliferation of global health actors has exacerbated this problem further. 99 Accountability problems are commonly referenced because many analysts view governments as guarantors of food security, and insecurity thus represents a government failure, which might be rectified or reduced if governments were more accountable to their citizens. The intersectoral nature of food security also means that many parts of a government may be responsible, but hard to hold accountable. 70 100 Increasing the participation and voice of at-risk groups is a common recommendation. 81 One important pathway is that greater participation and better governance are associated with improved access to safe water, although there are likely many more, as well. 100 101 Adequacy of global food production and its persistent scarcity in particular settings points to distribution, or allocation issues. 100 The same dynamic plays out within countries, where poor distribution systems leave some areas vulnerable even as food is sufficient when measured at the national level. 102 Distributional issues are not strictly limited to food-the distribution of rights and entitlements are also core governance issues with large implications for nutrition. 73 103 104 Among the most prominent nutrition governance frameworks identified in this review was developed at the Institute for Development Studies by Mejía Acosta and Fanzo, and Haddad et al. 105 106 The framework highlights cooperation and coordination-both prominent themes in undernutrition as explained above-and also adds sustainable funding and monitoring and advocacy. The explicit inclusion of funding recognises the central requirement of adequate resources, which the authors characterise as the 'cement' that holds cooperation and coordination together. 105 The monitoring and advocacy category acknowledges the need for governments to collect relevant information and produce analyses to BMJ Global Health understand where there are problems, design and implement solutions and track progress. Advocacy represents the critical role of civil society in detecting problems, raising awareness and facilitating solutions, whether by direct delivery or influencing the government.\", 'cite_spans': [{'start': 307, 'end': 309, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 1128, 'end': 1130, 'text': '97', 'ref_id': 'BIBREF96'}, {'start': 1131, 'end': 1133, 'text': '98', 'ref_id': 'BIBREF97'}, {'start': 1214, 'end': 1216, 'text': '99', 'ref_id': 'BIBREF98'}, {'start': 1616, 'end': 1618, 'text': '70', 'ref_id': 'BIBREF68'}, {'start': 1619, 'end': 1622, 'text': '100', 'ref_id': 'BIBREF99'}, {'start': 1708, 'end': 1710, 'text': '81', 'ref_id': 'BIBREF79'}, {'start': 1882, 'end': 1889, 'text': '100 101', 'ref_id': None}, {'start': 2022, 'end': 2025, 'text': '100', 'ref_id': 'BIBREF99'}, {'start': 2195, 'end': 2198, 'text': '102', 'ref_id': 'BIBREF101'}, {'start': 2369, 'end': 2371, 'text': '73', 'ref_id': 'BIBREF71'}, {'start': 2372, 'end': 2379, 'text': '103 104', 'ref_id': None}, {'start': 2563, 'end': 2570, 'text': '105 106', 'ref_id': None}, {'start': 2936, 'end': 2939, 'text': '105', 'ref_id': 'BIBREF104'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Very different views on governance came from studies focusing on obesity, where primary themes include the globalisation of food, the products and marketing of multinational corporations (MNCs) and individual lifestyle choices. 40-42 63 107 Globalisation has changed the landscape of food and nutrition by concentrating power in large firms, changing consumer taste through marketing, and limiting the effectiveness of traditional governance mechanisms. Representation, participation, voice, accountability and regulation all are rooted in national structures and are easy to circumvent for MNCs. Where accountability is discussed, it emphasises corporate accountability 108 and tends to focus on global level regulatory issues concerning trade and health. 42 Addressing the Australian context, Sacks et al developed a matrix of sectors and governance levels for thinking about some of these issues, which they used to identify policy options. 109 The sectors ranged from primary production and food processing to distributions, marketing, retail and catering/food service. Governance levels include local, state, national and international. Although the authors do not use the term, this can be considered a nutrition governance framework. Sacks et al identify policy issues and the level of government where they may be addressed. For example, in food processing, safety standards are usually a state government responsibility and product composition standards are usually decided at the national level.', 'cite_spans': [{'start': 228, 'end': 240, 'text': '40-42 63 107', 'ref_id': None}, {'start': 671, 'end': 674, 'text': '108', 'ref_id': 'BIBREF107'}, {'start': 757, 'end': 759, 'text': '42', 'ref_id': 'BIBREF41'}, {'start': 944, 'end': 947, 'text': '109', 'ref_id': 'BIBREF108'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Analysing nutrition governance frameworks These nutrition governance frameworks include elements that are well supported by intuition and research, and draw attention to some critical areas of nutrition governance in both undernutrition and obesity. Their many strengths are evident in the above review: individually, they identify some of the most pressing issues in nutrition governance, and collectively, they provide a place to begin understanding the very difficult landscape of one of humanity's greatest problems.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"However, a synthetic view of scholarship on nutrition governance finds an incomplete picture. There is no shared language or methods common to all the frameworks, and none articulate the philosophical principles on which they are based. Furthermore, they emphasise global-level, technical perspectives, and tend not to consider political issues or variation in state capacity, which can run from strong to absent, as in humanitarian settings. This is limiting, and sometimes becomes problematic. A main limitation is that the frameworks explain only the part of nutrition governance on which they are focused, but do not illuminate the larger landscape. Additionally, the lack of a philosophical basis means that they have difficulty explaining their priorities or defending their boundaries, should the need arise. For instance, the frameworks by Morris et al and Mejía Acosta and Fanzo do not include participation or transparency among their central elements. This choice may reflect that the dominant historical problem in undernutrition is inadequate food, and in this perspective the most basic citizen view can be presumed-the demand for more food. It may also reflect a strong focus on the multilateral architecture of aid, which tends to neglect crucial factors such as domestic political commitment. A full-text search of the Sacks et al framework article does not find a single mention of either 'cooperation' or 'coordination'. It is unlikely that any analyst of governance-including the authors of these fine papers-would say that participation is unimportant, or that transparency is seldom needed, or that coordination is trivial.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Observing the different elements in nutrition governance frameworks raises a dilemma that can be resolved by weighing breadth and depth in either of two directions. In the more inclusive direction, additional elements are added to the framework to increase its explanatory coverage, as with some of the other frameworks covered earlier. In the direction of specificity, the framework must be qualified to particular settings in which the included elements did matter or might matter most. Neither direction is completely satisfying because they trade off universality and specificity without establishing the relationship between the two.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"An obvious division in uses of nutrition governance lies between those concerned with undernutrition and those focused on obesity. The papers reviewed here focused on one or the other, but not both. This division appears to be highly influential on the governance problems that were reported. The authors focusing on undernutrition typically highlighted administrative issues, such as coordination for service delivery, distributional problems and responsiveness or accountability to citizen demand. The authors focusing on obesity typically emphasised political or political economic issues, including the globalisation of the food industry, multinational corporate accountability problems, coordination for regulatory and policy making purposes and the political economy of production and consumption, which includes the contest for public opinion and allows for conflict over food choices. This division suggests that either analysts employ different definitions of governance or refer to 'governance' with reference to specific manifestations rather than underlying principles.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The absence of discussion on these underlying principles creates additional problems, as well. First, these definitions do not prioritise the importance of their elements, meaning it is difficult to know if anything is more important than anything else. Second, the lack of prioritisation disguises the interaction or possible causality between the elements. Third, it is hard to determine what would not qualify as a governance problem, which disguises the difference between issues best approached from this perspective and those that could be addressed BMJ Global Health more easily with another lens. These limitations pose challenges for conceptualising nutrition governance more broadly or attempting to implement solutions.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Although it is not the focus of this paper, I speculate that historical differences between the communities studying undernutrition and obesity account for some of the differences in perspective. The authors writing on undernutrition were more likely to have technical backgrounds in medicine, nutrition sciences, agriculture and related areas. Those focusing on obesity were more likely to have experience with law and the social sciences, and many had previous experience with tobacco control or other areas of globalised trade and health, and tended to draw on scholarship by leading authors in those areas. 15 30 31 110 111 There was little or no overlap in these groups.', 'cite_spans': [{'start': 611, 'end': 613, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 614, 'end': 627, 'text': '30 31 110 111', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'A unified framework for nutrition governance As the basis for equitably realising the right to food and upholding the right to health, nutrition governance is grounded in universal principles. But as I have discussed above, current articulations of nutrition governance are divided by problem type-undernutrition or obesityand grounded in specific contexts where those problems are found. At one time, undernutrition was the only nutrition problem, and when obesity first emerged as a public health problem it was confined to relatively distinct geographies. This is no longer the case. The nutrition transition 112 and the double burden of undernutrition and obesity mean that single countries are required to deal with both problems. Accordingly, it is for both philosophical and practical considerations that a unified framework for nutrition governance is desirable.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"The starting point for a unified nutrition governance framework is a definition of governance itself. A simple and classic definition of politics was offered by Lasswell in the 1930s as who gets what, when and how, which refers to the underlying definition of politics as a distributive process. 113 I argue that governance can be considered as the structures through which such distributive decisions are made and enforced. This conceptualisation emphasises the structural or formalised elements of the process, which is reflected in common usage of 'governance' in connection with a normative judgement, as in good or strong governance, or bad or weak governance. The conception of something that can be judged this way means there is a standard for doing so, which in this case I define as any of the three dimensions of governance I will propose.\", 'cite_spans': [{'start': 296, 'end': 299, 'text': '113', 'ref_id': 'BIBREF112'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The basis for my conceptualisation of governance is the social contract that underlies modern nations, as first articulated by Rousseau 114 and Locke 115 in the Enlightenment. This idea holds that citizens cede some powers to the state in exchange for the protection of their remaining rights, and is based on the principle that citizens are the ultimate source of power and the ultimate conveyors of legitimacy. 114 115 I apply the concept of citizens as the source of power and authority to governance and propose that it can be distilled around the primary principles of accountability, participation and responsiveness. Accountability recognises citizens as the source of state power. Participation comes from the recognition that state legitimacy is conditioned on the consent of those governed. Responsiveness refers to the timeliness of the link between what people want, as expressed by participation, and the accountability that may be exercised when needed services are not forthcoming. With particular reference to nutrition, timeliness can be of vital importance, and thus responsiveness is elevated to primary status along with accountability and participation, even though it could be argued that these latter two principles should already reflect responsiveness. Evaluating governance means that each principle should be measured with reference to the authority and legitimacy granted by citizens and their judgements of performance. Stated concisely:', 'cite_spans': [{'start': 127, 'end': 139, 'text': 'Rousseau 114', 'ref_id': None}, {'start': 150, 'end': 153, 'text': '115', 'ref_id': 'BIBREF114'}, {'start': 413, 'end': 420, 'text': '114 115', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Nutrition governance is the ability of institutions and other structures to uphold the principles of participation, responsiveness, and accountability in the realization of the right to food and the achievement of optimal nutrition for all citizens.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'These three primary principles are central to human rights law, appearing prominently in the International Covenant on Economic, Social and Cultural Rights, 116 and beneath them lie many others. As reviewed by Lee et al., for the WHO Commission on Social Determinants of Health, broad conceptions of governance include the three mentioned above and also transparency, a consensus orientation, the rule of law, effectiveness and efficiency and equity and inclusiveness. 15 No doubt there are many more, to be sure. However, I argue that these others are secondary. For instance, I would argue that accountability, participation and responsiveness all require transparency, which for that reason is not a leading independent category. Similarly, I argue that the leading three also depend on equity and the rule of law. A consensus orientation, effectiveness and efficiency and equity and inclusiveness are all factors that citizens would reflect in their participation and their preferences for accountability.', 'cite_spans': [{'start': 157, 'end': 160, 'text': '116', 'ref_id': 'BIBREF115'}, {'start': 469, 'end': 471, 'text': '15', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'With this definition established, it can be used to clarify governance challenges and how they relate to each other. In my view, existing scholarship can be categorised in four areas, as shown below in table 2 as a map of sample nutrition governance problems in undernutrition and obesity at the national and global levels. This exercise reveals how existing frameworks tend to focus on only one square, for example, undernutrition at the global level, as by Morris et al. 53 table 3 further develops this idea by applying the three main pillars of accountability, participation and responsiveness to undernutrition and obesity. Note that this is a characterisation of existing scholarship, and is not inclusive of many important issues that are covered lightly or not at all. Inadequate attention BMJ Global Health has been paid to the interaction of global, national and local levels, or to the differences in capacity and context in strong states, weak stakes, humanitarian disasters or elsewhere, for instance.', 'cite_spans': [{'start': 473, 'end': 475, 'text': '53', 'ref_id': 'BIBREF52'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Employing the three categories of accountability, participation and responsiveness facilitates a comparison of undernutrition and obesity problems from a governance perspective. This exercise highlights undernutrition as a problem of dysfunctional structures-mainly people do not get what they want and cannot enforce accountability, although there can be information and education aspects, as well. Aligning services with wants thus addresses the problem, meaning that people who need food then get food. Obesity problems are different-people get too much of what they want, or want unhealthful things (these are also causes of undernutrition-overweight). Because of this, obesity can-and does-occur where governance structures function well. In such cases, a principal challenge lies in the contest for perception and opinion on food and related policies. The formal structural governance problems are subtle because they concern broad political economy issues that are hard to analyse and remain unknown to many people. These include tax policy, agricultural policies, inadequate government authority and regulatory capture and ineffectiveness. Although the beneficiaries of the food industry are engaged, those harmed are not necessarily inclined to think of themselves as harmed or to identify any particular agent as the cause of their problems.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Governance has emerged as an important focus in development programming over the last three decades, and nutrition governance in particular has great potential to improve health. But this analysis finds that although the concept of 'nutrition governance' has become increasingly prominent in scholarship on poor nutritional outcomes, it remains weakly specified and is invoked by different authors to mean different things. An important division of approaches and general meanings exists between those who have focused on undernutrition and those who have concentrated on obesity. Those in the former group have stressed coordination problems and structural issues related to the general functioning of government and the low accountability of international actors. Those in the later group have emphasised international trade policies, regulatory issues and corporate behaviour.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': 'By developing a definition of governance based on the social contract and applying it to nutrition, this paper presents a framework for considering all nutrition problems at the same time. Using the framework to assess undernutrition and obesity finds that its principles apply well in either case, but they indicate different weaknesses. In general, undernutrition problems relate to structural flaws, such as poor or absent accountability, weak or missing participation or inadequate responsiveness. Under the assumption that people do not want to be undernourished, then the problem can be crudely characterised as unmet demand-citizens are not getting a service entitlement they need and want. Some of these issues may also underlie obesity problems, but those scenarios are additionally characterised by more insidious dynamics. Accountability and participation can be strong, but may be corrupted by marketing and other influences on citizen perception. The demands expressed by citizens may be accurately-and harmfully-expressed in unhealthy foods, habits and environments. This shifts the intervention area from governance structures per se to the inputs-the things that citizens want-and can be characterised as a contest for perceptions about good choices in food, food policy and related issues of regulation, tax and trade.', 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': \"The vast prevalence of obesity and undernutrition shows that governments, international agencies and other actors have failed to uphold the right to food and optimal nutrition for most of the world's citizens. This is among the leading embarrassments to all humanity, and is of such widespread consequence that delay in remedial action cannot be justified. The clarification of the three basic governance principles of accountability, participation and responsiveness provides categories for assessing government performance and aid programmes alike. Advancing the state-citizen contract is central to all areas of development, and hence the imperative to assess how aid affects governance applies to every donor-supported project. Projects that bypass or weaken the social contract have been common in the past, but should never be accepted. These ideas may be particularly useful to civil society groups and academic organisations that monitor development assistance efforts and seek to compel governments to uphold the right to food. \", 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': 'For global level institutions, the implications of this analysis lie in two areas. For undernutrition problems, interventions to strengthen the connection between states and their citizens and mechanisms to allow states to hold international actors accountable would help address many major weaknesses. In turn, this would help states and international actors better promote participation and become more responsive. This task is urgent. Undernutrition tends to affect the most vulnerable and is prioritised in the Sustainable Development Goals for that reason. With particular reference to obesity, many of the governance problems identified by this paper have international dimensions that constrain national policy solutions. Globalisation is increasing the importance of this dynamic and points to an urgent need for supranational regulation of the food industry and concerted efforts to contest the perceptions it advances through marketing. No country has yet succeeded in turning the still-rising tide of obesity, regardless of the strength of its governance or the size of its income, further indicating the need for coordinated global action.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Acknowledgements I gratefully acknowledge helpful comments from Prerna Banati, Yarlini Balarajan, Carmen Jacqueline Ho, and the anonymous reviewers. All errors remain my own.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Contributors I am the sole author of this work and am responsible for its content.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Funding UNICEF Office of Research-Innocenti.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Competing interests None declared.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Patient consent Not required.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Provenance and peer review Not commissioned; externally peer reviewed. open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is Table 3 Comparison of governance areas for undernutrition and obesity at global and national levels', 'cite_spans': [], 'ref_spans': [{'start': 391, 'end': 398, 'text': 'Table 3', 'ref_id': None}], 'section': 'Twitter @jessebump'}, {'text': 'Accountability Global: multilaterals, bilaterals, NGOs and others that have a legal or adopted nutrition mandate are not punished or rewarded for their individual or collective performance. Persistent coordination problems result. Also, accountability for food production or crop diversion hard to establish.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'Global: accountability is very weak for transnational corporate activities and foreign government policies related to food, such as in subsidy, tax and trade. Largely, accountability mechanisms are absent.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'National: engagement of many sectors creates coordination problems and clouds accountabilities. Government tends to be least accountable to the marginalised people most vulnerable to undernutrition, indicating the need for improved state performance overall.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': \"National: accountabilities for unhealthy foods and deceptive marketing are difficult to establish precisely, and citizens' demand for accountability is often influenced in favour of private interests and against health professionals.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'Global: in theory, national representation in the UN system assures the channel of participation by citizens, but this is highly problematic in many cases, including weak or failed states, or for marginalised or excluded groups, such as migrants, refugees or the vulnerable. Areas of low participation are at greatest risk of undernutrition.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'Global: national representation in global affairs is predominantly in non-health areas and is often linked to corporate interests. This calls for supranational regulatory mechanisms to allow more participation, or the channels for other states and citizens to influence national government positions.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'National: participation by citizens is weak in many cases. People who need nutrition interventions may not be aware, and even if they are, cannot always express their demand effectively. Typically, this need is not visible or meaningful to the state, not reflected in programmes of services, and weak participation means it does not connect to democratic or judicial accountability mechanisms.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'National: participation is often strong-because citizens exercise electoral and economic power in support of corporate interests, and food products and consumption patterns that are unhealthful. The participation problem is not the ability to influence, but the contest for perception about foods, food companies and regulation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'Global: multilaterals, bilaterals, NGOs and others operating in nutrition do not respond to the demands and needs of those they ostensibly serve. This is underpinned by low participation and missing or absent accountability mechanisms.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'Global: extremely limited accountability mechanisms mean that there is no easily identified authority to respond specifically to obesity-related issues.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'National: those most likely to suffer undernutrition are typically not able to organise or participate, making it difficult for even well-intentioned states to identify and respond.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'National: government responses may be more immediate to well-organised corporate demands; responsiveness to citizens often concentrated around infrequent elections. Citizens may favour unhealthy policies, as well.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http:// creativecommons. org/ licenses/ by-nc/ 4. 0/.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'UN Special Rapporteur on the right to food', 'authors': [{'first': 'De', 'middle': [], 'last': 'Schutter', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Report on agroecology and the right to food', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'General Comment No. 12: The right to adequate food', 'authors': [{'first': '', 'middle': [], 'last': 'Un Cescr', 'suffix': ''}], 'year': 1999, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Population, development and food security: an unresolved challenge for the twenty-first century', 'authors': [{'first': 'M', 'middle': [], 'last': 'Villarreal', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Stloukal', 'suffix': ''}], 'year': 2005, 'venue': 'Genus', 'volume': '61', 'issn': '', 'pages': '215--261', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The right to food: Holding global actors accountable under international law', 'authors': [{'first': 'S', 'middle': [], 'last': 'Narula', 'suffix': ''}], 'year': 2005, 'venue': \"Colum J Transnat'l L\", 'volume': '44', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': \"Assessing countries' commitment to accelerate nutrition action demonstrated in PRSPs, UNDAFs and through nutrition governance. SCN news / United Nations\", 'authors': [{'first': 'K', 'middle': [], 'last': 'Engesveen', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Nishida', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Prudhon', 'suffix': ''}], 'year': 2009, 'venue': 'Administrative Committee on Coordination, Subcommittee on Nutrition', 'volume': '37', 'issn': '', 'pages': '10--16', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study', 'authors': [{'first': 'M', 'middle': [], 'last': 'Ng', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fleming', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Robinson', 'suffix': ''}], 'year': 2013, 'venue': 'The Lancet', 'volume': '384', 'issn': '', 'pages': '766--81', 'other_ids': {'DOI': ['10.1016/S0140-6736(14)60460-8']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases', 'authors': [{'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}], 'year': 2006, 'venue': 'Global Health', 'volume': '2', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-2-4']}}, 'BIBREF7': {'ref_id': 'b7', 'title': \"Strong nutrition governance is a key to addressing nutrition transition in low and middle-income countries: review of countries' nutrition policies\", 'authors': [{'first': 'B', 'middle': ['F'], 'last': 'Sunguya', 'suffix': ''}, {'first': 'Kic', 'middle': [], 'last': 'Ong', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Dhakal', 'suffix': ''}], 'year': 2014, 'venue': 'Nutr J', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1475-2891-13-65']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Displacement in urban areas: new challenges, new partnerships', 'authors': [{'first': 'J', 'middle': [], 'last': 'Crisp', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Morris', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Refstie', 'suffix': ''}], 'year': 2012, 'venue': 'Disasters', 'volume': '36', 'issn': '', 'pages': '23--42', 'other_ids': {'DOI': ['10.1111/j.1467-7717.2012.01284.x']}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Off the map: the health and social implications of being a non-notified slum in India', 'authors': [{'first': 'R', 'middle': [], 'last': 'Subbaraman', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'O&apos;brien', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Shitole', 'suffix': ''}], 'year': 2012, 'venue': 'Environ Urban', 'volume': '24', 'issn': '', 'pages': '643--63', 'other_ids': {'DOI': ['10.1177/0956247812456356']}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Invisibility and the Welfare State in the Developing World. Hasmath R, ed. Inclusive Growth, Development and Welfare Policy: A Critical Assessment', 'authors': [{'first': 'W', 'middle': ['J'], 'last': 'Poverty', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '211--239', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Public opinion and the politics of obesity in America', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Oliver', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2005, 'venue': 'J Health Polit Policy Law', 'volume': '30', 'issn': '', 'pages': '923--54', 'other_ids': {'DOI': ['10.1215/03616878-30-5-923']}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'The Perils of Ignoring History: Big Tobacco Played Dirty and Millions Died. How Similar Is Big Food?', 'authors': [{'first': 'K', 'middle': ['D'], 'last': 'Brownell', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Warner', 'suffix': ''}], 'year': 2009, 'venue': 'Milbank Quarterly', 'volume': '87', 'issn': '', 'pages': '259--94', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Coca-Cola Funds Scientists Who Shift Blame for Obesity Away From Bad Diets', 'authors': [{'first': 'A', 'middle': [], 'last': 'O&apos;connor', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Globalization, Global Governance and the Social Determinants of Health: A review of the linkages and agenda for action. Ottowa: Globalization and Health Knowledge Network', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koivusalo', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Ollila', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Food security and nutrition interventions in response to the AIDS epidemic: assessing global action and evidence', 'authors': [{'first': 'N', 'middle': ['L'], 'last': 'Aberman', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Rawat', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Drimie', 'suffix': ''}], 'year': 2014, 'venue': 'AIDS Behav', 'volume': '18', 'issn': '5', 'pages': '554--65', 'other_ids': {'DOI': ['10.1007/s10461-014-0822-z']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Nutritional contribution of street foods to the diet of people in developing countries: a systematic review', 'authors': [{'first': 'N', 'middle': ['P'], 'last': 'Steyn', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Mchiza', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Hill', 'suffix': ''}], 'year': 2014, 'venue': 'Public Health Nutr', 'volume': '17', 'issn': '', 'pages': '1363--74', 'other_ids': {'DOI': ['10.1017/S1368980013001158']}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Health and welfare effects of integrating AIDS treatment with food assistance in resource constrained settings: A systematic review of theory and evidence', 'authors': [{'first': 'N', 'middle': [], 'last': 'Tirivayi', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Groot', 'suffix': ''}], 'year': 2011, 'venue': 'Soc Sci Med', 'volume': '73', 'issn': '', 'pages': '685--92', 'other_ids': {'DOI': ['10.1016/j.socscimed.2011.06.056']}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Clinic-Based Food Assistance is Associated with Increased Medication Adherence among HIV-Infected Adults on Long-Term Antiretroviral Therapy in Zambia', 'authors': [{'first': 'N', 'middle': [], 'last': 'Tirivayi', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Koethe', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Groot', 'suffix': ''}], 'year': 2012, 'venue': 'J AIDS Clin Res', 'volume': '03', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.4172/2155-6113.1000171']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'The right to food in the post-Cold War era', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Marchione', 'suffix': ''}], 'year': 1996, 'venue': 'Food Policy', 'volume': '21', 'issn': '', 'pages': '83--102', 'other_ids': {'DOI': ['10.1016/0306-9192(95)00070-4']}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Bilateral health aid: lessons from Europe', 'authors': [{'first': 'P', 'middle': ['S'], 'last': 'Hill', 'suffix': ''}], 'year': 2000, 'venue': 'Aust N Z J Public Health', 'volume': '24', 'issn': '', 'pages': '432--438', 'other_ids': {'DOI': ['10.1111/j.1467-842X.2000.tb01607.x']}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Development and governance: an uneasy relationship', 'authors': [{'first': 'W', 'middle': [], 'last': 'Hout', 'suffix': ''}], 'year': 2009, 'venue': 'Governance and the Depoliticisation of Development. London: Routledge', 'volume': '', 'issn': '', 'pages': '29--43', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Public-Private Partnerships for Combating Micronutrient Malnutrition', 'authors': [{'first': 'M', 'middle': [], 'last': 'Chopra', 'suffix': ''}], 'year': 2001, 'venue': 'Food Nutr Bull', 'volume': '22', 'issn': '', 'pages': '431--436', 'other_ids': {'DOI': ['10.1177/156482650102200416']}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Governing Health Systems', 'authors': [{'first': 'M', 'middle': [], 'last': 'Reich', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Takemi', 'suffix': ''}], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Governance for global and national health: a role for framework conventions?', 'authors': [{'first': 'T', 'middle': ['G'], 'last': 'Evans', 'suffix': ''}], 'year': 2013, 'venue': 'Health Hum Rights', 'volume': '15', 'issn': '', 'pages': '5--7', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Interactions with the recipient community in targeted food and nutrition programs', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Marchione', 'suffix': ''}], 'year': 2005, 'venue': 'J Nutr', 'volume': '135', 'issn': '', 'pages': '886--895', 'other_ids': {'DOI': ['10.1093/jn/135.4.886']}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Proceedings of the fourth international congress on tropical medicine and malaria', 'authors': [{'first': 'O', 'middle': [], 'last': 'Address', 'suffix': ''}], 'year': 1948, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Spaces for change?: the politics of citizen participation in new democratic arenas: Zed Books', 'authors': [{'first': 'A', 'middle': [], 'last': 'Cornwall', 'suffix': ''}, {'first': 'V', 'middle': ['S'], 'last': 'Coelho', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Grand challenges in global health governance', 'authors': [{'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}, {'first': 'E', 'middle': ['A'], 'last': 'Mok', 'suffix': ''}], 'year': 2009, 'venue': 'Br Med Bull', 'volume': '90', 'issn': '', 'pages': '7--18', 'other_ids': {'DOI': ['10.1093/bmb/ldp014']}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'The Pit and the Pendulum: Can globalization take health governance forward?', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2004, 'venue': 'Development', 'volume': '47', 'issn': '', 'pages': '11--17', 'other_ids': {'DOI': ['10.1057/palgrave.development.1100025']}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Bridging the divide: global governance of trade and health', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Sridhar', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Patel', 'suffix': ''}], 'year': 2009, 'venue': 'Lancet', 'volume': '373', 'issn': '', 'pages': '416--438', 'other_ids': {'DOI': ['10.1016/S0140-6736(08)61776-6']}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'The new International Health Regulations: an historic development for international law and public health', 'authors': [{'first': 'D', 'middle': ['P'], 'last': 'Fidler', 'suffix': ''}, {'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}], 'year': 2006, 'venue': 'J Law Med Ethics', 'volume': '34', 'issn': '', 'pages': '85--94', 'other_ids': {'DOI': ['10.1111/j.1748-720X.2006.00011.x']}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'The race for Ebola drugs: pharmaceuticals, security and global health governance', 'authors': [{'first': 'A', 'middle': [], 'last': 'Roemer-Mahler', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Elbe', 'suffix': ''}], 'year': 2016, 'venue': 'Third World Q', 'volume': '37', 'issn': '', 'pages': '487--506', 'other_ids': {'DOI': ['10.1080/01436597.2015.1111136']}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Ebola: a crisis in global health leadership', 'authors': [{'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Friedman', 'suffix': ''}], 'year': 2014, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Non-communicable diseases and global health governance: enhancing global processes to improve health development', 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Magnusson', 'suffix': ''}], 'year': 2007, 'venue': 'Global Health', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-3-2']}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Governance matters VIII: aggregate and individual governance indicators', 'authors': [{'first': 'D', 'middle': [], 'last': 'Kaufmann', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kraay', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Mastruzzi', 'suffix': ''}], 'year': 1996, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': \"Portfolio Review Summary: Summary Review of DFID's Governance Portfolio\", 'authors': [{'first': '', 'middle': [], 'last': 'Dfid', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Governance', 'suffix': ''}], 'year': 2004, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'The world health report 2007: A safer future: global public health security in the 21st century', 'authors': [], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Joint Evaluation of the REACH Initiative (Renewed Effort Against Child Hunger and Undernutrition', 'authors': [], 'year': 2011, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Diet, health and globalization: five key questions', 'authors': [{'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}], 'year': 1999, 'venue': 'Proc Nutr Soc', 'volume': '58', 'issn': '', 'pages': '335--378', 'other_ids': {'DOI': ['10.1017/S0029665199000452']}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'A global response to a global problem: the epidemic of overnutrition', 'authors': [{'first': 'M', 'middle': [], 'last': 'Chopra', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Galbraith', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Darnton-Hill', 'suffix': ''}], 'year': 2002, 'venue': 'Bull World Health Organ', 'volume': '80', 'issn': '', 'pages': '952--960', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Trade liberalization and the diet transition: a public health response', 'authors': [{'first': 'G', 'middle': [], 'last': 'Rayner', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}], 'year': 2006, 'venue': 'Health Promot Int', 'volume': '21', 'issn': 'suppl_1', 'pages': '67--74', 'other_ids': {'DOI': ['10.1093/heapro/dal053']}}, 'BIBREF42': {'ref_id': 'b42', 'title': \"Rethinking global health challenges: towards a 'global compact' for reducing the burden of chronic disease\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Magnusson', 'suffix': ''}], 'year': 2009, 'venue': 'Public Health', 'volume': '123', 'issn': '', 'pages': '265--74', 'other_ids': {'DOI': ['10.1016/j.puhe.2008.12.023']}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The role of business in addressing the long-term implications of the current food crisis', 'authors': [{'first': 'D', 'middle': [], 'last': 'Yach', 'suffix': ''}], 'year': 2008, 'venue': 'Global Health', 'volume': '4', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-4-12']}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Anatomy of a crisis: the causes and consequences of surging food prices', 'authors': [{'first': 'D', 'middle': [], 'last': 'Headey', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Fan', 'suffix': ''}], 'year': 2008, 'venue': 'Agricultural Economics', 'volume': '39', 'issn': '', 'pages': '375--91', 'other_ids': {'DOI': ['10.1111/j.1574-0862.2008.00345.x']}}, 'BIBREF45': {'ref_id': 'b45', 'title': 'Rethinking the global food crisis: The role of trade shocks', 'authors': [{'first': 'D', 'middle': [], 'last': 'Headey', 'suffix': ''}], 'year': 2011, 'venue': 'Food Policy', 'volume': '36', 'issn': '', 'pages': '136--182', 'other_ids': {'DOI': ['10.1016/j.foodpol.2010.10.003']}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Understanding and responding to the links between conflict and hunger', 'authors': [{'first': 'E', 'middle': [], 'last': 'Messer', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Cohen', 'suffix': ''}], 'year': 2011, 'venue': 'Dev Pract', 'volume': '21', 'issn': '', 'pages': '481--488', 'other_ids': {'DOI': ['10.1080/09614524.2011.562281']}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Price Volatility in Food and Agricultural Markets: Policy Responses', 'authors': [{'first': 'I', 'middle': [], 'last': 'Fao', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Unctad', 'suffix': ''}], 'year': 2011, 'venue': 'Food and Agricultural Organization', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'The 2008 food price crisis: rethinking food security policies: UN', 'authors': [{'first': 'A', 'middle': [], 'last': 'Mittal', 'suffix': ''}], 'year': 2009, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'High food prices: the what, who, and how of proposed policy actions', 'authors': [{'first': 'Von', 'middle': [], 'last': 'Braun', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Ahmed', 'middle': ['A'], 'last': 'Asenso-Okyere', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Closing the gap in a generation: Health equity through action on the social determinants of health', 'authors': [], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Maternal and Child Undernutrition Study Group. Effective international action against undernutrition: why has it proven so difficult and what can be done to accelerate progress?', 'authors': [{'first': 'S', 'middle': ['S'], 'last': 'Morris', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Cogill', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Uauy', 'suffix': ''}], 'year': 2008, 'venue': 'Lancet', 'volume': '371', 'issn': '', 'pages': '608--629', 'other_ids': {'DOI': ['10.1016/S0140-6736(07)61695-X']}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'The history of the SUN Movement: Scaling Up Nutrition', 'authors': [], 'year': 2018, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF54': {'ref_id': 'b54', 'title': 'Nutrition Landscape Information System (NLIS) country profile indicators: interpretation guide. Geneva: WHO, 2012. 56. REACH. REACH Country Facilitator Manual', 'authors': [], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF55': {'ref_id': 'b55', 'title': 'Conflicts of interest and global health and nutrition governance: The illusion of robust principles', 'authors': [{'first': 'J', 'middle': [], 'last': 'Richter', 'suffix': ''}], 'year': 2015, 'venue': 'BMJ', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF56': {'ref_id': 'b56', 'title': \"Activists: Don't join SUN, a nutrition drive\", 'authors': [{'first': 'India', 'middle': [], 'last': 'Times Of', 'suffix': ''}], 'year': 2017, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF57': {'ref_id': 'b57', 'title': 'Nutrition and sustainability: an emerging food policy discourse', 'authors': [{'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Barling', 'suffix': ''}], 'year': 2013, 'venue': 'Proc Nutr Soc', 'volume': '72', 'issn': '', 'pages': '1--12', 'other_ids': {'DOI': ['10.1017/S002966511200290X']}}, 'BIBREF58': {'ref_id': 'b58', 'title': 'Nutrition: the new world disorder', 'authors': [{'first': 'G', 'middle': [], 'last': 'Cannon', 'suffix': ''}], 'year': 2002, 'venue': 'Asia Pac J Clin Nutr', 'volume': '11', 'issn': 's3', 'pages': '498--509', 'other_ids': {'DOI': ['10.1046/j.1440-6047.11.supp3.5.x']}}, 'BIBREF59': {'ref_id': 'b59', 'title': 'Feeding the world in the coming decades requires improvements in investment, technology and institutions', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martorell', 'suffix': ''}], 'year': 2002, 'venue': 'J Nutr', 'volume': '132', 'issn': '', 'pages': '3435--3441', 'other_ids': {'DOI': ['10.1093/jn/132.11.3435S']}}, 'BIBREF60': {'ref_id': 'b60', 'title': 'Primary health care: making Alma-Ata a reality', 'authors': [{'first': 'J', 'middle': [], 'last': 'Walley', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Lawn', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Tinker', 'suffix': ''}], 'year': 2008, 'venue': 'Lancet', 'volume': '372', 'issn': '', 'pages': '1001--1008', 'other_ids': {'DOI': ['10.1016/S0140-6736(08)61409-9']}}, 'BIBREF61': {'ref_id': 'b61', 'title': 'Ethical consequences for professionals from the globalization of food, nutrition and health', 'authors': [{'first': 'N', 'middle': ['W'], 'last': 'Solomons', 'suffix': ''}], 'year': 2002, 'venue': 'Asia Pac J Clin Nutr', 'volume': '11', 'issn': 's3', 'pages': '653--65', 'other_ids': {'DOI': ['10.1046/j.1440-6047.11.supp3.14.x']}}, 'BIBREF62': {'ref_id': 'b62', 'title': 'Three decades of the WHO code and marketing of infant formulas', 'authors': [{'first': 'S', 'middle': [], 'last': 'Forsyth', 'suffix': ''}], 'year': 2012, 'venue': 'Curr Opin Clin Nutr Metab Care', 'volume': '15', 'issn': '', 'pages': '273--280', 'other_ids': {'DOI': ['10.1097/MCO.0b013e32835204ad']}}, 'BIBREF63': {'ref_id': 'b63', 'title': 'Non-compliance with the International Code of Marketing of Breast Milk Substitutes is not confined to the infant formula industry', 'authors': [{'first': 'S', 'middle': [], 'last': 'Forsyth', 'suffix': ''}], 'year': 2013, 'venue': 'J Public Health', 'volume': '35', 'issn': '', 'pages': '185--90', 'other_ids': {'DOI': ['10.1093/pubmed/fds084']}}, 'BIBREF64': {'ref_id': 'b64', 'title': 'We are forgotten on earth\": international development targets, poverty, and gender in Ethiopia', 'authors': [{'first': 'Von', 'middle': [], 'last': 'Massow', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2000, 'venue': 'Gend Dev', 'volume': '8', 'issn': '', 'pages': '45--54', 'other_ids': {'DOI': ['10.1080/741923410']}}, 'BIBREF65': {'ref_id': 'b65', 'title': 'Nutrition getting the attention it deserves?', 'authors': [{'first': '', 'middle': [], 'last': 'Irin', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF66': {'ref_id': 'b66', 'title': 'GAIN gains NGO status from WHO after it severs big business ties (or does it?): NutraIngredients', 'authors': [{'first': 'S', 'middle': [], 'last': 'Starling', 'suffix': ''}], 'year': 2014, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF67': {'ref_id': 'b67', 'title': 'Role of government in public health: Current scenario in India and future scope', 'authors': [{'first': 'S', 'middle': [], 'last': 'Lakshminarayanan', 'suffix': ''}], 'year': 2011, 'venue': 'J Family Community Med', 'volume': '18', 'issn': '', 'pages': '26--30', 'other_ids': {'DOI': ['10.4103/1319-1683.78635']}}, 'BIBREF68': {'ref_id': 'b68', 'title': 'Flaws in Child Nutrition and Health Governance', 'authors': [{'first': 'A', 'middle': [], 'last': 'Gupta', 'suffix': ''}, {'first': 'N', 'middle': ['S'], 'last': 'Khaira', 'suffix': ''}], 'year': 2008, 'venue': 'Economic and Political Weekly', 'volume': '43', 'issn': '', 'pages': '17--21', 'other_ids': {}}, 'BIBREF69': {'ref_id': 'b69', 'title': 'Why India needs a national nutrition strategy', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}], 'year': 2011, 'venue': 'BMJ', 'volume': '343', 'issn': '', 'pages': '6687--6731', 'other_ids': {'DOI': ['10.1136/bmj.d6687']}}, 'BIBREF70': {'ref_id': 'b70', 'title': 'Health system challenges in organizing quality diabetes care for urban poor in South India', 'authors': [{'first': 'U', 'middle': [], 'last': 'Bhojani', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Devedasan', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Mishra', 'suffix': ''}], 'year': 2014, 'venue': 'PLoS One', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pone.0106522']}}, 'BIBREF71': {'ref_id': 'b71', 'title': \"Pakistan's maternal and child health policy: analysis, lessons and the way forward\", 'authors': [{'first': 'S', 'middle': [], 'last': 'Siddiqi', 'suffix': ''}, {'first': 'I', 'middle': ['U'], 'last': 'Haq', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Ghaffar', 'suffix': ''}], 'year': 2004, 'venue': 'Health Policy', 'volume': '69', 'issn': '', 'pages': '117--147', 'other_ids': {'DOI': ['10.1016/j.healthpol.2003.12.007']}}, 'BIBREF72': {'ref_id': 'b72', 'title': 'Food security and marine capture fisheries: characteristics, trends, drivers and future perspectives', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Garcia', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Rosenberg', 'suffix': ''}], 'year': 2010, 'venue': 'Philos Trans R Soc Lond B Biol Sci', 'volume': '365', 'issn': '', 'pages': '2869--80', 'other_ids': {'DOI': ['10.1098/rstb.2010.0171']}}, 'BIBREF73': {'ref_id': 'b73', 'title': 'Getting food policy on the Mayoral table: a comparison of two election cycles in New York and London', 'authors': [{'first': 'N', 'middle': [], 'last': 'Freudenberg', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Atkinson', 'suffix': ''}], 'year': 2015, 'venue': 'Public Health', 'volume': '129', 'issn': '', 'pages': '295--302', 'other_ids': {'DOI': ['10.1016/j.puhe.2015.02.018']}}, 'BIBREF74': {'ref_id': 'b74', 'title': 'The politics of success in the fight against malnutrition in Peru', 'authors': [{'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Food Policy', 'volume': '44', 'issn': '', 'pages': '26--35', 'other_ids': {'DOI': ['10.1016/j.foodpol.2013.10.009']}}, 'BIBREF75': {'ref_id': 'b75', 'title': 'Brazilian obesity prevention and control initiatives', 'authors': [{'first': 'P', 'middle': ['C'], 'last': 'Jaime', 'suffix': ''}, {'first': 'Acf', 'middle': [], 'last': 'Da Silva', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Gentil', 'suffix': ''}], 'year': 2013, 'venue': 'Obesity Reviews', 'volume': '14', 'issn': '2', 'pages': '88--95', 'other_ids': {'DOI': ['10.1111/obr.12101']}}, 'BIBREF76': {'ref_id': 'b76', 'title': 'Role of innovative institutional structures in integrated governance. A case study of integrating health and nutrition programs in Chhattisgarh', 'authors': [{'first': 'A', 'middle': [], 'last': 'Kalita', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mondal', 'suffix': ''}], 'year': 2012, 'venue': 'India. J Health Organ Manag', 'volume': '26', 'issn': '', 'pages': '758--77', 'other_ids': {'DOI': ['10.1108/14777261211277005']}}, 'BIBREF77': {'ref_id': 'b77', 'title': 'Perspectives for integration into the local health system of community-based management of acute malnutrition in children under 5 years: a qualitative study in Bangladesh', 'authors': [{'first': 'C', 'middle': ['E'], 'last': 'Kouam', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Delisle', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Ebbing', 'suffix': ''}], 'year': 2014, 'venue': 'Nutr J', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1475-2891-13-22']}}, 'BIBREF78': {'ref_id': 'b78', 'title': 'Scaling up nutrition in fragile and conflict-affected states: The pivotal role of governance', 'authors': [{'first': 'Saj', 'middle': [], 'last': 'Taylor', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Perez-Ferrer', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Griffiths', 'suffix': ''}], 'year': 2015, 'venue': 'Soc Sci Med', 'volume': '126', 'issn': '', 'pages': '119--146', 'other_ids': {'DOI': ['10.1016/j.socscimed.2014.12.016']}}, 'BIBREF79': {'ref_id': 'b79', 'title': 'Tackling the drivers of child undernutrition in developing countries: what works and how should interventions be designed?', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pridmore', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Carr-Hill', 'suffix': ''}], 'year': 2011, 'venue': 'Public Health Nutr', 'volume': '14', 'issn': '', 'pages': '688--93', 'other_ids': {'DOI': ['10.1017/S1368980010001795']}}, 'BIBREF80': {'ref_id': 'b80', 'title': 'Drinking water quality governance: A comparative case study of Brazil, Ecuador, and Malawi', 'authors': [{'first': 'G', 'middle': ['L'], 'last': 'Kayser', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Amjad', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Dalcanale', 'suffix': ''}], 'year': 2015, 'venue': 'Environ Sci Policy', 'volume': '48', 'issn': '', 'pages': '186--95', 'other_ids': {'DOI': ['10.1016/j.envsci.2014.12.019']}}, 'BIBREF81': {'ref_id': 'b81', 'title': 'Utilisation of wartime nutrition survival experiences', 'authors': [{'first': 'T', 'middle': [], 'last': 'Giay', 'suffix': ''}], 'year': 1998, 'venue': 'Asia Pacific journal of clinical nutrition', 'volume': '7', 'issn': '', 'pages': '311--314', 'other_ids': {}}, 'BIBREF82': {'ref_id': 'b82', 'title': 'Lessons from collaborative governance and sociobiology theories for reinforcing sustained cooperation: a government food security case study', 'authors': [{'first': 'L', 'middle': ['A'], 'last': 'Montoya', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Montoya', 'suffix': ''}, {'first': 'Sánchez', 'middle': [], 'last': 'González', 'suffix': ''}, {'first': 'O', 'middle': ['D'], 'last': '', 'suffix': ''}], 'year': 2015, 'venue': 'Public Health', 'volume': '129', 'issn': '', 'pages': '916--947', 'other_ids': {'DOI': ['10.1016/j.puhe.2015.01.030']}}, 'BIBREF83': {'ref_id': 'b83', 'title': \"A stakeholder analysis of the perceived outcomes of developing and implementing England's obesity strategy\", 'authors': [{'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'A', 'middle': ['L'], 'last': 'Ahern', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Jebb', 'suffix': ''}], 'year': 2008, 'venue': 'BMC Public Health', 'volume': '14', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1471-2458-14-441']}}, 'BIBREF84': {'ref_id': 'b84', 'title': 'Community-based interventions for obesity prevention: lessons learned by Australian policy-makers', 'authors': [{'first': 'M', 'middle': ['M'], 'last': 'Haby', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Doherty', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Welch', 'suffix': ''}], 'year': 2012, 'venue': 'BMC Res Notes', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1756-0500-5-20']}}, 'BIBREF85': {'ref_id': 'b85', 'title': 'Good governance for nutrition in the Philippines: elements, experiences, and lessons learned', 'authors': [{'first': 'F', 'middle': ['S'], 'last': 'Solon', 'suffix': ''}], 'year': 2006, 'venue': 'Food Nutr Bull', 'volume': '27', 'issn': '', 'pages': '343--52', 'other_ids': {'DOI': ['10.1177/156482650602700409']}}, 'BIBREF86': {'ref_id': 'b86', 'title': 'Précis of nutrition of children and women in Haiti: analyses of data from', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Ayoya', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Heidkamp', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Ngnie-Teta', 'suffix': ''}], 'year': 1995, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF88': {'ref_id': 'b88', 'title': 'Governing childhood obesity: framing regulation of fast food advertising in the Australian print media', 'authors': [{'first': 'J', 'middle': [], 'last': 'Henderson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Coveney', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Ward', 'suffix': ''}], 'year': 2009, 'venue': 'Soc Sci Med', 'volume': '69', 'issn': '', 'pages': '1402--1410', 'other_ids': {'DOI': ['10.1016/j.socscimed.2009.08.025']}}, 'BIBREF89': {'ref_id': 'b89', 'title': 'Farmers are the most trusted part of the Australian food chain: results from a national survey of consumers', 'authors': [{'first': 'J', 'middle': [], 'last': 'Henderson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Coveney', 'suffix': ''}, {'first': 'P', 'middle': ['R'], 'last': 'Ward', 'suffix': ''}], 'year': 2011, 'venue': 'Aust N Z J Public Health', 'volume': '35', 'issn': '', 'pages': '319--343', 'other_ids': {'DOI': ['10.1111/j.1753-6405.2011.00725.x']}}, 'BIBREF90': {'ref_id': 'b90', 'title': 'The Danish tax on saturated fat: why it did not survive', 'authors': [{'first': 'S', 'middle': [], 'last': 'Vallgårda', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Holm', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Jensen', 'suffix': ''}], 'year': 2015, 'venue': 'Eur J Clin Nutr', 'volume': '69', 'issn': '', 'pages': '223--229', 'other_ids': {'DOI': ['10.1038/ejcn.2014.224']}}, 'BIBREF91': {'ref_id': 'b91', 'title': 'A systematic review of health system barriers and enablers for antiretroviral therapy (ART) for HIV-infected pregnant and postpartum women', 'authors': [{'first': 'C', 'middle': ['J'], 'last': 'Colvin', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Konopka', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Chalker', 'suffix': ''}], 'year': 2014, 'venue': 'PLoS One', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pone.0108150']}}, 'BIBREF92': {'ref_id': 'b92', 'title': 'The role of health systems and policy in producing behavior and social change to enhance child survival and development in low-and middle-income countries: an examination of the evidence', 'authors': [{'first': 'L', 'middle': ['F'], 'last': 'Vélez', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sanitato', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Barry', 'suffix': ''}], 'year': 2014, 'venue': 'J Health Commun', 'volume': '19', 'issn': '', 'pages': '89--121', 'other_ids': {'DOI': ['10.1080/10810730.2014.939313']}}, 'BIBREF93': {'ref_id': 'b93', 'title': 'Agriculture for improved nutrition: the current research landscape', 'authors': [{'first': 'R', 'middle': [], 'last': 'Turner', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Jeff', 'suffix': ''}], 'year': 2013, 'venue': 'Food Nutr Bull', 'volume': '34', 'issn': '', 'pages': '369--77', 'other_ids': {'DOI': ['10.1177/156482651303400401']}}, 'BIBREF94': {'ref_id': 'b94', 'title': 'Food Policy for Developing Countries: The Role of Government in Global, National, and Local Food Systems. 1 den', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pinstrup-Andersen', 'suffix': ''}, {'first': 'D', 'middle': ['D'], 'last': 'Watson', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ii', 'suffix': ''}], 'year': 2011, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF95': {'ref_id': 'b95', 'title': 'Standing Committee on Nutrition Mandate', 'authors': [{'first': '', 'middle': [], 'last': 'Unscn', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Un', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF96': {'ref_id': 'b96', 'title': 'Maternal and Child Nutrition Study Group. The politics of reducing malnutrition: building commitment and accelerating progress', 'authors': [{'first': 'S', 'middle': [], 'last': 'Gillespie', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Mannar', 'suffix': ''}], 'year': 2013, 'venue': 'Lancet', 'volume': '382', 'issn': '', 'pages': '552--69', 'other_ids': {'DOI': ['10.1016/S0140-6736(13)60842-9']}}, 'BIBREF97': {'ref_id': 'b97', 'title': 'Global nutrition: What should change?', 'authors': [{'first': 'A', 'middle': [], 'last': 'Müller', 'suffix': ''}, {'first': 'D', 'middle': ['C'], 'last': 'Coitinho', 'suffix': ''}], 'year': 2011, 'venue': 'Food Nutr Bull', 'volume': '32', 'issn': '2', 'pages': '56--64', 'other_ids': {'DOI': ['10.1177/15648265110322S202']}}, 'BIBREF98': {'ref_id': 'b98', 'title': 'Recent Shifts in Global Governance: Implications for the Response to Non-communicable Diseases', 'authors': [{'first': 'D', 'middle': [], 'last': 'Sridhar', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Brolan', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Durrani', 'suffix': ''}], 'year': 2013, 'venue': 'PLoS Med', 'volume': '10', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pmed.1001487']}}, 'BIBREF99': {'ref_id': 'b99', 'title': 'Reducing Child Undernutrition: Past Drivers and Priorities for the Post-MDG Era', 'authors': [{'first': 'L', 'middle': ['C'], 'last': 'Smith', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}], 'year': 2015, 'venue': 'World Dev', 'volume': '68', 'issn': '', 'pages': '180--204', 'other_ids': {'DOI': ['10.1016/j.worlddev.2014.11.014']}}, 'BIBREF100': {'ref_id': 'b100', 'title': 'Responseoriented measuring inequalities in Tehran: second round of UrbanHealth Equity Assessment and Response Tool (Urban HEART-2), concepts and framework', 'authors': [{'first': 'M', 'middle': [], 'last': 'Asadi-Lari', 'suffix': ''}, {'first': 'M', 'middle': ['R'], 'last': 'Vaez-Mahdavi', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Faghihzadeh', 'suffix': ''}], 'year': 2013, 'venue': 'Med J Islam Repub Iran', 'volume': '27', 'issn': '', 'pages': '236--284', 'other_ids': {}}, 'BIBREF101': {'ref_id': 'b101', 'title': 'Agriculture, health, and wealth convergence: bridging traditional food systems and modern agribusiness solutions', 'authors': [{'first': 'L', 'middle': [], 'last': 'Dube', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Webb', 'suffix': ''}, {'first': 'N', 'middle': ['K'], 'last': 'Arora', 'suffix': ''}], 'year': 2014, 'venue': 'Ann N Y Acad Sci', 'volume': '1331', 'issn': '', 'pages': '1--14', 'other_ids': {'DOI': ['10.1111/nyas.12602']}}, 'BIBREF102': {'ref_id': 'b102', 'title': 'Food security in the Asia-Pacific: Malthus, limits and environmental challenges', 'authors': [{'first': 'C', 'middle': ['D'], 'last': 'Butler', 'suffix': ''}], 'year': 2009, 'venue': 'Asia Pac J Clin Nutr', 'volume': '18', 'issn': '', 'pages': '577--84', 'other_ids': {}}, 'BIBREF103': {'ref_id': 'b103', 'title': 'Can experience-based household food security scales help improve food security governance?', 'authors': [{'first': 'R', 'middle': [], 'last': 'Pérez-Escamilla', 'suffix': ''}], 'year': 2012, 'venue': 'Glob Food Sec', 'volume': '1', 'issn': '', 'pages': '120--125', 'other_ids': {'DOI': ['10.1016/j.gfs.2012.10.006']}}, 'BIBREF104': {'ref_id': 'b104', 'title': 'Fighting maternal and child malnutrition: analysing the political and institutional determinants of delivering a national multisectoral response in six countries', 'authors': [{'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Fanzo', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF105': {'ref_id': 'b105', 'title': 'Accelerating reductions in undernutrition: what can nutrition governance tell us', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Fanzo', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF106': {'ref_id': 'b106', 'title': 'Food and Globalization', 'authors': [{'first': 'L', 'middle': [], 'last': 'Phillips', 'suffix': ''}], 'year': 2006, 'venue': 'Annual Review of Anthropology', 'volume': '35', 'issn': '', 'pages': '37--57', 'other_ids': {'DOI': ['10.1146/annurev.anthro.35.081705.123214']}}, 'BIBREF107': {'ref_id': 'b107', 'title': 'An accountability framework to promote healthy food environments', 'authors': [{'first': 'V', 'middle': ['I'], 'last': 'Kraak', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Swinburn', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Lawrence', 'suffix': ''}], 'year': 2014, 'venue': 'Public Health Nutr', 'volume': '17', 'issn': '', 'pages': '2467--83', 'other_ids': {'DOI': ['10.1017/S1368980014000093']}}, 'BIBREF108': {'ref_id': 'b108', 'title': 'A systematic policy approach to changing the food system and physical activity environments to prevent obesity', 'authors': [{'first': 'G', 'middle': [], 'last': 'Sacks', 'suffix': ''}, {'first': 'B', 'middle': ['A'], 'last': 'Swinburn', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Lawrence', 'suffix': ''}], 'year': 2008, 'venue': 'Aust New Zealand Health Policy', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1743-8462-5-13']}}, 'BIBREF109': {'ref_id': 'b109', 'title': 'Global health promotion: how can we strengthen governance and build effective strategies?', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2006, 'venue': 'Health Promot Int', 'volume': '21', 'issn': 'suppl_1', 'pages': '42--50', 'other_ids': {'DOI': ['10.1093/heapro/dal050']}}, 'BIBREF110': {'ref_id': 'b110', 'title': 'The multiple meanings of global health governance: a call for conceptual clarity', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kamradt-Scott', 'suffix': ''}], 'year': 2014, 'venue': 'Global Health', 'volume': '10', 'issn': '', 'pages': '28--38', 'other_ids': {'DOI': ['10.1186/1744-8603-10-28']}}, 'BIBREF111': {'ref_id': 'b111', 'title': 'The nutrition transition in high-and low-income countries: what are the policy lessons?', 'authors': [{'first': 'B', 'middle': [], 'last': 'Popkin', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Ng', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Sw', 'suffix': ''}], 'year': 2007, 'venue': 'Agricultural Economics', 'volume': '37', 'issn': '', 'pages': '199--211', 'other_ids': {'DOI': ['10.1111/j.1574-0862.2007.00245.x']}}, 'BIBREF112': {'ref_id': 'b112', 'title': 'Politics: Who Gets What, When, How', 'authors': [{'first': 'H', 'middle': ['D'], 'last': 'Lasswell', 'suffix': ''}], 'year': 1936, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF114': {'ref_id': 'b114', 'title': 'Two Treatises of Government. London: Awnsham Churchill, 1690', 'authors': [{'first': 'J', 'middle': [], 'last': 'Locke', 'suffix': ''}], 'year': None, 'venue': 'BMJ Global Health', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF115': {'ref_id': 'b115', 'title': 'International Covenant on Economic, Social and Cultural Rights', 'authors': [], 'year': 1966, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': \"Search conducted 3 May 2015. Search detail: ('nutritional status' (MeSH Terms) OR ('nutritional' (All Fields) AND 'status'(All Fields)) OR 'nutritional status' (All Fields) OR 'nutrition' (All Fields) OR 'nutritional sciences' (MeSH Terms) OR ('nutritional' (All Fields) AND 'sciences' (All Fields)) OR 'nutritional sciences' (All Fields)) AND ('Governance (Oxf)' (Journal) OR 'governance' (All Fields)). ii These included: Mejía Acosta et al 105 ; Gillespie et al 97 ; Haddad et al 106 ;. Sunguya et al.8\", 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'data sharing statement No additional data are available.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Nutrition governance literature search strategy and results by source', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': \"the need for international legal standards iii Data obtained 18 March 2016 from World Bank's 'Projects and Operations' website: http://www.worldbank.org/projects/ search?lang=en&searchTerm=&mjthemecode_exact=2\", 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'Sample nutrition governance problems at national and global levels', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n"
     ]
    }
   ],
   "source": [
    "# query the text index field created on the body_text field\n",
    "\n",
    "for c in db.pmc_content.find({'$text':{'$search':'Ebola'}}):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
